Citrus Sinensis ID: 039736
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9L5 | 792 | Wall-associated receptor | yes | no | 0.548 | 0.438 | 0.566 | 1e-115 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.582 | 0.505 | 0.554 | 1e-114 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.592 | 0.501 | 0.532 | 1e-114 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.600 | 0.499 | 0.503 | 1e-112 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.612 | 0.529 | 0.501 | 1e-112 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.614 | 0.527 | 0.487 | 1e-111 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.556 | 0.446 | 0.558 | 1e-111 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.548 | 0.462 | 0.548 | 1e-111 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.593 | 0.488 | 0.508 | 1e-110 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.540 | 0.468 | 0.563 | 1e-109 |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 414 bits (1065), Expect = e-115, Method: Compositional matrix adjust.
Identities = 205/362 (56%), Positives = 271/362 (74%), Gaps = 15/362 (4%)
Query: 265 LGLGIGLGFLSLV-LLGCYL-YKVIREKRSRMLKEKLFKQNGGYLLQQRL-SSCGSSEKA 321
L +G+G F SL+ ++G YL YK I+++R K+K FK+NGG LLQQ+L S+ G EK
Sbjct: 373 LAIGLGASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKT 432
Query: 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEV 381
+F++ EL++AT+N++ +R LGQGG GTVYKGML DG IVAVK+S+ +D+ ++E+FINEV
Sbjct: 433 IVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEV 492
Query: 382 VILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
VILSQINHR+IVKLLGCCLET+VPVLVYE+I NG L H+HD E E
Sbjct: 493 VILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHD------------EFDENI 540
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+W R+R+A ++AGA++Y+HS+AS PI+HRD+KS+NI+LD+K+ AKVSDFGTSR+V
Sbjct: 541 MATWNIRLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTV 600
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
D THLTT V GT GY DPEYFQSSQ+TDKSDVYSFGVVL+EL+TG+K I R +E R L
Sbjct: 601 DHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTL 660
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621
YFI KENKL +I+DAR+ + A A++A CL L +KRP+M++VSM+L+
Sbjct: 661 ATYFILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDS 720
Query: 622 LR 623
+R
Sbjct: 721 IR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 213/384 (55%), Positives = 285/384 (74%), Gaps = 15/384 (3%)
Query: 250 CKPDGK-KFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLL 308
C+P+ K P K L G+ IGL L + +L+K+I+++R+ +K FK+NGG LL
Sbjct: 341 CRPNPKITKPTKPPVLQGILIGLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLL 400
Query: 309 QQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSR 367
+Q+L++ G+ E +KIF+++EL++ATDN++ R LGQGG GTVYKGML DGSIVAVKRS+
Sbjct: 401 KQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSK 460
Query: 368 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQ 427
+D+ ++E+FINE+V+LSQINHR+IVKLLGCCLETEVP+LVYEYI NG L +HD
Sbjct: 461 VVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHD---- 516
Query: 428 QEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487
E + +++WE R+R+A E+AGA+ YMHSAAS PIFHRDIK++NILLD+K+
Sbjct: 517 ---------ESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYR 567
Query: 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
AKVSDFGTSRSV D+THLTT V GTFGY DPEYF SSQYT KSDVYSFGVVL+EL+TG+
Sbjct: 568 AKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGE 627
Query: 548 KPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSK 607
KP+ R EE R L +F+ KEN++++I+D R+ E++ E + AVA+LA CL K
Sbjct: 628 KPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGK 687
Query: 608 KRPTMKQVSMDLEGLRRSQRCVEI 631
RP MK+VS +LE +R S +++
Sbjct: 688 NRPNMKEVSNELERIRSSPEDLDV 711
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 211/396 (53%), Positives = 288/396 (72%), Gaps = 21/396 (5%)
Query: 234 QCKNGFLVDGILKGLHCKPDGKKFPVKLVTLL-GLGIGLGFLSLVLLGCY-LYKVIREKR 291
QCK+ V+ + C+P K P +L ++ G+ IG L L G + LYK ++++R
Sbjct: 316 QCKDQSCVN-LPGWFDCQP---KKPEQLKRVIQGVLIGSALL-LFAFGIFGLYKFVQKRR 370
Query: 292 SRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTV 350
+ K F++NGG LL+Q+L+ G+ E ++IF++ EL++ATDN+N++R LGQGG GTV
Sbjct: 371 KLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTV 430
Query: 351 YKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410
YKGML DG IVAVKRS+A+D+ ++E+FINEVV+L+QINHR+IVKLLGCCLETEVPVLVYE
Sbjct: 431 YKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYE 490
Query: 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPI 470
++ NG L +HD E + +++WE R+ +A E+AGA++Y+HSAAS PI
Sbjct: 491 FVPNGDLCKRLHD-------------ESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPI 537
Query: 471 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDK 530
+HRDIK++NILLD++ AKVSDFGTSRSV D+THLTT V GTFGY DPEYFQSS++T+K
Sbjct: 538 YHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEK 597
Query: 531 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREED 590
SDVYSFGVVL+ELLTG+KP R EE R L A+F+ KEN++L+I+D R+ E +
Sbjct: 598 SDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQ 657
Query: 591 IEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
+ +VA LA CL KKRP M++VS++LE +R S
Sbjct: 658 VMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-112, Method: Compositional matrix adjust.
Identities = 208/413 (50%), Positives = 280/413 (67%), Gaps = 33/413 (7%)
Query: 220 KSESCSANPEKFFCQCKNGFLVDGILKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLL 279
K +SC P F C+ K + + +G+ +G L + +
Sbjct: 326 KDQSCVNKPGWFTCEPKKPGQIKPVFQGVL-----------------IGSALLLFAFGIF 368
Query: 280 GCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQ 338
G LYK I+++R F++NGG LL+Q+L+ G+ E +KIF++ EL++ATDN+N
Sbjct: 369 G--LYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNT 426
Query: 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+R LGQGG GTVYKGML DG IVAVKRS+A+D+ ++E+FINEVV+L+QINHR+IVKLLGC
Sbjct: 427 NRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGC 486
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
CLETEVPVLVYE++ NG L + D E + ++WE R+ +A E+AGA
Sbjct: 487 CLETEVPVLVYEFVPNGDLCKRLRD-------------ECDDYIMTWEVRLHIAIEIAGA 533
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
++Y+HSAAS PI+HRDIK++NILLD+K+ KVSDFGTSRSV D+THLTT V GTFGY D
Sbjct: 534 LSYLHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVD 593
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 578
PEYFQSS++TDKSDVYSFGVVL+EL+TGK P + EE R A+F++ KEN+ L+I+
Sbjct: 594 PEYFQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIV 653
Query: 579 DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
D R+ E + + AVA+LA CL KKRP M++VS++LE +R S EI
Sbjct: 654 DERIKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSEI 706
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 404 bits (1039), Expect = e-112, Method: Compositional matrix adjust.
Identities = 203/405 (50%), Positives = 282/405 (69%), Gaps = 17/405 (4%)
Query: 221 SESCSANPEKFFCQCKNGFLVDGILKGLHCKPDGKKFPVKL-VTLLGLGIGLGFLSLVLL 279
+ +C F CQC +G D + C K+ P L T + LG +GFL ++L
Sbjct: 293 TSTCENTLGSFHCQCPSG--SDLNTTTMSCIDTPKEEPKYLGWTTVLLGTTIGFLIILLT 350
Query: 280 GCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEELQRATDNYNQ 338
Y+ + +R +++ L+++ F+QNGG +L QRLS G S KIFT E ++ ATD YN+
Sbjct: 351 ISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNE 410
Query: 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
SR LGQGG GTVYKG+L D SIVA+K++R D++Q+EQFINEV++LSQINHR++VKLLGC
Sbjct: 411 SRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGC 470
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
CLETEVP+LVYE+IS+GTL H+H SSL+WE+R+R+A EVAG
Sbjct: 471 CLETEVPLLVYEFISSGTLFDHLHGSMFD-------------SSLTWEHRLRIAIEVAGT 517
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+AY+HS ASIPI HRD+K++NILLD+ +AKV+DFG SR +P D+ LTT VQGT GY D
Sbjct: 518 LAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLD 577
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 578
PEY+ + +KSDVYSFGVVL+ELL+G+K +C R + ++LV+YF+S KEN+L EI+
Sbjct: 578 PEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEII 637
Query: 579 DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
D +V E + +I+ A +A+ C R+ ++RP+MK+V+ +LE LR
Sbjct: 638 DGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 403 bits (1035), Expect = e-111, Method: Compositional matrix adjust.
Identities = 202/414 (48%), Positives = 284/414 (68%), Gaps = 25/414 (6%)
Query: 218 PLKSESCSANPE------KFFCQCKNGFLVDGILKGLHCKPDGKKFPVKLVTLLGLGIGL 271
P+ +CS + F C C++ + ++ CKP G V+ T++ LG +
Sbjct: 288 PIHKHNCSGDSTCENKLGHFRCNCRSRYELNTTTN--TCKPKGNPEYVEWTTIV-LGTTI 344
Query: 272 GFLSLVL-LGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEEL 329
GFL ++L + C +K ++ + L+++ F+QNGG +L QRLS G S KIFT E +
Sbjct: 345 GFLVILLAISCIEHK-MKNTKDTELRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGM 403
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH 389
+ ATD Y+++R LGQGG GTVYKG+LPD SIVA+K++R D +Q+EQFINEV++LSQINH
Sbjct: 404 KEATDGYDENRILGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINH 463
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
R++VKLLGCCLETEVP+LVYE+IS+GTL H+H SSL+WE+R+
Sbjct: 464 RNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFD-------------SSLTWEHRL 510
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
R+A E+AG +AY+HS+ASIPI HRDIK++NILLD+ +AKV+DFG SR +P DK L T
Sbjct: 511 RMAVEIAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATM 570
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
VQGT GY DPEY+ + +KSDVYSFGVVL+ELL+G+K +C R + +++V+YF S
Sbjct: 571 VQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASAT 630
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
KEN+L EI+D +V E + +I+ A +A+ C RL ++RP MK+V+ +LE LR
Sbjct: 631 KENRLHEIIDGQVMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 402 bits (1034), Expect = e-111, Method: Compositional matrix adjust.
Identities = 205/367 (55%), Positives = 267/367 (72%), Gaps = 15/367 (4%)
Query: 262 VTLLGLGIGLGFLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEK 320
VT++G+G G L LV+ +L K ++++R K K FK+NGG LLQQ+L++ G+ EK
Sbjct: 376 VTMIGVGSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEK 435
Query: 321 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINE 380
+IF++ EL++ATDN+++SR LGQGG GTVYKGML DG VAVK+S+ +D+ ++E+FINE
Sbjct: 436 TRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINE 495
Query: 381 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440
VVILSQINHRH+VKLLGCCLETEVP LVYE+I NG L HIH EE +
Sbjct: 496 VVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIH-------------EESDD 542
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500
+ +W R+R+A ++AGA++Y+HSAAS PI+HRDIKS+NILLD+K+ KVSDFGTSRSV
Sbjct: 543 YTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVT 602
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEER 559
D TH TT + GT GY DPEY+ SSQYTDKSDVYSFGVVL+EL+TG+KP I ++ +E R
Sbjct: 603 IDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIR 662
Query: 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
L +F KEN+ EI+DAR+ + E + AVA LA CL KKRP M++V DL
Sbjct: 663 GLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDL 722
Query: 620 EGLRRSQ 626
E + SQ
Sbjct: 723 EKILASQ 729
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 198/361 (54%), Positives = 275/361 (76%), Gaps = 14/361 (3%)
Query: 266 GLGIGLGFLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSS-EKAKIF 324
GL +G L LVL L K ++++R + K FK+NGG LL+Q+L++ G + + +KIF
Sbjct: 350 GLVLGFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIF 409
Query: 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVIL 384
+++EL++ATDN+N +R LGQGG GTVYKGML DG IVAVKRS+ +D+ ++E+FINEV +L
Sbjct: 410 SSKELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVL 469
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
SQINHR+IVKL+GCCLETEVP+LVYE+I NG L +H + + +++
Sbjct: 470 SQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLH-------------HDSDDYTMT 516
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
W+ R+R++ E+AGA+AY+HSAAS P++HRD+K++NILLD+K+ AKVSDFGTSRS+ D+T
Sbjct: 517 WDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQT 576
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
HLTT V GTFGY DPEYFQ+SQ+TDKSDVYSFGVVL+EL+TG+KP + R EE R LV++
Sbjct: 577 HLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSH 636
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
F K+N++L+I+D+R+ + E + AVA+LA CL L KKRP M++VS++LE +R
Sbjct: 637 FNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
Query: 625 S 625
S
Sbjct: 697 S 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 398 bits (1022), Expect = e-110, Method: Compositional matrix adjust.
Identities = 213/419 (50%), Positives = 286/419 (68%), Gaps = 43/419 (10%)
Query: 233 CQCKNGFLVDGILKGLHCKP--------DGKKFPV----KLVTLLG-------------L 267
C C +GF + + G CK DG PV K V LLG +
Sbjct: 305 CSCASGFEGNPYIPG-ECKDINECVRGIDGN--PVCTAGKCVNLLGGYTCEYTNHRPLVI 361
Query: 268 GIGLGFLSLVLLGC--YLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIF 324
G+ F +LV +G +LYK IR +R K+K FK+NGG LLQQ+L++ G+ + ++F
Sbjct: 362 GLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVF 421
Query: 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVIL 384
+ EL++AT+N++ +R LG+GG GTVYKGML DG IVAVK+S+ +D+ ++E+FINEVVIL
Sbjct: 422 NSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVIL 481
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
SQINHR+IVKLLGCCLET+VP+LVYE+I NG L H+HD + + + +
Sbjct: 482 SQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHD------------DSDDYTMTT 529
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
WE R+R+A ++AGA++Y+HSAAS PI+HRDIKS+NI+LD+K AKVSDFGTSR+V D T
Sbjct: 530 WEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHT 589
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
HLTT V GT GY DPEYFQSSQ+TDKSDVYSFGVVL EL+TG+K + R +E R L Y
Sbjct: 590 HLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATY 649
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
F KEN+L +I+DAR+ + + A A++A CL + +KRP+M+QVSM+LE +R
Sbjct: 650 FTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-109, Method: Compositional matrix adjust.
Identities = 203/360 (56%), Positives = 268/360 (74%), Gaps = 18/360 (5%)
Query: 273 FLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQR 331
F + + G LYK IR++R + K FK+NGG LL+Q+L++ GS E +KIF++ EL++
Sbjct: 366 FFVIGIFG--LYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEK 423
Query: 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
ATDN++ R LGQGG GTVYK ML DGSIVAVKRS+ +D+ ++E+FINE+V+LSQINHR+
Sbjct: 424 ATDNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRN 483
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IVKLLGCCLETEVP+LVYEYI NG L +HD E + ++WE R+R+
Sbjct: 484 IVKLLGCCLETEVPILVYEYIPNGDLFKRLHD-------------EYDDYMMTWEVRLRI 530
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+AGA++YMHSAAS PIFHRDIK++NILLD+K+ AK+SDFGTSRSV D+THLTT V
Sbjct: 531 AVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVA 590
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571
GTFGY DPEYF SSQYT KSDVYSFGVVL+EL+TG+KP+ R EE L YF+ KE
Sbjct: 591 GTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKE 650
Query: 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
N+ ++I+D R+ E+++ + AVA+LA CL KRP M++VS+ LE +R S + +++
Sbjct: 651 NRAVDIIDIRIKDESKQ--VMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSSPKDLDV 708
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | ||||||
| 356531931 | 666 | PREDICTED: wall-associated receptor kina | 0.958 | 0.911 | 0.602 | 0.0 | |
| 87162779 | 684 | Protein kinase; Peptidoglycan-binding Ly | 0.946 | 0.875 | 0.598 | 0.0 | |
| 357507639 | 776 | Wall-associated receptor kinase-like pro | 0.946 | 0.771 | 0.598 | 0.0 | |
| 356566933 | 667 | PREDICTED: wall-associated receptor kina | 0.949 | 0.901 | 0.600 | 0.0 | |
| 290490602 | 678 | LysM type receptor kinase [Lotus japonic | 0.969 | 0.905 | 0.588 | 0.0 | |
| 290490588 | 678 | LysM type receptor kinase [Lotus japonic | 0.969 | 0.905 | 0.587 | 0.0 | |
| 357507635 | 679 | Wall-associated receptor kinase-like pro | 0.965 | 0.899 | 0.567 | 0.0 | |
| 255547606 | 594 | kinase, putative [Ricinus communis] gi|2 | 0.845 | 0.900 | 0.599 | 0.0 | |
| 255547604 | 541 | conserved hypothetical protein [Ricinus | 0.783 | 0.916 | 0.563 | 0.0 | |
| 290490590 | 486 | LysM type receptor kinase [Lotus japonic | 0.706 | 0.919 | 0.562 | 1e-151 |
| >gi|356531931|ref|XP_003534529.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2015), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/652 (60%), Positives = 481/652 (73%), Gaps = 45/652 (6%)
Query: 6 LYTYLSIL--LMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSF 63
L+ L IL +++LC F H L+ CQQ YL +C+ + S+ KGYLCNG Q C SF
Sbjct: 3 LFHNLKILSTILLLCMFPHSLK---CQQAYLNGTVYDCSDNPSVPKGYLCNGLQKSCTSF 59
Query: 64 ITFRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHN 106
+ FRS+PPYD+P IAYLLGSEAS KS+IVPV CSCSG++YQHN
Sbjct: 60 LLFRSKPPYDSPEKIAYLLGSEASTIASINMISRNDKIPSNKSIIVPVFCSCSGNIYQHN 119
Query: 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTE 166
PYT NDTY+ + T+QGLTTCQA++G+NYY N+ G ELTVP CAC T NQT
Sbjct: 120 TPYTASKNDTYYELVKETFQGLTTCQAMMGRNYYAPVNIVIGAELTVPKLCACPTENQTA 179
Query: 167 NGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDA------IRVFTPLLIPLK 220
G+T LL Y+ GD + IG +GVD QS+++AN L + + TP+L+PL
Sbjct: 180 RGITSLLVYLVNYGDTIKSIGRAYGVDEQSVLEANKLAEPQSSNRSMDLFALTPILVPLI 239
Query: 221 SESCSANPEKFFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLL 279
+SC NP+KF+C+C DGILKG C + DG+KFP KLV LG+GIG GFL L LL
Sbjct: 240 GKSCKENPDKFYCRCYQA--PDGILKGPFCGESDGQKFPAKLVAGLGVGIGAGFLCLFLL 297
Query: 280 GCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQS 339
G Y+ I++KR +LKEKLF+QNGGYLLQ++LS G+ E AK+FTAEELQRATDNYN+S
Sbjct: 298 GYKSYQYIQKKRESILKEKLFRQNGGYLLQEKLSY-GNGEMAKLFTAEELQRATDNYNRS 356
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
RFLGQGG+GTVYKGMLPDG+IVAVK+S+ I++ QI+ F+NEVVILSQINHR+IVKLLGCC
Sbjct: 357 RFLGQGGYGTVYKGMLPDGTIVAVKKSKEIERNQIKTFVNEVVILSQINHRNIVKLLGCC 416
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
LETE P+LVYE+I N TLSHHIH + SLSW +R+R+ACEVAGAV
Sbjct: 417 LETETPILVYEFIPNETLSHHIHRRDNE-------------PSLSWVSRLRIACEVAGAV 463
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
YMH +ASIPIFHRDIK +NILLD +SAKVSDFGTSRSVP DKTHLTTAV GTFGY DP
Sbjct: 464 TYMHFSASIPIFHRDIKPTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYIDP 523
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILD 579
EYFQSSQ++DKSDVYSFGVVL+EL+TG+KPI E+E +NLVA FISL K+N++ EI D
Sbjct: 524 EYFQSSQFSDKSDVYSFGVVLVELITGRKPISFLYEDEGQNLVAQFISLMKKNQVSEIFD 583
Query: 580 ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
ARV K+AR++DI AVA LAM CLRLN KKRPTMK+VS +LE LR++Q +++
Sbjct: 584 ARVLKDARKDDILAVANLAMRCLRLNGKKRPTMKEVSAELEALRKAQSSLQM 635
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|87162779|gb|ABD28574.1| Protein kinase; Peptidoglycan-binding LysM [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 778 bits (2010), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/640 (59%), Positives = 468/640 (73%), Gaps = 41/640 (6%)
Query: 13 LLMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFITFRSEPPY 72
L ++LC + + CQQ L +C+ + S KGYLCN PQN C SF+TFRS+P Y
Sbjct: 25 LYILLCMLPYSIN---CQQILLNTTVTDCSGTPSAPKGYLCNSPQNSCNSFLTFRSKPSY 81
Query: 73 DTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNAPYTTKPND 115
D P SIAYLLGSEAS K++IVP+ CSCSG++YQHN PYT + D
Sbjct: 82 DNPTSIAYLLGSEASTIASINNISRNEKLPTNKTIIVPILCSCSGNIYQHNTPYTVQKGD 141
Query: 116 TYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAY 175
TYF + N TYQ LTTCQAL GQNYY +N+ G E+TVP+ CAC T Q G+T LL Y
Sbjct: 142 TYFHLVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKGITSLLVY 201
Query: 176 MAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRV----FTPLLIPLKSESCSANPEKF 231
+ G+ + IG +GVD QSI++AN L + V TP+L+PL+ +SC +P+ F
Sbjct: 202 IVNYGETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSCKEDPDSF 261
Query: 232 FCQCKNGFLVDGILKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIREKR 291
+C C G L DG H G+KFP KLV LG+GIG GFL L LL LY+ I++KR
Sbjct: 262 YCTCSQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLYQYIKKKR 317
Query: 292 SRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVY 351
+ + KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATD+YNQSRFLGQGG+GTVY
Sbjct: 318 ASIRKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQGGYGTVY 377
Query: 352 KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411
KGMLPDG+IVAVK+S+ +D+ QIE F+NEVVILSQINHR+IVKLLGCCLETE P+LVYEY
Sbjct: 378 KGMLPDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETETPLLVYEY 437
Query: 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIF 471
I +GTLS HIH + SSLSWE+R+R+ACEVAGAV YMH +ASIPIF
Sbjct: 438 IHSGTLSQHIHGKDRD-------------SSLSWESRLRIACEVAGAVTYMHFSASIPIF 484
Query: 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 531
HRDIK SNILLD+ +SAKVSDFGTSRS+P DKTHLTTAV GTFGY DPEYFQSSQ+TDKS
Sbjct: 485 HRDIKPSNILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQSSQFTDKS 544
Query: 532 DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI 591
DVYSFGVVL+EL+TG+KPI E+E +N+ A+FIS+ KEN+L +ILD + EAR++DI
Sbjct: 545 DVYSFGVVLVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVNEARKDDI 604
Query: 592 EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
A+A LAM CLRLN KKRPTMK+VSM+LE LR+ Q + I
Sbjct: 605 LAIANLAMRCLRLNGKKRPTMKEVSMELEALRKVQSSLHI 644
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507639|ref|XP_003624108.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|355499123|gb|AES80326.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/640 (59%), Positives = 468/640 (73%), Gaps = 41/640 (6%)
Query: 13 LLMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFITFRSEPPY 72
L ++LC + + CQQ L +C+ + S KGYLCN PQN C SF+TFRS+P Y
Sbjct: 25 LYILLCMLPYSIN---CQQILLNTTVTDCSGTPSAPKGYLCNSPQNSCNSFLTFRSKPSY 81
Query: 73 DTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNAPYTTKPND 115
D P SIAYLLGSEAS K++IVP+ CSCSG++YQHN PYT + D
Sbjct: 82 DNPTSIAYLLGSEASTIASINNISRNEKLPTNKTIIVPILCSCSGNIYQHNTPYTVQKGD 141
Query: 116 TYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAY 175
TYF + N TYQ LTTCQAL GQNYY +N+ G E+TVP+ CAC T Q G+T LL Y
Sbjct: 142 TYFHLVNETYQSLTTCQALKGQNYYASENIAIGAEVTVPVLCACPTTTQMAKGITSLLVY 201
Query: 176 MAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRV----FTPLLIPLKSESCSANPEKF 231
+ G+ + IG +GVD QSI++AN L + V TP+L+PL+ +SC +P+ F
Sbjct: 202 IVNYGETVKSIGEAYGVDEQSILEANELQPSENRSVILFALTPILLPLRGKSCKEDPDSF 261
Query: 232 FCQCKNGFLVDGILKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIREKR 291
+C C G L DG H G+KFP KLV LG+GIG GFL L LL LY+ I++KR
Sbjct: 262 YCTCSQGRLADGSCNESH----GQKFPAKLVAALGVGIGAGFLVLFLLSYRLYQYIKKKR 317
Query: 292 SRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVY 351
+ + KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATD+YNQSRFLGQGG+GTVY
Sbjct: 318 ASIRKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDDYNQSRFLGQGGYGTVY 377
Query: 352 KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411
KGMLPDG+IVAVK+S+ +D+ QIE F+NEVVILSQINHR+IVKLLGCCLETE P+LVYEY
Sbjct: 378 KGMLPDGTIVAVKKSKHLDRNQIETFVNEVVILSQINHRNIVKLLGCCLETETPLLVYEY 437
Query: 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIF 471
I +GTLS HIH + SSLSWE+R+R+ACEVAGAV YMH +ASIPIF
Sbjct: 438 IHSGTLSQHIHGKDRD-------------SSLSWESRLRIACEVAGAVTYMHFSASIPIF 484
Query: 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 531
HRDIK SNILLD+ +SAKVSDFGTSRS+P DKTHLTTAV GTFGY DPEYFQSSQ+TDKS
Sbjct: 485 HRDIKPSNILLDNNYSAKVSDFGTSRSIPLDKTHLTTAVGGTFGYMDPEYFQSSQFTDKS 544
Query: 532 DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI 591
DVYSFGVVL+EL+TG+KPI E+E +N+ A+FIS+ KEN+L +ILD + EAR++DI
Sbjct: 545 DVYSFGVVLVELITGRKPITFNDEDEGQNMTAHFISVMKENQLPQILDNALVNEARKDDI 604
Query: 592 EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
A+A LAM CLRLN KKRPTMK+VSM+LE LR+ Q + I
Sbjct: 605 LAIANLAMRCLRLNGKKRPTMKEVSMELEALRKVQSSLHI 644
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356566933|ref|XP_003551679.1| PREDICTED: wall-associated receptor kinase-like 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/643 (60%), Positives = 475/643 (73%), Gaps = 42/643 (6%)
Query: 14 LMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFITFRSEPPYD 73
+++LC F H L+ CQQ YL +C+ + S KGYLCNG Q C SF+ FRS+PPYD
Sbjct: 13 ILLLCMFPHSLK---CQQAYLNGTVYDCSDNPSAPKGYLCNGLQKSCTSFLLFRSKPPYD 69
Query: 74 TPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNAPYTTKPNDT 116
+P IAYLLGSEAS KS+IVPV CSCSG++YQHN PYT NDT
Sbjct: 70 SPGIIAYLLGSEASTIASINRISRNDKIPSNKSIIVPVFCSCSGNIYQHNTPYTASKNDT 129
Query: 117 YFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAYM 176
Y+ + T+QGLTTCQA++GQNYY N+ G ELTVP+ CAC T NQT GVT LL ++
Sbjct: 130 YYELVKETFQGLTTCQAMMGQNYYASINIAIGAELTVPMLCACPTENQTARGVTSLLVHL 189
Query: 177 AQAGDNMSFIGNEFGVDVQSIVDANMLPNGDA------IRVFTPLLIPLKSESCSANPEK 230
GD + IG +GVD QS+++AN L + + TP+++PL +SC NP+K
Sbjct: 190 VNYGDTIKSIGRAYGVDEQSVLEANKLAVSQSKNSSMDLLALTPIIVPLIGKSCKENPDK 249
Query: 231 FFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYLYKVIRE 289
F+C+C DG KG C + DG+KFP KLV LG+GIG GFL L LLG Y+ I++
Sbjct: 250 FYCRCYQA--PDGSSKGPFCDESDGQKFPAKLVAGLGVGIGAGFLCLFLLGYKSYQYIQK 307
Query: 290 KRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGT 349
KR +LKEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATDNYN+SRFLGQGG+GT
Sbjct: 308 KRETILKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNRSRFLGQGGYGT 367
Query: 350 VYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409
VYKGML DG+IVAVK+S+ I++ QI+ F+NEVV+LSQINHR+IVKLLGCCLETE P+LVY
Sbjct: 368 VYKGMLLDGTIVAVKKSKEIERNQIQTFVNEVVVLSQINHRNIVKLLGCCLETETPILVY 427
Query: 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIP 469
E+I NGTLSHHIH + S SW +R+R+ACEVAGAVAYMH AASI
Sbjct: 428 EFIPNGTLSHHIHRRDNE-------------PSPSWISRLRIACEVAGAVAYMHFAASIS 474
Query: 470 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD 529
IFHRDIK +NILLD +SAKVSDFGTSRSVP DKTHLTTAV GTFGY DPEYFQSSQ++D
Sbjct: 475 IFHRDIKPTNILLDSNYSAKVSDFGTSRSVPLDKTHLTTAVGGTFGYIDPEYFQSSQFSD 534
Query: 530 KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREE 589
KSDVYSFGVVL+EL+TG+KPI E+E +NL+A FISL KEN++ EILDA + KEAR++
Sbjct: 535 KSDVYSFGVVLVELITGRKPISFLYEDEGQNLIAQFISLMKENQVFEILDASLLKEARKD 594
Query: 590 DIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEID 632
DI A+A LAM CLRLN KKRPTMK+VS +LE LR++Q ++++
Sbjct: 595 DILAIANLAMRCLRLNGKKRPTMKEVSTELEALRKAQSSLQMN 637
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490602|dbj|BAI79288.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 768 bits (1984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/652 (58%), Positives = 478/652 (73%), Gaps = 38/652 (5%)
Query: 6 LYTYLSILLMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFIT 65
L+ +L IL L F+ Q QQ YL + +C + S KGYLCNG + C SF+
Sbjct: 3 LHYHLQILSTTLLLFMFP-QPLNSQQLYLNSSVYDCTDNPSAPKGYLCNGLKKSCTSFLV 61
Query: 66 FRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNAP 108
F S+PPYD P+SIAYLLGSEAS KSVIVPV CSCSG++YQH+ P
Sbjct: 62 FTSKPPYDNPLSIAYLLGSEASTIASINNISMNGKIPTNKSVIVPVFCSCSGNIYQHSTP 121
Query: 109 YTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENG 168
YT NDTY+++ TYQGLTTCQA++GQNYY ++ G ELTVP+ CAC T+N G
Sbjct: 122 YTVVKNDTYYMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKG 181
Query: 169 VTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLP-------NGDAIRVFTPLLIPLKS 221
V++LL +M + G+ ++ IG +GVD QS+ +AN LP N + TP+L+PL+
Sbjct: 182 VSFLLVHMVRDGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRG 241
Query: 222 ESCSANPEKFFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 280
+SC NP+KF+C+C L DG KGL C + DG+KFP KLV LG+GIG GFL L + G
Sbjct: 242 QSCKENPDKFYCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSG 300
Query: 281 CYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 340
LY+ I++KR R+ EKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+SR
Sbjct: 301 YKLYQYIQKKRKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSR 360
Query: 341 FLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
FLGQGG+G VYKGMLPDG+IVAVKRS+ I+++QI+ F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 361 FLGQGGYGMVYKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCL 420
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
ETE P+LVYE+I NGTLS HIH ++ + SSL WE+R+R+ACEVAGA+A
Sbjct: 421 ETETPLLVYEFIPNGTLSQHIH-----------MKNYESSSSLPWESRLRIACEVAGALA 469
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
YMH +ASIPIFHRDIK +NILLD F AKVSDFGTS+SVP DKTHLTT V+GTFGY DPE
Sbjct: 470 YMHFSASIPIFHRDIKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPE 529
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
YFQS Q+TDKSDVYSFGVVL+EL+TGK+PI E+E +NLV FISL KE++L +ILDA
Sbjct: 530 YFQSCQFTDKSDVYSFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDA 589
Query: 581 RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEID 632
V KEAR +DI ++A LA CLRLN KKRPTMK+VS +LE LR+ Q ++I+
Sbjct: 590 VVVKEARIDDILSIASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQIN 641
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490588|dbj|BAI79281.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1977), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/652 (58%), Positives = 477/652 (73%), Gaps = 38/652 (5%)
Query: 6 LYTYLSILLMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFIT 65
L+ +L IL L F+ Q QQ YL + +C + S KGYLCNG + C SF+
Sbjct: 3 LHYHLQILSTTLLLFMFP-QPLNSQQLYLNSSVYDCTDNPSAPKGYLCNGLKKSCTSFLV 61
Query: 66 FRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNAP 108
F S+PPYD P+SIAYLLGSEAS KSVIVPV CSCSG++YQH+ P
Sbjct: 62 FTSKPPYDNPLSIAYLLGSEASTIASINNISMNGKIPTNKSVIVPVFCSCSGNIYQHSTP 121
Query: 109 YTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENG 168
YT NDTY+++ TYQGLTTCQA++GQNYY ++ G ELTVP+ CAC T+N G
Sbjct: 122 YTVVKNDTYYMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLIAKG 181
Query: 169 VTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLP-------NGDAIRVFTPLLIPLKS 221
V++LL +M + G+ ++ IG +GVD QS+ +AN LP N + TP+L+PL+
Sbjct: 182 VSFLLVHMVRDGEMVNSIGEAYGVDEQSMREANGLPVVPSSANNSVTLNALTPILVPLRG 241
Query: 222 ESCSANPEKFFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 280
+SC NP+KF+C+C L DG KGL C + DG+KFP KLV LG+GIG GFL L + G
Sbjct: 242 QSCKENPDKFYCKCSQA-LHDGSSKGLFCNESDGQKFPAKLVVPLGVGIGAGFLCLFVSG 300
Query: 281 CYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 340
LY+ I++KR R+ EKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+SR
Sbjct: 301 YKLYQYIQKKRKRIHTEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNRSR 360
Query: 341 FLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
FLGQGG+G VYKGMLPDG+IVAVKRS+ I+++QI+ F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 361 FLGQGGYGMVYKGMLPDGTIVAVKRSKEIERSQIDTFVNEVVILSQINHRNIVKLLGCCL 420
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
ETE P+LVYE+I NGTLS HIH ++ + SSL WE+R+R+ACEVAGA+A
Sbjct: 421 ETETPLLVYEFIPNGTLSQHIH-----------MKNYESSSSLPWESRLRIACEVAGALA 469
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
YMH +ASIPIFHRDIK +NILLD F AKVSDFGTS+SVP DKTHLTT V+GTFGY DPE
Sbjct: 470 YMHFSASIPIFHRDIKPTNILLDSNFCAKVSDFGTSKSVPQDKTHLTTNVKGTFGYIDPE 529
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
YFQS Q+TDKSDVYSFGVVL+EL+TGK+PI E+E +NLV FISL KE++L +ILD
Sbjct: 530 YFQSCQFTDKSDVYSFGVVLVELITGKRPISFFYEDEGQNLVGEFISLMKEDQLSQILDP 589
Query: 581 RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEID 632
V KEAR +DI ++A LA CLRLN KKRPTMK+VS +LE LR+ Q ++I+
Sbjct: 590 VVVKEARIDDILSIASLARRCLRLNGKKRPTMKEVSAELEALRKVQNTLQIN 641
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507635|ref|XP_003624106.1| Wall-associated receptor kinase-like protein [Medicago truncatula] gi|87162780|gb|ABD28575.1| Protein kinase [Medicago truncatula] gi|355499121|gb|AES80324.1| Wall-associated receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/652 (56%), Positives = 467/652 (71%), Gaps = 41/652 (6%)
Query: 6 LYTY-LSILLMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSFI 64
LY Y L ++ LC F Q CQQ YL N +C ++ KGYLCNG + C SF+
Sbjct: 3 LYNYILHFTVLFLCMFS---QLFNCQQVYLNNTVFDCTNPSTVPKGYLCNGLKKSCTSFL 59
Query: 65 TFRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHNA 107
F+S+P YD P IAYLL SEAS KS+IVPV CSC G++YQH+
Sbjct: 60 VFKSKPLYDNPTKIAYLLRSEASAIASINKIPLNEKIPSNKSIIVPVFCSCDGNIYQHST 119
Query: 108 PYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTEN 167
Y+ K NDTY+ + TYQGLTTCQAL+GQNYY ++ ELTVPI CAC TAN T
Sbjct: 120 SYSVKQNDTYYELVKETYQGLTTCQALMGQNYYAPVSIQLDAELTVPILCACPTANLTAK 179
Query: 168 GVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPN----GDAIRVF--TPLLIPLKS 221
GVT LL +M G+ + IG +GVD S+ +AN L ++ +F TP+L+PL+
Sbjct: 180 GVTSLLVHMVNYGETVKSIGEAYGVDEHSMREANELSGLQSANSSVILFASTPILVPLRR 239
Query: 222 ESCSANPEKFFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVLLG 280
++C N ++F+C+C D KG++C + +K P KLV G+GIG L L LL
Sbjct: 240 KNCKENSDRFYCKCSEALHGDESSKGIYCDESPRRKVPAKLVAASGMGIGTVLLCLFLLS 299
Query: 281 CYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSR 340
C LY+ I+++R+ KEKLF+QNGGYLLQ++LSS G+ E AK+FTAEELQRATDNYN+SR
Sbjct: 300 CKLYQHIKKRRASTHKEKLFRQNGGYLLQEKLSSYGNGEMAKLFTAEELQRATDNYNRSR 359
Query: 341 FLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
FLGQGG+GTVYKGMLPDG+IVAVK+S+ +++ QIE F+NEVVILSQINHR+IVKLLGCCL
Sbjct: 360 FLGQGGYGTVYKGMLPDGTIVAVKKSKELERNQIETFVNEVVILSQINHRNIVKLLGCCL 419
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
ETE P+LVYE+I NGTLS HIH Q+ SSLSWENR+R+ACEVAGAVA
Sbjct: 420 ETETPLLVYEFIPNGTLSQHIHMKDQE-------------SSLSWENRLRIACEVAGAVA 466
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
YMH +ASIPIFHRDIK +NILLD FSAKVSDFGTSRS+P DKTHLTT V GT+GY DPE
Sbjct: 467 YMHFSASIPIFHRDIKPTNILLDSNFSAKVSDFGTSRSIPLDKTHLTTFVGGTYGYIDPE 526
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
YFQS+Q+T+KSDVYSFGVVL+EL+T +KPI E++ +NL+A+FIS+ KEN++ +I+DA
Sbjct: 527 YFQSNQFTNKSDVYSFGVVLVELITSRKPISFYDEDDGQNLIAHFISVMKENQVSQIIDA 586
Query: 581 RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEID 632
R+ KEA ++ I A++ LA CLRLN KKRPTMK+VS +LE LR++Q EI+
Sbjct: 587 RLQKEAGKDTILAISSLARRCLRLNHKKRPTMKEVSAELETLRKAQSSFEIN 638
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547606|ref|XP_002514860.1| kinase, putative [Ricinus communis] gi|223545911|gb|EEF47414.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 727 bits (1876), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/611 (59%), Positives = 442/611 (72%), Gaps = 76/611 (12%)
Query: 25 QQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNL-CQSFITFRSEPPYDTPVSIAYLLG 83
Q S CQQ YL N L C + SISKGYLCNG + CQS+ITF S PPYDTP+SIAY+LG
Sbjct: 20 QPSNCQQDYLNNTQLNCGVNPSISKGYLCNGNDQVPCQSYITFLSLPPYDTPISIAYVLG 79
Query: 84 SEASKSVIVPVSCSCSGSLYQHNAPYTTKP-NDTYFLVANNTYQGLTTCQALLGQNYYDE 142
S +YQHN PYT K ++YF +ANNTYQGLTTCQAL GQNYYD
Sbjct: 80 S-----------------IYQHNTPYTIKNLTESYFTIANNTYQGLTTCQALTGQNYYDP 122
Query: 143 KNLGSGVELTVPIRCACATANQTENGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANM 202
++L G+EL VP+RCAC + NQT +GV LL YM GD +S IG FG D SI++AN
Sbjct: 123 EHLQVGMELMVPLRCACPSRNQTADGVISLLMYMVTWGDTLSSIGQAFGADAASILEANR 182
Query: 203 LPNGDAIRVFTPLLIPLKSESCSANPEKFFCQCKNGFLVDGILKGLHCKPDGKKFPVKLV 262
L I FTP+L+PL+ E C A+PE FFCQC G G+ GL+C+ D KKFP KL+
Sbjct: 183 LSQNSIIFPFTPILVPLRRERCMADPENFFCQCPKG----GV-GGLNCRQDSKKFPTKLI 237
Query: 263 TLLGLGIGLGFLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAK 322
LLG GIG+G L L L L+ ++E+R+R+ KE+LF+QNGG+LLQQ+LSSCG +KAK
Sbjct: 238 ILLGTGIGMGLLCLFLFSYKLFHFLKERRNRIRKERLFEQNGGFLLQQKLSSCGGGKKAK 297
Query: 323 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVV 382
+FTAEELQRATDNYNQSRFLGQGG+GTV+KGMLPDGSIVAVKRS+ ID+TQI QFINEVV
Sbjct: 298 LFTAEELQRATDNYNQSRFLGQGGYGTVFKGMLPDGSIVAVKRSKTIDRTQIAQFINEVV 357
Query: 383 ILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSS 442
ILSQINHR+IVKLLGCCLETE+P+LVYE+I NG LS+HIH EQ QE SS
Sbjct: 358 ILSQINHRNIVKLLGCCLETELPLLVYEFIPNGNLSNHIH------EQDQE-------SS 404
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
WE R+R+A EVAGAVAYMHS+AS PIFHRDIKSSNILLDDK+SAKVSDFGTSR++P D
Sbjct: 405 FPWELRLRIASEVAGAVAYMHSSASSPIFHRDIKSSNILLDDKYSAKVSDFGTSRAIPFD 464
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
+THLTTAVQGTFG E+ER+LV
Sbjct: 465 RTHLTTAVQGTFG---------------------------------------NEDERSLV 485
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
A+FIS KE++LL+ILD RVA+EAR ED+ A+A+LA C+RLN KKRPTM++V+M+L+GL
Sbjct: 486 AHFISSMKEDRLLQILDPRVAREARREDMHAIAKLATSCVRLNGKKRPTMREVAMELDGL 545
Query: 623 RRSQRCVEIDK 633
R+S+RC++ID+
Sbjct: 546 RKSERCLQIDQ 556
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547604|ref|XP_002514859.1| conserved hypothetical protein [Ricinus communis] gi|223545910|gb|EEF47413.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/584 (56%), Positives = 404/584 (69%), Gaps = 88/584 (15%)
Query: 63 FITFRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQH 105
F+TF S PPYD+P++I+YLLGSEAS KS+IVP+SCSC+ S+Y H
Sbjct: 4 FLTFSSRPPYDSPITISYLLGSEASSIALINNVSSIFTFLSEKSIIVPISCSCTSSIYHH 63
Query: 106 NAPYTTKPN-DTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQ 164
N Y + + DTYF +ANNTYQGLTTCQA++ QN Y + L G EL VP+RCAC T NQ
Sbjct: 64 NTSYFIQDSTDTYFTIANNTYQGLTTCQAIMDQNNYPSQGLPVGSELIVPLRCACPTQNQ 123
Query: 165 TENGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKSESC 224
TENGV LL +M GD ++ I N FGVD SI+ AN L I FTP+L+PL +E+
Sbjct: 124 TENGVISLLVHMVTWGDTIASIANSFGVDEASILAANKLSENSTIYPFTPILVPLTNENR 183
Query: 225 SANPE-KFFCQCKNGFLVDGILKGLHCKPDGKKFPVKLVTLLGLGIGLGFLSLVLLGCYL 283
NP F CQ NG + G + G++C +G+GIGL V + +L
Sbjct: 184 LTNPAANFSCQYPNGSVAVGGVDGMYCTSRS----------VGIGIGL----TVFIPVHL 229
Query: 284 YKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLG 343
EELQRATDNY+QSRFLG
Sbjct: 230 ------------------------------------------QEELQRATDNYSQSRFLG 247
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
QGGF TVYKGMLPDGSIVAVKRS+ ID+TQIEQFINEVVILSQINHR+IVKLLGCCLETE
Sbjct: 248 QGGFSTVYKGMLPDGSIVAVKRSKTIDRTQIEQFINEVVILSQINHRNIVKLLGCCLETE 307
Query: 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463
P+LVYE+ISNGTLS HI++ Q+ SSL WE+R R+A EVAGA+AYMH
Sbjct: 308 FPLLVYEFISNGTLSQHIYNQDQE-------------SSLPWEHRFRIASEVAGALAYMH 354
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
SAAS PIFHRDIKS+NILLDDK+SAKVSDFGTSRS+P D+THLTT VQGTFGY DPEYF
Sbjct: 355 SAASFPIFHRDIKSANILLDDKYSAKVSDFGTSRSIPFDRTHLTTVVQGTFGYLDPEYFY 414
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583
+SQ+T+KSDVYSFGVVL+EL TG+KPI TR E+ERNLVA+FIS+AKEN+LL++LDARVA
Sbjct: 415 TSQFTEKSDVYSFGVVLIELFTGEKPISSTRAEDERNLVAHFISMAKENRLLDLLDARVA 474
Query: 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
KEAR ED+ ++A+L + C+R N K RP++++V+M+L+G+ +S +
Sbjct: 475 KEARREDVYSIAKLVIKCVRSNGKNRPSIREVAMELDGIMKSHQ 518
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|290490590|dbj|BAI79282.1| LysM type receptor kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1399), Expect = e-151, Method: Compositional matrix adjust.
Identities = 278/494 (56%), Positives = 345/494 (69%), Gaps = 47/494 (9%)
Query: 6 LYTYLSIL--LMILCTFLHDLQQSTCQQTYLGNVDLECNKSVSISKGYLCNGPQNLCQSF 63
L+ +L IL ++L F H L QQ YL + +C + S KGYLCNG + C SF
Sbjct: 3 LHYHLHILSTTLLLFMFPHSLNS---QQIYLNSSVYDCTNNPSAPKGYLCNGLKKSCTSF 59
Query: 64 ITFRSEPPYDTPVSIAYLLGSEAS-----------------KSVIVPVSCSCSGSLYQHN 106
+ F S+PPYD PVSIAYLLGSEAS KSVIVPV CSCSG++YQH+
Sbjct: 60 LVFTSKPPYDNPVSIAYLLGSEASTIASMNNISMNDKIPSNKSVIVPVFCSCSGNIYQHS 119
Query: 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTE 166
PYT NDTY+++ TYQGLTTCQA++GQNYY ++ G ELTVP+ CAC T+N T
Sbjct: 120 TPYTVVKNDTYYMLVKTTYQGLTTCQAMMGQNYYAAVSIAVGAELTVPVLCACPTSNLTT 179
Query: 167 NGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLP-------NGDAIRVFTPLLIPL 219
GV++LL +M + G+ + IG +GVD QS+ +AN LP N + TP+L+PL
Sbjct: 180 KGVSFLLVHMVRDGETVKSIGEAYGVDEQSMGEANGLPVVPSSANNSVILNALTPILVPL 239
Query: 220 KSESCSANPEKFFCQCKNGFLVDGILKGLHC-KPDGKKFPVKLVTLLGLGIGLGFLSLVL 278
+ +SC NP+KF+C+C L DG K L C + DG+KFP KLV LG+GIG GFL L L
Sbjct: 240 RGQSCKENPDKFYCKCSQA-LHDGSSKELFCDESDGQKFPAKLVVSLGVGIGAGFLCLFL 298
Query: 279 LGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQ 338
G LY+ I++KR + KEKLF+QNGGYLLQ++ S G+ EKAK+FTAEELQRATDNYN+
Sbjct: 299 SGYKLYQCIQKKRKCVHKEKLFRQNGGYLLQEKFSLYGNGEKAKLFTAEELQRATDNYNR 358
Query: 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
SRFLGQGG+G VYKGMLPDG+IVAVKRS+ I++ QI+ F+NEVVILSQINHR+IVKLLGC
Sbjct: 359 SRFLGQGGYGMVYKGMLPDGTIVAVKRSKEIERNQIDSFVNEVVILSQINHRNIVKLLGC 418
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
CLETE P+LVYE+I NGTLS HIH SSL WE+R+R+ACEVAGA
Sbjct: 419 CLETETPLLVYEFIPNGTLSQHIHSS----------------SSLPWESRLRIACEVAGA 462
Query: 459 VAYMHSAASIPIFH 472
+AYMH +ASIPIFH
Sbjct: 463 LAYMHFSASIPIFH 476
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 633 | ||||||
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.519 | 0.439 | 0.559 | 7.2e-105 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.529 | 0.458 | 0.567 | 2.2e-103 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.518 | 0.414 | 0.565 | 1.1e-101 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.527 | 0.444 | 0.548 | 4.6e-101 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.518 | 0.426 | 0.554 | 6.7e-100 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.519 | 0.417 | 0.561 | 5.2e-97 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.521 | 0.458 | 0.537 | 1.6e-96 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.608 | 0.521 | 0.465 | 7.8e-95 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.510 | 0.422 | 0.541 | 1e-93 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.511 | 0.408 | 0.532 | 1.1e-93 |
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 7.2e-105, Sum P(3) = 7.2e-105
Identities = 192/343 (55%), Positives = 256/343 (74%)
Query: 284 YKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 342
YK ++++R + K F++NGG LL+Q+L+ G+ E ++IF++ EL++ATDN+N++R L
Sbjct: 363 YKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVL 422
Query: 343 GQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402
GQGG GTVYKGML DG IVAVKRS+A+D+ ++E+FINEVV+L+QINHR+IVKLLGCCLET
Sbjct: 423 GQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLET 482
Query: 403 EVPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 462
EVPVLVYE++ NG L +HD R+ +A E+AGA++Y+
Sbjct: 483 EVPVLVYEFVPNGDLCKRLHDESDDYTMTWEV-------------RLHIAIEIAGALSYL 529
Query: 463 HSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 522
HSAAS PI+HRDIK++NILLD++ AKVSDFGTSRSV D+THLTT V GTFGY DPEYF
Sbjct: 530 HSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYF 589
Query: 523 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 582
QSS++T+KSDVYSFGVVL+ELLTG+KP R EE R L A+F+ KEN++L+I+D R+
Sbjct: 590 QSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRI 649
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
E + + +VA LA CL KKRP M++VS++LE +R S
Sbjct: 650 KDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSS 692
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1002 (357.8 bits), Expect = 2.2e-103, Sum P(2) = 2.2e-103
Identities = 198/349 (56%), Positives = 261/349 (74%)
Query: 284 YKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 342
+K+I+++R+ +K FK+NGG LL+Q+L++ G+ E +KIF+++EL++ATDN++ R L
Sbjct: 376 FKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVL 435
Query: 343 GQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402
GQGG GTVYKGML DGSIVAVKRS+ +D+ ++E+FINE+V+LSQINHR+IVKLLGCCLET
Sbjct: 436 GQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLET 495
Query: 403 EVPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 462
EVP+LVYEYI NG L +HD R+R+A E+AGA+ YM
Sbjct: 496 EVPILVYEYIPNGDLFKRLHDESDDYTMTWEV-------------RLRIAIEIAGALTYM 542
Query: 463 HSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 522
HSAAS PIFHRDIK++NILLD+K+ AKVSDFGTSRSV D+THLTT V GTFGY DPEYF
Sbjct: 543 HSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYF 602
Query: 523 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 582
SSQYT KSDVYSFGVVL+EL+TG+KP+ R EE R L +F+ KEN++++I+D R+
Sbjct: 603 LSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRI 662
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
E++ E + AVA+LA CL K RP MK+VS +LE +R S +++
Sbjct: 663 KDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSPEDLDV 711
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 1.1e-101, Sum P(2) = 1.1e-101
Identities = 193/341 (56%), Positives = 253/341 (74%)
Query: 284 YKVIREKRSRMLKEKLFKQNGGYLLQQRL-SSCGSSEKAKIFTAEELQRATDNYNQSRFL 342
YK I+++R K+K FK+NGG LLQQ+L S+ G EK +F++ EL++AT+N++ +R L
Sbjct: 394 YKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRIL 453
Query: 343 GQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402
GQGG GTVYKGML DG IVAVK+S+ +D+ ++E+FINEVVILSQINHR+IVKLLGCCLET
Sbjct: 454 GQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 513
Query: 403 EVPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 462
+VPVLVYE+I NG L H+HD R+R+A ++AGA++Y+
Sbjct: 514 KVPVLVYEFIPNGNLFEHLHDEFDENIMATWNI------------RLRIAIDIAGALSYL 561
Query: 463 HSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 522
HS+AS PI+HRD+KS+NI+LD+K+ AKVSDFGTSR+V D THLTT V GT GY DPEYF
Sbjct: 562 HSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYF 621
Query: 523 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 582
QSSQ+TDKSDVYSFGVVL+EL+TG+K I R +E R L YFI KENKL +I+DAR+
Sbjct: 622 QSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARI 681
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
+ A A++A CL L +KRP+M++VSM+L+ +R
Sbjct: 682 RDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 984 (351.4 bits), Expect = 4.6e-101, Sum P(2) = 4.6e-101
Identities = 191/348 (54%), Positives = 263/348 (75%)
Query: 285 KVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSS-EKAKIFTAEELQRATDNYNQSRFLG 343
K ++++R + K FK+NGG LL+Q+L++ G + + +KIF+++EL++ATDN+N +R LG
Sbjct: 369 KFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLG 428
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
QGG GTVYKGML DG IVAVKRS+ +D+ ++E+FINEV +LSQINHR+IVKL+GCCLETE
Sbjct: 429 QGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETE 488
Query: 404 VPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 463
VP+LVYE+I NG L +H H R+R++ E+AGA+AY+H
Sbjct: 489 VPILVYEHIPNGDLFKRLH-HDSDDYTMTWDV------------RLRISVEIAGALAYLH 535
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
SAAS P++HRD+K++NILLD+K+ AKVSDFGTSRS+ D+THLTT V GTFGY DPEYFQ
Sbjct: 536 SAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQ 595
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583
+SQ+TDKSDVYSFGVVL+EL+TG+KP + R EE R LV++F K+N++L+I+D+R+
Sbjct: 596 TSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIK 655
Query: 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVEI 631
+ E + AVA+LA CL L KKRP M++VS++LE +R S +E+
Sbjct: 656 EGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSPEDLEL 703
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 974 (347.9 bits), Expect = 6.7e-100, Sum P(2) = 6.7e-100
Identities = 189/341 (55%), Positives = 250/341 (73%)
Query: 284 YKVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFL 342
YK IR +R K+K FK+NGG LLQQ+L++ G+ + ++F + EL++AT+N++ +R L
Sbjct: 380 YKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRIL 439
Query: 343 GQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402
G+GG GTVYKGML DG IVAVK+S+ +D+ ++E+FINEVVILSQINHR+IVKLLGCCLET
Sbjct: 440 GEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLET 499
Query: 403 EVPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYM 462
+VP+LVYE+I NG L H+HD R+R+A ++AGA++Y+
Sbjct: 500 DVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEV------------RLRIAVDIAGALSYL 547
Query: 463 HSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF 522
HSAAS PI+HRDIKS+NI+LD+K AKVSDFGTSR+V D THLTT V GT GY DPEYF
Sbjct: 548 HSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYF 607
Query: 523 QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 582
QSSQ+TDKSDVYSFGVVL EL+TG+K + R +E R L YF KEN+L +I+DAR+
Sbjct: 608 QSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARI 667
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
+ + A A++A CL + +KRP+M+QVSM+LE +R
Sbjct: 668 RDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIR 708
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 5.2e-97, P = 5.2e-97
Identities = 193/344 (56%), Positives = 248/344 (72%)
Query: 285 KVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 343
K ++++R K K FK+NGG LLQQ+L++ G+ EK +IF++ EL++ATDN+++SR LG
Sbjct: 399 KFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILG 458
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
QGG GTVYKGML DG VAVK+S+ +D+ ++E+FINEVVILSQINHRH+VKLLGCCLETE
Sbjct: 459 QGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETE 518
Query: 404 VPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 463
VP LVYE+I NG L HIH+ R+R+A ++AGA++Y+H
Sbjct: 519 VPTLVYEFIPNGNLFQHIHEESDDYTKTWGM-------------RLRIAVDIAGALSYLH 565
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
SAAS PI+HRDIKS+NILLD+K+ KVSDFGTSRSV D TH TT + GT GY DPEY+
Sbjct: 566 SAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYG 625
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERNLVAYFISLAKENKLLEILDARV 582
SSQYTDKSDVYSFGVVL+EL+TG+KP I ++ +E R L +F KEN+ EI+DAR+
Sbjct: 626 SSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARI 685
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
+ E + AVA LA CL KKRP M++V DLE + SQ
Sbjct: 686 RDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILASQ 729
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 1.6e-96, Sum P(2) = 1.6e-96
Identities = 185/344 (53%), Positives = 248/344 (72%)
Query: 285 KVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 343
K R+++ K K F++NGG LLQQ+ S GS + K+F++ +L+ ATD +N SR LG
Sbjct: 338 KANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILG 397
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
QGG GTVYKGML DG IVAVK+S+A+ + +E+FINE+++LSQINHR++VK+LGCCLETE
Sbjct: 398 QGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETE 457
Query: 404 VPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 463
VP+LVYE+I N L H+H+ R+ +ACEVA A++Y+H
Sbjct: 458 VPILVYEFIPNRNLFDHLHNPSEDFPMSWEV-------------RLCIACEVADALSYLH 504
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
SA SIPI+HRD+KS+NILLD+K AKVSDFG SRSV D THLTT VQGT GY DPEY Q
Sbjct: 505 SAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQ 564
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583
S+ +T KSDVYSFGV+L+ELLTG+KP+ L R +E R L AYF+ + ++L EILDAR+
Sbjct: 565 SNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIK 624
Query: 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
+E E++ AVA+LA CL LNS+ RPTM+ V ++L+ ++ ++
Sbjct: 625 EECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRK 668
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 923 (330.0 bits), Expect = 7.8e-95, Sum P(2) = 7.8e-95
Identities = 187/402 (46%), Positives = 258/402 (64%)
Query: 223 SCSANPEKFFCQCKNGFLVDGILKGLHCKPDGKKFPXXXXXXXXXXXXXXXXXXXXXXXX 282
+C F C C++ + ++ CKP G
Sbjct: 299 TCENKLGHFRCNCRSRYELNTTTNT--CKPKGNPEYVEWTTIVLGTTIGFLVILLAISCI 356
Query: 283 XYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSE-KAKIFTAEELQRATDNYNQSRF 341
+K+ K + L+++ F+QNGG +L QRLS G S KIFT E ++ ATD Y+++R
Sbjct: 357 EHKMKNTKDTE-LRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRI 415
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LGQGG GTVYKG+LPD SIVA+K++R D +Q+EQFINEV++LSQINHR++VKLLGCCLE
Sbjct: 416 LGQGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLE 475
Query: 402 TEVPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAY 461
TEVP+LVYE+IS+GTL H+H +R+R+A E+AG +AY
Sbjct: 476 TEVPLLVYEFISSGTLFDHLHG-------------SMFDSSLTWEHRLRMAVEIAGTLAY 522
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 521
+HS+ASIPI HRDIK++NILLD+ +AKV+DFG SR +P DK L T VQGT GY DPEY
Sbjct: 523 LHSSASIPIIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLATMVQGTLGYLDPEY 582
Query: 522 FQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDAR 581
+ + +KSDVYSFGVVL+ELL+G+K +C R + +++V+YF S KEN+L EI+D +
Sbjct: 583 YNTGLLNEKSDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQ 642
Query: 582 VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
V E + +I+ A +A+ C RL ++RP MK+V+ +LE LR
Sbjct: 643 VMNENNQREIQKAARIAVECTRLTGEERPGMKEVAAELEALR 684
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 933 (333.5 bits), Expect = 1.0e-93, P = 1.0e-93
Identities = 183/338 (54%), Positives = 244/338 (72%)
Query: 285 KVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 343
K++R++R K K FK+NGG LLQQ+L++ G EK K+F++ EL++ATDN+N +R +G
Sbjct: 402 KLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIG 461
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
QGG GTVYKGML DG VAVK+S +D+ ++++FINEV+ILSQINHRH+VKLLGCCLETE
Sbjct: 462 QGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETE 521
Query: 404 VPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 463
VP+LVYE+I NG L H+H+ R+R+A +++GA +Y+H
Sbjct: 522 VPILVYEFIPNGNLFQHLHEEFDDYTALWGV-------------RMRIAVDISGAFSYLH 568
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
+AA PI+HRDIKS+NILLD+K+ AKVSDFGTSRSV D TH TT + GT GY DPEY+
Sbjct: 569 TAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYG 628
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERNLVAYFISLAKENKLLEILDARV 582
SS +T+KSDVYSFGVVL+EL+TG+KP I L+ +E L YF +EN+L EI+DAR+
Sbjct: 629 SSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARI 688
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
+ + E + AVA LA+ CL+ K RP M++VS LE
Sbjct: 689 RNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALE 726
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 1.1e-93, Sum P(2) = 1.1e-93
Identities = 180/338 (53%), Positives = 245/338 (72%)
Query: 285 KVIREKRSRMLKEKLFKQNGGYLLQQRLSSC-GSSEKAKIFTAEELQRATDNYNQSRFLG 343
K + ++R K+K FK+NGG LL Q L++ G EK ++F + EL++AT+N++++R LG
Sbjct: 401 KFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVLG 460
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403
GG GTVYKGML DG VAVK+S+ ID+ ++++FINEVVILSQINHRH+VKLLGCCLETE
Sbjct: 461 HGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETE 520
Query: 404 VPVLVYEYISNGTLSHHIHDHXXXXXXXXXXXXXXXXXXXXXXNRVRVACEVAGAVAYMH 463
VP+LVYE+I NG L HIH+ R+R+A ++AGA++Y+H
Sbjct: 521 VPMLVYEFIINGNLFKHIHEEESDDYTMLWGM------------RLRIAVDIAGALSYLH 568
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523
S+AS PI+HRDIKS+NILLD+K+ AKV+DFGTSRSV D+TH TT + GT GY DPEY+Q
Sbjct: 569 SSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQ 628
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA-KENKLLEILDARV 582
SSQYT+KSDVYSFGV+L EL+TG KP+ + + +E +A +A KE +L +I+DAR+
Sbjct: 629 SSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARI 688
Query: 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
+ + E + AVA++AM CL KKRP M++V +LE
Sbjct: 689 RNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELE 726
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 633 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-50 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-05 | |
| pfam01476 | 43 | pfam01476, LysM, LysM domain | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-04 | |
| cd00118 | 45 | cd00118, LysM, Lysine Motif is a small domain invo | 0.001 | |
| smart00257 | 44 | smart00257, LysM, Lysin motif | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 4e-52
Identities = 80/282 (28%), Positives = 123/282 (43%), Gaps = 36/282 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQINHRHIV 393
Y LG+G FG VY G +VA+K + K E+ + E+ IL ++ H +IV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L + + LV EY G L + + L E++
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR-------LSEDE---------ARFYLR 104
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++ A+ Y+HS I HRD+K NILLD+ K++DFG +R + + LTT V GT
Sbjct: 105 QILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GT 159
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
Y PE Y D++S GV+L ELLTGK P + L+ F + K
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF-----PGDDQLLELFKKIGKPKP 214
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ ++ EA+ +L L + +KR T ++
Sbjct: 215 PFPPPEWDISPEAK--------DLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 3e-50
Identities = 78/224 (34%), Positives = 118/224 (52%), Gaps = 25/224 (11%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI-EQFINEVVILSQINHRHIVKLLGCC 399
LG+GGFGTVY G VA+K + D + + E+ + E+ IL ++NH +IVKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ LV EY G+L + +++ + LS + +R+ ++ +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---------------LSEDEILRILLQILEGL 105
Query: 460 AYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
Y+H S I HRD+K NILLD D K++DFG S+ + +DK+ L T V GT Y
Sbjct: 106 EYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMA 161
Query: 519 PE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI--CLTREEEER 559
PE Y++KSD++S GV+L EL K I L ++ E+R
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKR 205
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-49
Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 40/281 (14%)
Query: 342 LGQGGFGTVYKGMLPDGSI-----VAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKL 395
LG+G FG VYKG L VAVK + + QIE+F+ E I+ +++H +IVKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
LG C E E ++V EY+ G L ++ ++ + LS + + A ++
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPK--------------ELSLSDLLSFALQI 112
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A + Y+ S HRD+ + N L+ + K+SDFG SR + +D + +
Sbjct: 113 ARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 574
+ PE + ++T KSDV+SFGV+L E+ T G++P A + K+
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP-------YPGMSNAEVLEYLKKGYR 222
Query: 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
L + +L + C + + RPT ++
Sbjct: 223 LPK---------PPNCPPELYKLMLQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 88/284 (30%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
Y R LG G FGTVYK G IVAVK + R+ + + E+ IL +++H +I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V+L+ + + LV EY G L ++ LS + ++A
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG----------------PLSEDEAKKIA 104
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
++ + Y+HS I HRD+K NILLD+ K++DFG ++ + + LTT V G
Sbjct: 105 LQILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-G 160
Query: 513 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571
T Y PE + Y K DV+S GV+L ELLTGK P + E L L
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQLIRRILGPP 218
Query: 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ E + ++EA+ +L CL + KRPT +++
Sbjct: 219 LEFDEPKWSSGSEEAK--------DLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 2e-48
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 41/281 (14%)
Query: 342 LGQGGFGTVYKGML----PDGSI-VAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKL 395
LG+G FG VYKG L + VAVK + + QIE+F+ E I+ +++H ++VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
LG C E E +V EY+ G L ++ ++ LS + + A ++
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNR---------------PKLSLSDLLSFALQI 111
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A + Y+ S HRD+ + N L+ + K+SDFG SR + +D + +
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 574
+ PE + ++T KSDV+SFGV+L E+ T G++P + + K
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP------YPGMS-NEEVLEYLKNGYR 221
Query: 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
L + +L + C + + RPT ++
Sbjct: 222 LPQ---------PPNCPPELYDLMLQCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 8e-48
Identities = 84/295 (28%), Positives = 134/295 (45%), Gaps = 51/295 (17%)
Query: 342 LGQGGFGTVYKGMLPDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLL 396
LG+G FG VYKG L VAVK + + + + F+ E ++ ++ H ++V+LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C E E LV EY+ G L ++ + + + E S+LS ++ + A ++A
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLR-------KSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-------- 508
+ Y+ S HRD+ + N L+ + K+SDFG SR V +D +
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 509 --AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565
A PE + +T KSDV+SFGV+L E+ T G P +
Sbjct: 173 WMA---------PESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---------------Y 208
Query: 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
L+ E +LE L E + + EL + C +L+ + RPT ++ LE
Sbjct: 209 PGLSNEE-VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 8e-46
Identities = 81/281 (28%), Positives = 132/281 (46%), Gaps = 45/281 (16%)
Query: 340 RFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQ--IEQFINEVVILSQINHRHIVKLL 396
LG+G FG+VY + D G ++AVK ++ +E E+ ILS + H +IV+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 397 GCCLETEVPVL-VY-EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
G + E L ++ EY+S G+LS + L E +R
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKK----------------FGKLP-EPVIRKYTR 108
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP-NDKTHLTTAVQG 512
++ +AY+HS I HRDIK +NIL+D K++DFG ++ + + T +V+G
Sbjct: 109 QILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA--YFISLAK 570
T + PE + +Y +D++S G ++E+ TGK P E N +A Y I +
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW-----SELGNPMAALYKIGSSG 220
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
E + +++EA+ + CLR + KKRPT
Sbjct: 221 EPPE---IPEHLSEEAK--------DFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 82/291 (28%), Positives = 137/291 (47%), Gaps = 52/291 (17%)
Query: 342 LGQGGFGTVYKGML-PDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKL 395
LG+G FG VYKG L DG VAVK + + + E+F+ E I+ +++H +IV+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
LG C + E +V EY+ G L + H + L+ ++ +++A ++
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---------------KLTLKDLLQMALQI 111
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A + Y+ S HRD+ + N L+ + K+SDFG SR + D + + G
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY----RKRGGG 164
Query: 516 YFD-----PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISL 568
PE + ++T KSDV+SFGV+L E+ T G++P ++ EE + L
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLEL 216
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
++ L E + + EL + C + + RPT ++ DL
Sbjct: 217 LEDGYRLPRP---------ENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQINHRH 391
Y + +G+G FG VY DG + +K + + + E +NEV IL ++NH +
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I+K E +V EY G LS I ++Q+++ + EEQ L W
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQ---ILDW------ 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
++ A+ Y+HS I HRDIK NI L K+ DFG S+ + + T V
Sbjct: 109 FVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV- 164
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571
GT Y PE Q+ Y KSD++S G VL EL T K P E NL + LA +
Sbjct: 165 GTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF------EGENL----LELALK 214
Query: 572 --NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ ++ + E R L L+ + ++RP++ Q+
Sbjct: 215 ILKGQYPPIPSQYSSELR--------NLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 1e-36
Identities = 70/212 (33%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
+G+GGFG VYK G VA+K + K + E+ INE+ IL + H +IVK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC---EVAG 457
+ + +V E+ S G+L + Q L E Q +A E+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST------NQTLTESQ------------IAYVCKELLK 109
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+ Y+HS I HRDIK++NILL K+ DFG S + + K T GT +
Sbjct: 110 GLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWM 164
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Y K+D++S G+ +EL GK P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 136 bits (341), Expect = 7e-35
Identities = 80/293 (27%), Positives = 122/293 (41%), Gaps = 35/293 (11%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQINH-R 390
+Y R LG+G FG VY D +VA+K ++E+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IVKL + LV EY+ G+L + ++ LS +
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-------------GPLSESEALF 105
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTH---- 505
+ ++ A+ Y+HS I HRDIK NILLD D K+ DFG ++ +P+ +
Sbjct: 106 ILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162
Query: 506 -LTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
L + GT GY PE + SD++S G+ L ELLTG P + +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
I L L E +A ++L L + K R +
Sbjct: 223 TLKIILELPTPSLASPLS----PSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 8e-31
Identities = 82/285 (28%), Positives = 130/285 (45%), Gaps = 39/285 (13%)
Query: 335 NYNQSRFLGQGGFG--TVYKGMLPDGSIVAVKRS--RAIDKTQIEQFINEVVILSQINHR 390
+Y R LG+G FG T+Y+ D S+V K + + + +NE+VILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+I+ ++ ++ EY + GTL I +++ Q EEE L L
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLF------ 108
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ AV+Y+H A I HRDIK+ NI L K+ DFG S+ + ++ + T V
Sbjct: 109 ---QIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV 162
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
GT Y PE Q +Y KSD+++ G VL ELL L R + N + + + +
Sbjct: 163 -GTPYYMSPELCQGVKYNFKSDIWALGCVLYELL------TLKRTFDATNPLNLVVKIVQ 215
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
N + + + E L L+ + +KRPT +V
Sbjct: 216 GNY--TPVVSVYSSELI--------SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 41/280 (14%)
Query: 341 FLGQGGFGTVYKGML-PDGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGC 398
LGQG G VYK P G I A+K+ D+ +Q + E+ L ++VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+ +V EY+ G+L+ + +K E L+ +A ++
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL--------KKVGKIPEPVLAY--------IARQILKG 111
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+ Y+H+ I HRDIK SN+L++ K K++DFG S+ + N T V GT Y
Sbjct: 112 LDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMS 168
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 578
PE Q Y+ +D++S G+ LLE GK P + E++
Sbjct: 169 PERIQGESYSYAADIWSLGLTLLECALGKFP----------------FLPPGQPSFFELM 212
Query: 579 DARVAKEARE-EDIEAVAELA---MGCLRLNSKKRPTMKQ 614
A E E CL+ + KKRP+ +
Sbjct: 213 QAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 75/290 (25%), Positives = 133/290 (45%), Gaps = 30/290 (10%)
Query: 340 RFLGQGGFGTVYKG----MLPDGS--IVAVKRSR-AIDKTQIEQFINEVVILSQINHRHI 392
R LG+G FG V+ G + P+ +VAVK + + F E +L+ H +I
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
VK G C E + P++V+EY+ +G L+ + H + + L+ +++A
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD--AAFLKSPDSPMGELTLSQLLQIA 128
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQ 511
++A + Y+ AS HRD+ + N L+ K+ DFG SR V D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570
+ PE ++T +SDV+SFGVVL E+ T GK+P ++ L+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP--------------WY-GLSN 230
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
E +++E + + V ++ +GC + + ++R +K + L+
Sbjct: 231 E-EVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-30
Identities = 73/214 (34%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG+G FG V D G + A+K + + I + ++E + E ILS+INH IVKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 398 CCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 455
+TE + LV EY G L H+ + S E R R A E+
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL----------------SKEGRFS-EERARFYAAEI 102
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A+ Y+HS I +RD+K NILLD K++DFG ++ + ++ + T GT
Sbjct: 103 VLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPE 158
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE Y D +S GV+L E+LTGK P
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 68/221 (30%), Positives = 106/221 (47%), Gaps = 29/221 (13%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR--SRAIDKTQIEQFINEVVILSQINHRH 391
NY +G+G FG VYKG+ L G VA+K+ I + ++ + E+ +L + H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IVK +G ++ ++ EY NG+L I E SL V
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE------------SL-------V 101
Query: 452 AC---EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
A +V +AY+H + HRDIK++NIL K++DFG + + ND +
Sbjct: 102 AVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDA 157
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+V GT + PE + S + SD++S G ++ELLTG P
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 36/281 (12%)
Query: 341 FLGQGGFGTVYKGM-LPDGSIVAVKR--SRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FGTV K DG I+ K + + + +Q ++EV IL ++ H +IV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 398 CCL--ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
+ + +V EY G L+ I Q+ +++++ +EEE R+ ++
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIW---------RILTQL 114
Query: 456 AGAVAYMH--SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
A+ H S + HRD+K +NI LD + K+ DFG ++ + +D + T V GT
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
Y PE Y +KSD++S G ++ EL P + + S KE K
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKEGK 226
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
I R + E E+ L ++ KRP+ ++
Sbjct: 227 FRRI-PYRYSSELN--------EVIKSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 37/272 (13%)
Query: 342 LGQGGFGTVYKGMLP-DGSIVAVKRS--RAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G FG V+K + D + A+K+ +++ + E+ I+E +L++++ +I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
L+ +V EY NG L + ++ + L E+Q W R ++
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-----MQRGRPLPEDQ-----VW----RFFIQILLG 113
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+A++HS I HRDIKS N+ LD + K+ D G ++ + +D T+ + GT Y
Sbjct: 114 LAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLS 169
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 578
PE + Y +KSDV++ GVVL E TGK P + N A + + +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRG------- 216
Query: 579 DARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610
V + + +A+L CL + ++RP
Sbjct: 217 ---VFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 338 QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ--IEQFINEVVILSQINHRHIVK 394
+ +G G FG VY + L G ++AVK R D I++ +E+ +L + H ++VK
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
G + E + EY S GTL EE E + E+ +RV
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTL-----------------EELLEHGRILDEHVIRVYTL 106
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++ +AY+HS I HRDIK +NI LD K+ DFG + + N+ T + VQ
Sbjct: 107 QLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 514 FG---YFDPEYFQSSQYTDK---SDVYSFGVVLLELLTGKKP 549
G Y PE + +D++S G V+LE+ TGK+P
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 70/215 (32%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 340 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
R +G+G FG V D + A+K + + ++K + +NE IL ++NH +V L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 454
+ E LV + + G L +H+ QK + EEQ V+ CE
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFSEEQ----------VKFWICE 108
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ A+ Y+HS I HRDIK NILLD++ ++DF + V D LTT+ GT
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTP 163
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GY PE Y+ D +S GV E L GK+P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 36/255 (14%)
Query: 339 SRFLGQGGFGTVYKGMLP-----DGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHI 392
+ LG+G FG V G VAVK ++ F E+ IL ++H +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 393 VKLLGCCLET--EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
VK G C + L+ EY+ +G+L ++ H+ Q K+ L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL---------------L 113
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ ++ + Y+ S I HRD+ + NIL++ + K+SDFG ++ +P DK +
Sbjct: 114 FSSQICKGMDYLGSQRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKE 170
Query: 511 QGTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC--------LTREEEERN 560
G F PE ++S+++ SDV+SFGV L EL T P + + +
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM 230
Query: 561 LVAYFISLAKENKLL 575
+V + L KE + L
Sbjct: 231 IVTRLLELLKEGERL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
N + +G+G G VYK G VA+K+ R + K E INE++I+ H +I
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNI 77
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V L + +V EY+ G+L+ I + + E Q V
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQ---------IAYVC 122
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
EV + Y+HS I HRDIKS NILL S K++DFG + + +K+ + V G
Sbjct: 123 REVLQGLEYLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-G 178
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T + PE + Y K D++S G++ +E+ G+ P
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 71/219 (32%), Positives = 112/219 (51%), Gaps = 27/219 (12%)
Query: 340 RFLGQGGFGTVYKGML--PDGSIV--AVKR-SRAIDKTQIEQFINEVVILSQINHRHIVK 394
R +G+G FG VY G L DG + AVK +R D ++EQF+ E +I+ +H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 395 LLGCCLETE-VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LLG CL +E P++V Y+ +G L + I K + +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK---------------DLIGFGL 105
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN---DKTHLTTAV 510
+VA + Y+ AS HRD+ + N +LD+ F+ KV+DFG +R + + H T
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ + E Q+ ++T KSDV+SFGV+L EL+T P
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 35/220 (15%)
Query: 342 LGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+G G FG V +G L VA+K ++ + DK +++ F+ E I+ Q +H +I++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
G ++ +++ EY+ NG+L + ++ + + V + +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGK---------------FTVGQLVGMLRGI 115
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-----V 510
A + Y+ + + HRD+ + NIL++ KVSDFG SR + + + TT +
Sbjct: 116 ASGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ T PE ++T SDV+SFG+V+ E+++ G++P
Sbjct: 173 RWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 75/299 (25%), Positives = 135/299 (45%), Gaps = 38/299 (12%)
Query: 342 LGQGGFGTVYKGM------LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQINHRHIVK 394
LG+G FG V K + VAVK +++ ++E +L Q+NH H++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQ--------QQEQKQELEEEQELSSLSWE 446
L G C + +L+ EY G+L + + ++ + + + +L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ + A +++ + Y+ A + + HRD+ + N+L+ + K+SDFG SR V + +++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 507 TTAVQGTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563
+ +G + E YT +SDV+SFGV+L E++T G P
Sbjct: 185 KRS-KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-------------- 229
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
+ +A E L +L E E E + L + C + KRPT +S +LE +
Sbjct: 230 -YPGIAPER-LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCL 400
+G+G FG VYKG+L + VAVK R+ +F+ E IL Q +H +IVKL+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+ + +V E + G+L + + + K+ L+ ++ + A +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ---------------MSLDAAAGME 107
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT----FGY 516
Y+ S I HRD+ + N L+ + K+SDFG SR ++ + T G +
Sbjct: 108 YLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKW 161
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546
PE +YT +SDV+S+G++L E +
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 43/282 (15%)
Query: 340 RFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ-----IEQFINEVVILSQINHRHIV 393
LG G FG+VY+G+ L DG AVK D Q ++Q E+ +LS++ H +IV
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+ LG E + + E + G+L+ + + E L Q L L
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL---------- 115
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
Y+H ++ HRDIK +NIL+D K++DFG ++ V + + +G+
Sbjct: 116 ------EYLHDRNTV---HRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGS 164
Query: 514 FGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572
+ PE Q Y +D++S G +LE+ TGK P + VA + +
Sbjct: 165 PYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSK 218
Query: 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
+L I D ++ EA+ + + CL+ + RPT +
Sbjct: 219 ELPPIPD-HLSDEAK--------DFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 12/216 (5%)
Query: 342 LGQGGFGTVY----KGMLP--DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
LG+G FG V+ +LP D +VAVK + ++ + F E +L+ + H+HIV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
G C E ++V+EY+ +G L+ + H + E+ L+ + +A ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAG-GEDVAPGQLTLGQMLAIASQI 131
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTF 514
A + Y+ AS+ HRD+ + N L+ K+ DFG SR + D +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T +SD++SFGVVL E+ T GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
R LG G FG V++G+ + VA+K ++ D + + F EV L ++ H+H++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
E ++ E + G+L + + Q L + +AC+VA +
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL--------------IDMACQVAEGM 117
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
AY+ SI HRD+ + NIL+ + KV+DFG +R + + +L++ + + + P
Sbjct: 118 AYLEEQNSI---HRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAP 173
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E ++ KSDV+SFG++L E+ T G+ P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 69/212 (32%), Positives = 113/212 (53%), Gaps = 26/212 (12%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LG G FG V+ G VA+K R ++ + FI E ++ +++H ++V+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
+V EY++NG L +++ +E+K +L E L + +V A+ Y
Sbjct: 71 QRPIFIVTEYMANGCLLNYL------RERKGKLGTEWLLD---------MCSDVCEAMEY 115
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---FGYFD 518
+ S I HRD+ + N L+ + KVSDFG +R V +D+ T+ QGT +
Sbjct: 116 LESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAP 169
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE F S+++ KSDV+SFGV++ E+ + GK P
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
+G G FG V+ G + VA+K R ++ E FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
LV+E++ +G LS ++ + S E + + +V +AY
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQR---------------GKFSQETLLGMCLDVCEGMAY 115
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 521
+ S+ I HRD+ + N L+ + KVSDFG +R V +D+ +T + + PE
Sbjct: 116 LESSNVI---HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 522 FQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
F S+Y+ KSDV+SFGV++ E+ + GK P
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
R LG G FG V+ G + VAVK + + E F+ E I+ ++ H +V+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYA 68
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
C E E +V EY+S G+L + + E L V +A ++A
Sbjct: 69 VCSEEEPIYIVTEYMSKGSL--------------LDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---F 514
+AY+ S I HRD+ + NIL+ + K++DFG +R + +D+ TA +G
Sbjct: 115 GMAYLESRNYI---HRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPI 168
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T KSDV+SFG++L E++T G+ P
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/223 (28%), Positives = 115/223 (51%), Gaps = 34/223 (15%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKR---------SRAIDKTQIEQFINEVVILSQINHRH 391
+G G FG+VY GM G ++AVK+ S+ ++ ++ E+ +L ++ H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV+ LG L+ + + EY+ G+++ ++++ +E Q L L+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN------- 120
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--- 508
Y+H+ I HRDIK +NIL+D+K K+SDFG S+ + + T
Sbjct: 121 ---------YLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 509 --AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
++QG+ + PE + + YT K+D++S G +++E+LTGK P
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 73/284 (25%), Positives = 126/284 (44%), Gaps = 48/284 (16%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
+G+G FG V G G VAVK + D T + F+ E +++ + H ++V+LLG L+
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
+V EY++ G+L + + + ++ ++ A +V + Y
Sbjct: 72 GNPLYIVTEYMAKGSLV--------------DYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 521
+ HRD+ + N+L+ + AKVSDFG ++ + V+ T PE
Sbjct: 118 LEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEA 170
Query: 522 FQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
+ +++ KSDV+SFG++L E+ + G+ P R L +++
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRI-----------------PLKDVVPH 211
Query: 581 RVAKEAREEDIE----AVAELAMGCLRLNSKKRPTMKQVSMDLE 620
V K R E E V ++ C L+ KRPT KQ+ L
Sbjct: 212 -VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 65/237 (27%), Positives = 112/237 (47%), Gaps = 24/237 (10%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR---AIDKTQIEQFINEVVILSQIN 388
N+ + +G+G F VYK + L DG +VA+K+ + +D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H +++K L +E +V E G LS I + ++QK+ + E W+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMI---KHFKKQKRLIPERT-----IWKYF 112
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
V ++ A+ +MHS I HRDIK +N+ + K+ D G R + KT
Sbjct: 113 V----QLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAH 164
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
++ GT Y PE + Y KSD++S G +L E+ + P ++ NL +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLC 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 31/218 (14%)
Query: 340 RFLGQGGFGTVYK-GMLPDGSIVAVKRS--RAIDKTQIEQFINEVVILSQINHRHIVK-- 394
+ LG+G +G+VYK L D A+K ++ + + E +NE+ IL+ +NH +I+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 395 ---LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
L G L +V EY G LS I +++++++ + E+ W R+
Sbjct: 66 EAFLDGNKL-----CIVMEYAPFGDLSKAI---SKRKKKRKLIPEQ-----EIW----RI 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
++ + +H I HRD+KS+NILL K+ D G S+ + K ++
Sbjct: 109 FIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE ++ Y+ KSD++S G +L E+ T P
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 66/220 (30%), Positives = 115/220 (52%), Gaps = 14/220 (6%)
Query: 342 LGQGGFGTVYKG--MLPDG----SIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
LG+G FG VYKG P+ + VA+K + A K Q ++F E ++S + H +IV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIV 71
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LLG C + + +++EY+++G L + + + E +E SSL + + +A
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 512
++A + Y+ +S HRD+ + N L+ + + K+SDFG SR + D + +
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC 551
+ PE ++T +SD++SFGVVL E+ + G +P
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 80/299 (26%), Positives = 142/299 (47%), Gaps = 40/299 (13%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKR-SRAIDKTQIEQFINE 380
EL R + R LGQG FG VY+G+ + G VA+K + + +F+NE
Sbjct: 2 ELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 381 VVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440
++ + N H+V+LLG + ++V E ++ G L ++ + ++ E E L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL------RSRRPEAENNPGL 113
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500
+ + +++A E+A +AY+ A+ HRD+ + N ++ + + K+ DFG +R +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI- 169
Query: 501 NDKTHLTTAVQGTFG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP-ICLTREE 556
+ + +G + PE + +T KSDV+SFGVVL E+ T ++P L+ EE
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE 229
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
V F+ + L++ E + + EL C + N K RPT ++
Sbjct: 230 -----VLKFV---IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 71/246 (28%), Positives = 115/246 (46%), Gaps = 37/246 (15%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGM---LPDGSI---VAVKRSRAIDKTQIEQ-FINEVV 382
+ D+ R LG G FG VY+G+ ++ VAVK Q E F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 383 ILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSS 442
I+S+ NH++IV+L+G E ++ E ++ G L + +++ + E+ SS
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERP---------SS 112
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS---AKVSDFGTSRSV 499
L+ ++ + A +VA Y+ I HRDI + N LL K AK++DFG +R +
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
Query: 500 -------PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI- 550
+ L + PE F +T K+DV+SFGV+L E+ + G P
Sbjct: 170 YRASYYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223
Query: 551 CLTREE 556
T +E
Sbjct: 224 GRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 50/287 (17%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVK----------RSRAIDKTQIEQFINEVVILSQINHR 390
+G+G +G VY + + G ++AVK R + K ++ +E+ L ++H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV+ LG E + EY+ G++ + + + +EQ EQ L L
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGL------- 121
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTA 509
AY+HS I HRD+K+ N+L+D K+SDFG S+ + + +
Sbjct: 122 ---------AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169
Query: 510 VQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567
+QG+ + PE S Y+ K D++S G V+LE+ G++P + EE +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--WSDEEA----IAAMFK 223
Query: 568 LAKENK---LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
L + + + ++ A + C +N RPT
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVAL--------DFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 28/216 (12%)
Query: 342 LGQGGFGTVYKG--MLPDGSI--VAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLL 396
LG G FG+V KG ++ G VAVK + ++F+ E +++Q++H IV+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C E +LV E G L ++ + E A +VA
Sbjct: 63 GVCKG-EPLMLVMELAPLGPLLKYLKKRR----------EIPVSDLKEL------AHQVA 105
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF-- 514
+AY+ S + HRD+ + N+LL ++ AK+SDFG SR++ + G +
Sbjct: 106 MGMAYLESKHFV---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
++ PE +++ KSDV+S+GV L E + G KP
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 84/295 (28%), Positives = 136/295 (46%), Gaps = 32/295 (10%)
Query: 340 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG V+ + P D +VAVK + + F E +L+ + H HIV
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
K G C+E + ++V+EY+ +G L+ + H E EL+ + +A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ---SQMLHIAQ 127
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 512
++A + Y+ AS HRD+ + N L+ + K+ DFG SR V D +
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571
+ PE ++T +SDV+S GVVL E+ T GK+P Y +S
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-------------WYQLS---N 228
Query: 572 NKLLE-ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
N+++E I RV + R E V +L +GC + R +K++ L+ L ++
Sbjct: 229 NEVIECITQGRVLQRPRTCPKE-VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/298 (25%), Positives = 135/298 (45%), Gaps = 45/298 (15%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI--VAVKRSRA--IDKTQIEQFINEVVILSQINHRHIV 393
+ LG+G FG+V +G L DGS VAVK + ++IE+F++E + +H +++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 394 KLLGCCLETE------VPVLVYEYISNGTL-SHHIHDHQQQQEQKQELEEEQELSSLSWE 446
KL+G C E P+++ ++ +G L S ++ +K L Q L
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QTL------ 115
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 505
++ ++A + Y+ + I HRD+ + N +L + + V+DFG S+ + + D
Sbjct: 116 --LKFMVDIALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564
+ + E YT KSDV++FGV + E+ T G+ P E +
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY--- 227
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
L N+L + E+ ++ + +L C R + K RPT ++ LE +
Sbjct: 228 ---LRHGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 73/311 (23%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQINHRHIVKLL 396
+G+G +G VYK G +VA+K+ R ++ E F I E+ +L ++ H +IV+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 397 GCCLETEVP--VLVYEYIS---NGTLSHHIHDHQQQQEQ---KQELEEEQELSSLSWENR 448
+V+EY+ G L + Q + KQ LE
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE------------- 111
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
+ Y+HS I HRDIK SNIL+++ K++DFG +R + T
Sbjct: 112 ---------GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 509 AVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKP---------------ICL 552
T Y PE +++Y + D++S G +L EL GK +C
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCG 219
Query: 553 TREEEE----RNLVAYFISLA----KENKLLEILDARVAKEAREEDIEAVAELAMGCLRL 604
+ +E L +F +L + +L E + A +L L L
Sbjct: 220 SPTDENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSA--------LDLLDKLLTL 270
Query: 605 NSKKRPTMKQV 615
+ KKR + Q
Sbjct: 271 DPKKRISADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 28/212 (13%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
LG+G +G+VYK + G +VA+K + +++ I E+ IL Q + +IVK G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV- 459
+ +V EY G++S + + K L EE+ +A + +
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM-----KITNKT-LTEEE------------IAAILYQTLK 110
Query: 460 --AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
Y+HS I HRDIK+ NILL+++ AK++DFG S + D V GT +
Sbjct: 111 GLEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWM 166
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Q Y +K+D++S G+ +E+ GK P
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 63/220 (28%), Positives = 112/220 (50%), Gaps = 26/220 (11%)
Query: 338 QSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHI 392
+ + +G G FG V++G+L VA+K + + Q + F++E I+ Q +H +I
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
++L G + + +++ EY+ NG L ++ DH + E SS +R
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDH------------DGEFSSYQLVGMLR-- 114
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK--THLTTAV 510
G A M + + HRD+ + NIL++ KVSDFG SR + +D T+ T+
Sbjct: 115 ----GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGG 170
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ + PE ++T SDV+SFG+V+ E+++ G++P
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 69/212 (32%), Positives = 115/212 (54%), Gaps = 26/212 (12%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LG G FG V G VA+K + ++ ++FI E ++ +++H +V+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC-T 69
Query: 402 TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+ P+ +V EY+SNG L +++ +H ++ + Q LE + +V +A
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE---------------MCKDVCEGMA 114
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF--GYFD 518
Y+ S I HRD+ + N L+DD+ KVSDFG SR V +D+ T++V F +
Sbjct: 115 YLESKQFI---HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 169
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE S+++ KSDV++FGV++ E+ + GK P
Sbjct: 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 342 LGQGGFGTVYKGML--PDGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGC 398
LG G G V K +L P G I+AVK R I++ +Q + E+ IL + N +IV G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 399 CL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
++ + EY+ G+L + +E + + E L ++A V
Sbjct: 68 FYNNGDI-SICMEYMDGGSLD------KILKEVQGRIPERI----LG-----KIAVAVLK 111
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+ Y+H I HRD+K SNIL++ + K+ DFG S + N L GT Y
Sbjct: 112 GLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFVGTSSYM 166
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
PE Q + Y+ KSD++S G+ L+EL TG+ P
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 73/229 (31%), Positives = 115/229 (50%), Gaps = 29/229 (12%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSI--VAVKRSRA-IDKTQIEQFINEVV 382
E+QR ++ R +G+G FG VY+G M P+ VAVK + + E+F+ E
Sbjct: 2 EIQR--EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 383 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
I+ Q +H HIVKL+G TE PV +V E G L ++ Q K L +L+
Sbjct: 60 IMRQFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYL------QVNKYSL----DLA 107
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
SL + + +++ A+AY+ S HRDI + N+L+ K+ DFG SR + +
Sbjct: 108 SL-----ILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ + + + + PE ++T SDV+ FGV + E+L G KP
Sbjct: 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 59/216 (27%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 342 LGQGGFGTVYKGM-LPDGS----IVAVKRSR-AIDKTQIEQFINEVVILSQINHRHIVKL 395
LG G FGTVYKG+ +P+G VA+K R ++ ++E +++ ++H H+V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
LG CL + L+ + + G L ++ +H+ + L+W ++
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHK---------DNIGSQYLLNW------CVQI 118
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTF 514
A ++Y+ + HRD+ + N+L+ K++DFG ++ + D+ +
Sbjct: 119 AKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ E YT KSDV+S+GV + EL+T G KP
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQINHR 390
Y + LG+G +G VYK G IVA+K+ R +D + E + E+ +L ++ H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDN-EEEGIPSTALREISLLKELKHP 58
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IVKLL LV+EY L ++ + S+ ++
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-------LSPNLIKSIMYQ---- 106
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ +AY HS I HRD+K NIL++ K++DFG +R+ T V
Sbjct: 107 ----LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159
Query: 511 QGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
T Y PE S Y+ D++S G + E++TGK
Sbjct: 160 V-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 63/206 (30%), Positives = 106/206 (51%), Gaps = 19/206 (9%)
Query: 341 FLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 399
LG+G FG V+KG L D + VAVK + +++ +F++E IL Q +H +IVKL+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ + +V E + G + +++K EL+ +Q V+ A + A +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQ---------LVKFALDAAAGM 106
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
AY+ S I HRD+ + N L+ + K+SDFG SR + + Q + P
Sbjct: 107 AYLESKNCI---HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLT 545
E +Y+ +SDV+S+G++L E +
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 49/235 (20%)
Query: 342 LGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQI-----EQFIN-EVVILSQIN-HRHIV 393
+G+G F TV A+K +DK Q+ +++ E +L+++N H I+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKI---LDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
KL + E V EY NG L +I + SL + A
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRKY----------------GSLDEKCTRFYAA 109
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ-- 511
E+ A+ Y+HS I HRD+K NILLD K++DFGT++ + + + +
Sbjct: 110 EILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 512 -----------------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE SD+++ G ++ ++LTGK P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 79/315 (25%), Positives = 137/315 (43%), Gaps = 70/315 (22%)
Query: 342 LGQGGFGTVY------------KGMLPDGS-----IVAVKRSRA-IDKTQIEQFINEVVI 383
LG+G FG V+ K + + +VAVK R E F+ EV I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
LS+++ +I +LLG C ++ EY+ NG L+ + H + SL
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC-----NSKSL 127
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PND 502
S+ + +A ++A + Y+ S+ HRD+ + N L+ ++ K++DFG SR++ +D
Sbjct: 128 SFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 503 KTHLTTAVQGTFGYFD-------P------EYFQSSQYTDKSDVYSFGVVLLELLT--GK 547
Y+ P E ++T KSDV++FGV L E+LT +
Sbjct: 185 -------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 548 KPI-CLTREEEERNLVAYFISLAKENKLLEILD--ARVAKEAREEDIEAVAELAMGCLRL 604
+P LT ++ N +F +++ L K+ + EL + C R
Sbjct: 232 QPYEHLTDQQVIENAGHFF----RDDGRQIYLPRPPNCPKD--------IYELMLECWRR 279
Query: 605 NSKKRPTMKQVSMDL 619
+ + RPT +++ + L
Sbjct: 280 DEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
R LG G FG V++G+ + + VAVK + + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
E +V E + G+L ++ +L + +A +VA +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--------------GAGRALKLPQLIDMAAQVASGM 116
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
AY+ + I HRD+ + N+L+ + KV+DFG +R + D + + P
Sbjct: 117 AYLEAQNYI---HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAP 173
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E ++++ KSDV+SFG++L E++T G+ P
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 27/294 (9%)
Query: 340 RFLGQGGFGTVY----KGMLP--DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG V+ + P D +VAVK + + F E +L+ + H HIV
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
K G C + + ++V+EY+ +G L+ + H + + Q L + +A
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQG 512
++A + Y+ AS HRD+ + N L+ K+ DFG SR V D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571
+ PE ++T +SDV+SFGV+L E+ T GK+P + L+
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---------------WFQLSNT 232
Query: 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+ I RV + R E V ++ +GC + ++R +K++ L L ++
Sbjct: 233 EVIECITQGRVLERPRVCPKE-VYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 28/225 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID----KTQIEQFINEVVILSQIN 388
D+Y +G G VY + LP+ VA+KR ID +T +++ EV +SQ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H ++VK + + LV Y+S G+L I + +E +++
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSSY----PRGGLDEAIIAT------ 106
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHL 506
V EV + Y+HS I HRDIK+ NILL + S K++DFG S S+ D+T
Sbjct: 107 --VLKEVLKGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
Query: 507 T-TAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKP 549
GT + PE + Y K+D++SFG+ +EL TG P
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 43/287 (14%)
Query: 342 LGQGGFGTVYKG--MLPDGSI--VAVKRSRAIDKTQI-EQFINEVVILSQINHRHIVKLL 396
LG G FG V +G G + VAVK ++ + I + F+ E I+ ++H ++++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G L T ++V E G+L + L A ++A
Sbjct: 63 GVVL-THPLMMVTELAPLGSLLDRLRKDA--------------LGHFLISTLCDYAVQIA 107
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT--F 514
+ Y+ S I HRD+ + NILL K+ DFG R++P ++ H F
Sbjct: 108 NGMRYLESKRFI---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 573
+ PE ++ ++ SDV+ FGV L E+ T G++P + L+ +
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP---------------WAGLSGS-Q 208
Query: 574 LLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDL 619
+L+ +D + R E + + + + C N RPT + L
Sbjct: 209 ILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 68/246 (27%), Positives = 122/246 (49%), Gaps = 35/246 (14%)
Query: 337 NQSRF---LGQGGFGTV----------YKGMLPDG-----SIVAVKRSRA-IDKTQIEQF 377
Q R LG+G FG V + G +VAVK RA + KT F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 378 INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
+ E+ I+S++ + +I++LLG C+ + ++ EY+ NG L+ + Q+E +
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL----SQREIESTFTHA 120
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
+ S+S N + +A ++A + Y+ AS+ HRD+ + N L+ + ++ K++DFG SR
Sbjct: 121 NNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 498 SVPNDKTHLTTAVQG----TFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL--LTGKKPIC 551
++ + + +QG + E ++T SDV++FGV L E+ L ++P
Sbjct: 178 NLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
Query: 552 LTREEE 557
L +E+
Sbjct: 235 LLSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 3e-22
Identities = 76/303 (25%), Positives = 149/303 (49%), Gaps = 46/303 (15%)
Query: 342 LGQGGFGTVY----KGMLP-------------DGSIVAVKRSRA-IDKTQIEQFINEVVI 383
LG+G FG V+ +GM +VAVK R +K F+ E+ I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
+S++ +I++LL C+ ++ ++ EY+ NG L+ + H+ Q+ ++ ++ ++
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA-----DVVTI 127
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
S+ + +A ++A + Y+ +S+ HRD+ + N L+ ++ K++DFG SR++ +
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD 184
Query: 504 THLTTAVQG----TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPIC-LTREE 556
+ +QG + E ++T SDV++FGV L E+LT ++P L+ E+
Sbjct: 185 YY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616
N +F ++ L K A D ++ +L + C R N+K+RP+ +++
Sbjct: 242 VIENTGEFFRDQGRQVYLP--------KPALCPD--SLYKLMLSCWRRNAKERPSFQEIH 291
Query: 617 MDL 619
L
Sbjct: 292 ATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 65/232 (28%), Positives = 114/232 (49%), Gaps = 20/232 (8%)
Query: 334 DNYNQSRFLGQGGFGTVYK----GMLP--DGSIVAVK--RSRAIDKTQIEQFINEVVILS 385
+N R +GQG FG V++ G+LP ++VAVK + A Q + F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMA 63
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHD------HQQQQEQKQELEEEQE 439
+ +H +IVKLLG C + L++EY++ G L+ + +
Sbjct: 64 EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499
LS ++ +A +VA +AY+ + HRD+ + N L+ + K++DFG SR++
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 500 -PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
D + + PE ++YT +SDV+++GVVL E+ + G +P
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 5e-22
Identities = 76/296 (25%), Positives = 140/296 (47%), Gaps = 40/296 (13%)
Query: 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIE--------QFINEVVI 383
A + SR LGQG FG VY+G + G + +R KT E +F+NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
+ + N H+V+LLG + + +++ E ++ G L ++ + + E+E +
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL------RSLRPEMENNPVQAPP 116
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
S + +++A E+A +AY+++ + HRD+ + N ++ + F+ K+ DFG +R + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDI-YET 172
Query: 504 THLTTAVQGTFG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEER 559
+ +G + PE + +T SDV+SFGVVL E+ T ++P ++ E+ R
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232
Query: 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
E LL+ D + + EL C + N K RP+ ++
Sbjct: 233 --------FVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 82/285 (28%), Positives = 132/285 (46%), Gaps = 39/285 (13%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF--INEVVILSQINHRH 391
Y + R +G+G FG V+ D +V +K+ T+ E+ NE +L ++H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I++ LE + ++V EY GTL+ +I Q+ L+E+ L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFV------- 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ A+ ++H+ I HRD+K+ NILLD K K+ DFG S+ + + K+ T V
Sbjct: 109 --QILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV 162
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
GT Y PE + Y KSD+++ G VL EL + L R E NL A + +
Sbjct: 163 -GTPCYISPELCEGKPYNQKSDIWALGCVLYELAS------LKRAFEAANLPALVLKIMS 215
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
I D R + + R +L + L L+ KRP + Q+
Sbjct: 216 -GTFAPISD-RYSPDLR--------QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLL 396
+G+G FG VYK + +VA+K ID + +IE E+ LSQ +I K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G L+ ++ EY G+ + K +E ++ + +R EV
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL---------KPGKLDETYIAFI-----LR---EVL 108
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ Y+H I HRDIK++NILL ++ K++DFG S + + + T V GT +
Sbjct: 109 LGLEYLHEEGKI---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFW 164
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
PE + S Y +K+D++S G+ +EL G+ P+
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 77/289 (26%), Positives = 121/289 (41%), Gaps = 42/289 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-----SRAIDKTQIEQFINEVVILSQIN 388
N+ + + LGQG FG VY D G +AVK+ K ++ E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H IV+ GC + E + EY+ G++ + + E Q L
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE------- 115
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT- 507
V Y+HS I HRDIK +NIL D + K+ DFG S+ + + T
Sbjct: 116 ---------GVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG 163
Query: 508 -TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
+V GT + PE Y K+DV+S G ++E+LT K P E +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW------AEFEAMAAIF 217
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+A + + L + V+ +AR N+KKRP+ +++
Sbjct: 218 KIATQPTNPQ-LPSHVSPDAR--------NFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 67/237 (28%), Positives = 118/237 (49%), Gaps = 36/237 (15%)
Query: 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAI------DKTQI 374
+I EL+R + LG G FGTVYKG+ +P+G V + + I K +
Sbjct: 2 RILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 375 EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL 434
E F++E +I++ ++H H+V+LLG CL + LV + + +G L ++H+H+ +
Sbjct: 55 E-FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL-- 110
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
L+W ++A + Y+ + HRD+ + N+L+ K++DFG
Sbjct: 111 -------LLNW------CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFG 154
Query: 495 TSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+R + D K + + + E ++T +SDV+S+GV + EL+T G KP
Sbjct: 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 72/226 (31%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 340 RFLGQGGFGTVYKGMLPD------GSI-VAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
FLG G FG VY+G D G I VAVK R A D+ + E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IVKLLG CL E ++ E + G L ++ D + ++ L L L +
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLL----TLKEL-----LD 110
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA-----KVSDFGTSRSV-PNDKT 504
+ +VA Y+ I HRD+ + N L+ +K K+ DFG +R + +D
Sbjct: 111 ICLDVAKGCVYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T +SDV+SFGV++ E+LT G++P
Sbjct: 168 RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 4e-21
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN-----EVVILSQIN 388
Y + + LG+G + VYK G IVA+K+ + ++ + + IN E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQ---QQQEQKQELEEEQELSSLSW 445
H +I+ LL LV+E++ L I D + K + L +L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYM-----LMTLR- 113
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
+ Y+HS I HRD+K +N+L+ K++DFG +RS +
Sbjct: 114 ------------GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
Query: 506 LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
+T V T Y PE F + Y D++S G + ELL
Sbjct: 159 MTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 31/290 (10%)
Query: 342 LGQGGFGTVYKGML------PDGSIVAVK--RSRAIDKTQIEQFINEVVILSQI-NHRHI 392
LG+G FG V K + S VAVK + A +K + ++E+ ++ I H++I
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVSEMEMMKMIGKHKNI 78
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+ LLG C + +V EY ++G L + + E + +L+ ++ V A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQ 511
+VA + ++ AS HRD+ + N+L+ + K++DFG +R + + D TT +
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570
+ PE YT +SDV+SFGV+L E+ T G P EE L K
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLK 248
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
E +E + +E + L C +RPT KQ+ DL+
Sbjct: 249 EGYRME----KPQNCTQE-----LYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 342 LGQGGFGTVYKGML-PDGSI--VAVKRSR-AI-DKTQIEQFINEVVILSQINHRHIVKLL 396
LG+G FG+V +G L D SI VAVK + AI ++++E F++E V + + +H ++++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 397 GCCLETE------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
G CL+T PV++ ++ +G L H + + + Q L + V+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDL-HSFLLYSRLGDCPQYLPTQM---------LVK 116
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTA 509
++A + Y+ S + I HRD+ + N +L++ + V+DFG S+ + N D
Sbjct: 117 FMTDIASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 568
+ + E YT KSDV+SFGV + E+ T G+ P E + L
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE------IYDYL 227
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
+ N+L + D ++ + L C LN K RP+ + + +LE
Sbjct: 228 RQGNRLKQPPDC----------LDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 7e-21
Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 336 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKR------SRAIDKTQIEQFINEVVILSQINH 389
+ + LG+G +GTVY G+ G ++AVK+ + + + E+ EV +L + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+IV+ LG CL+ + E++ G++S L L +
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSIS-------------SILNRFGPLPEPVFCKYT 108
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-----SVPNDKT 504
+ ++ VAY+H+ + HRDIK +N++L K+ DFG +R + +
Sbjct: 109 K---QILDGVAYLHNNCVV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
++ ++ GT + PE S Y KSD++S G + E+ TGK P+
Sbjct: 163 NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 28/213 (13%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LG G FG V+ G + VAVK + E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVV-- 70
Query: 402 TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+E P+ +V EY+S G+L + D + + +L N V +A +VA +A
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGR--------------ALKLPNLVDMAAQVAAGMA 116
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT---FGYF 517
Y+ I HRD++S+NIL+ D K++DFG +R + +++ TA QG +
Sbjct: 117 YIERMNYI---HRDLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWT 170
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++T KSDV+SFG++L EL+T G+ P
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 40/283 (14%)
Query: 342 LGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 399
+G+G FG V+ G L D + VAVK R ++ +F+ E IL Q +H +IV+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ + +V E + G + E L + +++ A +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---------------RTEGPRLKVKELIQMVENAAAGM 107
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA--VQGTFGYF 517
Y+ S I HRD+ + N L+ +K K+SDFG SR D + +T Q +
Sbjct: 108 EYLESKHCI---HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWT 163
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLE 576
PE +Y+ +SDV+SFG++L E + G P ++ R E
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------E 207
Query: 577 ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
++ V E +AV L C + +RP+ V +L
Sbjct: 208 AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 78/301 (25%), Positives = 135/301 (44%), Gaps = 47/301 (15%)
Query: 342 LGQGGFGTVYK---GMLPD--GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLL 396
LG+G FG+V L D G +VAVK+ + + F E+ IL + H +IVK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 397 GCCLETEVP--VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
G C LV EY+ G+L ++ H+++ + ++ L A +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL---------------YASQ 116
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG-- 512
+ + Y+ S + HRD+ + NIL++ + K+ DFG ++ +P DK + G
Sbjct: 117 ICKGMEYLGSKRYV---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 513 -TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC---------LTREEEERNLV 562
F Y PE S+++ SDV+SFGVVL EL T C + +++ + +V
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
+ I L K N L A+ + + C + +RP+ ++++ +E +
Sbjct: 233 YHLIELLKNNGRLPAPPGCPAE---------IYAIMKECWNNDPSQRPSFSELALQVEAI 283
Query: 623 R 623
R
Sbjct: 284 R 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 76/288 (26%), Positives = 133/288 (46%), Gaps = 46/288 (15%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
LG G +G VY+G+ VAVK + D ++E+F+ E ++ +I H ++V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
++ E+++ G L ++ + QE++++ + +A +++ A+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC-----------NRQEVNAVVL---LYMATQISSAME 118
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+ I HRD+ + N L+ + KV+DFG SR + D + + PE
Sbjct: 119 YLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY-FISLAKENKLLEIL 578
++++ KSDV++FGV+L E+ T G P Y I L++ +LLE
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLE-- 219
Query: 579 DARVAKEAREEDIEA----VAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
K R E E V EL C + N RP+ ++ E +
Sbjct: 220 -----KGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
Y + +GQG GTVY + + G VA+K+ + + E INE++++ + H +IV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 453
L L + +V EY++ G+L+ + + E ++ C
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 122
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E A+ ++HS I HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQI---EQFINEVVILSQINHRH 391
Y + +G+G FG +Y S V + + K + E EV++L+++ H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV E +V EY G L I Q+ L E ++ LSW
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRI------NRQRGVLFSEDQI--LSW------ 106
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+++ + ++H I HRDIKS NI L + AK+ DFG +R + ND L
Sbjct: 107 FVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTC 162
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE Q+ Y +K+D++S G VL EL T K P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 66/292 (22%), Positives = 134/292 (45%), Gaps = 42/292 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-----RSRAIDKTQI-EQFINEVVILSQI 387
+ + + LG G F + Y+ + G+++AVK R+ + ++ ++ E E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
NH HI+++LG E L E+++ G++SH + + +E ++
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE------------AVI--- 105
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKT-- 504
+ ++ ++Y+H I HRD+K +N+L+D +++DFG + + T
Sbjct: 106 -INYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161
Query: 505 -HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ GT + PE + QY DV+S G V++E+ T K P E+ N +A
Sbjct: 162 GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP---WNAEKHSNHLA 218
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ +I A A E + ++ + CL L + RP +++
Sbjct: 219 L---------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 23/216 (10%)
Query: 335 NYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKR--SRAIDKTQIEQFINEVVILSQINHRH 391
Y +G+G G V+K G VA+K+ R ++ Q + E+ L H +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+VKLL VLV EY+ LS + D EE+ L ++ +R+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRD------------EERPLPEAQVKSYMRM 107
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
+ VAYMH+ I HRD+K +N+L+ K++DFG +R ++ L +
Sbjct: 108 LLK---GVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 512 GTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 546
T Y PE + + +Y D+++ G + ELL G
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 20/211 (9%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ LG G FG V+ G VA+K ++ E FI E ++ +++H +V+L G C
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ + +V E++ NG L +++ ++++ +L ++ LS + +V +
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYL------RQRQGKLSKDMLLS---------MCQDVCEGM 113
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
Y+ + I HRD+ + N L+ KVSDFG +R V +D+ ++ + + P
Sbjct: 114 EYLERNSFI---HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPP 170
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E F S+Y+ KSDV+SFGV++ E+ T GK P
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN--EVVILSQINHRHI 392
Y + +G+G +G VYK G IVA+K+ + +++ E+ +L ++NH +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+KLL LV+E++ L I D Q+ L E + S ++
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR------GLPESL-IKSYLYQ------ 106
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
+ +A+ HS I HRD+K N+L++ + K++DFG +RS + T V
Sbjct: 107 --LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-V 160
Query: 513 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
T Y PE Y+ D++S G + ELL+ +
Sbjct: 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 39/290 (13%)
Query: 342 LGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKTQIEQ----FINEVVILSQINHRH 391
LG+G FG V+ ++V VK A+ KT+ E F E+ + +++H++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V+LLG C E E ++ EY G L + + + K E + LS+ + +V +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFL----RATKSKDEKLKPPPLST---KQKVAL 122
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
++A + ++ +A + HRD+ + N L+ + KVS S+ V N + +
Sbjct: 123 CTQIALGMDHLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570
+ PE Q ++ KSDV+SFGV++ E+ T G+ P F L+
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP---------------FYGLSD 224
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
E L + ++ E + +L C +N K RP+ ++ L
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 340 RFLGQGGFGTV----YKGMLPD-GSIVAVKRSRAIDKTQIEQ-FINEVVILSQINHRHIV 393
R LG+G FG V Y G +VAVK + Q + E+ IL + H +IV
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 394 KLLGCCLET--EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
K GCC E + L+ EY+ G+L ++ H L+ +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-----------------KLNLAQLLLF 112
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A ++ +AY+HS I HRD+ + N+LLD+ K+ DFG +++VP +
Sbjct: 113 AQQICEGMAYLHSQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169
Query: 512 G---TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545
G F ++ E + ++++ SDV+SFGV L ELLT
Sbjct: 170 GDSPVF-WYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 61/250 (24%), Positives = 119/250 (47%), Gaps = 34/250 (13%)
Query: 321 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAI--DKTQIEQF 377
A+I EL++ + LG G FGTV+KG+ +P+G + + + D++ + F
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 378 ---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL 434
+ ++ + ++H +IV+LLG C + LV + G+L H+ H+
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHR--------- 103
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
SL + + ++A + Y+ + HR++ + NILL +++DFG
Sbjct: 104 ------DSLDPQRLLNWCVQIAKGMYYLEEHRMV---HRNLAARNILLKSDSIVQIADFG 154
Query: 495 TSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 552
+ + P+DK + + + + E +YT +SDV+S+GV + E+++ G +P
Sbjct: 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
Query: 553 TREEEERNLV 562
R E +L+
Sbjct: 215 MRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 60/223 (26%), Positives = 110/223 (49%), Gaps = 23/223 (10%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LG G FG V+ G + VA+K + E F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 402 TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
T+ P+ ++ EY+ NG+L + + E L+ + +A ++A +A
Sbjct: 71 TQEPIYIITEYMENGSLVDFL--------------KTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
++ I HRD++++NIL+ + K++DFG +R + +++ + + PE
Sbjct: 117 FIERKNYI---HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEERNL 561
+T KSDV+SFG++L E++T G+ P +T E +NL
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 52/211 (24%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ LG G FG V+ G + + VAVK + ++ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ E ++ EY++ G+L + + E + + + ++A +
Sbjct: 71 TKEEPIYIITEYMAKGSL--------------LDFLKSDEGGKVLLPKLIDFSAQIAEGM 116
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
AY+ I HRD++++N+L+ + K++DFG +R + +++ + + P
Sbjct: 117 AYIERKNYI---HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 173
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E +T KSDV+SFG++L E++T GK P
Sbjct: 174 EAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF-----INEVVILSQIN-HRHIVK 394
LG G FG+VY G +VA+K+ K + + + EV L ++N H +IVK
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L E + V+EY+ G L +Q +++K + E + S+ ++
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNL------YQLMKDRKGKPFSESVIRSIIYQ-------- 107
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ +A++H FHRD+K N+L+ K++DFG +R + + + T V T
Sbjct: 108 ILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-TDYV-STR 162
Query: 515 GYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGK 547
Y PE +S+ Y+ D+++ G ++ EL T +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 81/291 (27%), Positives = 135/291 (46%), Gaps = 50/291 (17%)
Query: 342 LGQGGFGTVYKGMLPDG--SIVAVKR-----------SRAIDKTQIEQFINEVVIL-SQI 387
LG G FG VYK + +++A+K R DK+ I ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS-IGDIVSEVTIIKEQL 66
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H +IV+ LE + +V + I L H +E+KQ EE+ W
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF---NSLKEKKQRFTEER-----IWNI 118
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
V++ A+ Y+H I HRD+ +NI+L + ++DFG ++ ++ LT
Sbjct: 119 FVQMVL----ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLT 171
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567
+ V GT Y PE ++ Y +K+DV++FG +L ++ T + P T +S
Sbjct: 172 SVV-GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----------MLS 220
Query: 568 LAKENKLLEILDARVAKEAREEDI--EAVAELAMGCLRLNSKKRPTMKQVS 616
LA +I++A E E + E V ++ CL +++ RP + QVS
Sbjct: 221 LA-----TKIVEAVY--EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKR---SRAIDKTQIEQFINEVVILSQ 386
D++ + LG G FG V ML G A+K ++ + Q+E +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
I H +V L G + LV EY+ G L H+ + E
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-------RKSGRFPEPV-------- 102
Query: 447 NRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
R A +V A+ Y+HS I +RD+K N+LLD K++DFG ++ V
Sbjct: 103 --ARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T + GT Y PE S Y D ++ G+++ E+L G P
Sbjct: 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 4e-19
Identities = 74/295 (25%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 332 ATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVK--RSRAIDKTQIEQFINEVVI 383
+ + R LGQG FG VY+G D + VAVK A + +IE F+NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASV 62
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
+ H+V+LLG + + ++V E +++G L ++ + + E E
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL------RSLRPEAENNPGRPPP 116
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
+ + +++A E+A +AY+++ + HRD+ + N ++ F+ K+ DFG +R + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDI-YET 172
Query: 504 THLTTAVQGTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560
+ +G + PE + +T SD++SFGVVL E+ + ++P
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP----------- 221
Query: 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ L+ E L ++D + + E V +L C + N K RPT ++
Sbjct: 222 ----YQGLSNEQVLKFVMDGGYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)
Query: 342 LGQGGFGTVY---KGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ +G +G V+ K G I A+K ++ I K Q++Q + E ILSQ ++VKL
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 396 LGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
+ + + LV EY+ G L+ + + + SL + E
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLEN----------------VGSLDEDVARIYIAE 101
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-------SVPNDKTHLT 507
+ A+ Y+HS I HRD+K NIL+D K++DFG S+ ND
Sbjct: 102 IVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT Y PE ++ D +S G +L E L G P
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-19
Identities = 85/363 (23%), Positives = 150/363 (41%), Gaps = 43/363 (11%)
Query: 271 LGFLSLVLLGCYLYKVIREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFTAEELQ 330
LG ++ L + + IR + + LK ++ ++G + LQ S+ +K T ++
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQ-----FFDSKVSKSITINDIL 689
Query: 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSRAIDKTQIEQFINEVVILSQINH 389
+ N + +G G YKG + VK ++ I + + ++ H
Sbjct: 690 SSLKEEN---VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-SSEIAD---MGKLQH 742
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+IVKL+G C + L++EYI LS + L +LSWE R
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLS-------------------EVLRNLSWERRR 783
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
++A +A A+ ++H S + ++ I++D K + + D ++
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
Y PE ++ T+KSD+Y FG++L+ELLTGK P ++V +
Sbjct: 843 -----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCY 896
Query: 570 KENKLLEILDARVAKEA--REEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG-LRRSQ 626
+ L +D + + + +I V LA+ C + RP V LE R S
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
Query: 627 RCV 629
CV
Sbjct: 957 SCV 959
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 71/283 (25%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LGQG FG V+ G + VA+K + E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-- 70
Query: 402 TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+E P+ +V EY+S G+L + + + L V +A ++A +A
Sbjct: 71 SEEPIYIVTEYMSKGSL--------------LDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+ + HRD++++NIL+ + KV+DFG +R + +++ + + PE
Sbjct: 117 YVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKK---PICLTREEEERNLVAYFISLAKENKLLEI 577
++T KSDV+SFG++L EL T + P + RE +L+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------------------VLDQ 215
Query: 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
++ E E++ +L C R ++RPT + + LE
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 7e-19
Identities = 53/190 (27%), Positives = 100/190 (52%), Gaps = 8/190 (4%)
Query: 360 IVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLS 418
+VAVK R +K F+ EV ILS++ +I++LLG C++ + ++ EY+ NG L+
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 419 HHIHDHQ---QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475
+ H +++ + L ++S+ + + VA ++A + Y+ +S+ HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 476 KSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVY 534
+ N L+ + + K++DFG SR++ D + + E ++T SDV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 535 SFGVVLLELL 544
+FGV L E+L
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 73/281 (25%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 342 LGQGGFGTVYK-GMLPDGSIVAVKRSRAID-KTQI-EQFINEVVILSQINHRHIVKLLGC 398
LG G G+V K +P G+++A K+ I K+ + +Q + E+ I+ + +IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
L + E++ G+L I+ ++ + E ++A V
Sbjct: 72 FLNENNICMCMEFMDCGSLDR-IY---------------KKGGPIPVEILGKIAVAVVEG 115
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+ Y+++ I HRDIK SNIL++ + K+ DFG S + N + GT Y
Sbjct: 116 LTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMS 170
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEIL 578
PE Q +YT KSDV+S G+ ++EL GK P + +++ I L++L
Sbjct: 171 PERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI--------LDLL 222
Query: 579 DARVAKEA---REEDIEAVAELAMG-CLRLNSKKRPTMKQV 615
V + D + CL + +RPT +Q+
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 8e-19
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 28/216 (12%)
Query: 342 LGQGGFGTVYKG---MLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLL 396
LG G FGTV KG M VAVK ++ D ++ + E ++ Q+++ +IV+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C E E +LV E G L+ + ++ E+ N + +V+
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEK----------------NITELVHQVS 105
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF-- 514
+ Y+ + HRD+ + N+LL + AK+SDFG S+++ D+ + G +
Sbjct: 106 MGMKYLEETNFV---HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV 162
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
++ PE +++ KSDV+SFGV++ E + G+KP
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 35/218 (16%)
Query: 342 LGQGGFGTVYKG-MLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
+G G +G VYK + G +VA+K + E E+ +L + H +IV G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+ +V EY G+L I+ Q + L E Q +++ V E +A
Sbjct: 71 RRDKLWIVMEYCGGGSLQD-IY-----QVTRGPLSELQ----IAY-----VCRETLKGLA 115
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ------GTF 514
Y+H I HRDIK +NILL + K++DFG S LT + GT
Sbjct: 116 YLHETGKI---HRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTP 165
Query: 515 GYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Y K D+++ G+ +EL + P
Sbjct: 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
DN+ + +G+G G V G VAVK+ + + E NEVVI+ H +I
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V++ L + +V E++ G L+ + + +EQ +
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ------------------IATV 120
Query: 453 CE-VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG----TSRSVPNDKTHLT 507
C V A++++H+ I HRDIKS +ILL K+SDFG S+ VP K+
Sbjct: 121 CLAVLKALSFLHAQGVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--- 174
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT + PE Y + D++S G++++E++ G+ P
Sbjct: 175 --LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 51/243 (20%)
Query: 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSRAI-DKTQIEQFINE 380
FTAE+L+ + +G+G FGTV K ML P G+I+AVKR R+ D+ + ++ + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52
Query: 381 V-VILSQINHRHIVKLLGCCLETEVPVLVYEY--ISNGTLSHHIHDHQQQQEQKQELEEE 437
+ V++ + +IVK G + E IS ++++ K + E
Sbjct: 53 LDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEV-----LKSVIPE- 106
Query: 438 QELSSLSWENRVRVACEVAGAVAYM------HSAASIPIFHRDIKSSNILLDDKFSAKVS 491
E+ G +A + + I HRD+K SNILLD + K+
Sbjct: 107 ----------------EILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLC 150
Query: 492 DFGTSRSVPND--KTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTG 546
DFG S + + KT G Y PE S Y +SDV+S G+ L E+ TG
Sbjct: 151 DFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 547 KKP 549
K P
Sbjct: 207 KFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 43/298 (14%)
Query: 340 RFLGQGGFGTVYKGMLP--DGSI--VAVKRSRA--IDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG+V + L DGS VAVK +A + IE+F+ E + + +H +++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 394 KLLGCCLETE------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
KL+G L + +P+++ ++ +G L + + EE +L +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--------LMSRIGEEP--FTLPLQT 114
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHL 506
VR ++A + Y+ S I HRD+ + N +L++ + V+DFG S+ + D
Sbjct: 115 LVRFMIDIASGMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQ 171
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565
A + + E + YT SDV++FGV + E++T G+ P E + Y
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL 228
Query: 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
I K N+L + D +E V EL C K RP+ + + LE +
Sbjct: 229 I---KGNRLKQPPDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 58/217 (26%), Positives = 110/217 (50%), Gaps = 12/217 (5%)
Query: 342 LGQGGFGTVYKGML-----PDGSIVAVKRSRAIDKTQ-IEQFINEVVILSQINHRHIVKL 395
LG+ FG +YKG L +VA+K + I+ Q +F E ++++++H +IV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACE 454
LG + + +++EY++ G L + + +E+ + SSL + + +A +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGT 513
+A + Y+ S + H+D+ + NIL+ ++ K+SD G SR + D +
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE +++ SD++SFGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKRSRAIDKTQIEQFINEVVILSQ 386
E + D + LG+G +G VY + +A+K D ++ E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDH---QQQQEQKQELEEEQELSSL 443
+ HR+IV+ LG E + E + G+LS + + EQ +Q L L
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPN 501
Y+H I HRDIK N+L++ +S K+SDFGTS+ +
Sbjct: 122 K----------------YLHDNQ---IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAG 161
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKP 549
T GT Y PE Y +D++S G ++E+ TGK P
Sbjct: 162 INP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 27/222 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-RSRAIDKTQIEQFINEVVILSQINH---R 390
Y + +G+G +G VY+G +P G +VA+K + + EV +LSQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+I K G L+ ++ EY G++ + L + ++ +R
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSV--------------RTLMKAGPIAEKYISVIIR 108
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
EV A+ Y+H + HRDIK++NIL+ + + K+ DFG + + + + +T V
Sbjct: 109 ---EVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV 162
Query: 511 QGTFGYFDPEYFQSSQYTD-KSDVYSFGVVLLELLTGKKPIC 551
GT + PE +Y D K+D++S G+ + E+ TG P
Sbjct: 163 -GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG V+KG+ D V + ID + +IE E+ +LSQ + ++ K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
L+ ++ EY+ G+ + + +E Q + L E+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--------RAGPFDEFQIATMLK---------EILK 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+ Y+HS I HRDIK++N+LL ++ K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Q S Y K+D++S G+ +EL G+ P
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 69/225 (30%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF---INEVVILSQINHRH 391
+ R +G G FG VY + +VA+K+ K E++ I EV L Q+ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++ GC L LV EY G+ S + H K+ L+E V +
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVH------KKPLQE------------VEI 117
Query: 452 ACEVAGAV---AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
A GA+ AY+HS I HRDIK+ NILL + + K++DFG++ V + +
Sbjct: 118 AAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-- 172
Query: 509 AVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
GT + PE QY K DV+S G+ +EL K P+
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 27/224 (12%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKR--SRAIDKTQIEQF-INEVVILSQINHRHIVKLLG 397
LG+GGFG V + G + A K+ + + K + EQ +NE IL +++ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 398 CCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 455
ET+ + LV ++ G L +HI++ + E R A ++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---------------EARAIFYAAQI 104
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
+ ++H I +RD+K N+LLDD + ++SD G + + K GT G
Sbjct: 105 ICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPG 159
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559
Y PE Q Y D ++ G L E++ G+ P +E+ E+
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 27/222 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKRSR-AIDKTQIEQFINEVVILSQINH 389
+ + + LG G FGTVYKG+ +P+G VA+K R A ++ ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
H+ +LLG CL + V L+ + + G L ++ +H+ Q L L+W
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI-GSQYL--------LNW---- 114
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-KTHLTT 508
++A + Y+ + HRD+ + N+L+ K++DFG ++ + D K +
Sbjct: 115 --CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ + E YT +SDV+S+GV + EL+T G KP
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 342 LGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQFI-NEVVILSQINHRHIVKLLG 397
LG GGFG V + A+K R I +T ++ I +E IL + NH IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ + ++ EY G L + D +E + R +AC V
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-------FDE--------YTARFYIAC-VVL 104
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGY 516
A Y+H+ I +RD+K N+LLD K+ DFG ++ + + KT T GT Y
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEY 158
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE + Y D +S G++L ELLTG+ P
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 70/233 (30%), Positives = 106/233 (45%), Gaps = 28/233 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQF-INEVVILSQINHRH 391
+ Q R LG+GGFG V + G + A K+ + I K + E +NE IL ++N R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V L + LV ++ G L HI+ + EE + V
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRA---------VFY 107
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + +H I +RD+K NILLDD ++SD G + VP +T
Sbjct: 108 AAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC-----LTREEEER 559
GT GY PE ++ +YT D ++ G +L E++ G+ P + REE ER
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-18
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
LGQG FG V+ G + VA+K + E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-- 70
Query: 402 TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+E P+ +V E++ G+L + +E + L V +A ++A +A
Sbjct: 71 SEEPIYIVTEFMGKGSL--------------LDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+ I HRD++++NIL+ D K++DFG +R + +++ + + PE
Sbjct: 117 YIERMNYI---HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKK---PICLTREEEERNLVAYFISLAKENKLLEI 577
++T KSDV+SFG++L EL+T + P + RE +LE
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------------------VLEQ 215
Query: 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
++ + E++ EL C + + +RPT + + LE
Sbjct: 216 VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 76/263 (28%), Positives = 116/263 (44%), Gaps = 57/263 (21%)
Query: 313 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAI-- 369
SS SS + +A ++ + +G G GTVYK + P G + A+K I
Sbjct: 53 SSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK---VIYG 109
Query: 370 --DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVPVLVYEYISNGTLS-HHI 421
+ T Q E+ IL +NH ++VK C + E+ VL+ E++ G+L HI
Sbjct: 110 NHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEGTHI 164
Query: 422 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481
D EQ L+ VA ++ +AY+H I HRDIK SN+L
Sbjct: 165 AD-------------EQFLAD--------VARQILSGIAYLHRRH---IVHRDIKPSNLL 200
Query: 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD---------KSD 532
++ + K++DFG SR + ++V GT Y PE TD D
Sbjct: 201 INSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERIN----TDLNHGAYDGYAGD 255
Query: 533 VYSFGVVLLELLTGKKPICLTRE 555
++S GV +LE G+ P + R+
Sbjct: 256 IWSLGVSILEFYLGRFPFGVGRQ 278
|
Length = 353 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 33/295 (11%)
Query: 342 LGQGGFGTVYKGMLP-DGSIV--AVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLL 396
+G+G FG V + M+ DG + A+K + + F E+ +L ++ +H +I+ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C + EY G L + + + +E S+L+ + ++ A +VA
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTF 514
+ Y+ I HRD+ + N+L+ + ++K++DFG SR V KT V+
Sbjct: 130 TGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--- 183
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISLAKEN 572
+ E S YT KSDV+SFGV+L E+++ G P C +T E
Sbjct: 184 -WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---------------- 226
Query: 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
L E L E + V EL C R +RP Q+S+ L + +++
Sbjct: 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 58/222 (26%), Positives = 108/222 (48%), Gaps = 40/222 (18%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID-----------KTQIEQFINEVVILSQINHR 390
LG G FG V KG V R + ID K+ ++ + E I+ Q+++
Sbjct: 3 LGSGNFGCVKKG-------VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV+++G C E E +LV E S G L+ + + + ++ N V
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE---------------ITVSNVVE 99
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ +V+ + Y+ + HRD+ + N+LL ++ AK+SDFG S+++ D ++
Sbjct: 100 LMHQVSMGMKYLEGKNFV---HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156
Query: 511 QGTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
G + ++ PE +++ +SDV+S+G+ + E + G+KP
Sbjct: 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQI--EQFINEVVILSQINHRHIVKLLGC 398
+G+G +G V K G IVA+K+ + + + + + EV +L Q+ H +IV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
LV+EY+ TL + + L + + S W+ + A
Sbjct: 69 FRRKGRLYLVFEYVER-TL------LELLEASPGGLPPD-AVRSYIWQ--------LLQA 112
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYF 517
+AY HS I HRDIK NIL+ + K+ DFG +R++ LT V T Y
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYR 168
Query: 518 DPEYF-QSSQYTDKSDVYSFGVVLLELLTG 546
PE + Y DV++ G ++ ELL G
Sbjct: 169 APELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 344 QGGFGTVYKGMLPDGSIVAVKRSRAIDKT--------QIEQFINEVVILSQINHRHIVKL 395
+G FG ++ G+L K KT Q+ + E +L ++H++I+ +
Sbjct: 16 EGTFGRIFYGIL--IDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 396 LGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C+E E P ++Y Y++ G L + Q+ L E +LS + V +A +
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFL--------QQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGT 513
+A ++Y+H + H+DI + N ++D++ K++D SR + P D L
Sbjct: 126 IACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ E + +Y+ SDV+SFGV+L EL+T G+ P
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 79/296 (26%), Positives = 137/296 (46%), Gaps = 48/296 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVKRSRAI-DKTQIEQFINEVVILSQ 386
+N + + LG G FG V + G+ ++ VAVK + ++ E ++E+ I+S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 387 I-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+ NH +IV LLG C +++ EY G L + + +K+E S L+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-------RKRE-------SFLTL 140
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
E+ + + +VA +A++ S I HRD+ + N+LL K+ DFG +R + ND +
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197
Query: 506 LTTAVQGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560
+ V+G + PE + YT +SDV+S+G++L E+ + G P
Sbjct: 198 V---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY------PGMP 248
Query: 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616
+ + F L KE R+A+ + ++ C + KRPT KQ+
Sbjct: 249 VDSKFYKLIKEG-------YRMAQPEHAPA--EIYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG VYKG+ D V + ID + +IE E+ +LSQ + +I + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
L+ ++ EY+ G+ + + LEE + L E+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--------KPGPLEETYIATILR---------EILK 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+ Y+HS I HRDIK++N+LL ++ K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE + S Y K+D++S G+ +EL G+ P
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 31/226 (13%)
Query: 340 RFLGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVK 394
+ LG+G FG V KG ++ +K+ + +E + E +L+ H + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 395 LLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-A 452
L C +T+ + V EY++ G L HI Q+ E R R A
Sbjct: 61 LH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFD--------------EPRARFYA 102
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQ 511
E+ + ++H I +RD+K N+LLD + K++DFG + + T T+
Sbjct: 103 AEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
GT Y PE Y D ++ GV+L E+L G+ P E+E
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-17
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
Y + +GQG GTVY + + G VA+K+ + + E INE++++ + + +IV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 453
L L + +V EY++ G+L+ + + E ++ C
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 122
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E A+ ++HS + HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIV 393
+ +G G FG V G L VA+K +A +K Q F++E I+ Q +H +I+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK-QRRDFLSEASIMGQFDHPNII 68
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
L G +++ ++V EY+ NG+L + H Q +++
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF------------------TVIQLVG 110
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+ G + M + + HRD+ + NIL++ KVSDFG SR + +D T G
Sbjct: 111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 514 FG--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T SDV+S+G+V+ E+++ G++P
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 76/280 (27%), Positives = 128/280 (45%), Gaps = 42/280 (15%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
+G+G FG V +G G VAVK + D T + F+ E ++++++H+++V+LLG L
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC-DVTA-QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
+ + V E +S G L + + + +L ++ + +VA + Y
Sbjct: 71 NGLYI-VMELMSKGNLVNFLRTRGRALVSVIQL--------------LQFSLDVAEGMEY 115
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY 521
+ S + HRD+ + NIL+ + AKVSDFG +R + V+ T PE
Sbjct: 116 LESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEA 168
Query: 522 FQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
+ +++ KSDV+S+GV+L E+ + G+ P Y KE K E ++
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFSYGRAP--------------YPKMSLKEVK--ECVEK 212
Query: 581 RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
E E V L C KKRP+ ++ LE
Sbjct: 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 61/212 (28%), Positives = 113/212 (53%), Gaps = 30/212 (14%)
Query: 342 LGQGGFGTVYKGMLPD--GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+G+G FG V ML D G+ VAVK + D T + F+ E +++Q+ H ++V+LLG
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIKN-DATA-QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+E + + +V EY++ G+L ++ + S L + ++ + +V A
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEA 114
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+ Y+ + + HRD+ + N+L+ + AKVSDFG ++ + + V+ T
Sbjct: 115 MEYLEANNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----A 167
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE + +++ KSDV+SFG++L E+ + G+ P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 32/224 (14%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G +G VYK G +VA+K ++ +I++ N + S NH +I G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS--NHPNIATFYGA 71
Query: 399 CLETEVPV------LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
++ P LV E G+++ + + +++ + L+EE +++ R
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKRLKEEW----IAYILR---- 120
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
E +AY+H I HRDIK NILL K+ DFG S + + T + G
Sbjct: 121 -ETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-G 175
Query: 513 TFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPIC 551
T + PE + Y +SDV+S G+ +EL GK P+C
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG V+KG+ D V + ID + +IE E+ +LSQ + ++ K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
L+ ++ EY+ G+ + + L+E Q + L E+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQIATILR---------EILK 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+ Y+HS I HRDIK++N+LL + K++DFG + + + + T V GT +
Sbjct: 113 GLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 168
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577
PE + S Y K+D++S G+ +EL G+ P E + + + K N
Sbjct: 169 APEVIKQSAYDSKADIWSLGITAIELAKGEPP------HSELHPMKVLFLIPKNNP--PT 220
Query: 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
L+ +K + E CL RPT K++
Sbjct: 221 LEGNYSKPLK--------EFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/219 (27%), Positives = 113/219 (51%), Gaps = 29/219 (13%)
Query: 340 RFLGQGGFGTVYKGM-LPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
+ LG G FGTVYKG+ +PDG VA+K R K ++ ++E +++ + ++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN-KEILDEAYVMAGVGSPYV 71
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+LLG CL + V LV + + G L ++ +++ + Q+L L+W
Sbjct: 72 CRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GSQDL--------LNW------C 115
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQ 511
++A ++Y+ + + HRD+ + N+L+ K++DFG +R + D+T + +
Sbjct: 116 VQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ E ++T +SDV+S+GV + EL+T G KP
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 60/250 (24%)
Query: 332 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQ 386
+Y LG+G FG VYK + G +VA+K+ + + + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITALREIKILKK 63
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL-----EEEQELS 441
+ H ++V L+ + E + + ++ + + +LS
Sbjct: 64 LKHPNVVPLID---------MAVER------------PDKSKRKRGSVYMVTPYMDHDLS 102
Query: 442 SLSWENRVRVACEVAGA----------VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491
L V++ + + Y+H I HRDIK++NIL+D++ K++
Sbjct: 103 GLLENPSVKL--TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIA 157
Query: 492 DFGTSR----SVPNDK------THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVL 540
DFG +R PN K T T + T Y PE +YT D++ G V
Sbjct: 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF 217
Query: 541 LELLTGKKPI 550
E+ T +PI
Sbjct: 218 AEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 23/231 (9%)
Query: 336 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQF-INEVVILSQINHRH 391
+ Q R LG+GGFG V + G + A KR + I K + E +NE IL ++N +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V L + LV ++ G L HI++ EEE+ L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEERALF---------Y 107
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + +H ++ +RD+K NILLDD ++SD G + +P +
Sbjct: 108 AAEILCGLEDLHRENTV---YRDLKPENILLDDYGHIRISDLGLAVKIP--EGESIRGRV 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
GT GY PE + +YT D + G ++ E++ G+ P +E+ +R V
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 24/216 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
Y + +GQG GTV+ + + G VA+K+ + + E INE++++ ++ + +IV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 453
L L + +V EY++ G+L+ + + + Q + C
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQ------------------IAAVCR 122
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E A+ ++H+ + HRDIKS N+LL S K++DFG + +++ +T V GT
Sbjct: 123 ECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 77/291 (26%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 341 FLGQGGFGTVYKGMLPDGSI---VAVKRSRA-IDKTQIEQFINEVVILSQINHR-HIVKL 395
+G+G FG V K + + A+KR + K F E+ +L ++ H +I+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
LG C L EY +G L + + + S+LS + + A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A + Y+ I HRD+ + NIL+ + + AK++DFG SR V+ T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMG 171
Query: 516 -----YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISL 568
+ E S YT SDV+S+GV+L E+++ G P C +T E
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------ 219
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
L E L E + V +L C R +RP+ Q+ + L
Sbjct: 220 -----LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 89/299 (29%), Positives = 132/299 (44%), Gaps = 47/299 (15%)
Query: 342 LGQGGFGTVY--------KGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQI-NHR 390
LG+G FG V K VAVK + A DK + ++E+ ++ I H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHK 78
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQ----ELEEEQELSSLSWE 446
+I+ LLG C + ++ EY S G L ++ + +L EEQ L+++
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ----LTFK 134
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 505
+ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +R V N D
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI---HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564
TT + + PE YT +SDV+SFGV+L E+ T G P EE
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 244
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAM---GCLRLNSKKRPTMKQVSMDLE 620
L KE R+ K A EL M C +RPT KQ+ DL+
Sbjct: 245 LFKLLKEGH-------RMDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +IV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC- 453
L L + +V EY++ G+L+ + + E ++ C
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------------------EGQIAAVCR 123
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E A+ ++HS + HRDIKS NILL S K++DFG + +++ +T V GT
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Y K D++S G++ +E++ G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 68/233 (29%), Positives = 105/233 (45%), Gaps = 28/233 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQF-INEVVILSQINHRH 391
+ R LG+GGFG V + G + A K+ + I K + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V L + LV ++ G L HI++ +EE+ V
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-----FDEERA---------VFY 107
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + +H I +RD+K NILLDD ++SD G + +P +T
Sbjct: 108 AAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI-----CLTREEEER 559
GT GY PE ++ +YT D + G ++ E++ GK P + REE ER
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
LG G FG VYK + G A K + + ++E F+ E+ ILS+ H +IV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 459
++ E+ G L + LE E+ L+ E ++R C ++ A+
Sbjct: 73 YENKLWILIEFCDGGALDSIM------------LELERGLT----EPQIRYVCRQMLEAL 116
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
++HS I HRD+K+ NILL K++DFG S + T + GT + P
Sbjct: 117 NFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAP 172
Query: 520 EY-----FQSSQYTDKSDVYSFGVVLLELLTGKKP 549
E F+ + Y K+D++S G+ L+EL + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/229 (27%), Positives = 109/229 (47%), Gaps = 15/229 (6%)
Query: 335 NYNQSRF---LGQGGFGTVYKGML----PDGSIVAVKRSRAIDKTQI---EQFINEVVIL 384
N + RF LG+ FG VYKG L P AV DK + E+F +E ++
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
S++ H +IV LLG + + +++ Y S+ L + + +++ S+L
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDK 503
+ V + ++A + ++ S + H+D+ + N+L+ DK + K+SD G R V D
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC 551
L + PE +++ SD++S+GVVL E+ + G +P C
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 84/307 (27%), Positives = 133/307 (43%), Gaps = 47/307 (15%)
Query: 334 DNYNQSRFLGQGGFGTVY--------KGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVI 383
D + LG+G FG V K + VAVK + A +K + ++E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK-DLSDLVSEMEM 73
Query: 384 LSQI-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQ----ELEEEQ 438
+ I H++I+ LLG C + ++ EY S G L ++ + + + +EQ
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498
+++++ V +VA + Y+ S I HRD+ + N+L+ + K++DFG +R
Sbjct: 134 ----MTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARD 186
Query: 499 VPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREE 556
V N D TT + + PE YT +SDV+SFGV++ E+ T G P E
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAM---GCLRLNSKKRPTMK 613
E L KE R+ K A EL M C RPT K
Sbjct: 247 E-------LFKLLKEGH-------RMDKPA-----NCTNELYMMMRDCWHAIPSHRPTFK 287
Query: 614 QVSMDLE 620
Q+ DL+
Sbjct: 288 QLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 72/237 (30%), Positives = 107/237 (45%), Gaps = 38/237 (16%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQF----INEVVIL 384
+R D ++ +G+G +G VYK D G +VA+K+ R + E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRL--DNEKEGFPITAIREIKIL 60
Query: 385 SQINHRHIVKLLGCCLETEVPV----------LVYEYISNGTLSHHIHDHQQQQEQKQEL 434
Q+NHR+IV L + + + LV+EY+ HD E
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--------HDLMGLLESG--- 109
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
L S ++ ++ + Y H HRDIK SNILL++K K++DFG
Sbjct: 110 -----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161
Query: 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPI 550
+R ++++ T T Y PE + Y DV+S G +L EL T KKPI
Sbjct: 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
LG G FG VYK + G++ A K + ++E ++ E+ IL+ NH +IVKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 459
++ E+ G + + LE ++ L+ E +++V C ++ A+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIM------------LELDRGLT----EPQIQVICRQMLEAL 123
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFD 518
Y+H S+ I HRD+K+ N+LL K++DFG S N KT + GT +
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMA 178
Query: 519 PEY-----FQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE + + Y K+D++S G+ L+E+ + P
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 85/309 (27%), Positives = 137/309 (44%), Gaps = 41/309 (13%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYK----GMLPDG----SIVAVK--RSRAIDKTQIEQF 377
E+ R D + LG+G FG V G+ + + VAVK +S A +K +
Sbjct: 14 EVPR--DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDL 70
Query: 378 INEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
I+E+ ++ I H++I+ LLG C + ++ EY S G L ++ + +
Sbjct: 71 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
+ LS+++ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLA 187
Query: 497 RSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTR 554
R + + D TT + + PE YT +SDV+SFGV+L E+ T G P
Sbjct: 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247
Query: 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAM---GCLRLNSKKRPT 611
EE L KE + ++ EL M C +RPT
Sbjct: 248 VEE-------LFKLLKEGHRM------------DKPSNCTNELYMMMRDCWHAVPSQRPT 288
Query: 612 MKQVSMDLE 620
KQ+ DL+
Sbjct: 289 FKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 25/225 (11%)
Query: 342 LGQGGFGTVYK----GMLPD----GSIVAVK--RSRAIDKTQIEQFINEVVILSQIN-HR 390
LG+G FG V + G+ VAVK + A DK + I+E+ ++ I H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK-DLADLISEMELMKLIGKHK 78
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQ----ELEEEQELSSLSWE 446
+I+ LLG C + ++ EY + G L + + ++ EEQ LS++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ----LSFK 134
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTH 505
+ V A +VA + Y+ S I HRD+ + N+L+ + K++DFG +R V + D
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
T+ + + PE YT +SDV+SFG+++ E+ T G P
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 20/219 (9%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHR 390
N+ + +G+G F VY+ L DG VA+K+ + +D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+++K +E +V E G LS I ++Q+ E W+ V
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPE--------KTVWKYFV- 113
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ A+ +MHS + HRDIK +N+ + K+ D G R + KT ++
Sbjct: 114 ---QLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL 166
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE + Y KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 58/218 (26%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 342 LGQGGFGTVYKGML-PDG---SIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLL 396
+G G FG V +G L G VA+K ++ + Q F++E I+ Q +H +I+ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G ++ +++ E++ NG L + + Q + + +R
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ------------FTVIQLVGMLR------ 113
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH--LTTAVQGTF 514
G A M + + HRD+ + NIL++ KVSDFG SR + +D + T+++ G
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 515 G--YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T SDV+S+G+V+ E+++ G++P
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 68/239 (28%), Positives = 102/239 (42%), Gaps = 58/239 (24%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR---AIDKTQIEQFINEVVILSQ 386
R+ + + +G+G +G VY+ G IVA+K+ R D I + E+ +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLN 62
Query: 387 INHRHIVKLLGCCLETEVPV--------LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
+ H +IV+L EV V LV EY EQ
Sbjct: 63 LRHPNIVELK------EVVVGKHLDSIFLVMEYC------------------------EQ 92
Query: 439 ELSSLSWENRVR------VAC---EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489
+L+SL +N V C ++ + Y+H I HRD+K SN+LL DK K
Sbjct: 93 DLASL-LDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148
Query: 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
++DFG +R+ +T V T Y PE + YT D+++ G +L ELL K
Sbjct: 149 IADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 28/210 (13%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 399
LG G GTVYK L I+AVK +++ Q ++E+ IL + + +I+ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ E++ G+L + E L R+A V +
Sbjct: 69 FVENRISICTEFMDGGSLDVY------------RKIPEHVLG--------RIAVAVVKGL 108
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
Y+ S + I HRD+K SN+L++ + K+ DFG S + N + GT Y P
Sbjct: 109 TYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAP 162
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
E QY SDV+S G+ +EL G+ P
Sbjct: 163 ERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 68/235 (28%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQI-EQFINEVV-------ILSQINHRHIV 393
LG+G FGTVY ++ D VA +R + + + + E NE V +LS+++H IV
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
K LE + ++ EY L + +E K + E W
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKL------EELKHTGKTLSENQVCEW------FI 113
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++ V YMH I HRD+K+ NI L + K+ DFG SR + L T GT
Sbjct: 114 QLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGT 168
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568
Y PE + Y KSD++S G +L E+ CL E +N ++ + +
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM------CCLAHAFEGQNFLSVVLRI 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 68/236 (28%), Positives = 110/236 (46%), Gaps = 47/236 (19%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILS 385
R+ D Y + + +G +G VY+ G IVA+K+ + ++K + E F + E+ IL
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEK-EKEGFPITSLREINILL 59
Query: 386 QINHRHIVKLLGCCLETEVPV--------LVYEYISNG--TLSHHIHDHQQQQEQKQELE 435
++ H +IV + EV V +V EY+ + +L + Q E K +
Sbjct: 60 KLQHPNIVTV------KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML 113
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495
Q LS VA++H I HRD+K+SN+LL+++ K+ DFG
Sbjct: 114 --QLLS----------------GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGL 152
Query: 496 SRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+R + T V T Y PE + +Y+ D++S G + ELLT KKP+
Sbjct: 153 AREYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 342 LGQGGFGTVYKGMLPDGSI---VAVKRSRA-IDKTQIEQFINEVVILSQIN-HRHIVKLL 396
+G+G FG V K + + A+KR + K F E+ +L ++ H +I+ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C L EY +G L + + + S+LS + + A +VA
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG- 515
+ Y+ I HRD+ + NIL+ + + AK++DFG SR V+ T G
Sbjct: 135 RGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKTMGR 184
Query: 516 ----YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISLA 569
+ E S YT SDV+S+GV+L E+++ G P C +T E L +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---- 240
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
R+ K +D V +L C R +RP+ Q+ + L
Sbjct: 241 -----------RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR---AIDKTQIEQFINEVVILSQINHR 390
N+ + +G+G F VY+ L D VA+K+ + +D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+++K L +E +V E G LS I ++Q+ L E+ + W+ V
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR----LIPERTV----WKYFV- 113
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ AV +MHS + HRDIK +N+ + K+ D G R + KT ++
Sbjct: 114 ---QLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSL 166
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE + Y KSD++S G +L E+ + P
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 78/290 (26%), Positives = 118/290 (40%), Gaps = 52/290 (17%)
Query: 340 RFLGQGGFGTVYKG-MLPDGSIVAVK---RSRAIDKTQIEQFINEVVILS-QINHRHIVK 394
R LG+G FG V + G + AVK + + +E + E ILS NH + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C + V E+++ G L HI ++ E + A E
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF----------------YAAE 104
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGT 513
+ A+ ++H I +RD+K N+LLD + K++DFG + + N KT T+ GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGT 159
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
Y PE Q Y D ++ GV+L E+L G P E N E+
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF------EAEN----------EDD 203
Query: 574 LLEIL--DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621
L E + D V +D + + M K PTM+ S+ L G
Sbjct: 204 LFEAILNDEVVYPTWLSQDAVDILKAFM-------TKNPTMRLGSLTLGG 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 60/222 (27%), Positives = 98/222 (44%), Gaps = 36/222 (16%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVK 394
R LG G FG + +G L S VA+ RA Q F+ E + L Q +H +IV+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L G ++V EY+SNG L + H+ Q L Q + L
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ------LVAGQLMGMLP---------- 114
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
G + M + + H+ + + +L++ K+S F R + DK+ A+ T
Sbjct: 115 --GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSE---AIYTTM 166
Query: 515 G------YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE Q ++ SDV+SFG+V+ E+++ G++P
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 65/226 (28%), Positives = 91/226 (40%), Gaps = 48/226 (21%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCC 399
LG+G G+V K L + G I A+K ++ Q + E+ I +IVK G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR---VRVACEVA 456
L+ + E E L S+ + + R+ +V
Sbjct: 69 LD---------------------ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL 107
Query: 457 GAVA--------YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
G +A Y+HS I HRDIK SNILL K K+ DFG S L
Sbjct: 108 GKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVS-------GELVN 157
Query: 509 AVQGTFG----YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
++ GTF Y PE Q Y+ SDV+S G+ LLE+ + P
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 31/197 (15%)
Query: 358 GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417
G VAVK + + E NEVVI+ H+++V++ L E ++ E++ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE-VAGAVAYMHSAASIPIFHRDIK 476
+ + + L EEQ + CE V A+ Y+HS I HRDIK
Sbjct: 106 TDIV--------SQTRLNEEQ----------IATVCESVLQALCYLHSQGVI---HRDIK 144
Query: 477 SSNILLDDKFSAKVSDFG----TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSD 532
S +ILL K+SDFG S+ VP K+ + GT + PE + Y + D
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPEVISRTPYGTEVD 199
Query: 533 VYSFGVVLLELLTGKKP 549
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 9e-16
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 47/231 (20%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIE--QFINEVVILSQINHRHI 392
Y + +G G +G V + G VA+K+ + I+ + + E+ +L + H +I
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 393 VKLLGCCLETEVPV-----------LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
+ LL ++ +V E + D + + Q L ++
Sbjct: 62 IGLL------DILRPPSPEDFNDVYIVTELME--------TDLHKVIKSPQPLTDD---- 103
Query: 442 SLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV- 499
++ ++ + Y+HSA I HRD+K SNIL++ K+ DFG +R V
Sbjct: 104 ------HIQYFLYQILRGLKYLHSANVI---HRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 500 --PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
++K LT V T Y PE SS+YT D++S G + ELLT K
Sbjct: 155 PDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 65/226 (28%), Positives = 96/226 (42%), Gaps = 34/226 (15%)
Query: 342 LGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN---HRHIVK 394
LG+G FG V YK +I A+K+ I + ++E + E I N H +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 395 LLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
L C +TE V V EY + G L HIH + + A
Sbjct: 67 LF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAV-----------------FYAA 108
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHLTTAVQ 511
V + Y+H I +RD+K N+LLD + K++DFG + D+ T+
Sbjct: 109 CVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFC 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
GT + PE + YT D + GV++ E+L G+ P EEE
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 335 NYNQSRFLGQGGFGT--VYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
YN R +G+G FG + + + D + + +E E V+L+++ H +I
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V +V EY G L I Q+ +L E + L W
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKL------QRGKLFPEDTI--LQW------F 106
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
++ V ++H + HRDIKS NI L K+ DFG++R + + + T V G
Sbjct: 107 VQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T Y PE +++ Y +KSD++S G +L EL T K P
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 336 YNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQF-INEVVILSQINHRH 391
+ R LG+GGFG V + G + A K+ + I K + E +NE IL ++N R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V L + LV ++ G L HI++ + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--------------PGFDEQRAIFY 107
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + + I +RD+K NILLDD+ ++SD G + +P +T
Sbjct: 108 AAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571
GT GY PE + +YT D + G ++ E++ G+ P +E +R
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR------------ 210
Query: 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613
E +D RV KE +EE E +E A R+ K P +
Sbjct: 211 ----EEVDRRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 71/220 (32%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF---INEVVILSQINHRHIVKLLG 397
+G G FG VY +VAVK+ K E++ I EV L Q+ H + ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
C L+ LV EY G+ S + H K+ L+E V +A G
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVH------KKPLQE------------VEIAAITHG 129
Query: 458 AV---AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT-SRSVPNDKTHLTTAVQGT 513
A+ AY+HS I HRDIK+ NILL + K++DFG+ S+S P + GT
Sbjct: 130 ALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGT 180
Query: 514 FGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ PE QY K DV+S G+ +EL K P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 74/250 (29%), Positives = 111/250 (44%), Gaps = 40/250 (16%)
Query: 311 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAI 369
R S E A++F E+ ++ + R +G G FG VY + +VA+K+
Sbjct: 5 RAGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS 61
Query: 370 DKTQIEQF---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQ 426
K E++ I EV L +I H + ++ GC L LV EY G+ S + H
Sbjct: 62 GKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-- 118
Query: 427 QQEQKQELEEEQELSSLSWENRVRVACEVAGAV---AYMHSAASIPIFHRDIKSSNILLD 483
K+ L+E V +A GA+ AY+HS I HRDIK+ NILL
Sbjct: 119 ----KKPLQE------------VEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLT 159
Query: 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVL 540
+ K++DFG++ + + GT + PE QY K DV+S G+
Sbjct: 160 EPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 214
Query: 541 LELLTGKKPI 550
+EL K P+
Sbjct: 215 IELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
DN+ + +G+G G V + G +VAVK+ + + E NEVVI+ H ++
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V++ L + +V E++ G L+ + + +EQ V
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-----------------VC 122
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG----TSRSVPNDKTHLTT 508
V A++ +H+ I HRDIKS +ILL K+SDFG S+ VP K+
Sbjct: 123 LAVLKALSVLHAQGVI---HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---- 175
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT + PE Y + D++S G++++E++ G+ P
Sbjct: 176 -LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 55/212 (25%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ LG G FG V+ + VAVK + +E F+ E ++ + H +VKL
Sbjct: 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
T+ P+ ++ E+++ G+L + K + +Q L L + + ++A
Sbjct: 71 --TKEPIYIITEFMAKGSLLDFL---------KSDEGSKQPLPKL-----IDFSAQIAEG 114
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+A++ I HRD++++NIL+ K++DFG +R + +++ + +
Sbjct: 115 MAFIEQRNYI---HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE +T KSDV+SFG++L+E++T G+ P
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 28/225 (12%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKR---SRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
+GQGG+G V+ D G IVA+KR S ++ + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ E L EY+ G D + L E+ R +A E+
Sbjct: 69 AFQDDEYLYLAMEYVPGG-------DFRTLLNNLGVLSEDHA--------RFYMA-EMFE 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
AV +H I HRD+K N L+D K++DFG S+ + +V G+ Y
Sbjct: 113 AVDALHELGYI---HRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYM 165
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC-LTREEEERNL 561
PE + Y D +S G +L E L G P T E NL
Sbjct: 166 APEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 27/222 (12%)
Query: 342 LGQGGFGTVYKGMLPDG----SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG+G FG V L +I A+K+ ++ +E + E +L+ + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 398 CCLETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 455
C +T+ + V EY++ G L HI Q + + R R A E+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHI-----QSSGRFDEA------------RARFYAAEI 105
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
+ ++H I +RD+K N+LLD K++DFG + N + +T GT
Sbjct: 106 ICGLQFLHKKGII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPD 161
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
Y PE + +Y + D +SFGV+L E+L G+ P E+E
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR------SRAIDKTQIEQFINEVVILSQI 387
N+ + LG+G FG VY D G +AVK+ S+ K ++ E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSK-EVNALECEIQLLKNL 61
Query: 388 NHRHIVKLLGCCLETEVPVL--VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
H IV+ GC + E L EY+ G++ K +L+ L+
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI-------------KDQLKAYGALT---- 104
Query: 446 ENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
EN R ++ V+Y+HS I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161
Query: 505 HLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T +V GT + PE Y K+DV+S ++E+LT K P
Sbjct: 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSR-AIDKTQIEQFIN----EVVILSQIN 388
N+ + LGQG FG VY D G +AVK+ + + + + +N E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 389 HRHIVKLLGCCLETEVPVL--VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H IV+ GC + L E++ G++ K +L+ L+ E
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI-------------KDQLKSYGALT----E 105
Query: 447 NRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
N R ++ V+Y+HS I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 106 NVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS 162
Query: 506 LT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T +V GT + PE Y K+D++S G ++E+LT K P
Sbjct: 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 67/252 (26%), Positives = 96/252 (38%), Gaps = 55/252 (21%)
Query: 334 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSR---AIDKTQIEQFINEVVILSQINH 389
D++ + +G+G FG V+ G + A+K R I + QI E IL+ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTL-SHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
IVKL + E LV EY+ G L + I K EE R
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--------KDVFPEE--------TAR 104
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS------------ 496
+A E+ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 105 FYIA-ELVLALDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 497 -----------------RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV 539
R + + V GT Y PE + + Y + D +S GV+
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 540 LLELLTGKKPIC 551
L E+L G P
Sbjct: 220 LYEMLYGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKT-----QIEQFINEVVILSQIN 388
N+ + + LGQG FG VY D G +A K+ + ++ ++ E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 389 HRHIVKLLGCCLE--TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H IV+ GC + + + EY+ G++ + + E Q L +S
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS-- 120
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
Y+HS I HRDIK +NIL D + K+ DFG S+ +
Sbjct: 121 --------------YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSG 163
Query: 507 T--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
T +V GT + PE Y K+DV+S G ++E+LT K P E E +
Sbjct: 164 TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA----EYEAMAAIF 219
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
I+ N L + +++ AR+ +GC+ + ++ RP+ +++
Sbjct: 220 KIATQPTNPQLP---SHISEHARD---------FLGCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 340 RFLGQGGFGTV----YKGMLPDG----SIVAVKRSRAIDK-TQIEQFINEVVILSQINHR 390
R LG+G FG V Y P+G VAVK + I E+ IL + H
Sbjct: 10 RDLGEGHFGKVELCRYD---PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 391 HIVKLLGCCLET--EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+IVK G C E L+ E++ +G+L ++ ++ + KQ+L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL-------------- 112
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
+ A ++ + Y+ S + HRD+ + N+L++ + K+ DFG ++++ DK + T
Sbjct: 113 -KYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168
Query: 509 A--VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545
+ ++ PE S++ SDV+SFGV L ELLT
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-15
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 334 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRH 391
D++ + LG G G V K P G I+A K K I Q I E+ +L + N +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV G + S+G +S + +H Q L+E + + E +V
Sbjct: 65 IVGFYGA------------FYSDGEISICM-EHMDGGSLDQVLKEAKRIPE---EILGKV 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
+ V +AY+ I HRD+K SNIL++ + K+ DFG S + + + +
Sbjct: 109 SIAVLRGLAYLREKHQI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
GT Y PE Q + Y+ +SD++S G+ L+EL G+ PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 47/268 (17%)
Query: 358 GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417
G VAVK+ + + E NEVVI+ +H ++V + L + +V E++ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477
+ + + +EQ V V A++Y+H+ I HRDIKS
Sbjct: 107 TDIVTHTRMNEEQI-----------------ATVCLSVLRALSYLHNQGVI---HRDIKS 146
Query: 478 SNILLDDKFSAKVSDFG----TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV 533
+ILL K+SDFG S+ VP K+ + GT + PE Y + D+
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPKRKS-----LVGTPYWMAPEVISRLPYGTEVDI 201
Query: 534 YSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEA 593
+S G++++E++ G+ P YF E L + R R +D
Sbjct: 202 WSLGIMVIEMIDGEPP--------------YF----NEPPLQAMRRIRDNLPPRVKDSHK 243
Query: 594 VAELAMGCLRLNSKKRPTMKQVSMDLEG 621
V+ + G L L + P+ + + +L
Sbjct: 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 75/252 (29%), Positives = 115/252 (45%), Gaps = 40/252 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPD--GS-----IVAVKRSRAIDKTQIEQFINEVVILSQI 387
++N LG+G FG V ML + G+ I +K+ I +E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+ L C +T + V EY++ G L +HI QQ K +E
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGK--FKEPHA------- 103
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTH 505
V A E+A + ++HS I +RD+K N++LD + K++DFG + ++ KT
Sbjct: 104 --VFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT- 157
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ER 559
T GT Y PE Y D ++FGV+L E+L G+ P E+E E
Sbjct: 158 -TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
Query: 560 NLVAYFISLAKE 571
N V+Y SL+KE
Sbjct: 217 N-VSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 34/220 (15%)
Query: 342 LGQGGFGTVYKGMLPDGSIVA---VKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLG 397
+G G FG V G G A VK RA + F+ EV ++NH ++++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV--RVACEV 455
C+E+ +LV E+ G L K L + + + + V R+ACEV
Sbjct: 63 QCIESIPYLLVLEFCPLGDL-------------KNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGTF 514
A + ++H A I H D+ N L S K+ D+G + P D + T
Sbjct: 110 ASGLLWLHQADFI---HSDLALRNCQLTADLSVKIGDYGLALEQYPED--YYITKDCHAV 164
Query: 515 G--YFDPEYFQSSQ-------YTDKSDVYSFGVVLLELLT 545
+ PE + T KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 35/219 (15%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGC 398
LG G FG VYK + ++A ++ ID + ++E ++ E+ IL+ +H +IVKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 399 CL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVA 456
E + +L+ E+ + G + + LE E+ L+ E ++RV C +
Sbjct: 71 FYYENNLWILI-EFCAGGAVDAVM------------LELERPLT----EPQIRVVCKQTL 113
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFG 515
A+ Y+H I HRD+K+ NIL K++DFG S N +T + GT
Sbjct: 114 EALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPY 168
Query: 516 YFDPEYF-----QSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ PE + Y K+DV+S G+ L+E+ + P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 34/204 (16%)
Query: 358 GSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLL--GCCLETEVPVLVYEYI 412
G VA+K R ++ Q +F E + +++ H +IV LL G + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFH 472
TL ++ L + L + R+ +V A+A H+ I H
Sbjct: 62 PGRTL-------------REVLAADGALPA---GETGRLMLQVLDALACAHNQG---IVH 102
Query: 473 RDIKSSNILL---DDKFSAKVSDFGTSRSVPN----DKTHLT--TAVQGTFGYFDPEYFQ 523
RD+K NI++ + AKV DFG +P D LT T V GT Y PE +
Sbjct: 103 RDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLR 162
Query: 524 SSQYTDKSDVYSFGVVLLELLTGK 547
T SD+Y++G++ LE LTG+
Sbjct: 163 GEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 336 YNQSRFLGQGGFGTVYKGML----PDGSIVAVKR---SRAIDKTQIEQFINEVVILSQIN 388
Y + + +G+G FG K +L DG +K S+ K + E+ EV +LS +
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMK 57
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H +IV+ E +V +Y G L I+ Q+ L E ++ L W
Sbjct: 58 HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKIN------AQRGVLFPEDQI--LDW--- 106
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
++ A+ ++H I HRDIKS NI L + K+ DFG +R V N L
Sbjct: 107 ---FVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELAR 159
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
GT Y PE ++ Y +KSD+++ G VL E+ T K
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 70/225 (31%), Positives = 113/225 (50%), Gaps = 44/225 (19%)
Query: 340 RFLGQGGFGTVY---KGMLPD-GSIVAVK---------RSRAIDKTQIEQFINEVVILSQ 386
+ LGQG FG V+ K PD G + A+K R R K E IL++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK-------MERDILAE 54
Query: 387 INHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+NH IVKL +TE + L+ +++ G L + K+ + E+++
Sbjct: 55 VNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL--------SKEVMFTEEDV----- 100
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKT 504
+ +A E+A A+ ++HS + I +RD+K NILLD++ K++DFG S+ S+ ++K
Sbjct: 101 --KFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT Y PE +T +D +SFGV++ E+LTG P
Sbjct: 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 77/285 (27%)
Query: 334 DNYNQSRFLGQGGFGTVYK----GMLPDGSI--VAVK--RSRAIDKTQIEQFINEVVILS 385
DN + LG G FG V + G+ + ++ VAVK ++ A + E ++E+ ILS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILS 96
Query: 386 QI-NHRHIVKLLGCCLETEVPVLVY-EYISNGTL---------------------SHHIH 422
+ H++IV LLG C PVLV EY G L S
Sbjct: 97 HLGQHKNIVNLLGACTHGG-PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSS 155
Query: 423 DHQQQQEQKQELEEEQELSSLSWENRV--------------------------------- 449
D++ +K+ + + SS + V
Sbjct: 156 DYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLL 215
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
R + +VA + ++ S I HRD+ + N+LL D AK+ DFG +R + ND ++
Sbjct: 216 RFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV--- 269
Query: 510 VQGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
V+G + PE YT +SDV+S+G++L E+ + GK P
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/219 (28%), Positives = 99/219 (45%), Gaps = 23/219 (10%)
Query: 334 DNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRH 391
D++ + LG G G V+K P G I+A K K I Q I E+ +L + N +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV G + E++ G+L Q +K EQ L +V
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLD--------QVLKKAGRIPEQILG--------KV 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
+ V + Y+ I HRD+K SNIL++ + K+ DFG S + + + +
Sbjct: 109 SIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFV 163
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
GT Y PE Q + Y+ +SD++S G+ L+E+ G+ PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 64/258 (24%), Positives = 113/258 (43%), Gaps = 32/258 (12%)
Query: 336 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
Y R LG G G V+ + D VAVK+ D ++ + E+ I+ +++H +IVK
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 395 LLGCCLETEVPVLVYEYI--SNGTLSHHIHDHQQ-------QQEQKQELEEEQELSSLSW 445
VYE + S L+ + + Q+ + +L E LS
Sbjct: 67 -------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSE 113
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPND-- 502
E+ ++ + Y+HSA + HRD+K +N+ ++ + K+ DFG +R V
Sbjct: 114 EHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 503 -KTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560
K +L+ + + Y P + YT D+++ G + E+LTGK E E+
Sbjct: 171 HKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 561 LVAYFISLAKENKLLEIL 578
L+ + + +E E+L
Sbjct: 230 LILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 34/244 (13%)
Query: 340 RFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V KG +I +K+ + ++ + E IL+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 396 LGCCLETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
L CC +T+ + V EY++ G L I Q+ +K + E R R A
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFD------------EPRSRFYAA 103
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQG 512
EV A+ ++H I +RD+K NILLD + K++DFG + + N T TT G
Sbjct: 104 EVTLALMFLHRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCG 158
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNL---VAYFIS 567
T Y PE Q +Y D ++ GV++ E++ G+ P E++ E L V Y +
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW 218
Query: 568 LAKE 571
L+KE
Sbjct: 219 LSKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-14
Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 31/236 (13%)
Query: 336 YNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSR---AIDKTQIEQFINEVVILSQINHRH 391
Y+ R +G+GG G VY P S VA+K+ R + + ++F+ E I + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV + C + + YI TL + Q++ +EL E+ + + + +
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSI 118
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV-SDFGTSRS------------ 498
++ + Y+HS + HRD+K NILL F V D+G +
Sbjct: 119 FHKICATIEYVHSKG---VLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 499 --VPNDKTHLTT---AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
N T + GT Y PE ++ +D+Y+ GV+L ++LT P
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 342 LGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG G FG V +KG +I +K+ + Q++ E IL +++H IV ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR--VACEV 455
+ + E++ G L H+ + + N V E+
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR------------------KAGRFPNDVAKFYHAEL 127
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A Y+HS I +RD+K N+LLD+K KV+DFG ++ VP D+T + GT
Sbjct: 128 VLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTF---TLCGTPE 180
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE QS + D ++ GV+L E + G P
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 64/238 (26%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 335 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSRAID-----KTQIEQFINEVVILS 385
N+ R LG G +G V+ G G + A+K + KT E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTA-EHTRTERQVLE 59
Query: 386 QINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+ + L +T+ + L+ +Y++ G L H++ Q++ E
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-------QREHFTES------- 105
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E RV +A E+ A+ ++H + I +RDIK NILLD + ++DFG S+ ++
Sbjct: 106 -EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 505 HLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560
+ GT Y PE + S + D +S GV+ ELLTG P + + E+N
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV---DGEQN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQINH 389
D+ + + +G G FG V+ A+K I Q + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
I++L + ++ EY+ G L ++ +S + N
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR------------------NSGRFSNST 102
Query: 450 RV--ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
+ A E+ A+ Y+HS I +RD+K NILLD + K++DFG ++ + D+T
Sbjct: 103 GLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW-- 156
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT Y PE QS + D ++ G+++ E+L G P
Sbjct: 157 -TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 49/236 (20%)
Query: 341 FLGQGGFGTVYKGM-LPDGSIVAVKRSRAI----DKTQIEQFIN----------EVVILS 385
LG+G +G V K G IVA+K+ + I D T+ Q + E+ I++
Sbjct: 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+I H +I+ L+ +E + LV + ++ D ++ ++K L E Q L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCILL- 126
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
++ + +H HRD+ +NI ++ K K++DFG +R
Sbjct: 127 --------QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 506 LTTAVQG-------------TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
T + T Y PE + +Y D++S G + ELLTGK
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 37/220 (16%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSR------AIDKTQIEQFINEVVILSQINHRHIVK 394
+G+G +G VYKG G IVA+K+ R + T I E+ +L ++ H +IV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQHPNIVC 63
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L ++ L++E+ LS + + + Q ++ E S L +
Sbjct: 64 LQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLY---------Q 109
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VP-NDKTHLTTAVQ 511
+ + + HS + HRD+K N+L+D+K K++DFG +R+ +P TH
Sbjct: 110 ILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--- 163
Query: 512 GTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPI 550
T Y PE S Y+ D++S G + E+ T KKP+
Sbjct: 164 -TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 64/235 (27%)
Query: 340 RFLGQGGFGTVYKGMLPD---GSIVAVKRSRAI-----DKTQIEQFINEVVILSQI-NHR 390
+ LG+G +G V+K + D +VA+K+ I + T ++ E++ L ++ +H
Sbjct: 13 QKLGKGAYGIVWKAI--DRRTKEVVALKK---IFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 391 HIVKLLGCCLETEVPV----------LVYEYIS---NGTLSHHIHDHQQQQEQKQELEEE 437
+IVKLL V LV+EY+ + + +I LE+
Sbjct: 68 NIVKLLN--------VIKAENDKDIYLVFEYMETDLHAVIRANI------------LEDV 107
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
+ + ++ A+ Y+HS I HRD+K SNILL+ K++DFG +R
Sbjct: 108 H---------KRYIMYQLLKALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLAR 155
Query: 498 SVPNDKTHLTTAVQ----GTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
S+ + + V T Y PE S++YT D++S G +L E+L GK
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 81/327 (24%), Positives = 131/327 (40%), Gaps = 76/327 (23%)
Query: 342 LGQGGFGTVYK------GMLPDGSIVAVKRSRAIDKTQIEQ--FINEVVILSQI-NHRHI 392
LG+G FG V + VAVK + T E + E+ IL I +H ++
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLK-EGATASEYKALMTELKILIHIGHHLNV 73
Query: 393 VKLLGCCLETEVPVLV-YEYISNGTLSHHIHDHQ-----------QQQEQKQELEEEQEL 440
V LLG C + P++V EY G LS+++ + +++E KQ+ ++Q L
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 441 SS----------------------------------LSWENRVRVACEVAGAVAYMHSAA 466
S L+ E+ + + +VA + ++ S
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193
Query: 467 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPEYFQSS 525
I HRD+ + NILL + K+ DFG +R + D ++ + + PE
Sbjct: 194 CI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDK 250
Query: 526 QYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAK 584
YT +SDV+SFGV+L E+ + G P + +EE F KE
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRM 295
Query: 585 EAREEDIEAVAELAMGCLRLNSKKRPT 611
A E + + + C N + RPT
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDRPT 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 342 LGQGGFGTVYKGMLP-DGSIVAVK--RSRAIDKTQIEQFI--NEVVILSQINHRHIVKLL 396
+G+G FG V DG AVK + +AI K + ++ I V+L + H +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEV 455
+ V +Y++ G L H L+ E+ E R R A E+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFH-------------LQRERSFP----EPRARFYAAEI 105
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTF 514
A A+ Y+HS + I +RD+K NILLD + ++DFG + + + KT T+ GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTP 160
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE + Y D + G VL E+L G P
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 69/248 (27%), Positives = 108/248 (43%), Gaps = 32/248 (12%)
Query: 335 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR 390
++N LG+G FG V KG +I +K+ I +E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 391 HIVKLLGCCLET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+ L C +T + V EY++ G L + I Q++ + V
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI----------------QQVGRFKEPHAV 104
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
A E+A + ++HS I +RD+K N++LD + K++DFG + D T
Sbjct: 105 FYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKT 160
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ERNLVA 563
GT Y PE Y D ++FGV+L E+L G+ P E+E E N VA
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VA 219
Query: 564 YFISLAKE 571
Y S++KE
Sbjct: 220 YPKSMSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 65/224 (29%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 340 RFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V+ KG +I A+K+ + +E + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 396 LGCCLET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C +T E V EY++ G L HI Q A E
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI----------------QSCHKFDLPRATFYAAE 104
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGT 513
+ + ++HS I +RD+K NILLD K++DFG + ++ D T GT
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGT 159
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
Y PE +Y D +SFGV+L E+L G+ P EEE
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 68/242 (28%), Positives = 110/242 (45%), Gaps = 40/242 (16%)
Query: 319 EKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF 377
+ A++F ++ ++ ++ R +G G FG VY + + +VA+K+ K E++
Sbjct: 3 DVAELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 378 ---INEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL 434
I EV L ++ H + ++ GC L LV EY G+ S + H K+ L
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH------KKPL 112
Query: 435 EEEQELSSLSWENRVRVACEVAGAV---AYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491
+E V +A GA+ AY+HS I HRD+K+ NILL + K+
Sbjct: 113 QE------------VEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLG 157
Query: 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEY---FQSSQYTDKSDVYSFGVVLLELLTGKK 548
DFG++ + + GT + PE QY K DV+S G+ +EL K
Sbjct: 158 DFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
Query: 549 PI 550
P+
Sbjct: 213 PL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 335 NYNQSRFLGQGGFGTVY---KGMLPD-GSIVAVK--RSRAI---DKTQIEQFINEVVILS 385
N+ + LG G +G V+ K D G + A+K + A+ KT E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTV-EHTRTERNVLE 59
Query: 386 QINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+ + L +TE + L+ +Y+S G + H++ Q+ E++
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------QRDNFSEDE------ 106
Query: 445 WENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
VR + E+ A+ ++H + I +RDIK NILLD + ++DFG S+ +++
Sbjct: 107 ----VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEERN 560
T + GT Y PE + K+ D +S G+++ ELLTG P L E ERN
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL---EGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 470 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD 529
I HRD+K SNIL++ + K+ DFG S + + + + GT Y PE Q + YT
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTV 177
Query: 530 KSDVYSFGVVLLELLTGKKPI----------CLTREEEE-------RNLVAYFISLAKEN 572
+SD++S G+ L+E+ G+ PI R E R + + +
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237
Query: 573 KLLEILDARVAKEA--------REEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
+ E+LD V + +E + V + CL+ N K+R +K+++ R
Sbjct: 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK----CLKKNPKERADLKELTKHPFIKRA 293
Query: 625 SQRCVEI 631
V+
Sbjct: 294 ELEEVDF 300
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 31/216 (14%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVV------ILSQINHRHIVK 394
LG+GGFG V + + G + A K+ +DK ++++ E + IL ++N IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 395 LLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
L E++ + LV ++ G L +HI++ ++ L E + +
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGER--------------GLEMERVIHYSA 102
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++ + ++HS + I +RD+K N+LLDD+ + ++SD G + + + KT T GT
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGT 157
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GY PE + Y+ D ++ G + E++ G+ P
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 342 LGQGGFGTVYK-GMLPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG+GGFG V M G + A K+ R + E + E IL++++ R IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 398 CCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
+T+ + LV ++ G L +HI++ ++EE ++
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN----------VDEEN--PGFPEPRACFYTAQII 107
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ ++H I +RD+K N+LLD+ + ++SD G + + D T GT G+
Sbjct: 108 SGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSKTKGYAGTPGF 163
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Q +Y D ++ GV L E++ + P
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 69/248 (27%), Positives = 111/248 (44%), Gaps = 32/248 (12%)
Query: 335 NYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR 390
++N LG+G FG V KG +I +K+ I +E + E +L+ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 391 HIVKLLGCCLET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+ L C +T + V EY++ G L +HI +Q + +E Q V
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQA---------V 104
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
A E++ + ++H I +RD+K N++LD + K++DFG + D T
Sbjct: 105 FYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-TTRT 160
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE------ERNLVA 563
GT Y PE Y D +++GV+L E+L G+ P E+E E N V+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VS 219
Query: 564 YFISLAKE 571
Y SL+KE
Sbjct: 220 YPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 342 LGQGGFGTVYKGML--PDGSIVAVKRSRA-IDKTQIEQFINEV-VILSQINHRHIVKLLG 397
LG+G +G V K M P G+I+AVKR RA ++ + ++ + ++ + + ++ + V G
Sbjct: 9 LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 398 CCL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
E +V +I + + ++ K E L ++A +
Sbjct: 68 ALFREGDV------WICMEVMDTSLDKFYKKVYDKGLTIPEDILG--------KIAVSIV 113
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
A+ Y+HS S+ HRD+K SN+L++ K+ DFG S + + A G Y
Sbjct: 114 KALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GCKPY 169
Query: 517 FDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Y KSDV+S G+ ++EL TG+ P
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 60/244 (24%), Positives = 106/244 (43%), Gaps = 31/244 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDG----SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
R +G+G + V L ++ VK+ D I+ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 396 LGCCLETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C +TE + V EY++ G L H+ Q Q++ EE S E
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHM------QRQRKLPEEHARFYS----------AE 104
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQG 512
++ A+ Y+H I +RD+K N+LLD + K++D+G + P D T + G
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCG 158
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP--ICLTREEEERNLVAYFISLAK 570
T Y PE + Y D ++ GV++ E++ G+ P I + + ++N Y +
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218
Query: 571 ENKL 574
E ++
Sbjct: 219 EKQI 222
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 25/223 (11%)
Query: 340 RFLGQGGFGTVYKGMLPDG----SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V L ++ A+K+ + +E + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 396 LGCCLET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C +T E V E+++ G L HI D + + A E
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF----------------YAAE 104
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ + ++HS I +RD+K N++LD K++DFG + +T GT
Sbjct: 105 IVCGLQFLHSKGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTP 160
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
Y PE Q +YT D +SFGV+L E+L G+ P E+E
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR-AIDKTQIEQF-INEVVILSQI---NH 389
Y + +G+G +GTVYK L G VA+K+ R + + I + E+ +L Q+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 390 RHIVKLLGCC----LETEVPV-LVYEYIS---NGTLSHHIHDHQQQQEQKQELEEEQELS 441
+IV+LL C + E+ + LV+E++ LS K L E +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC---------PKPGLPPET-IK 110
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
L ++ V ++HS I HRD+K NIL+ K++DFG +R + +
Sbjct: 111 DLMR--------QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYS 158
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL 543
+ LT+ V T Y PE S Y D++S G + EL
Sbjct: 159 FEMALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 36/219 (16%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQ------FINEVVILSQINHRHIVK 394
+G+GGFG VY D G + A+K +DK +I+ +NE ++LS ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 395 LLGCCLETEVP---VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++ P + + ++ G L +H+ H E++
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF----------------Y 102
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K H A
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 156
Query: 512 GTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKP 549
GT GY PE Q + Y +D +S G +L +LL G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 33/238 (13%)
Query: 336 YNQSRFLGQGGFGTVYKGML---PDGSIVAVKRSRAIDKTQIEQF----INEVVILSQIN 388
Y +G+G +G VYK DG A+K+ + DK Q E+ +L ++
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELK 60
Query: 389 HRHIVKLLGCCLE-TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H ++V L+ LE + V L+++Y + L I H+Q K+ + SL W+
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQA---KRVSIPPSMVKSLLWQ 116
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 502
+ V Y+HS + HRD+K +NIL+ ++ K+ D G +R
Sbjct: 117 --------ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 503 KTHLTTA--VQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
L V T Y PE ++ YT D+++ G + ELLT +PI RE +
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAK 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 340 RFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V K ++ +K+ I K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 454
+ V EY++ G L H L E+ S E+R R E
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFH-------------LSRERVFS----EDRTRFYGAE 103
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ A+ Y+HS I +RD+K N++LD K++DFG + D + T GT
Sbjct: 104 IVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTP 159
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 60/211 (28%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 344 QGGFGTVY---KGMLPDG-SIVAVKRSRAIDKTQIEQFINEVVIL-SQINHRHIVKLLGC 398
+G FG+VY K D +I +K+S I K Q+ E I+ Q ++ KL
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+ LV EY++ G + I + L L + + EV
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI----------------KTLGGLPEDWAKQYIAEVVLG 109
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
V +H I HRDIK N+L+D K++DFG SR+ +K GT Y
Sbjct: 110 VEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLA 161
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE SD +S G V+ E L G P
Sbjct: 162 PETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 340 RFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFI--NEVVILSQINHRHIVK 394
+ +G+G FG V + AVK + +AI K + E+ I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
L + V +YI+ G L +H+ Q ++ LE R R A
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL------QRERCFLEP-----------RARFYAA 103
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQ 511
E+A A+ Y+HS + I +RD+K NILLD + ++DFG + N T+
Sbjct: 104 EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFC 157
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE Y D + G VL E+L G P
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 342 LGQGGFGTVYKGMLPDGSIV----AVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG V + D + ++++ + ++++ + E +L+Q+N IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
E LV +I+ G L HH+ Q+E + +L + ++ E+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTA-----------ELLC 104
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
A+ +H + +RD+K NILLD + + DFG + + T GT Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYL 160
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE YT D ++ GV+L E+LTG P
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/242 (23%), Positives = 101/242 (41%), Gaps = 29/242 (11%)
Query: 340 RFLGQGGFGTVYKGMLPDG----SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
R +G+G + V L ++ VK+ D I+ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 396 LGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
L C +T + LV EY++ G L H+ Q Q++ EE A E
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHM------QRQRKLPEEHARF----------YAAE 104
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTAVQG 512
+ A+ ++H I +RD+K N+LLD K++D+G + P D T + G
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCG 158
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572
T Y PE + +Y D ++ GV++ E++ G+ P + + + N Y + E
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
Query: 573 KL 574
+
Sbjct: 219 PI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 67/217 (30%), Positives = 97/217 (44%), Gaps = 29/217 (13%)
Query: 340 RFLGQGGFGTVYKGMLP-DGSIVAVK--RSRAIDKTQIEQFI--NEVVILSQINHRHIVK 394
+ +G+G FG V DGS AVK + + I K + + I V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
L E V +Y++ G L H L+ E+ E R R A
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFH-------------LQRERCFL----EPRARFYAA 103
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQG 512
EVA A+ Y+HS + I +RD+K NILLD + ++DFG + V ++T T+ G
Sbjct: 104 EVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCG 158
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T Y PE + Y D + G VL E+L G P
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQ------FINEVVILSQINHRHIVK 394
+G+GGFG VY D G + A+K +DK +I+ +NE ++LS ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 395 LLGCCLETEVP---VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++ P + + ++ G L +H+ H E +
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF----------------Y 102
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K H A
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV 156
Query: 512 GTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKP 549
GT GY PE Q Y +D +S G +L +LL G P
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 58/240 (24%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQ-FINEVVILSQINHRH 391
Y ++G+G +G V P G VA+K+ + Q + E+ IL + H +
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 392 IVKLLG-----------------CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL 434
I+ +L +ET++ Y+ I LS+ DH Q
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDL----YKLIKTQHLSN---DHIQY------- 110
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
++ + Y+HSA + HRD+K SN+LL+ K+ DFG
Sbjct: 111 ----------------FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFG 151
Query: 495 TSRSVPNDKTH---LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+R + H LT V T Y PE S YT D++S G +L E+L+ +P+
Sbjct: 152 LARIADPEHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 68/255 (26%), Positives = 99/255 (38%), Gaps = 64/255 (25%)
Query: 340 RFLGQGGFGTVYKGMLPD-GSIVAVKR---SRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ +G+G FG V D G I A+K+ S ++K Q+ E IL++ ++ +VKL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
+ L+ EY+ G D +K EE E R +A E
Sbjct: 67 YYSFQDENYLYLIMEYLPGG-------DMMTLLMKKDTFTEE--------ETRFYIA-ET 110
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ---- 511
A+ +H I HRDIK N+LLD K K+SDFG + K+H T +
Sbjct: 111 ILAIDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSH 165
Query: 512 -----------------------------------GTFGYFDPEYFQSSQYTDKSDVYSF 536
GT Y PE F + Y + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 537 GVVLLELLTGKKPIC 551
GV++ E+L G P C
Sbjct: 226 GVIMYEMLVGYPPFC 240
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 37/229 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR-AIDKTQI-EQFINEVVILSQINHR 390
D Y + +G+G +G VYK G +VA+K++R +D+ I + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 391 -HIVKLLGCCLETEVPV------LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
+IV+LL E LV+EY+ + L + + + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP---------- 108
Query: 444 SWENRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSR--SV 499
++ ++ VA+ H + HRD+K N+L+D K K++D G R S+
Sbjct: 109 --AKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163
Query: 500 PNDK-THLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 546
P TH T Y PE S+ Y+ D++S G + E+
Sbjct: 164 PVKSYTHEIV----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSR-AIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
LG+G +G+VYK + P G +A+K R +D+++ Q I E+ IL + +IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ EY+ G+L D E E L R+ V +
Sbjct: 69 FIEGAVYMCMEYMDAGSL-----DKLYAGGVATEGIPEDVLR--------RITYAVVKGL 115
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTHLTTAVQGTFGYF 517
++ +I HRD+K +N+L++ K+ DFG S ++ KT++ G Y
Sbjct: 116 KFLKEEHNI--IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYM 168
Query: 518 DPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKP 549
PE +S YT +SDV+S G+ +LE+ G+ P
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 65/273 (23%), Positives = 108/273 (39%), Gaps = 60/273 (21%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SRAIDKTQIEQFINEVVILSQ 386
D + LG G FG V + + VAVK ++ + ++E+ IL
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66
Query: 387 I-NHRHIVKLLGCCLETEVPVLV-YEYISNGTLSHHIH---------------------- 422
I NH ++V LLG C + P++V E+ G LS+ +
Sbjct: 67 IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126
Query: 423 ---------------------DHQQQQEQKQELEEEQE---LSSLSWENRVRVACEVAGA 458
Q +E + S L+ E+ + + +VA
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYF 517
+ ++ S I HRD+ + NILL + K+ DFG +R + D ++ + + +
Sbjct: 187 MEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE YT +SDV+SFGV+L E+ + G P
Sbjct: 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 340 RFLGQGGFGTVYKGMLP-DGSIVAVK---RSRAIDKTQIEQFINEV-VILSQINHRHIVK 394
+ +G+G FG V DG AVK + +++ + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
L TE V ++++ G L H L+ E+ E R R A
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFH-------------LQRERSFP----EPRARFYAA 103
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E+A A+ Y+HS I I +RD+K NILLD + ++DFG + ++ TT GT
Sbjct: 104 EIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGT 159
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE + Y + D + G VL E+L G P
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 68/243 (27%), Positives = 106/243 (43%), Gaps = 29/243 (11%)
Query: 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYK-GMLPDGSIVAVKRSRAIDKTQIEQFI 378
+ + E L TD + +G+G +G VYK DGS+ AVK I E+
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIE 66
Query: 379 NEVVILSQI-NHRHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQ 432
E IL + NH ++VK G + + V LV E + G+++ + K
Sbjct: 67 AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---------KG 117
Query: 433 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492
L Q L + ++ + GA+ + + I HRD+K +NILL + K+ D
Sbjct: 118 LLICGQRL------DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS-----DVYSFGVVLLELLTGK 547
FG S + + + T+V GT + PE Q D S DV+S G+ +EL G
Sbjct: 172 FGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 548 KPI 550
P+
Sbjct: 231 PPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 65/262 (24%), Positives = 102/262 (38%), Gaps = 57/262 (21%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
D++ + +G+G FG V D G I A+K ++ ++K Q+ E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+VK+ + L+ E++ G D +K L EE ++
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGG-------DMMTLLMKKDTLSEEATQFYIA----- 108
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG--------------- 494
E A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 109 ----ETVLAIDAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 495 -TSRSVPND------------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 535
+ + P+D + L + GT Y PE F + Y D +S
Sbjct: 162 NLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 536 FGVVLLELLTGKKPICLTREEE 557
GV++ E+L G P C +E
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 27/226 (11%)
Query: 342 LGQGGFGTVYKGMLP-DGSIVAVKRSR-AIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
LG+G + TV+KG ++VA+K R ++ I EV +L + H +IV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
LV+EY+ + + KQ L+ L +S N ++ +
Sbjct: 73 HTERCLTLVFEYLDS--------------DLKQYLDNCGNL--MSMHNVKIFMFQLLRGL 116
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGYF 517
+Y H I HRD+K N+L+++K K++DFG +R SVP KT+ V T Y
Sbjct: 117 SYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVV--TLWYR 170
Query: 518 DPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
P+ S++Y+ D++ G +L E+ TG+ + +EE +L+
Sbjct: 171 PPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 58/240 (24%), Positives = 107/240 (44%), Gaps = 30/240 (12%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDG-------SIVAVKRSRAIDKTQI-EQFINEVVILSQ 386
N+ + LG G +G V+ G ++ +K++ + K + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 387 INHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
I + L +T+ + L+ +YI+ G L H+ ++ +EQ+ ++
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI----------- 109
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
+ E+ A+ ++H + I +RDIK NILLD ++DFG S+ D+
Sbjct: 110 -----YSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 506 LTTAVQGTFGYFDPEYFQSSQYT-DKS-DVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ GT Y P+ + DK+ D +S GV++ ELLTG P + E+ + ++
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 46/239 (19%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRA------------IDKTQIE 375
+L+ ++++ + +G+G FG V +V K S+ I ++
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEV--------QLVRHKSSKQVYAMKLLSKFEMIKRSDSA 88
Query: 376 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
F E I++ N IV+L + + +V EY+ G L + + ++ ++
Sbjct: 89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--------DIP 140
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495
E+ W R A EV A+ +HS I HRD+K N+LLD K++DFGT
Sbjct: 141 EK-------WA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGT 188
Query: 496 S-RSVPNDKTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKP 549
+ N TAV GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 189 CMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 61/224 (27%), Positives = 109/224 (48%), Gaps = 37/224 (16%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQINH 389
N+ + +G+G +G VYK G +VA+K+ R +D T+ E I E+ +L ++NH
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LD-TETEGVPSTAIREISLLKELNH 58
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+IVKLL LV+E++ Q+L++ + S LS
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLH------------------QDLKKFMDASPLSGIPLP 100
Query: 450 RVAC---EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKT 504
+ ++ +A+ HS + HRD+K N+L++ + + K++DFG +R+ VP +T
Sbjct: 101 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 156
Query: 505 HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 547
+ V T Y PE + Y+ D++S G + E++T +
Sbjct: 157 YTHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 470 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD 529
+ HRD+K SNILLD + K+ DFG S + + K +A G Y PE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPPDPNP 193
Query: 530 K----SDVYSFGVVLLELLTGKKP 549
K +DV+S G+ L+EL TG+ P
Sbjct: 194 KYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 77/252 (30%), Positives = 103/252 (40%), Gaps = 61/252 (24%)
Query: 327 EELQRATDNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVI 383
+ Y SR LG G GTV + DG AVK + + + EV
Sbjct: 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCC 84
Query: 384 LSQINHRHIVKLLGCCLE--------TEVPV----LVYEYISNGTLSHHIHDHQQQQEQK 431
L + IVK C E V LV +Y + G L
Sbjct: 85 LLNCDFFSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDL-------------- 126
Query: 432 QELEEEQELSSLSWENRVRVACEVAG--------AVAYMHSAASIPIFHRDIKSSNILLD 483
QE+ S + NR E AG AV ++HS I HRDIKS+NILL
Sbjct: 127 -----RQEIKSRAKTNRTFREHE-AGLLFIQVLLAVHHVHSKHMI---HRDIKSANILLC 177
Query: 484 DKFSAKVSDFGTSR----SVPND--KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFG 537
K+ DFG S+ +V +D +T GT Y PE ++ Y+ K+D++S G
Sbjct: 178 SNGLVKLGDFGFSKMYAATVSDDVGRTFC-----GTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 538 VVLLELLTGKKP 549
V+L ELLT K+P
Sbjct: 233 VLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 36/226 (15%)
Query: 341 FLGQGGFGTVYKGM-LPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLG 397
+G G +G VYKG + G + A+K ++ +I+Q IN + S +HR+I G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYG 70
Query: 398 CCLETEVP------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++ P LV E+ G+++ I + + L+EE W +
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEE-------W---IAY 115
Query: 452 AC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
C E+ ++++H + HRDIK N+LL + K+ DFG S + T +
Sbjct: 116 ICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 172
Query: 511 QGTFGYFDPEYFQSSQYTD-----KSDVYSFGVVLLELLTGKKPIC 551
GT + PE + D KSD++S G+ +E+ G P+C
Sbjct: 173 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 60/284 (21%), Positives = 119/284 (41%), Gaps = 55/284 (19%)
Query: 350 VYKGMLPDGSIV--AVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP-- 405
+YKG+ + ++ K+ K I+ NE+ L +I+ +I+K+ G ++
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 406 --VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463
L+ EY + G L ++ L++E+ LS++ ++ +A + + ++
Sbjct: 96 RLSLILEYCTRGYL-------------REVLDKEK---DLSFKTKLDMAIDCCKGLYNLY 139
Query: 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGYFDPEY 521
+ P ++++ S + L+ + + K+ G + S P K YF +
Sbjct: 140 KYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV------YFSYKM 191
Query: 522 FQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILD 579
S+YT K D+YS GVVL E+ TGK P E + + +N L++
Sbjct: 192 LNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF------ENLTTKEIYDLIINKNNSLKL-- 243
Query: 580 ARVAKEAREEDIEAVAEL---AMGCLRLNSKKRPTMKQVSMDLE 620
++ E+ C +S KRP +K++ +L
Sbjct: 244 ----------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQF--INEVVILSQINHR 390
D+Y + LG+G + TVYKG +G +VA+K R + + + F I E +L + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKGLKHA 63
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV L E LV+EY+ L ++ H L EN
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHP---------------GGLHPENVKL 107
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTT 508
++ ++Y+H I HRD+K N+L+ D K++DFG +R SVP +H +
Sbjct: 108 FLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYS 161
Query: 509 AVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 546
T Y P+ S++Y+ D++ G + +E++ G
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKR-SRAIDKTQIEQF-INEVVILSQINHR 390
+ Y + +G+G +G V+K + G IVA+K+ + D I++ + E+ +L Q+ H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
++V L+ LV+EY + T+ + + + + E + + W+
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVP-------EHLIKKIIWQ---- 108
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
AV + H I HRD+K NIL+ + K+ DFG +R + T V
Sbjct: 109 ----TLQAVNFCHKHNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV 161
Query: 511 QGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTG 546
T Y PE +QY DV++ G V ELLTG
Sbjct: 162 -ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G +G VYK G IVA+K+ R D+ I E+ +L ++NH +IV+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACEVAG 457
LV+E++ D ++ + + L S ++ +
Sbjct: 67 VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQ--------LLQ 110
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VP-NDKTHLTTAVQGTF 514
+AY HS + HRD+K N+L+D + + K++DFG +R+ VP TH T
Sbjct: 111 GIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TL 163
Query: 515 GYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
Y PE S QY+ D++S G + E++ ++P+
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 69/262 (26%), Positives = 103/262 (39%), Gaps = 57/262 (21%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAID---KTQIEQFINEVVILSQINH 389
+++ + +G+G FG V D G + A+K R D K Q+ E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+VK+ + L+ E++ G D +K L EE E +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGG-------DMMTLLMKKDTLTEE--------ETQF 105
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT-------------- 495
+A E A+ +H I HRDIK N+LLD K K+SDFG
Sbjct: 106 YIA-ETVLAIDSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYR 161
Query: 496 --SRSVPNDKT------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 535
+ S+P+D T L + GT Y PE F + Y D +S
Sbjct: 162 NLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 536 FGVVLLELLTGKKPICLTREEE 557
GV++ E+L G P C +E
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 32/228 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD---GSIVA---VKRSRAIDKTQIEQFINEVVILSQI 387
+++ +G+G FG V ++ + G I A +K+S + + + F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
N I +L + + LV EY G L ++ ++ Q + E+
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD----------------ED 102
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
+ +A V +HS + HRDIK N+L+D K++DFG++ + +K +
Sbjct: 103 MAQFY--LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160
Query: 508 TAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE + Y + D +S GV+ E++ G+ P
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 69/277 (24%), Positives = 111/277 (40%), Gaps = 47/277 (16%)
Query: 340 RFLGQGGFGTVY------KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ LG+G FG V G I+ ++ I K ++ + E +L H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKIL--RKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-A 452
L + V EY + G L H L E+ + E R R
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFH-------------LSRERVFT----EERARFYG 101
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
E+ A+ Y+HS + +RDIK N++LD K++DFG + +D + T G
Sbjct: 102 AEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-G 157
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572
T Y PE + + Y D + GVV+ E++ G+ P ++ ER
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP--FYNQDHER------------- 202
Query: 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKR 609
L E++ + R EA + LA G L+ + K+R
Sbjct: 203 -LFELILMEEIRFPRTLSPEAKSLLA-GLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 30/222 (13%)
Query: 334 DNYNQSRFLGQGGFGTV----YK-GMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN 388
+++N R LG G FG V YK P +I ++S+ I + Q++ +E IL+ IN
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H V L G + LV E++ G + +++
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------------------ 131
Query: 449 VRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
V C A + + S+ I +RD+K N+LLD K++DFG ++ V T
Sbjct: 132 --VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----T 185
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT Y PE + + +D ++ G+ + E+L G P
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 28/183 (15%)
Query: 369 IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQ 428
ID Q E+ + E + NH +V L C V E++S G L H+ Q
Sbjct: 39 IDWVQTEKHVFE----TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM------Q 88
Query: 429 EQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488
Q++ EE + E++ A+ ++H I +RD+K N+LLD +
Sbjct: 89 RQRKLPEEHARF----------YSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHI 135
Query: 489 KVSDFGTSRS--VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546
K++D+G + P D T+ GT Y PE + Y D ++ GV++ E++ G
Sbjct: 136 KLTDYGMCKEGIRPGD---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192
Query: 547 KKP 549
+ P
Sbjct: 193 RSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 329 LQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVIL 384
LQ ++Y+ + +G+G FG V +K ++ + + I ++ F E I+
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+ N +V+L + + +V EY+ G L + + ++ ++
Sbjct: 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--------------- 142
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
W EV A+ +HS I HRD+K N+LLD K++DFGT + D+T
Sbjct: 143 WAKFY--TAEVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGTCMKM--DET 195
Query: 505 ---HLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKP 549
TAV GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 196 GMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 37/246 (15%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQF----INEVVIL---SQINHRHIV 393
+G G +GTVYK P G VA+K R +T + + EV +L +H +IV
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 394 KLLGCCL------ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
+L+ C ET+V LV+E++ Q+ + L++ L E
Sbjct: 66 RLMDVCATSRTDRETKV-TLVFEHVD--------------QDLRTYLDKVPP-PGLPAET 109
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
+ + + ++H+ I HRD+K NIL+ K++DFG +R + + + LT
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALT 165
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567
V T Y PE S Y D++S G + E+ K C E ++ + I
Sbjct: 166 PVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 224
Query: 568 LAKENK 573
L E+
Sbjct: 225 LPPEDD 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 57/183 (31%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 370 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQE 429
D+ Q +E+ L+ +H IVK + +L+ EY S G L+ I +Q
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-----KQR 159
Query: 430 QKQELE-EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488
K+ L +E E+ L ++ + A+ +HS + HRD+KS+NI L
Sbjct: 160 LKEHLPFQEYEVGLLFYQ--------IVLALDEVHSRK---MMHRDLKSANIFLMPTGII 208
Query: 489 KVSDFGTSRSVPNDKTHLTTAVQ--GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546
K+ DFG S+ +D L A GT Y PE ++ +Y+ K+D++S GV+L ELLT
Sbjct: 209 KLGDFGFSKQY-SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 547 KKP 549
+P
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/227 (26%), Positives = 110/227 (48%), Gaps = 29/227 (12%)
Query: 342 LGQGGFGTVYKG--MLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGC 398
LG+G + TV+KG L + ++VA+K R + I EV +L + H +IV L
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+ LV+EY+ ++ KQ +++ + S+ N ++
Sbjct: 73 VHTDKSLTLVFEYLD--------------KDLKQYMDDCGNIMSM--HNVKIFLYQILRG 116
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGY 516
+AY H + HRD+K N+L++++ K++DFG +R SVP KT+ V T Y
Sbjct: 117 LAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV--TLWY 170
Query: 517 FDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
P+ SS+Y+ + D++ G + E+ +G+ + E+E +L+
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 76/298 (25%), Positives = 132/298 (44%), Gaps = 58/298 (19%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKR--SRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G +G V K + G IVA+K+ DK + + E+ +L Q+ H ++V L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR-VACEVAG 457
+ LV+E++ H + D ++ + E+RVR ++
Sbjct: 69 FRRKKRLYLVFEFVD-----HTVLDDLEKYPNGLD------------ESRVRKYLFQILR 111
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHLTTAVQGTFG 515
+ + HS I HRDIK NIL+ K+ DFG +R++ P + + T T
Sbjct: 112 GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRW 165
Query: 516 YFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPI---------------CLT------ 553
Y PE ++Y D+++ G ++ E+LTG +P+ CL
Sbjct: 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLIPRH 224
Query: 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
+E ++N + + L E K +E L+ R K + V +LA CLR++ RP+
Sbjct: 225 QEIFQKNPLFAGMRLP-EVKEIEPLEKRFPKLS-----GLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 60/235 (25%), Positives = 94/235 (40%), Gaps = 46/235 (19%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDK-TQIEQFINEVVILSQINHR 390
Y +G G +G V + G VA+K+ A D T ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 391 HIVKLLGCCLETEVP----VLVYEYISNGTLSHHIHDHQQQQEQKQELEEE-------QE 439
+I+ + L V V + L H IH Q L EE Q
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMESDLHHIIH-------SDQPLTEEHIRYFLYQL 116
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499
L L Y+HSA + HRD+K SN+L+++ ++ DFG +R +
Sbjct: 117 LRGLK----------------YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 500 ---PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
P + + T T Y PE +YT D++S G + E+L G++ +
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 32/223 (14%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH-RHIVKLLGCC 399
+G G +G VYKG + G + A+K + + E+ E+ +L + +H R+I G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 400 LETEVP------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
++ P LV E+ G+++ +L + + ++L + +
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVT--------------DLVKNTKGNALKEDWIAYICR 128
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E+ +A++H+ I HRDIK N+LL + K+ DFG S + T + GT
Sbjct: 129 EILRGLAHLHAHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GT 184
Query: 514 FGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPIC 551
+ PE + Y +SD++S G+ +E+ G P+C
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 63/227 (27%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSI-VAVKR-SR----AIDKTQIEQFINEVVILSQI 387
D Y +G G +G V VA+K+ SR AI + + E+ +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHM 71
Query: 388 NHRHIVKLLGC-----CLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
+H +++ LL LE V LV + G ++I Q+ + + Q L
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
L Y+HSA I HRD+K SNI +++ K+ DFG +R
Sbjct: 130 GLK----------------YIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH--T 168
Query: 502 DKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
D +T V T Y PE Y D++S G ++ ELLTGK
Sbjct: 169 DD-EMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 380 EVVILSQINHRHIVKLLGCCL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
E +LSQ+ H +IV E + +V + G L H + +EQK +L E
Sbjct: 49 EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL------KEQKGKLLPEN 102
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498
++ + W ++A A+ Y+H I HRD+K+ N+ L KV D G +R
Sbjct: 103 QV--VEW------FVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV 151
Query: 499 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 558
+ N +T + GT Y PE F + Y KSDV++ G + E+ T K ++
Sbjct: 152 LENQCDMASTLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF----NAKD 206
Query: 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
N + Y I++ ++ ++ E + EL L +KRP++K +
Sbjct: 207 MNSLVY-----------RIIEGKLPPMPKDYSPE-LGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIE--QFINEVVILSQINHRH 391
+ LG+GG+G V++ G+ I A+K + I + Q + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV L+ L+ EY+S G L H LE E + E+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMH-------------LERE----GIFMED---T 101
Query: 452 AC----EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
AC E++ A+ ++H I +RD+K NILLD + K++DFG + ++ T +T
Sbjct: 102 ACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
GT Y PE S + D +S G ++ ++LTG P
Sbjct: 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAI-DKTQIEQFINEVVILSQINHRHI 392
Y Q + +G G G V G VAVK+ SR ++T ++ E+V+L +NH++I
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+ LL P E + L + D Q EL+ E+ +S L ++ +
Sbjct: 83 ISLL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER-MSYLLYQ----ML 133
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
C + ++HSA I HRD+K SNI++ + K+ DFG +R+ + + T
Sbjct: 134 C----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVV 184
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546
T Y PE Y + D++S G ++ EL+ G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 56/223 (25%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQINHR 390
D Y + +G+G +G VYK +A+K+ R D+ I E+ +L ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRV 449
+IV+L + LV+EY+ D ++ + + + L + ++
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLD--------LDLKKHMDSSPDFAKNPRLIKTYLYQ--- 110
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA-KVSDFGTSRSVPNDKTHLTT 508
+ +AY HS + HRD+K N+L+D + +A K++DFG +R+ T
Sbjct: 111 -----ILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 509 AVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
V T Y PE S Y+ D++S G + E++ +KP+
Sbjct: 163 EVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 29/227 (12%)
Query: 342 LGQGGFGTVYKG--MLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGC 398
LG+G + TVYKG L D ++VA+K R + I EV +L + H +IV L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+ LV+EY+ ++ KQ L++ ++ N ++
Sbjct: 73 IHTEKSLTLVFEYLD--------------KDLKQYLDDCGNSINM--HNVKLFLFQLLRG 116
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQGTFGY 516
+ Y H + HRD+K N+L++++ K++DFG +R S+P KT+ V T Y
Sbjct: 117 LNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVV--TLWY 170
Query: 517 FDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
P+ S+ Y+ + D++ G + E+ TG+ + EE+ + +
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 56/215 (26%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 340 RFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V K ++ +K+ I K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 454
+ V EY + G L H L E+ S E+R R E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFH-------------LSRERVFS----EDRARFYGAE 103
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ A+ Y+HS + +RD+K N++LD K++DFG + +D + T GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 159
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 59/223 (26%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ--IEQFINEVVILSQINHRH 391
N+ Q LG+G + TVYKG G IVA+K +D + I E+ ++ ++ H +
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHEN 59
Query: 392 IVKLLGCCLETEVP-VLVYEYISNGTLSHHIHDHQQQQEQKQELEEE---QELSSLSW-- 445
IV+L + TE +LV+EY+ L ++ H + + Q L +++
Sbjct: 60 IVRLHDV-IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
ENRV HRD+K N+L++ + K++DFG +R+
Sbjct: 118 ENRV---------------------LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156
Query: 506 LTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 547
+ V T Y P+ S+ Y+ D++S G ++ E++TG+
Sbjct: 157 FSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 335 NYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQI-EQFINEVVILSQI-N 388
Y + LGQG +G V + ++ K + K + ++ + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 389 HRHIVKLLGCCLETEVP-------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
H++I C + ++ + +YE + L I Q L + S
Sbjct: 61 HKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQP-------LTDAHFQS 109
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+ ++ C + Y+HSA + HRD+K N+L++ K+ DFG +R
Sbjct: 110 FI-----YQILC----GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSE 157
Query: 502 DKT----HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPI 550
+ +T V T Y PE S Q YT DV+S G +L ELL G+KP+
Sbjct: 158 NPGENAGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 340 RFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
+ LG+G FG V K ++ +K+ + K ++ + E +L H + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 454
+ V EY + G L H L E+ S E+R R E
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFH-------------LSRERVFS----EDRARFYGAE 103
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ A+ Y+HS ++ +RD+K N++LD K++DFG + D + T GT
Sbjct: 104 IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTP 160
Query: 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 28/238 (11%)
Query: 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVKRSRAIDKTQIE 375
K I +L+ ++Y + +G+G FG V +K ++ + + I ++
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 376 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
F E I++ N +V+L + +V EY+ G L + + ++ ++
Sbjct: 89 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK------ 142
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495
W R A EV A+ +HS I HRD+K N+LLD K++DFGT
Sbjct: 143 ---------WA-RFYTA-EVVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGT 188
Query: 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKP 549
+ + GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 45/229 (19%)
Query: 342 LGQGGFGTVYKGM---LPDG-----SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
LGQG F ++KG+ + D + V +K + E F ++SQ++H+H+V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
G C+ + ++V EY+ G+L + L++ + L ++SW+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTY-------------LKKNKNLINISWK------L 103
Query: 454 EVAGAVAY-MHSAASIPIFHRDIKSSNILL----DDKFSA----KVSDFGTSRSV-PNDK 503
EVA +A+ +H + H ++ + N+LL D K K+SD G S +V P +
Sbjct: 104 EVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE- 162
Query: 504 THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTG-KKPI 550
+ + PE ++ Q + +D +SFG L E+ +G KP+
Sbjct: 163 -----ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 65/279 (23%)
Query: 342 LGQGGFGTVYKG------MLPDGSIVAVKRSR-AIDKTQIEQFINEVVILSQINHR-HIV 393
LG+G FG V + VAVK + ++ ++E+ IL I H ++V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 394 KLLGCCLETEVPVLV-YEYISNGTLSHHIHDHQQQ----------------------QEQ 430
LLG C + P++V E+ G LS+++ + + ++
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 431 KQELE--------------EEQELSS---------------LSWENRVRVACEVAGAVAY 461
K+ L+ EE+ LS L+ E+ + + +VA + +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPE 520
+ S I HRD+ + NILL + K+ DFG +R + D ++ + + PE
Sbjct: 195 LASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEE 558
YT +SDV+SFGV+L E+ + G P + +EE
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 48/232 (20%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ-IEQF-INEVVILSQINHRH 391
Y + +G+G +GTV+K IVA+KR R D + + + E+ +L ++ H++
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 392 IVKLLGCCLETEVPVLVYEYIS----------NGTLSHHIHDHQQQQEQKQELEEEQELS 441
IV+L + LV+EY NG + I + Q L+
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI----VKSFMFQLLK------ 110
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--V 499
+A+ HS + HRD+K N+L++ K++DFG +R+ +
Sbjct: 111 ----------------GLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
Query: 500 PNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
P +A T Y P+ F + Y+ D++S G + EL +P+
Sbjct: 152 P---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 22/185 (11%)
Query: 364 KRSRAIDKTQIEQFINEVVILSQINHRHIVKL---LGCCLETEVPVLVYEYISNGTLSHH 420
KR +A + I Q NE++ L ++NH +I+K+ L T + Y++ L
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSF 252
Query: 421 IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480
++D + L + R + ++ AV Y+H + HRDIK NI
Sbjct: 253 MYDEAFDWKD----------RPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENI 298
Query: 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 540
L+ + DFGT+ ++ GT PE Y + +D++S G++L
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358
Query: 541 LELLT 545
L++L+
Sbjct: 359 LDMLS 363
|
Length = 501 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKT--QIEQFINEVVILSQINH 389
+D + +G+G +G V+K + +GS AVK I +IE N + LS +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DH 74
Query: 390 RHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
++VK G + +V LV E + G+++ + ++ E+ +E L
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH--- 131
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E + ++H +I HRD+K +NILL + K+ DFG S + + +
Sbjct: 132 ---------EALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179
Query: 505 HLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPI 550
T+V GT + PE Q Y + DV+S G+ +EL G P+
Sbjct: 180 RRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 39/216 (18%)
Query: 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQ-------FINEVVILSQINHRHIV 393
LG+G + TVYKG G +VA+K R +E I E +L + H +IV
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR------LEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
L + LV+EY+ L ++ D LS N
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG---------------GGLSMHNVRLFLF 110
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 511
++ +AY H + HRD+K N+L+ ++ K++DFG +R SVP+ KT+ V
Sbjct: 111 QLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVV- 165
Query: 512 GTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTG 546
T Y P+ S++Y+ D++ G + E+ TG
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 75/317 (23%), Positives = 135/317 (42%), Gaps = 74/317 (23%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRS-----------RAIDKTQIEQFINEVV 382
+ Y + +G G FG V+ +V KR+ R + + + Q + EV
Sbjct: 13 NEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64
Query: 383 ILSQINHRHIVKLLGCCLE--TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440
++ ++ H++IV+ + L + ++ E+ G LS +I Q+ + ++EE
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHA-- 119
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIP----IFHRDIKSSNILLDDKFS--------- 487
V + ++ A+AY H+ P + HRD+K NI L
Sbjct: 120 -------IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 488 --------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF--QSSQYTDKSDVYSFG 537
AK+ DFG S+++ + + + GT Y+ PE ++ Y DKSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 538 VVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAEL 597
++ EL +GK P + N + IS K L I +++E +I L
Sbjct: 231 CIIYELCSGKTPF------HKANNFSQLISELKRGPDLPI-----KGKSKELNI-----L 274
Query: 598 AMGCLRLNSKKRPTMKQ 614
L L++K+RP+ Q
Sbjct: 275 IKNLLNLSAKERPSALQ 291
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTHLTTAVQGTFG 515
A+ Y+H+A +FHRD+K NIL + K+ DFG +R ND T T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 516 YFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGK 547
Y PE S S+YT D++S G + E+LTGK
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 29/216 (13%)
Query: 342 LGQGGFGTVYKGMLPDGSIVA---VK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLL 396
+G G FG V + + VA VK ++ A K Q +F+ + + H +I++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCL 61
Query: 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
G C+E +LV+EY G L ++ Q + Q L + R+ACE+A
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ------------RMACEIA 109
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGTFG 515
V +MH H D+ N L + KV D+G S D
Sbjct: 110 AGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 516 YFDPEY---FQ----SSQYTDKSDVYSFGVVLLELL 544
+ PE F +++ T S+V++ GV L EL
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 23/216 (10%)
Query: 336 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRH 391
Y + +G G G V Y +L D ++ K SR ++T ++ E+V++ +NH++
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL-DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I+ LL P E + L + D Q + EL+ E+ +S L ++ +
Sbjct: 78 IISLL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHER-MSYLLYQ----M 128
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
C + ++HSA I HRD+K SNI++ + K+ DFG +R+ + + T
Sbjct: 129 LC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYV 179
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
T Y PE Y + D++S G ++ E++ K
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+HSA + HRD+K SN+LL+ K+ DFG +R ++K T T Y PE
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPE 178
Query: 521 -YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
S+YT DV+S G + ELL G+KP+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINHR 390
+Y + +G G +G VYK L G + AVK D + I+Q E+ ++ + H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHC 66
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV G L E + EY G+L H ++ E ++
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYH-----------------VTGPLSELQIA 109
Query: 451 VAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
C E +AY+HS + HRDIK +NILL D K++DFG + + +
Sbjct: 110 YVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
Query: 510 VQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ GT + PE ++ Y D+++ G+ +EL + P+
Sbjct: 167 I-GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQIN 388
Y + +GQG FG V+K IVA+K+ ++ E F + E+ IL +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69
Query: 389 HRHIVKLLGCCLETEVP--------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440
H ++V L+ C P LV+E+ H + + K L E +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-----HDLAGLLSNKNVKFTLSEIK-- 122
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--S 498
+V + + Y+H I HRD+K++NIL+ K++DFG +R S
Sbjct: 123 ---------KVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 499 VP-NDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ N K + T T Y PE Y D++ G ++ E+ T + PI
Sbjct: 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 342 LGQGGFGTVYKG--MLPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQIN---HRHI 392
+G+G +G V+K + G VA+KR R +T E I EV +L + H ++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 393 VKLLGCCL------ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
V+L C ET++ LV+E++ Q+ L++ E + E
Sbjct: 67 VRLFDVCTVSRTDRETKL-TLVFEHVD--------------QDLTTYLDKVPE-PGVPTE 110
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ ++ + ++HS + HRD+K NIL+ K++DFG +R
Sbjct: 111 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--A 165
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
T+V T Y PE S Y D++S G + E+ +KP+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 24/213 (11%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
+G G +G VYK + G + A+K + E++++ H +IV G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+ + E+ G+L H LS V+ E +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH----------------VTGPLSESQIAYVSRETLQGLY 120
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+HS + HRDIK +NILL D K++DFG S + + + GT + PE
Sbjct: 121 YLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPE 176
Query: 521 YF---QSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ Y D+++ G+ +EL + P+
Sbjct: 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 60/233 (25%), Positives = 95/233 (40%), Gaps = 32/233 (13%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG VY+ D I A+K + + K ++ I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 398 CCLETEVPV---LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
+ LV +Y+S G L H+ Q+E + E+R +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL-----QKEGRFS------------EDRAKFYIA 103
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQG 512
E+ A+ ++H I +RD+K NILLD + DFG S+ N T G
Sbjct: 104 ELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCG 158
Query: 513 TFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
T Y PE YT D +S GV++ E+ G P ++ +A+
Sbjct: 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+A V +HS + HRDIK N+LLD +++DFG+ + D T ++ GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167
Query: 515 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 25/217 (11%)
Query: 336 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKR-SRAI-DKTQIEQFINEVVILSQINHR 390
Y + +G G G V Y + G VA+K+ SR + T ++ E+V++ +NH+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+I+ LL P E + L + D Q + +L+ E+ +S L ++
Sbjct: 76 NIIGLLNVF----TPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHER-MSYLLYQ---- 126
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ C + ++HSA I HRD+K SNI++ + K+ DFG +R+ +T V
Sbjct: 127 MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYV 178
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
T Y PE Y + D++S G ++ E++ G
Sbjct: 179 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 75/299 (25%), Positives = 125/299 (41%), Gaps = 64/299 (21%)
Query: 342 LGQGGFGTVYKGML---PDGSIVA----VKRSRAI---DKTQIEQFINEVVILSQINHRH 391
LGQG F +YKG+L D IV V + D F ++SQ++H+H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+VKL G C+ E ++V EY+ G L +H E+ SL W ++ V
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH-------------REKNNVSLHW--KLDV 106
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFS----AKVSDFGTSRSVPNDKT 504
A ++A A+ Y+ + H ++ NIL+ K+SD G +V + +
Sbjct: 107 AKQLASALHYLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 505 HLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEERN 560
+ + PE + + T +D +SFG LLE+ + G++P+ L+ E+ER
Sbjct: 164 RVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER- 217
Query: 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
++ L + D +A L C + KRP+ + + DL
Sbjct: 218 -------FYQDQHRLPMP-----------DCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTFGYF 517
+ Y+HSA I HRDIK N+L++ K+ DFG +R P++ H+T V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 518 DPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 547
PE S+ YT D++S G + ELL +
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 41/128 (32%), Positives = 69/128 (53%), Gaps = 12/128 (9%)
Query: 427 QQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486
Q+ E+ EE EL+ L E+ + + +VA ++++ S I HRD+ + NILL
Sbjct: 196 DQDVTSEILEEDELA-LDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGR 251
Query: 487 SAKVSDFGTSRSVPNDKTHLTTAVQGT----FGYFDPEYFQSSQYTDKSDVYSFGVVLLE 542
K+ DFG +R + ND ++ V+G + PE + YT +SDV+S+G++L E
Sbjct: 252 ITKICDFGLARDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 543 LLT-GKKP 549
+ + G P
Sbjct: 309 IFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 24/227 (10%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCCL 400
+G+G +G VYK DG + I+ T I E+ +L ++ H +++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 401 -ETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACEVAG 457
++ V L+++Y + L H I H+ + K+ ++ + + SL ++ +
Sbjct: 69 SHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ--------ILD 119
Query: 458 AVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 511
+ Y+H+ + HRD+K +NIL+ ++ K++D G +R + P V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 512 GTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
TF Y PE ++ YT D+++ G + ELLT +PI R+E+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 40/173 (23%), Positives = 70/173 (40%), Gaps = 37/173 (21%)
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLV--------YEYISNGTLSHHIHDHQQQQEQK 431
E ++L +NH ++++ + + +V Y Y++ S + Q +K
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKR--SRPLPIDQALIIEK 164
Query: 432 QELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491
Q LE + Y+H+ I HRD+K+ NI ++D +
Sbjct: 165 QILE----------------------GLRYLHAQR---IIHRDVKTENIFINDVDQVCIG 199
Query: 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELL 544
D G ++ L A GT PE +Y K+D++S G+VL E+L
Sbjct: 200 DLGAAQFPVVAPAFLGLA--GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 30/220 (13%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI--EQFINEVVILSQINH 389
T+ Y + +G G FG V G VA+K+ T + ++ E+ +L + H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 390 RHIVKLLGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+I+ L + E V E + GT H + + ++Q + Q L L
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLK---- 122
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
Y+HSA + HRD+K SNIL+++ K+ DFG +R D T
Sbjct: 123 ------------YVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR--IQD--PQMT 163
Query: 509 AVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGK 547
T Y PE + Q Y + D++S G + E+L GK
Sbjct: 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 336 YNQSRFLGQGGFGTV---YKGMLPDGSIVAVKR-SRAI-DKTQIEQFINEVVILSQINHR 390
Y + +G G G V Y +L VA+K+ SR ++T ++ E+V++ +NH+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+I+ LL P E + + + D Q + EL+ E+ +S L ++
Sbjct: 84 NIIGLL----NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER-MSYLLYQ---- 134
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ C + ++HSA I HRD+K SNI++ + K+ DFG +R+ + + T
Sbjct: 135 MLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY 185
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
T Y PE Y + D++S G ++ E++ G
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 58/226 (25%), Positives = 90/226 (39%), Gaps = 60/226 (26%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN--EVVILSQIN-HRHIVKLLG 397
+G+G F V K G A+K + K+ +EQ N E+ L +++ H +I++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 398 CCLETEVPVL----------VYEYISNGTLSHHIHDHQQQQEQKQELEEE-------QEL 440
+ + L +YE I +K+ L E+ Q L
Sbjct: 66 VLFDRKTGRLALVFELMDMNLYELIKG---------------RKRPLPEKRVKSYMYQLL 110
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500
SL +MH IFHRDIK NIL+ D K++DFG+ R +
Sbjct: 111 KSLD----------------HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGI- 149
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLT 545
T T Y PE + Y K D+++ G V E+L+
Sbjct: 150 -YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 24/227 (10%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLGCCL 400
+G+G +G VYK DG + I+ T I E+ +L ++ H +++ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 401 -ETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL-SSLSWENRVRVACEVAG 457
+ V L+++Y + L H I H+ + K+ ++ + + SL ++ +
Sbjct: 69 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------ILD 119
Query: 458 AVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSR--SVPNDKTHLTTAVQ 511
+ Y+H+ + HRD+K +NIL+ ++ K++D G +R + P V
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 512 GTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
TF Y PE ++ YT D+++ G + ELLT +PI R+E+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)
Query: 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQ-----FINEVVILS 385
A +Y LG+G + TVYKG+ +G +VA+K + + E+ I E +L
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLK 58
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+ H +IV L E V+EY+ L+ ++ H L
Sbjct: 59 GLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHP---------------GGLHP 102
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDK 503
N ++ +AY+H I HRD+K N+L+ K++DFG +R S+P+ +
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-Q 158
Query: 504 THLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGK 547
T+ + V T Y P+ ++ Y+ D++ G + +E+L G+
Sbjct: 159 TYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+A V + S + HRDIK NIL+D +++DFG+ + D T ++ GT
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 167
Query: 515 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 21/172 (12%)
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
E+ IL I+HR I+ L+ +V + + D ++
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRS-------- 179
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS-RS 498
L E + + + A+AY+H I HRD+K+ NI LD+ +A + DFG + +
Sbjct: 180 -GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 499 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ T GT PE Y K+D++S G+VL E+ +
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 28/220 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRS--RAIDKTQIEQFINEVVILSQINHRHIVKLLG 397
+ + K P ++VAVK+ + K ++ E++ Q+ H +I+ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ +V ++ G+ + H + L L+ ++ +V
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-----------LPELAIAFILK---DVLN 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS-VPNDKTHLTTAVQGTFGY 516
A+ Y+HS I HR +K+S+ILL +S S S + + K
Sbjct: 113 ALDYIHSKGFI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 517 FD-----PEYFQSS--QYTDKSDVYSFGVVLLELLTGKKP 549
+ PE Q + Y +KSD+YS G+ EL G P
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+A V + S + HRDIK N+LLD +++DFG+ + D T + GT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 515 GYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKP 549
Y PE Q+ +Y + D +S GV + E+L G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/268 (23%), Positives = 96/268 (35%), Gaps = 69/268 (25%)
Query: 334 DNYNQSRFLGQGGFGTV-YKGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
++++ + +G+G FG V G I A+K +S K Q+ E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+V L + + L+ E++ G L + + E R
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---------------TRF 105
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS------------- 496
+A E A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 106 YMA-ECVLAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161
Query: 497 ---------------RSVPNDKTHLTTAVQ------------------GTFGYFDPEYFQ 523
SV D +LT + + GT Y PE F
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221
Query: 524 SSQYTDKSDVYSFGVVLLELLTGKKPIC 551
Y + D +S G ++ E L G P C
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPFC 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/137 (24%), Positives = 64/137 (46%), Gaps = 13/137 (9%)
Query: 417 LSHHIHDHQQQQEQKQELEEEQELSS-----LSWENRVRVACEVAGAVAYMHSAASIPIF 471
+ +D + + E + LS L+ + + +VA + ++ S +
Sbjct: 203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--- 259
Query: 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF---GYFDPEYFQSSQYT 528
HRD+ + N+LL K+ DFG +R + +D +++ TF + PE + YT
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYT 317
Query: 529 DKSDVYSFGVVLLELLT 545
SDV+S+G++L E+ +
Sbjct: 318 TLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 37/248 (14%)
Query: 342 LGQGGFGTVYKGMLPDG---SIVAVKRSRAIDKTQIE-QFINEVVILSQINHRHIVKLLG 397
+G G FG V G + G + V VK R Q + +F+ E + H ++++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV--RVACEV 455
C E +LV E+ G L K L ++ ++ + R+ACE+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDL-------------KGYLRSCRKAELMTPDPTTLQRMACEI 109
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT-AVQGTF 514
A + ++H I H D+ N LL + K+ D+G S + + ++T +
Sbjct: 110 ALGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 515 GYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566
+ PE T +S+V+S GV + EL G +P R + ++ Y +
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY---RHLSDEQVLTYTV 223
Query: 567 SLAKENKL 574
+E +L
Sbjct: 224 ---REQQL 228
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 33/106 (31%), Positives = 58/106 (54%), Gaps = 8/106 (7%)
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
LS+ + V + +VA + ++ AS HRD+ + N+L+ + K+ DFG +R + D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 503 KTHLTTAVQGTF---GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545
+++ TF + PE ++ YT SDV+SFG++L E+ T
Sbjct: 293 SNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 64/257 (24%), Positives = 98/257 (38%), Gaps = 67/257 (26%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIV-AVKRSRAID---KTQIEQFINEVVILSQINHRHIVKL 395
+ +G G FG V D + + A+K R D + Q E IL++ ++ +VKL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 396 LGCCLETEVPVLVYEYISNGTL-SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
+ + V +YI G + S I + + EE +L+ R +A E
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI---------RLGIFEE-DLA------RFYIA-E 109
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG-------------------- 494
+ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 110 LTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 495 --TSRSVPN-----DKTHLTT---------------AVQGTFGYFDPEYFQSSQYTDKSD 532
S D+ L ++ GT Y PE + YT D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 533 VYSFGVVLLELLTGKKP 549
+S GV+L E+L G+ P
Sbjct: 227 WWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 63/263 (23%), Positives = 117/263 (44%), Gaps = 39/263 (14%)
Query: 300 FKQNGGYLLQQRLS----SCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML 355
F+ N L ++ S + ++ K+ + + +Y +G G FG VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 356 PDGS-IVAVKRSRAIDKTQIEQFIN-EVVILSQINHRHIVKL-----LGCCLETEVPV-- 406
D S VA+K+ Q Q+ N E++I+ +NH +I+ L C + E +
Sbjct: 88 IDTSEKVAIKKV-----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 407 -LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA 465
+V E+I H H + L + S ++ A+AY+HS
Sbjct: 143 NVVMEFIPQTV--HKYMKHYARNNHALPLFLVKLYSY-----------QLCRALAYIHSK 189
Query: 466 ASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQ 523
I HRD+K N+L+D + K+ DFG+++++ + ++ + F Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY-ICSRF-YRAPELMLG 244
Query: 524 SSQYTDKSDVYSFGVVLLELLTG 546
++ YT D++S G ++ E++ G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 63/250 (25%), Positives = 95/250 (38%), Gaps = 61/250 (24%)
Query: 340 RFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVV-------ILSQINHRH 391
+ LG+G G V+ L G + A+K +DK ++ + N+V IL+ ++H
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALK---VLDKKEMIKR-NKVKRVLTEQEILATLDHPF 62
Query: 392 IVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+ L +TE + LV +Y G L L + Q LS E R
Sbjct: 63 LPTLY-ASFQTETYLCLVMDYCPGGELFR--------------LLQRQPGKCLS-EEVAR 106
Query: 451 V-ACEVAGAVAYMHSAASIPIFHRDIKSSNILL-----------DDKFSAKVSD------ 492
A EV A+ Y+H I +RD+K NILL D + V
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 493 --FGTSRSVPNDKTHLTTAVQ---------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 541
G+ RS N T + + GT Y PE + D ++ G++L
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 542 ELLTGKKPIC 551
E+L G P
Sbjct: 224 EMLYGTTPFK 233
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 52/232 (22%), Positives = 100/232 (43%), Gaps = 28/232 (12%)
Query: 324 FTAEELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI--EQ 376
F EE+ + + Y + +G G +G+V + G VA+K+ +++I ++
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
E+ +L + H +++ LL + + + + L Q+ L E
Sbjct: 61 AYRELTLLKHMQHENVIGLL----DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSE 116
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
++ + L ++ + + Y+HSA I HRD+K N+ +++ K+ DFG +
Sbjct: 117 DK-VQYLVYQ--------MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 547
R + T T Y PE + Y D++S G ++ E+LTGK
Sbjct: 165 RHADAEMTGYVV----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQ--IEQFINEVVILSQINHRHIVKLLGC 398
+G+G +G V K + IVA+K+ + ++ + E + E+ +L + +IV+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAG 457
LV+EY+ +K LE +E+ + +VR ++
Sbjct: 69 FRRRGKLYLVFEYV-----------------EKNMLELLEEMPNGVPPEKVRSYIYQLIK 111
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
A+ + H I HRDIK N+L+ K+ DFG +R++ T T Y
Sbjct: 112 AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR 168
Query: 518 DPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
PE + Y D++S G +L EL G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 56/233 (24%), Positives = 100/233 (42%), Gaps = 27/233 (11%)
Query: 323 IFTAEELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKT-QIE 375
F +EL + + Y +G G +G+V G VAVK+ SR +
Sbjct: 2 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 61
Query: 376 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
+ E+ +L + H +++ LL + P E ++ L H+ +L
Sbjct: 62 RTYRELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHL--------MGADLN 109
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495
+ L+ ++ + ++ + Y+HSA I HRD+K SN+ +++ K+ DFG
Sbjct: 110 NIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 166
Query: 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 547
+R ++ T T Y PE + Y D++S G ++ ELLTG+
Sbjct: 167 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 58/239 (24%), Positives = 97/239 (40%), Gaps = 47/239 (19%)
Query: 334 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH 389
+++ + + G +G VY K ++ + + I + QI+Q E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNG---TLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+V + C ET+ + +V EY+ G TL +I +L
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNI-------------------GALPV 100
Query: 446 E-NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR------- 497
+ R+ A E A+ Y+H+ I HRD+K N+L+ K++DFG S+
Sbjct: 101 DMARMYFA-ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156
Query: 498 ------SVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ D + L V GT Y PE Y D ++ G++L E L G P
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 25/171 (14%)
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
++ + +KL + VL+ +YI +G L + +K+ E E+ +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--------KKEGKLSEAEVKKI---- 114
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRSVPNDKTHL 506
+R E A+ +H I H DIK N+L D K + D+G + + +
Sbjct: 115 -IRQLVE---ALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY- 166
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
GT YF PE + Y D ++ GV+ ELLTGK P +EE
Sbjct: 167 ----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 28/136 (20%), Positives = 54/136 (39%), Gaps = 11/136 (8%)
Query: 371 KTQIEQFINEVVILSQINHRHIVKLL-----GCCLETEVPVLVYEYISNGTLS----HHI 421
K N V +L + +++K+ G E EV +L + ++ L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAIL--QLLARKGLPVPKVLAS 61
Query: 422 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481
+ E E + L +S E + +A ++A +A +H + + H D+ NIL
Sbjct: 62 GESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNIL 121
Query: 482 LDDKFSAKVSDFGTSR 497
+DD + D+ +
Sbjct: 122 VDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 29/161 (18%)
Query: 344 QGGFGTVYKGMLPDGS----IVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+G FG VY G + S + VK++ I+K + Q E L+ IV L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YS 72
Query: 400 LETEVPV-LVYEYISNGTLSH--HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
L++ V LV EY+ G + HI+ + +EE + +S EVA
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGY---------FDEEMAVKYIS---------EVA 114
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
A+ Y+H I HRD+K N+L+ ++ K++DFG S+
Sbjct: 115 LALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 446 ENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E+R++ + ++ + Y+H+A I HRD+K N+ +++ K+ DFG +R ++ T
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 505 HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 547
T Y PE + YT D++S G ++ E+LTGK
Sbjct: 174 GYVV----TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 8/88 (9%)
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
Y+HSA I HRD+K SN+ +++ ++ DFG +R ++ T T Y PE
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPE 185
Query: 521 YFQS-SQYTDKSDVYSFGVVLLELLTGK 547
+ Y D++S G ++ ELL GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 30/98 (30%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT------SRSVPNDKT 504
VA ++ A+ Y+H I HRDIK+ N+L++ + DFG S S P
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP---- 317
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 542
+ GT PE YT D++S G+V+ E
Sbjct: 318 -FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 29/94 (30%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGT 513
V A+ Y+H I HRDIK+ NI ++ + DFG + P D + GT
Sbjct: 191 VLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGT 246
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
PE Y D++S G+VL E+ T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 23/157 (14%)
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
++V L + + LV ++ G L HI E+ + R
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK----------------R 89
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
A E+ A+ +H I RD+ +NILLDD+ +++ F V + + AV
Sbjct: 90 WAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEV--EDSCDGEAV 144
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
+ Y PE S+ T+ D +S G +L ELLTGK
Sbjct: 145 ENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 64/258 (24%), Positives = 95/258 (36%), Gaps = 69/258 (26%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLG 397
LG G FG V D ++ A+K R D + Q+ E IL++ ++ +VKL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ + V +YI G + + + E+ E R +A E+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL--------IRMEVFPEVLA-------RFYIA-ELTL 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV------------------ 499
A+ +H I HRDIK NIL+D K++DFG
Sbjct: 113 AIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 500 ---PND----------------------KTH---LTTAVQGTFGYFDPEYFQSSQYTDKS 531
P+D K H L ++ GT Y PE YT
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 532 DVYSFGVVLLELLTGKKP 549
D +S GV+L E+L G+ P
Sbjct: 230 DWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|144899 pfam01476, LysM, LysM domain | Back alignment and domain information |
|---|
Score = 39.7 bits (94), Expect = 1e-04
Identities = 13/44 (29%), Positives = 22/44 (50%), Gaps = 1/44 (2%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIP 218
Y + GD +S I +G+ V+ + + N L + + V L IP
Sbjct: 1 YTVKKGDTLSSIAKRYGITVEELAELNGL-SSPNLYVGQKLKIP 43
|
The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 61/258 (23%), Positives = 93/258 (36%), Gaps = 69/258 (26%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLG 397
LG G FG V D ++ A+K R D + Q+ E IL++ ++ +V+L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ + V +YI G + + E L+ R +A E+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPE------------DLA---RFYIA-ELTC 112
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS--------------------- 496
AV +H I HRDIK NIL+D K++DFG
Sbjct: 113 AVESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQD 169
Query: 497 -------------------------RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 531
R+ + L ++ GT Y PE + YT
Sbjct: 170 SMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLC 229
Query: 532 DVYSFGVVLLELLTGKKP 549
D +S GV+L E+L G+ P
Sbjct: 230 DWWSVGVILYEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 18/108 (16%)
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN------------ 501
+ A+ Y H+ + + H D+K NIL++ S V D T+R++P
Sbjct: 239 QTGVALDYFHT--ELHLMHTDLKPENILMET--SDTVVDPVTNRALPPDPCRVRICDLGG 294
Query: 502 --DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
D+ H TA+ T Y PE + +D++S G ++ EL TGK
Sbjct: 295 CCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 30/103 (29%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF---------GTSRSVPNDKTHLTT 508
+ Y+H I HR+IK+S+IL+ +S G V D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 509 AVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKP 549
+V + PE + Y KSD+YS G+ EL TG+ P
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 54/253 (21%), Positives = 105/253 (41%), Gaps = 52/253 (20%)
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
F ++ Q++H+HIV L G C+ ++V E++ G L +H
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-------------R 97
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL-----DDKFSA--K 489
+ ++ + W + +VA ++A A++Y+ + H ++ + NILL D + K
Sbjct: 98 KSDVLTTPW--KFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152
Query: 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLEL-LTGK 547
+SD G +V + + + + PE + S+ + +D +SFG L E+ G+
Sbjct: 153 LSDPGIPITVLSRQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGE 207
Query: 548 KPIC-LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNS 606
P+ T E+ER + + K L A+L C+ +
Sbjct: 208 IPLKDKTLAEKERFYEGQCMLVTPSCKEL-------------------ADLMTHCMNYDP 248
Query: 607 KKRPTMKQVSMDL 619
+RP + + D+
Sbjct: 249 NQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 56/253 (22%), Positives = 106/253 (41%), Gaps = 52/253 (20%)
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
F ++SQ++H H+ + G C+ ++V E++ +G L L +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-------------VCLRK 109
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA-------K 489
E+ ++W ++ VA ++A A++Y+ + H ++ + NILL A K
Sbjct: 110 EKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLEL-LTGK 547
+SD G S + + + + + PE + + +D +SFG LLE+ G+
Sbjct: 165 LSDPGVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 548 KPI-CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNS 606
P+ T E+ER K+++L E + +A L CL
Sbjct: 220 VPLKERTPSEKER-------FYEKKHRL------------PEPSCKELATLISQCLTYEP 260
Query: 607 KKRPTMKQVSMDL 619
+RP+ + + DL
Sbjct: 261 TQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.001
Identities = 15/43 (34%), Positives = 21/43 (48%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLI 217
Y + GD + I ++GV V+ + AN L N D I L I
Sbjct: 3 YTVKPGDTLWSIAKKYGVTVEELAAANPLINPDCIYPGQKLKI 45
|
LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45 |
| >gnl|CDD|197609 smart00257, LysM, Lysin motif | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.002
Identities = 12/43 (27%), Positives = 23/43 (53%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLI 217
Y + GD +S I +G+ V +++ N + + D ++V L I
Sbjct: 2 YTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44
|
Length = 44 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 78/347 (22%), Positives = 127/347 (36%), Gaps = 100/347 (28%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI 387
D++ + LG+G FG VYK L +G V +K +A + +E ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LK--KATEYGAVEIWMNERVRRACP 188
Query: 388 NHRHIVKLLGCCLET-----EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEE----- 436
N + LE E LV+ Y TL+ D Q +E +E
Sbjct: 189 N--SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA----DLMQSKEFPYNVEPYLLGK 242
Query: 437 -EQELSSLSWENRV--RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKVSD 492
+ L EN++ + ++ A+ +HS I HRD+K NI+ + S K+ D
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIID 299
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGY------FDPEYFQSSQYT------------------ 528
G + ++ Y DP Y QY
Sbjct: 300 LGAA-----------ADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALS 348
Query: 529 ---------DKSDVYSFGVVLLE-----LLTGKKPICLTREEEERN--LVAYFISLAKEN 572
D+ D+YS G++ L+ L + I R+ + + LVA+
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW-------R 401
Query: 573 KLLEILDARVAKEARE------EDIEAVAELAMGCLRLNSKKRPTMK 613
KL+E R + + R D A EL +R ++R + K
Sbjct: 402 KLVE---PRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.67 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK06347 | 592 | autolysin; Reviewed | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| COG1388 | 124 | LytE FOG: LysM repeat [Cell envelope biogenesis, o | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| PF01476 | 44 | LysM: LysM domain; InterPro: IPR018392 This domain | 98.59 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 98.58 | |
| PRK10783 | 456 | mltD membrane-bound lytic murein transglycosylase | 98.58 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 98.47 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.46 | |
| COG3858 | 423 | Predicted glycosyl hydrolase [General function pre | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 98.33 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 98.29 | |
| PRK14125 | 103 | cell division suppressor protein YneA; Provisional | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| smart00257 | 44 | LysM Lysin motif. | 98.08 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.0 | |
| PRK13914 | 481 | invasion associated secreted endopeptidase; Provis | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PRK10871 | 319 | nlpD lipoprotein NlpD; Provisional | 97.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.73 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.65 | |
| cd00118 | 46 | LysM Lysin domain, found in a variety of enzymes i | 97.64 | |
| PRK11198 | 147 | LysM domain/BON superfamily protein; Provisional | 97.62 | |
| TIGR02899 | 44 | spore_safA spore coat assembly protein SafA. in wh | 97.61 | |
| TIGR02907 | 338 | spore_VI_D stage VI sporulation protein D. SpoVID, | 97.55 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.54 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.4 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.4 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.14 | |
| smart00257 | 44 | LysM Lysin motif. | 96.96 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-58 Score=484.64 Aligned_cols=290 Identities=49% Similarity=0.824 Sum_probs=258.6
Q ss_pred cccccCHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEE
Q 039736 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399 (633)
Q Consensus 320 ~~~~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~ 399 (633)
....|+++|++.||++|+..++||+|+||.||+|.+++|..||||++.........+|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999998899999988775443144699999999999999999999999
Q ss_pred eeCCc-eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 400 LETEV-PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 400 ~~~~~-~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
.+.+. .+||||||++|+|.++|+.... . .|+|.+|++||.++|+||+|||+...|+|+||||||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~-------------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKss 206 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG-------------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSS 206 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCC-------------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHH
Confidence 99984 9999999999999999987532 1 7999999999999999999999999889999999999
Q ss_pred CeeecCCCcEEEeecCCCccCCC-CCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 479 NILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
|||||+++++||+|||+|+..+. ........ .||.+|+|||++..+..++|+|||||||+|+||+||++|.+......
T Consensus 207 NILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~ 285 (361)
T KOG1187|consen 207 NILLDEDFNAKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRG 285 (361)
T ss_pred HeeECCCCCEEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcc
Confidence 99999999999999999977654 22221111 79999999999999999999999999999999999999988766555
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhh-cccCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVA-KEARE-EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
...+..|......+.++.+++|+.+. ..++. +....+..++.+|++.+|.+||+|.||+++|+.+..
T Consensus 286 ~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 286 ELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 66689999889988899999999987 66664 688899999999999999999999999999976654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=410.14 Aligned_cols=256 Identities=31% Similarity=0.490 Sum_probs=224.9
Q ss_pred CccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+...+.||+|.||.||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+++|+|..++..|||||||++|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 345788999999999999997777999999887532 3468999999999999999999999999988999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+||.... ...+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||||
T Consensus 287 sLl~yLr~~~--------------~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 287 SLLDYLRTRE--------------GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred cHHHHhhhcC--------------CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccc
Confidence 9999998622 346899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 496 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
|+...++.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+...... .+
T Consensus 350 Ar~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev 413 (468)
T KOG0197|consen 350 ARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EV 413 (468)
T ss_pred ccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HH
Confidence 99666665555555566789999999999999999999999999999999 88887543332 24
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.+.++...+...|..|+..+++||..||+.+|++|||++.+...|+.+...
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 455667777788999999999999999999999999999999999988754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=404.56 Aligned_cols=257 Identities=35% Similarity=0.542 Sum_probs=213.6
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-ceEEEEeeccC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYISN 414 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-~~~LV~E~~~~ 414 (633)
..+.||+|+||+||+|.+++...||||++..... ...++|.+|+.+|++++|||||+|+|+|.+.. ...+||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3456999999999999995434499999876432 22569999999999999999999999999887 78999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cEEEeec
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKVSDF 493 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI~Df 493 (633)
|+|.++++... ...++|..+++||.|||+||.|||+++. ||||||||+|||++.++ ++||+||
T Consensus 125 GsL~~~l~~~~--------------~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 125 GSLSVLLHKKR--------------KRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CcHHHHHhhcc--------------cCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence 99999998741 2479999999999999999999999984 99999999999999998 9999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccc--cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ--SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|+++...... ...+...||+.|||||.+. ...++.|+||||||++||||+||+.||....... ....+
T Consensus 189 Glsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~------~~~~v--- 258 (362)
T KOG0192|consen 189 GLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ------VASAV--- 258 (362)
T ss_pred ccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHH---
Confidence 9998764322 2223367999999999999 6699999999999999999999999986543311 11111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.....+...+..+...+..|+..||+.||+.||++.|++..|+.+....
T Consensus 259 ------~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 259 ------VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ------HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 1122233445557889999999999999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=419.69 Aligned_cols=274 Identities=27% Similarity=0.466 Sum_probs=227.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.+.+....+.||+|+||.||+|... +...||||.++..... ..++|.+|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3456667889999999999999943 2457999999986655 67899999999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++|+|||..|+|.+||............... ...+|+..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~--~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQD--TPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999776542211100000 1346999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceec-ccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
+..+||+||||++..-..+++... ...-+.+||+||.+..+++|++||||||||+|||++| |+-|+.+..+++.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---- 714 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---- 714 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH----
Confidence 999999999999987544443332 4456789999999999999999999999999999999 9999876555442
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
......+ ++ -..|+.++.++++||..||+.+|++||+++||-..|+......
T Consensus 715 ---Ie~i~~g--------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 715 ---IECIRAG--------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---HHHHHcC--------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 2222222 22 4578899999999999999999999999999999999887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=369.20 Aligned_cols=249 Identities=29% Similarity=0.428 Sum_probs=208.1
Q ss_pred ccCCcccccCcEEEEEEEcC-CCCEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-eEEEEeecc
Q 039736 337 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-PVLVYEYIS 413 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-~~LV~E~~~ 413 (633)
+..+.||+|..|+||+++.+ +++.+|+|.+.. .+....++..+|++++++.+||+||+++|.|..++. ..++||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 34778999999999999965 688999999854 345566789999999999999999999999999984 999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
+|||++++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|.+||+|
T Consensus 162 gGSLd~~~k~~----------------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 162 GGSLDDILKRV----------------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecc
Confidence 99999998652 468999999999999999999996 66 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||.++.+.+. .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ...+....+.....++
T Consensus 223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEP 298 (364)
T ss_pred ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCC
Confidence 9999877543 55667899999999999999999999999999999999999999865311 1112222222222111
Q ss_pred hhhhhhchhhhcccCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEARE-EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
....|. .++.++..++..||++||.+||++.|++++
T Consensus 299 ----------pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 ----------PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ----------CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122334 378899999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=401.92 Aligned_cols=274 Identities=25% Similarity=0.455 Sum_probs=231.5
Q ss_pred ccCHHHHHHHhcCC---------ccCCcccccCcEEEEEEEcC----CCCEEEEEEccccC-hhHHHHHHHHHHHHhccC
Q 039736 323 IFTAEELQRATDNY---------NQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAID-KTQIEQFINEVVILSQIN 388 (633)
Q Consensus 323 ~~~~~el~~~~~~~---------~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~ 388 (633)
.+++|+-..|...| .+.+.||.|.||.||+|+++ ....||||.++... ..+..+|+.|+.||.++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 45565544444333 45678999999999999975 23579999999754 556779999999999999
Q ss_pred CCCceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 039736 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASI 468 (633)
Q Consensus 389 H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 468 (633)
||||++|.|+.......++|.|||+||+|+.||+.+. ..+++.+..-|.++||.||.||.+.+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D---------------GqftviQLVgMLrGIAsGMkYLsdm~-- 751 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND---------------GQFTVIQLVGMLRGIASGMKYLSDMN-- 751 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC---------------CceEeehHHHHHHHHHHHhHHHhhcC--
Confidence 9999999999999999999999999999999998764 35999999999999999999999999
Q ss_pred CeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceec--ccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-
Q 039736 469 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT- 545 (633)
Q Consensus 469 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~--~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt- 545 (633)
+|||||.++|||++.+..+||+|||++|.+.++.....+ ...-+.+|.|||.+...++|.++||||||++|||.++
T Consensus 752 -YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSy 830 (996)
T KOG0196|consen 752 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 830 (996)
T ss_pred -chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEeccc
Confidence 999999999999999999999999999987655422222 2334579999999999999999999999999999887
Q ss_pred CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 546 GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 546 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
|.+|+....+. .+...++..++...|++|+..|.+||+.||++|-.+||.+.+|+.+|.++.+.
T Consensus 831 GERPYWdmSNQ----------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 831 GERPYWDMSNQ----------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred CCCcccccchH----------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 99997433322 23344556667778899999999999999999999999999999999999877
Q ss_pred ccccc
Q 039736 626 QRCVE 630 (633)
Q Consensus 626 ~~~~~ 630 (633)
...++
T Consensus 895 P~SLk 899 (996)
T KOG0196|consen 895 PNSLK 899 (996)
T ss_pred chhhc
Confidence 65444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=361.00 Aligned_cols=203 Identities=33% Similarity=0.553 Sum_probs=182.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
..+|...+.||+|+||+||+|+.+ ++..||||.+... .++..+.+..|+++|+.++|||||+|++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357888899999999999999964 6799999987664 5667788899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC----
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---- 485 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---- 485 (633)
||+++|+|.+|++.. +.+++.....+..|||.||++||+++ ||||||||.||||+.+
T Consensus 89 EyC~gGDLs~yi~~~----------------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~ 149 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----------------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARND 149 (429)
T ss_pred EeCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCC
Confidence 999999999999874 36999999999999999999999999 9999999999999865
Q ss_pred --CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 486 --FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 486 --~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
-.+||+|||+|+.+.. .......+|++-|||||++..++|+.|+|+||.|++||||++|+.||......
T Consensus 150 ~~~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred CCceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 5699999999998863 33445678999999999999999999999999999999999999999755443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.49 Aligned_cols=248 Identities=26% Similarity=0.435 Sum_probs=211.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
..|...+.||+|||+.||.++. ..|+.||+|++.. ......+...+|++|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 7899999998765 23456678899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|++++|+|..++.. +.++++.++..+..||+.||.|||+++ |+|||||..|+||+++.++|
T Consensus 98 ELC~~~sL~el~Kr----------------rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----------------RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred EecCCccHHHHHHh----------------cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEE
Confidence 99999999998863 357999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||||.....+.. .....+||+-|+|||++....++..+||||+||+||-|+.|++||....-.+. ...+.
T Consensus 159 IgDFGLAt~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik 231 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIK 231 (592)
T ss_pred ecccceeeeecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHH
Confidence 999999998754322 23456899999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. + -..|...+.+..+||.++|+.||.+|||+++|+.+
T Consensus 232 ~~----~-------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 232 LN----E-------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hc----C-------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0 12244556778899999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.17 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=210.3
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEE-EEeeCCc-eEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLG-CCLETEV-PVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g-~~~~~~~-~~LV 408 (633)
.+|.+.++||+|.||+|||+. +.+|..||.|.+.- .+....++...|+.+|++++|||||++++ .+.++.. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999999 55899999998763 45566778999999999999999999999 4444444 8999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC-CCCeeccCCCCCCeeecCCCc
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA-SIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-~~~ivHrDIk~~NILl~~~~~ 487 (633)
||+++.|+|...+...+.+ ...+++..+|+++.|++.||+++|+.- ...++||||||.||+|+++|.
T Consensus 99 mE~c~~GDLsqmIk~~K~q------------kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv 166 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ------------KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV 166 (375)
T ss_pred HHhhcccCHHHHHHHHHhc------------cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc
Confidence 9999999999999765542 357999999999999999999999932 123999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++.+.... ......+||+.||+||.+.+..|+.||||||+||++|||..-+.||.+. ++...-.
T Consensus 167 vKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~- 238 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCK- 238 (375)
T ss_pred eeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHH-
Confidence 9999999999886543 3445678999999999999999999999999999999999999999754 2222111
Q ss_pred HHhhchhhhhhchhhhcccC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 568 LAKENKLLEILDARVAKEAR-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
...++.. ...| .-.+..+.+|+..|+..||+.||+...+++.+..
T Consensus 239 KI~qgd~---------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 KIEQGDY---------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHcCCC---------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111111 1123 5567889999999999999999996666555543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=400.87 Aligned_cols=265 Identities=28% Similarity=0.521 Sum_probs=221.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
.+.+..+.||+|.||.||+|... +|. .||||.++.. +.++..+|++|..+|++++|||||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 45666889999999999999964 343 4999998774 5567889999999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+++|||++|+|..||++.+..... ...|+..+.+.++.|||+|+.||++++ +|||||.++|+||++..
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~---------~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQ---------PSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERR 839 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCC---------CCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccC
Confidence 999999999999999876542211 347999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecc-cccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTA-VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~-~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
.+||+|||||+.+.....+.... ..-...|||||.+..+.+|.|+|||||||+|||++| |..|+......+.
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------ 913 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------ 913 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------
Confidence 99999999999765444333222 234579999999999999999999999999999999 7788754333221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+......+ +.+.|..|+..+++||.+||+.+|++||++..|++.+..+....
T Consensus 914 ~~~~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 914 LLDVLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11122222 34567889999999999999999999999999999999887654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=356.97 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=202.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh-------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK-------TQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~-------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.+.|...+.||+|+||.|-+|.. ++|+.||||++..... .......+|+++|++++|||||++.+++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45677889999999999999994 4799999998764211 122345799999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.||||||++||.|.+.+-.+. .+.+.....++.|++.|+.|||++| |+||||||+|||+..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----------------~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----------------YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSN 311 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----------------ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEecc
Confidence 999999999999999987653 4666777889999999999999999 999999999999986
Q ss_pred C---CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCC--C-cccchhhHHHHHHHHHhCCCCCCCCchhhh
Q 039736 485 K---FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY--T-DKSDVYSFGVVLLELLTGKKPICLTREEEE 558 (633)
Q Consensus 485 ~---~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~--s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~ 558 (633)
+ ..+||+|||+|+..+ ........+||+.|.|||++.++.. + .|+|+||+||+||-+++|.+||.....+..
T Consensus 312 ~~e~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s 389 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS 389 (475)
T ss_pred CCcceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc
Confidence 6 889999999999875 3345567899999999999977543 3 488999999999999999999964332220
Q ss_pred hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+ ......++.. + ......+..++..+|+.+||..||++|||+.|++++
T Consensus 390 --l----~eQI~~G~y~--f----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 --L----KEQILKGRYA--F----GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --H----HHHHhcCccc--c----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 0111111110 0 111234556788999999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=348.55 Aligned_cols=269 Identities=26% Similarity=0.372 Sum_probs=202.8
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhc--cCCCCceEEEEEEeeCC----ceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLETE----VPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~g~~~~~~----~~~L 407 (633)
......++||+|+||.||+|.+ +++.||||++.. .+.+.|.+|-+|++. ++|+||+++++.-.... ..+|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 3455678899999999999999 579999999875 445678889888876 47999999998865433 6899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh------cCCCCeeccCCCCCCee
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS------AASIPIFHRDIKSSNIL 481 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~------~~~~~ivHrDIk~~NIL 481 (633)
|+||.++|+|.+||..+ .++|....+|+..+++||+|||+ +.+|+|+|||||++|||
T Consensus 286 Vt~fh~kGsL~dyL~~n-----------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN-----------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred EeeeccCCcHHHHHHhc-----------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 99999999999999764 69999999999999999999996 44789999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCC-CC-----cccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQ-YT-----DKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~-~s-----~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
|.+|+++.|+|||+|..+..+... ..-..+||.+|||||++.+.. +. .+.||||+|.|||||+++-..++...
T Consensus 349 vK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~ 428 (534)
T KOG3653|consen 349 VKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGP 428 (534)
T ss_pred EccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCC
Confidence 999999999999999887533322 223367999999999997642 22 37999999999999999766553211
Q ss_pred hh--------hhh--cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 555 EE--------EER--NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 555 ~~--------~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
.+ +.. ...+.++......+.+..+-..... ...+..+.+.+..||..|++.|.|+.=+.+.+.++..
T Consensus 429 vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 429 VPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 11 100 0111111111111111111111111 2346778999999999999999999999888888775
Q ss_pred hc
Q 039736 625 SQ 626 (633)
Q Consensus 625 s~ 626 (633)
..
T Consensus 506 ~~ 507 (534)
T KOG3653|consen 506 LW 507 (534)
T ss_pred cC
Confidence 44
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=365.51 Aligned_cols=260 Identities=29% Similarity=0.502 Sum_probs=215.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC--C--CE-EEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD--G--SI-VAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~--g--~~-vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.++....++||+|+||.||+|.+.. + .. ||||..+. ....+..+|++|+++|++++|||||+++|++..+..
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455566899999999999999642 2 23 89999885 456788899999999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+|||++.||+|.++|.... ..+++.++++++.+.|.||+|||+.+ ++||||.++|+|++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~---------------~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK---------------KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSK 297 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecC
Confidence 999999999999999998753 25999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceec-ccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++... ...... .-.-+..|+|||.+..+.+++++|||||||++||+++ |..|+.+....+.
T Consensus 298 ~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---- 371 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---- 371 (474)
T ss_pred CCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH----
Confidence 9999999999988653 111111 1235689999999999999999999999999999999 8889865443321
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
. ..+.-...+...+...+..+..++.+||..||++||+|.++.+.|+.+.....
T Consensus 372 ---~--------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 372 ---K--------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---H--------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 0 11112223334455667888999999999999999999999999999886554
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.76 Aligned_cols=259 Identities=21% Similarity=0.348 Sum_probs=207.1
Q ss_pred cccCHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChh---HHHHHHHHHHHHhccCCCCceEEEEE
Q 039736 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT---QIEQFINEVVILSQINHRHIVKLLGC 398 (633)
Q Consensus 322 ~~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~---~~~~~~~Ei~il~~l~H~nIv~l~g~ 398 (633)
+.++.++++ ......||+|++|.||+|.+ +|+.||||+++..... ..+.|.+|+.+|++++||||++++|+
T Consensus 13 ~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDID-----KYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcC-----CCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 345555552 23346799999999999999 6899999998764332 25678899999999999999999999
Q ss_pred Eee----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeecc
Q 039736 399 CLE----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHR 473 (633)
Q Consensus 399 ~~~----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHr 473 (633)
+.+ ....++||||+++|+|.+++... ..++|...++++.+++.||.|||+. + ++||
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hr 147 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE----------------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYK 147 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhC----------------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCC
Confidence 977 34578999999999999998653 3589999999999999999999985 6 7899
Q ss_pred CCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 474 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 474 DIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
||||+|||+++++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.
T Consensus 148 dlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~ 223 (283)
T PHA02988 148 NLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223 (283)
T ss_pred cCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998653321 12357889999999976 688999999999999999999999986
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
.....+ ......... .....+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 224 ~~~~~~------~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 224 NLTTKE------IYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCHHH------HHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 443221 111111111 1112233456789999999999999999999999999998763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=361.92 Aligned_cols=244 Identities=27% Similarity=0.474 Sum_probs=207.3
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
..++-||+|+.|.||+|++ .++.||||+++.... .+|+-|++|+|+||+.|.|+|.....+++||||+..|.
T Consensus 127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 3477899999999999999 578999998875332 57889999999999999999999999999999999999
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCC
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 496 (633)
|...|+.. .+++......|..+||.||.|||.+. |||||||+-||||+.+..+||+|||-+
T Consensus 199 L~~VLka~----------------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 199 LYEVLKAG----------------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred HHHHHhcc----------------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccch
Confidence 99999764 46888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhh
Q 039736 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLE 576 (633)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (633)
+..... .....+.||..|||||++.+...++|+||||||||||||+||..|+..-+. ...+ ..
T Consensus 260 ~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAII---------wG 322 (904)
T KOG4721|consen 260 KELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAII---------WG 322 (904)
T ss_pred Hhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeE---------Ee
Confidence 876443 222356799999999999999999999999999999999999999742111 1111 11
Q ss_pred hhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 577 ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 577 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
+-...+....|..++..+.-|+++||+..|.+||++++|+.+|+-...
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 112233445678888999999999999999999999999999986543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=359.54 Aligned_cols=276 Identities=27% Similarity=0.437 Sum_probs=209.6
Q ss_pred HhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccC-hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 403 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 403 (633)
..++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||++++|++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 346788999999999999999973 235689999987532 33456789999999999 8999999999987654
Q ss_pred -ceEEEEeeccCCCchhhcchhhhhHHHHHH----------------------------------------------HHH
Q 039736 404 -VPVLVYEYISNGTLSHHIHDHQQQQEQKQE----------------------------------------------LEE 436 (633)
Q Consensus 404 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~----------------------------------------------~~~ 436 (633)
..++||||+++|+|.+++............ ...
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999999754321000000 000
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCC
Q 039736 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFG 515 (633)
Q Consensus 437 ~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~ 515 (633)
......+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 001235899999999999999999999998 999999999999999999999999999865432221 1223346788
Q ss_pred cCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHH
Q 039736 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAV 594 (633)
Q Consensus 516 y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 594 (633)
|+|||.+.+..++.++||||||++||||++ |..||......+. +......+. ....+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~---------~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGT---------RMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCC---------CCCCCCCCCHHH
Confidence 999999999999999999999999999997 9999864332111 111111110 011123345678
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 595 AELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 595 ~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.99 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=216.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.+.....++||+|.||.|.......+..||||.++..... ...+|.+|+++|.+++||||++|+|+|..++..++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 3455667899999999999999977799999999986544 457999999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
|++|+|.+|+..+.. +.+.-...++|+.|||.||+||.+.+ +|||||.++|+|+|+++++||+
T Consensus 617 mEnGDLnqFl~ahea--------------pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKia 679 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL--------------PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIA 679 (807)
T ss_pred HhcCcHHHHHHhccC--------------cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEec
Confidence 999999999987643 22455667789999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCchhhhhcHHHHHHHH
Q 039736 492 DFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 492 DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt--G~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|||+++.+-.+.. ......+-+.+|||+|.+..+++|+++|||+||+.|||+++ ...|+....++.. .+-...+
T Consensus 680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~ 756 (807)
T KOG1094|consen 680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEF 756 (807)
T ss_pred CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhh
Confidence 9999997754443 34445667899999999999999999999999999999876 6777643322211 1111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
+.. -........|.-++..+++++..||..|.++||+++++...|.+..
T Consensus 757 ~~~------~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRD------QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCC------CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111 1112223346678899999999999999999999999999998653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=341.42 Aligned_cols=242 Identities=29% Similarity=0.441 Sum_probs=203.0
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||..+. +.++.+|+|.++. ....+.+...+|..+|.+++||.||++.-.|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999984 4689999998875 3344567788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+.||.|..+|... ..+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|++
T Consensus 104 ld~~~GGeLf~hL~~e----------------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi 164 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----------------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHI 164 (357)
T ss_pred EeccCCccHHHHHHhc----------------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcE
Confidence 9999999999999753 45888888899999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
+|+|||+++...... ..+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+... +....
T Consensus 165 ~LtDFgL~k~~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I 237 (357)
T KOG0598|consen 165 KLTDFGLCKEDLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKI 237 (357)
T ss_pred EEeccccchhcccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHH
Confidence 999999998653332 23345789999999999999999999999999999999999999997543322 22222
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
.... ....+.-...+..+++...|..||++|.
T Consensus 238 ~~~k----------~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGK----------LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCc----------CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2211 1122233456788999999999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.63 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=206.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC--ceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~LV~E 410 (633)
.++...+.||+|+||+||++... +|+..|||.+...+....+.+.+|+.+|++++|||||+++|.....+ ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999964 48999999877654333667889999999999999999999855544 5899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~k 489 (633)
|+++|+|.+++.... ..|++..+.+++.||++||.|||+++ |+||||||+||||+. ++.+|
T Consensus 97 y~~~GsL~~~~~~~g---------------~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~K 158 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---------------GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVK 158 (313)
T ss_pred ccCCCcHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEE
Confidence 999999999997653 16999999999999999999999999 999999999999999 79999
Q ss_pred EeecCCCccCCC--CCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPN--DKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||+++.... ..........||+.|||||++..+. ...++|||||||++.||+||+.|+... .....+..
T Consensus 159 laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~ 233 (313)
T KOG0198|consen 159 LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALL 233 (313)
T ss_pred eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHH
Confidence 999999987753 2222334578999999999998643 335999999999999999999998532 11111111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
....+. ....+|...+....+++..|++.||++|||+.|++.+--.
T Consensus 234 ~ig~~~---------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 234 LIGRED---------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred HHhccC---------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 111111 1124555667788999999999999999999999987654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.63 Aligned_cols=267 Identities=27% Similarity=0.514 Sum_probs=213.9
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 403 (633)
.++++...+.+.....||+|.||+||+|.|. | .||||.++.. ..+..+.|.+|+..+++-+|.||+-++|+|...+
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3666666677788899999999999999994 3 5999998753 4567889999999999999999999999998877
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
. .+|..+++|-+|..++|..+. .+...+.+.||.|||+|+.|||..+ |||||||+.||||.
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~et---------------kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQET---------------KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLH 522 (678)
T ss_pred e-eeeehhccCchhhhhccchhh---------------hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEc
Confidence 6 999999999999999987643 5888999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCC-CCcceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 484 DKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
++++|||+|||++..-.. ..........|...|||||+++. ..|+..+||||||+|+|||++|..|+.....+..
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI- 601 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI- 601 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-
Confidence 999999999999864321 11111122347789999999864 4689999999999999999999999863222111
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
++ +...+- +.+.+ ......+..++.+|+..||..++++||.+.+|+.+|+.+..+
T Consensus 602 -----if-mVGrG~----l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 602 -----IF-MVGRGY----LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -----EE-Eecccc----cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 001110 00111 112345678999999999999999999999999999888775
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=355.46 Aligned_cols=264 Identities=25% Similarity=0.441 Sum_probs=228.1
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++--..+....++||.|.||.||.|+|+. ...||||.++.. ....++|+.|+.+|+.++|||+|+|+|+|..+..+|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 33334567778999999999999999864 457999999864 4467899999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|.|||.+|+|.+||+.... ..++-...+.||.||+.||+||...+ +|||||.++|+|+.++..
T Consensus 341 iTEfM~yGNLLdYLRecnr--------------~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhi 403 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNR--------------SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHI 403 (1157)
T ss_pred EEecccCccHHHHHHHhch--------------hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccce
Confidence 9999999999999976543 34777788999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||+++.+..+.........-.+.|.|||-+....++.|+|||+|||+|||+.| |..|+.+-+ +
T Consensus 404 VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l----- 472 (1157)
T KOG4278|consen 404 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L----- 472 (1157)
T ss_pred EEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H-----
Confidence 9999999999997766544444455789999999999999999999999999999998 877864322 1
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..+-++++..++.+.|+.|++.+++||++||+++|.+||++.|+-+.++.+..+.
T Consensus 473 -----SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 473 -----SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred -----HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1234556677788889999999999999999999999999999999999887654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=342.75 Aligned_cols=275 Identities=23% Similarity=0.373 Sum_probs=208.3
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc--CCCCceEEEEEEeeCC----c
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI--NHRHIVKLLGCCLETE----V 404 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l--~H~nIv~l~g~~~~~~----~ 404 (633)
....+....+.||+|.||.||+|.+ .|+.||||++...++ +.+.+|.+|++.+ +|+||+.+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3345778889999999999999999 489999999887443 4678899998874 9999999998866443 5
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCCeeccCCCCCC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-----SAASIPIFHRDIKSSN 479 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-----~~~~~~ivHrDIk~~N 479 (633)
++||.+|.++|||.|||.. ..++....++++..+|.||++|| .+|+|.|.|||||++|
T Consensus 284 LwLvTdYHe~GSL~DyL~r-----------------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-----------------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred EEEeeecccCCcHHHHHhh-----------------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 7999999999999999965 37999999999999999999999 4689999999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcce---ecccccCCCcCchhccccCC------CCcccchhhHHHHHHHHHhCCCCC
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~------~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
||+.+++.+.|+|+|||.....+.... ....+||.+|||||++...- .-..+||||||.|+||+.-+-.--
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 999999999999999998775553332 23457999999999996542 123699999999999997632110
Q ss_pred CCCchhhhhcHHHHHHHHHhhchhhhhhc----hhhhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 551 CLTREEEERNLVAYFISLAKENKLLEILD----ARVAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
. ..+.....+..-...++...++.+ .+++... ..+....+.+||+.||..+|..|.|+-.|.+.|.+
T Consensus 427 g----i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 427 G----IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred C----EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 0 000011111111111122222111 1122222 34667889999999999999999999999999999
Q ss_pred hhhhccccc
Q 039736 622 LRRSQRCVE 630 (633)
Q Consensus 622 i~~s~~~~~ 630 (633)
+.++...++
T Consensus 503 l~~~~ek~k 511 (513)
T KOG2052|consen 503 LSNSDEKIK 511 (513)
T ss_pred HhcChhhhc
Confidence 987654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=347.17 Aligned_cols=262 Identities=28% Similarity=0.388 Sum_probs=207.4
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV 408 (633)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++... ........+||.||++|+||||++|.+...+. +..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667889999999999999 5689999999887543 34455677999999999999999999999876 689999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+|||+. +|..++.... -.++..++..++.|++.||+|+|+.+ |+|||||.+|||||.+|.+
T Consensus 197 FeYMdh-DL~GLl~~p~---------------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~L 257 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---------------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVL 257 (560)
T ss_pred Eecccc-hhhhhhcCCC---------------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCE
Confidence 999987 7877776542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||||+.+........+..+-|..|.|||.+.+ ..|+.++|+||.||||.||+.|++.+.+..+-+... . +..
T Consensus 258 KiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~--k-Ifk 334 (560)
T KOG0600|consen 258 KIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH--K-IFK 334 (560)
T ss_pred EeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH--H-HHH
Confidence 999999999876666555666678999999999876 579999999999999999999999987665443221 1 112
Q ss_pred HHhh---c-----hhh--hhhc------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKE---N-----KLL--EILD------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~---~-----~~~--~~~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+... . ++. ..+. ..+.+. -...+....+|+..+|..||.+|.|+.++++.
T Consensus 335 lcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 335 LCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred HhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2111 0 111 0000 011110 12234667899999999999999999998763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=338.78 Aligned_cols=255 Identities=23% Similarity=0.403 Sum_probs=206.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC----CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999853 35689999987643 34456789999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+++ ++||||||+|||++.++.+
T Consensus 85 ~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~ 146 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---------------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146 (266)
T ss_pred EEeCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcE
Confidence 99999999999986532 36899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~ 567 (633)
|++|||.+...............++..|+|||.+.++.++.++||||||+++||+++ |+.||......+. . .
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~------~-~ 219 (266)
T cd05064 147 KISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV------I-K 219 (266)
T ss_pred EECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------H-H
Confidence 999999876543222221222335678999999999999999999999999999775 9999864432211 1 1
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
...+. .....+..++..+.+++.+||+.+|++||++.||.+.|+++
T Consensus 220 ~~~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AVEDG---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHCC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11111 11122344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.36 Aligned_cols=255 Identities=25% Similarity=0.486 Sum_probs=217.3
Q ss_pred cCCcccccCcEEEEEEEc-CCCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 338 QSRFLGQGGFGTVYKGML-PDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~-~~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..++||+|+||+||+|.+ .+|+ +||||++... ..+...++++|+-+|.+++||||++|+|+|..+. ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 367899999999999995 4454 6899987653 3455678999999999999999999999998765 8899999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
|+.|+|.||++.++. .+.-...+.|..|||+||.|||++. +|||||.++||||.+-..+||.
T Consensus 779 mP~G~LlDyvr~hr~---------------~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD---------------NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred cccchHHHHHHHhhc---------------cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEE
Confidence 999999999987654 6888999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceec-ccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTT-AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|||+++....+...... ...-.+.|||-|.+....++.++|||||||.+||++| |..|++....++.
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------- 909 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------- 909 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-----------
Confidence 99999988655544332 3345678999999999999999999999999999999 9999876554442
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
.+++....+...|+-+...++.++.+||..|+..||+++++...+.++.+..+
T Consensus 910 -----~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 910 -----PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred -----hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 22333333456688889999999999999999999999999999999877653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=348.88 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=206.5
Q ss_pred hcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHH--HHHHHHHHHhccC-CCCceEEEEEEeeCC-ceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIE--QFINEVVILSQIN-HRHIVKLLGCCLETE-VPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~--~~~~Ei~il~~l~-H~nIv~l~g~~~~~~-~~~L 407 (633)
.++|...++||.|.||+||+|+ ...|+.||||+++..-.. .+ .=++|++-|++++ ||||++|.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4678889999999999999999 457899999998863222 22 2368999999999 999999999999888 8999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|||||+. +|.+++++. ...+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..
T Consensus 88 VfE~Md~-NLYqLmK~R---------------~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~ 148 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---------------NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDV 148 (538)
T ss_pred eHHhhhh-hHHHHHhhc---------------CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccce
Confidence 9999975 899988765 247999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhcc-ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||+||..... ...+..+.|..|.|||++ +.+-|+.+.|+||+|||++|+.+-++-|-+..+-++.. -+-
T Consensus 149 iKiaDFGLARev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc 223 (538)
T KOG0661|consen 149 IKIADFGLAREVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KIC 223 (538)
T ss_pred eEecccccccccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHH
Confidence 999999999987543 334556789999999986 56789999999999999999999998886554433211 111
Q ss_pred HHHhhc---------hhhhhhchhh--------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKEN---------KLLEILDARV--------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~---------~~~~~~d~~l--------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.++..+ .+...+.-.+ ..-. ...+.+..+|+.+|+++||++|||+.|.+++
T Consensus 224 ~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 224 EVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 222111 1111111111 1111 2256789999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.51 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=211.8
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
..|....+||+|+.|.||.+. ..+++.||||++........+-.++|+.+|+..+|+|||++++.+...+..+.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 466777899999999999999 4478899999988766666678899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.|.+... .+++.++..|+.++++||+|||.++ |+|||||++|||++.+|.+||+|
T Consensus 353 ~ggsLTDvVt~~-----------------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltD 412 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----------------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTD 412 (550)
T ss_pred CCCchhhhhhcc-----------------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEee
Confidence 999999998653 5899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++..+..... .....+||+.|||||.+....|.+|+||||||++++||+-|.+||..... ...+.-+..++
T Consensus 413 FGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng 485 (550)
T KOG0578|consen 413 FGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG 485 (550)
T ss_pred eeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcC
Confidence 999988755443 34457899999999999999999999999999999999999999864221 11111111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....++..+..+.+++.+||+.|+++|+++.|++++
T Consensus 486 ~--------P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 486 T--------PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred C--------CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1 1122345566889999999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.59 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=208.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~ 406 (633)
...+|...+.||+|+|++|++|+. ..++.+|||++... .....+-...|-+.|.+| .||.|++|+-.|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999994 46899999987642 222334456788899999 8999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+|+||++||+|.++|+.. +.++......+|.+|+.||+|||++| ||||||||+|||||+|+
T Consensus 151 FvLe~A~nGdll~~i~K~----------------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----------------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDG 211 (604)
T ss_pred EEEEecCCCcHHHHHHHh----------------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCC
Confidence 999999999999999774 46889999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcc------------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 487 SAKVSDFGTSRSVPNDKTH------------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~------------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
++||+|||-|+.+...... ....++||..|.+||.+..+..+..+|+|+|||+||+|+.|++||....
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999887432211 1145789999999999999999999999999999999999999996432
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+ ...|..++ + +.-++++..++.+.+|+.+.|..||.+|+|..||.++
T Consensus 292 e------yliFqkI~---------~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 292 E------YLIFQKIQ---------A--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H------HHHHHHHH---------H--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2 11122211 1 1234556666888999999999999999999888764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=340.46 Aligned_cols=276 Identities=24% Similarity=0.423 Sum_probs=206.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-----------------CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKL 395 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-----------------g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l 395 (633)
++|...++||+|+||.||++.+++ +..||+|.+... ......+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997532 336999988764 34445689999999999999999999
Q ss_pred EEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHH---HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeec
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQE---LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFH 472 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 472 (633)
++++.+.+..++||||+++|+|.+++............ .........++|..+++++.||+.||.|||+++ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99999999999999999999999998653211000000 000011246899999999999999999999999 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh--CCCC
Q 039736 473 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKP 549 (633)
Q Consensus 473 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt--G~~p 549 (633)
|||||+|||+++++.+||+|||+++....... .......++..|+|||.+..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322 12223446789999999998899999999999999999997 4556
Q ss_pred CCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 550 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
+........ ............ .......+..++..+.+|+.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 643322211 111111111100 000111223455788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=325.78 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=201.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+.|+...++|+|+||.||+++.+ +|+.||||++.... +.-.+-.++|+++|++++|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 45777889999999999999965 69999999986543 3334467899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++.--| +-|... ...++.....+++.|+++|+.|+|+++ ++||||||+||||+.++.+||
T Consensus 82 ~~dhTvL-~eLe~~---------------p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKL 142 (396)
T KOG0593|consen 82 YCDHTVL-HELERY---------------PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKL 142 (396)
T ss_pred ecchHHH-HHHHhc---------------cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEe
Confidence 9987433 333322 235888899999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH------
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA------ 563 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~------ 563 (633)
+|||+|+.+... ....+..+.|..|.|||.+-+ .+|...+||||.||++.||++|.+-|.+..+-+...+..
T Consensus 143 CDFGFAR~L~~p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L 221 (396)
T KOG0593|consen 143 CDFGFARTLSAP-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNL 221 (396)
T ss_pred ccchhhHhhcCC-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHccc
Confidence 999999988642 334455678999999999876 789999999999999999999998875544332211111
Q ss_pred --HHHHHHhh-chhhhhhchhhh-----cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 564 --YFISLAKE-NKLLEILDARVA-----KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 564 --~~~~~~~~-~~~~~~~d~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.....+.. +....+.-|... +..-+....-+.++++.|++.||.+|++-+|++.
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111 111111111110 0011223457889999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=387.62 Aligned_cols=264 Identities=27% Similarity=0.438 Sum_probs=215.0
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
...+...+.||+|+||.||+|.. .+|..||||+++..... ..+|++++++++||||++++|+|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34677889999999999999996 47899999988653321 23568899999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.++++ .++|..+.+|+.|+|+||+|||+...++++||||||+||+++.++.+++.
T Consensus 765 ~~~g~L~~~l~-------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~ 825 (968)
T PLN00113 765 IEGKNLSEVLR-------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR 825 (968)
T ss_pred CCCCcHHHHHh-------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence 99999999984 38899999999999999999997766669999999999999999988886
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||........ ....++.+|+|||++.+..++.|+|||||||++|||++|+.|++.... .......|.......
T Consensus 826 -~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 826 -LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD 898 (968)
T ss_pred -eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc
Confidence 6665443221 123578999999999999999999999999999999999999853322 223445555444444
Q ss_pred chhhhhhchhhhcc--cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 572 NKLLEILDARVAKE--AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 572 ~~~~~~~d~~l~~~--~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.....++|+.+... .+.++..++.+++.+||+.||++||||.||++.|+++.++.
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 45556667666432 34566778899999999999999999999999999997644
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.59 Aligned_cols=256 Identities=22% Similarity=0.433 Sum_probs=209.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998788899999876533 23568899999999999999999999999888999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 146 (261)
T cd05072 84 AKGSLLDFLKSDE--------------GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIAD 146 (261)
T ss_pred CCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECC
Confidence 9999999986532 246899999999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||++...............++..|+|||++..+.++.++||||||+++|||++ |+.|+........ ... ...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~ 219 (261)
T cd05072 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----LQR 219 (261)
T ss_pred CccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----HHc
Confidence 99998765433222233346778999999998899999999999999999998 9999854322211 111 111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
. .........+..+.+++.+||..+|++||+++++.+.|+.+
T Consensus 220 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 220 G---------YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred C---------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 00111223446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.81 Aligned_cols=249 Identities=35% Similarity=0.576 Sum_probs=196.0
Q ss_pred cCCcccccCcEEEEEEEcC-----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 338 QSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~-----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999975 2568999999653 344578999999999999999999999999988889999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.++|.... ...+++..+++|+.||++||.|||+.+ ++|+||+++||++++++.+||+
T Consensus 83 ~~~g~L~~~L~~~~--------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~ 145 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--------------KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLS 145 (259)
T ss_dssp -TTEBHHHHHHHTC--------------TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEE
T ss_pred cccccccccccccc--------------ccccccccccccccccccccccccccc---cccccccccccccccccccccc
Confidence 99999999997751 236999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 492 DFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 492 DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|||++........ ...........|+|||.+....++.++||||||+++|||++ |+.|+......+ .....
T Consensus 146 ~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~- 218 (259)
T PF07714_consen 146 DFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL- 218 (259)
T ss_dssp STTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc-
Confidence 9999987632222 22233456789999999999999999999999999999999 678864332211 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.+. .....+..++..+.+++.+||+.||++||++.|+++.|
T Consensus 219 ~~~---------~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQG---------QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTT---------EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccc---------ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 11122334567799999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=331.00 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=204.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..+.||+|+||.||++.+.++..+|+|.++.... ..++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 45777889999999999999988888999998764322 24578899999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.++++... ..++|..++.++.|++.||.|||+++ ++||||||+||++++++.+||+||
T Consensus 83 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~ 144 (256)
T cd05114 83 NGCLLNYLRQRQ---------------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDF 144 (256)
T ss_pred CCcHHHHHHhCc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCC
Confidence 999999886432 25899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. ........
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~ 218 (256)
T cd05114 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGF 218 (256)
T ss_pred CCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC
Confidence 9998654332222223345678999999998889999999999999999999 8889854332211 11111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
. ...+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 219 ~----------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 219 R----------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred C----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 1112223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=331.98 Aligned_cols=262 Identities=24% Similarity=0.380 Sum_probs=207.6
Q ss_pred hcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.+.|+..+.||.|..++||+|+ ...++.||||++.-.. ..+.+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578899999999999999999 4578999999976422 2346788999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
||.+||+.+.+...-. ..+++..+..|.+++++||.|||.+| .||||||+.||||+++|.+||
T Consensus 105 fMa~GS~ldIik~~~~--------------~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--------------DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred hhcCCcHHHHHHHHcc--------------ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEE
Confidence 9999999999976543 35889999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcc---eecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 491 SDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 491 ~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+|||.+..+...... .....+||+.|||||.+.. ..|+.|+||||||+...||.+|..||....... ..
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk------vL 241 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK------VL 241 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH------HH
Confidence 999998766332211 1145689999999999643 458899999999999999999999986443322 11
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+.+. ..-..-..+..+........+.+++..||++||.+|||+++++++
T Consensus 242 l~tLqn~-pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 242 LLTLQND-PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHhcCC-CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111 000000011112223344689999999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=350.11 Aligned_cols=272 Identities=26% Similarity=0.409 Sum_probs=207.4
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccC-hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
.++|+..+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999973 235689999987532 33456788999999999 89999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhH-----------HHHHH----------------------------------------
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQ-----------EQKQE---------------------------------------- 433 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~-----------~~~~~---------------------------------------- 433 (633)
.++||||+++|+|.+++....... .....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999997533100 00000
Q ss_pred --------HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc
Q 039736 434 --------LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505 (633)
Q Consensus 434 --------~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~ 505 (633)
.........++|..+++++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 000011236899999999999999999999998 999999999999999999999999999876433221
Q ss_pred e-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhh
Q 039736 506 L-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583 (633)
Q Consensus 506 ~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 583 (633)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +......+ ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~---------~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEG---------YR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhC---------cc
Confidence 1 122335678999999999999999999999999999998 8888754322210 11111111 11
Q ss_pred cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 584 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
...+...+.++.+|+.+||+.||++||++.||++.|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111222346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=332.43 Aligned_cols=258 Identities=26% Similarity=0.482 Sum_probs=213.8
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++..+|+..++||+|+||.||+|...++..+|+|.+........+.+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999988899999999887666566789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...+++.++++++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 83 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl 145 (261)
T cd05148 83 LMEKGSLLAFLRSPE--------------GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKV 145 (261)
T ss_pred ecccCCHHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEE
Confidence 999999999997542 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||++......... .....++..|+|||.+..+.++.++||||||+++|||++ |+.|+......+. +...
T Consensus 146 ~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~------~~~~- 217 (261)
T cd05148 146 ADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV------YDQI- 217 (261)
T ss_pred ccccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHH-
Confidence 999999876433221 123345778999999998899999999999999999998 8888854332211 1111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
........+..++..+.+++.+||+.||++|||++++++.|+.+
T Consensus 218 ---------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 ---------TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---------HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111222345567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=335.55 Aligned_cols=270 Identities=27% Similarity=0.472 Sum_probs=210.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCC------CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+|.... ...||+|.++... .....+|.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467889999999999999998532 2579999887533 334567899999999999999999999999888999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
++|||+++|+|.+++.....................+++..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 999999999999999654221000000000001146899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999986533221 22233456788999999998999999999999999999998 9999865433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
... +........+..++..+.+|+.+||+.||++||++.||+++|+.+
T Consensus 236 -~~~---------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 -IEM---------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -HHH---------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111 111111223455678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=330.51 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=208.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+..+.||+|+||.||+|... .++.||+|.++.. ....+++.+|++++++++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777899999999999999964 5789999988753 334567899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 85 ~~~~L~~~~~~~~--------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 147 (263)
T cd05052 85 TYGNLLDYLRECN--------------RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD 147 (263)
T ss_pred CCCcHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCC
Confidence 9999999986432 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++ ....
T Consensus 148 f~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~---- 217 (263)
T cd05052 148 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYEL---- 217 (263)
T ss_pred CccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH----
Confidence 99998765433222222334678999999999999999999999999999998 888875432221 1111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
+........+...+..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 218 ------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 ------LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ------HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111111223344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=349.36 Aligned_cols=273 Identities=27% Similarity=0.432 Sum_probs=208.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
.++|+..+.||+|+||.||++.. .++..||||+++.. .....+.+.+|+.+++.+ +|+||+++++.+...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45788899999999999999873 23457999998753 334456788999999999 89999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHH-----------------------------------------------------
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQK----------------------------------------------------- 431 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~----------------------------------------------------- 431 (633)
.++||||+++|+|.+++..........
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986532110000
Q ss_pred -HHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc-eecc
Q 039736 432 -QELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTA 509 (633)
Q Consensus 432 -~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~ 509 (633)
...........+++.++++++.||+.||+|||+++ ++||||||+|||+++++.+||+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 00000111235899999999999999999999998 999999999999999999999999999865433221 1122
Q ss_pred cccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCH
Q 039736 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEARE 588 (633)
Q Consensus 510 ~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 588 (633)
..++..|+|||++.+..++.++||||||+++|||++ |+.||........ +..... .......+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~---------~~~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVK---------RGYQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHH---------cccCccCCC
Confidence 335678999999998999999999999999999997 9999854322110 011111 111111122
Q ss_pred HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 589 EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 589 ~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
..+..+.+++.+||+.||++||++.||++.|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=312.23 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=206.5
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChh--HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKT--QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~--~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|...++||+|.||.||+|+. .+|+.||||+++..... -....++|++.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999994 57999999998764322 23467899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
||+. +|+..+++.. ..|+..++..++.++++||+|||++. |+||||||.|+|++++|.+||
T Consensus 82 fm~t-dLe~vIkd~~---------------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKi 142 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---------------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKI 142 (318)
T ss_pred eccc-cHHHHhcccc---------------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEe
Confidence 9975 8998887653 37999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+|+.+....... +..+-|..|.|||.+.+ .+|+..+|+||.||++.||+-|.+-|.+..+-+ . ...+...+
T Consensus 143 ADFGLAr~f~~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--Q-L~~If~~L 218 (318)
T KOG0659|consen 143 ADFGLARFFGSPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--Q-LSKIFRAL 218 (318)
T ss_pred ecccchhccCCCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--H-HHHHHHHc
Confidence 9999999986544333 23367999999999876 569999999999999999999987665443322 2 22233333
Q ss_pred hhchhhh------hhchhhh--------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLE------ILDARVA--------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~------~~d~~l~--------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+...+ +.|-.-. ...-..+.....+|+..++..||.+|+|+.|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 2221111 1111100 11112345667999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=330.31 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=208.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..+.||+|++|.||+|..++++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45788899999999999999998778899999987543 23467889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.... ...++|..+.+++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 84 KYGSLLEYLQGGA--------------GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred cCCcHHHHHhccC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECC
Confidence 9999999986532 136899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++...............+..|+|||++.+..++.++||||||+++|||++ |+.|+........ ...
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~---- 216 (261)
T cd05068 147 FGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV------LQQ---- 216 (261)
T ss_pred cceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHH----
Confidence 99998765322211122223468999999999999999999999999999999 9988754322211 001
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
++.......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 217 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 ------VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111111122334557899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.20 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=207.4
Q ss_pred cCCccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|.+.. ...||||.++.. ......+|.+|+.++++++|+||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999999642 358999988753 334456889999999999999999999999998999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++..+++++.|++.||.|||+.+ |+||||||+||++++++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~ 145 (266)
T cd05033 84 TEYMENGSLDKFLREND---------------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVC 145 (266)
T ss_pred EEcCCCCCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCE
Confidence 99999999999986532 36899999999999999999999988 9999999999999999999
Q ss_pred EEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 489 kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+. .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~ 218 (266)
T cd05033 146 KVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------I 218 (266)
T ss_pred EECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------H
Confidence 9999999987752222 22222345678999999999999999999999999999998 9988753322211 0
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
...... .....+...+..+.+++.+||+.+|++||++.||+++|+++
T Consensus 219 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 KAVEDG---------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111110 01112334457789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.46 Aligned_cols=252 Identities=26% Similarity=0.394 Sum_probs=202.5
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.|+..+.||+|+||.||++.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++.+++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367788999999999999985 478999999876422 2233467899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 81 ~~~~g~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl 143 (285)
T cd05631 81 IMNGGDLKFHIYNMG--------------NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRI 143 (285)
T ss_pred ecCCCcHHHHHHhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEE
Confidence 999999988875422 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ........
T Consensus 144 ~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~ 218 (285)
T cd05631 144 SDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVK 218 (285)
T ss_pred eeCCCcEEcCCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhh
Confidence 99999987543221 23346899999999999999999999999999999999999998654322110 00000000
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
.....++......+.+|+.+||+.||++||+ +.|++++
T Consensus 219 ----------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 ----------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111233445678899999999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.41 Aligned_cols=258 Identities=23% Similarity=0.460 Sum_probs=206.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.+|+..+.||+|+||.||+|.+. +|+ .||+|.++.. .....+++.+|+.+++.++|+||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 343 3899998753 334566899999999999999999999999764 5789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++|+|.+++.... ..+++..+++++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~g~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~ 147 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQH 147 (316)
T ss_pred eeecCCCCCHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCc
Confidence 999999999999986542 35889999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCccee-cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++.......... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 148 ~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~------- 220 (316)
T cd05108 148 VKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------- 220 (316)
T ss_pred EEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999999987654332221 22234678999999999999999999999999999998 9999854322211
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....... .....+..+...+.+++.+||+.||++||++.+++..|.++....
T Consensus 221 ~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 221 SSILEKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111111 111112334567889999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=346.19 Aligned_cols=274 Identities=24% Similarity=0.398 Sum_probs=210.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~ 404 (633)
.++|...++||+|+||.||+|... .+..||||+++... ....+.|.+|++++++++ ||||++++|++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999842 13479999987533 334568999999999996 9999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHH-------------------------------------------------------
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQE------------------------------------------------------- 429 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~------------------------------------------------------- 429 (633)
.+|||||+++|+|.++++.......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999976432100
Q ss_pred -------------------------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 430 -------------------------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 430 -------------------------~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.............+++.++++++.|+++||.|||+.+ ++||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0000111112346899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 999999999999865432221 1223346788999999998899999999999999999997 8888753221110
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
+......+ .....+...+..+.+++.+||+.||++||++.+|.+.|+++..
T Consensus 349 --~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 01111111 1112233455788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.09 Aligned_cols=273 Identities=26% Similarity=0.456 Sum_probs=213.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.+|...+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999742 345799999887666666789999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++++|.+++.....................++|..+++++.||+.||+|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 99999999999999754321000000000011235899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999986543322 12223446788999999999999999999999999999999 9999754433221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
......+.. ...+...+..+.+++.+||+.||++||++.+|+++|+.+..+
T Consensus 235 ~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGRV---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCCC---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111111 111223456789999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=343.15 Aligned_cols=257 Identities=28% Similarity=0.488 Sum_probs=221.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCC---C--CEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD---G--SIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~---g--~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+.....++||.|.||.||+|++.+ | -.||||.-+. ...+..+.|+.|..+|++++||||++|+|+|.+ ...++
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 445556799999999999999632 3 2699998876 456668899999999999999999999999975 46799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|||.++-|.|..||..+.. .|+......++.||..+|.|||+.. +|||||..+|||+...--
T Consensus 468 vmEL~~~GELr~yLq~nk~---------------sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKD---------------SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQC 529 (974)
T ss_pred EEecccchhHHHHHHhccc---------------cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcce
Confidence 9999999999999987643 6888999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+|++|||+++.+.++..+......-+..|||||.+.-.++|.++|||.|||.+||+++ |..||.+-.+.+
T Consensus 530 VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------- 600 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------- 600 (974)
T ss_pred eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------
Confidence 9999999999998777666665667889999999999999999999999999999988 999987543322
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
+...++..-+...|+.|+..|+.|+.+||+.||.+||.+.|+...|+.+...
T Consensus 601 -------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 601 -------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred -------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 2222333334567888999999999999999999999999999999998764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=326.69 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=203.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|...+.||+|+||.||+|...++..+|+|.++.... ..++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35777889999999999999987777899998875332 34578999999999999999999999998888999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..++|..+++++.||+.||.|||+.+ ++|+||||+||++++++.+||+||
T Consensus 83 ~~~l~~~i~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 83 NGCLLNYLREHG---------------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred CCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCC
Confidence 999999886432 25899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++..............++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+. ........
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~~~ 218 (256)
T cd05113 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVSQGL 218 (256)
T ss_pred ccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHhcCC
Confidence 9998654332222222335678999999998889999999999999999999 9999754332211 11111110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
....+......+.+++.+||+.||.+||++.+++..|+
T Consensus 219 ----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 ----------RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112223578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=331.05 Aligned_cols=264 Identities=27% Similarity=0.494 Sum_probs=206.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~ 406 (633)
.+|+..+.||+|+||.||++.. .+++.||+|+++.......+.|.+|++++++++||||+++.+++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 25789999998877666778899999999999999999999987543 4578
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+|+||+++|+|.+++.... ..++|..++.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~ 145 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---------------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESEN 145 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCC
Confidence 9999999999999986432 35899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++|..+.......
T Consensus 146 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------- 217 (284)
T cd05081 146 RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------- 217 (284)
T ss_pred eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------
Confidence 99999999998764432221 11222345699999999888999999999999999999988765322110
Q ss_pred HHHHHhhc--------hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 565 FISLAKEN--------KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 565 ~~~~~~~~--------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
+....... .+.+.+........+...+..+.+|+.+||+.+|++|||+.||++.|+.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000 011111111111223345578999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.31 Aligned_cols=266 Identities=21% Similarity=0.271 Sum_probs=202.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||.||++..+ +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 57899999886532 2335678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++++.|..+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl 141 (287)
T cd07848 81 YVEKNMLELLEEM----------------PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKL 141 (287)
T ss_pred cCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEE
Confidence 9998777544321 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH-----
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF----- 565 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~----- 565 (633)
+|||+++..............|+..|+|||++.+..++.++|||||||++|||++|+.||......+........
T Consensus 142 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07848 142 CDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP 221 (287)
T ss_pred eeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC
Confidence 999999876443322233456899999999999888999999999999999999999998654332211000000
Q ss_pred ----HHHHhhchhhhhhchhhh------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ----ISLAKENKLLEILDARVA------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ----~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..............+... .......+..+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 222 AEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000 00111234679999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.36 Aligned_cols=270 Identities=27% Similarity=0.484 Sum_probs=212.3
Q ss_pred cCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5788899999999999999984 2345699999887666667789999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++......... .........+++..++.++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVL---MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 158 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCcccc---ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 99999999999998654311000 000111235999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. .
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~------~ 232 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------I 232 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------H
Confidence 999999999866433221 1222345778999999998899999999999999999998 8888754332211 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
... ..+.. ...+...+..+.+++.+||+.||.+|||+.|+...|+.+..+
T Consensus 233 ~~i-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECI-TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHH-HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 111 11111 011223346789999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=324.25 Aligned_cols=250 Identities=28% Similarity=0.433 Sum_probs=202.5
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+|+..+.||+|+||.||+|..+++..+|+|.+..... ..++|.+|++++++++|+||+++++++...+..++|+||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4777899999999999999987777899998764322 234688999999999999999999999988899999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
++|.+++.... ..++|..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 84 ~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 84 GCLLNYLRERK---------------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred CCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcc
Confidence 99999986532 25899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
+++..............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. .... ..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~-~~-- 216 (256)
T cd05059 146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESV-SA-- 216 (256)
T ss_pred cceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHH-Hc--
Confidence 998654332222222234567999999999999999999999999999999 7888864332221 0110 00
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
......+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus 217 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 -------GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -------CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 011122233567899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.74 Aligned_cols=263 Identities=27% Similarity=0.374 Sum_probs=205.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||++... +|..+|+|.+... .....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999964 6789999987653 33445679999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl 145 (331)
T cd06649 84 HMDGGSLDQVLKEA----------------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKL 145 (331)
T ss_pred cCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEE
Confidence 99999999998542 35889999999999999999999853 2999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 146 ~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~ 219 (331)
T cd06649 146 CDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVV 219 (331)
T ss_pred ccCcccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhccccc
Confidence 9999997653321 2234689999999999998999999999999999999999999864433221 000000000
Q ss_pred h------------------------------chhhhhhchhhh---ccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 571 E------------------------------NKLLEILDARVA---KEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 571 ~------------------------------~~~~~~~d~~l~---~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
. ....+.++.... ... .......+.+|+.+||+.||++|||+.|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 000011110000 000 112456799999999999999999999999
Q ss_pred HHH
Q 039736 617 MDL 619 (633)
Q Consensus 617 ~~L 619 (633)
++-
T Consensus 300 ~h~ 302 (331)
T cd06649 300 NHT 302 (331)
T ss_pred cCh
Confidence 874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.24 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=204.7
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..++||+|+||.||+|...++..+|+|.++.... ..+.|.+|+.++++++|+|++++++++. ++..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999987888999998875333 2457899999999999999999999875 456899999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+++|.+++.... ...+++.+++.++.+++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~df 146 (260)
T cd05070 84 KGSLLDFLKDGE--------------GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADF 146 (260)
T ss_pred CCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCc
Confidence 999999986532 235899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~----- 215 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQ----- 215 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHH-----
Confidence 9998764332222222345678999999988889999999999999999999 888875432211 1111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
+........+.+.+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 216 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 216 -----VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111122334456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=339.33 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=204.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|... +++.||||+++... ....+.+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58899999987532 234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 141 (333)
T cd05600 81 EYVPGGDFRTLLNNL----------------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIK 141 (333)
T ss_pred eCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEE
Confidence 999999999998542 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+.. ....
T Consensus 142 L~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~ 211 (333)
T cd05600 142 LTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLK 211 (333)
T ss_pred EEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHH
Confidence 999999986543 223456899999999999999999999999999999999999998654432211 1111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..+............+..+.+++.+||..+|.+||++.|++++
T Consensus 212 ~~~---~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 212 YWK---ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred hcc---ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0000000000012345678899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=328.13 Aligned_cols=267 Identities=27% Similarity=0.499 Sum_probs=209.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCC------CCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|...+.||+|+||.||+|...+ +..||||.++..... ..+.|.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788999999999999998632 478999998764433 4578999999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++........... ........+++.++..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~ 159 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLK--SPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL 159 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhc--ccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence 99999999999999976432111000 00011346899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+. ...
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~ 236 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IEC 236 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH
Confidence 999999999976533221 11223345788999999999999999999999999999998 9999864433221 111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
. ..+. ....+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 237 ---~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ---I-TQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---H-HcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 0111 111223445778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.08 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=209.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|...+.||+|.||.||||+-+ +.+.||+|.+.+. .+.+.+.+.+|++|+++++||||+.++++|......++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 6789999986553 34567789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+.+ +|..+|... ..+++..+..|+.|++.||.|||+++ |.|||+||+|||++.++++|+
T Consensus 82 ~a~g-~L~~il~~d----------------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~Kl 141 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----------------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKL 141 (808)
T ss_pred hhhh-hHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceee
Confidence 9987 999999764 46999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||+|+.+.. .....+...||+-|||||.+.++.|+..+|.||+||+||||.+|++||... .....+..+..
T Consensus 142 cdFg~Ar~m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~ 214 (808)
T KOG0597|consen 142 CDFGLARAMST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK 214 (808)
T ss_pred chhhhhhhccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc
Confidence 99999998754 345556788999999999999999999999999999999999999998532 11222222222
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
++ -..|......+..++...|.+||..|.+-.+++.+
T Consensus 215 d~-----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 215 DP-----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CC-----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 21 12344666788999999999999999999887653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.77 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=203.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|.+. +|+ .+++|.+.... .....++..|+.++++++||||++++|++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677899999999999999963 344 47888775432 334567888999999999999999999875 455789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++|+|.+++.... ..++|..++.|+.||+.||.|||+.+ ++||||||+||++++++.
T Consensus 86 i~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~ 147 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---------------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCc
Confidence 999999999999996532 36899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+........
T Consensus 148 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------- 220 (279)
T cd05111 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------- 220 (279)
T ss_pred EEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999999986543322 22233456789999999999999999999999999999998 9999864432221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
........ ....+..+...+.+++.+||..||++|||+.|+++.|..+....
T Consensus 221 ~~~~~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 221 PDLLEKGE---------RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHCCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11111111 01111223456788999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.76 Aligned_cols=273 Identities=26% Similarity=0.446 Sum_probs=209.2
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CC--EEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~--~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+++++++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 33 5789988753 344556889999999999 799999999999998899999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+++|+|.+++.....................+++..++.++.|++.||+|||+++ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999654321100000000111246899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||......+ ....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 999999987432111 1111223567999999998889999999999999999998 999985433221 1111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
+........+......+.+|+.+||+.+|.+||++.++++.|+.+....+
T Consensus 231 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 231 ----------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred ----------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11111112233455678999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=330.89 Aligned_cols=274 Identities=27% Similarity=0.424 Sum_probs=211.6
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
...++|+..+.||+|+||.||++... +...+|+|.+... ......++.+|++++.++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467888999999999999999853 2368999988753 334556789999999999 799999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..+++|||+++|+|.+++.....................+++..+++++.|++.||.|||+.+ ++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998754321110000000012347999999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-- 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-- 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--
Confidence 99999999999999876433221 1122335678999999998899999999999999999998 8888754322211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
+.. +........+......+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus 244 ----~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 ----FKL----------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHH----------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111 1111111233445578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=311.24 Aligned_cols=236 Identities=28% Similarity=0.419 Sum_probs=202.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||.|+||.|...+.+ +|..+|+|+++.. ...+.+...+|..+|+.+.||.++++.+.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46777899999999999999954 6889999998763 4456778889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++||.|..+++.. +.++...+.-+|.||+.||+|||+.+ |++|||||+|||||.+|.+|
T Consensus 124 eyv~GGElFS~Lrk~----------------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iK 184 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----------------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIK 184 (355)
T ss_pred eccCCccHHHHHHhc----------------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEE
Confidence 999999999999764 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+..... +...+||+.|+|||.+....+...+|.|||||++|||+.|.+||....... .+.
T Consensus 185 itDFGFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~------iY~--- 251 (355)
T KOG0616|consen 185 ITDFGFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ------IYE--- 251 (355)
T ss_pred EEeccceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH------HHH---
Confidence 9999999987432 556789999999999999999999999999999999999999997654421 111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCC
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKR 609 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R 609 (633)
.++...+ .+|.-....+.+|+...|+.|-.+|
T Consensus 252 ------KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 ------KILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ------HHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1122211 2455556778889999999998888
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=319.93 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=198.6
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
+.||+|+||.||+|... +++.||+|..... ..+....|.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 6889999987643 344456799999999999999999999999999999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++... ...++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 142 (252)
T cd05084 81 LTFLRTE---------------GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR 142 (252)
T ss_pred HHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCc
Confidence 9998643 235899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCccee-cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhh
Q 039736 498 SVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLL 575 (633)
Q Consensus 498 ~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (633)
.......... .....+..|+|||.+.++.++.++||||||+++|||++ |..|+........ .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~ 206 (252)
T cd05084 143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------R 206 (252)
T ss_pred ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------H
Confidence 6532211111 11123457999999999999999999999999999998 8888753322111 0
Q ss_pred hhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 576 EILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 576 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
..+........+...+..+.+++.+||+.+|++|||+.|+.++|.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 207 EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred HHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0111111122233445788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.69 Aligned_cols=255 Identities=25% Similarity=0.435 Sum_probs=206.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..++||+|+||.||+|..++++.||+|.+..... ..++|.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888999999999999999988899999998875432 3467889999999999999999999864 55789999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 83 ENGSLVDFLKTPE--------------GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred CCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEcc
Confidence 9999999885432 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||++...............++..|+|||.+..+.++.++||||||+++|||++ |+.||......+. ...
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~---- 215 (260)
T cd05067 146 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV------IQN---- 215 (260)
T ss_pred CcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH------HHH----
Confidence 99997764332222223345778999999998889999999999999999999 9999864332211 111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
+........+...+..+.+++.+||+.+|++||+++++...|+.+
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 216 ------LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 011111122233456799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.62 Aligned_cols=275 Identities=27% Similarity=0.436 Sum_probs=209.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC-C
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET-E 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~-~ 403 (633)
.++|+..+.||+|+||.||+|... .++.||+|+++.. .....+.+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 457888999999999999999732 2478999998753 234456788999999999 899999999988754 4
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHH---------------------------------------------HHHHHHHhh
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQE---------------------------------------------QKQELEEEQ 438 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~---------------------------------------------~~~~~~~~~ 438 (633)
..++++||+++|+|.+++........ .........
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999864321000 000000011
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcce-ecccccCCCcC
Q 039736 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYF 517 (633)
Q Consensus 439 ~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~ 517 (633)
....++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++++||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1247999999999999999999999998 9999999999999999999999999998764332221 22344677899
Q ss_pred chhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHH
Q 039736 518 DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAE 596 (633)
Q Consensus 518 APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 596 (633)
|||++.+..++.++|||||||+||||++ |..|+......+. +....... .....+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEG---------TRMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhcc---------CCCCCCccCCHHHHH
Confidence 9999999999999999999999999998 9999854322111 11111111 111122334567899
Q ss_pred HHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 597 LAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 597 L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
++.+||+.+|++||++.|++++|+++..+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=336.32 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=197.9
Q ss_pred CcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||++.. .+|+.||||+++.. .......+.+|++++++++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 47899999988752 2344567889999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~ 141 (323)
T cd05571 81 ELFFHLSRE----------------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred cHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 998888642 36899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhh
Q 039736 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 575 (633)
Q Consensus 496 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (633)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .......
T Consensus 142 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~~---- 210 (323)
T cd05571 142 CKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME---- 210 (323)
T ss_pred CcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HHHHHcC----
Confidence 97542221 112335689999999999999999999999999999999999999864332211 1111110
Q ss_pred hhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 576 EILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 576 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
+ ...+......+.+++.+||+.||++|| ++.|++++
T Consensus 211 ---~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 ---E----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---C----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 122334456788999999999999999 78988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=327.43 Aligned_cols=265 Identities=26% Similarity=0.453 Sum_probs=206.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
..++|+..+.||+|+||.||+|... .+..||||++... ......+|.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998752 2467999987643 23345678999999999999999999999998889
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++........ .......++|..++.++.|++.||.|||+.+ ++||||||+||++++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~ 154 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEME------NNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 154 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCcccc------ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcC
Confidence 9999999999999999865332100 0001235789999999999999999999988 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |..|+........
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---- 230 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---- 230 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 9999999999998654322211 112345778999999999899999999999999999999 6788754332211
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.. ...+... ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 231 --~~-~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 --LR-FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --HH-HHHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 1111111 11223345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=332.35 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=202.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999964 68999999886422 234567889999999999999999999999989999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~k 141 (291)
T cd05612 81 EYVPGGELFSYLRNS----------------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIK 141 (291)
T ss_pred eCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEE
Confidence 999999999998643 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ......
T Consensus 142 l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~ 211 (291)
T cd05612 142 LTDFGFAKKLRDRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKIL 211 (291)
T ss_pred EEecCcchhccCCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 99999998764321 23458999999999998889999999999999999999999986543221 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
. .. ...+......+.+|+.+||+.||.+||+ +.|++++
T Consensus 212 ~-~~----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 212 A-GK----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred h-CC----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1 10 1123333567889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=326.28 Aligned_cols=272 Identities=26% Similarity=0.440 Sum_probs=209.3
Q ss_pred CCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+|...+.||+|+||.||+|... ....+++|.+... .....+++.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999852 2357999987653 23456689999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHH--------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQ--------ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~--------~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
++||+.+|+|.+++........... ..........+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999865322100000 0000011246899999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998653322211 122345678999999988889999999999999999998 998885433221
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
. . . .+........+......+.+++.+||+.+|++||++.|+++.|+++..+
T Consensus 238 ~---~----~---------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 L---F----N---------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred H---H----H---------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 1 1 1111111222334456889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=317.75 Aligned_cols=247 Identities=27% Similarity=0.448 Sum_probs=200.3
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCch
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLS 418 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 418 (633)
++||+|+||.||+|...++..+|+|..+... ......+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4699999999999998888999999876543 333457889999999999999999999999999999999999999999
Q ss_pred hhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 419 HHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 419 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
+++.... ..++|..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 81 SFLRKKK---------------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCcccee
Confidence 9885432 35889999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 499 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
.............++..|+|||++..+.++.++||||||+++|||++ |..||........ ... ...
T Consensus 143 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~-~~~------ 209 (250)
T cd05085 143 EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQ-VEK------ 209 (250)
T ss_pred ccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHH-HHc------
Confidence 43322222222334678999999999999999999999999999999 8889854332211 000 000
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
......+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 210 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 ---GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111223344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=336.60 Aligned_cols=245 Identities=25% Similarity=0.379 Sum_probs=201.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +|+.||+|.++.. .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999964 6889999987642 2234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 98 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----------------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred cCCCCChHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEE
Confidence 999999999988642 35888899999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... ....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ......
T Consensus 159 l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~ 228 (329)
T PTZ00263 159 VTDFGFAKKVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKIL 228 (329)
T ss_pred EeeccCceEcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHh
Confidence 99999998764322 23468999999999999999999999999999999999999986433211 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
++ . ...+......+.+|+.+||+.||.+||+ +.|++.+
T Consensus 229 -~~--------~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 229 -AG--------R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -cC--------C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 0 1122223456889999999999999997 6777754
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.42 Aligned_cols=255 Identities=28% Similarity=0.380 Sum_probs=207.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc----Ch-hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI----DK-TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~----~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~ 404 (633)
...+|...+.||+|+||.|+.|.. .+|+.||+|.+... .. ...+...+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456888999999999999999984 47899999976542 11 23445668999999999 9999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+.+|+|.+++... ..+++.....++.|++.|++|+|+++ |+||||||+|||+|.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----------------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~ 155 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----------------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDG 155 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----------------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecC
Confidence 99999999999999999762 36888999999999999999999999 999999999999999
Q ss_pred C-CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC-CC-cccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 485 K-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 485 ~-~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+ +++||+|||++.... .........+|++.|+|||++.+.. |+ .++||||+||+||-|++|+.||+....
T Consensus 156 ~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------ 228 (370)
T KOG0583|consen 156 NEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------ 228 (370)
T ss_pred CCCCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------
Confidence 9 999999999999874 2223345578999999999999877 76 689999999999999999999964221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHH-HHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREED-IEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
...+...... . -.+|... ..++..|+.+|+..||.+|+++.||+ .-.-++.
T Consensus 229 ~~l~~ki~~~---------~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 229 PNLYRKIRKG---------E--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred HHHHHHHhcC---------C--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1111111111 0 1223333 67889999999999999999999999 4444443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.18 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=199.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999854 68899999886432 22344678999999999999999999999988899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+
T Consensus 85 ~~~-~l~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~ 145 (288)
T cd07871 85 LDS-DLKQYLDNC---------------GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLA 145 (288)
T ss_pred CCc-CHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEC
Confidence 974 888887543 125789999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++....... ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.... ......
T Consensus 146 DfG~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~ 221 (288)
T cd07871 146 DFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLG 221 (288)
T ss_pred cCcceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhC
Confidence 9999976532221 1223457899999998865 5688999999999999999999999865543332111 111110
Q ss_pred ---h---------chhhhhhchhhhc----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ---E---------NKLLEILDARVAK----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ---~---------~~~~~~~d~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ........+.... ........++.+|+.+||+.||.+|||++|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0011111111000 0011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.04 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred ccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC--ceEEE
Q 039736 337 NQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLV 408 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~LV 408 (633)
...+.||+|+||.||++.. .+++.||+|..+... ....+.|.+|++++++++||||+++++++...+ ..+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7789999999999988652 357789999887543 234567889999999999999999999987543 57899
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.. ..++|.+++.++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~~~~-----------------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----------------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred ecCCCCCCHHHHHHH-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcE
Confidence 999999999998853 25899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~ 225 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQ 225 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccc
Confidence 99999999876433221 11222356679999999988999999999999999999999999754321110 0000000
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.......+.+.++.......+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000011122222222222234455678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.11 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=202.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
..++|+.+..||+|+||.||.++- .+|+.+|+|+++.. ...+++..+.|-.+|...++++||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 457899999999999999999995 47999999999874 34567788899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||.+||++..+|... ..|+......++.+++-|++-||++| +|||||||+|+|||..|+
T Consensus 219 iMEylPGGD~mTLL~~~----------------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GH 279 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK----------------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGH 279 (550)
T ss_pred EEEecCCccHHHHHHhc----------------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCC
Confidence 99999999999999764 46999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCC-----------------------CCc-----c------------------eecccccCCCcCchhc
Q 039736 488 AKVSDFGTSRSVPN-----------------------DKT-----H------------------LTTAVQGTFGYFDPEY 521 (633)
Q Consensus 488 ~kI~DfGla~~~~~-----------------------~~~-----~------------------~~~~~~gt~~y~APE~ 521 (633)
+||+||||+.-+.. +.. . .....+|||.|||||+
T Consensus 280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV 359 (550)
T KOG0605|consen 280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV 359 (550)
T ss_pred EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence 99999999843210 000 0 0112469999999999
Q ss_pred cccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh-hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHh
Q 039736 522 FQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE-RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMG 600 (633)
Q Consensus 522 l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~ 600 (633)
+.+..|+..+|.||+|||+|||+.|.+||......+. +.+..|-.. +..........+..+||.+
T Consensus 360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--------------l~fP~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--------------LKFPEEVDLSDEAKDLITR 425 (550)
T ss_pred HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--------------ccCCCcCcccHHHHHHHHH
Confidence 9999999999999999999999999999987665542 222222111 1111122334778899999
Q ss_pred ccccCCCCCCC
Q 039736 601 CLRLNSKKRPT 611 (633)
Q Consensus 601 Cl~~dP~~RPt 611 (633)
|+. ||++|.-
T Consensus 426 ll~-d~~~RLG 435 (550)
T KOG0605|consen 426 LLC-DPENRLG 435 (550)
T ss_pred Hhc-CHHHhcC
Confidence 999 9999976
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=321.39 Aligned_cols=258 Identities=25% Similarity=0.467 Sum_probs=203.7
Q ss_pred CccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-----
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV----- 404 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~----- 404 (633)
|...+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999988743 34456789999999999999999999999876554
Q ss_pred -eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 405 -PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 405 -~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
.++++||+++|+|..++...... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~ 147 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----------GLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLR 147 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----------CCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEEC
Confidence 79999999999999998654321 01236899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l 561 (633)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 148 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---- 223 (273)
T cd05035 148 EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---- 223 (273)
T ss_pred CCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998764332221 112235678999999988889999999999999999999 888875433211
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
....... + .....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 224 --~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 224 --IYDYLRH-G---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHHHc-C---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111111 1 01122344567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=320.75 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=204.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..++||+|+||.||+|...++..||+|+++.... ..++|.+|++++++++|+||+++++.+. ++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 56888999999999999999987667899999875332 3457889999999999999999999874 456799999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ...++|..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~df 146 (262)
T cd05071 84 KGSLLDFLKGEM--------------GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF 146 (262)
T ss_pred CCcHHHHHhhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccC
Confidence 999999996532 135899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|.++..............++..|+|||++.++.++.++||||||+++|||++ |+.|+......+. ......
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~------~~~~~~-- 218 (262)
T cd05071 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVER-- 218 (262)
T ss_pred CceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH------HHHHhc--
Confidence 9998664333222223346678999999998899999999999999999999 7778754322211 000000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+.+.+..+.+++.+|++.||++||++.++.+.|+..
T Consensus 219 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 219 --------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 001112334567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=324.37 Aligned_cols=269 Identities=25% Similarity=0.445 Sum_probs=206.0
Q ss_pred cCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|.. .++..||+|.++.. .......|.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4677789999999999999984 24678999998753 33445678899999999999999999999999899999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHH-HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQE-LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
||||+++|+|.+++............ .........+++.+.+.++.|++.||.|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998543210000000 000001235899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
.+||+|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |..|+........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999986533221 12223345678999999988889999999999999999999 8888754322111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
....... .....+......+.+++.+||+.||++||++.+|.++|..
T Consensus 236 -~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKR---------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111 1111233445678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=340.37 Aligned_cols=248 Identities=26% Similarity=0.471 Sum_probs=210.1
Q ss_pred cCCcccccCcEEEEEEEcC--CCC--EEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 338 QSRFLGQGGFGTVYKGMLP--DGS--IVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~--~g~--~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
..++||+|.||.|++|.|. +|+ .||||.++..... ...+|++|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4678999999999999985 343 6999999875544 67899999999999999999999999987 6789999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
+.|+|.+.|++.. ...|-......++.|||.||.||.+++ +|||||..+|+||-..-.+||+|
T Consensus 193 plGSLldrLrka~--------------~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK--------------KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred ccchHHHHHhhcc--------------ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeec
Confidence 9999999998721 346778888999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 493 FGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 493 fGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
||+.+.++.....+ .....-.+.|+|||.+..+.++.++|||+|||.||||+| |..|+-+....
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------- 322 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------- 322 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-------------
Confidence 99999886544332 223345678999999999999999999999999999999 78887543322
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.+.+.+|..-+...+..|++.++++++.||..+|++|||+..|.+.+
T Consensus 323 ---qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 323 ---QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 23444555555667889999999999999999999999999997443
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=320.80 Aligned_cols=256 Identities=27% Similarity=0.490 Sum_probs=206.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CC---CEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g---~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||+|... ++ ..+|+|..+.. .....+++.+|++++++++|+||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357788899999999999999964 23 37999988754 34446689999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++++|.+++... ...++|.+++.++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 84 v~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~ 145 (268)
T cd05063 84 ITEYMENGALDKYLRDH---------------DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLE 145 (268)
T ss_pred EEEcCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCc
Confidence 99999999999998643 236899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
+||+|||++........... .....+..|+|||++..+.++.++||||||+++|||++ |+.|+......+ .
T Consensus 146 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~ 219 (268)
T cd05063 146 CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------V 219 (268)
T ss_pred EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------H
Confidence 99999999986643222111 11223467999999998899999999999999999997 999985432211 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
..... .. .....+.+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 220 ~~~i~-~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 220 MKAIN-DG---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHh-cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111 10 11122234457789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.89 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=209.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|... +++.||||.++. .+......+.+|++++++++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888999999999999999954 789999997653 23344567899999999999999999999999989999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++
T Consensus 82 e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~ 146 (267)
T cd08228 82 ELADAGDLSQMIKYFKK------------QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EecCCCcHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEE
Confidence 99999999988854321 0235889999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+...... ........
T Consensus 147 l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~- 220 (267)
T cd08228 147 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKI- 220 (267)
T ss_pred ECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHH-
Confidence 999999887643221 112345788999999998888999999999999999999999998532211 11111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
... .............+.+++.+||+.+|++||++.||++.|++++
T Consensus 221 ~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 221 EQC--------DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hcC--------CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 100 0011112344577899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.42 Aligned_cols=277 Identities=27% Similarity=0.395 Sum_probs=212.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC--------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~--------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||++... ++..+|+|.++.. ......++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999742 2357999998753 234456788999999999 799999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..++||||+++|+|.+++.....................++|.++++++.|++.||+|||+++ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999764321000000000001235899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....++
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 99999999999999765432211 1112234568999999998889999999999999999998 888875433221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
.+. .... ....+.+......+.+|+.+||+.+|++||++.||++.|+++.....+
T Consensus 251 ---~~~-~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 251 ---LFK-LLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred ---HHH-HHHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 111 1111 111122334557888999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=318.46 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=197.8
Q ss_pred cccccCcEEEEEEEc---CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 341 FLGQGGFGTVYKGML---PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~---~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.++++++|+||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 357899999886532 334668999999999999999999999885 45679999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++... ..+++..+++++.|++.||+|||+++ ++||||||+||++++++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~ 141 (257)
T cd05116 81 PLNKFLQKN----------------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGL 141 (257)
T ss_pred cHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcc
Confidence 999988542 35899999999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 496 SRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 496 a~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
++.......... ....++..|+|||.+....++.++|+||||+++|||++ |+.||......+. . .....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~-~~i~~- 213 (257)
T cd05116 142 SKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV------T-QMIES- 213 (257)
T ss_pred ccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------H-HHHHC-
Confidence 987644332211 12234578999999988889999999999999999998 9999864332211 1 11111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 214 --------~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 214 --------GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 111123344567889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.29 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=196.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 406 (633)
+|+..+.||+|+||.||+|+.. +|+.||||++... ......++.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999954 6899999987642 2234457889999999999999999999886432 479
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||++ ++|.+++... ..+++..+..++.||++||.|||+++ |+||||||+|||++.++
T Consensus 81 lv~e~~~-~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 140 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----------------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADC 140 (338)
T ss_pred EEEecCC-CCHHHHHHhc----------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCC
Confidence 9999995 6888877542 35899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCc--ceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 487 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.+||+|||+++....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 141 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~--- 217 (338)
T cd07859 141 KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL--- 217 (338)
T ss_pred cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---
Confidence 999999999986532211 11234568999999999876 67899999999999999999999998654322111
Q ss_pred HHHHHHHh-----------hchhhhhhc---hhhhccc---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAK-----------ENKLLEILD---ARVAKEA---REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~-----------~~~~~~~~d---~~l~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ .....+.++ +...... -......+.+++.+||+.||++|||+.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 11111000 000011110 0000000 01234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=333.52 Aligned_cols=249 Identities=26% Similarity=0.416 Sum_probs=208.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..|+..+.||+|.||.||+|... .++.||+|++... ...++++..+|+.+|.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35667789999999999999954 6889999998753 345678889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+.+|++.+.|... ..+.+..+.-|.+++..||.|||+++ .+|||||+.|||+..+|.+|++
T Consensus 93 ~~gGsv~~lL~~~----------------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~ 153 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG----------------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLA 153 (467)
T ss_pred hcCcchhhhhccC----------------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEE
Confidence 9999999999753 23477777789999999999999999 8999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++.......... ..++||+.|||||++....|+.|+||||+|++.+||.+|.+|+......
T Consensus 154 DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------- 217 (467)
T KOG0201|consen 154 DFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------------- 217 (467)
T ss_pred ecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------------
Confidence 999998876554443 5678999999999999889999999999999999999999997532221
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
++.-.+-..-.......+...+.+++..||.+||+.||++.+++++
T Consensus 218 -rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 218 -RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1111111111122223566789999999999999999999999876
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.87 Aligned_cols=253 Identities=25% Similarity=0.300 Sum_probs=205.2
Q ss_pred CCccCCcccccCcEEEEEEEcC-C-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-D-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.|...+.||+|+||.||++... + ++.||+|............+.+|+.+++.++||||+++++++...+..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999843 3 6789999876655556667889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++..... ...++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 148 ~gg~L~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 148 SGGDLNKQIKQRLK------------EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred CCCCHHHHHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEe
Confidence 99999998864321 1246899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++....... .......||++|+|||++.+..++.++||||||+++|||++|+.||......+ .+.....
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~~- 285 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVLY- 285 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-
Confidence 999987643322 22334568999999999999999999999999999999999999986433211 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.. ...+......+.+++.+||+.||++||++.+++.+
T Consensus 286 ~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 286 GKY---------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCC---------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 000 11223345678999999999999999999998753
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.91 Aligned_cols=268 Identities=24% Similarity=0.394 Sum_probs=205.5
Q ss_pred CCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+|...+.||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666788999999999999853 247899999875433 334678899999999999999999999999899999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++++|.+++.....................+++..+++++.|++.||+|||+++ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998543211000000000011235899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+......+ ..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------VI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH
Confidence 99999999886533221 12223346789999999998899999999999999999998 777875432211 11
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.. ..... ....+.+++..+.+|+.+||+.+|++||++.||+..|+.
T Consensus 237 ~~-i~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM-IRNRQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH-HHcCC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11110 112344566779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=317.94 Aligned_cols=250 Identities=26% Similarity=0.466 Sum_probs=206.8
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4678889999999999999998 588999999876544 56789999999999999999999999998889999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+++|.+++.... ...++|..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~ 146 (256)
T cd05039 84 KGSLVDYLRSRG--------------RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDF 146 (256)
T ss_pred CCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccc
Confidence 999999986532 136899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++....... ....+..|+|||++..+.++.++||||||+++|||++ |..|+......+. . .....
T Consensus 147 g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~- 214 (256)
T cd05039 147 GLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PHVEK- 214 (256)
T ss_pred ccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---H----HHHhc-
Confidence 99987632221 2334678999999998899999999999999999997 9988754332211 0 11110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+...+..+.+++.+||..+|++||++.|++++|+.+
T Consensus 215 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 215 --------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111122334457889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.66 Aligned_cols=262 Identities=27% Similarity=0.415 Sum_probs=205.9
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCC------CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.+++|...+.||+|++|.||+|...+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678889999999999999999743 5689999876533 3345579999999999999999999999998889
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++...+.... ....++|..+++++.||+.||+|||+.+ ++||||||+||+++.
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~ 151 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPE---------RPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEec
Confidence 9999999999999999976432100 1235899999999999999999999998 999999999999987
Q ss_pred CC---cEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhh
Q 039736 485 KF---SAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEER 559 (633)
Q Consensus 485 ~~---~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~ 559 (633)
++ .+||+|||+++......... ......+..|+|||++.++.++.++|||||||++|||++ |+.||......+.
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~- 230 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV- 230 (277)
T ss_pred cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 54 69999999998763322111 112233568999999999999999999999999999997 9988864433221
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
....... .....+...+..+.+++.+||+.+|++||++.||+++|..
T Consensus 231 -----~~~~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 231 -----MEFVTGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----HHHHHcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111111 1112233445788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=322.71 Aligned_cols=265 Identities=26% Similarity=0.455 Sum_probs=210.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC-----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~-----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~ 405 (633)
.++|...+.||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999755 688999988753 34456778999999999999999999999876 4678
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++++||+++|+|.+++........ .....+++..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~ 153 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA--------NNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEE 153 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc--------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCC
Confidence 999999999999999865422100 01246999999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
+.+||+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+......+ ...
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~ 230 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAA 230 (280)
T ss_pred CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHH
Confidence 99999999999866433222 1122345778999999998889999999999999999999 999985432211 111
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
....+ .....+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 231 ----~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 ----YLKDG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----HHHcC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111 0011122344678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=305.87 Aligned_cols=265 Identities=24% Similarity=0.373 Sum_probs=214.5
Q ss_pred hcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ceE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 406 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 406 (633)
.++|...++||+|||+.||.+. ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 5678999999999888888999999999999999999999999887544 389
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
|+++|...|||.+.+..... +...+++.+.++|+.+|.+||++||+.. ||+.||||||.|||+.+.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~------------kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~ 166 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI------------KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSG 166 (302)
T ss_pred EEeehhccccHHHHHHHHhh------------cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCC
Confidence 99999999999999976443 1347999999999999999999999988 5799999999999999999
Q ss_pred cEEEeecCCCccCCCCCcce--------ecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 487 SAKVSDFGTSRSVPNDKTHL--------TTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~--------~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
.++|.|||.+...+-.-... -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 167 ~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 167 LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 99999999997653211110 01234688999999985 34578999999999999999999999853211
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.+ ..-...+..+.+........++.+.+++++|++.||.+||++.|++..++.+.
T Consensus 247 ~G-------------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 QG-------------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred cC-------------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11 01111222223322223346789999999999999999999999999998764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=317.78 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=197.3
Q ss_pred cccccCcEEEEEEEcC---CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 341 FLGQGGFGTVYKGMLP---DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
.||+|+||.||+|.+. ++..||+|.+.... ....+.|.+|+.++++++|+||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999853 35579999887643 334567999999999999999999999885 456899999999999
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCC
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 496 (633)
|.+++... ...+++..+++++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++
T Consensus 81 L~~~l~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~ 142 (257)
T cd05115 81 LNKFLSGK---------------KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLS 142 (257)
T ss_pred HHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCcc
Confidence 99988643 236899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 497 RSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 497 ~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
........... ....++..|+|||.+....++.++||||||+++|||++ |+.|+......+. .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~--- 212 (257)
T cd05115 143 KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIE--- 212 (257)
T ss_pred ccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHH---
Confidence 86543322211 11223578999999988889999999999999999996 9999854332211 11111
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
.......+..+..++.+++.+||..||++||++.+|.+.|+.+
T Consensus 213 ------~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 213 ------QGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111223344567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.80 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=194.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CCCEEEEEEccccC--hhHHHHHHHHHHHHhcc---CCCCceEEEEEEee-----
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSRAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLE----- 401 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~----- 401 (633)
++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999852 46889999876432 22234566777777665 69999999999862
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
....++||||++ ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil 142 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--------------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 142 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEE
Confidence 345899999996 68988885432 235899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+++++.+||+|||+++..... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 143 ~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--- 217 (290)
T cd07862 143 VTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--- 217 (290)
T ss_pred EcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---
Confidence 999999999999999765432 222345689999999999988999999999999999999999999875443221
Q ss_pred HHHHHHHHh---hchhh-------hhhchhh---hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 562 VAYFISLAK---ENKLL-------EILDARV---AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 562 ~~~~~~~~~---~~~~~-------~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...+..... ..... ..+.+.. ......+....+.+|+.+||+.||++|||+.|+++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 111111110 00000 0000000 00011223466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=319.92 Aligned_cols=257 Identities=26% Similarity=0.491 Sum_probs=200.0
Q ss_pred ccCCcccccCcEEEEEEEcCCC-C--EEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC------Cce
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDG-S--IVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EVP 405 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g-~--~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------~~~ 405 (633)
...+.||+|+||.||+|.+.+. . .||+|.++.. .....+.|.+|+++++.++|+||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997543 2 6999987653 355577899999999999999999999987532 246
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++++||+++|+|.+++...+.. .....++|...+.++.|++.||+|||+++ |+||||||+|||++++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG----------DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNEN 148 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc----------CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCC
Confidence 8999999999999887532210 01235899999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
+.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~-- 223 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I-- 223 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence 999999999998764332211 122345678999999999999999999999999999999 788875432211 1
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
... ...+.. ...+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 224 -~~~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 224 -YDY-LRQGNR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHH-HHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 111110 011233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=336.41 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=193.7
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+|+..++||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4455788999999999999954 68999999986533 334567899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+.. .+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 155 ~~~~L~~~~--------------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 155 DGGSLEGTH--------------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred CCCcccccc--------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcc
Confidence 999986532 3456677889999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+++....... ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+ .......
T Consensus 212 fG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCA 287 (353)
T ss_pred cccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHH
Confidence 999987643221 1233568999999998743 223468999999999999999999986322111 1111100
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ......+......+.+|+.+||+.||++||++.|++++
T Consensus 288 ~~~----------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICM----------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred Hhc----------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111233445678999999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.31 Aligned_cols=253 Identities=26% Similarity=0.423 Sum_probs=203.4
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|...+.||+|++|.||++...++..+|+|++..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 46788899999999999999987777899998765332 3457889999999999999999999875 456899999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ...++|..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 84 ~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~df 146 (260)
T cd05069 84 KGSLLDFLKEGD--------------GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADF 146 (260)
T ss_pred CCCHHHHHhhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCC
Confidence 999999986532 235899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+. .......
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~- 219 (260)
T cd05069 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV------LEQVERG- 219 (260)
T ss_pred ccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcC-
Confidence 9997654332222222345678999999998899999999999999999999 8888754322211 0111110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.....+...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 ---------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112233455788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.38 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=195.1
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999987642 334556788999999999999999999999999999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~ 141 (312)
T cd05585 81 FHHLQRE----------------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCK 141 (312)
T ss_pred HHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccc
Confidence 9988642 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus 142 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~------ 208 (312)
T cd05585 142 LNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQE------ 208 (312)
T ss_pred cCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcC------
Confidence 643222 12234568999999999999999999999999999999999999986432211 11111111
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT---MKQVSMD 618 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt---~~ev~~~ 618 (633)
....+......+.+++.+||+.||++||+ +.|++.+
T Consensus 209 -----~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 -----PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 01223344567889999999999999985 5666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.70 Aligned_cols=261 Identities=24% Similarity=0.374 Sum_probs=209.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++.. .+|+.+|||.+... .....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 47899999987542 2334568899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++..... ....++|..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++
T Consensus 82 e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~ 146 (267)
T cd08229 82 ELADAGDLSRMIKHFKK------------QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVK 146 (267)
T ss_pred EecCCCCHHHHHHHhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEE
Confidence 99999999998864221 1246899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+. ......
T Consensus 147 l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~-- 219 (267)
T cd08229 147 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKK-- 219 (267)
T ss_pred ECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhh--
Confidence 999999876643322 1223458889999999998889999999999999999999999985432111 111110
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
+.....+ ...+......+.+++.+||+.||++||||.+|++.++++-
T Consensus 220 ----~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 ----IEQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000001 1112235578999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.55 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=208.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..++|...+.||+|+||.||++..+++..||||.+.... ...+++.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346888999999999999999998778899999887533 2346789999999999999999999999988899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++.... ...+++.++..++.+++.||.|||+.+ ++|+||||+||++++++.+||+
T Consensus 83 ~~~~~L~~~i~~~~--------------~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~ 145 (261)
T cd05034 83 MSKGSLLDFLKSGE--------------GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIA 145 (261)
T ss_pred cCCCCHHHHHhccc--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEEC
Confidence 99999999986532 136899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++...............++..|+|||.+.+..++.++|+||||+++|||++ |+.|+........ ......
T Consensus 146 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~------~~~~~~ 219 (261)
T cd05034 146 DFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV------LEQVER 219 (261)
T ss_pred ccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHc
Confidence 999998764322222222334678999999998889999999999999999999 9999854332211 111110
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
......+...+..+.+++.+||+.+|++||+++|+.+.|+.
T Consensus 220 ----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 220 ----------GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01111223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.31 Aligned_cols=275 Identities=26% Similarity=0.402 Sum_probs=211.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC--------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~--------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||++... ++..||+|.++.. .....+++.+|+.+++.+ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888899999999999999731 2457999988653 344567889999999999 899999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..+++|||+++|+|.+++.....................++|.++++++.||++||.|||+++ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 9999999999999999999764321100000000001236899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 999999999999998764332221 222345678999999998889999999999999999998 777774332221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ... .....+..++..+.+++.+||+.+|++||++.|+++.|+++....
T Consensus 248 ---~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 248 ---LFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred ---HHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 11111 111 111123345578899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.03 Aligned_cols=242 Identities=25% Similarity=0.379 Sum_probs=197.8
Q ss_pred CcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 36899999988652 2345567889999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~ 141 (328)
T cd05593 81 ELFFHLSRE----------------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGL 141 (328)
T ss_pred CHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcC
Confidence 998887542 35899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhh
Q 039736 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 575 (633)
Q Consensus 496 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (633)
++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. .......
T Consensus 142 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~---- 210 (328)
T cd05593 142 CKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME---- 210 (328)
T ss_pred CccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccC----
Confidence 87543221 122335689999999999998999999999999999999999999864332211 1111100
Q ss_pred hhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 576 EILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 576 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
+ ...+......+.+++.+||+.||++|| ++.|++++
T Consensus 211 ---~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 ---D----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---C----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0 112334456788999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.49 Aligned_cols=242 Identities=26% Similarity=0.377 Sum_probs=197.0
Q ss_pred CcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||++.. .+|+.||+|.++.. .......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 36899999988652 2344567888999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 141 (323)
T cd05595 81 ELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGL 141 (323)
T ss_pred cHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHH
Confidence 998877542 35899999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhh
Q 039736 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLL 575 (633)
Q Consensus 496 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 575 (633)
++....... ......|++.|+|||++.++.++.++|||||||++|||++|+.||........ .......
T Consensus 142 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~---- 210 (323)
T cd05595 142 CKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILME---- 210 (323)
T ss_pred hccccCCCC-ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcC----
Confidence 875422211 12235689999999999999999999999999999999999999864432211 1111100
Q ss_pred hhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 576 EILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 576 ~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
. ...+......+.+++.+||+.||++|| ++.+++++
T Consensus 211 -----~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 211 -----E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred -----C--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0 112334456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.81 Aligned_cols=272 Identities=27% Similarity=0.442 Sum_probs=207.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC--EEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS--IVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~--~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|... ++. .+|+|+++.. .....+.+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999964 444 4688877653 344556788999999999 899999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+++|+|.++++....................+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 9999999999999754321000000000001236899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||+| |..||......+ ....
T Consensus 164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK 235 (303)
T ss_pred EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HHHH
Confidence 99999998643211 11111224668999999988889999999999999999998 999985432221 1111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... ......+......+.+|+.+||+.+|++||++.+++.+|+++....
T Consensus 236 ~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 236 LPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred Hhc----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 110 0111122234467899999999999999999999999999887655
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.33 Aligned_cols=245 Identities=29% Similarity=0.423 Sum_probs=209.8
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCc
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV 404 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~ 404 (633)
....++|...+.||+|.||.|+++..+ +++.+|||.+++. ..++++..+.|..|+...+ ||.|++|+.++...+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 334578999999999999999999965 6789999998863 4566788889999988875 9999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|.||||+.||++..+.+. ..++...+.-+|..|+.||+|||+++ ||+||||.+|||||.
T Consensus 444 l~fvmey~~Ggdm~~~~~~-----------------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHT-----------------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDT 503 (694)
T ss_pred EEEEEEecCCCcEEEEEec-----------------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcc
Confidence 9999999999996666543 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
+|++||+||||++...... ..+...+||+.|||||++.+..|+..+|.|||||+||||+.|..||.++++++.
T Consensus 504 eGh~kiADFGlcKe~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------ 576 (694)
T KOG0694|consen 504 EGHVKIADFGLCKEGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------ 576 (694)
T ss_pred cCcEEecccccccccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------
Confidence 9999999999998753222 245678999999999999999999999999999999999999999987666542
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
+..+..++ -.||...+.+...+++++|.++|++|.-+
T Consensus 577 FdsI~~d~-----------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FDSIVNDE-----------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHHhcCC-----------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 33333221 23566677888999999999999999887
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.05 Aligned_cols=268 Identities=25% Similarity=0.449 Sum_probs=208.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+++...++||+|+||.||++... ++..+|+|.++.......+.|.+|+++++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 356899999887766777789999999999999999999999999889999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++|+|.+++............ ........+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAG-GEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcc-cccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999764321110000 00011235899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~ 234 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA------I 234 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH------H
Confidence 999999999765332211 1122335678999999999999999999999999999998 8888753322211 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
..... ......+...+..+.+++.+||+.||++||++.||.+.|++
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQ----------GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHc----------CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11100 00111223345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=320.19 Aligned_cols=263 Identities=27% Similarity=0.446 Sum_probs=199.7
Q ss_pred CcccccCcEEEEEEEcCC-CC--EEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLPD-GS--IVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~-g~--~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|...+ +. .+++|.++.. .....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999743 43 5788988753 344566889999999999 799999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++.....................+++.++++++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 9999999754321000000000011235899999999999999999999988 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ .+.....
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~--- 226 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQ--- 226 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhC---
Confidence 98643211 11111223567999999988889999999999999999997 999985432211 1111111
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
....+.+......+.+|+.+||+.||.+|||+.|++..|.++.
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111122334467899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.34 Aligned_cols=266 Identities=26% Similarity=0.383 Sum_probs=207.5
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--------------hhHHHHHHHHHHHHhccC
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--------------KTQIEQFINEVVILSQIN 388 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--------------~~~~~~~~~Ei~il~~l~ 388 (633)
+...+-.+..++|+..+.||+|.||.|-+|+. .+++.||||++.... ....++..+||.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 33444455678999999999999999999994 478999999865321 112467889999999999
Q ss_pred CCCceEEEEEEeeC--CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 039736 389 HRHIVKLLGCCLET--EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA 466 (633)
Q Consensus 389 H~nIv~l~g~~~~~--~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 466 (633)
|+|||+|+.+..+. +..|||+||+..|.+...-... ..|+..++++++.++..||+|||.++
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----------------~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----------------PELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc----------------ccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 99999999998753 5789999999998875443221 12899999999999999999999999
Q ss_pred CCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCc----ceecccccCCCcCchhccccCC----CCcccchhhHHH
Q 039736 467 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT----HLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGV 538 (633)
Q Consensus 467 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~----~s~ksDV~SfGv 538 (633)
||||||||+|+||+++|++||+|||.+........ ..-....||+.|+|||...++. .+.+.||||+||
T Consensus 231 ---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 231 ---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred ---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 99999999999999999999999999986632211 1112357999999999987743 346899999999
Q ss_pred HHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 539 VLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 539 vL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+||-|+.|+.||.....- ..+. .++...+.....++..+.+.+|++++|++||+.|.+..+|..+
T Consensus 308 TLYCllfG~~PF~~~~~~------~l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFEL------ELFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hHHHhhhccCCcccchHH------HHHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999999999998643221 1111 2223333223334567889999999999999999999999887
Q ss_pred HHhhh
Q 039736 619 LEGLR 623 (633)
Q Consensus 619 L~~i~ 623 (633)
.....
T Consensus 373 pwvt~ 377 (576)
T KOG0585|consen 373 PWVTR 377 (576)
T ss_pred ceecc
Confidence 65443
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=315.40 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=205.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||++... +|+.|++|.+.. ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999964 688999998754 3345567899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.++++... ...+++..+++++.|++.||.|||+.+ ++|+||||+||++++++.+||+
T Consensus 81 ~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~ 143 (256)
T cd08529 81 AENGDLHKLLKMQR--------------GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIG 143 (256)
T ss_pred CCCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEc
Confidence 99999999987532 246899999999999999999999988 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||+++....... ......|+..|+|||++.++.++.++|+||||+++|||++|+.|+........ ......
T Consensus 144 df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~- 215 (256)
T cd08529 144 DLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILKIIR- 215 (256)
T ss_pred ccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHc-
Confidence 9999887643322 12334578899999999999999999999999999999999999865432110 111110
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....+......+.+++.+||+.+|++||++.|++++
T Consensus 216 ~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 G---------VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C---------CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0 0112223445778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=334.36 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=201.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCC--CCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~--g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578889999999999999998543 368999987542 233456788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++++
T Consensus 110 ~Ey~~~g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----------------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred EeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCE
Confidence 9999999999988643 35899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....
T Consensus 171 kL~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i 240 (340)
T PTZ00426 171 KMTDFGFAKVVDTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKI 240 (340)
T ss_pred EEecCCCCeecCCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHH
Confidence 999999998654321 23468999999999998889999999999999999999999986543221 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
... . ...+......+.+++.+||+.||++|+ +++|+.++
T Consensus 241 ~~~---------~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 241 LEG---------I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred hcC---------C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 110 0 112233345678999999999999995 89888765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=332.49 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=199.5
Q ss_pred CCccCCcccccCcEEEEEEEc----CCCCEEEEEEcccc----ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCce
Q 039736 335 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAI----DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~----~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 405 (633)
+|+..+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999874 35789999987642 223345678899999999 599999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~ 141 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----------------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSE 141 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCC
Confidence 9999999999999988542 35899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
+.+||+|||+++..............||..|+|||.+.+. .++.++||||||+++|||++|+.||......... ...
T Consensus 142 ~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~ 219 (332)
T cd05614 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEV 219 (332)
T ss_pred CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHH
Confidence 9999999999986543333333345689999999999765 4788999999999999999999998643221110 001
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
...... .++ ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 220 SRRILK-------CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHhc-------CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011110 111 12233456788999999999999999 77788754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=324.69 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=206.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccC-hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
.++|...+.||+|+||.||++.. ..+..||||.++... ....+.+.+|+++++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45788899999999999999973 134579999887543 34456789999999999 79999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+.+|+|.++++.... ..+++.+++.++.|++.||+|||+++ ++|+||||+|||++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~ 176 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE--------------SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTH 176 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcC
Confidence 9999999999999999864321 24899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
++.+|++|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---- 252 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---- 252 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----
Confidence 999999999999876433221 1222345778999999999999999999999999999998 9999754332211
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
+..... .......+......+.+++.+||..+|++||++.|+++.|+++
T Consensus 253 --~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 --FYKLIK---------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111 1111111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=320.53 Aligned_cols=260 Identities=24% Similarity=0.445 Sum_probs=206.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..++||+|+||.||+|.+ .+|+ .||+|.++.. .....+++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5678889999999999999985 3444 4899988653 34446678899999999999999999999975 45789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---------------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNH 147 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 999999999999986532 35899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ...
T Consensus 148 ~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~-- 222 (279)
T cd05109 148 VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPD-- 222 (279)
T ss_pred EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence 9999999998764332211 122235678999999998899999999999999999998 888875432221 111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
..... .....+......+.+++.+||+.||++||++.|+++.|+++....+-
T Consensus 223 --~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 223 --LLEKG---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred --HHHCC---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 11111 01112233456788999999999999999999999999998876643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.84 Aligned_cols=276 Identities=25% Similarity=0.386 Sum_probs=211.1
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCceEEEEEEee
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLE 401 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~ 401 (633)
+...++|...++||+|+||.||+|++. .+..||||+++... ....+.+.+|+++|.++. ||||++++|.+..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 334457778899999999999999853 24589999987542 333457889999999997 9999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHH--------------------------------------------------
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQK-------------------------------------------------- 431 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~-------------------------------------------------- 431 (633)
.+..++|+||+++|+|.++++.........
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 889999999999999999997643210000
Q ss_pred --------------------------------HHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 432 --------------------------------QELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 432 --------------------------------~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
...........++|..+++++.|++.||+|||+.+ ++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 00000011246899999999999999999999988 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986532221 11223356788999999998889999999999999999998 888875432211
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
. .... +........+......+.+|+.+||+.+|.+||+++||++.|+++.
T Consensus 350 ~------~~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q------FYNA---------IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHH---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 0111 1111111223345578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=347.20 Aligned_cols=260 Identities=25% Similarity=0.358 Sum_probs=217.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCC-CEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEE-EEeeC------C
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDG-SIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLG-CCLET------E 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g-~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g-~~~~~------~ 403 (633)
..++++.+.|.+|||+.||.+....+ ..+|+|++-..++...+...+|+++|++|+ |+|||.+++ ..... -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34667788999999999999998766 999999998888889999999999999997 999999999 43321 2
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
+.+|.||||++|+|.|++..... ..|++.++++|+.|+++|+++||... |||||||||-+||||+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--------------~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--------------TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLS 180 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--------------ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEc
Confidence 46899999999999999976543 24999999999999999999999987 7799999999999999
Q ss_pred CCCcEEEeecCCCccCCCCC-ccee-------cccccCCCcCchhcc---ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 039736 484 DKFSAKVSDFGTSRSVPNDK-THLT-------TAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~-~~~~-------~~~~gt~~y~APE~l---~~~~~s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
.+++.||||||.+....... .... -...-|+-|.|||.+ .+..+++|+||||+||+||-|+....||+.
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~ 260 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEE 260 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCc
Confidence 99999999999986542211 1100 012368999999986 466799999999999999999999999853
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. .-..+++..+...-...+...|..||..||+.||.+||++-+|+..+.+|...+
T Consensus 261 s-------------------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 261 S-------------------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred C-------------------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 2 123455665555555688899999999999999999999999999999988765
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.33 Aligned_cols=255 Identities=23% Similarity=0.427 Sum_probs=206.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..+.||+|+||.||++...++..+|+|.++.. ....+.|.+|++++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 4578889999999999999999877888999987753 2345678999999999999999999999877 7789999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 83 AKGSLLDFLKSDE--------------GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred CCCcHHHHHHhCC--------------ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECC
Confidence 9999999986532 235889999999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||.+...............++..|+|||++..+.++.++|+||||+++|||++ |+.|+........ .. ....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~----~~~~ 218 (260)
T cd05073 146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IR----ALER 218 (260)
T ss_pred CcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HH----HHhC
Confidence 99998664333222223345678999999998889999999999999999999 8888754322111 11 1111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 219 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 219 ---------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---------CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111112233456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=329.97 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=202.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..++||+|+||.||++... +|..+|+|.+... .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368899999999999999999965 6788999987653 33445678999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|+++|+|.+++... ..+++.....++.+++.||.|||+. + ++||||||+|||++.++.+|
T Consensus 84 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~k 144 (333)
T cd06650 84 HMDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIK 144 (333)
T ss_pred cCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEE
Confidence 99999999998542 3588899999999999999999974 5 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH---
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI--- 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~--- 566 (633)
|+|||++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||................
T Consensus 145 L~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 221 (333)
T cd06650 145 LCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221 (333)
T ss_pred EeeCCcchhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCC
Confidence 99999997653221 123468899999999998889999999999999999999999986543221100000000
Q ss_pred ------------------HHHh----hchhhhhhchhhhcc---cC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 ------------------SLAK----ENKLLEILDARVAKE---AR-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ------------------~~~~----~~~~~~~~d~~l~~~---~~-~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ........+...... .+ .....++.+|+.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 222 PAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000 000000011000000 00 1134678999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=315.71 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=210.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|... +|+.||+|.++. .+....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999975 789999998753 23334668899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++..... ....+++.++++++.+++.||.|||+.+ ++||||+|+||+++.++.++
T Consensus 82 e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~ 146 (267)
T cd08224 82 ELADAGDLSRMIKHFKK------------QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVK 146 (267)
T ss_pred ecCCCCCHHHHHHHhcc------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEE
Confidence 99999999998854321 0235899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..... ..........
T Consensus 147 l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~ 221 (267)
T cd08224 147 LGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE 221 (267)
T ss_pred EeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhh
Confidence 999999876543221 12234578899999999988899999999999999999999999853321 1111111100
Q ss_pred hhchhhhhhchhhhcccCH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 570 KENKLLEILDARVAKEARE-EDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.......+. .....+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 222 ----------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 222 ----------KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----------cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001111222 44567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.01 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=204.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||++... +|+.||||+++... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999964 68999999986532 234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~k 141 (350)
T cd05573 81 EYMPGGDLMNLLIRK----------------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIK 141 (350)
T ss_pred cCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 999999999998653 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCC----------------------------cceecccccCCCcCchhccccCCCCcccchhhHHHHHH
Q 039736 490 VSDFGTSRSVPNDK----------------------------THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 541 (633)
Q Consensus 490 I~DfGla~~~~~~~----------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ 541 (633)
|+|||++....... ........||+.|+|||.+.+..++.++|||||||+||
T Consensus 142 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 221 (350)
T cd05573 142 LADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILY 221 (350)
T ss_pred eecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhh
Confidence 99999998764332 11123356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 039736 542 ELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-MKQVSMD 618 (633)
Q Consensus 542 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-~~ev~~~ 618 (633)
||++|+.||........ ...... +. ..+........+..+.+++.+|+. ||.+||+ +.|++++
T Consensus 222 ell~g~~Pf~~~~~~~~------~~~i~~------~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 222 EMLYGFPPFYSDTLQET------YNKIIN------WK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhccCCCCCCCCCHHHH------HHHHhc------cC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999999865432211 111111 00 001111111245778899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=348.38 Aligned_cols=261 Identities=27% Similarity=0.326 Sum_probs=207.9
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 403 (633)
.+.....++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++..++|+||+++.+.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 33445567999999999999999999984 47899999987642 3455667889999999999999999988775432
Q ss_pred --------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 404 --------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 404 --------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~------------~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDL 169 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAK------------TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDI 169 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhc------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 25799999999999999865322 1246899999999999999999999998 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 170 KP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 170 KSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred CHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999998654321 122234568999999999999999999999999999999999999986433
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+ .+..... .. ....+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 250 ~~~------~~~~~~~-~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 MEE------VMHKTLA-GR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHH------HHHHHhc-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 211 1111111 00 111233455779999999999999999999999864
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.34 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=208.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCC----CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 467788999999999999998643 2479999877644 4556789999999999999999999998865 557899
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~ 146 (270)
T cd05056 85 MELAPLGELRSYLQVNK---------------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCV 146 (270)
T ss_pred EEcCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCe
Confidence 99999999999986532 25899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++..............++..|+|||.+....++.++||||||+++|||++ |..||......+. ...
T Consensus 147 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~ 220 (270)
T cd05056 147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGR 220 (270)
T ss_pred EEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH
Confidence 999999998765443222223335568999999988889999999999999999996 9999865433221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ....+...+..+.+++.+|+..+|++|||+.|++..|+.++.+.
T Consensus 221 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 221 IENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred HHcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 11100 01123345578999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.72 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=197.1
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+..+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++...+..++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999995 4688999996432 35678999999999999999999999999999999998
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
. ++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|
T Consensus 166 ~-~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~D 225 (391)
T PHA03212 166 K-TDLYCYLAAK----------------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGD 225 (391)
T ss_pred C-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEe
Confidence 5 6887777442 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh----hhcHHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE----ERNLVAYFISL 568 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~----~~~l~~~~~~~ 568 (633)
||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.|+....... .......+...
T Consensus 226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred CCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 99997543322222334569999999999999899999999999999999999998875432110 00011111110
Q ss_pred Hhh----------chhhhhh---chhhh---ccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKE----------NKLLEIL---DARVA---KEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~----------~~~~~~~---d~~l~---~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..+.+.. ..... ... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0000000 00000 000 01235678899999999999999999999863
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=318.70 Aligned_cols=254 Identities=24% Similarity=0.476 Sum_probs=203.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CC---CEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g---~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.|+..+.||+|+||.||+|... ++ ..||||.++.. .....++|..|+.++++++||||+++.+++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999964 23 36999998754 3455678999999999999999999999999888999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 85 e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~k 146 (269)
T cd05065 85 EFMENGALDSFLRQND---------------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCK 146 (269)
T ss_pred ecCCCCcHHHHHhhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEE
Confidence 9999999999886532 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcc--eecccc--cCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 490 VSDFGTSRSVPNDKTH--LTTAVQ--GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~--~~~~~~--gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
|+|||++......... ...... .+..|+|||++.++.++.++||||||+++|||++ |..|+......+. ..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~- 222 (269)
T cd05065 147 VSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---IN- 222 (269)
T ss_pred ECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HH-
Confidence 9999998765432211 111111 2457999999999999999999999999999886 9999854332211 11
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
.. .. ......+.+++..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 223 --~i-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 223 --AI-EQ---------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HH-Hc---------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 00 011112334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.49 Aligned_cols=251 Identities=27% Similarity=0.430 Sum_probs=202.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-----hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...+.||+|++|.||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999985 468999999875421 2234578899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|+||+++++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||+++++++
T Consensus 82 v~e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~ 142 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----------------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGN 142 (263)
T ss_pred EEEECCCCcHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 99999999999988542 35889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
++|+|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ .
T Consensus 143 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~ 216 (263)
T cd06625 143 VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------I 216 (263)
T ss_pred EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------H
Confidence 99999999976533221111 234578899999999998899999999999999999999999853221110 0
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ........+......+.+++.+||..+|++|||+.|++.+
T Consensus 217 ~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 FKIA---------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHh---------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0110 0111122334455678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.82 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=201.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
..++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568889999999999999999964 6889999988642 22334567889999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.. ..++...+..++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 121 v~Ey~~gg~L~~~l~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ 180 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----------------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH 180 (370)
T ss_pred EEcCCCCCcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCC
Confidence 9999999999998853 24778888899999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+||+|||++...............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......
T Consensus 181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------ 254 (370)
T cd05596 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------ 254 (370)
T ss_pred EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------
Confidence 99999999987643332223345699999999998653 47889999999999999999999986543221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
.+........ .+........+..+.+|+.+||+.+|.+ ||++.|++.+
T Consensus 255 ~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 TYSKIMDHKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHcCCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111111100 0000111234567889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=315.94 Aligned_cols=249 Identities=26% Similarity=0.455 Sum_probs=201.7
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~LV~E~~ 412 (633)
++|...+.||+|+||.||++.. .|..||+|..+... ..+.|.+|+.++++++|+|++++++++.. ++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 58889999886532 34578899999999999999999998654 45689999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++..+++++.|++.||+|||+++ ++||||||+||++++++.+||+|
T Consensus 83 ~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~d 145 (256)
T cd05082 83 AKGSLVDYLRSRG--------------RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSD 145 (256)
T ss_pred CCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecC
Confidence 9999999986532 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++...... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+ .......
T Consensus 146 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~- 214 (256)
T cd05082 146 FGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEK- 214 (256)
T ss_pred CccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhc-
Confidence 99987653221 22334668999999998899999999999999999998 888875332211 1111110
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 215 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 215 ---------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111122334567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.45 Aligned_cols=255 Identities=26% Similarity=0.459 Sum_probs=204.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-C---CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-D---GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~---g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.+|+..+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++++++||||+++.+++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3379999886532 34456889999999999999999999999988999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++.++++++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 84 ~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 145 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---------------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVC 145 (267)
T ss_pred EEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeE
Confidence 99999999999986432 35899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||++........... ....++..|+|||.+.++.++.++||||||+++||+++ |+.|+......+. .
T Consensus 146 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~------~ 219 (267)
T cd05066 146 KVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV------I 219 (267)
T ss_pred EeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH------H
Confidence 9999999987644322211 11223568999999998899999999999999999887 9999854332211 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
... .+. .....+...+..+.+++.+||+.+|.+||+|.++++.|.++
T Consensus 220 ~~~-~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 220 KAI-EEG---------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHH-hCC---------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 110 01112233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.60 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=195.4
Q ss_pred CcccccCcEEEEEEEc----CCCCEEEEEEcccc----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGML----PDGSIVAVKRSRAI----DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+.||+|+||.||++.. .+++.||||.++.. .......+.+|+++++.++||||+++++.+..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 35789999988642 123345678899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~ 142 (323)
T cd05584 82 LSGGELFMHLERE----------------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLT 142 (323)
T ss_pred CCCchHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEe
Confidence 9999999888542 35788889999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||+++....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .......
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~- 214 (323)
T cd05584 143 DFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILK- 214 (323)
T ss_pred eCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHc-
Confidence 9999875432221 2233568999999999998889999999999999999999999986433221 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.. ...+......+.+++.+||+.||++|| ++.+++.+
T Consensus 215 --------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 215 --------GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --------CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 10 122333456788999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.37 Aligned_cols=272 Identities=25% Similarity=0.426 Sum_probs=204.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCC---------------CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD---------------GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLG 397 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~---------------g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g 397 (633)
++|+..+.||+|+||.||++...+ ...||+|.++.. .....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 235899988753 3445567999999999999999999999
Q ss_pred EEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 398 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
++...+..++||||+++++|.+++........ .........++|..+++++.|++.||+|||+++ ++||||||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIEST----FTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhcccccc----ccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 99999999999999999999999864321000 000011235789999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh--CCCCCCCCc
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICLTR 554 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt--G~~p~~~~~ 554 (633)
+||++++++.+||+|||++......... ......++..|+|||.+.++.++.++||||||+++|||++ |..|+....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999999999865332221 1222345778999999998999999999999999999998 556664433
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.+.. .......... .+.......+...+..+.+|+.+||+.||++||++.+|++.|.+
T Consensus 238 ~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 238 DEQV---IENTGEFFRN------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred hHHH---HHHHHHhhhh------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2221 1100000100 00000111122345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.86 Aligned_cols=264 Identities=27% Similarity=0.448 Sum_probs=208.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888999999999999999863 23689999986543 34456788999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++........ .......++|..++.++.|++.||.|||+.+ ++||||||+||+++++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~ 155 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAE------NNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAED 155 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchh------hccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCC
Confidence 999999999999999965432110 0011346899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
+.+||+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+. .
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~- 231 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV---L- 231 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---H-
Confidence 9999999999986543221 12223346789999999998889999999999999999998 8888754332221 1
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.. ..... ....+...+..+.+++.+||+.+|++|||+.|++..|++
T Consensus 232 --~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 --KF-VIDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --HH-HhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11 11110 112233446789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.12 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=202.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.+++.++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999954 6889999998753 2234557889999999999999999999999989999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 e~~~~~~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~k 142 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---------------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIK 142 (330)
T ss_pred CCCCCCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEE
Confidence 9999999999986532 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
|+|||++...............||+.|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 143 L~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------ 216 (330)
T cd05601 143 LADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------ 216 (330)
T ss_pred eccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------
Confidence 9999999876544333334456899999999986 4567889999999999999999999986433221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+........... ..........+.+|+..|++ +|++||++.+++.+
T Consensus 217 ~~~~i~~~~~~~~-------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 217 TYNNIMNFQRFLK-------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHHcCCCccC-------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 1111111111000 01112245678899999997 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.04 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=203.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
..|...+.||+|+||.||++.+ .++..||+|.++... ....+.+.+|+.++++++|+||+++.+++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 357889999987543 34456899999999999999999999998875 467
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++++|.+++... ...++|..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~ 145 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---------------KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 145 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCC
Confidence 9999999999999998543 135899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchh-------
Q 039736 486 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE------- 556 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~------- 556 (633)
+.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++++.|.......
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~ 225 (284)
T cd05079 146 HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225 (284)
T ss_pred CCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccc
Confidence 99999999999876433221 112344677899999998888999999999999999999987764321100
Q ss_pred --hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 557 --EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 557 --~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
....... ... .+........+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 226 THGQMTVTR-LVR---------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccHHH-HHH---------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 000 0111111122334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.34 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=202.2
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999953 68899999886532 1223467889999999999999999999998889999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 81 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l 143 (285)
T cd05605 81 LMNGGDLKFHIYNMG--------------NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRI 143 (285)
T ss_pred ccCCCcHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEE
Confidence 999999998875421 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+...
T Consensus 144 ~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~-- 216 (285)
T cd05605 144 SDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERR-- 216 (285)
T ss_pred eeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHH--
Confidence 99999987543222 12346899999999999889999999999999999999999998653322110 001000
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
+. .....++...+..+.+|+.+||+.||++|| ++.+++.+
T Consensus 217 -------~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 -------VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -------hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00 011223344567789999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.16 Aligned_cols=252 Identities=29% Similarity=0.476 Sum_probs=202.7
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.+|+..+.||+|+||.||++.+.++..+|+|.++.... ...+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777899999999999999987788999998765322 23578899999999999999999999998889999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..+++..++.++.+++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 83 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 144 (256)
T cd05112 83 HGCLSDYLRAQR---------------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDF 144 (256)
T ss_pred CCcHHHHHHhCc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCC
Confidence 999999886432 35889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++..............++.+|+|||.+.++.++.++||||||+++|||++ |+.|+......+ ........
T Consensus 145 g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~- 217 (256)
T cd05112 145 GMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAG- 217 (256)
T ss_pred cceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCC-
Confidence 9998654332221222335678999999998899999999999999999998 898875433221 11111110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
.....+...+..+.+|+.+||+.+|++||++.|+++.|.
T Consensus 218 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 218 ---------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 000111223467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.44 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=195.4
Q ss_pred CcccccCcEEEEEEEcC----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCceEEEEeecc
Q 039736 340 RFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLVYEYIS 413 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~LV~E~~~ 413 (633)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999987543 34556788999999999999999999998764 556899999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+||
T Consensus 81 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~df 142 (262)
T cd05058 81 HGDLRNFIRSET---------------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADF 142 (262)
T ss_pred CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCc
Confidence 999999986532 24788889999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcc---eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCchhhhhcHHHHHHHHH
Q 039736 494 GTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 494 Gla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~-p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+++........ ......++..|+|||.+.+..++.++||||||+++|||++|+. |+......+ ... ...
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~---~~~ 216 (262)
T cd05058 143 GLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV---YLL 216 (262)
T ss_pred cccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHh
Confidence 999865332211 1122345778999999988899999999999999999999654 443221111 111 111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
... ....+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 217 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 217 QGR----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred cCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 100 011122334678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.98 Aligned_cols=248 Identities=28% Similarity=0.478 Sum_probs=198.7
Q ss_pred CcccccCcEEEEEEEcC--C--CCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP--D--GSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~--~--g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
++||+|+||.||+|++. + +..+|+|.+..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999853 2 26899998875433 34567899999999999999999999876 4567999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 80 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~ 140 (257)
T cd05060 80 GPLLKYLKKR----------------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFG 140 (257)
T ss_pred CcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEecccc
Confidence 9999998653 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceec--ccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 495 TSRSVPNDKTHLTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 495 la~~~~~~~~~~~~--~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
+++........... ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .... ...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~----~~~ 213 (257)
T cd05060 141 MSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM----LES 213 (257)
T ss_pred ccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHc
Confidence 99876433322211 1224568999999999999999999999999999998 999985433221 1111 111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
. .....+...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 214 ~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 G---------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1 011223345578899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.68 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=197.1
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 46789999998653 23445678999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||
T Consensus 82 ~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL 142 (381)
T cd05626 82 YIPGGDMMSLLIRM----------------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKL 142 (381)
T ss_pred cCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEE
Confidence 99999999998643 35888899999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCc----------------------------------------------ceecccccCCCcCchhcccc
Q 039736 491 SDFGTSRSVPNDKT----------------------------------------------HLTTAVQGTFGYFDPEYFQS 524 (633)
Q Consensus 491 ~DfGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~APE~l~~ 524 (633)
+|||+++....... .......||..|+|||.+.+
T Consensus 143 ~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (381)
T cd05626 143 TDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222 (381)
T ss_pred eeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC
Confidence 99999764311000 00123469999999999998
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHh--cc
Q 039736 525 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMG--CL 602 (633)
Q Consensus 525 ~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~--Cl 602 (633)
..++.++|||||||++|||++|+.||......+.. ....... ..+..........++.+|+.+ |+
T Consensus 223 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 223 KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHH------HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccC
Confidence 88999999999999999999999999654332210 0111000 000011111234566777776 55
Q ss_pred ccCCCCCCCHHHHHHH
Q 039736 603 RLNSKKRPTMKQVSMD 618 (633)
Q Consensus 603 ~~dP~~RPt~~ev~~~ 618 (633)
..++..||++.|++.+
T Consensus 290 ~~~~~~R~~~~~~l~h 305 (381)
T cd05626 290 AEERLGRNGADDIKAH 305 (381)
T ss_pred cccccCCCCHHHHhcC
Confidence 6677779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.70 Aligned_cols=263 Identities=23% Similarity=0.345 Sum_probs=197.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999965 688999998865322 223467789999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++ ++|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~-~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 144 (303)
T cd07869 84 YVH-TDLCQYMDKH---------------PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKL 144 (303)
T ss_pred CCC-cCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEE
Confidence 996 6787777543 235888999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 145 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 221 (303)
T cd07869 145 ADFGLARAKSVPSH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVL 221 (303)
T ss_pred CCCCcceeccCCCc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHh
Confidence 99999875432221 1223457899999999865 457889999999999999999999996532211 1111111111
Q ss_pred hhchhh--------hhhch---------hhhccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 570 KENKLL--------EILDA---------RVAKEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 570 ~~~~~~--------~~~d~---------~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...... ...++ .+.... .......+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00000 000000 0012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=334.46 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=200.4
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
....++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334568999999999999999999964 5789999987542 223345678999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----------------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~ 178 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----------------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKH 178 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCC
Confidence 999999999999998853 24788889999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+.+||+|||++...............||+.|+|||.+.+. .++.++||||||++||||++|+.||......+
T Consensus 179 ~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---- 254 (370)
T cd05621 179 GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---- 254 (370)
T ss_pred CCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----
Confidence 9999999999987643332223345699999999998653 37889999999999999999999996543221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
.+........ .+...........+.+++..|+..++.+ ||++.|++++
T Consensus 255 --~~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 255 --TYSKIMDHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHHHhCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111100 0000111233566788899999755543 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=325.39 Aligned_cols=275 Identities=26% Similarity=0.395 Sum_probs=209.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC--------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~--------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||++... ....+|+|.++.. ......++.+|+++++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999731 2457999987753 334566789999999999 699999999999988
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..++++||+++|+|.+++.....................++|.++++++.|++.||.|||+++ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 8999999999999999999654321000000000001236899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
++++.+||+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..|+......+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-- 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-- 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998764322111 112234567999999998899999999999999999999 8888754332211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+. ..... .....+...+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 246 ----~~-~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 ----FK-LLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ----HH-HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 11111 011223344567889999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=334.60 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=199.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +|+.||||+++.. .......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 6899999998653 2234556888999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 E~~~~g~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~k 141 (364)
T cd05599 81 EYLPGGDMMTLLMKK----------------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIK 141 (364)
T ss_pred CCCCCcHHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEE
Confidence 999999999998642 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcc-------------------------------------eecccccCCCcCchhccccCCCCcccc
Q 039736 490 VSDFGTSRSVPNDKTH-------------------------------------LTTAVQGTFGYFDPEYFQSSQYTDKSD 532 (633)
Q Consensus 490 I~DfGla~~~~~~~~~-------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksD 532 (633)
|+|||++......... ......||+.|+|||++....++.++|
T Consensus 142 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 221 (364)
T cd05599 142 LSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221 (364)
T ss_pred EeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeee
Confidence 9999998754221100 011245899999999999999999999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-
Q 039736 533 VYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT- 611 (633)
Q Consensus 533 V~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt- 611 (633)
||||||++|||++|..||......+. ........ ..+...........+.+++.+|+. +|.+|++
T Consensus 222 iwSlG~il~el~~G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 222 WWSLGVIMYEMLVGYPPFCSDNPQET------YRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred eecchhHHHHhhcCCCCCCCCCHHHH------HHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 99999999999999999865432211 11111100 000001111234567889999996 9999998
Q ss_pred --HHHHHHH
Q 039736 612 --MKQVSMD 618 (633)
Q Consensus 612 --~~ev~~~ 618 (633)
+.|++.+
T Consensus 288 ~~~~~ll~h 296 (364)
T cd05599 288 NGVNEIKSH 296 (364)
T ss_pred CCHHHHhcC
Confidence 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.00 Aligned_cols=267 Identities=25% Similarity=0.413 Sum_probs=206.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
..++|+..+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24589999876433 3344578899999999999999999999998889
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++........ .......+++..+.+++.|++.||.|||+++ ++||||||+||++++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAE------NNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccc------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 9999999999999999975332100 0011245688899999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+.....++
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~----- 229 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----- 229 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999999865332211 1122235678999999999999999999999999999999 777875432221
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
........+ . ...+......+.+++.+||+.||++|||+.|+++.|....
T Consensus 230 -~~~~~~~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 -VLKFVMDGG-Y---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -HHHHHHcCC-C---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111110 0 1122334578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.05 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=213.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-eEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-PVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-~~LV~ 409 (633)
++|...+++|+|+||.++..+.+ ++..+++|++.. ......+...+|+.++++++|||||.+.+.+.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999877743 677899998654 334445578899999999999999999999999998 99999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
+|++||+|.+.+...+. ..++.+.++.|+.|++.|+.|||+.. |+|||||+.|||++.+..+|
T Consensus 84 ~Y~eGg~l~~~i~~~k~--------------~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~Vk 146 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG--------------VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVK 146 (426)
T ss_pred eecCCCCHHHHHHHHhh--------------ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCcee
Confidence 99999999999976542 46889999999999999999999888 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+.+..+. .....+.||+.||.||.+.+..|..|+||||+||++|||++-+++|...+..+ .....
T Consensus 147 LgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki- 218 (426)
T KOG0589|consen 147 LGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKI- 218 (426)
T ss_pred ecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHH-
Confidence 99999999986554 34456789999999999999999999999999999999999999986543222 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.+......+..+..++..|+..|++.+|..||++.+++.+-
T Consensus 219 ---------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 219 ---------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ---------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 11123455677888999999999999999999999999873
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.34 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=194.7
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHH---hccCCCCceEEEEEEeeCCceEEE
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVIL---SQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il---~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
|+..+.||+|+||.||++... +|+.||||+++.. .....+.+.+|++++ ++++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999864 6899999998643 223345666776654 567899999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|..++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 81 ~E~~~~~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~ 140 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----------------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFV 140 (324)
T ss_pred EcCCCCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcE
Confidence 999999999877743 35899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 141 kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i 213 (324)
T cd05589 141 KIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSI 213 (324)
T ss_pred EeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 999999987542221 122345689999999999999999999999999999999999999865433221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.... ...+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 214 VNDE-----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HhCC-----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1100 112333456788999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=334.52 Aligned_cols=261 Identities=23% Similarity=0.303 Sum_probs=199.4
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 406 (633)
+|+..+.||+|+||.||++.. .+|+.||||++... +....+++.+|+++++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 47899999988642 3344567889999999999999999999998766 689
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++
T Consensus 81 lv~e~~~-~~l~~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~ 140 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----------------PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNC 140 (372)
T ss_pred EEeeccc-cCHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCC
Confidence 9999997 577776643 236899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+++..............++..|+|||.+.+. .++.++|||||||++|||++|+.||......... ..+
T Consensus 141 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i 217 (372)
T cd07853 141 VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL---DLI 217 (372)
T ss_pred CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH---HHH
Confidence 999999999986543332223334578999999998774 4789999999999999999999999655432211 111
Q ss_pred HHHHhhchh----------hhhhchhh--------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKL----------LEILDARV--------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~----------~~~~d~~l--------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ...+.... ...........+.+|+.+||+.||++|||+.|++.+
T Consensus 218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 111110000 00000000 001112235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.64 Aligned_cols=272 Identities=26% Similarity=0.430 Sum_probs=207.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC-----------------CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD-----------------GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVK 394 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~-----------------g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~ 394 (633)
..+|+..+.||+|+||.||++...+ +..||+|.+... .....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988532 246899988754 3445678999999999999999999
Q ss_pred EEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 395 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+++++..++..++++||+++++|.+++.......... ......+++..++.++.|++.||.|||+++ ++|||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~d 155 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-----ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRD 155 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-----cccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccc
Confidence 9999999999999999999999999986543210000 001236899999999999999999999998 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh--CCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPIC 551 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt--G~~p~~ 551 (633)
|||+||++++++.++|+|||+++....... .......++..|+|||.+..+.++.++||||||+++|||++ |..|+.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999986533222 22233456789999999998899999999999999999998 666764
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
...... ............ +.......+...+.++.+++.+||+.||++|||+.||++.|++
T Consensus 236 ~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 236 HLTDQQ---VIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CcChHH---HHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 322211 111111111110 0111111223345689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.54 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=196.2
Q ss_pred CcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||++.. .+|+.||+|.++.. .......+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999988652 2334567788999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
+|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg 141 (325)
T cd05594 81 ELFFHLSRE----------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG 141 (325)
T ss_pred cHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCC
Confidence 998887542 358999999999999999999997 67 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++....... ......||+.|+|||++.++.++.++||||||+++|||++|+.||.....+.. .......
T Consensus 142 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~--- 211 (325)
T cd05594 142 LCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME--- 211 (325)
T ss_pred CCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcC---
Confidence 9875432221 12234689999999999999999999999999999999999999865432221 1111000
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
....+......+.+++.+||+.||++|+ ++.+++++
T Consensus 212 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 --------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0112333456788999999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=310.64 Aligned_cols=247 Identities=28% Similarity=0.493 Sum_probs=200.1
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCch
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLS 418 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 418 (633)
++||+|+||.||++...+++.||+|..+.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 47999999999999987799999998776433 35668999999999999999999999999999999999999999999
Q ss_pred hhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 419 HHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 419 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
+++.... ..+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++..
T Consensus 81 ~~l~~~~---------------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 81 TFLRKKK---------------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccc
Confidence 9986432 25889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCccee-cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhh
Q 039736 499 VPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLE 576 (633)
Q Consensus 499 ~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (633)
......... .....+..|+|||.+.++.++.++|+||||+++|||++ |..|+......... .
T Consensus 143 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~--------- 206 (251)
T cd05041 143 EEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------E--------- 206 (251)
T ss_pred ccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------H---------
Confidence 542221111 11234567999999998899999999999999999999 78887543322110 0
Q ss_pred hhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 577 ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 577 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
.+........+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 207 RIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 01111111223344568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=315.17 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=205.3
Q ss_pred HHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 328 el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
|++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|++++++++|+||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34566778888889999999999999954 67889999887766666778999999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL--SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~ 143 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---------------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNT 143 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---------------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcC
Confidence 9999999999999986532 234 78888999999999999999998 999999999999986
Q ss_pred -CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 485 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 485 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
++.+||+|||++........ ......++..|+|||++.... ++.++||||||+++|||++|+.|+.........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-- 220 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-- 220 (268)
T ss_pred CCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--
Confidence 67999999999876533221 122235789999999986644 788999999999999999999998532211100
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... .......+......+.+++.+||+.+|++|||+.|++.+
T Consensus 221 --~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 221 --MFKVGM----------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --Hhhhhh----------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 001112334455678999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=330.96 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=195.2
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68899999986532 233457888999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++++|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vk 141 (363)
T cd05628 81 EFLPGGDMMTLLMKK----------------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVK 141 (363)
T ss_pred cCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEE
Confidence 999999999998642 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCc----------------------------------ceecccccCCCcCchhccccCCCCcccchhh
Q 039736 490 VSDFGTSRSVPNDKT----------------------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 535 (633)
Q Consensus 490 I~DfGla~~~~~~~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~S 535 (633)
|+|||+++....... .......||+.|+|||.+.+..++.++||||
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS 221 (363)
T cd05628 142 LSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (363)
T ss_pred EeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh
Confidence 999999875432110 0012346999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccc--cCCCCCCCHH
Q 039736 536 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLR--LNSKKRPTMK 613 (633)
Q Consensus 536 fGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~--~dP~~RPt~~ 613 (633)
|||++|||++|+.||......+. +........ .. .+... ......+.+++.+++. .++..||++.
T Consensus 222 lGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~~--~~---~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ 288 (363)
T cd05628 222 LGVIMYEMLIGYPPFCSETPQET------YKKVMNWKE--TL---IFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVE 288 (363)
T ss_pred hHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCcC--cc---cCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHH
Confidence 99999999999999965432221 111111000 00 00000 1123455666665433 3444679999
Q ss_pred HHHHH
Q 039736 614 QVSMD 618 (633)
Q Consensus 614 ev~~~ 618 (633)
||+++
T Consensus 289 ei~~h 293 (363)
T cd05628 289 EIKTN 293 (363)
T ss_pred HHhCC
Confidence 99886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.14 Aligned_cols=275 Identities=26% Similarity=0.409 Sum_probs=206.1
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccC-hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC-
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE- 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~- 403 (633)
.++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999973 346789999987532 33456788999999999 6899999999887554
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHH---------------------H------------------------------H
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQ---------------------K------------------------------Q 432 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~---------------------~------------------------------~ 432 (633)
..+++|||+++|+|.++++........ . .
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 578999999999999998653210000 0 0
Q ss_pred HHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccc
Q 039736 433 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQ 511 (633)
Q Consensus 433 ~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~ 511 (633)
.-........++|.++.+++.|+++||+|||+++ |+||||||+||++++++++||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0000001235899999999999999999999998 999999999999999999999999999865332211 112234
Q ss_pred cCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHH
Q 039736 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREED 590 (633)
Q Consensus 512 gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 590 (633)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ +.....++. ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~---------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGT---------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccC---------CCCCCCCC
Confidence 5678999999988899999999999999999997 8888754322111 111111110 01111223
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 591 IEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 591 ~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
...+.+++..||+.||++||++.||+++|+.+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 45689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.21 Aligned_cols=271 Identities=26% Similarity=0.420 Sum_probs=207.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-----CCCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEee--CCce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLE--TEVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-----~g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~ 405 (633)
+.|...+.||+|+||.||++.+. ++..+|||.++..... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3678999998765443 56789999999999999999999999887 4578
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
+++|||+++|+|.+++.... ..++|..++.++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---------------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~ 145 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---------------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESE 145 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---------------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCC
Confidence 99999999999999986542 25899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.++|+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.............
T Consensus 146 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 225 (284)
T cd05038 146 DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI 225 (284)
T ss_pred CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc
Confidence 999999999998775332211 112335567999999988899999999999999999999999875432211000000
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.........+.+.+........+..++..+.+|+.+||+.+|++|||+.||+++|+.+.
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 226 -AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred -ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 00000000111111111112223344578999999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.87 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=195.2
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999988752 233455678899888876 899999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG 141 (329)
T cd05618 81 GDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 141 (329)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCC
Confidence 9998887542 36899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh--hhcHHHHHHHHHhhc
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNLVAYFISLAKEN 572 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~ 572 (633)
+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||....... ......+........
T Consensus 142 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 220 (329)
T cd05618 142 MCKEGLRPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220 (329)
T ss_pred ccccccCCCC-ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC
Confidence 9975422211 1233568999999999999999999999999999999999999985321111 111111111111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT------MKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt------~~ev~~~ 618 (633)
....+......+.+++.+||+.||++||+ +.+++.+
T Consensus 221 ----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 ----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 01233445567889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.03 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=201.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4788899999999999999995 468899999987654455567889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.++++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 89 ~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~d 149 (267)
T cd06646 89 GGGSLQDIYHVT----------------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLAD 149 (267)
T ss_pred CCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECc
Confidence 999999988542 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.|+......+... . .
T Consensus 150 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~-~ 221 (267)
T cd06646 150 FGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-M 221 (267)
T ss_pred Cccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------e-e
Confidence 999986532211 122345788999999884 4457889999999999999999999975322111100 0 0
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.... ...+... .....+..+.+++.+||+.+|++||++++++++|
T Consensus 222 ~~~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 SKSN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ecCC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000 0001110 0122346789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.34 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=196.6
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||+||++... +|+.||+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 68899999876422 22345678899999999999999999999998899999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 145 (280)
T cd05608 81 RYHIYNVDE------------ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAV 145 (280)
T ss_pred HHHHHhccc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccce
Confidence 888754221 1246899999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ..
T Consensus 146 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~---------~~ 213 (280)
T cd05608 146 ELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQ---------RI 213 (280)
T ss_pred ecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHH---------hh
Confidence 6543322 123346899999999999999999999999999999999999998643221110 00000 00
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
... ....+...+..+.+++.+||+.||++|| +++|++.+
T Consensus 214 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 214 LND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111 0122344567789999999999999999 77777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=311.73 Aligned_cols=248 Identities=26% Similarity=0.472 Sum_probs=200.3
Q ss_pred CcccccCcEEEEEEEcCC--C--CEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLPD--G--SIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~--g--~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+++.+|+.++++++|+||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 2699999877555 567789999999999999999999999988 888999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++..... ..++|...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 80 ~~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg 142 (257)
T cd05040 80 GSLLDRLRKDAL--------------GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFG 142 (257)
T ss_pred CcHHHHHHhccc--------------ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccc
Confidence 999999865321 36899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 495 TSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 495 la~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+......+. .. .....
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~---~~~~~ 216 (257)
T cd05040 143 LMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LK---KIDKE 216 (257)
T ss_pred ccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHhc
Confidence 99876442221 1123457789999999999899999999999999999999 9999854322211 11 11100
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
. .....+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 217 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 G---------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C---------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 001122334567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.01 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=195.3
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|... +++.||||+++.. .....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5789999988652 233455678899998876 799999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg 141 (321)
T cd05591 81 GDLMFQIQRS----------------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFG 141 (321)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecc
Confidence 9998888542 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~-- 212 (321)
T cd05591 142 MCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDD-- 212 (321)
T ss_pred cceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC--
Confidence 987543222 122345689999999999998999999999999999999999999965443221 11111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-------TMKQVSMD 618 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-------t~~ev~~~ 618 (633)
...+......+.+++.+||+.||++|| ++.+++++
T Consensus 213 ---------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 ---------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011222346788999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.27 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=196.1
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||+|.++.. .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 6889999998752 233455688899999998 799999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~~~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg 141 (329)
T cd05588 81 GDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYG 141 (329)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCc
Confidence 9998887542 36999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh--hhcHHHHHHHHHhhc
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--ERNLVAYFISLAKEN 572 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~ 572 (633)
+++...... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+ ......+........
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 220 (329)
T cd05588 142 MCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220 (329)
T ss_pred cccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC
Confidence 987532211 12233568999999999999999999999999999999999999986422111 111111111111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC------HHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT------MKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt------~~ev~~~ 618 (633)
. ...+......+.+++.+||+.||.+||+ +.+++++
T Consensus 221 --------~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 221 --------Q--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0 1123334567899999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.62 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=204.1
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999985 468899999887655555678899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 100 ~~~~L~~~~~~-----------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~d 159 (296)
T cd06654 100 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 159 (296)
T ss_pred CCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECc
Confidence 99999998843 24789999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++......... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||........ . . ......
T Consensus 160 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~---~-~~~~~~ 232 (296)
T cd06654 160 FGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L---Y-LIATNG 232 (296)
T ss_pred cccchhccccccc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H---H-HHhcCC
Confidence 9998865332211 1234578899999999988899999999999999999999999864432111 0 0 000000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......+......+.+++.+||..||++||++.|++.+
T Consensus 233 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 --------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00011223345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=317.75 Aligned_cols=270 Identities=25% Similarity=0.421 Sum_probs=206.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|+..+.||+|+||.||++... ++..||+|.+.... ....++|.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999887543 34456789999999999999999999999998899
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHH------HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQE------LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~------~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
++++||+++|+|.+++............ .........+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 9999999999999999754321100000 000011235899999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
|++++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876532221 11122234667999999998899999999999999999998 877875332221
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.. .....+.. ...+...+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 241 ------~~-~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ------VI-YYVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HH-HHHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 11111111 11223345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.01 Aligned_cols=271 Identities=25% Similarity=0.442 Sum_probs=205.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC-----------------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-----------------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKL 395 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-----------------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l 395 (633)
++|+..+.||+|+||.||++... ++..||+|.++.. .....++|.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57888999999999999998532 2347999998753 34445689999999999999999999
Q ss_pred EEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
++++...+..++||||+++|+|.+++......... .......+++.+++.++.|++.||+|||+.+ ++||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-----EKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-----ccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 99999999999999999999999998764321100 0111235889999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh--CCCCCCC
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT--GKKPICL 552 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt--G~~p~~~ 552 (633)
||+|||++.++.++|+|||+++........ ......++..|+|||....+.++.++||||||+++|||++ |..|+..
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999865333221 1122334678999999888889999999999999999998 6677653
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
....+.. .......... ........+..++..+.+|+.+||+.||++||++.||.+.|++
T Consensus 237 ~~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LSDEQVI---ENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cChHHHH---HHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3222210 0000000000 0000111123345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.03 Aligned_cols=275 Identities=27% Similarity=0.388 Sum_probs=210.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC--------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 403 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 403 (633)
.+|...+.||+|+||.||++... .+..||+|.++.. .....+++.+|+++++++ +|+||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999732 1236999987753 334567899999999999 7999999999999988
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++++||+++|+|.+++.....................++|.++++++.|++.||.|||+++ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 999999999999999998754211000000000011246899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l 561 (633)
+++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 9999999999999866432211 1122334567999999999999999999999999999998 888875433222
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
...... .. ...+.+......+.+++.+||+.+|++||++.|++..|+++.....
T Consensus 245 --~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 --LFKLLK-EG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --HHHHHH-cC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 111111 11 1112233445678999999999999999999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=310.21 Aligned_cols=255 Identities=32% Similarity=0.516 Sum_probs=204.5
Q ss_pred CcccccCcEEEEEEEcCC----CCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLPD----GSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++.... +..|++|.++..... ..+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999753 789999998765433 367889999999999999999999999998899999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++....... .......+++..+++++.|++.||+|||+++ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg 150 (262)
T cd00192 81 GDLLDYLRKSRPVF-------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFG 150 (262)
T ss_pred CcHHHHHhhccccc-------cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccc
Confidence 99999987642100 0000146999999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 495 TSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 495 la~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
.+........ .......++..|+|||.+....++.++||||+|+++|||++ |..|+......+ .... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~- 222 (262)
T cd00192 151 LSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEY-LRK- 222 (262)
T ss_pred cccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHH-HHc-
Confidence 9987754321 12233457889999999998889999999999999999999 688886542221 1111 111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
......+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111233444678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.18 Aligned_cols=241 Identities=25% Similarity=0.394 Sum_probs=191.6
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999988652 223344566677777654 899999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg 141 (316)
T cd05592 81 GDLMFHIQSS----------------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCc
Confidence 9999888542 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +......
T Consensus 142 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~--- 211 (316)
T cd05592 142 MCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSILND--- 211 (316)
T ss_pred CCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcC---
Confidence 997643222 222345689999999999998999999999999999999999999865433211 1111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 617 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~-ev~~ 617 (633)
....+......+.+++.+||+.||++||++. ++.+
T Consensus 212 --------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 --------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1112333456788999999999999999975 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.58 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=197.1
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999999985 47899999987542 2334567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~k 141 (377)
T cd05629 81 EFLPGGDLMTMLIKY----------------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIK 141 (377)
T ss_pred eCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEE
Confidence 999999999988642 35888999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCc----------------------------------------------ceecccccCCCcCchhccc
Q 039736 490 VSDFGTSRSVPNDKT----------------------------------------------HLTTAVQGTFGYFDPEYFQ 523 (633)
Q Consensus 490 I~DfGla~~~~~~~~----------------------------------------------~~~~~~~gt~~y~APE~l~ 523 (633)
|+|||+++....... .......||+.|+|||.+.
T Consensus 142 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (377)
T cd05629 142 LSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221 (377)
T ss_pred EeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHc
Confidence 999999963311000 0001245899999999999
Q ss_pred cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccc
Q 039736 524 SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLR 603 (633)
Q Consensus 524 ~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~ 603 (633)
+..++.++|||||||++|||++|+.||......+. +........ .+...........+.+|+.+|+.
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 222 QQGYGQECDWWSLGAIMFECLIGWPPFCSENSHET------YRKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred cCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc
Confidence 98999999999999999999999999865433211 111111000 00000011234568899999997
Q ss_pred cCCCCC---CCHHHHHHH
Q 039736 604 LNSKKR---PTMKQVSMD 618 (633)
Q Consensus 604 ~dP~~R---Pt~~ev~~~ 618 (633)
+|.+| +++.|++.+
T Consensus 289 -~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 289 -NAENRLGRGGAHEIKSH 305 (377)
T ss_pred -CHhhcCCCCCHHHHhcC
Confidence 66665 699998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=324.40 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=197.2
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCC-CceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHR-HIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~-nIv~l~g~~~~~~~~~LV~ 409 (633)
+|+..+.||+|+||.||+|... +++.||||+++.. .....+.+..|+++++.++|+ +|+++.+++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999964 5779999988642 234456788899999999765 5888999998888999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 81 E~~~~g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~k 141 (324)
T cd05587 81 EYVNGGDLMYHIQQV----------------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIK 141 (324)
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEE
Confidence 999999999888542 35889999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... ......||..|+|||++.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 142 L~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~ 214 (324)
T cd05587 142 IADFGMCKENIFGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQSIM 214 (324)
T ss_pred EeecCcceecCCCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999875322111 12335689999999999999999999999999999999999999865432211 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM-----KQVSM 617 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~-----~ev~~ 617 (633)
. . ....+......+.+++.+||+.||.+|++. .++.+
T Consensus 215 ~---------~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 215 E---------H--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred c---------C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 0 112233445678899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.44 Aligned_cols=239 Identities=23% Similarity=0.406 Sum_probs=188.7
Q ss_pred cccccCcEEEEEEEcCC-------------------------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEE
Q 039736 341 FLGQGGFGTVYKGMLPD-------------------------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL 395 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~~~-------------------------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l 395 (633)
+||+|+||.||+|.+.. ...|++|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13589998876555556688999999999999999999
Q ss_pred EEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
++++.+....++||||+++|+|..++... ...+++..+++++.|+++||+|||+.+ ++||||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 143 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---------------KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNV 143 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCC
Confidence 99999999999999999999999888543 236889999999999999999999998 999999
Q ss_pred CCCCeeecCCC-------cEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHH-hC
Q 039736 476 KSSNILLDDKF-------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELL-TG 546 (633)
Q Consensus 476 k~~NILl~~~~-------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~ell-tG 546 (633)
||+|||++.++ .+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999998643 48999999986542221 1246788999998875 56889999999999999995 68
Q ss_pred CCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 547 KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 547 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
+.|+......+. ...+ . .. ...+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 ~~p~~~~~~~~~---~~~~----~---------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 219 EVPLKERTPSEK---ERFY----E---------KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred CCCccccChHHH---HHHH----H---------hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 888754322211 0000 0 00 0111122346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=314.04 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=207.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.+|+..+.||+|+||.||+|... +|+ .+|+|...... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46777899999999999999864 333 68999876543 3455688999999999999999999999987 78899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|+||+++|+|.+++.... ..+++..+++++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---------------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQH 147 (279)
T ss_pred EEecCCCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCe
Confidence 999999999999986542 35899999999999999999999988 999999999999999999
Q ss_pred EEEeecCCCccCCCCCccee-cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++.......... ....++..|+|||.+....++.++|+||||+++|||++ |+.|+......+.
T Consensus 148 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------- 220 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI------- 220 (279)
T ss_pred EEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------
Confidence 99999999987643322211 11223568999999988889999999999999999999 9999865432221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
....... .....+..+...+.+++.+||..||++||++.++++.|+++.....
T Consensus 221 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 221 PDLLEKG---------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHHHhCC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 1111110 0111223344678899999999999999999999999999876653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.31 Aligned_cols=236 Identities=27% Similarity=0.408 Sum_probs=191.3
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 5789999988642 233456778899888876 699999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~i~~~----------------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG 141 (320)
T cd05590 81 GDLMFHIQKS----------------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG 141 (320)
T ss_pred chHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCC
Confidence 9999888543 35889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........
T Consensus 142 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~-- 212 (320)
T cd05590 142 MCKEGIFNGK-TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDE-- 212 (320)
T ss_pred CCeecCcCCC-cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCC--
Confidence 9876422211 22335689999999999998999999999999999999999999865433221 11111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
...+......+.+++.+||+.||++||++
T Consensus 213 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 ---------VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 01122345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=313.97 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=206.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+|+.. +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57888999999999999999953 3467999988654433 4678999999999999999999999999888999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++........ ......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~-------~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~ 154 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDE-------KLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQR 154 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccc-------cccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCC
Confidence 99999999999999975432100 000125899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
.++++|||+++..............++..|+|||.+.++..+.++||||||+++|||++ |..||....... ..
T Consensus 155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~ 228 (275)
T cd05046 155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VL 228 (275)
T ss_pred cEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HH
Confidence 99999999987653332222233456778999999988888999999999999999999 777874322211 11
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.. ..... .....+...+..+.+++.+||+.+|++||++.|++..|++
T Consensus 229 ~~-~~~~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 229 NR-LQAGK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HH-HHcCC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11 11111 1111123345688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=329.79 Aligned_cols=247 Identities=27% Similarity=0.365 Sum_probs=206.1
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
-|...+.||+|+-|.|-.|+. .+|+.+|||++... .........+|+-||+.+.|||++++++++.+...+|||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 466788999999999999995 47999999987653 22234456789999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|-|.+++-.+ ++|+..+..+++.||+.|+.|+|..+ |+|||+||+|+|||.++++||
T Consensus 93 yv~gGELFdylv~k----------------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKI 153 (786)
T KOG0588|consen 93 YVPGGELFDYLVRK----------------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKI 153 (786)
T ss_pred ecCCchhHHHHHhh----------------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEee
Confidence 99999999999764 46999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||||.....+. .-...+|.+.|.|||++++..|. .++||||.|||||.|+||+.||+.+ ..+.++.-+
T Consensus 154 ADFGMAsLe~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV---- 224 (786)
T KOG0588|consen 154 ADFGMASLEVPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKV---- 224 (786)
T ss_pred eccceeecccCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHH----
Confidence 9999998754433 33446799999999999998876 5899999999999999999999622 222111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
..+. -+.|...+.+.++|+.+|+..||+.|.|+.||+++-
T Consensus 225 ~~G~----------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 225 QRGV----------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred HcCc----------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1110 123455667889999999999999999999999874
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=313.37 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=198.1
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+|+..+.||+|+||.||+|.. .+++.||+|..... .....+++.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999985 47889999987643 3444567999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 82 ~~~~l~~~~--------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~d 138 (279)
T cd06619 82 DGGSLDVYR--------------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCD 138 (279)
T ss_pred CCCChHHhh--------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEee
Confidence 999986432 4678888999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc-HHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN-LVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~ 571 (633)
||++....... .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...........
T Consensus 139 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 215 (279)
T cd06619 139 FGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE 215 (279)
T ss_pred CCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc
Confidence 99998653321 223468899999999999889999999999999999999999985432211110 00000000000
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
..+.+ ........+.+++.+||+.||++||++.|++++-
T Consensus 216 ------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 216 ------DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred ------CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00000 1122345688999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=332.11 Aligned_cols=251 Identities=23% Similarity=0.332 Sum_probs=194.8
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+|+..++||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999995 468899999886532 3345678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL 142 (382)
T cd05625 82 YIPGGDMMSLLIRM----------------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (382)
T ss_pred CCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 99999999988642 35788889999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCC----------------------------------------------cceecccccCCCcCchhcccc
Q 039736 491 SDFGTSRSVPNDK----------------------------------------------THLTTAVQGTFGYFDPEYFQS 524 (633)
Q Consensus 491 ~DfGla~~~~~~~----------------------------------------------~~~~~~~~gt~~y~APE~l~~ 524 (633)
+|||++....... ........||+.|+|||.+.+
T Consensus 143 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 222 (382)
T cd05625 143 TDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222 (382)
T ss_pred eECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC
Confidence 9999975321000 000112468999999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhcccc
Q 039736 525 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRL 604 (633)
Q Consensus 525 ~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~ 604 (633)
..++.++|||||||+||||++|+.||......+. ....... ...+...........+.+++.+++ .
T Consensus 223 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLET------QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHH------HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-c
Confidence 9999999999999999999999999965433221 0111100 000111111223455667777665 5
Q ss_pred CCCCCCC---HHHHHHH
Q 039736 605 NSKKRPT---MKQVSMD 618 (633)
Q Consensus 605 dP~~RPt---~~ev~~~ 618 (633)
+|.+|++ +.|++.+
T Consensus 289 ~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 289 GPEDRLGKNGADEIKAH 305 (382)
T ss_pred CHhHcCCCCCHHHHhcC
Confidence 9999997 8887653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.15 Aligned_cols=238 Identities=26% Similarity=0.347 Sum_probs=193.0
Q ss_pred CcccccCcEEEEEEEc----CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 340 RFLGQGGFGTVYKGML----PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999887532 2234567789999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||+++++.+||+||
T Consensus 82 ~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Df 142 (318)
T cd05582 82 GGDLFTRLSKE----------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDF 142 (318)
T ss_pred CCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeec
Confidence 99999888542 35899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|+++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...... .
T Consensus 143 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~~-~- 213 (318)
T cd05582 143 GLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILK-A- 213 (318)
T ss_pred cCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHHc-C-
Confidence 9998653322 122345689999999999988899999999999999999999999865432211 111111 0
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
. ...+......+.+|+.+||+.||++||++.+
T Consensus 214 -------~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 -------K--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -------C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 1123334567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=314.75 Aligned_cols=247 Identities=24% Similarity=0.344 Sum_probs=193.3
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||.||++... +|+.+|+|++.... ......+..|++++++++||||+++.+++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999854 68999999876421 12233556799999999999999999999998899999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 81 ~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~ 143 (277)
T cd05607 81 KYHIYNVG--------------ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAV 143 (277)
T ss_pred HHHHHhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeee
Confidence 98875432 235899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.|+........ .........
T Consensus 144 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-------- 211 (277)
T cd05607 144 ELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-------- 211 (277)
T ss_pred ecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh--------
Confidence 764322 12234689999999999998899999999999999999999999854322111 000001100
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
...... ........+.+|+.+||+.||++||++.|+++.+
T Consensus 212 -~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 212 -EDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 000000 0112456789999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=322.78 Aligned_cols=241 Identities=25% Similarity=0.373 Sum_probs=194.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+|+..+.||+|+||.||+|... +++.||||.++.. .....+.+..|..++..+ +|++|+++.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999864 5789999987652 223345677788888877 5899999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 81 E~~~~g~L~~~~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~k 141 (323)
T cd05616 81 EYVNGGDLMYQIQQV----------------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred cCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEE
Confidence 999999998887542 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus 142 L~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~~~i~ 214 (323)
T cd05616 142 IADFGMCKENMWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM 214 (323)
T ss_pred EccCCCceecCCCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999975432211 22345689999999999999999999999999999999999999865433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
. .. ..++.....++.+++.+||+.||++|++.
T Consensus 215 ~---------~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 E---------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred h---------CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 00 12233445678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=309.38 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=203.9
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++|+||+++++++.+++..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999764 78999999875432 678999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++... ...++|..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|
T Consensus 81 ~~~~L~~~l~~~---------------~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~d 142 (256)
T cd06612 81 GAGSVSDIMKIT---------------NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLAD 142 (256)
T ss_pred CCCcHHHHHHhC---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcc
Confidence 999999998543 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+......... .....
T Consensus 143 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~~~~-- 213 (256)
T cd06612 143 FGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FMIPN-- 213 (256)
T ss_pred cccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hhhcc--
Confidence 999987643321 222344788999999999889999999999999999999999998643221110 00000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+ ....+......+.+++.+||+.||++|||+.|++++
T Consensus 214 ----~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 ----KPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred ----CCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 011123344678999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=310.95 Aligned_cols=239 Identities=23% Similarity=0.398 Sum_probs=189.4
Q ss_pred CcccccCcEEEEEEEcCC-------------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 340 RFLGQGGFGTVYKGMLPD-------------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~-------------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
+.||+|+||.||+|.+.+ ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 2258999877655555668889999999999999999999999988999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|..++... ...+++..+++++.||++||+|||+.+ ++||||||+|||++.++
T Consensus 81 lv~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---------------SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREG 142 (262)
T ss_pred EEEecccCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCC
Confidence 999999999998887543 235899999999999999999999998 99999999999998766
Q ss_pred c-------EEEeecCCCccCCCCCcceecccccCCCcCchhccc-cCCCCcccchhhHHHHHHHHH-hCCCCCCCCchhh
Q 039736 487 S-------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELL-TGKKPICLTREEE 557 (633)
Q Consensus 487 ~-------~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDV~SfGvvL~ell-tG~~p~~~~~~~~ 557 (633)
. +|++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred ccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 4 899999998765322 1234778899999987 466889999999999999998 5777764322111
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
. ..... .. . .........+.+|+.+||+.||.+||++.+|++.|
T Consensus 218 ~-------~~~~~-~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 218 K-------ERFYE-GQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred H-------HHHHh-cC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1 00000 00 0 01112245788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=311.65 Aligned_cols=267 Identities=24% Similarity=0.354 Sum_probs=204.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEee-----CC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE-----TE 403 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-----~~ 403 (633)
....|...+.||+|+||.|+.+.. .+|+.||||++.. ......++-.+|+++|++++|+||+.+.+++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 344566678999999999999995 4789999999873 445567788999999999999999999999875 24
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..|+|+|+|+ -+|...++.. ..|+..+...+..|+++||.|+|+.+ ++||||||+|+|++
T Consensus 100 DvYiV~elMe-tDL~~iik~~----------------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n 159 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQ----------------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLN 159 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcC----------------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeec
Confidence 6799999994 5888888653 34999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCC-CcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 484 DKFSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
.+..+||+|||+|+..... .....+..+.|..|.|||.+.. ..||...||||.||++.||++|++-|.+.+.-....+
T Consensus 160 ~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l 239 (359)
T KOG0660|consen 160 ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL 239 (359)
T ss_pred cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH
Confidence 9999999999999987532 1222245667999999998755 5799999999999999999999998876554332222
Q ss_pred HHHHHHHHhhchhhhhhchhhh---------cccC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVA---------KEAR-----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~---------~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.........++.+..+-....+ ...+ +.......+|+.+||..||.+|+|++|.+++
T Consensus 240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 2221111111111111111100 0001 1334667899999999999999999999864
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.34 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=204.0
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
..++....++|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4445556689999999999999999999964 6789999987542 22334567889999999999999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
++..++||||+++|+|.+++.. ..++...+..++.||+.||.|||+++ |+||||||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIl 174 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML 174 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEE
Confidence 9999999999999999988853 24788888999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC----CCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++.++.+||+|||+++..............||+.|+|||.+... .++.++|||||||++|||++|+.||.......
T Consensus 175 l~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 254 (371)
T cd05622 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 254 (371)
T ss_pred ECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999987644333233445699999999998653 37889999999999999999999996543221
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK--RPTMKQVSMDL 619 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~L 619 (633)
.+......... +...........+.+++.+|+..++.+ ||++.|++++.
T Consensus 255 ------~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 ------TYSKIMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ------HHHHHHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111100 001111234567889999999844433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.94 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=193.6
Q ss_pred CcccccCcEEEEEEEcCC---CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGMLPD---GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~---g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998543 3579999887543 233457889999999999999999999999888899999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++...... ....+++..+.+++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+
T Consensus 81 ~L~~~l~~~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~ 146 (269)
T cd05087 81 DLKGYLRSCRKA-----------ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGL 146 (269)
T ss_pred cHHHHHHHhhhc-----------ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccc
Confidence 999999754321 0235678888999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCcce-ecccccCCCcCchhccccC-------CCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 496 SRSVPNDKTHL-TTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 496 a~~~~~~~~~~-~~~~~gt~~y~APE~l~~~-------~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
++......... .....++..|+|||++.+. .++.++|+||||+++|||++ |+.||......+. ...
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~-- 221 (269)
T cd05087 147 SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTY-- 221 (269)
T ss_pred cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHH--
Confidence 97654332221 1234567889999998642 35789999999999999996 9999854332221 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
... +......++.+ .......+.+++..|| .+|++|||++||++.|+
T Consensus 222 -~~~-~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 -TVR-EQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -Hhh-cccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000 11111111111 1123456788999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.97 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=193.0
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 6789999998753 233456788999999888 699999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (327)
T cd05617 81 GDLMFHMQRQ----------------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYG 141 (327)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccc
Confidence 9998877542 36999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||+.|+|||++.+..++.++||||||++||||++|+.||......................
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 218 (327)
T cd05617 142 MCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-- 218 (327)
T ss_pred cceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--
Confidence 987532211 12234568999999999999999999999999999999999999996433222211111111111111
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
....+...+..+.+++.+||+.||++||++
T Consensus 219 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 --------PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 011233345678899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.38 Aligned_cols=262 Identities=22% Similarity=0.277 Sum_probs=202.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhH--HHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQ--IEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~--~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV 408 (633)
+.|+.++.|++|.||.||+|+. ++++.||+|+++-..... --..++||.+|.+.+|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4577789999999999999995 478999999987533211 11457899999999999999999988754 468999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||++. +|...++... .+++..+..-+..|+++|++|||.+. |+|||||++|+|++..|.+
T Consensus 156 Me~~Eh-DLksl~d~m~---------------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---------------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred HHHHHh-hHHHHHHhcc---------------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcE
Confidence 999986 8888887653 37889999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+||.++..... .+..+-|..|.|||.+.+ ..|++..|+||+|||+.||+++++-|.+..+-+. ...+..
T Consensus 217 KiaDFGLAR~ygsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ---l~~If~ 292 (419)
T KOG0663|consen 217 KIADFGLAREYGSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ---LDKIFK 292 (419)
T ss_pred EecccchhhhhcCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH---HHHHHH
Confidence 99999999988665433 344567999999999876 4699999999999999999999988865543332 222222
Q ss_pred HHhh---chhhhhh--------------chhhhcccCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKE---NKLLEIL--------------DARVAKEAREE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~---~~~~~~~--------------d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+.- .....+- -..++..++.. ..+.-++|+...+..||.+|.|+.|.+++
T Consensus 293 llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 293 LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 2211 1000000 01111222211 34667899999999999999999998764
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.78 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=199.3
Q ss_pred CcccccCcEEEEEEEcCC-------CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~-------g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+.||+|+||.||+|...+ +..+|||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998642 2579999876532 34566889999999999999999999999998899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-----
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF----- 486 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----- 486 (633)
+++|+|.+++....... .....++|.+++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 81 ~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 81 MEGGDLLSYLRDARVER---------FGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred cCCCcHHHHHHHhhhcc---------cCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCc
Confidence 99999999997543210 01235899999999999999999999988 99999999999999887
Q ss_pred cEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
.+|++|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.|+......+ ....
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~ 225 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH 225 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH
Confidence 8999999999765332211 1112345678999999999999999999999999999998 999875432211 1111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
. .. ......+...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 226 ---~-~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 ---V-TA---------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---H-hc---------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00 00111233445778999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.52 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=196.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+|+..+.||+|+||.||++... +++.||||.+.... ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999953 68899999886422 2334568899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL 142 (376)
T cd05598 82 YIPGGDMMSLLIRL----------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKL 142 (376)
T ss_pred CCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEE
Confidence 99999999998653 35788888999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCC------------------------------------------CcceecccccCCCcCchhccccCCCC
Q 039736 491 SDFGTSRSVPND------------------------------------------KTHLTTAVQGTFGYFDPEYFQSSQYT 528 (633)
Q Consensus 491 ~DfGla~~~~~~------------------------------------------~~~~~~~~~gt~~y~APE~l~~~~~s 528 (633)
+|||++...... .........||+.|+|||++.+..++
T Consensus 143 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 222 (376)
T cd05598 143 TDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT 222 (376)
T ss_pred EeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC
Confidence 999997532100 00001134689999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC
Q 039736 529 DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK 608 (633)
Q Consensus 529 ~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 608 (633)
.++|||||||++|||++|+.||......+.. ...... ...+...........+.+++.+|+ .+|.+
T Consensus 223 ~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~-------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~ 288 (376)
T cd05598 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQ------LKVINW-------ETTLHIPSQAKLSREASDLILRLC-CGAED 288 (376)
T ss_pred cceeeeeccceeeehhhCCCCCCCCCHHHHH------HHHhcc-------CccccCCCCCCCCHHHHHHHHHHh-cCHhh
Confidence 9999999999999999999999654432210 001000 000001111123456677777766 59999
Q ss_pred CC---CHHHHHHH
Q 039736 609 RP---TMKQVSMD 618 (633)
Q Consensus 609 RP---t~~ev~~~ 618 (633)
|+ ++.|++.+
T Consensus 289 R~~~~t~~ell~h 301 (376)
T cd05598 289 RLGKNGADEIKAH 301 (376)
T ss_pred cCCCCCHHHHhCC
Confidence 99 88998866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.92 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=198.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999864 67889999886532 22334677899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+||++++++.+||+
T Consensus 86 ~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~ 146 (309)
T cd07872 86 LDK-DLKQYMDDC---------------GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLA 146 (309)
T ss_pred CCC-CHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEC
Confidence 975 787776543 235889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ......
T Consensus 147 Dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~ 222 (309)
T cd07872 147 DFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLG 222 (309)
T ss_pred ccccceecCCCccc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhC
Confidence 99999765332211 123457899999998865 4688999999999999999999999865543322111 111110
Q ss_pred h---chhhh------hhchhhhc-------ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 E---NKLLE------ILDARVAK-------EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~---~~~~~------~~d~~l~~-------~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ..... ..+..... .........+.+|+.+||+.||.+|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 223 TPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 00000 00000000 0011234577899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.96 Aligned_cols=254 Identities=24% Similarity=0.427 Sum_probs=198.7
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC------
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET------ 402 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~------ 402 (633)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999854 67899999886543 2345778999999998 699999999998753
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
...+++|||+.+|+|.+++.... ...++|..+..++.|++.||+|||+++ ++||||||+||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili 144 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--------------GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL 144 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEE
Confidence 35789999999999999986532 236899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++++.+||+|||++........ ......|+..|+|||++. ...++.++|||||||++|||++|+.|+.......
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~ 223 (272)
T cd06637 145 TENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223 (272)
T ss_pred CCCCCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9999999999999986533221 223356889999999986 3457889999999999999999999985322211
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. . .... . .. ....+...+..+.+|+.+||..||.+|||+.|++++
T Consensus 224 ~~-----~-~~~~-~-----~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 AL-----F-LIPR-N-----PA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HH-----H-HHhc-C-----CC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 10 0 0000 0 00 011112334678899999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=318.72 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=202.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||.||++... ++..+|+|.++.. .....+++.+|++++++++||||+++++++.+++..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999954 6788999987653 333456788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+++|+|.+++... ..+++..+..++.|+++||.|||+ ++ ++||||||+|||+++++.+||
T Consensus 81 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l 141 (308)
T cd06615 81 MDGGSLDQVLKKA----------------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 141 (308)
T ss_pred cCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEE
Confidence 9999999998643 358899999999999999999998 46 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...+.....
T Consensus 142 ~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~ 215 (308)
T cd06615 142 CDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVS 215 (308)
T ss_pred ccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccc
Confidence 9999987653321 1234678999999999888899999999999999999999999854332111 111100000
Q ss_pred hc--------------------hhhhhhchhhh---cccC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 571 EN--------------------KLLEILDARVA---KEAR-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 571 ~~--------------------~~~~~~d~~l~---~~~~-~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
.. ...+..+.... ...+ ......+.+++.+||+.||++||++.|++++--
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 216 EGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred cccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00 00000000000 0001 123457899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=320.84 Aligned_cols=241 Identities=27% Similarity=0.396 Sum_probs=192.1
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|... +++.||||.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999886531 23345667788888764 899999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05619 81 GDLMFHIQSC----------------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCC
Confidence 9999888542 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||..|+|||.+.+..++.++|||||||++|||++|+.||......+. .......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~--- 211 (316)
T cd05619 142 MCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL------FQSIRMD--- 211 (316)
T ss_pred cceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC---
Confidence 987532211 122345689999999999998999999999999999999999999865432211 1111000
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 617 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~-ev~~ 617 (633)
.+ ..+......+.+++.+||+.||++||++. ++.+
T Consensus 212 ----~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 212 ----NP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ----CC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01 12223445688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=295.05 Aligned_cols=248 Identities=27% Similarity=0.384 Sum_probs=206.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|-||.||.|+.+ ++-.||+|++....- .-..++.+|++|-+.++||||+++++++.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 57888999999999999999964 577999998765221 12346889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||..+|+|...|...+ ...++......+..|+|.||.|+|..+ ++||||||+|+|++.++..|
T Consensus 102 Eya~~gel~k~L~~~~--------------~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--------------MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred EecCCchHHHHHHhcc--------------cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCee
Confidence 9999999999997543 246888888999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||.+...+.. .....+||..|.+||...+..++.++|+|++|++.||++.|.+||.....++ .+....
T Consensus 165 iAdfGwsV~~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e------tYkrI~ 235 (281)
T KOG0580|consen 165 IADFGWSVHAPSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE------TYKRIR 235 (281)
T ss_pred ccCCCceeecCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH------HHHHHH
Confidence 9999999865422 2345679999999999999999999999999999999999999985433211 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. +.-.+|........+++.+|+.++|.+|.+..|++++
T Consensus 236 k-----------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 K-----------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred H-----------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 1112334455778899999999999999999999875
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=322.16 Aligned_cols=242 Identities=25% Similarity=0.383 Sum_probs=195.4
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 5789999988753 233456678899999888 699999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++.++..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg 141 (318)
T cd05570 81 GDLMFHIQRS----------------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFG 141 (318)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccC
Confidence 9998887542 35899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 142 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~--- 211 (318)
T cd05570 142 MCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILED--- 211 (318)
T ss_pred CCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcC---
Confidence 987532221 11233468999999999999999999999999999999999999986443221 11111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM-----KQVSMD 618 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~-----~ev~~~ 618 (633)
. ...+......+.+|+.+||+.||++||++ .+++.+
T Consensus 212 ------~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 ------E--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ------C--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 11233345678999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=308.44 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=202.7
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+|+..+.||+|+||.||++... +++.+|+|.++. ......+.+.+|+.++++++|+||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999954 688999998754 23445667889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++...++++.|++.||.|||+++ ++|+||||+||++++++.++++|
T Consensus 81 ~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~d 143 (255)
T cd08219 81 DGGDLMQKIKLQR--------------GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGD 143 (255)
T ss_pred CCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcc
Confidence 9999998885432 235789999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ...... .+
T Consensus 144 fg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~-~~ 215 (255)
T cd08219 144 FGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVC-QG 215 (255)
T ss_pred cCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHh-cC
Confidence 999976643221 2223458889999999998889999999999999999999999986432211 111111 11
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ...+......+.+++.+||+.||++||++.|++..
T Consensus 216 ~~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SY---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11 11223345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.02 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=200.1
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 68899999876432 22344678899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 82 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~ 144 (285)
T cd05632 82 MNGGDLKFHIYNMG--------------NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRIS 144 (285)
T ss_pred ccCccHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEe
Confidence 99999998886432 236999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++........ .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||.......... ........
T Consensus 145 Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~ 219 (285)
T cd05632 145 DLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLE 219 (285)
T ss_pred cCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhc
Confidence 9999976533221 123468999999999998899999999999999999999999986543322110 00000000
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
. ...++......+.+|+..||+.||++||+ +.|++.+
T Consensus 220 ~----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 T----------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c----------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 01123334567889999999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=309.34 Aligned_cols=253 Identities=33% Similarity=0.531 Sum_probs=200.1
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHH--HHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIE--QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~--~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
|+..+.||+|+||+||++... +++.+|+|.+......... ...+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 5668999998875544332 3456999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.. ...+++..++.++.|+++||.|||+.+ ++|+||||+||++++++.++|+|
T Consensus 81 ~~~~L~~~l~~----------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~D 141 (260)
T PF00069_consen 81 PGGSLQDYLQK----------------NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLID 141 (260)
T ss_dssp TTEBHHHHHHH----------------HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESS
T ss_pred ccccccccccc----------------ccccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence 99999999972 246899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||.+.... ..........++..|+|||.+. +...+.++||||+|+++|+|++|+.|+........... .......
T Consensus 142 fg~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~ 217 (260)
T PF00069_consen 142 FGSSVKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKR 217 (260)
T ss_dssp GTTTEEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHT
T ss_pred cccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccc
Confidence 99997641 1222334456889999999998 88899999999999999999999999865422221111 1111100
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ...... ........+.+++.+||+.||++||++.+++++
T Consensus 218 ~-----~~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 218 P-----LPSSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp H-----HHHHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c-----cccccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 001112789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.14 Aligned_cols=251 Identities=28% Similarity=0.413 Sum_probs=199.9
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
|+..+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++++++|+|++++.+.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999964 68899999876422 22234677899999999999999999999998999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 82 ~~g~~L~~~l~~~~--------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~ 144 (285)
T cd05630 82 MNGGDLKFHIYHMG--------------EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRIS 144 (285)
T ss_pred cCCCcHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEe
Confidence 99999998885432 235899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++......... ....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... .......
T Consensus 145 Dfg~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~---~~~~~~~- 218 (285)
T cd05630 145 DLGLAVHVPEGQTI--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVK- 218 (285)
T ss_pred eccceeecCCCccc--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH---HHHhhhh-
Confidence 99999765432221 23468999999999999999999999999999999999999986432211000 0000000
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
......+......+.+|+.+||+.||++||| +.|++++
T Consensus 219 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 ---------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ---------hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0111123334567889999999999999999 8888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=312.92 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=200.3
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
|+..+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|+||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999965 4778899988766666778899999999999999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++++||+|||
T Consensus 87 ~~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg 148 (282)
T cd06643 87 GAVDAVMLEL---------------ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG 148 (282)
T ss_pred CcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccc
Confidence 9998887542 236899999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
++....... .......++..|+|||.+. +..++.++|||||||++|||++|+.|+......+ ......
T Consensus 149 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~ 221 (282)
T cd06643 149 VSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLKIA 221 (282)
T ss_pred ccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHHHh
Confidence 997653221 1223345889999999984 3457789999999999999999999975432211 011111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... .+. ...+......+.+++.+||+.||.+||++.+++++
T Consensus 222 ~~~------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 222 KSE------PPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred hcC------CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100 000 11223345678999999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=309.35 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=199.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|...+.||+|+||.||+|.. +++.||+|..+... ..+.+.+|+.++++++|+|++++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999986 68889999886532 345788999999999999999999998754 4799999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ...+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 82 ~~~L~~~l~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 82 KGNLVNFLRTRG--------------RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred CCCHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCC
Confidence 999999986532 235899999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++....... .....+..|+|||.+.++.++.++|+||||+++|||++ |+.|+......+. .....
T Consensus 145 g~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~-- 211 (254)
T cd05083 145 GLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVE-- 211 (254)
T ss_pred ccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHh--
Confidence 9987643221 11234567999999998899999999999999999998 8888754332211 11111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.......+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 212 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 -------KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -------CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111112223445778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=317.65 Aligned_cols=258 Identities=26% Similarity=0.481 Sum_probs=202.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|... +|+ .||+|.+.... .....++.+|+.++++++|+||++++|++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677889999999999999853 444 57999876543 33345788999999999999999999998754 5689
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.
T Consensus 86 v~e~~~~g~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---------------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNH 147 (303)
T ss_pred eehhcCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCc
Confidence 999999999999986532 35899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ .
T Consensus 148 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~--- 221 (303)
T cd05110 148 VKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---P--- 221 (303)
T ss_pred eEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---
Confidence 999999999876433221 1222345678999999998899999999999999999997 8888754322211 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....... ....+..+...+.+++..||..+|++||++.|+++.|+++....
T Consensus 222 -~~~~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 222 -DLLEKGE---------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred -HHHHCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1111110 01112233467889999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.65 Aligned_cols=240 Identities=25% Similarity=0.383 Sum_probs=191.7
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +|+.||+|.++... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 68899999886521 23345667788888754 899999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~i~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg 141 (316)
T cd05620 81 GDLMFHIQDK----------------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFG 141 (316)
T ss_pred CcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccC
Confidence 9999887542 35889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||..|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------~~~~~~~--- 211 (316)
T cd05620 142 MCKENVFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------FESIRVD--- 211 (316)
T ss_pred CCeecccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC---
Confidence 987532211 122345689999999999999999999999999999999999999865432211 1111000
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK-QVS 616 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~-ev~ 616 (633)
. ...+......+.+++.+||+.||++||++. ++.
T Consensus 212 ----~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 ----T----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ----C----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 112223456788999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.86 Aligned_cols=247 Identities=28% Similarity=0.425 Sum_probs=206.5
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.+|+..+.||+|.||.|-++.. ..|+.||||.++. .++++.-...+|++||+.++||||+.++.+|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999995 5799999997765 34455567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||..+|.|.||+... +.|++.+...++.||..|+.|+|.++ ++|||||.+|||||.|+++|
T Consensus 133 EYaS~GeLYDYiSer----------------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 133 EYASGGELYDYISER----------------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred EecCCccHHHHHHHh----------------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCee
Confidence 999999999999764 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++-.+..+. .-..++|++-|.+||++.+..|. +.+|-||+||+||-|+.|..||++.+... .+.++
T Consensus 194 IADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~------lvrQI 265 (668)
T KOG0611|consen 194 IADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR------LVRQI 265 (668)
T ss_pred eeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH------HHHHh
Confidence 99999998764432 33557899999999999998875 78999999999999999999997654322 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
. ...+. .++.+....-||++||..||++|-|+.+|..+-
T Consensus 266 s---------~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 266 S---------RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred h---------ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 11111 122234556899999999999999999998653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=321.35 Aligned_cols=255 Identities=22% Similarity=0.324 Sum_probs=197.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999954 6889999998642 2334556889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~k 142 (331)
T cd05597 81 DYYVGGDLLTLLSKF---------------EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIR 142 (331)
T ss_pred ecCCCCcHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEE
Confidence 999999999998543 235889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
|+|||++...............||+.|+|||.+.. +.++.++|||||||++|||++|+.||......+ .
T Consensus 143 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~ 216 (331)
T cd05597 143 LADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (331)
T ss_pred EEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------H
Confidence 99999997654433322233468999999999863 457889999999999999999999986432211 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCC--CCCCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNS--KKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP--~~RPt~~ev~~~ 618 (633)
............ +. ......+..+.+++.+|+..++ ..||++.+++.+
T Consensus 217 ~~~i~~~~~~~~-----~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 YGKIMNHKEHFQ-----FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHcCCCccc-----CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 111111110000 00 0111234567788888775443 348899999877
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=316.09 Aligned_cols=250 Identities=24% Similarity=0.434 Sum_probs=204.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+..+.||.|++|.||+|.. .+|+.|++|.+........+.+.+|+++++.++|+||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999984 478999999887655555678899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.. ..+++.+++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|
T Consensus 99 ~~~~L~~~~~~-----------------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~d 158 (296)
T cd06655 99 AGGSLTDVVTE-----------------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTD 158 (296)
T ss_pred CCCcHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcc
Confidence 99999988743 25899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......++..|+|||.+.+..++.++|||||||++|||++|+.||......... .......
T Consensus 159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~ 231 (296)
T cd06655 159 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG 231 (296)
T ss_pred Cccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC
Confidence 999886543322 122345788999999999888999999999999999999999998654332210 0000000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. + ....+......+.+++.+||..||++||++.+++.+
T Consensus 232 -~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 -T-----P--ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -C-----c--ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0 011123345678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.88 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=201.6
Q ss_pred CCccCCcccccCcEEEEEEEcCC--CCEEEEEEccc----------cChhHHHHHHHHHHHHhc-cCCCCceEEEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPD--GSIVAVKRSRA----------IDKTQIEQFINEVVILSQ-INHRHIVKLLGCCLE 401 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~--g~~vAVK~~~~----------~~~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~ 401 (633)
+|+..+.||+|+||.||+|.... ++.+|+|.+.. .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 68899997643 223345678889988875 799999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCe
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNI 480 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NI 480 (633)
++..+++|||+++++|.+++..... ....+++..+++++.|++.||.|||+ .+ ++|+||+|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~ni 145 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE------------KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNI 145 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh------------ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHE
Confidence 9999999999999999998854221 12468999999999999999999996 56 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+++.++.+||+|||++....... ......++..|+|||.+.++.++.++||||||+++|||++|+.|+.......
T Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--- 220 (269)
T cd08528 146 MLGEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--- 220 (269)
T ss_pred EECCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---
Confidence 99999999999999998754332 2234458889999999998889999999999999999999999985432211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
..... .+... ...........+.+++.+||+.||++||++.|+..+++
T Consensus 221 ---~~~~~-~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 ---LATKI-VEAVY--------EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HHHHH-hhccC--------CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11111 11100 00011123467899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.26 Aligned_cols=237 Identities=27% Similarity=0.403 Sum_probs=189.0
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHH-HHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|... +|+.||+|++.... .....++.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 68999999886421 223345555654 56789999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg 141 (323)
T cd05575 81 GELFFHLQRE----------------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (323)
T ss_pred CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccC
Confidence 9999888542 35889999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~--- 211 (323)
T cd05575 142 LCKEGIEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNK--- 211 (323)
T ss_pred CCcccccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcC---
Confidence 987542221 12234568999999999999999999999999999999999999986433221 11111111
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
. ...+......+.+++.+||+.||.+||++.
T Consensus 212 ------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 212 ------P--LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ------C--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0 011223356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.90 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=207.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..++||+|+||.||+|... +|+.||||++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999964 5899999988642 2234567999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++........ . .......+++..+++++.||++||+|||+.+ |+||||||+||+++.++.+|
T Consensus 82 EY~eGGSL~~lL~s~~~~~~----l-~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKES----L-SKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EcCCCCCHHHHHHHhhhccc----c-chhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEE
Confidence 99999999999865321100 0 0011235788899999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCc-----------------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 039736 490 VSDFGTSRSVPNDKT-----------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 490 I~DfGla~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 999999986521100 011124689999999999999999999999999999999999999864
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhhh
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRR 624 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-t~~ev~~~L~~i~~ 624 (633)
....... .. . ...++.-. ....+.+..+.+++.+||+.||++|| +++++.+.|+....
T Consensus 234 ~~~~ki~-----~~-----~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 234 KKGRKIS-----YR-----D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred cchhhhh-----hh-----h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 3221110 00 0 00011000 00123446788999999999999995 57888888887754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.75 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=202.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+.|+..+.||+|+||.||+|... ++..+++|.+...+....+.+.+|++++++++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56788899999999999999964 58899999988777777788999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|..++... ...+++..++.++.|++.||+|||+++ ++||||||+||+++.++++||+|
T Consensus 92 ~~~~l~~~~~~~---------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 92 PGGAVDAIMLEL---------------DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred CCCcHHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEcc
Confidence 999998877543 235899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||++....... .......++..|+|||++. ...++.++||||||+++|||++|+.|+....... ....
T Consensus 154 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~ 226 (292)
T cd06644 154 FGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLK 226 (292)
T ss_pred Cccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHH
Confidence 99987643221 1122345788999999984 3456789999999999999999999975432111 1111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... .+. ...+......+.+++.+||+.||++||++.|++++
T Consensus 227 ~~~~~------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 227 IAKSE------PPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HhcCC------Ccc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11100 000 01123344678899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=334.07 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=194.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--------
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-------- 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-------- 402 (633)
...+|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++|+||+++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999996 468899999875432 1234799999999999999999887532
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
...++||||+++ +|.+++..... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl 203 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYAR------------NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLI 203 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhh------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEE
Confidence 135689999974 77777653221 1346899999999999999999999999 9999999999999
Q ss_pred cCCC-cEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 483 DDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~-~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+.++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||......+.
T Consensus 204 ~~~~~~vkL~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~-- 279 (440)
T PTZ00036 204 DPNTHTLKLCDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ-- 279 (440)
T ss_pred cCCCCceeeeccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--
Confidence 9664 799999999987643222 123457999999999865 4689999999999999999999999865443221
Q ss_pred HHHHHHHHHhhc---hh------------hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKEN---KL------------LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~~---~~------------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.. ........ .+ .......+...++...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 280 ~~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 280 LVR-IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHH-HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 111 11111100 00 00001111122233345678999999999999999999999854
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.21 Aligned_cols=250 Identities=26% Similarity=0.485 Sum_probs=200.9
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
+|...+.||+|+||.||+|...+|+.+|+|.++... ....+.+.+|++++++++|+||+++.+++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998789999999876421 22345788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+
T Consensus 81 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~ 141 (265)
T cd06631 81 MEFVPGGSISSILNRF----------------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGII 141 (265)
T ss_pred EecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeE
Confidence 9999999999998542 35889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCC-----cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 489 KVSDFGTSRSVPNDK-----THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 489 kI~DfGla~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+|+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 142 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----- 216 (265)
T cd06631 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA----- 216 (265)
T ss_pred EeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----
Confidence 999999987642211 1112234588999999999988899999999999999999999999854322111
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
........ ......+......+.+++.+||+.+|++||++.|++.
T Consensus 217 -~~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 -MFYIGAHR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -HHHhhhcc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011123344567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.89 Aligned_cols=241 Identities=24% Similarity=0.375 Sum_probs=194.2
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+|+..+.||+|+||.||++... +|+.||+|++... .....+.+..|..+++.+. |++|+++.+++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999854 6889999988642 2334556788999998886 577888999999888999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+|||+++++.+|
T Consensus 81 Ey~~~g~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ik 141 (323)
T cd05615 81 EYVNGGDLMYHIQQV----------------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIK 141 (323)
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEE
Confidence 999999999888542 36899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .....
T Consensus 142 L~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~ 214 (323)
T cd05615 142 IADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQSIM 214 (323)
T ss_pred EeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 99999987643222 122335689999999999998999999999999999999999999865432211 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
. .. ..++......+.+++.+||+.||.+|++.
T Consensus 215 ~---------~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 215 E---------HN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred h---------CC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1 00 12233445678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=321.38 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=198.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++..++|+||+++.+++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999964 6789999987642 2233456888999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 81 Ey~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~k 142 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---------------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIR 142 (331)
T ss_pred eCCCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEE
Confidence 9999999999996532 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
|+|||+++..............|++.|+|||++.+ +.++.++||||||++||||++|+.||......+ .
T Consensus 143 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~ 216 (331)
T cd05624 143 LADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (331)
T ss_pred EEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------H
Confidence 99999998764433322333568999999999875 567889999999999999999999986433221 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
............ +. ....+.+..+.+++.+|+..++++ |+++.+++++
T Consensus 217 ~~~i~~~~~~~~-----~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 217 YGKIMNHEERFQ-----FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHcCCCccc-----CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111111110000 00 001123467888999988866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.79 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=198.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..++||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++..++|+||+++.+++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 5778999987542 2233446888999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 81 ey~~~g~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~k 142 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---------------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 142 (332)
T ss_pred eccCCCcHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEE
Confidence 9999999999996532 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
|+|||++...............||+.|+|||++. .+.++.++|||||||++|||++|+.||......+ .
T Consensus 143 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~ 216 (332)
T cd05623 143 LADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T 216 (332)
T ss_pred EeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------H
Confidence 9999999765433333333456999999999986 3467899999999999999999999986433221 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
............ . ..........+.+|+.+|+..++++ |+++.|++++
T Consensus 217 ~~~i~~~~~~~~-----~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 YGKIMNHKERFQ-----F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHhCCCcccc-----C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111111110000 0 0111233567788888888654444 7899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.64 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=204.5
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|+||.||.+.. .+++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 578889999999999988884 46889999986543 345567889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~ 143 (256)
T cd08221 81 ANGGTLYDKIVRQK--------------GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLG 143 (256)
T ss_pred cCCCcHHHHHHhcc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEEC
Confidence 99999999886532 135899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++........ ......++..|+|||.+.+...+.++||||||+++|||++|+.|+......+ .......
T Consensus 144 d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~- 215 (256)
T cd08221 144 DFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQ- 215 (256)
T ss_pred cCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHc-
Confidence 9999987643332 2233458899999999988888999999999999999999999985433221 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
+.. ...+......+.+++.+||+.+|++||++.|+++++
T Consensus 216 ~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 GNY---------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCC---------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 101 111233456788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.07 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=202.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999964 68899999876532 34456788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+
T Consensus 81 ~~~~~L~~~~~~~-----------------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~ 140 (274)
T cd06609 81 CGGGSCLDLLKPG-----------------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLA 140 (274)
T ss_pred eCCCcHHHHHhhc-----------------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEc
Confidence 9999999988542 5899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||+++....... ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ..... .
T Consensus 141 d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~-~ 212 (274)
T cd06609 141 DFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIP-K 212 (274)
T ss_pred ccccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhh-h
Confidence 9999987653321 12234578899999999988899999999999999999999999854332110 00000 0
Q ss_pred chhhhhhchhhhcccCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ..+ ..+.. .+..+.+++.+||..+|++|||+++++++
T Consensus 213 ~-----~~~----~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 213 N-----NPP----SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c-----CCC----CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 011 11111 45678899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=309.01 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=203.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.|+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++++++|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 5667889999999999999964 5789999987643 2445678999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~L~~~i~~-----------------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~d 144 (277)
T cd06640 85 GGGSALDLLRA-----------------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred CCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcc
Confidence 99999998853 25788899999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+.........
T Consensus 145 fg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------------- 210 (277)
T cd06640 145 FGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------------- 210 (277)
T ss_pred cccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------------
Confidence 999977643221 122345788999999999888999999999999999999999998543222110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+........+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 211 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 ---FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0001111122344566788999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.55 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=205.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999964 57889999988765556778999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.... ..+++.++..++.|++.||.|||+++ ++||||+|+||++++++.+||+|
T Consensus 83 ~~~~l~~~~~~~~---------------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d 144 (262)
T cd06613 83 GGGSLQDIYQVTR---------------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLAD 144 (262)
T ss_pred CCCcHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECc
Confidence 9999999886531 36899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.|+.......... ...
T Consensus 145 ~g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~~ 217 (262)
T cd06613 145 FGVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LIS 217 (262)
T ss_pred cccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH
Confidence 999976543211 12234578899999999776 88999999999999999999999986433222100 000
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
... . -.+. ...+...+..+.+++.+||..+|.+|||+.+|+.
T Consensus 218 ~~~-~---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 KSN-F---PPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hcc-C---CCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 0 0000 1112344567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.73 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=203.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+..+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999995 478999999987655555667889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.. ..+++.++.+++.|++.||.|||+.+ ++||||||+||+++.++.++|+|
T Consensus 99 ~~~~L~~~~~~-----------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~D 158 (297)
T cd06656 99 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (297)
T ss_pred CCCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECc
Confidence 99999998743 25889999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++......... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||.......... .....
T Consensus 159 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~- 230 (297)
T cd06656 159 FGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN- 230 (297)
T ss_pred CccceEccCCccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccC-
Confidence 9999765433221 223457889999999999889999999999999999999999985433211100 00000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.......+......+.+++.+||+.+|++||++.++++
T Consensus 231 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 231 -------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001112334466889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.82 Aligned_cols=247 Identities=25% Similarity=0.416 Sum_probs=200.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.|+..+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556778999999999999854 5789999987643 2345567899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.. ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|
T Consensus 85 ~~~~L~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~d 144 (277)
T cd06642 85 GGGSALDLLKP-----------------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLAD 144 (277)
T ss_pred CCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcc
Confidence 99999988743 25889999999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 145 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~----- 212 (277)
T cd06642 145 FGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFL----- 212 (277)
T ss_pred ccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhh-----
Confidence 999976643221 11234578899999999998899999999999999999999999753221110 000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+........+...+..+.+++.+||+.+|++||++.|++.+
T Consensus 213 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 213 -----IPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -----hhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00011111223445678999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.84 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=191.5
Q ss_pred CcccccCcEEEEEEEcCC---CCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGMLPD---GSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~---g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997533 3578899876432 334567889999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.+++....... ....++...++++.||+.||+|||+++ ++||||||+|||+++++++||+|||+
T Consensus 81 ~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~ 146 (269)
T cd05042 81 DLKNYLRSNRGMV-----------AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGL 146 (269)
T ss_pred cHHHHHHhccccc-----------cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccc
Confidence 9999997643210 123568888999999999999999998 99999999999999999999999999
Q ss_pred CccCCCCCcce-ecccccCCCcCchhcccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 496 SRSVPNDKTHL-TTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 496 a~~~~~~~~~~-~~~~~gt~~y~APE~l~~-------~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
++......... .....++..|+|||++.. ..++.++||||||+++|||++ |..|+......+. ..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~ 220 (269)
T cd05042 147 ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LK 220 (269)
T ss_pred ccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HH
Confidence 87643322111 122345678999998743 356789999999999999999 7777754322211 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
....+. ...+.++. .+......+.+++..|| .||++|||++||++.|.
T Consensus 221 ~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 221 QVVREQ-DIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHhhcc-CccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 11111111 22334566778889998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=306.77 Aligned_cols=249 Identities=25% Similarity=0.448 Sum_probs=195.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
.+|+..+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999853 6889999987532 223456788999999999999999999988753 567
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ ++||||+|+||+++.+
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~ 142 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----------------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSA 142 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCC
Confidence 8999999999999998642 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~----- 217 (266)
T cd06651 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA----- 217 (266)
T ss_pred CCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-----
Confidence 9999999999976532111 111234578899999999988899999999999999999999999853321110
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
........ .....+......+..++ +||..+|++||+++||+.
T Consensus 218 -~~~~~~~~---------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 -IFKIATQP---------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -HHHHhcCC---------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00000000 01122333345566676 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.01 Aligned_cols=248 Identities=26% Similarity=0.496 Sum_probs=199.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh---------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---------TQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
+|.....||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999853 578999998754211 123578899999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~ 141 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----------------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----------------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcC
Confidence 99999999999999998542 35888999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcc-----eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 485 KFSAKVSDFGTSRSVPNDKTH-----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
++.+||+|||+++........ ......|+..|+|||.+.++.++.++|+||||+++|||++|+.||........
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 220 (267)
T cd06628 142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA- 220 (267)
T ss_pred CCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-
Confidence 999999999999876422111 11123578899999999998899999999999999999999999864322110
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.... ... .....+......+.+++.+||+.||.+||++.|+++
T Consensus 221 -----~~~~------~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 -----IFKI------GEN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHHH------hcc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0000 001 111223345577899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.43 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=198.2
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||+|... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999964 68999999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++ ++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 81 ~~-~~l~~~~~~~~~-------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~ 143 (285)
T cd07861 81 LS-MDLKKYLDSLPK-------------GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLA 143 (285)
T ss_pred CC-CCHHHHHhcCCC-------------CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEEC
Confidence 97 688888754321 246899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++....... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+........ ....+.....
T Consensus 144 dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~ 220 (285)
T cd07861 144 DFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGT 220 (285)
T ss_pred cccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 999997653221 112233568899999988654 478899999999999999999999865433211 1111100000
Q ss_pred --h------chhhh-------hhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 --E------NKLLE-------ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 --~------~~~~~-------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+ ..+.+ +..... .........++.+++.+||+.||++|||+.||+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 221 PTEDVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred CChhhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 00000 000000 00111245677899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.65 Aligned_cols=251 Identities=32% Similarity=0.525 Sum_probs=202.1
Q ss_pred CccCCcccccCcEEEEEEEcCC-----CCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~-----g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
|+..+.||+|+||.||++...+ +..||+|.++..... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3457889999999999999753 388999998765433 5678999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++
T Consensus 81 e~~~~~~l~~~~~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~ 143 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--------------KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVK 143 (258)
T ss_pred eccCCCCHHHHHHhhhh--------------ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEE
Confidence 99999999999865322 12899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++...............++..|+|||.+.+..++.++||||+|++++||++ |..|+....... .....
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~ 217 (258)
T smart00219 144 ISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYL 217 (258)
T ss_pred EcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 99999998765442222222336789999999988889999999999999999998 777765422211 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.. .. ....+...+..+.+++.+||..||++|||+.|+++.|
T Consensus 218 ~~-~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 KK-GY---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred hc-CC---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 10 1112223556789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=316.74 Aligned_cols=261 Identities=24% Similarity=0.365 Sum_probs=199.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999864 57899999876432 22344677899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++ ++|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+
T Consensus 86 ~~-~~l~~~l~~~---------------~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 146 (301)
T cd07873 86 LD-KDLKQYLDDC---------------GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLA 146 (301)
T ss_pred cc-cCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEEC
Confidence 97 5888887543 235889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 147 dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~ 222 (301)
T cd07873 147 DFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILG 222 (301)
T ss_pred cCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcC
Confidence 9999976532221 1122346889999998865 3578899999999999999999999875543321 111111110
Q ss_pred ---hchhhhhhc---------hhhhc----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 571 ---ENKLLEILD---------ARVAK----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 571 ---~~~~~~~~d---------~~l~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
......+++ +.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001111111 00000 011223457889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.30 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=200.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677788999999999999985 468899999987655555667889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++... ..+++.+.+.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|
T Consensus 89 ~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~d 149 (267)
T cd06645 89 GGGSLQDIYHVT----------------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLAD 149 (267)
T ss_pred CCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECc
Confidence 999999988542 36899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
||++....... .......|+..|+|||.+. .+.++.++|||||||++|||++|+.|+........ . ....
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~ 222 (267)
T cd06645 150 FGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMT 222 (267)
T ss_pred ceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhhh
Confidence 99987653221 1123346889999999974 45688999999999999999999999753322111 0 0000
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... . ..+.... ....+..+.+++.+||+.+|++||++++++++
T Consensus 223 ~~~-~---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 KSN-F---QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccC-C---CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000 0 0000000 11234568899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=310.53 Aligned_cols=240 Identities=23% Similarity=0.418 Sum_probs=191.0
Q ss_pred CcccccCcEEEEEEEcCC--------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGMLPD--------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888887765555667889999999999999999999999998899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc----
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS---- 487 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---- 487 (633)
+++|+|.+++.... ..+++..+++++.||+.||.|||+.+ ++||||||+||+++.++.
T Consensus 81 ~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~ 142 (258)
T cd05078 81 VKFGSLDTYLKKNK---------------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTG 142 (258)
T ss_pred CCCCcHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccC
Confidence 99999999987542 25899999999999999999999998 999999999999987765
Q ss_pred ----EEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCC-CCCCCCchhhhhcH
Q 039736 488 ----AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGK-KPICLTREEEERNL 561 (633)
Q Consensus 488 ----~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~-~p~~~~~~~~~~~l 561 (633)
++++|||++...... ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.........
T Consensus 143 ~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-- 215 (258)
T cd05078 143 NPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-- 215 (258)
T ss_pred CCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--
Confidence 699999998755321 224578899999999874 5789999999999999999995 444322111100
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
.... . ....+.....++.+|+.+||+.||++|||++++++.|+
T Consensus 216 -----~~~~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 -----QFYE---------D--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----HHHH---------c--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 0 01122233467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.54 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=205.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||+||++... +|+.||+|.+.... ....+.+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777899999999999999954 68899999876533 33456889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+++|+|.+++... ..+++..+..++.+++.||.|||+ ++ ++||||||+||++++++.++|
T Consensus 85 ~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l 145 (284)
T cd06620 85 MDCGSLDRIYKKG----------------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKL 145 (284)
T ss_pred CCCCCHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEE
Confidence 9999999887542 358999999999999999999997 46 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh-----hcHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE-----RNLVAYF 565 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~-----~~l~~~~ 565 (633)
+|||++....... .....|+..|+|||.+.++.++.++||||||+++|||++|+.||......+. ......+
T Consensus 146 ~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd06620 146 CDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222 (284)
T ss_pred ccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH
Confidence 9999987543221 1234689999999999888999999999999999999999999875433211 0111111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
..... ...........+..+.+|+.+||+.||++|||+.|++++.--+.
T Consensus 223 ~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 223 QQIVQ---------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHhh---------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11111 00000011224567899999999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.55 Aligned_cols=238 Identities=27% Similarity=0.485 Sum_probs=189.5
Q ss_pred CcccccCcEEEEEEEcCCCC-----------EEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 340 RFLGQGGFGTVYKGMLPDGS-----------IVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~-----------~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975433 5888877654333 5788999999999999999999999988 778999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC--
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-- 486 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-- 486 (633)
+||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ ++||||||+||+++.++
T Consensus 79 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~ 140 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---------------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLN 140 (259)
T ss_pred EEcCCCCcHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccc
Confidence 99999999999986532 25899999999999999999999998 99999999999999888
Q ss_pred -----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccC--CCCcccchhhHHHHHHHHHh-CCCCCCCCchhhh
Q 039736 487 -----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLT-GKKPICLTREEEE 558 (633)
Q Consensus 487 -----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~ 558 (633)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+.
T Consensus 141 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 141 EGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 799999999987543 1223466789999999876 78999999999999999999 4666543321111
Q ss_pred hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
..++ .. . ...+......+.+++.+||..+|.+|||+.|+++.|+
T Consensus 216 ---~~~~----~~--------~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 ---ERFY----QD--------Q---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---HHHH----hc--------C---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 0 0011111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=304.52 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=200.9
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-CceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-~~~~LV~E 410 (633)
+|+..+.||+|++|.||++... +++.||+|++... .....+.+.+|++++++++|+|++++.+.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999954 5789999987642 334556788999999999999999999987644 45789999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.+++.... ...+++.++++++.+++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 81 ~~~~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l 143 (257)
T cd08223 81 FCEGGDLYHKLKEQK--------------GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKV 143 (257)
T ss_pred ccCCCcHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEE
Confidence 999999999986532 236899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ ......+++.|+|||.+.+..++.++||||||++++||++|+.|+...+... .......
T Consensus 144 ~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~ 216 (257)
T cd08223 144 GDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIE 216 (257)
T ss_pred ecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHh
Confidence 99999976643222 2233457899999999999999999999999999999999999986433211 1111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.. ...+......+.+++.+||+.||++||++.|++++
T Consensus 217 -~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 -GKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -cCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 12233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.27 Aligned_cols=260 Identities=25% Similarity=0.340 Sum_probs=196.9
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----- 403 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----- 403 (633)
..++|...+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999853 6889999998642 3344567889999999999999999999986543
Q ss_pred -ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 404 -VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 404 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
..++||||+++ +|.+.++ ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~ 156 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 46999999975 5555542 24788889999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.++.+||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||...+.... .
T Consensus 157 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~ 231 (359)
T cd07876 157 KSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---W 231 (359)
T ss_pred CCCCCEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 99999999999999764322 122334689999999999999999999999999999999999999975432211 0
Q ss_pred HHHHHHHhhc----------hhhhhhchh--hh----------------cccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 563 AYFISLAKEN----------KLLEILDAR--VA----------------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 563 ~~~~~~~~~~----------~~~~~~d~~--l~----------------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
.......... ......... .. ..........+.+|+.+||+.||++|||+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 311 (359)
T cd07876 232 NKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311 (359)
T ss_pred HHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHH
Confidence 0000000000 000000000 00 0001112456889999999999999999999
Q ss_pred HHHH
Q 039736 615 VSMD 618 (633)
Q Consensus 615 v~~~ 618 (633)
++.+
T Consensus 312 ~l~h 315 (359)
T cd07876 312 ALRH 315 (359)
T ss_pred HhcC
Confidence 9986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.93 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=201.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-----hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667789999999999999975 78999999875432 33566889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 81 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~ 141 (258)
T cd06632 81 LELVPGGSLAKLLKKY----------------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVV 141 (258)
T ss_pred EEecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 9999999999988542 35889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||++....... ......++..|++||.+.... ++.++|+||||+++|||++|+.||....... ....
T Consensus 142 kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~ 213 (258)
T cd06632 142 KLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFK 213 (258)
T ss_pred EEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHH
Confidence 999999988754332 223345788999999987766 8999999999999999999999985432111 0111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... ....+......+.+++.+||+.+|++||++.+++.+
T Consensus 214 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 214 IGRSKE---------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHhccc---------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 110000 112233345678899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=320.16 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=190.0
Q ss_pred CcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHH-HHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++.. .+|+.||+|++... .......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 46899999987642 2233445566654 57789999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG 141 (325)
T cd05604 81 GELFFHLQRE----------------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFG 141 (325)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecC
Confidence 9998887542 36899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+......
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~--- 211 (325)
T cd05604 142 LCKEGIAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHK--- 211 (325)
T ss_pred CcccCCCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcC---
Confidence 987542221 12234568999999999999999999999999999999999999986543221 11111111
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
.+ ..+......+.+++.+|++.+|.+||++.+.+
T Consensus 212 ------~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 212 ------PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ------Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 00 11223446678999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=326.10 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=196.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +++.||+|+++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999864 6889999988642 2334567888999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++++|
T Consensus 81 E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vk 141 (360)
T cd05627 81 EFLPGGDMMTLLMKK----------------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVK 141 (360)
T ss_pred eCCCCccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEE
Confidence 999999999998643 35889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCc----------------------------------ceecccccCCCcCchhccccCCCCcccchhh
Q 039736 490 VSDFGTSRSVPNDKT----------------------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 535 (633)
Q Consensus 490 I~DfGla~~~~~~~~----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~S 535 (633)
|+|||+++....... .......||+.|+|||++.+..++.++||||
T Consensus 142 L~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 221 (360)
T cd05627 142 LSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS 221 (360)
T ss_pred EeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc
Confidence 999999875422110 0012346899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC---H
Q 039736 536 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT---M 612 (633)
Q Consensus 536 fGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt---~ 612 (633)
|||++|||++|+.||......+. ........ ..+...........+.+|+.+++ .||.+|++ +
T Consensus 222 lGvilyel~tG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 287 (360)
T cd05627 222 LGVIMYEMLIGYPPFCSETPQET------YRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGV 287 (360)
T ss_pred ccceeeecccCCCCCCCCCHHHH------HHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCH
Confidence 99999999999999865433221 11111100 00000000113456777887766 49999985 6
Q ss_pred HHHHHH
Q 039736 613 KQVSMD 618 (633)
Q Consensus 613 ~ev~~~ 618 (633)
.|++++
T Consensus 288 ~ei~~h 293 (360)
T cd05627 288 EEIKSH 293 (360)
T ss_pred HHHhcC
Confidence 676654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=304.66 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=203.2
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|+||.+|++.. .+|+.||+|++... .....+++.+|+.++++++|+||+++.+++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46889999987642 334556889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++.... ...+++.++++++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~ 143 (256)
T cd08218 81 CEGGDLYKKINAQR--------------GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLG 143 (256)
T ss_pred CCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEe
Confidence 99999998886432 125789999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++........ ......|+..|+|||++.++..+.++|+||||++++||++|+.|+......+ ........
T Consensus 144 d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~ 216 (256)
T cd08218 144 DFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIRG 216 (256)
T ss_pred eccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhcC
Confidence 9999986543221 1223457889999999998899999999999999999999999985432221 11111110
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ....+......+.+++.+||+.+|++||++.||+++
T Consensus 217 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 S----------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred C----------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0 011233445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.44 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=189.1
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHH-HHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEV-VILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei-~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +++.||+|++.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 57889999876421 12233444444 457889999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++.....++.||++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG 141 (325)
T cd05602 81 GELFYHLQRE----------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141 (325)
T ss_pred CcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCC
Confidence 9999888642 35778888899999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+......
T Consensus 142 ~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~--- 211 (325)
T cd05602 142 LCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNK--- 211 (325)
T ss_pred CCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHhC---
Confidence 997542221 12234568999999999999999999999999999999999999986443222 11111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
. ...+......+.+++.+||+.||.+||++.+.+
T Consensus 212 ------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 212 ------P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ------C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0 112233456788999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.33 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=197.8
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----- 403 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----- 403 (633)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999853 6889999988653 3344567889999999999999999999886432
Q ss_pred -ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 404 -VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 404 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
..++||||+++ +|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill 152 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 152 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------------------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEE
Confidence 46999999975 5655552 24788899999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.++.+||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|+.||......+.. .
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~ 228 (355)
T cd07874 153 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW--N 228 (355)
T ss_pred CCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H
Confidence 999999999999998653321 223346899999999999989999999999999999999999998654422210 0
Q ss_pred HHHHHHH-------h--hchhhhhhc----------hhh--------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 039736 563 AYFISLA-------K--ENKLLEILD----------ARV--------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615 (633)
Q Consensus 563 ~~~~~~~-------~--~~~~~~~~d----------~~l--------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev 615 (633)
....... . ......+++ +.. ....+......+.+|+.+||+.||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 0000000 0 000000000 000 000111234578899999999999999999999
Q ss_pred HHH
Q 039736 616 SMD 618 (633)
Q Consensus 616 ~~~ 618 (633)
+++
T Consensus 309 l~h 311 (355)
T cd07874 309 LQH 311 (355)
T ss_pred hcC
Confidence 986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.47 Aligned_cols=191 Identities=22% Similarity=0.375 Sum_probs=164.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..+|...+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++...+..++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999964 5678999975432 235699999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+. |+|.+++... ...++|..+++|+.||+.||.|||+++ |+||||||+|||++.++.+||+
T Consensus 139 ~~-~~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 199 (357)
T PHA03209 139 YS-SDLYTYLTKR---------------SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIG 199 (357)
T ss_pred cC-CcHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEe
Confidence 95 6888887543 246899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
|||+++...... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 200 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 200 DLGAAQFPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cCccccccccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999997543221 122345899999999999999999999999999999999976665
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.15 Aligned_cols=237 Identities=27% Similarity=0.414 Sum_probs=188.1
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHH-HHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||++... +|+.||+|++... .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 6889999987642 1223345555654 67889999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 141 (321)
T cd05603 81 GELFFHLQRE----------------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFG 141 (321)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCC
Confidence 9998877532 35888889999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........
T Consensus 142 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~--- 211 (321)
T cd05603 142 LCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHK--- 211 (321)
T ss_pred CCccCCCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcC---
Confidence 987532221 12234568999999999998899999999999999999999999986543211 11111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
. ...+......+.+++.+||+.||.+||+..
T Consensus 212 ------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 ------P--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------C--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 122334456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=304.36 Aligned_cols=271 Identities=25% Similarity=0.400 Sum_probs=222.1
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEcCC------CCEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEE
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCC 399 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~ 399 (633)
.|+.....+++...++.+|.||.||+|.|++ .+.|-+|.++. .++-+...++.|.-++..+.|||+..+.|++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4555566788888999999999999997643 45678887765 3455677899999999999999999999999
Q ss_pred eeCC-ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 400 LETE-VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 400 ~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
.++. .++.+|.++.-|+|+.||...+.. .....+.++-.+...++.|++.|++|||+++ +||.||.++
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~--------~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaR 425 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGD--------DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAAR 425 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccC--------CCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhh
Confidence 8754 689999999999999999744321 1122457888999999999999999999999 999999999
Q ss_pred CeeecCCCcEEEeecCCCccC-CCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchh
Q 039736 479 NILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREE 556 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~-~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~ 556 (633)
|++||+..++||+|-.++|.. +.+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-++.
T Consensus 426 NCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 426 NCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred cceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 999999999999999999986 3333334444556789999999999999999999999999999999 89997544333
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
+ +...+....+...|..|+.+++.++.-||+.+|++||++++++.-|+++-.
T Consensus 506 E----------------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 506 E----------------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred H----------------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 2 122233334455678899999999999999999999999999999988653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.26 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=192.9
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhcc---CCCCceEEEEEEeeC-----C
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLET-----E 403 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~-----~ 403 (633)
+|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999964 68899999876422 11223455677766655 799999999988642 3
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~ 142 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--------------PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVT 142 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 4789999997 48888875432 235899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+++.+||+|||+++...... ......++..|+|||.+.+..++.++|||||||++|||++|++||........ +..
T Consensus 143 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~ 218 (288)
T cd07863 143 SGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK 218 (288)
T ss_pred CCCCEEECccCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH
Confidence 99999999999998664322 12234578999999999988999999999999999999999999865433221 111
Q ss_pred HHHHHHhhc---hhhh-------hhchhh---hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKEN---KLLE-------ILDARV---AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~---~~~~-------~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ .... ...+.. ......+....+.+|+.+||+.||++|||+.|++.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 219 -IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred -HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111000 0000 000000 001112345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.64 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=204.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||++... ++..+|+|..+.......+.|.+|++++++++|+||+++++.+..++..++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999964 6889999998876667778899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++... ...+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+
T Consensus 84 ~~~~~L~~~~~~~---------------~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~ 145 (280)
T cd06611 84 CDGGALDSIMLEL---------------ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLA 145 (280)
T ss_pred cCCCcHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEc
Confidence 9999999988643 236899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|||++........ ......++..|+|||.+. ...++.++|+||||+++|||++|+.|+....... ...
T Consensus 146 d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~ 218 (280)
T cd06611 146 DFGVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLL 218 (280)
T ss_pred cCccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHH
Confidence 9999876533221 122345889999999875 3446789999999999999999999985432211 011
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... .+. ...+......+.+++.+||+.+|.+||++.+++++
T Consensus 219 ~~~~~~------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 219 KILKSE------PPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHhcCC------CCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111000 000 11123345678899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.03 Aligned_cols=258 Identities=28% Similarity=0.500 Sum_probs=200.6
Q ss_pred CccCCcccccCcEEEEEEEcC----CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
|...+.||+|+||.||+|.+. .++.||||+++.. .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999987653 3445678899999999999999999999886532
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++++||+++|+|.+++...... .....+++...++++.|++.||+|||+.+ ++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~ 147 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----------EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLN 147 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEc
Confidence 247899999999999887543211 00235889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l 561 (633)
+++.+||+|||+++........ ......++..|++||.+....++.++||||||+++|||++ |+.|+......+ .
T Consensus 148 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~ 224 (273)
T cd05074 148 ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I 224 (273)
T ss_pred CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H
Confidence 9999999999999876433221 1122345678999999998889999999999999999999 888875433211 1
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
..+ ...... ...+......+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 225 ~~~---~~~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YNY---LIKGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHH---HHcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 111110 011223456899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=303.68 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=202.9
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 409 (633)
+|+..+.||+|+||.||++.. .+|+.+|+|.+.. ......+.+.+|++++++++|+||+++++++... ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477788999999999999985 4678999998764 3344566788999999999999999999987643 4579999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH-----hcCCCCeeccCCCCCCeeecC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-----SAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-----~~~~~~ivHrDIk~~NILl~~ 484 (633)
||+++++|.+++..... ....+++..++.++.|++.||.||| +.+ ++|+||+|+||++++
T Consensus 81 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~ 145 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK------------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDA 145 (265)
T ss_pred hhccCCCHHHHHHHHhh------------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEec
Confidence 99999999999865321 1347999999999999999999999 555 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++.+||+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+....... +.
T Consensus 146 ~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~-- 219 (265)
T cd08217 146 NNNVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA-- 219 (265)
T ss_pred CCCEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH--
Confidence 999999999999876543321 223468899999999999889999999999999999999999986543211 11
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ......+......+.+++.+||+.+|++||++.||+++
T Consensus 220 --~~~~~---------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 --SKIKE---------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHhc---------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11111 11122334456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.25 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=201.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||.||++... +|..||+|.++.. .....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999975 6899999987643 344457899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+++++|.+++..... ...+++..+.+++.+++.||.|||+ .+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l 144 (286)
T cd06622 81 MDAGSLDKLYAGGVA-------------TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKL 144 (286)
T ss_pred cCCCCHHHHHHhccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEE
Confidence 999999888864321 2368999999999999999999997 46 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
+|||++....... .....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||........ ...
T Consensus 145 ~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~ 218 (286)
T cd06622 145 CDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQ 218 (286)
T ss_pred eecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHH
Confidence 9999997653221 12335788999999986543 47899999999999999999999854322111 111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. .+.+. .....+......+.+++.+||+.+|++||++.+++.+
T Consensus 219 ~~---------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 LS---------AIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HH---------HHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 10 11110 0112334456778999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.40 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=189.9
Q ss_pred CcccccCcEEEEEEEcCCC---CEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 340 RFLGQGGFGTVYKGMLPDG---SIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g---~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
+.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 356677665432 345668999999999999999999999999988999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
+|.++++..... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 81 ~L~~~l~~~~~~------------~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~ 145 (268)
T cd05086 81 DLKSYLSQEQWH------------RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145 (268)
T ss_pred cHHHHHHhhhcc------------cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccccc
Confidence 999999754221 234677788899999999999999998 99999999999999999999999999
Q ss_pred CccCCCCC-cceecccccCCCcCchhcccc-------CCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 496 SRSVPNDK-THLTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 496 a~~~~~~~-~~~~~~~~gt~~y~APE~l~~-------~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+....... ........++..|+|||++.. ..++.++||||||+++|||++ |..|+......+ .+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~ 219 (268)
T cd05086 146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLN 219 (268)
T ss_pred ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHH
Confidence 86532211 111223457889999998753 245789999999999999997 466764332211 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
....+ ......++.+. ......+.+++..|| .+|++||+++||++.|.
T Consensus 220 ~~~~~-~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 220 HVIKD-QQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHhh-cccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 11122222222 223466788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=303.49 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=197.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
.+|+..+.||+|+||.||+|... +|+.||||.+... .....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999964 5889999987532 123456788999999999999999999988764 457
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
+++|||+++|+|.+++... ..+++...++++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~ 142 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----------------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSV 142 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCC
Confidence 8999999999999888542 35788999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........
T Consensus 143 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----- 217 (265)
T cd06652 143 GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----- 217 (265)
T ss_pred CCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-----
Confidence 9999999999986532111 112234588899999999888899999999999999999999999853321110
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
....... ......+......+.+++.+|+. +|++||+++||+++
T Consensus 218 -~~~~~~~---------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 218 -IFKIATQ---------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -HHHHhcC---------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111000 01122344555678889999985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=307.24 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=196.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~L 407 (633)
-.|...+++|.|+||.||+|.+. +++.||||+.-...+.. -+|+++|+++.|||||+|+-++.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 45777899999999999999965 56899999876533211 26999999999999999999887432 2358
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC-C
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-F 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~ 486 (633)
|||||+. +|.++++..... ...++...+.-+..||.+||.|||+++ |+||||||+|+|+|.+ |
T Consensus 100 VleymP~-tL~~~~r~~~~~------------~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg 163 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRA------------NQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTG 163 (364)
T ss_pred HHHhchH-HHHHHHHHHhhc------------CCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCC
Confidence 9999986 888888653211 235778888889999999999999998 9999999999999975 9
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||.|+....+... ....-+..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+ ....+
T Consensus 164 ~LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d---QL~eI 238 (364)
T KOG0658|consen 164 VLKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD---QLVEI 238 (364)
T ss_pred eEEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH---HHHHH
Confidence 9999999999987544333 33456889999999876 579999999999999999999999886644322 22223
Q ss_pred HHHHhhchhhh--hhchh--------hhc-----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLE--ILDAR--------VAK-----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~--~~d~~--------l~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..++.-+...+ .+.+. +.. -.......+..+|+.++++.+|.+|.++.|++.+
T Consensus 239 ik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 239 IKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 33332211111 11111 111 1223445788999999999999999999998753
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=308.90 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=199.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 58999999876432 2233567899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|..++.. ...++|..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l 141 (286)
T cd07847 81 YCDHTVLNELEKN----------------PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141 (286)
T ss_pred ccCccHHHHHHhC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEE
Confidence 9999888777643 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... . .....
T Consensus 142 ~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~-~~~~~ 217 (286)
T cd07847 142 CDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--L-IRKTL 217 (286)
T ss_pred CccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHh
Confidence 99999987644321 1223347789999999876 557899999999999999999999986544322111 0 00000
Q ss_pred hh--chhhhhh----------chhhhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KE--NKLLEIL----------DARVAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~--~~~~~~~----------d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ....+.. .+...... .......+.+++.+||+.||++||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 0000000 00000000 01234678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.27 Aligned_cols=270 Identities=24% Similarity=0.322 Sum_probs=204.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCC-ceEEEEEEeeCC-----
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRH-IVKLLGCCLETE----- 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~----- 403 (633)
...|...++||+|+||+||+|+. .+|+.||+|+++.... .......+|+.+|++++|+| |++|.+++..++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999994 4789999998775433 23345689999999999999 999999998877
Q ss_pred -ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 404 -VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 404 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
.++||+||++. +|..++...... ...++...+..+..||++||+|||+++ |+||||||.||||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~------------~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi 153 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKK------------PQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLI 153 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhcccc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEE
Confidence 78999999965 899888664320 024666889999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+++|.+||+|||+|+...-.... .+..++|..|.|||.+.+. .|++..|+||+||++.||++++.-|.+..+. ..+
T Consensus 154 ~~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql 230 (323)
T KOG0594|consen 154 SSSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQL 230 (323)
T ss_pred CCCCcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHH
Confidence 99999999999999976433222 3456789999999999876 7999999999999999999998887655442 222
Q ss_pred HHHHHHHHhhc---hhhhh---hc--hhhhccc-CH-------HHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 039736 562 VAYFISLAKEN---KLLEI---LD--ARVAKEA-RE-------EDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGL 622 (633)
Q Consensus 562 ~~~~~~~~~~~---~~~~~---~d--~~l~~~~-~~-------~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i 622 (633)
. .+...+..+ ..... .+ ....... +. .......+++.+|++.+|.+|.|++.++.+ +..+
T Consensus 231 ~-~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 231 F-RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred H-HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 2 222222211 11100 00 0010000 11 111467899999999999999999999987 5554
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.20 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=206.7
Q ss_pred cccCHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEE
Q 039736 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCC 399 (633)
Q Consensus 322 ~~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~ 399 (633)
.++..+++..++++|+..+.||+|+||.||++.. .+++.+|+|.+..... ..+.+.+|+.+++++ +|||++++++++
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 10 SMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 3466677778889999999999999999999996 4688999998865322 235677899999999 899999999998
Q ss_pred eeC-----CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 400 LET-----EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 400 ~~~-----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
... +..++|+||+++|+|.++++.... ....+++..++.++.|++.||.|||+.+ ++|||
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 153 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLI------------CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRD 153 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 753 357999999999999998864321 1246899999999999999999999998 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC-----CCcccchhhHHHHHHHHHhCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-----~s~ksDV~SfGvvL~elltG~~p 549 (633)
|||+||++++++.+||+|||++........ ......|+..|+|||.+.... ++.++||||||+++|||++|+.|
T Consensus 154 lkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 154 VKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence 999999999999999999999886543221 112345788999999986543 68899999999999999999999
Q ss_pred CCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 550 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+........ ...... ... +.+ ..+......+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~------~~~~~~-~~~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 233 LFDMHPVKT------LFKIPR-NPP-----PTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCCCcHHHH------HHHHhc-CCC-----CCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 854322111 011110 000 000 1122344578999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.94 Aligned_cols=261 Identities=22% Similarity=0.262 Sum_probs=198.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC---CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
..+|...+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999743 3578999987653 23458999999999999999999999989999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|++. ++|.+++.. ...++|..++.++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 166 e~~~-~~l~~~l~~----------------~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~ 225 (392)
T PHA03207 166 PKYK-CDLFTYVDR----------------SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAV 225 (392)
T ss_pred hhcC-CCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEE
Confidence 9996 678887732 246999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++....... .......||..|+|||++....++.++|||||||++|||++|+.||..............+...
T Consensus 226 l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~ 305 (392)
T PHA03207 226 LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305 (392)
T ss_pred EccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHH
Confidence 999999976643322 1223456899999999999999999999999999999999999998654432211111111111
Q ss_pred Hhhc----------hhhhh---hchhhhcccC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKEN----------KLLEI---LDARVAKEAR-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~----------~~~~~---~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .+.+. .....+..+. ......+.+++.+||..||++|||+.|++.+
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1000 00000 0000000000 1123567889999999999999999999875
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=314.54 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=194.3
Q ss_pred cCCccccc--CcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 338 QSRFLGQG--GFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 338 ~~~~ig~G--~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
..++||+| +|++||++.. .+|+.||+|+++.. .....+.+.+|+++++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 47899999998653 2334456778999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ...+++..++.++.|++.||+|||+++ ++||||||+|||++.++.++++|
T Consensus 82 ~~~~l~~~~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~ 144 (327)
T cd08227 82 AYGSAKDLICTHF--------------MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG 144 (327)
T ss_pred CCCcHHHHHHhhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcc
Confidence 9999999986432 135899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcc------eecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 493 FGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 493 fGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
|+........... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~- 221 (327)
T cd08227 145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE- 221 (327)
T ss_pred cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH-
Confidence 9876543211110 0112346778999999976 4588999999999999999999999864322110 000
Q ss_pred HHHHHhhchhhhhhc-------------------h-----------------hhhcccCHHHHHHHHHHHHhccccCCCC
Q 039736 565 FISLAKENKLLEILD-------------------A-----------------RVAKEAREEDIEAVAELAMGCLRLNSKK 608 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d-------------------~-----------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 608 (633)
... ......++ . .............+.+|+.+||+.||++
T Consensus 222 ---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 222 ---KLN-GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred ---Hhc-CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 000 00000000 0 0000112234567899999999999999
Q ss_pred CCCHHHHHHH
Q 039736 609 RPTMKQVSMD 618 (633)
Q Consensus 609 RPt~~ev~~~ 618 (633)
|||+.|++++
T Consensus 298 Rpt~~ell~~ 307 (327)
T cd08227 298 RPSASTLLNH 307 (327)
T ss_pred cCCHHHHhcC
Confidence 9999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=310.79 Aligned_cols=265 Identities=23% Similarity=0.363 Sum_probs=203.7
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 401 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~ 401 (633)
+.++.+..+.++|+..+.||+|+||.||++... +++.+|+|.++.... ....+.+|+.+++++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334666778899999999999999999999853 678999998765322 235677899999999 69999999998853
Q ss_pred -----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 402 -----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 402 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
++..++||||+++|+|.+++..... ....+++..+..++.|+++||.|||+++ ++|||||
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk 151 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK------------RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVK 151 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc------------cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCC
Confidence 3468999999999999998764321 0236889999999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
|+||++++++.+||+|||+++....... ......|+..|+|||++.. ..++.++||||||+++|||++|+.|+.
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~ 230 (286)
T cd06638 152 GNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230 (286)
T ss_pred HHhEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence 9999999999999999999986543221 1223458999999999853 447889999999999999999999985
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
....... + ..... . ..+.. ..+......+.+|+.+||+.||++|||+.|+++++
T Consensus 231 ~~~~~~~--~----~~~~~-~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 231 DLHPMRA--L----FKIPR-N-----PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred CCchhHH--H----hhccc-c-----CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 4322110 0 00000 0 00000 01122345688999999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.53 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=201.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999854 688999998775433 3677899999999999999999999999988999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~ 141 (264)
T cd06626 81 CSGGTLEELLEHG----------------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLG 141 (264)
T ss_pred CCCCcHHHHHhhc----------------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEc
Confidence 9999999998642 24889999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceec---ccccCCCcCchhccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTT---AVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~---~~~gt~~y~APE~l~~~~---~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
|||++............ ...++..|+|||++.+.. .+.++||||||+++|||++|+.||....... ...
T Consensus 142 d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~ 216 (264)
T cd06626 142 DFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIM 216 (264)
T ss_pred ccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHH
Confidence 99999876443322211 345788999999998766 8899999999999999999999985432111 000
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
..... . ..+.+ .........+.+++.+||+.+|++||++.|++.
T Consensus 217 ~~~~~-~-----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 217 FHVGA-G-----HKPPI--PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHhc-C-----CCCCC--CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0 00001 011123567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.34 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=195.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|...+.||+|+||.||++... .++.||||.... ..+.+|+++|++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36888899999999999999965 578899996432 24568999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
. ++|.+++... ...++|.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 243 ~-~~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 243 R-SDLYTYLGAR---------------LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred C-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcc
Confidence 5 6888877542 236999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchh-hh----hcHHHHHH
Q 039736 493 FGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE-EE----RNLVAYFI 566 (633)
Q Consensus 493 fGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~-~~----~~l~~~~~ 566 (633)
||+++....... .......||..|+|||++.+..++.++|||||||+||||++|..++...... .. ..+...+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 999986543221 1222356999999999999999999999999999999999988765432211 10 11111111
Q ss_pred HHHh-hc--------hhhhhhchh----hhcccC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAK-EN--------KLLEILDAR----VAKEAR-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~-~~--------~~~~~~d~~----l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .. ++...+... ...... ......+.+|+.+||+.||.+|||+.|++++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1000 00 000000000 000000 0122467899999999999999999999875
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=301.95 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=201.3
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||++.. .+++.+|+|.+... .....+.+.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999885 36889999987643 334567889999999999999999999999988899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC-CcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-FSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-~~~kI 490 (633)
+++++|.+++.... ...+++..+++++.++++||.|||+++ ++||||+|+||+++++ +.+||
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l 143 (256)
T cd08220 81 APGGTLAEYIQKRC--------------NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143 (256)
T ss_pred CCCCCHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEE
Confidence 99999999986532 235899999999999999999999998 9999999999999854 56899
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .......
T Consensus 144 ~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~ 215 (256)
T cd08220 144 GDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS 215 (256)
T ss_pred ccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh
Confidence 99999987643321 123457889999999998889999999999999999999999985433211 1111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....+......+.+++.+||+.+|++|||+.|++.+
T Consensus 216 ~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 G----------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred c----------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0 0011222345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=317.92 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=197.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC------
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET------ 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------ 402 (633)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999853 6789999998652 334456788999999999999999999987643
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
...|+||||+++ +|.+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 159 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 159 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------------------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEE
Confidence 246999999975 6666552 24788899999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.++.+||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 160 ~~~~~~kL~DfG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-- 235 (364)
T cd07875 160 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN-- 235 (364)
T ss_pred CCCCcEEEEeCCCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 999999999999998653321 2233468999999999999999999999999999999999999996554322110
Q ss_pred HHHHHHHhh----------chhhhhhch--------------hh----hcccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 563 AYFISLAKE----------NKLLEILDA--------------RV----AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 563 ~~~~~~~~~----------~~~~~~~d~--------------~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
.+...... ......... .. ...........+.+|+.+||+.||.+|||+.|
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 236 -KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred -HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 00000000 000000000 00 00001112356889999999999999999999
Q ss_pred HHHH
Q 039736 615 VSMD 618 (633)
Q Consensus 615 v~~~ 618 (633)
++++
T Consensus 315 ~L~h 318 (364)
T cd07875 315 ALQH 318 (364)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.19 Aligned_cols=266 Identities=25% Similarity=0.364 Sum_probs=202.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|++|.||+|... +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999965 5789999987643 23345678999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++++.|..+... ...+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl 141 (288)
T cd07833 81 YVERTLLELLEAS----------------PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKL 141 (288)
T ss_pred cCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEE
Confidence 9998776655432 235899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH--
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS-- 567 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~-- 567 (633)
+|||++...............++..|+|||++.+. .++.++||||||+++|||++|+.|+......+..........
T Consensus 142 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 221 (288)
T cd07833 142 CDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL 221 (288)
T ss_pred EeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999987654433233345678899999999887 789999999999999999999999865433221100000000
Q ss_pred ------HH-hhc-----hhhhhhchh-hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 ------LA-KEN-----KLLEILDAR-VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ------~~-~~~-----~~~~~~d~~-l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ... ...+..++. ....++...+..+.+++++||..+|++||++++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000 000000000 0111222336789999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=320.80 Aligned_cols=246 Identities=26% Similarity=0.441 Sum_probs=203.2
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.|+.++.||.|+||.||.++. .+.+.||||++.-. ..+.+++++.|+.+|++++|||++.+.||+..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678899999999999994 47889999998754 34456788999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+- ||-.|.+.-++ +++-...+.-|..+.+.||.|||+++ .||||||+.||||++.|.||+
T Consensus 107 YCl-GSAsDlleVhk---------------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK---------------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred HHh-ccHHHHHHHHh---------------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeee
Confidence 995 57777775443 47888999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+|||.|..... ...++||+.|||||++ ..|+|+.|+||||+|+...||.-.++|...... ......
T Consensus 168 aDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYH 236 (948)
T KOG0577|consen 168 ADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH 236 (948)
T ss_pred ccccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHH
Confidence 99999876532 3457899999999987 468999999999999999999999999753221 111111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
+..++ .|.+. ..+.+..+.+++..||++-|.+|||..+++++-
T Consensus 237 IAQNe------sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 237 IAQNE------SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred HHhcC------CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 11111 12222 356678899999999999999999999998764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=312.52 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=201.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999965 489999998765322 34567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++
T Consensus 81 e~~~~~~L~~~~~~~~--------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~ 143 (316)
T cd05574 81 DYCPGGELFRLLQRQP--------------GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIM 143 (316)
T ss_pred EecCCCCHHHHHHhCC--------------CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEE
Confidence 9999999999886432 236899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcc----------------------------eecccccCCCcCchhccccCCCCcccchhhHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTH----------------------------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 541 (633)
Q Consensus 490 I~DfGla~~~~~~~~~----------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ 541 (633)
|+|||++......... ......|+..|+|||.+.+..++.++||||||+++|
T Consensus 144 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~ 223 (316)
T cd05574 144 LSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223 (316)
T ss_pred EeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHH
Confidence 9999998754321110 111235788999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 039736 542 ELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT----MKQVSM 617 (633)
Q Consensus 542 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt----~~ev~~ 617 (633)
||++|+.||........ +.. +.+..............+.+++.+||+.||++||+ +.|++.
T Consensus 224 ~l~~g~~pf~~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 224 EMLYGTTPFKGSNRDET------FSN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHhhCCCCCCCCchHHH------HHH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 99999999864432211 111 11111111111124678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=318.55 Aligned_cols=258 Identities=21% Similarity=0.316 Sum_probs=195.5
Q ss_pred HHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET----- 402 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~----- 402 (633)
...++|...+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 467899999886532 23345678999999999999999999987643
Q ss_pred -CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 403 -EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 403 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
...++++|++ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil 150 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----------------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVA 150 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEE
Confidence 3468999988 7788777642 35899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+++++.+||+|||+++...... ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 151 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-- 224 (343)
T cd07878 151 VNEDCELRILDFGLARQADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-- 224 (343)
T ss_pred ECCCCCEEEcCCccceecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--
Confidence 9999999999999998654321 23458999999999876 5688999999999999999999999865432211
Q ss_pred HHHHHHHHHhh-----------chhhhhhchhhhcccC--------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKE-----------NKLLEILDARVAKEAR--------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~-----------~~~~~~~d~~l~~~~~--------~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......... ......+. .+. ..+ ......+.+|+.+||+.||++|||+.|++.+
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 225 -LKRIMEVVGTPSPEVLKKISSEHARKYIQ-SLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -HHHHHHHhCCCCHHHHHhcchhhHHHHhh-ccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0001100000 00000000 000 000 1123457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=302.48 Aligned_cols=257 Identities=27% Similarity=0.408 Sum_probs=204.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||.|+||.||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999953 67899999886432 23567889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++..... ...+++.....++.|++.||.|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~ 144 (267)
T cd06610 81 LSGGSLLDIMKSSYP-------------RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIA 144 (267)
T ss_pred cCCCcHHHHHHHhcc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEc
Confidence 999999999865321 136899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcc---eecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 492 DFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 492 DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
|||++......... ......|+..|+|||++... .++.++|+||||+++|||++|+.|+....... .+..
T Consensus 145 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~ 218 (267)
T cd06610 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLML 218 (267)
T ss_pred ccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHH
Confidence 99998766433222 22334588999999998877 78999999999999999999999986432211 0111
Q ss_pred HHhhchhhhhhchhhhccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ..+.+.... ....+..+.+++.+||+.||++||++.|++++
T Consensus 219 ~~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 219 TLQN------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HhcC------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111 001111111 12345778999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=311.91 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=199.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 58899999876432 2234578899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.++... ...++|..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|
T Consensus 81 ~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l 141 (286)
T cd07846 81 FVDHTVLDDLEKY----------------PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKL 141 (286)
T ss_pred cCCccHHHHHHhc----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEE
Confidence 9999888876543 135899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+. ........
T Consensus 142 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~---~~~~~~~~ 217 (286)
T cd07846 142 CDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ---LYHIIKCL 217 (286)
T ss_pred EeeeeeeeccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH---HHHHHHHh
Confidence 99999987543322 2223457889999999875 4578899999999999999999988864432111 00000000
Q ss_pred hh--chhhhhhc----------hhhh-----cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KE--NKLLEILD----------ARVA-----KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~--~~~~~~~d----------~~l~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ....+.++ +... .......+..+.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 00000000 0000 00112345779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=311.42 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=160.9
Q ss_pred CCcccccCcEEEEEEEcC---CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceEEEEeecc
Q 039736 339 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYIS 413 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~ 413 (633)
.++||+|+||.||+|... +++.||+|.++.... ...+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 457899998865322 2356789999999999999999999864 345789999986
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee----cCCCcEE
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAK 489 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~k 489 (633)
++|.+++........ ......+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+|
T Consensus 84 -~~l~~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07868 84 -HDLWHIIKFHRASKA-------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred -CCHHHHHHhcccccc-------cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence 478777754321100 011235899999999999999999999999 9999999999999 4668999
Q ss_pred EeecCCCccCCCCCcc--eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 490 VSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 490 I~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
|+|||+++........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999999876433221 2234568999999999876 45889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=307.55 Aligned_cols=262 Identities=25% Similarity=0.330 Sum_probs=202.0
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999964 68999999887543 33456789999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+ +++|.+++.... ..+++.+++.++.||++||+|||+++ ++|+||||+||+++.++.++|+
T Consensus 81 ~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~ 141 (286)
T cd07832 81 M-PSDLSEVLRDEE---------------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIA 141 (286)
T ss_pred c-CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEe
Confidence 9 999999886432 36899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++...............++..|+|||.+.+. .++.++||||+|+++|||++|+.++......+. .........
T Consensus 142 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~ 218 (286)
T cd07832 142 DFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLG 218 (286)
T ss_pred eeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcC
Confidence 9999987654432223345688999999998654 468899999999999999999877754332211 111111111
Q ss_pred hch---------hhhhhc---hh----hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENK---------LLEILD---AR----VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~---------~~~~~d---~~----l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... +.++.. +. .......+....+.+++.+||+.||++||++++++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000000 00 0000112334788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.99 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=200.1
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
|.....||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 334567999999999999853 6889999998765555667889999999999999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
++|.+++.. ..+++..++.++.||+.||.|||+++ ++||||||+||++++++.+||+|||
T Consensus 104 ~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg 163 (292)
T cd06658 104 GALTDIVTH-----------------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFG 163 (292)
T ss_pred CcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCc
Confidence 999988743 25889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ +.. .
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~------~ 230 (292)
T cd06658 164 FCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRR------I 230 (292)
T ss_pred chhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH------H
Confidence 9876533221 12234588999999999888899999999999999999999999864332111 100 0
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+.+.+. ........+.+++.+||..||++|||+.|++++
T Consensus 231 ~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 231 RDNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HhcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011111111 111234578899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=303.11 Aligned_cols=252 Identities=24% Similarity=0.492 Sum_probs=201.6
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+|+..+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999984 578999999876422 2235688999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF- 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 486 (633)
|+||+++++|.+++... .++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++
T Consensus 81 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~ 141 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----------------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQ 141 (268)
T ss_pred EEeccCCCcHHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 99999999999988542 35889999999999999999999998 99999999999998775
Q ss_pred cEEEeecCCCccCCCCCc---ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
.+||+|||++........ .......++..|+|||.+.+..++.++||||+|+++|||++|+.|+........ ..
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~ 218 (268)
T cd06630 142 RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LA 218 (268)
T ss_pred EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HH
Confidence 699999999977643211 112234578899999999888899999999999999999999999853322111 11
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
..... .........+......+.+++.+||+.+|++||++.|++.
T Consensus 219 ~~~~~---------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 219 LIFKI---------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHH---------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11100 0001112334455678899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=303.01 Aligned_cols=254 Identities=24% Similarity=0.446 Sum_probs=198.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC----------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID----------KTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~----------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 403 (633)
+|...+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667889999999999999853 68899999875311 112346788999999999999999999999989
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++|+||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~ 142 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----------------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVD 142 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEc
Confidence 999999999999999988653 35899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+++.++|+|||+++........ ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+......+.
T Consensus 143 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-- 220 (272)
T cd06629 143 ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-- 220 (272)
T ss_pred CCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--
Confidence 9999999999999865432211 123345889999999987654 78999999999999999999999853222110
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ....... .. +........+.+..+.+++.+||+.+|++||++.+|+++
T Consensus 221 ---~-~~~~~~~-~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 ---M-FKLGNKR-SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---H-HHhhccc-cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0 0000000 00 001111122345788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=338.50 Aligned_cols=278 Identities=26% Similarity=0.424 Sum_probs=219.4
Q ss_pred HHHHHhcCCccCCcccccCcEEEEEEEcC----C----CCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEE
Q 039736 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLP----D----GSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLG 397 (633)
Q Consensus 328 el~~~~~~~~~~~~ig~G~~G~Vy~g~~~----~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g 397 (633)
.++...++....+.||+|.||.|++|... . ...||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34444555666679999999999999842 1 357999998863 345677899999999999 5999999999
Q ss_pred EEeeCCceEEEEeeccCCCchhhcchhh-hhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 398 CCLETEVPVLVYEYISNGTLSHHIHDHQ-QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 398 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
+|..++..++|+||++.|+|.++|+..+ ........ ........|+..+.+.++.|||.|++||++.. ++||||.
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~-~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG-VFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccC-CCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence 9999999999999999999999998876 10000000 00000024999999999999999999999988 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCcceecccc--cCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ--GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLT 553 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~ 553 (633)
++|||++++..+||+|||+|+.......+...... -...|||||.+....++.|+|||||||+||||+| |..|+..-
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999987655554433322 3557999999999999999999999999999999 77776431
Q ss_pred chhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
.... .+.+.+.+..+.+.|..+..+++++|+.||+.+|++||++.|+++.|+.+..
T Consensus 526 ~~~~---------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 526 PPTE---------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CcHH---------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1111 1122333444456677888999999999999999999999999999999643
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=307.97 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=196.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+.|...+.||+|+||.||+|... +|+.||+|.+... .....+++.+|+++++.++||||+++.+++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999964 6889999987532 2344567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+|
T Consensus 95 e~~~-g~l~~~~~~~---------------~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 95 EYCL-GSASDILEVH---------------KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred HhhC-CCHHHHHHHc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEE
Confidence 9997 5776666432 236899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+........ ..
T Consensus 156 L~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~ 224 (307)
T cd06607 156 LADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY 224 (307)
T ss_pred EeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH
Confidence 9999998765322 2235788999999874 46688999999999999999999999854322111 00
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
...... .....+......+.+++.+||+.||++||++.+++.+.
T Consensus 225 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 225 HIAQND---------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred HHhcCC---------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000000 00111223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.38 Aligned_cols=259 Identities=23% Similarity=0.406 Sum_probs=201.7
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee-
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE- 401 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~- 401 (633)
+..++..+...|+..+.||+|+||.||+|.. .+++.+|+|...... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4455556678899999999999999999996 467899999876533 3345688899999998 69999999999863
Q ss_pred -----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 402 -----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 402 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~ 148 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--------------GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIK 148 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCC
Confidence 346799999999999999886432 235888899999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
|+||++++++.++|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.
T Consensus 149 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 149 GQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred HHHEEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999876532211 122345889999999885 3457889999999999999999999985
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
........ ... .............+..+.+++.+||+.||.+||++.|+++
T Consensus 228 ~~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 228 DMHPMRAL------FLI---------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccCHHhhh------hhH---------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 43221110 000 0000001112234567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.02 Aligned_cols=202 Identities=24% Similarity=0.386 Sum_probs=160.9
Q ss_pred CCcccccCcEEEEEEEcC---CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceEEEEeecc
Q 039736 339 SRFLGQGGFGTVYKGMLP---DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVLVYEYIS 413 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~LV~E~~~ 413 (633)
.++||+|+||.||+|... ++..||+|.++.... ...+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999964 357899998875332 2357789999999999999999999864 456789999987
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee----cCCCcEE
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAK 489 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~~~~k 489 (633)
+ +|.+++....... .......+++..+.+++.|++.||.|||+.+ ++||||||+|||+ +.++++|
T Consensus 84 ~-~l~~~~~~~~~~~-------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~k 152 (317)
T cd07867 84 H-DLWHIIKFHRASK-------ANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 152 (317)
T ss_pred C-cHHHHHHhhhccc-------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEE
Confidence 4 7777775332100 0011235899999999999999999999998 9999999999999 5678999
Q ss_pred EeecCCCccCCCCCcc--eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 490 VSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 490 I~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
|+|||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred EeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999999876433221 1233568999999999876 45789999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.77 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=201.1
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.|+..+.||+|+||.||+++. .++..||+|++... .......+.+|++++++++|+|++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788899999999999995 46889999987642 23345678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+. |+|.+++... ...++|.++..++.+++.||.|||+.+ ++||||+|+||+++.++.+||
T Consensus 106 ~~~-g~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl 166 (317)
T cd06635 106 YCL-GSASDLLEVH---------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 166 (317)
T ss_pred CCC-CCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEE
Confidence 997 5777766432 236899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+|||++...... ....++..|+|||++. .+.++.++||||||+++|||++|+.|+........ ...
T Consensus 167 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~ 235 (317)
T cd06635 167 ADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH 235 (317)
T ss_pred ecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH------HHH
Confidence 999998764322 2235788999999973 46788999999999999999999999854322111 011
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
..... ............+.+++.+||+.+|.+||++.++++++..+....+.
T Consensus 236 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 236 IAQNE---------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHhcc---------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 11100 00111223456789999999999999999999999987655544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.34 Aligned_cols=262 Identities=22% Similarity=0.326 Sum_probs=196.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999964 68899999876432 22234677899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++ ++|.+++... ...+++..++.++.||++||.|||+.+ ++||||||+||+++.++++||+
T Consensus 81 ~~-~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~ 141 (284)
T cd07839 81 CD-QDLKKYFDSC---------------NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLA 141 (284)
T ss_pred CC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEEC
Confidence 97 5787776542 235899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ . .........
T Consensus 142 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~-~~~~~~~~~ 218 (284)
T cd07839 142 DFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-Q-LKRIFRLLG 218 (284)
T ss_pred ccchhhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-H-HHHHHHHhC
Confidence 99999865432211 1234578899999998764 468999999999999999999998643322111 1 111111110
Q ss_pred hc------hhhhhhchhhh---------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 EN------KLLEILDARVA---------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~------~~~~~~d~~l~---------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ...+..+.... ..........+.+++.+||+.||.+|||+.|++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00 00000010000 01112245678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=295.31 Aligned_cols=250 Identities=31% Similarity=0.476 Sum_probs=204.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999877655566789999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||+|+||++++++.++|+||
T Consensus 81 ~~~L~~~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~ 142 (253)
T cd05122 81 GGSLKDLLKSTN---------------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDF 142 (253)
T ss_pred CCcHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeec
Confidence 999999886531 36899999999999999999999988 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|.+........ .....++..|++||.+.+...+.++||||||++++||++|+.|+......... ..... ..
T Consensus 143 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~ 213 (253)
T cd05122 143 GLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NG 213 (253)
T ss_pred ccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cC
Confidence 99987654332 23456889999999999888999999999999999999999998543221110 00000 00
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... + ..+......+.+++.+||+.||++|||+.|++++
T Consensus 214 ~~~-----~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 214 PPG-----L--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCC-----c--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0 0111124678999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=299.86 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=206.2
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|++|.||++... +++.|+||++..... ...+.+.+|+..+++++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999975 589999999876543 4567899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++||||+|+||+++.++.++|
T Consensus 81 ~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l 141 (264)
T cd06623 81 MDGGSLADLLKKV----------------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKI 141 (264)
T ss_pred cCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEE
Confidence 9999999998643 368999999999999999999999 88 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++......... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+........ .........
T Consensus 142 ~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~ 217 (264)
T cd06623 142 ADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAICD 217 (264)
T ss_pred ccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHhc
Confidence 999999876433222 1234578899999999999999999999999999999999999854432111 111111111
Q ss_pred hchhhhhhchhhhcccCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....+.. .+..+.+++.+||+.+|++||++.|++++
T Consensus 218 ~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 G----------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C----------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 01112223 56789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=301.99 Aligned_cols=247 Identities=24% Similarity=0.423 Sum_probs=200.4
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
-|+..+.||+|+||.||+|.. .+++.||+|..... .....+.+.+|++++++++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 356678899999999999985 36889999987643 2344567889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 85 ~~~~l~~~i~~-----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~d 144 (277)
T cd06641 85 GGGSALDLLEP-----------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLAD 144 (277)
T ss_pred CCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEee
Confidence 99999988853 25899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..... ..
T Consensus 145 fg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~- 215 (277)
T cd06641 145 FGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PK- 215 (277)
T ss_pred cccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hc-
Confidence 999876543221 1223457889999999998889999999999999999999999985322111 00000 00
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 216 --------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 --------NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --------CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111223345678899999999999999999999995
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.36 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=203.8
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788899999999999999985 367899999987655555678899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|
T Consensus 99 ~~~~L~~~~~~-----------------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~d 158 (293)
T cd06647 99 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 158 (293)
T ss_pred CCCcHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEcc
Confidence 99999998853 24789999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++......... .....+++.|+|||.+..+.++.++|+||||+++|||++|+.||.......... .....
T Consensus 159 fg~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~- 230 (293)
T cd06647 159 FGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN- 230 (293)
T ss_pred Ccceecccccccc-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcC-
Confidence 9998765433221 223457889999999988889999999999999999999999986433221100 00000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+......+......+.+++.+||+.+|++||++.+++.+
T Consensus 231 -------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 -------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011122344678899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=316.82 Aligned_cols=240 Identities=27% Similarity=0.366 Sum_probs=186.6
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc---CCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI---NHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
||+|+||.||+|... +|+.||||++... .......+..|..++.+. +||||+++.+.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 6899999987542 122334556677777665 699999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 81 g~L~~~l~~~----------------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg 141 (330)
T cd05586 81 GELFWHLQKE----------------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFG 141 (330)
T ss_pred ChHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCC
Confidence 9998887542 35899999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
+++....... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....... +.
T Consensus 142 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~ 213 (330)
T cd05586 142 LSKANLTDNK-TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAF-GK 213 (330)
T ss_pred cCcCCCCCCC-CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHc-CC
Confidence 9976432221 22345689999999998764 47899999999999999999999986543221 1111111 00
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP----TMKQVSM 617 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP----t~~ev~~ 617 (633)
. .+. .......+.+++.+||+.||++|| ++.|+++
T Consensus 214 ~------~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 V------RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C------CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 000 112345678999999999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.47 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=199.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999964 57899999876543 234567889999999999999999999999888999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 81 e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~ 141 (305)
T cd05609 81 EYVEGGDCATLLKNI----------------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIK 141 (305)
T ss_pred ecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEE
Confidence 999999999998542 35899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCC--------------CcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 490 VSDFGTSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 490 I~DfGla~~~~~~--------------~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
|+|||+++..... .........++..|+|||.+.+..++.++|+||||+++|||++|+.||.....
T Consensus 142 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 142 LTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred EeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999998742100 00011123578899999999888899999999999999999999999864332
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
.+ ......... ...+. .....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 222 ~~------~~~~~~~~~----~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 222 EE------LFGQVISDD----IEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HH------HHHHHHhcc----cCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 21 111111100 00000 011345678999999999999999996655555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.56 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=205.6
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
..+++|+..+.||+|++|.||+|..+ +++.+++|.+..... ..+.+.+|++++++++|+|++++++.+...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999975 688999999876544 4567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 95 e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~ 156 (286)
T cd06614 95 EYMDGGSLTDIITQNF---------------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156 (286)
T ss_pred eccCCCcHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEE
Confidence 9999999999986532 26999999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||++........ ......++..|++||.+.+..++.++|+||||+++|||++|+.|+........ .....
T Consensus 157 l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~ 229 (286)
T cd06614 157 LADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLIT 229 (286)
T ss_pred ECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999876533221 11233478899999999988899999999999999999999999854332211 00000
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ..... ...+......+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~-~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 230 T-KGIPP-------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred h-cCCCC-------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 00000 01112245678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=309.40 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=198.4
Q ss_pred cCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 338 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999854 688999999865444456678899999999999999999999999999999999999999
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCC
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 496 (633)
|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 105 L~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 105 LTDIVSQ-----------------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred HHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhH
Confidence 9887632 35899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhh
Q 039736 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLE 576 (633)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (633)
........ ......|+..|+|||++.+..++.++||||||+++|||++|+.||......+. ...... ..
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~--- 233 (297)
T cd06659 165 AQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKRLRD-SP--- 233 (297)
T ss_pred hhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-cC---
Confidence 76533221 12335688999999999988899999999999999999999999864332221 111100 00
Q ss_pred hhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 577 ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 577 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+.. .........+.+++.+||+.+|++||++.|++++
T Consensus 234 --~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 234 --PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0111234568899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=303.38 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=202.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999975 68899999877643 345567899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++++|.+++.... ..+++....+++.|++.||+|||+ .+ ++||||||+||++++++.++|+
T Consensus 82 ~~~~L~~~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~ 143 (265)
T cd06605 82 DGGSLDKILKEVQ---------------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLC 143 (265)
T ss_pred CCCcHHHHHHHcc---------------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEe
Confidence 9999999886531 368899999999999999999999 88 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||.+......... ...++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .............
T Consensus 144 d~g~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~ 219 (265)
T cd06605 144 DFGVSGQLVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE 219 (265)
T ss_pred ecccchhhHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC
Confidence 99998765322111 1557889999999999899999999999999999999999985432111 1111111111111
Q ss_pred chhhhhhchhhhcccCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ....+.. ....+.+++.+||..||++|||+.|++.+
T Consensus 220 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 P----------PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred C----------CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 0111122 45678999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=305.77 Aligned_cols=262 Identities=24% Similarity=0.358 Sum_probs=197.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999864 68899999876432 22345788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+
T Consensus 81 ~~-~~l~~~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~ 142 (284)
T cd07860 81 LH-QDLKKFMDASP--------------LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLA 142 (284)
T ss_pred cc-cCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEe
Confidence 96 68888875432 246899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++........ ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+ ...........
T Consensus 143 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~ 219 (284)
T cd07860 143 DFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGT 219 (284)
T ss_pred eccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 9999876533221 112234678999999887644 5889999999999999999999986543221 11111110000
Q ss_pred h-c--------------hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 E-N--------------KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~-~--------------~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. . ....+....+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 220 PDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred CChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0 0 0000000000 00011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.99 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=200.9
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 345567999999999999985 4688999998876555556678999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+||
T Consensus 100 ~~~L~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~ 159 (285)
T cd06648 100 GGALTDIVTH-----------------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDF 159 (285)
T ss_pred CCCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEccc
Confidence 9999988754 25889999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ........
T Consensus 160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~~~-- 230 (285)
T cd06648 160 GFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIRDN-- 230 (285)
T ss_pred ccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHhc--
Confidence 99876543322 1223458899999999988889999999999999999999999985432211 11111100
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
..+.. ..+......+.+++.+||+.+|++||++.|+++
T Consensus 231 ----~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 ----LPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ----CCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 00111 011224467899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.18 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=200.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999964 6899999987642 2234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+|
T Consensus 81 e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~k 141 (290)
T cd05580 81 EYVPGGELFSHLRKS----------------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIK 141 (290)
T ss_pred ecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 999999999988653 36899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++..... .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+....... ......
T Consensus 142 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~ 211 (290)
T cd05580 142 ITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL 211 (290)
T ss_pred EeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh
Confidence 9999999876443 223458899999999988888999999999999999999999986433211 000111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSM 617 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~ 617 (633)
.+ ....+......+.+++.+||+.||.+|| +++|++.
T Consensus 212 -~~----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 212 -EG----------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cC----------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 00 0112233356788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.79 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=201.0
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC-----
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE----- 403 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~----- 403 (633)
.++++|+..+.||+|++|.||+|... +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999964 578999998776443 346788999999999 6999999999997654
Q ss_pred -ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 404 -VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 404 -~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~ 146 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK------------KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh------------cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEE
Confidence 37999999999999998865321 0246899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++++.+||+|||++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.|+.......
T Consensus 147 ~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 225 (275)
T cd06608 147 TKNAEVKLVDFGVSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225 (275)
T ss_pred ccCCeEEECCCccceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence 9999999999999876533221 1223458889999998753 346789999999999999999999985322111
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ....... ..+. ...+......+.+++.+||..||++|||+.|++++
T Consensus 226 ~------~~~~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 A------LFKIPRN------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred H------HHHhhcc------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0011100 0001 11122355688999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=301.47 Aligned_cols=248 Identities=25% Similarity=0.449 Sum_probs=198.8
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccC---CCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.|+..+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.++++++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 46899999987643 3345567889999999997 999999999999988999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++.. ..+++...+.++.|++.||.|||+.+ ++||||+|+||++++++.++
T Consensus 82 e~~~~~~L~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~ 141 (277)
T cd06917 82 EYAEGGSVRTLMKA-----------------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVK 141 (277)
T ss_pred ecCCCCcHHHHHHc-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEE
Confidence 99999999988743 25899999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++......... .....|+..|+|||.+.++ .++.++|+||||+++|||++|+.|+........ .. .
T Consensus 142 l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-~ 213 (277)
T cd06917 142 LCDFGVAALLNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-L 213 (277)
T ss_pred EccCCceeecCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-c
Confidence 9999999876443321 2234588899999998764 468899999999999999999999864322111 00 0
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ..+.+.. ......+.+++.+||+.||++||++.|++.+
T Consensus 214 ~~~~-----~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 214 IPKS-----KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cccC-----CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0000 0011111 1145678899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=302.96 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=193.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHH-HhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVI-LSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~i-l~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++..+|+||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999964 68999999886532 2233456666665 666789999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|++ |+|.+++...... ...+++..+++++.|++.||+|||++ + ++||||||+||+++.++.+|
T Consensus 81 ~~~-~~l~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~k 144 (283)
T cd06617 81 VMD-TSLDKFYKKVYDK------------GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVK 144 (283)
T ss_pred hhc-ccHHHHHHHhccC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEE
Confidence 997 6888877543210 24689999999999999999999987 6 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc----CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
|+|||+++...... ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+....... ...
T Consensus 145 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~ 217 (283)
T cd06617 145 LCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQL 217 (283)
T ss_pred Eeeccccccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHH
Confidence 99999998654321 1122457889999998865 446889999999999999999999985321110 001
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... ..+.+ .....+..+.+++.+||..+|++||++.+++.+
T Consensus 218 ~~~~~~------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 218 KQVVEE------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHhc------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111100 00111 011245678999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.12 Aligned_cols=260 Identities=27% Similarity=0.337 Sum_probs=201.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 409 (633)
++|...+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999974 578999998875332 3456789999999999999999999998654 3689999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++..... ....+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++
T Consensus 81 e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~ 145 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK------------RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVK 145 (287)
T ss_pred EecCCCCHHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEE
Confidence 99999999988754221 1246889999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||++........ ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......... .
T Consensus 146 l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~-~ 220 (287)
T cd06621 146 LCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSY-I 220 (287)
T ss_pred Eeecccccccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHH-H
Confidence 999999876532211 12346889999999999999999999999999999999999986542210 011111111 1
Q ss_pred hhchhhhhhchhhhccc--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEA--REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~--~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... +.+.... .......+.+++.+||+.+|++|||+.|++++
T Consensus 221 ~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 221 VNMPN-----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hcCCc-----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11000 1111111 12245678999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.49 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=193.7
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCC------CCceEEEEEE
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINH------RHIVKLLGCC 399 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H------~nIv~l~g~~ 399 (633)
+++...+++|+..++||+|+||.||+|... .++.||||+++.... ..+++..|+.++++++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344455688999999999999999999854 578999999865322 23345567777776654 4688999988
Q ss_pred eeC-CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCC
Q 039736 400 LET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKS 477 (633)
Q Consensus 400 ~~~-~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~ 477 (633)
..+ +..++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .+ |+||||||
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP 260 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----------------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKP 260 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 765 4678999987 67888887542 368999999999999999999998 47 99999999
Q ss_pred CCeeecCCC----------------cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHH
Q 039736 478 SNILLDDKF----------------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 541 (633)
Q Consensus 478 ~NILl~~~~----------------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ 541 (633)
+|||++.++ .+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ 336 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHH
Confidence 999998765 499999998864322 123456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchhhhhcHHHHHH--------HHHhhchhhhh----------hchhhh----ccc---CHHHHHHHHH
Q 039736 542 ELLTGKKPICLTREEEERNLVAYFI--------SLAKENKLLEI----------LDARVA----KEA---REEDIEAVAE 596 (633)
Q Consensus 542 elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~~~~~----------~d~~l~----~~~---~~~~~~~l~~ 596 (633)
||++|+.||......+......... .........++ .++... ... .......+.+
T Consensus 337 elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 416 (467)
T PTZ00284 337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD 416 (467)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence 9999999997654332211111000 00000000000 011000 000 0011356789
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 039736 597 LAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 597 L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|+.+||+.||++|||+.|++++
T Consensus 417 li~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 417 LIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHhCCcChhhCCCHHHHhcC
Confidence 9999999999999999999973
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=304.65 Aligned_cols=262 Identities=23% Similarity=0.311 Sum_probs=199.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV 408 (633)
++|+..+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888899999999999999975 588999998875332 2233567899999999999999999999877 789999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 ~e~~~-~~L~~~~~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~ 145 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---------------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGIL 145 (293)
T ss_pred ehhcC-cCHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcE
Confidence 99997 48888875432 25899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.|+.......... ....
T Consensus 146 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~---~~~~ 221 (293)
T cd07843 146 KICDFGLAREYGSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN---KIFK 221 (293)
T ss_pred EEeecCceeeccCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHH
Confidence 99999999876443211 1234478899999998764 46889999999999999999999986543322110 0000
Q ss_pred HHhh-----------------chhhhhhchhhhcccCHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKE-----------------NKLLEILDARVAKEAREE-DIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~-----------------~~~~~~~d~~l~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ..........+...++.. ....+.+++.+||+.||++|||+.|++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000000111111122222 35678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.02 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=199.0
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEEEe
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVYE 410 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV~E 410 (633)
|+..+.||+|++|.||+|... +|+.+|+|++.... ....+.+.+|++++++++|+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556789999999999999965 57899999987642 33456788999999999999999999999987 78999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++ +|.+++... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++++.+||
T Consensus 81 ~~~~-~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l 141 (287)
T cd07840 81 YMDH-DLTGLLDSP---------------EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKL 141 (287)
T ss_pred cccc-cHHHHHhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEE
Confidence 9975 888877543 136899999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......... .......
T Consensus 142 ~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~ 218 (287)
T cd07840 142 ADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELC 218 (287)
T ss_pred ccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHh
Confidence 9999998765443222233456788999998764 45789999999999999999999998654432211 1111110
Q ss_pred hh---chh--------------hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KE---NKL--------------LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~---~~~--------------~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ... .......+.......++..+.+++.+||..+|.+||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 000 00000111111111135788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=338.74 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=199.3
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
...++|...+.||+|+||.||++... .+..||+|.+.. ........|..|+.++++++||||+++++++.+. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999954 577899998764 2344566889999999999999999999988654 458
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCC----CCeeccCCCCCCee
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAAS----IPIFHRDIKSSNIL 481 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~----~~ivHrDIk~~NIL 481 (633)
||||||+++|+|.++|..... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+|||
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~------------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK------------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 999999999999999965322 02469999999999999999999998542 24999999999999
Q ss_pred ecC-----------------CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHH
Q 039736 482 LDD-----------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLE 542 (633)
Q Consensus 482 l~~-----------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~e 542 (633)
|+. .+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+|||
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYE 235 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHH
Confidence 964 3459999999998764322 2234568999999999854 458899999999999999
Q ss_pred HHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 543 LLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 543 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
|++|+.||....... ..+.. .... +.+. ....+..+.+|+..||+.+|.+||++.|++.
T Consensus 236 LLTGk~PF~~~~~~~-----qli~~-lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 236 LCSGKTPFHKANNFS-----QLISE-LKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHCCCCCCcCCcHH-----HHHHH-HhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999985432211 11111 1100 0000 1123467899999999999999999999984
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.28 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=195.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999965 688999998765322 2234567899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++ +|.+++.... ..+++.....++.|+++||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~~-~L~~~~~~~~---------------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~ 145 (291)
T cd07844 85 LDT-DLKQYMDDCG---------------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLA 145 (291)
T ss_pred CCC-CHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEEC
Confidence 984 8988875432 35889999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..........
T Consensus 146 dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~ 222 (291)
T cd07844 146 DFGLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLG 222 (291)
T ss_pred ccccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcC
Confidence 99998754322111 122346788999999865 4578999999999999999999999864431111 1111111110
Q ss_pred h---chhhhh-------------h-chhhhccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 571 E---NKLLEI-------------L-DARVAKEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 571 ~---~~~~~~-------------~-d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
. ...... . ...+.... .......+.+++.+||+.+|++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 223 TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000 0 00000000 0111267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=285.85 Aligned_cols=254 Identities=26% Similarity=0.406 Sum_probs=203.2
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--------hhHHHHHHHHHHHHhcc-CCCCceEEEEEEe
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--------KTQIEQFINEVVILSQI-NHRHIVKLLGCCL 400 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~ 400 (633)
..-..|...+.||+|..++|-+...+ +|...|+|++.... ..-.+.-.+|+.||+++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34457788899999999999888754 67889999865321 12234556799999998 5999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
.+...++|+|.|+.|.|.|+|... ..++++...+|..|+.+|++|||..+ ||||||||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~----------------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENI 154 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK----------------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENI 154 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh----------------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhhe
Confidence 999999999999999999999763 46999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
|+|++.++||+|||++..+..+.. -+..+||++|+|||.+.. ..|+..+|.||.||+||-|+.|.+||....
T Consensus 155 Llddn~~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk 232 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK 232 (411)
T ss_pred eeccccceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH
Confidence 999999999999999998865543 355789999999998853 357789999999999999999999984210
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+. +..+..+++. ....+...+......+|+.+||+.||.+|.|++|++.+
T Consensus 233 -----Qml--MLR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 233 -----QML--MLRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -----HHH--HHHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 000 1111111111 01122234556788999999999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.40 Aligned_cols=264 Identities=24% Similarity=0.319 Sum_probs=196.3
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++++|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++|+||+++.+++.+++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 356899999999999999999985 3688999998765332 22346778999999999999999999999888999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++++|
T Consensus 83 e~~~-~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 143 (291)
T cd07870 83 EYMH-TDLAQYMIQH---------------PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELK 143 (291)
T ss_pred eccc-CCHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEE
Confidence 9996 6777666432 135788899999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++....... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......+ .+.. .+..
T Consensus 144 l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~ 220 (291)
T cd07870 144 LADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTV 220 (291)
T ss_pred EeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHH
Confidence 999999976432211 11233468899999998754 478899999999999999999999865433211 1111 1110
Q ss_pred Hhhc---------hhhhhhchhhhccc---------CHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 569 AKEN---------KLLEILDARVAKEA---------REEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 569 ~~~~---------~~~~~~d~~l~~~~---------~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.... .+............ .......+.+++.+|++.||.+|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 221 LGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 00000000000000 0112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.24 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=198.3
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChh-----HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKT-----QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~-----~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
+|+..+.||+|++|.||+|... +|+.||||+++..... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999964 6899999998754322 334677899999999999999999999998899999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+ +|+|.+++.... ..+++..+++++.||++||.|||+++ ++||||+|+||+++.++.+
T Consensus 81 ~e~~-~~~L~~~i~~~~---------------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~ 141 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---------------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVL 141 (298)
T ss_pred Eccc-CCCHHHHHhccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCE
Confidence 9999 899999986532 25899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++........ .....++..|+|||.+.+ ..++.++||||||+++|||++|..++......+. +.... .
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~-~ 217 (298)
T cd07841 142 KLADFGLARSFGSPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIF-E 217 (298)
T ss_pred EEccceeeeeccCCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHH-H
Confidence 99999999876443221 122346788999998865 4578899999999999999999777654332111 10111 0
Q ss_pred HHhhc---------hhhhhhchhhhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKEN---------KLLEILDARVAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~---------~~~~~~d~~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... .+............ .......+.+++.+||+.||++|||+.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000 00000000000011 12235678999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.67 Aligned_cols=244 Identities=26% Similarity=0.437 Sum_probs=204.4
Q ss_pred cccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCchh
Q 039736 341 FLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSH 419 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 419 (633)
.||+|.||+||-|+.. +...+|||.+...+....+-+.+||.+.++++|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999964 456799999888777777889999999999999999999999999998899999999999999
Q ss_pred hcchhhhhHHHHHHHHHhhhcCCC--CHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-CCCcEEEeecCCC
Q 039736 420 HIHDHQQQQEQKQELEEEQELSSL--SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 496 (633)
Q Consensus 420 ~l~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kI~DfGla 496 (633)
.|+..- +++ ++...-.+.+||++||.|||++. |||||||-.||||+ -.|.+||+|||-+
T Consensus 662 LLrskW---------------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTs 723 (1226)
T KOG4279|consen 662 LLRSKW---------------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTS 723 (1226)
T ss_pred HHHhcc---------------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccc
Confidence 997653 356 67777888999999999999999 99999999999997 5889999999999
Q ss_pred ccCCCCCcceecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 497 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+.+.. -...+..+.||..|||||++..|+ |..++|||||||.+.||.||++||....... ..++.-+.
T Consensus 724 KRLAg-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGm- 793 (1226)
T KOG4279|consen 724 KRLAG-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGM- 793 (1226)
T ss_pred hhhcc-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhcc-
Confidence 87643 234556678999999999998764 7889999999999999999999985332211 01111110
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
-....+.|.+...+...++.+|+..||.+||++.++++
T Consensus 794 -----yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 794 -----YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred -----eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11234567888899999999999999999999999875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.47 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=200.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|+||.||+|... +|..+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999965 5789999987643 223455788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI 490 (633)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++ .+||
T Consensus 81 ~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l 143 (257)
T cd08225 81 CDGGDLMKRINRQR--------------GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKL 143 (257)
T ss_pred CCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEe
Confidence 99999999986432 135899999999999999999999998 99999999999999885 5699
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|||++|+.|+....... .......
T Consensus 144 ~d~~~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~ 216 (257)
T cd08225 144 GDFGIARQLNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ 216 (257)
T ss_pred cccccchhccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc
Confidence 99999987643221 2223458889999999988889999999999999999999999985432211 1111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..........+.+++.+||+.+|++|||+.|++++
T Consensus 217 -~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 -GYF---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -ccC---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 100 11122334678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.91 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=205.2
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+.|+..+.||.|.-|+||++.+++ +...|+|++.... .....+...|-+||+.++||-+..|++.+..+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345667899999999999999863 4899999987632 334567788999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++||+|...++.+. ...++...+.-+|.+++-||+|||-.| ||.|||||+||||-++|++.
T Consensus 157 eyCpGGdL~~LrqkQp--------------~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--------------GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIM 219 (459)
T ss_pred ecCCCccHHHHHhhCC--------------CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEE
Confidence 9999999998887654 357999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCC---------------------------------C-Cc---------------------ceecccccCC
Q 039736 490 VSDFGTSRSVPN---------------------------------D-KT---------------------HLTTAVQGTF 514 (633)
Q Consensus 490 I~DfGla~~~~~---------------------------------~-~~---------------------~~~~~~~gt~ 514 (633)
|+||.|+..... . .. ......+||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998743210 0 00 0112357999
Q ss_pred CcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHH
Q 039736 515 GYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAV 594 (633)
Q Consensus 515 ~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 594 (633)
.|+|||++.+..++.++|+|+|||+||||+.|+.||.+....+. +..++...+.-......+..+
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHH
Confidence 99999999999999999999999999999999999976654432 222222222222223556788
Q ss_pred HHHHHhccccCCCCCCC----HHHHHH
Q 039736 595 AELAMGCLRLNSKKRPT----MKQVSM 617 (633)
Q Consensus 595 ~~L~~~Cl~~dP~~RPt----~~ev~~ 617 (633)
.+||++.|.+||.+|.. +.||.+
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhc
Confidence 99999999999999998 777654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.97 Aligned_cols=251 Identities=29% Similarity=0.399 Sum_probs=210.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~L 407 (633)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+..... ...+.+.+|+.+|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457888899999999999999965 499999998765322 24568889999999998 9999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC--
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-- 485 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-- 485 (633)
|||+++||.|.+.+... .++......++.|++.++.|||+.+ ++||||||+|+|+...
T Consensus 114 vmEL~~GGeLfd~i~~~-----------------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----------------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDE 173 (382)
T ss_pred EEEecCCchHHHHHHHc-----------------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccC
Confidence 99999999999988542 2889999999999999999999999 9999999999999643
Q ss_pred --CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 --FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 --~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.+|++|||++..... .......+||+.|+|||.+....++.++||||.||++|.|++|..||..........
T Consensus 174 ~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--- 248 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--- 248 (382)
T ss_pred CCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---
Confidence 5799999999998765 334556789999999999999999999999999999999999999997655433211
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... .+.. ....+........+.+++..++..||.+|+|+.+++++
T Consensus 249 ---~i~-~~~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ---AIL-RGDF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ---HHH-cCCC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111 1111 22233345557888999999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=293.20 Aligned_cols=251 Identities=29% Similarity=0.481 Sum_probs=205.7
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 409 (633)
+|+..+.||+|++|.||+|... +++.|++|+..... ....+.+.+|++++++++|+||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999975 68899999876643 24567899999999999999999999999988 7899999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++... ..++|..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 81 e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~ 141 (260)
T cd06606 81 EYVSGGSLSSLLKKF----------------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVK 141 (260)
T ss_pred EecCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEE
Confidence 999999999998643 36899999999999999999999988 99999999999999999999
Q ss_pred EeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||.+......... ......++..|+|||.+.....+.++||||||++++||++|+.|+...... .......
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~ 216 (260)
T cd06606 142 LADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKI 216 (260)
T ss_pred EcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhc
Confidence 9999999876543321 123345788999999998888999999999999999999999998654311 1111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.........+......+.+++.+|++.||++||++.|++.+
T Consensus 217 ---------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 217 ---------GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---------cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11111122334446789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=294.92 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=204.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||++... +++.+++|.+... ......++.+|++++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999853 6789999987643 334456788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+
T Consensus 81 ~~~~~L~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~ 145 (256)
T cd08530 81 APFGDLSKAISKRKK------------KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIG 145 (256)
T ss_pred cCCCCHHHHHHHHHh------------hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEe
Confidence 999999999865321 1246899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++...... ......++..|++||.+.+..++.++|+||||+++|||++|+.|+......+. ......
T Consensus 146 d~g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~ 215 (256)
T cd08530 146 DLGISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RYKVQR 215 (256)
T ss_pred eccchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhc
Confidence 99999876543 22234578899999999998899999999999999999999999865432211 001111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....+......+.+++.+||+.+|++||++.|++++
T Consensus 216 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 G---------KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred C---------CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 1112233456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=300.17 Aligned_cols=262 Identities=23% Similarity=0.354 Sum_probs=198.8
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+|+..+.||+|++|.||+|... +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999964 688999998875432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++ +|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|
T Consensus 81 ~~-~l~~~~~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d 143 (284)
T cd07836 81 DK-DLKKYMDTHGV-------------RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLAD 143 (284)
T ss_pred Cc-cHHHHHHhcCC-------------CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEee
Confidence 85 88888754321 236899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh-
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK- 570 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~- 570 (633)
||++........ ......++..|++||.+.+. .++.++||||||+++|||++|+.|+......+.. ........
T Consensus 144 ~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~ 219 (284)
T cd07836 144 FGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL---LKIFRIMGT 219 (284)
T ss_pred cchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCC
Confidence 999976533221 11223468899999988654 4688999999999999999999998654432211 11111100
Q ss_pred --hchhhhhhc-hhh-----------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 571 --ENKLLEILD-ARV-----------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 571 --~~~~~~~~d-~~l-----------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
+.....+.+ +.+ ...........+.+++.+|++.||.+||++.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 000 01111233567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=295.33 Aligned_cols=242 Identities=29% Similarity=0.366 Sum_probs=196.2
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||.|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999974 48899999876422 23456789999999999999999999999999999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~ 141 (262)
T cd05572 81 WTILRDR----------------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAK 141 (262)
T ss_pred HHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCccc
Confidence 9999653 35889999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... ......++..|++||.+.+..++.++|+||||+++|||++|+.|+.....+. ...... +
T Consensus 142 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~---------~ 206 (262)
T cd05572 142 KLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYND---------I 206 (262)
T ss_pred ccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHH---------H
Confidence 765432 1223457889999999988889999999999999999999999986543211 111111 1
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSM 617 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~ 617 (633)
.+......++......+.+++.+||+.+|++||+ +.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 207 LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111112233334678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=301.89 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=196.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCc-----
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEV----- 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~----- 404 (633)
++|+..+.||+|+||.||+|... +|+.||||..+... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999964 68999999876432 223457888999999995 6999999999987665
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+++ +|.+++...... ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-----------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~ 145 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-----------PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDK 145 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-----------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEec
Confidence 7999999985 888887643220 0236899999999999999999999998 999999999999998
Q ss_pred -CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+. +.
T Consensus 146 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~ 222 (295)
T cd07837 146 QKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL 222 (295)
T ss_pred CCCeEEEeecccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH
Confidence 899999999999865322111 122346788999998865 4578999999999999999999999865432221 11
Q ss_pred HHHHHHHhhchhh---hhh-----------chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKENKLL---EIL-----------DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~~~---~~~-----------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+ ......... ... .+.............+.+++.+||+.||.+||++.|++.+
T Consensus 223 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 223 HIF-KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHH-HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 111 110000000 000 0000001112345678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=303.54 Aligned_cols=265 Identities=28% Similarity=0.375 Sum_probs=198.4
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC----
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE---- 403 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~---- 403 (633)
...++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999975 58899999886532 223346778999999999999999999987654
Q ss_pred ------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 404 ------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 404 ------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
..++|+||+++ +|.+.+... ...+++..++.++.|++.||+|||+.+ ++||||||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p 144 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---------------LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKC 144 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 68999999986 666665432 236899999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......
T Consensus 145 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 145 SNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 99999999999999999998764433222222346778999998865 45788999999999999999999998643322
Q ss_pred hhhcHHHHHHHHHhhc---hhhhhh--------ch------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 557 EERNLVAYFISLAKEN---KLLEIL--------DA------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~---~~~~~~--------d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+. ...+....... ...++. ++ ..... ....+..+.+++.+||+.||.+||++.+++.+
T Consensus 225 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 225 AQ---LELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HH---HHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 11111111110 000000 00 00000 11235678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.74 Aligned_cols=268 Identities=23% Similarity=0.318 Sum_probs=197.5
Q ss_pred CCccCCcccccCcEEEEEEEcC---CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP---DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~ 406 (633)
+|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4677889999999999999964 47899999887632 33345778899999999999999999999987 7799
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-- 484 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 484 (633)
+||||+++ +|.+++...... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~ 145 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQA-----------KRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEG 145 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccC-----------CCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCC
Confidence 99999975 676666433221 0136889999999999999999999998 999999999999999
Q ss_pred --CCcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhh-
Q 039736 485 --KFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEE- 558 (633)
Q Consensus 485 --~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~- 558 (633)
++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||++++||++|+.|+.....+..
T Consensus 146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 225 (316)
T cd07842 146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK 225 (316)
T ss_pred CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence 99999999999987643222 112234578899999988664 578999999999999999999999865433220
Q ss_pred ------hcHHHHHHHHHhhc------------hhhhhhchhhhcccC---------H--HHHHHHHHHHHhccccCCCCC
Q 039736 559 ------RNLVAYFISLAKEN------------KLLEILDARVAKEAR---------E--EDIEAVAELAMGCLRLNSKKR 609 (633)
Q Consensus 559 ------~~l~~~~~~~~~~~------------~~~~~~d~~l~~~~~---------~--~~~~~l~~L~~~Cl~~dP~~R 609 (633)
..+...+ ..+... ......+......++ . .....+.+++.+||+.||++|
T Consensus 226 ~~~~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 226 SNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred cchhHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 0011110 110000 000000000000001 1 334578999999999999999
Q ss_pred CCHHHHHHH
Q 039736 610 PTMKQVSMD 618 (633)
Q Consensus 610 Pt~~ev~~~ 618 (633)
||+.|++.+
T Consensus 305 ps~~eil~~ 313 (316)
T cd07842 305 ITAEEALEH 313 (316)
T ss_pred cCHHHHhcC
Confidence 999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.78 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=197.0
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
|+..+.||+|++|.||+|... +|..||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999864 78999999876432 223457889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
+ ++|.+++..... ..+++..+++++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|
T Consensus 81 ~-~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~d 142 (283)
T cd07835 81 D-LDLKKYMDSSPL--------------TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLAD 142 (283)
T ss_pred C-cCHHHHHhhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEee
Confidence 5 689888864321 25899999999999999999999988 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++........ .....++..|+|||++.+. .++.++|+||||+++|||++|+.||........ +...+......
T Consensus 143 f~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~ 219 (283)
T cd07835 143 FGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTP 219 (283)
T ss_pred cccccccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCC
Confidence 9999765322211 1223468899999988654 578899999999999999999999865433221 11111100000
Q ss_pred c--------hhhhhhc------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 N--------KLLEILD------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~--------~~~~~~d------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .+.+... ..............+.+++.+||+.||++|||+.|++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000 000001112334678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.24 Aligned_cols=267 Identities=24% Similarity=0.381 Sum_probs=199.1
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~ 405 (633)
.++|+..++||+|+||.||+|.. .+|+.||||+++... .....++.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 468999999986432 334567889999999999999999999876543 47
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++++||+++ +|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.+
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----------------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~ 142 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----------------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTN 142 (336)
T ss_pred EEEehhccc-CHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCC
Confidence 999999974 77666532 36899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc--eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.+||+|||+++........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... .
T Consensus 143 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~ 219 (336)
T cd07849 143 CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---L 219 (336)
T ss_pred CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 99999999999765332211 1123457899999998754 5688999999999999999999999865432211 1
Q ss_pred HHHHHHHhh---chhhhhhchhh---------hccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 563 AYFISLAKE---NKLLEILDARV---------AKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~---~~~~~~~d~~l---------~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
..+...... +....+.+... .... .......+.+++.+||+.||++|||+.|++.+ ++...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 220 NLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 111111110 00111111000 0000 01234678899999999999999999999987 55444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=293.31 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=198.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
.+|+..+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999995 36899999986421 234456888999999999999999999998764 357
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++++||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.+
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~ 142 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----------------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSA 142 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCC
Confidence 8999999999999888542 35889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.++|+|||+++....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||.......
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------ 216 (264)
T cd06653 143 GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------ 216 (264)
T ss_pred CCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------
Confidence 9999999999986532111 11123458899999999998889999999999999999999999985322111
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+. +..........+......+.+++.+||. +|..||+..+++.+
T Consensus 217 ~~~---------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 217 AIF---------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHH---------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 001 1111111123345556789999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.89 Aligned_cols=242 Identities=26% Similarity=0.456 Sum_probs=195.1
Q ss_pred cCCcccccCcEEEEEEEcC-CCCEEEEEEccc----cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc--eEEEEe
Q 039736 338 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA----IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV--PVLVYE 410 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~----~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~--~~LV~E 410 (633)
...+||+|+|-+||||... +|-.||=-.++. .+....++|..|+.+|+.|+|+||++++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999963 455555332221 234556899999999999999999999999987665 779999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~k 489 (633)
.+..|+|..|+.+.+ .++.+....|++||++||.|||++. |||+|||||-.||||+. .|.||
T Consensus 124 L~TSGtLr~Y~kk~~----------------~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VK 186 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR----------------RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVK 186 (632)
T ss_pred cccCCcHHHHHHHhc----------------cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCcee
Confidence 999999999997753 5888999999999999999999987 78999999999999986 58999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|+|||....... ...+.|||.|||||.+. ..|.+.+||||||+.++||+|+..|+. +-.+....+..+.
T Consensus 187 IGDLGLAtl~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 187 IGDLGLATLLRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKVT 257 (632)
T ss_pred ecchhHHHHhhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHHH
Confidence 99999998765432 24478999999999997 779999999999999999999999984 2333334443333
Q ss_pred hh---chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KE---NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~---~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ..+..+- .+++.++|.+|+.. ..+|||+.|++..
T Consensus 258 SGiKP~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 258 SGIKPAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred cCCCHHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 21 1111111 25678999999999 9999999999863
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=300.85 Aligned_cols=256 Identities=26% Similarity=0.357 Sum_probs=194.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|...+.||+|+||.||++... +|+.||+|++.... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999954 68999999876532 344567889999999996 99999999999988899999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+.. +|.++...... .....+++..+.+++.+++.||+|||+. + ++||||||+||+++.++.+||
T Consensus 85 ~~~-~l~~l~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 85 MDI-SLDKFYKYVYE-----------VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred ccC-CHHHHHHHHHH-----------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEE
Confidence 864 55544321100 0124689999999999999999999975 6 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+|||+++....... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..... .......
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~ 222 (288)
T cd06616 150 CDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQ 222 (288)
T ss_pred eecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhh
Confidence 99999976533221 1223578899999999776 688999999999999999999999853221 0111111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ..+.+....+...+..+.+|+.+||+.||++|||+.||+.+
T Consensus 223 ~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 223 VVKG------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hcCC------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1100 01112222223456789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=297.96 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=201.7
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+|+..+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999965 5899999987642 22456789999999999999999999999998889999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.+++... .++++..+..++.|+++||.|||+++ ++|+||+|+||++++++.++|
T Consensus 81 ~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l 141 (258)
T cd05578 81 LLLGGDLRYHLSQK----------------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHI 141 (258)
T ss_pred CCCCCCHHHHHHhc----------------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEE
Confidence 99999999988542 36889999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ..+.....
T Consensus 142 ~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~ 215 (258)
T cd05578 142 TDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQE 215 (258)
T ss_pred eecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhc
Confidence 9999998764432 12334578899999999888899999999999999999999999865432211 11111110
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM--KQVS 616 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~--~ev~ 616 (633)
. .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 216 ~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 216 T----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0 1112233445788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.36 Aligned_cols=252 Identities=30% Similarity=0.442 Sum_probs=205.9
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|+||.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999964 58899999987543 35566889999999999999999999999998999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++..... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 81 ~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~ 145 (258)
T cd08215 81 ADGGDLSQKIKKQKK------------EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLG 145 (258)
T ss_pred cCCCcHHHHHHHhhc------------cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEEC
Confidence 999999998866421 0246999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++....... .......|++.|+|||.+.+..++.++|+||||+++++|++|+.|+....... .......
T Consensus 146 d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~- 217 (258)
T cd08215 146 DFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK- 217 (258)
T ss_pred CccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-
Confidence 999998764432 22333468889999999988889999999999999999999999985432111 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ....+......+.+++.+||..+|++||++.|++++
T Consensus 218 ~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 218 GQ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 112233445778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.92 Aligned_cols=258 Identities=23% Similarity=0.304 Sum_probs=193.0
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeC--CceEEEEe
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVYE 410 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~--~~~~LV~E 410 (633)
|+..+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999953 68899999876532 222234567899999885 99999999999987 78999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++ |+|.+++... ...++|..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||
T Consensus 81 ~~~-~~l~~~l~~~---------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl 140 (282)
T cd07831 81 LMD-MNLYELIKGR---------------KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKL 140 (282)
T ss_pred cCC-ccHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEE
Confidence 997 5787777542 136899999999999999999999998 999999999999999 99999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++........ ....++..|+|||.+.. +.++.++|||||||++|||++|+.||......+. ........
T Consensus 141 ~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~ 215 (282)
T cd07831 141 ADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVL 215 (282)
T ss_pred EecccccccccCCCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHc
Confidence 999999876433221 22347889999997654 5578899999999999999999999865443221 11111111
Q ss_pred hh--chhhhhhchh------hh-------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KE--NKLLEILDAR------VA-------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~--~~~~~~~d~~------l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ..+....... .. .......+..+.+++.+||+.+|++||++.|++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0000000000 00 00112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=303.48 Aligned_cols=263 Identities=26% Similarity=0.344 Sum_probs=196.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~L 407 (633)
.++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999964 689999998764322 1223566899999999999999999998765 45799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++ +|.+++.... ..+++.+++.++.|+++||+|||+.+ ++||||||+||++++++.
T Consensus 86 v~e~~~~-~l~~~l~~~~---------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~ 146 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---------------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGC 146 (309)
T ss_pred EEecCCC-CHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999974 7888775431 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||++......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.
T Consensus 147 ~kL~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~ 222 (309)
T cd07845 147 LKIADFGLARTYGLPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLII 222 (309)
T ss_pred EEECccceeeecCCccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999999876433211 122335788999999865 4578999999999999999999999865433221 11111
Q ss_pred HHHhhc--hhh-hhhch------hhh----cc---cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKEN--KLL-EILDA------RVA----KE---AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~--~~~-~~~d~------~l~----~~---~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... ... ...+. .+. .. ........+.+++.+||+.||++|||+.|++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 111000 000 00000 000 00 001125667899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=297.06 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=187.5
Q ss_pred cccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHh---ccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 341 FLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILS---QINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~---~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..+++ ..+|+||+.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 68899999875421 122223445544433 4479999999999998889999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 81 ~~~L~~~i~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~df 141 (279)
T cd05633 81 GGDLHYHLSQH----------------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (279)
T ss_pred CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccC
Confidence 99999888542 35999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++........ ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......
T Consensus 142 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~--- 211 (279)
T cd05633 142 GLACDFSKKKP---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMT--- 211 (279)
T ss_pred CcceeccccCc---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHh---
Confidence 99976533221 22458999999999864 45789999999999999999999998643221110 011000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.......+...+..+.+++.+||+.||++|| ++.|++++
T Consensus 212 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 -------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011123344567889999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.84 Aligned_cols=245 Identities=23% Similarity=0.379 Sum_probs=197.5
Q ss_pred CCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 339 SRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
..+||+|+||.||++.. .+|+.||||++..........+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 47899999988655555566799999999999999999999999999999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++.. ..+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.
T Consensus 105 ~~~~~~-----------------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~ 164 (292)
T cd06657 105 TDIVTH-----------------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA 164 (292)
T ss_pred HHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccce
Confidence 887642 25789999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
....... ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+......... . .... .
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~----~~~~-----~ 231 (292)
T cd06657 165 QVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---K----MIRD-----N 231 (292)
T ss_pred ecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H----HHHh-----h
Confidence 6543221 122345789999999998888899999999999999999999998643322110 0 0000 0
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.+.+. ........+.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 232 LPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 111110 011234567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.52 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=202.6
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|+..+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999864 678999999876543 4567899999999999999999999999998999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+
T Consensus 81 ~~~~~L~~~~~~~----------------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~ 141 (254)
T cd06627 81 AENGSLRQIIKKF----------------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLA 141 (254)
T ss_pred CCCCcHHHHHHhc----------------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEe
Confidence 9999999888542 36899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++......... .....++..|+|||...+...+.++||||+|+++|||++|+.|+........ ......
T Consensus 142 d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~- 213 (254)
T cd06627 142 DFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQ- 213 (254)
T ss_pred ccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc-
Confidence 99999876543321 2234578899999999888889999999999999999999999854321110 001000
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
. .....+......+.+++.+||..+|++||++.|++.
T Consensus 214 ~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 D---------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred c---------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 011123334567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=307.49 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=202.4
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~ 404 (633)
.++|...+.||+|+||.||++.. .+++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35788899999999999999995 36899999987642 233445678899999999999999999988644 24
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~ 143 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----------------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNA 143 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcC
Confidence 799999996 6888777542 36899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||......+. ..
T Consensus 144 ~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~ 219 (337)
T cd07858 144 NCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LK 219 (337)
T ss_pred CCCEEECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HH
Confidence 9999999999998764332 12223457889999998865 4688999999999999999999999865432211 11
Q ss_pred HHHHHHh-----------hchhhhhhc-------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 564 YFISLAK-----------ENKLLEILD-------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 564 ~~~~~~~-----------~~~~~~~~d-------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
....... .......+. +... ......+..+.+++.+||+.+|++|||+.|++++ ++.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 1111110 000111100 0000 0112345778999999999999999999999988 66654
Q ss_pred hh
Q 039736 624 RS 625 (633)
Q Consensus 624 ~s 625 (633)
..
T Consensus 299 ~~ 300 (337)
T cd07858 299 DP 300 (337)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=294.35 Aligned_cols=243 Identities=28% Similarity=0.387 Sum_probs=195.3
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|++++++++|+||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999998865432 4566889999999999999999999999988899999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++... ..+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.
T Consensus 81 ~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~ 141 (265)
T cd05579 81 ASLLENV----------------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSK 141 (265)
T ss_pred HHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccch
Confidence 9988642 36899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCc-------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 498 SVPNDKT-------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 498 ~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
....... .......++..|++||.+.....+.++||||||+++|||++|+.|+......+ .+.....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~ 215 (265)
T cd05579 142 VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNILN 215 (265)
T ss_pred hcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc
Confidence 6533211 12223457889999999988888999999999999999999999986443221 1111111
Q ss_pred hchhhhhhchhhhcccCHH--HHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREE--DIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~--~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
.. ...+.. ....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 216 -~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 216 -GK----------IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CC----------cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 011111 2577899999999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=304.17 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=205.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcc--ccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~--~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 409 (633)
...|+.+++||+||.+.||++...+.+.+|+|++. ..+.....-|.+|+++|.+++ |.+|++|+++-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 35678889999999999999998788899999754 456677889999999999995 999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||=+ -+|..+|..... ....| .+..+..|++.++.++|.++ |||.||||.|.|+-. |.+|
T Consensus 440 E~Gd-~DL~kiL~k~~~--------------~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LK 499 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS--------------IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLK 499 (677)
T ss_pred eccc-ccHHHHHHhccC--------------CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEE
Confidence 9874 489999876533 12334 77889999999999999999 999999999999976 4899
Q ss_pred EeecCCCccCCCCCccee-cccccCCCcCchhccccCC-----------CCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 490 VSDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQ-----------YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~-----------~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
|+|||+|..+..+..... ...+||.-||+||.+.... .+.++||||+||+||+|+.|+.||...
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---- 575 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---- 575 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----
Confidence 999999999876655433 4567999999999885432 567999999999999999999997311
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHH-HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREED-IEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+ .-.++..++||....+++.-- ..++.++|+.||+.||++||++.|++++
T Consensus 576 -~n---------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 -IN---------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HH---------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 10 123566777876655554322 2239999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.18 Aligned_cols=266 Identities=27% Similarity=0.376 Sum_probs=198.1
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC--ce
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE--VP 405 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~--~~ 405 (633)
..++|+..+.||+|+||.||+|... +|+.+|+|++.. ........+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999965 578999998754 2233455678899999999 9999999999986543 57
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||++ ++|.+++.. ..++|..++.++.|++.||+|||+.+ ++||||||+||+++++
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~ 143 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----------------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSD 143 (337)
T ss_pred EEEecccc-cCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 99999997 588877743 25789999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc----ceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 486 FSAKVSDFGTSRSVPNDKT----HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+.+||+|||++........ .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+...
T Consensus 144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999987643322 12233468899999998765 457889999999999999999999986543322110
Q ss_pred HHHHH--------HHHHhhchhhhhhchhhh------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYF--------ISLAKENKLLEILDARVA------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~--------~~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ..........++++.... ..........+.+++.+||+.||++|||+.+++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 000000000111110000 00011245778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.16 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=194.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-----
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV----- 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~----- 404 (633)
.++|+..+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999964 68899999875432 2223356789999999999999999999876543
Q ss_pred ---eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 405 ---PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 405 ---~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
.++||||+.+ +|.+++... ...+++.+++.++.|++.||.|||+++ ++|+||||+||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil 151 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK---------------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANIL 151 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence 4999999964 777776432 125899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcc---eecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++.++.+||+|||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~ 231 (310)
T cd07865 152 ITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH 231 (310)
T ss_pred ECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999865332211 11234567889999988664 36889999999999999999999986544332
Q ss_pred hhcHHHHHHHHHhhchh-----hhhhch-hhhccc---------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKL-----LEILDA-RVAKEA---------REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~-----~~~~d~-~l~~~~---------~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......+......+.. .+..+. ...... +......+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 232 QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 21111111100000000 000000 000000 00123466799999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.66 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=197.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC------
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------ 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------ 402 (633)
..++|+..+.||+|+||.||++.. .+|+.||||++.. .+....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 347899999999999999999995 3789999998764 2334456788899999999999999999988643
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------------------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~ 151 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------------------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 151 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------------------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEE
Confidence 24699999996 477776632 3788889999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.... .
T Consensus 152 ~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~ 226 (353)
T cd07850 152 KSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---W 226 (353)
T ss_pred CCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---H
Confidence 9999999999999987543221 2234578899999999999999999999999999999999999865432211 0
Q ss_pred HHHHHHHhh--ch-----------------------hhhhhchhh----hcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 563 AYFISLAKE--NK-----------------------LLEILDARV----AKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 563 ~~~~~~~~~--~~-----------------------~~~~~d~~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
......... .. ..+...... ....+......+.+++.+||+.||++|||+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 306 (353)
T cd07850 227 NKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306 (353)
T ss_pred HHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHH
Confidence 000000000 00 000000000 0000113356788999999999999999999
Q ss_pred HHHHH
Q 039736 614 QVSMD 618 (633)
Q Consensus 614 ev~~~ 618 (633)
|++.+
T Consensus 307 eiL~~ 311 (353)
T cd07850 307 DALQH 311 (353)
T ss_pred HHhcC
Confidence 99865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=284.94 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=200.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+++|+..+.||+|.|+.||+... ..|+.+|+|.+.. ....+.+++.+|+.|-+.++||||++|.+...+++..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45777888999999999999874 4688888886542 33446778889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC---CC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD---KF 486 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~ 486 (633)
|+|+||+|-.-+-.. ...++..+-....||+++|.|+|.++ |||||+||.|+++-. .-
T Consensus 90 e~m~G~dl~~eIV~R----------------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----------------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred ecccchHHHHHHHHH----------------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCC
Confidence 999999987655332 13667778889999999999999999 999999999999954 34
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
-+|++|||+|.... .........||++|||||++...+++..+|||+-||+||-|+.|.+||...+... .+.
T Consensus 151 ~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye 222 (355)
T KOG0033|consen 151 AVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYE 222 (355)
T ss_pred ceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHH
Confidence 59999999999886 2334455789999999999999999999999999999999999999997532211 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... +.. -++ ..+-....++..+|+++||..||.+|.|+.|.+.+
T Consensus 223 ~I~~-g~y--d~~----~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 223 QIKA-GAY--DYP----SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHhc-ccc--CCC----CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111 000 011 11223345678899999999999999999998754
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.38 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=195.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999964 68899999876432 2234578899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~k 489 (633)
|++ ++|.+++.... ...+++.....++.||+.||+|||+++ ++||||+|+||+++. ++.+|
T Consensus 82 ~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~k 143 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--------------DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALK 143 (294)
T ss_pred ccc-ccHHHHHHhCC--------------CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEE
Confidence 996 57777764321 124678888999999999999999998 999999999999985 56799
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ....+ ..
T Consensus 144 l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~ 219 (294)
T PLN00009 144 LADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RI 219 (294)
T ss_pred EcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HH
Confidence 999999976543211 1123356889999998866 4578999999999999999999999865433221 11111 00
Q ss_pred Hhhc---------hhhhhhc--hh----hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKEN---------KLLEILD--AR----VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~---------~~~~~~d--~~----l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+ .+.+... +. ............+.+++.+|++.+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0000000 00 0000112334668899999999999999999999863
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=295.12 Aligned_cols=244 Identities=26% Similarity=0.402 Sum_probs=193.0
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||+||++... +|+.+|+|.+.... ....+.+.+|++++++++||||+++.+.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999876422 22345678899999999999999999999998999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++.
T Consensus 81 ~~~l~~~~~--------------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~ 143 (277)
T cd05577 81 KYHIYNVGE--------------PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAV 143 (277)
T ss_pred HHHHHHcCc--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchh
Confidence 999865321 36899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... ......++..|+|||.+.++.++.++||||||+++|||++|+.||.......... .+ ... .
T Consensus 144 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~----~~~----~ 210 (277)
T cd05577 144 ELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---EL----KRR----T 210 (277)
T ss_pred hhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HH----Hhc----c
Confidence 654321 1223457889999999988889999999999999999999999985433211000 00 000 0
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSM 617 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~ 617 (633)
. ......+......+.+++.+||+.||++|| ++.+++.
T Consensus 211 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 211 L--EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred c--cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0 001122334467789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.84 Aligned_cols=271 Identities=20% Similarity=0.257 Sum_probs=190.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCC--CCEEEEE------------------EccccChhHHHHHHHHHHHHhccCCCC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPD--GSIVAVK------------------RSRAIDKTQIEQFINEVVILSQINHRH 391 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~--g~~vAVK------------------~~~~~~~~~~~~~~~Ei~il~~l~H~n 391 (633)
..++|+..+.||+|+||.||++..+. +...++| +++ ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987532 2222222 111 12223456889999999999999
Q ss_pred ceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCee
Q 039736 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIF 471 (633)
Q Consensus 392 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 471 (633)
|+++++++...+..|+|+|++. ++|.+++....... .......+...|+.||+.||.|||+++ |+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-----------~~~~~~~~~~~i~~ql~~aL~yLH~~g---Ii 289 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDW-----------KDRPLLKQTRAIMKQLLCAVEYIHDKK---LI 289 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccc-----------cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 9999999999999999999985 56777664432100 112345677889999999999999998 99
Q ss_pred ccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 472 HrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
||||||+|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.++.
T Consensus 290 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred cCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999999998765443333334579999999999999999999999999999999999875433
Q ss_pred C-CchhhhhcHHHHHHHHH--hh------chhhhhhchhhhcccC---------HHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 552 L-TREEEERNLVAYFISLA--KE------NKLLEILDARVAKEAR---------EEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 552 ~-~~~~~~~~l~~~~~~~~--~~------~~~~~~~d~~l~~~~~---------~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
. ........+...+.... .+ ..+.+.++.......+ ......+.+++.+||+.||++|||+.
T Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~ 449 (501)
T PHA03210 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAA 449 (501)
T ss_pred cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHH
Confidence 2 21111111211111100 00 0111111110000000 01224567889999999999999999
Q ss_pred HHHHH
Q 039736 614 QVSMD 618 (633)
Q Consensus 614 ev~~~ 618 (633)
|++.+
T Consensus 450 elL~h 454 (501)
T PHA03210 450 ELLAL 454 (501)
T ss_pred HHhhC
Confidence 99864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=305.55 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=195.8
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------c
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------V 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~ 404 (633)
++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++|+||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 7899999999999999999995 46899999987642 2223456889999999999999999999987543 3
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++|+||+.. +|.+++ ...+++..+..++.|++.||+|||+++ ++||||||+||+++.
T Consensus 95 ~~lv~e~~~~-~l~~~~------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~ 152 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM------------------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNE 152 (342)
T ss_pred EEEEeccccc-CHHHHH------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence 5899999864 555443 125889999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..
T Consensus 153 ~~~~kL~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~---~~ 225 (342)
T cd07879 153 DCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LT 225 (342)
T ss_pred CCCEEEeeCCCCcCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 9999999999998653221 22356888999999876 4688999999999999999999999975432211 11
Q ss_pred HHHHHHh-----------hchhhhhhc--hhh-hccc---CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhhh
Q 039736 564 YFISLAK-----------ENKLLEILD--ARV-AKEA---REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRR 624 (633)
Q Consensus 564 ~~~~~~~-----------~~~~~~~~d--~~l-~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~~ 624 (633)
....... ......... +.. .... .......+.+++.+||+.||++||++.|++.+ ++.++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1111000 000000000 000 0000 01234568899999999999999999999965 766654
Q ss_pred h
Q 039736 625 S 625 (633)
Q Consensus 625 s 625 (633)
.
T Consensus 306 ~ 306 (342)
T cd07879 306 A 306 (342)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.73 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=199.5
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
|+..+.||+|++|.||++... +|+.+++|++..... .....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999964 688999998765332 24567889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++ +|.+++.... ..+++..++.++.|++.||.|||+++ ++|+||||+||++++++.+||+|
T Consensus 81 ~~-~l~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d 141 (283)
T cd05118 81 DT-DLYKLIKDRQ---------------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141 (283)
T ss_pred CC-CHHHHHHhhc---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEee
Confidence 75 8877775431 36899999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||.+....... .......++..|+|||.+.+. ..+.++|+||||+++|+|++|+.||......+.. .........
T Consensus 142 f~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~ 217 (283)
T cd05118 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGT 217 (283)
T ss_pred eeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCC
Confidence 99998765433 112234578889999998876 7889999999999999999999998654332210 001110000
Q ss_pred ---chhhhhhc------hhh-------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 ---NKLLEILD------ARV-------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ---~~~~~~~d------~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......+ ... ...........+.+++.+||+.||.+||++.|++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred CchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000 000 011123356789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=298.41 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=196.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.|+..+.||+|+||.||+|+.. +++.+|+|.+.. ......+++.+|+++++.++|+|++++.+++......++|+|
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999954 678999998753 233445678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||
T Consensus 96 ~~~-~~l~~~~~~~---------------~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl 156 (308)
T cd06634 96 YCL-GSASDLLEVH---------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156 (308)
T ss_pred ccC-CCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEE
Confidence 996 6887776432 235889999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+|||++...... ....++..|+|||.+. .+.++.++||||||+++|||++|+.|+......+.. ..
T Consensus 157 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~ 225 (308)
T cd06634 157 GDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YH 225 (308)
T ss_pred CCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HH
Confidence 999998765322 2235788999999974 456788999999999999999999997533221110 00
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
..... . + ..........+.+|+.+||+.+|++||++.+++.+-.-+
T Consensus 226 ~~~~~-~-----~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 226 IAQNE-S-----P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred HhhcC-C-----C---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00000 0 0 111223456788999999999999999999998775433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.25 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=207.0
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
-|....+||+|+||+||++..+ .|+.||||++.. ..+.++...|+.+|++.+.+++|+++|.+.....+++||||+.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3566789999999999999965 699999999876 3456788999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
-|+..+.++.. .++|++.++..+..+.++||+|||... -+|||||+.||||+-+|.+|++||
T Consensus 112 AGSiSDI~R~R---------------~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 112 AGSISDIMRAR---------------RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred CCcHHHHHHHh---------------cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhc
Confidence 99999998754 358999999999999999999999988 799999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|.|-.+.+.. .....+.||+.|||||++..-.|..++||||+|+...||.-|++|+..-.+-. .+....
T Consensus 174 GVAGQLTDTM-AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIFMIP---- 242 (502)
T KOG0574|consen 174 GVAGQLTDTM-AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIFMIP---- 242 (502)
T ss_pred cccchhhhhH-HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeEecc----
Confidence 9997664322 22345779999999999999999999999999999999999999975221100 000000
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
-.|.-.-..|+..+.++-++++.||-++|++|-|+-+++++
T Consensus 243 ----T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 243 ----TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ----CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 01111122356678889999999999999999999998875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.03 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=198.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~ 405 (633)
.++|+..+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999954 68999999876532 2345677889999999999999999988763 2457
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++|+||+. |+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~ 143 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----------------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNED 143 (334)
T ss_pred EEEEehhh-hhHHHHhccC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCC
Confidence 99999996 6888887542 35899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCc---ceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 FSAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 144 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--- 220 (334)
T cd07855 144 CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--- 220 (334)
T ss_pred CcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---
Confidence 9999999999976532221 11123468889999999865 4688999999999999999999999865432211
Q ss_pred HHHHHHHHh-----------hchhhhhhchh-hhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAK-----------ENKLLEILDAR-VAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~-----------~~~~~~~~d~~-l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+..... ...+.+..+.. ..... ....+..+.+++.+||+.+|++||++.+++.+
T Consensus 221 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111110 01111111100 00001 12345789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.96 Aligned_cols=255 Identities=23% Similarity=0.308 Sum_probs=199.7
Q ss_pred CCccCCcccccCcEEEEEEEc----CCCCEEEEEEccccC----hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCce
Q 039736 335 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 405 (633)
+|+..+.||+|++|.||++.. .+++.||||.++... ....+.+.+|+.++.++ +|+||+++.+.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 357889999876422 22345688999999999 599999999999988899
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~ 141 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----------------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSE 141 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCC
Confidence 9999999999999888542 35889999999999999999999988 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+.++|+|||+++..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.|+....... ....
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~ 219 (288)
T cd05583 142 GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSE 219 (288)
T ss_pred CCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHH
Confidence 99999999999876443322233345889999999987665 7889999999999999999999985322111 0011
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~ 621 (633)
....... . ....+......+.+++.+||+.||++|||+.++.+.|+.
T Consensus 220 ~~~~~~~---------~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 220 ISRRILK---------S--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHc---------c--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111100 0 012233345678899999999999999999888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=296.95 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=194.4
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456666777777766 7899999998653 44566789999999999999999999999999999999999999999
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCC
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 496 (633)
|.+++..... ..+++.....++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+
T Consensus 86 l~~~l~~~~~--------------~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~ 148 (314)
T cd08216 86 CEDLLKTHFP--------------EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYS 148 (314)
T ss_pred HHHHHHHhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccc
Confidence 9999875422 35888999999999999999999998 999999999999999999999999988
Q ss_pred ccCCCCCc------ceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 497 RSVPNDKT------HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 497 ~~~~~~~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
........ .......++..|+|||.+.. ..++.++|+||||+++|||++|+.||........ ........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 226 (314)
T cd08216 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGT 226 (314)
T ss_pred eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc
Confidence 75532211 11123446788999999876 3578999999999999999999999865332211 11100000
Q ss_pred H----hh-------chhhh----hhchh----hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 A----KE-------NKLLE----ILDAR----VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~----~~-------~~~~~----~~d~~----l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .. ..... ..++. ............+.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00 00000 00000 0111223345678899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.97 Aligned_cols=260 Identities=20% Similarity=0.303 Sum_probs=193.1
Q ss_pred Cccccc--CcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQG--GFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G--~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
..||+| +||+||++.. .+|+.||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8999999986 47899999987642 334457888999999999999999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++||+
T Consensus 84 ~~l~~~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~ 146 (328)
T cd08226 84 GSANSLLKTYFP--------------EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLS 146 (328)
T ss_pred CCHHHHHHhhcc--------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechH
Confidence 999998865421 25889999999999999999999998 9999999999999999999999998
Q ss_pred CCccCCCCCcc---e---ecccccCCCcCchhccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 495 TSRSVPNDKTH---L---TTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 495 la~~~~~~~~~---~---~~~~~gt~~y~APE~l~~~--~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
.+......... . .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~ 224 (328)
T cd08226 147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLK 224 (328)
T ss_pred HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhc
Confidence 65433211110 0 0112345679999998763 478999999999999999999999864332111 000000
Q ss_pred H----------------HHh-----------hch-----hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 567 S----------------LAK-----------ENK-----LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 567 ~----------------~~~-----------~~~-----~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
. ... +.. .....+..+....+..+...+.+|+.+||+.||++|||+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e 304 (328)
T cd08226 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS 304 (328)
T ss_pred CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence 0 000 000 00011111112223445678999999999999999999999
Q ss_pred HHHH
Q 039736 615 VSMD 618 (633)
Q Consensus 615 v~~~ 618 (633)
++++
T Consensus 305 ~l~~ 308 (328)
T cd08226 305 LLSH 308 (328)
T ss_pred HhhC
Confidence 9854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=295.22 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=197.1
Q ss_pred CCccCCcccccCcEEEEEEEc----CCCCEEEEEEccccC----hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCce
Q 039736 335 NYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 405 (633)
+|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.+++++ +|+||+++.+++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999885 368899999886522 12345678899999999 599999999999988889
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++|+||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||+|+|||++++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~ 141 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----------------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSN 141 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCC
Confidence 9999999999999988542 35889999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+++||+|||++...............|+..|+|||.+..+ .++.++||||||+++|||++|+.|+....... ....
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~ 219 (290)
T cd05613 142 GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAE 219 (290)
T ss_pred CCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHH
Confidence 9999999999987644332222345588999999998753 46789999999999999999999985322111 1111
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
........ ...++......+.+++.+||+.||++|| ++.+++.+
T Consensus 220 ~~~~~~~~-----------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 220 ISRRILKS-----------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHhhcc-----------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111100 0122334456789999999999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.73 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=204.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-----ceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETE-----VPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 406 (633)
+|...+.||+|++|.||+|... +|+.||||++.... ....+.+.+|+++++.++|+||+++.+++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 48999999887643 344568899999999999999999999988765 689
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
++|||++ ++|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 81 lv~e~~~-~~l~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~ 140 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----------------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNC 140 (330)
T ss_pred EEecchh-hhHHHHHhCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 9999998 4788777542 36899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+...
T Consensus 141 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~--- 217 (330)
T cd07834 141 DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN--- 217 (330)
T ss_pred CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---
Confidence 999999999987644321 112334578899999999887 78999999999999999999999986554322111
Q ss_pred HHHHHHh-----------hchhhhhhch---h---hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhhh
Q 039736 564 YFISLAK-----------ENKLLEILDA---R---VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLRR 624 (633)
Q Consensus 564 ~~~~~~~-----------~~~~~~~~d~---~---l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~~ 624 (633)
....... .....+.+.. . -...........+.+++.+||+.+|++||++.+++.+ +++++.
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 1111000 0000001000 0 0000112245678999999999999999999999986 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=288.91 Aligned_cols=242 Identities=26% Similarity=0.334 Sum_probs=187.8
Q ss_pred CcccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHH-HhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVI-LSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~i-l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999864 688999998865322 223344555544 4455899999999999998999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
++|.+++... ..+++..+.+++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 142 (260)
T cd05611 82 GDCASLIKTL----------------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFG 142 (260)
T ss_pred CCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecc
Confidence 9999988542 35889999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ +..... ...
T Consensus 143 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~ 210 (260)
T cd05611 143 LSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILS-RRI 210 (260)
T ss_pred cceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-ccc
Confidence 9876533 1234578899999999888889999999999999999999999864332211 111110 000
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.............+.+++.+||+.||++||++.++.+.
T Consensus 211 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 211 ------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 00111122345778999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=296.27 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=193.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|++|.||+|..++ ++.||||+++... .....++..|+.++.+.. |+||+++++++.++...+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567889999999999999999764 8999999987533 234456777887777775 9999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|+. ++|.+++... ...+++..+.+++.|++.||+|||+ .+ ++||||+|+||++++++.+|
T Consensus 95 ~~~-~~l~~l~~~~---------------~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 95 LMS-TCLDKLLKRI---------------QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred ccC-cCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEE
Confidence 985 4666665332 2368999999999999999999997 46 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
|+|||++......... ....++..|+|||.+.... ++.++||||||+++|||++|+.|+....... ...
T Consensus 156 L~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~ 228 (296)
T cd06618 156 LCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVL 228 (296)
T ss_pred ECccccchhccCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHH
Confidence 9999999765432221 2234778999999987553 7889999999999999999999985322111 011
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
....... . +.. ........++.+++.+||+.||++||++.+++++-
T Consensus 229 ~~~~~~~-~-----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 229 TKILQEE-P-----PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHhcCC-C-----CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1111110 0 000 01112456789999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.42 Aligned_cols=244 Identities=27% Similarity=0.425 Sum_probs=193.1
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
|...+.||+|+||.||+|+.. +|+.|++|++... .....+.+.+|++++++++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999953 6889999987642 233456788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+. |+|.+++... ...+++.+++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+
T Consensus 103 ~~-~~l~~~l~~~---------------~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~ 163 (313)
T cd06633 103 CL-GSASDLLEVH---------------KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 163 (313)
T ss_pred CC-CCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEe
Confidence 96 5777776432 236899999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|||++...... ....|+..|+|||++. .+.++.++||||||+++|||++|+.|+........ ....
T Consensus 164 dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~ 232 (313)
T cd06633 164 DFGSASKSSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHI 232 (313)
T ss_pred ecCCCcccCCC-----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH
Confidence 99998653221 2345788999999984 46688899999999999999999999854322111 0111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... . + ..........+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~-~-----~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 233 AQND-S-----P---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HhcC-C-----C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000 0 0 01112233568899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=293.62 Aligned_cols=258 Identities=17% Similarity=0.244 Sum_probs=181.8
Q ss_pred cCCccCCcccccCcEEEEEEEcCC----CCEEEEEEccccChhH-----------HHHHHHHHHHHhccCCCCceEEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAIDKTQ-----------IEQFINEVVILSQINHRHIVKLLGC 398 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~~~~~-----------~~~~~~Ei~il~~l~H~nIv~l~g~ 398 (633)
++|...++||+|+||.||+|...+ +..+|+|......... ......+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999654 3456666533211110 0112234445667789999999998
Q ss_pred EeeCC----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 399 CLETE----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 399 ~~~~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+.... ..++++|+... ++.+.+.. ....++..+..|+.|++.||+|||+.+ ++|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrD 151 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR----------------IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGD 151 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh----------------hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 76543 23566666532 44443322 123678888999999999999999998 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
|||+|||++.++.++|+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||++|+.
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~ 231 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKL 231 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999865322111 1122458999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 549 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 549 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
||........ .... ...+.+..+..+.. .....+..+.+++..|+..+|++||++.++.+.|+
T Consensus 232 P~~~~~~~~~--~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 232 PWKGFGHNGN--LIHA----AKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCccccchH--HHHH----hHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9965422111 0000 00000111111111 01223577899999999999999999999998763
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=291.22 Aligned_cols=260 Identities=27% Similarity=0.357 Sum_probs=194.1
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhcc---CCCCceEEEEEEeeCCc-----
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLETEV----- 404 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~~~----- 404 (633)
|+..+.||+|+||.||+|..+ +++.||+|+++... ......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999976 48999999986422 22234566788777665 69999999999988776
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||++++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--------------~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~ 142 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--------------KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTS 142 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEcc
Confidence 899999997 47888875432 135899999999999999999999998 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++.+||+|||++........ .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+......+. ....
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~ 218 (287)
T cd07838 143 DGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKI 218 (287)
T ss_pred CCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHH
Confidence 99999999999977643321 1223468899999999999999999999999999999999998865433221 1111
Q ss_pred HHHHHhhchh---------hhhhchhhh---cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 565 FISLAKENKL---------LEILDARVA---KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 565 ~~~~~~~~~~---------~~~~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
+......... ......... .....+....+.+++.+||+.||++||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 219 FDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1110000000 000000000 1111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=302.04 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=200.3
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEe
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCL 400 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~ 400 (633)
....++...+++|...+.||+|+||.||+|.. .+|+.||+|+++.. .....+.+.+|+.++++++|+||+++.+++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566777889999999999999999999984 47889999988653 2233457889999999999999999999886
Q ss_pred eC------CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 401 ET------EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 401 ~~------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
.. ...+++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ ++|||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~d 145 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRD 145 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 43 2367888876 7788777642 25899999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
|||+||++++++.+||+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...
T Consensus 146 lkp~NIll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 146 LKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred CChHHEEEcCCCCEEEecccccccccccc----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998653221 23457889999998866 56788999999999999999999998544
Q ss_pred chhhhhcHHHHHHHH----------Hhhchhhhh---hchhhhc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 554 REEEERNLVAYFISL----------AKENKLLEI---LDARVAK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~----------~~~~~~~~~---~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...... ....... ......... +...... +........+.+++.+|++.||.+||++.|++.
T Consensus 222 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 222 DHIDQL--KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CHHHHH--HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 322110 0000000 000000000 0000000 000113456889999999999999999999986
Q ss_pred H
Q 039736 618 D 618 (633)
Q Consensus 618 ~ 618 (633)
+
T Consensus 300 h 300 (345)
T cd07877 300 H 300 (345)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=293.71 Aligned_cols=248 Identities=25% Similarity=0.379 Sum_probs=209.0
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.-|...+.||+|-|..|-.++. -.|+.||||++.... .-....++.|+..|+.++|||||+|+.+.......|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3566778899999999998883 379999999987643 3344578899999999999999999999988889999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee-cCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL-DDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~k 489 (633)
.-++|+|.||+..+.. .+++....+++.||..|+.|+|+.. +|||||||+||.+ ..-|-+|
T Consensus 98 LGD~GDl~DyImKHe~---------------Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---------------GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred ecCCchHHHHHHhhhc---------------cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceE
Confidence 9999999999987643 5899999999999999999999999 9999999999866 5678899
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|.|||++-.+..+.. -+..+|...|.|||++.+-.|+ +++||||+|||||.|+.|+.||....+.+
T Consensus 160 LTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------- 226 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------- 226 (864)
T ss_pred eeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh-----------
Confidence 999999987754433 2446799999999999988776 68999999999999999999996544433
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+.-+||-.+ ..|.....+..+||..||..||++|-+.+||+..
T Consensus 227 ----TLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 227 ----TLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ----hhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2344455433 3567778899999999999999999999998754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=293.57 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=202.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+.||+|++|.||++... +|+.||+|..... .....+.+.+|++++++++ |+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999964 6899999987642 2334567889999999998 99999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++++|.+++... ..+++..++.|+.|++.||.|||+++ ++|+||+|+||+++.++++
T Consensus 81 ~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~ 141 (280)
T cd05581 81 LEYAPNGELLQYIRKY----------------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHI 141 (280)
T ss_pred EcCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCE
Confidence 9999999999988642 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCc-------------------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 489 KVSDFGTSRSVPNDKT-------------------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 489 kI~DfGla~~~~~~~~-------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
+++|||++........ .......++..|+|||.+.....+.++|+||||++++|+++|+.|
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p 221 (280)
T cd05581 142 KITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221 (280)
T ss_pred EecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence 9999999986643221 112234578899999999888899999999999999999999999
Q ss_pred CCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 039736 550 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM----KQVSM 617 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~----~ev~~ 617 (633)
+....... .+.... ......+......+.+++.+||+.+|++||++ .+++.
T Consensus 222 ~~~~~~~~------~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 222 FRGSNEYL------TFQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCccHHH------HHHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 86443111 011111 01112233445678999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=287.43 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=190.2
Q ss_pred HHHhcCCccCCcc--cccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCce
Q 039736 330 QRATDNYNQSRFL--GQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 330 ~~~~~~~~~~~~i--g~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 405 (633)
....++|+..+.+ |+|+||.||++.. .++..+|+|.......... |+.....+ +|+||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344567777766 9999999999995 3678899998765321111 22222222 799999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..++|.++..++.|+++||.|||+.+ ++||||||+||+++.+
T Consensus 85 ~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE----------------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRA 145 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCC
Confidence 9999999999999998643 26899999999999999999999999 9999999999999999
Q ss_pred C-cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 486 F-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 486 ~-~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
+ .++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .....+
T Consensus 146 ~~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~ 219 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL 219 (267)
T ss_pred CCeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH
Confidence 8 99999999987654322 2357889999999999899999999999999999999999986432221 111111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-MKQVSM 617 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-~~ev~~ 617 (633)
.... .. ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 220 ~~~~----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 220 LKRQ----------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHhh----------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1110 00 01112245577899999999999999996 688874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.69 Aligned_cols=198 Identities=30% Similarity=0.412 Sum_probs=170.1
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccC-C-----CCceEEEEEEeeCCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-H-----RHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H-----~nIv~l~g~~~~~~~~~L 407 (633)
+|.+.+.||+|.||.|-++... +++.||||+++... .-..+...|+.+|..|+ | -|+|++++++...+..+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999954 68999999998643 33456678999999997 4 399999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--C
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD--K 485 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~ 485 (633)
|+|.++. +|.++++.+. ...++...+..|+.||+.||..||+.+ |||+||||+||||.+ .
T Consensus 266 VfELL~~-NLYellK~n~--------------f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r 327 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNK--------------FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKR 327 (586)
T ss_pred eehhhhh-hHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCc
Confidence 9999964 9999998764 356999999999999999999999999 999999999999975 4
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
..+||+|||.|......-. ...-+..|.|||++.+.+|+.+.|+||||||+.||++|.+-|.+..+
T Consensus 328 ~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 328 SRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 4799999999987543221 23457789999999999999999999999999999999777765544
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.98 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=195.2
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeec
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
|+..+.||+|++|.||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578999998765322 22234567999999999 999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
+|+|.+++.... ...++|..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|
T Consensus 81 -~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d 142 (283)
T cd07830 81 -EGNLYQLMKDRK--------------GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIAD 142 (283)
T ss_pred -CCCHHHHHHhcc--------------cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEee
Confidence 889988886532 136899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc-cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc-HHH-------
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN-LVA------- 563 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~-l~~------- 563 (633)
||++........ .....++..|+|||.+. ...++.++|+||||+++|||++|+.|+......+... ...
T Consensus 143 ~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (283)
T cd07830 143 FGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTK 220 (283)
T ss_pred cccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCCh
Confidence 999986543222 12245788999999875 4557899999999999999999999985543222100 000
Q ss_pred --HHHHHHhhchhhhhhchhh---hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 --YFISLAKENKLLEILDARV---AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 --~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|.............+.... ...........+.+++.+||+.||++|||+.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 221 QDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000000000000000 000011124678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=291.10 Aligned_cols=260 Identities=26% Similarity=0.350 Sum_probs=198.3
Q ss_pred CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|+.++++++|+|++++.+++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456788999999999999965 58999999887642 333467789999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
+ ++|.+++.... ..+++..+++++.+++.||.|||+++ ++||||+|+||++++++.+||+|
T Consensus 81 ~-~~l~~~i~~~~---------------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d 141 (282)
T cd07829 81 D-MDLKKYLDKRP---------------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLAD 141 (282)
T ss_pred C-cCHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEec
Confidence 8 58999886531 35899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+. ..........
T Consensus 142 ~g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~ 217 (282)
T cd07829 142 FGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGT 217 (282)
T ss_pred CCcccccCCCccc-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCC
Confidence 9999876433221 1223457789999998776 789999999999999999999999865432211 1111111100
Q ss_pred ---chhhhh-----hchhh-------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 ---NKLLEI-----LDARV-------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ---~~~~~~-----~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.....+ .+... ....-......+.+++.+||+.||++||++.+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred CcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 00000 000011225678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.29 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=186.7
Q ss_pred cccccCcEEEEEEEc-CCCCEEEEEEccccC---hhHHHHHHHHHH---HHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 341 FLGQGGFGTVYKGML-PDGSIVAVKRSRAID---KTQIEQFINEVV---ILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~---il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.||+|+||.||++.. .+++.||+|.+.... ......+..|.. +++..+|+||+++.+.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 358899999875421 111223444443 4445579999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++... ..++|..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 g~~L~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~df 141 (278)
T cd05606 81 GGDLHYHLSQH----------------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDL 141 (278)
T ss_pred CCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccC
Confidence 99998887532 36999999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++........ ....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... ......
T Consensus 142 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~-- 212 (278)
T cd05606 142 GLACDFSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL-- 212 (278)
T ss_pred cCccccCccCC---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhh--
Confidence 99876532221 234589999999998755 58899999999999999999999986432211100 000000
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.. ....+...+..+.+++.+|+..+|.+|| ++.|++++
T Consensus 213 ----~~----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 ----TM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ----cc----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00 1122333457889999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.39 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=194.9
Q ss_pred cCCcc-CCcccccCcEEEEEEEcC-CCCEEEEEEccccChhH--------------HHHHHHHHHHHhccCCCCceEEEE
Q 039736 334 DNYNQ-SRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQ--------------IEQFINEVVILSQINHRHIVKLLG 397 (633)
Q Consensus 334 ~~~~~-~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~--------------~~~~~~Ei~il~~l~H~nIv~l~g 397 (633)
++|.. .+.||+|+||.||+|... +++.||||.++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999954 68999999876432211 124778999999999999999999
Q ss_pred EEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 398 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
++..++..++||||++ |+|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----------------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~ 147 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----------------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSP 147 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 9999999999999997 6888887532 35899999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCC-------------cceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHH
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDK-------------THLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLEL 543 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~el 543 (633)
+||+++.++.+||+|||++....... ........++..|+|||.+.+. .++.++||||||+++|||
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el 227 (335)
T PTZ00024 148 ANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227 (335)
T ss_pred HHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999997654111 1111123467889999998764 468899999999999999
Q ss_pred HhCCCCCCCCchhhhhcHHHHHHHHHhhch---hhhhh------------chhhhcccCHHHHHHHHHHHHhccccCCCC
Q 039736 544 LTGKKPICLTREEEERNLVAYFISLAKENK---LLEIL------------DARVAKEAREEDIEAVAELAMGCLRLNSKK 608 (633)
Q Consensus 544 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~------------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~ 608 (633)
++|+.|+......+. ...+........ ..+.. .+... .........+.+++.+||+.+|++
T Consensus 228 ~tg~~p~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~ 303 (335)
T PTZ00024 228 LTGKPLFPGENEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLE 303 (335)
T ss_pred HhCCCCCCCCCHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchh
Confidence 999999865443221 111111111100 00000 00000 001123467889999999999999
Q ss_pred CCCHHHHHHH
Q 039736 609 RPTMKQVSMD 618 (633)
Q Consensus 609 RPt~~ev~~~ 618 (633)
||++.|++.+
T Consensus 304 R~s~~~~l~~ 313 (335)
T PTZ00024 304 RISAKEALKH 313 (335)
T ss_pred ccCHHHHhcC
Confidence 9999999874
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.85 Aligned_cols=246 Identities=28% Similarity=0.435 Sum_probs=204.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.+.|+.-++||+||||.||-...+ +|+.+|.|++.... .......++|-.||.+++.+.||.+--.+...+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999988854 68999999775421 22334578899999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+..|.||+|.-+|..... +.+++..++-+|.+|+.||++||+.. ||.||+||+|||||+.|++
T Consensus 264 LtlMNGGDLkfHiyn~g~--------------~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Ghv 326 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--------------PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHV 326 (591)
T ss_pred EEeecCCceeEEeeccCC--------------CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCe
Confidence 999999999999987653 46899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
+|+|+|+|..++.+... +..+||.||||||++.++.|+...|.||+||+||||+.|+.||....+...
T Consensus 327 RISDLGLAvei~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------- 394 (591)
T KOG0986|consen 327 RISDLGLAVEIPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------- 394 (591)
T ss_pred EeeccceEEecCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------
Confidence 99999999988765543 334799999999999999999999999999999999999999854332211
Q ss_pred Hhhchhhhhhchhh---hcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 569 AKENKLLEILDARV---AKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 569 ~~~~~~~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
.+-+|.+. ..+++...+++..+|....|++||++|...+
T Consensus 395 ------~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 395 ------REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ------HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00112111 2356677788889999999999999997544
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.57 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=202.8
Q ss_pred CCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.|.+...||.|+||.||++..++ +-..|-|.+...+....++|+-||+||+...||+||+|++.+..++.+++..||+.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34456779999999999999764 34467787777778889999999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
||-....+-.- ...|+..++.-++.+++.||.|||++. |||||||+.|||++-+|.++|+||
T Consensus 113 GGAVDaimlEL---------------~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---------------GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred CchHhHHHHHh---------------ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecc
Confidence 99988877543 247999999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|.+...... ......+.||+.|||||+.. ..+|+.++||||||+.|.||..+.+|-.. .+....+..+
T Consensus 175 GVSAKn~~t-~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKi 247 (1187)
T KOG0579|consen 175 GVSAKNKST-RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKI 247 (1187)
T ss_pred cccccchhH-HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHH
Confidence 998654221 22334578999999999864 46789999999999999999999998421 1111111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+ .|.+ ..|......+.+++..||.+||..||++.+++++
T Consensus 248 aKSe------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 248 AKSE------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred hhcC------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1110 1111 1345667889999999999999999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=286.64 Aligned_cols=251 Identities=25% Similarity=0.349 Sum_probs=195.0
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
+|...+.||+|+||.||++... .+..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999864 3444555554431 222334577899999999999999999999988899999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.+
T Consensus 81 ~e~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~ 144 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH------------TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLL 144 (260)
T ss_pred EEeCCCCCHHHHHHHHhh------------cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCE
Confidence 999999999998865322 1346999999999999999999999998 999999999999986 469
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+....... .....
T Consensus 145 ~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~ 217 (260)
T cd08222 145 KIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRI 217 (260)
T ss_pred eecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHH
Confidence 9999999876533221 2223457889999999988888999999999999999999999985322111 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. . .....+......+.+++.+||+.+|++||++.|++++
T Consensus 218 ~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 VE-G---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred Hc-C---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 10 0 0111234455788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.08 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=193.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
.++|+..+.||+|+||.||+|... +++.+|||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999964 688999998754322 12345678999999999999999999876433
Q ss_pred --ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 404 --VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 404 --~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
..++|+||+++ +|...+... ...+++..+..++.|+++||.|||+.+ ++||||||+||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---------------~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil 147 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---------------SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 35999999975 566655432 236999999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcc----------eecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCC
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTH----------LTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~----------~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
+++++.+||+|||+++........ ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+
T Consensus 148 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred ECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 999999999999999865332211 11234578889999987654 5789999999999999999999998
Q ss_pred CCCchhhhhcHHHHHHHHHhh---------chhhhh--------hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 551 CLTREEEERNLVAYFISLAKE---------NKLLEI--------LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~---------~~~~~~--------~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
......... ......... ..+... ..+.+.. ........+.+++.+||+.||++|||+.
T Consensus 228 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ 303 (311)
T cd07866 228 QGKSDIDQL---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTAS 303 (311)
T ss_pred CCCCHHHHH---HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHH
Confidence 654332211 111111100 000000 0000000 0012236788999999999999999999
Q ss_pred HHHH
Q 039736 614 QVSM 617 (633)
Q Consensus 614 ev~~ 617 (633)
|++.
T Consensus 304 ell~ 307 (311)
T cd07866 304 DALE 307 (311)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.30 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=200.0
Q ss_pred HHhcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
..+-++....+||.|.||.||.+. .++|+..|+|.++..+ ........+|+.++..++|||+|+++|+=.+++..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 445677788999999999999999 5679999999766532 3345567899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
.|||+++|+|.+.+...+. ..+.....+..|++.|+.|||++| ||||||||.||+|+.+|.
T Consensus 1312 FMEyC~~GsLa~ll~~gri----------------~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI----------------EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred HHHHhccCcHHHHHHhcch----------------hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCc
Confidence 9999999999999865432 444455567889999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCccee---cccccCCCcCchhccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT---TAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~---~~~~gt~~y~APE~l~~~~---~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+|++|||.|........... ....||+.|||||.+.+.. ...++||||+|||++||+||++|+...+.+
T Consensus 1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----- 1447 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----- 1447 (1509)
T ss_pred EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----
Confidence 99999999998754432222 2457999999999997643 456899999999999999999998532211
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+..+..+. ..-....|.....+=.+++..||+.||++|-++.|++++
T Consensus 1448 ~aIMy~V~----------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 WAIMYHVA----------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hHHHhHHh----------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111100 011123344556667899999999999999888877664
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=296.93 Aligned_cols=269 Identities=21% Similarity=0.328 Sum_probs=198.6
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC---
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--- 403 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--- 403 (633)
....++|+..+.||+|+||.||++.. .+|+.||||++... .....+.+.+|+.++++++|+||+++++++..+.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999999984 47899999987542 2233456889999999999999999999987554
Q ss_pred ---ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 404 ---VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 404 ---~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
..++||||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ ++||||||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Ni 149 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH-----------------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNL 149 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 348999998 6788877642 25899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh-
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE- 558 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~- 558 (633)
++++++.+||+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........
T Consensus 150 ll~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 150 AVNEDCELKILDFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EEcCCCCEEEeecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998653321 22356889999999876 4588999999999999999999999865432111
Q ss_pred hcHHH-------HHHHHHhhchhhhhhch--hh----hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH--HHHhhh
Q 039736 559 RNLVA-------YFISLAKENKLLEILDA--RV----AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM--DLEGLR 623 (633)
Q Consensus 559 ~~l~~-------~~~~~~~~~~~~~~~d~--~l----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~--~L~~i~ 623 (633)
..... .+............... .. ...........+.+++.+|++.||++|||+.+++. .++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00000 00000000000000000 00 00011233456889999999999999999999983 344443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=296.15 Aligned_cols=262 Identities=22% Similarity=0.309 Sum_probs=197.8
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCc
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEV 404 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~ 404 (633)
+..++++|+..+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++||||+++.+++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999844 7899999987532 22334678899999999999999999999876 457
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++++||+ +++|.+++.. ..+++.....++.|+++||.|||+.+ ++||||+|+||++++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----------------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~ 143 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----------------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINE 143 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECC
Confidence 89999998 5688777643 25788888899999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 144 ~~~~~l~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~---~ 216 (328)
T cd07856 144 NCDLKICDFGLARIQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF---S 216 (328)
T ss_pred CCCEEeCccccccccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 9999999999997643221 22346888999998766 56889999999999999999999998654332111 1
Q ss_pred HHHHHHh-----------hchhhhhhch-hhhcccC-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAK-----------ENKLLEILDA-RVAKEAR-----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~-----------~~~~~~~~d~-~l~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
....... .....+.+.. ......+ ......+.+++.+||+.+|++||++.|++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 217 IITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111100 0000000000 0001111 1234788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=305.12 Aligned_cols=272 Identities=26% Similarity=0.420 Sum_probs=205.0
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------ceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------VPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~~~ 406 (633)
.+...+.||+|+||.||+|+. ..|+.||||..+.. .....+.+.+|+++|++++|+|||+++++=.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345577899999999999994 47999999987763 3445678899999999999999999999865433 568
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec---
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD--- 483 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--- 483 (633)
+||||+.+|||...|.+... ...|+..+.+.+..+++.||.|||+++ |+||||||.||++-
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-------------~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Ge 157 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-------------AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGE 157 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecC
Confidence 99999999999999977544 456999999999999999999999999 99999999999984
Q ss_pred -CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 484 -DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 484 -~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
..---||+|||.|+...++. ....++||..|++||.+.. +.|+..+|.|||||++||.+||..||...........
T Consensus 158 dgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~ 235 (732)
T KOG4250|consen 158 DGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE 235 (732)
T ss_pred CCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch
Confidence 33358999999999886544 6677899999999999984 8899999999999999999999999965443321111
Q ss_pred HHHHHHHHhhchhhhhhchhh------------hcccCHHHHHHHHHHHHhccccCCCCCC--CHHHHHHHHHhhhh
Q 039736 562 VAYFISLAKENKLLEILDARV------------AKEAREEDIEAVAELAMGCLRLNSKKRP--TMKQVSMDLEGLRR 624 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RP--t~~ev~~~L~~i~~ 624 (633)
..|....-....+.-..++.. ...........+-..+..+|..+|++|- ...+....+..|..
T Consensus 236 ~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 236 IMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 112111111000000000000 0111133345566677778888888888 77777777776654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.28 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=193.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC----------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET---------- 402 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~---------- 402 (633)
.+|...+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788999999999999999995 46889999998766556667888999999999999999999876543
Q ss_pred ----CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 403 ----EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 403 ----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ ++||||||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~ 143 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----------------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 24689999997 588776632 25889999999999999999999999 999999999
Q ss_pred Ceeec-CCCcEEEeecCCCccCCCCCcc--eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 479 NILLD-DKFSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 479 NILl~-~~~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
||+++ +++.+||+|||+++........ ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 144 Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred HEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99997 4667999999999765322111 1122357889999998754 457889999999999999999999996543
Q ss_pred hhhhhcHHHHHHHHHh-----hchhhhhhchhhh-----c-----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAK-----ENKLLEILDARVA-----K-----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~-----~~~~~~~~d~~l~-----~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+... ........ ............. . ........++.+++.+||+.||++|||+.|++.+
T Consensus 224 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 224 ELEQMQ--LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHH--HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 322110 00000000 0000000000000 0 0011234678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.62 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=191.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-C--CCEEEEEEcccc--ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC----Cc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-D--GSIVAVKRSRAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET----EV 404 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~--g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~----~~ 404 (633)
+|+..+.||+|+||.||++... . +..||+|++... .....+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 3 679999987642 222345788999999999 599999999976532 34
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++++||+. ++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||++++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~ 140 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----------------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNA 140 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcC
Confidence 688889886 6888887542 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcc---eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 485 KFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
++.+||+|||+++........ ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.|+........
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~-- 218 (332)
T cd07857 141 DCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-- 218 (332)
T ss_pred CCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--
Confidence 999999999999865432211 1123468899999998765 4688999999999999999999999865432211
Q ss_pred HHHHHHHHHh---hchhhhhhchh-------h----h---cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAK---ENKLLEILDAR-------V----A---KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~---~~~~~~~~d~~-------l----~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ++.+..+.++. . . ..........+.+++.+||+.||++|||+.|++.+
T Consensus 219 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 219 -LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred -HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00000000000 0 0 00011124678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=298.09 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=196.8
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc----
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV---- 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~---- 404 (633)
..++|+..+.||+|++|.||+|... +++.||||++... +....+.+.+|+.++++++|+||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999964 5789999987642 23345677889999999999999999988766554
Q ss_pred --eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 405 --PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 405 --~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||+|||+.+ ++||||||+||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill 151 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----------------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAV 151 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEE
Confidence 89999998 5688887753 35899999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
++++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 152 ~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--- 224 (343)
T cd07851 152 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--- 224 (343)
T ss_pred CCCCCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---
Confidence 99999999999999876432 223457888999999865 3678899999999999999999999864432211
Q ss_pred HHHHHHHHh-----------hchhhhhhchhh---hc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAK-----------ENKLLEILDARV---AK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~-----------~~~~~~~~d~~l---~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ......++.... .. .........+.+++.+||+.||++|||+.||+.+
T Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 111111000 000000100000 00 0001235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=278.25 Aligned_cols=236 Identities=32% Similarity=0.438 Sum_probs=192.6
Q ss_pred ccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 342 LGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999964 58899999876532 23456888999999999999999999999999999999999999999
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~~~l~~~----------------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~ 141 (250)
T cd05123 81 FSHLSKE----------------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK 141 (250)
T ss_pred HHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcce
Confidence 9998643 35899999999999999999999988 9999999999999999999999999998
Q ss_pred cCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 498 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... .......++..|++||.+.+...+.++|+||||+++|||++|+.|+....... ....... .
T Consensus 142 ~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~----- 208 (250)
T cd05123 142 ELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILK-D----- 208 (250)
T ss_pred ecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhc-C-----
Confidence 764332 12233457889999999988888999999999999999999999985443211 1111110 0
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
....+......+.+++.+||..||++||++.+
T Consensus 209 -----~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 -----PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -----CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11223333577889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=294.07 Aligned_cols=246 Identities=28% Similarity=0.369 Sum_probs=203.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
...|.....||+|.|+.|..|+. ..|..||||.+... +....+.+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 45788899999999999999994 36899999987753 3334456889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+.+|.+.+++..+. .........++.|+..+++|||++. |+|||||++||||+.+.++|
T Consensus 135 eya~~ge~~~yl~~~g----------------r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnik 195 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG----------------RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIK 195 (596)
T ss_pred EeccCchhHHHHHhcc----------------cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhccccccccee
Confidence 9999999999998754 3555778889999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++..+... .......|++.|.|||.+.+..+ .+++|+||+|++||-|+.|..||++..-.+.
T Consensus 196 IaDfgfS~~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------- 263 (596)
T KOG0586|consen 196 IADFGFSTFFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------- 263 (596)
T ss_pred eeccccceeeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc----------
Confidence 9999999887532 33455679999999999988765 4799999999999999999999975432221
Q ss_pred Hhhchhhhhhchhhhccc--CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEA--REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~--~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
-++.+...+ +.-...+..+|+++++..+|.+|++++++.+.
T Consensus 264 ---------r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 ---------RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ---------cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111122221 22223566789999999999999999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=313.28 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=178.2
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce---
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP--- 405 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~--- 405 (633)
+-..+|+..+.||+||||.||+++.+ ||+.+|||++... +........+|++.|++|+|||||+++..+.+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45568888999999999999999954 8999999987653 444566788999999999999999998765432111
Q ss_pred --------------------------------------------------------------------------------
Q 039736 406 -------------------------------------------------------------------------------- 405 (633)
Q Consensus 406 -------------------------------------------------------------------------------- 405 (633)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------------------EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCC--CHHH
Q 039736 406 ------------------------------------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL--SWEN 447 (633)
Q Consensus 406 ------------------------------------~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l--~~~~ 447 (633)
|+-|||++.-+|.++++. ..+ .-..
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~-----------------N~~~~~~d~ 698 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR-----------------NHFNSQRDE 698 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh-----------------cccchhhHH
Confidence 122222222222222211 112 2456
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCC-----------------CCCcceeccc
Q 039736 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP-----------------NDKTHLTTAV 510 (633)
Q Consensus 448 ~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~-----------------~~~~~~~~~~ 510 (633)
.++++.+|++||.|+|+++ ||||||||.|||||++..+||+|||+|.... .......+..
T Consensus 699 ~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 699 AWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ 775 (1351)
T ss_pred HHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence 7899999999999999999 9999999999999999999999999998721 0011123456
Q ss_pred ccCCCcCchhccccC---CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccC
Q 039736 511 QGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAR 587 (633)
Q Consensus 511 ~gt~~y~APE~l~~~---~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 587 (633)
+||.-|+|||.+.+. .|+.|+|+||+||||+||+.- |.... +.. . ....+..+.+..- ..+.
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM--ERa---~-iL~~LR~g~iP~~------~~f~ 840 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM--ERA---S-ILTNLRKGSIPEP------ADFF 840 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhcc---CCchH--HHH---H-HHHhcccCCCCCC------cccc
Confidence 799999999999764 499999999999999999964 43211 111 1 1111112211111 1112
Q ss_pred HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 588 EEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 588 ~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.+....-+.++.+++++||.+|||+.|++.
T Consensus 841 ~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 841 DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 223344578999999999999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=274.24 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=202.6
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeC
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLET 402 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~ 402 (633)
+++++.+.| .+.||+|++++|-.++ +.+|..+|||++.........+..+|++++.+.+ |+||++|+++|.++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356677766 4679999999998887 5689999999998877777889999999999985 99999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
..+|||||.|.||+|..+++.. ..+++.++-++..+||.||.+||..+ |.|||+||+|||-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~----------------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC 209 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR----------------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILC 209 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh----------------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceee
Confidence 9999999999999999999764 35899999999999999999999999 9999999999999
Q ss_pred cCCCc---EEEeecCCCccC--CCCC----cceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCC
Q 039736 483 DDKFS---AKVSDFGTSRSV--PNDK----THLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 483 ~~~~~---~kI~DfGla~~~--~~~~----~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
..... +||+||.+..-+ ..+- ...-...+|+..|||||+.. ...|+.+.|.||+|||||-|++|.+
T Consensus 210 ~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYp 289 (463)
T KOG0607|consen 210 ESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYP 289 (463)
T ss_pred cCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCC
Confidence 76543 899999887543 1111 11223457889999999863 2357789999999999999999999
Q ss_pred CCCCCchhh--------hhcHHHHHHHHHhhchhhhhhchhhhcccCH----HHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 549 PICLTREEE--------ERNLVAYFISLAKENKLLEILDARVAKEARE----EDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 549 p~~~~~~~~--------~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
||.+.-+.+ -+..-........++. -++|. ..+.+..+|+...+..|+.+|.++.+++
T Consensus 290 PFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk----------YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 290 PFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK----------YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred CccCccCCcCCccCCCccHHHHHHHHHHHhccC----------CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 997654322 1111111111111111 12232 2345667888888999999999998887
Q ss_pred H
Q 039736 617 M 617 (633)
Q Consensus 617 ~ 617 (633)
.
T Consensus 360 n 360 (463)
T KOG0607|consen 360 N 360 (463)
T ss_pred C
Confidence 6
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=273.60 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=199.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC---C--CCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEee-CCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP---D--GSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLE-TEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~---~--g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~ 404 (633)
...|+....||+|.||.||+++-. + ...+|||+++.... .-.....+|+.+++.++|||++.|..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999632 2 23799999886422 122356789999999999999999999987 778
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.+|++||++. +|...++-++... ...++.....+|..||+.|+.|||++- |+||||||.||||..
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~-----------~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmg 167 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASK-----------AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMG 167 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccch-----------hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEec
Confidence 9999999987 8888887655421 246888999999999999999999998 999999999999988
Q ss_pred C----CcEEEeecCCCccCCCCCcce--ecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 485 K----FSAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 485 ~----~~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
+ |++||+|||+++.+.+.-... ...++-|..|.|||.+.+. .||.+.||||.||++.||++-++-|.....+.
T Consensus 168 dgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~ 247 (438)
T KOG0666|consen 168 DGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKI 247 (438)
T ss_pred cCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhc
Confidence 7 999999999999886543332 2356789999999998774 58899999999999999999887775443221
Q ss_pred h------hcHHHHHHHHHhhchhhhhhc---------------hhhhcccC--------HHHHHHHHHHHHhccccCCCC
Q 039736 558 E------RNLVAYFISLAKENKLLEILD---------------ARVAKEAR--------EEDIEAVAELAMGCLRLNSKK 608 (633)
Q Consensus 558 ~------~~l~~~~~~~~~~~~~~~~~d---------------~~l~~~~~--------~~~~~~l~~L~~~Cl~~dP~~ 608 (633)
. .+-...+...+.-+.-.+|-+ ........ ..-...-.+|+.++|..||.+
T Consensus 248 ~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k 327 (438)
T KOG0666|consen 248 KTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK 327 (438)
T ss_pred ccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence 1 111111222221111000000 00000000 001133678999999999999
Q ss_pred CCCHHHHHHH
Q 039736 609 RPTMKQVSMD 618 (633)
Q Consensus 609 RPt~~ev~~~ 618 (633)
|.|+.+.+++
T Consensus 328 RIta~qAleh 337 (438)
T KOG0666|consen 328 RITAEQALEH 337 (438)
T ss_pred hccHHHHhcc
Confidence 9999998875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=267.95 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=192.4
Q ss_pred cCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeeccC
Q 039736 338 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
....||.|..|.|++.+.+ .|..+|||.+... +.++.++.+..+.++.+-+ .|.||+.+|+|..+...++.||.|.-
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3567999999999999965 5899999998764 4566778888888877765 89999999999999999999998842
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
.++.++... ..++++.-+=++...+.+||.||.+.. .|+|||+||+|||+|+.|++|++|||
T Consensus 176 -C~ekLlkri---------------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 176 -CAEKLLKRI---------------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred -HHHHHHHHh---------------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence 344444332 246788778889999999999998765 39999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
++-.+-+.... +...|.+.|||||.+.- ..|+.++||||||+.|+||.||+.|+..-..+-+ ..-..+.+
T Consensus 238 IsGrlvdSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-----~ltkvln~ 310 (391)
T KOG0983|consen 238 ISGRLVDSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-----VLTKVLNE 310 (391)
T ss_pred ccceeeccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-----HHHHHHhc
Confidence 99776443322 33458899999999864 4688899999999999999999999865433221 01111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+ -|.+. .....+..+.+++..||.+|+.+||...+++++
T Consensus 311 e------PP~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 E------PPLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred C------CCCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 12221 123367889999999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=310.18 Aligned_cols=145 Identities=29% Similarity=0.423 Sum_probs=130.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...++||+|+||.||+|... +++.||||+++.. .......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 6889999988643 2334567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+++|+.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 84 Ey~~g~~L~~li~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vk 144 (669)
T cd05610 84 EYLIGGDVKSLLHIY----------------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIK 144 (669)
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEE
Confidence 999999999998542 35888999999999999999999998 99999999999999999999
Q ss_pred EeecCCCc
Q 039736 490 VSDFGTSR 497 (633)
Q Consensus 490 I~DfGla~ 497 (633)
|+|||+++
T Consensus 145 L~DFGls~ 152 (669)
T cd05610 145 LTDFGLSK 152 (669)
T ss_pred EEeCCCCc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=271.47 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=199.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+.+++||+|.||.|-..+- ..|+.+|+|+++. ..++++..-+.|-++|+..+||.+..|--.+...+.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 46888999999999999999884 4789999999876 3455566677889999999999999998889999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+.||.|.-+|...+ .++.....-+-.+|..||.|||+.+ ||.||||.+|.|+|.+|++
T Consensus 247 MeyanGGeLf~HLsrer----------------~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHI 307 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER----------------VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHI 307 (516)
T ss_pred EEEccCceEeeehhhhh----------------cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCce
Confidence 99999999998886643 4777778888999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++.--.. ...+..++||+.|+|||++....|...+|.|.+||++|||+.|+.||...+.+.. ... +
T Consensus 308 KitDFGLCKE~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---FeL---I 380 (516)
T KOG0690|consen 308 KITDFGLCKEEIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---FEL---I 380 (516)
T ss_pred Eeeecccchhcccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---HHH---H
Confidence 99999999864322 2234567899999999999999999999999999999999999999975543321 111 1
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
+-+ . ..+|.....+...|+...|.+||.+|.
T Consensus 381 l~e---------d--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 LME---------D--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred Hhh---------h--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 100 0 123445556778889999999999995
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=309.98 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=210.9
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
..+++-..++|.+.+.||+|+||.|...+.+ .++.+|+|++.. ....+...|..|-.+|..-+.+.|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4455566689999999999999999999964 688999999876 333455678899999999999999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
+..+|+|||||+||+|..++... ..++...+..++.+|.-||+-||+.| +|||||||.|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----------------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvL 207 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----------------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVL 207 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----------------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeE
Confidence 99999999999999999999764 35888888899999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc----c-CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ----S-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~----~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
||..|++||+|||-+..+..++.-.....+|||.|++||++. + +.|+...|.||+||++|||+.|..||+...
T Consensus 208 ld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-- 285 (1317)
T KOG0612|consen 208 LDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-- 285 (1317)
T ss_pred ecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--
Confidence 999999999999999888777666666788999999999984 2 678999999999999999999999996432
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccC--HHHHHHHHHHHHhccccCCCCCCC---HHHHHHH
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAR--EEDIEAVAELAMGCLRLNSKKRPT---MKQVSMD 618 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPt---~~ev~~~ 618 (633)
++.-+ ..+++..-.-.+| .+.+....+||.+.+. +|+.|.. +.++-.+
T Consensus 286 ----lveTY---------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 286 ----LVETY---------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ----HHHHH---------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22222 2222221112233 3456778888888875 7788877 7776543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=271.75 Aligned_cols=220 Identities=24% Similarity=0.235 Sum_probs=175.9
Q ss_pred cCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCchhhcch
Q 039736 345 GGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHD 423 (633)
Q Consensus 345 G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 423 (633)
|.+|.||++.. .+++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78999999995 468899999987532 233455555566799999999999999999999999999999998854
Q ss_pred hhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCC
Q 039736 424 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503 (633)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 503 (633)
. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++++|||.+.......
T Consensus 79 ~----------------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~ 139 (237)
T cd05576 79 F----------------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC 139 (237)
T ss_pred h----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc
Confidence 2 35899999999999999999999998 9999999999999999999999999887653321
Q ss_pred cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhh
Q 039736 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583 (633)
Q Consensus 504 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 583 (633)
....++..|+|||.+..+.++.++||||+|+++|||++|+.|+....... .....
T Consensus 140 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------------~~~~~ 194 (237)
T cd05576 140 ----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------------NTHTT 194 (237)
T ss_pred ----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------------ccccc
Confidence 12335678999999988889999999999999999999998763221100 00000
Q ss_pred cccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 584 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
...+......+.+++.+||+.||++||++.
T Consensus 195 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 112233456788999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=267.45 Aligned_cols=238 Identities=30% Similarity=0.415 Sum_probs=192.0
Q ss_pred CcEEEEEEEcC-CCCEEEEEEccccChhH-HHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCchhhcch
Q 039736 346 GFGTVYKGMLP-DGSIVAVKRSRAIDKTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHD 423 (633)
Q Consensus 346 ~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~-~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 423 (633)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 57999999976 48999999987654443 67899999999999999999999999998999999999999999998854
Q ss_pred hhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCC
Q 039736 424 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503 (633)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 503 (633)
. ..+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~----------------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~ 141 (244)
T smart00220 81 R----------------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG 141 (244)
T ss_pred c----------------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc
Confidence 2 23889999999999999999999998 9999999999999999999999999998765432
Q ss_pred cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhh
Q 039736 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583 (633)
Q Consensus 504 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 583 (633)
......++..|++||.+....++.++||||||++++||++|..|+....... .. .......... .
T Consensus 142 --~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~-------~ 206 (244)
T smart00220 142 --LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL----FKKIGKPKPP-------F 206 (244)
T ss_pred --ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH----HHHHhccCCC-------C
Confidence 2233457889999999998889999999999999999999999985421111 00 1111110000 0
Q ss_pred cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 584 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
..........+.+++.+||..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0000014567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.72 Aligned_cols=280 Identities=20% Similarity=0.237 Sum_probs=186.0
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-----------------CCCCEEEEEEccccChhHHHHH--------------HHH
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-----------------PDGSIVAVKRSRAIDKTQIEQF--------------INE 380 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-----------------~~g~~vAVK~~~~~~~~~~~~~--------------~~E 380 (633)
..++|+..++||+|+||.||+|.. .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 2356899999875443333333 346
Q ss_pred HHHHhccCCCCc-----eEEEEEEee--------CCceEEEEeeccCCCchhhcchhhhhH-HHHH-------HHHHhhh
Q 039736 381 VVILSQINHRHI-----VKLLGCCLE--------TEVPVLVYEYISNGTLSHHIHDHQQQQ-EQKQ-------ELEEEQE 439 (633)
Q Consensus 381 i~il~~l~H~nI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~l~~~~~~~-~~~~-------~~~~~~~ 439 (633)
+.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++++...... .... .......
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677887753 346799999999999999997532100 0000 0001111
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCch
Q 039736 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519 (633)
Q Consensus 440 ~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~AP 519 (633)
...++|..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 235788999999999999999999998 99999999999999999999999999976543322222223457899999
Q ss_pred hccccCCC----------------------CcccchhhHHHHHHHHHhCCC-CCCCCchhhhhcHHHHHHHHHhhchhhh
Q 039736 520 EYFQSSQY----------------------TDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFISLAKENKLLE 576 (633)
Q Consensus 520 E~l~~~~~----------------------s~ksDV~SfGvvL~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 576 (633)
|.+..... ..+.||||+||+++||++|.. |+........ .... ...... ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~-~~~~~~--~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQ-YDNDLN--RWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhh-ccchHH--HHHh
Confidence 98754321 235799999999999999875 5432110000 0000 000000 0000
Q ss_pred hhchhhhcccCHHHHHHHHHHHHhccccCC---CCCCCHHHHHHH
Q 039736 577 ILDARVAKEAREEDIEAVAELAMGCLRLNS---KKRPTMKQVSMD 618 (633)
Q Consensus 577 ~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP---~~RPt~~ev~~~ 618 (633)
...................+|+.++|..+| .+|+|+.|++++
T Consensus 456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000001111112334677899999999766 689999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=295.90 Aligned_cols=273 Identities=20% Similarity=0.274 Sum_probs=173.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-C----CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEE------Ee
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-D----GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC------CL 400 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~----g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~------~~ 400 (633)
..++|...+.||+|+||.||+|... + +..||||++..... .+.+..| .+++..+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999964 4 68999998765322 1222222 1222222222222211 23
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHH----HHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL----EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~----~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
.+...++||||+.+++|.+++............. ..........+..+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 4567899999999999999986542110000000 00000112234456789999999999999998 9999999
Q ss_pred CCCeeecC-CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC----------------------CCCcccch
Q 039736 477 SSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS----------------------QYTDKSDV 533 (633)
Q Consensus 477 ~~NILl~~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksDV 533 (633)
|+|||+++ ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999996 68999999999987654444444456789999999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh-c---hhhhhhchhhhcc----c--CHHHHHHHHHHHHhccc
Q 039736 534 YSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE-N---KLLEILDARVAKE----A--REEDIEAVAELAMGCLR 603 (633)
Q Consensus 534 ~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~---~~~~~~d~~l~~~----~--~~~~~~~l~~L~~~Cl~ 603 (633)
|||||+||||+++..+.... +..+....... . .......+....+ + .........+|+.+||+
T Consensus 363 wSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999977664211 11111111000 0 0111111110000 0 00112345689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 039736 604 LNSKKRPTMKQVSMD 618 (633)
Q Consensus 604 ~dP~~RPt~~ev~~~ 618 (633)
.||++|||+.|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999985
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=272.81 Aligned_cols=241 Identities=27% Similarity=0.396 Sum_probs=199.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
.+|+.+..||+|+||.|-.|.-+ ..+.+|||+++.. ...+++--+.|-++|+.. +-|.++++..++..-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47888999999999999999854 4568999998762 233444556677888776 578899999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+.||+|--+++. .+.+.+..+.-+|.+||-||-+||+.+ |+.||||..||+||.+|++
T Consensus 429 MEyvnGGDLMyhiQQ----------------~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHi 489 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ----------------VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHI 489 (683)
T ss_pred EEEecCchhhhHHHH----------------hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCce
Confidence 999999999888865 356888899999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++.---+ ...+....||+.|+|||++....|+..+|.|||||+||||+.|++||++.++++. +
T Consensus 490 Ki~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F--- 559 (683)
T KOG0696|consen 490 KIADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------F--- 559 (683)
T ss_pred EeeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------H---
Confidence 99999999864322 2234567899999999999999999999999999999999999999987665442 1
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt 611 (633)
..+++... .+|...+.+...+.+..+.+.|.+|..
T Consensus 560 ------~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 ------QAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ------HHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 22333332 356667777888899999999999953
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-33 Score=263.97 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=190.3
Q ss_pred ccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhc-cCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 337 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQ-INHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
+.+..||.|+||+|+|-..+ .|+..|||+++... ..+.++++.|.+...+ -+.||||+++|.+..++..++.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 34667999999999998854 68999999988744 3567788889876544 579999999999999999999999996
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
- ||..+...-.. .....+++.-.-.|+.-..+||.||.+.-+ |+||||||+|||||..|.+||+||
T Consensus 147 ~-SlDklYk~vy~-----------vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 147 I-SLDKLYKRVYS-----------VQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred h-hHHHHHHHHHH-----------HHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecc
Confidence 3 65544322111 112468888788888999999999987643 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|++-.+.+. ...+...|...|||||.+... .++-+|||||+|+.|+|+.||+.|+...+. ..+.+.....
T Consensus 213 GIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~- 284 (361)
T KOG1006|consen 213 GICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI- 284 (361)
T ss_pred cchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-
Confidence 998765332 112334588899999999643 478899999999999999999999853221 1111111111
Q ss_pred chhhhhhch-hhhc-ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDA-RVAK-EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~-~l~~-~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
-|+ .+.. .........+..++.-|+.+|-..||...++.++
T Consensus 285 ------gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 ------GDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ------CCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 1111 1123456789999999999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=241.07 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=195.2
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+|...++||+|.||+||+|+. +.++.||+|+++..+ +......++|+-+++.++|.|||+++++...+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678899999999999995 468999999877533 33356788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+.. +|..+.... .+.++.....++..|+++||.+.|+++ +.|||+||.|.||+.+|+.|++
T Consensus 83 cdq-dlkkyfdsl---------------ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkla 143 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSL---------------NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLA 143 (292)
T ss_pred hhH-HHHHHHHhc---------------CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEec
Confidence 964 666665433 246888889999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCC-CCchhhhhcHHHHHHHH-
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPIC-LTREEEERNLVAYFISL- 568 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~-~~~~~~~~~l~~~~~~~- 568 (633)
|||+++.++-.-.. ....+-|..|.+|.++.+. .|++..|+||-||++.|+.....|.. +.+.+ ..+...++..
T Consensus 144 dfglarafgipvrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd--dqlkrif~~lg 220 (292)
T KOG0662|consen 144 DFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLG 220 (292)
T ss_pred ccchhhhcCCceEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH--HHHHHHHHHhC
Confidence 99999987543322 2234568999999998764 58899999999999999998555543 32222 2233333322
Q ss_pred -Hhhc---hhhhhhchhhhcccCH-----HH----HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 -AKEN---KLLEILDARVAKEARE-----ED----IEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 -~~~~---~~~~~~d~~l~~~~~~-----~~----~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..++ .+...-|-.....++. +. ...=.+|++..+.-+|.+|.++++.+++
T Consensus 221 ~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 1222222211111221 11 1233578888888999999999988753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=283.18 Aligned_cols=240 Identities=25% Similarity=0.341 Sum_probs=192.6
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++.|.....+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++... +|+||+++.+.+.+....|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56778888899999999998884 467889999887641 1233577666555 79999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee-cCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL-DDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-~~~~~~k 489 (633)
.+.+|-|.+.+.... ... ..+..|+.+|+.++.|||+++ +|||||||+|||+ ++.++++
T Consensus 397 ~l~g~ell~ri~~~~----------------~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lr 456 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----------------EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLR 456 (612)
T ss_pred hccccHHHHHHHhcc----------------hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEE
Confidence 999998877765432 122 677789999999999999999 9999999999999 5899999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||.++..+.+ .....-|..|.|||.+....+++++|+||||++||||++|+.|+.....+.+ .....
T Consensus 457 ltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e------i~~~i 526 (612)
T KOG0603|consen 457 LTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE------IHTRI 526 (612)
T ss_pred EEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH------HHHhh
Confidence 9999999987554 1223457899999999999999999999999999999999999875544311 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ...+....+....+|+.+||+.||.+||+|.++..+
T Consensus 527 ~------------~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 Q------------MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred c------------CCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1 122224556778999999999999999999998764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=269.31 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=196.4
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEcc--ccChh-----HHHHHHHHHHHHhccCCCCceEEEEEEe-eCCc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKT-----QIEQFINEVVILSQINHRHIVKLLGCCL-ETEV 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~--~~~~~-----~~~~~~~Ei~il~~l~H~nIv~l~g~~~-~~~~ 404 (633)
++|-.+++||+|||+.||++. +...+.||||+-. ....+ -.+...+|..|.+.|.||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456667899999999999999 4567899999743 22111 2345678999999999999999999987 4567
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
++-|+||++|.+|.-||..++ .++++++..|+.||+.||.||.+.. |||||-||||.||||.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhk----------------lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~ 605 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK----------------LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVN 605 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh----------------hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEec
Confidence 889999999999999997754 4899999999999999999999876 77999999999999954
Q ss_pred ---CCcEEEeecCCCccCCCCCcc------eecccccCCCcCchhccccC----CCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 485 ---KFSAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSS----QYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 485 ---~~~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~----~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
-|.+||+|||+++.+.++... .+....||..|++||.+--+ +++.|+||||.||++|..+.|+.||.
T Consensus 606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG 685 (775)
T KOG1151|consen 606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG 685 (775)
T ss_pred CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence 578999999999988654332 33446799999999987543 57889999999999999999999996
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...... .++.+..+...-+- .-...+....+...+|++||+..-++|....++..
T Consensus 686 hnqsQQ---------dILqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 686 HNQSQQ---------DILQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CchhHH---------HHHhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 433221 11111111111111 11112334466788999999999999988777653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=284.51 Aligned_cols=262 Identities=21% Similarity=0.396 Sum_probs=208.5
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 401 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~ 401 (633)
..++.+...++-|++.+.||.|.+|.||+++ .++|+.+|+|++...... .++...|.++|+.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555667889999999999999999999 457899999987764332 23455788888887 69999999999873
Q ss_pred -----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 402 -----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 402 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
++.++||||||.+||..|++..... ..+.|..+..|+.+++.||.+||.+. ++|||||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g--------------~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDik 150 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKG--------------NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIK 150 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcc--------------cchhhHHHHHHHHHHHHHHHHHhhcc---eeeeccc
Confidence 5689999999999999999976542 46999999999999999999999998 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-----CCCcccchhhHHHHHHHHHhCCCCCC
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----QYTDKSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDV~SfGvvL~elltG~~p~~ 551 (633)
-.|||++.++.+|+.|||++...... ........||+.|||||++... .|+.++|+||+|++..||--|.+|+.
T Consensus 151 G~NiLLT~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 151 GQNVLLTENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred CceEEEeccCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 99999999999999999999876432 2233456799999999998643 46779999999999999999999975
Q ss_pred CCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 552 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ..+.... -.|......+.....++.++|..||.+|-++||++.+++++
T Consensus 230 DmHPm------raLF~Ip--------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 230 DMHPM------RALFLIP--------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred Ccchh------hhhccCC--------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 32211 0111111 12222223456778899999999999999999999998864
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=255.85 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=193.1
Q ss_pred hcCCccC-CcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee----CCce
Q 039736 333 TDNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE----TEVP 405 (633)
Q Consensus 333 ~~~~~~~-~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~----~~~~ 405 (633)
+++|+.. ++||-|-.|.|-.... +.|+.+|+|++... ....+|+++.-.. .|||||.+++++.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4455443 5799999999988874 37899999987653 2445788765554 59999999999864 3467
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD- 484 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 484 (633)
.+|||+|+||.|.+.+.+++. ..++++++-.|..||+.|+.|||+.+ |.||||||+|+|.+.
T Consensus 135 LiVmE~meGGeLfsriq~~g~--------------~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--------------QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTT 197 (400)
T ss_pred EeeeecccchHHHHHHHHccc--------------ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecC
Confidence 899999999999988876543 46999999999999999999999999 999999999999974
Q ss_pred --CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 --KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 --~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
|-.+||+|||+|+...... .....+-|+.|.|||++...+|+...|+||+||++|-|+.|.+||....+.. +.
T Consensus 198 ~~na~lKLtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is 272 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS 272 (400)
T ss_pred CCCcceEecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC
Confidence 5679999999999764322 2234557999999999999999999999999999999999999997543211 11
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.-+......+.. ++ ..+.....++...++++.+|..+|.+|.|+.|+..+
T Consensus 273 pgMk~rI~~gqy-~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 273 PGMKRRIRTGQY-EF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hhHHhHhhccCc-cC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 111111111100 00 111123456778899999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=257.33 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=190.8
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee--------CC
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE--------TE 403 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--------~~ 403 (633)
.|....+||+|.||.||+++.. .|+.||+|+..-. ...--...++|+++|..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999954 5778899864321 11122356789999999999999999988853 23
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
.+|||+++++. +|...|.... ..++..++.++..++..||.|+|... |+|||+|+.|+||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---------------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt 158 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---------------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLIT 158 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---------------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEc
Confidence 57999999986 6777665432 36889999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCC---cceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 484 DKFSAKVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
.++.+||+|||+++.+.... ....+..+-|..|.+||.+.+ ..++++.|||+-||++.||++|.+-+....+....
T Consensus 159 ~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql 238 (376)
T KOG0669|consen 159 KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL 238 (376)
T ss_pred CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH
Confidence 99999999999998764222 222334456999999998765 67999999999999999999998877655443322
Q ss_pred cHHHHHHHHHhhc--------hhhhhh--chhhhccc--------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 560 NLVAYFISLAKEN--------KLLEIL--DARVAKEA--------REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 560 ~l~~~~~~~~~~~--------~~~~~~--d~~l~~~~--------~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+....-.....+ .+.+.+ .|-....+ +-.-.....+|+..++..||.+|+++++++.+
T Consensus 239 ~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 239 HLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2221111000000 011111 00000000 00012356789999999999999999988754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-31 Score=284.05 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=187.9
Q ss_pred CCccCCcccccCcEE-EEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGT-VYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~-Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
-|...+.+|.|+.|+ ||+|.+ +|+.||||++-.. -.....+|+..|+.- +|||||++++.-.++...|+..|.+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 345567789999886 899999 7899999987652 233556899999988 5999999999988888999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-----CCc
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-----KFS 487 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~~ 487 (633)
. -+|.+++..... . .....-...+.+..|++.||++||+.+ ||||||||.||||+. ..+
T Consensus 586 ~-~sL~dlie~~~~-d-----------~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 586 A-CSLQDLIESSGL-D-----------VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred h-hhHHHHHhcccc-c-----------hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCccee
Confidence 6 499999976411 0 011121455778899999999999988 999999999999975 368
Q ss_pred EEEeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhC-CCCCCCCchhhhhcHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG-KKPICLTREEEERNLVAY 564 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG-~~p~~~~~~~~~~~l~~~ 564 (633)
++|+|||+++....+..... ....||.||+|||++....-+.++||||+||++|..++| ++||...-..+ .+.
T Consensus 650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI--- 725 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI--- 725 (903)
T ss_pred EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh---
Confidence 99999999999876654433 346799999999999988888899999999999999995 89985321111 000
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...+..+.. + .. ..++ +..+||.+|+..+|..||++.+|+.
T Consensus 726 ---l~~~~~L~~-L-----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 726 ---LTGNYTLVH-L-----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---hcCccceee-e-----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 001111110 0 00 1111 6789999999999999999999974
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=268.26 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=189.7
Q ss_pred CCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 339 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
.+.||+|.||+||-|+.+ +|+.||||.+.+ ....+.+.+.+|+.||+++.||.||.|.-.|+..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 578999999999999954 799999998764 23344567889999999999999999999999999999999999654
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC---CcEEEee
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSD 492 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~~~kI~D 492 (633)
-|+-.|... .+.|+......+..||+.||.|||..+ |+|+||||+|||+.+. -++||+|
T Consensus 649 MLEMILSsE---------------kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 649 MLEMILSSE---------------KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred HHHHHHHhh---------------cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecc
Confidence 444333322 357888888899999999999999999 9999999999999653 4799999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+|+.+++. ...+.++||+.|+|||++.+..|...-|+||.||++|--++|..||....+-.+ -+. +.
T Consensus 711 FGfARiIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-----QIQ----NA 779 (888)
T KOG4236|consen 711 FGFARIIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-----QIQ----NA 779 (888)
T ss_pred ccceeecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-----Hhh----cc
Confidence 9999998654 345678899999999999999999999999999999999999999853322111 110 00
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
.+|-| .....+......+||...|+..=.+|-|...-+
T Consensus 780 ---aFMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 780 ---AFMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---ccccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 01111 111123345567778888888777888776544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=258.70 Aligned_cols=260 Identities=21% Similarity=0.301 Sum_probs=201.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCC--C----CceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINH--R----HIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H--~----nIv~l~g~~~~~~~~ 405 (633)
+++|....++|+|.||.|-....+ .+..||||+++...+- .+..+-|+++|+++++ | -+|++.+++.-.+..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 678999999999999999988854 4689999999875442 3456679999999943 2 367888889889999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec--
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-- 483 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-- 483 (633)
++|+|.+ |-|+.++|..+. ..+++..++..|+.|+++++++||+.+ ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~--------------y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss 228 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN--------------YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSS 228 (415)
T ss_pred EEEEecc-ChhHHHHhccCC--------------ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEecc
Confidence 9999998 559999997754 357899999999999999999999999 99999999999993
Q ss_pred ------------------CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh
Q 039736 484 ------------------DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545 (633)
Q Consensus 484 ------------------~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt 545 (633)
.+..+||.|||.|....... ...+.|..|.|||++.+-.++.++||||+||||.|+.+
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 24469999999998764433 34567999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhcHHHHHHHHHhh--------ch--------hhhhhchhh----------------hcccCHHHHHH
Q 039736 546 GKKPICLTREEEERNLVAYFISLAKE--------NK--------LLEILDARV----------------AKEAREEDIEA 593 (633)
Q Consensus 546 G~~p~~~~~~~~~~~l~~~~~~~~~~--------~~--------~~~~~d~~l----------------~~~~~~~~~~~ 593 (633)
|..-|...++.+... .+...+.. .+ ..++-+... .......+...
T Consensus 305 G~~LFqtHen~EHLa---MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 305 GETLFQTHENLEHLA---MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred cceecccCCcHHHHH---HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 999987766444321 11111110 00 000000000 00112344577
Q ss_pred HHHHHHhccccCCCCCCCHHHHHHH
Q 039736 594 VAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 594 l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|.+|+..+|..||.+|+|+.|++.+
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcC
Confidence 9999999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=267.70 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=204.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCC-EEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGS-IVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~-~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++.....||-||||.|-....+... ..|+|.++. .+..+.+....|-.||...+.|.||+++-.+.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555677999999999998875433 378887654 56667778889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|-+-||.|+..|++. +.+.......++..+.+|++|||+++ ||.|||||+|.+||.+|-+|
T Consensus 500 EaClGGElWTiLrdR----------------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----------------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HhhcCchhhhhhhhc----------------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceE
Confidence 999999999999774 45788888889999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|.|||+|+.+..+.. +..++||+.|.|||++.+..++..+|.||+|+++|||++|++||...+....-+ ..+
T Consensus 561 LVDFGFAKki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn------~IL 632 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN------LIL 632 (732)
T ss_pred EeehhhHHHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH------HHH
Confidence 999999999866544 566889999999999999999999999999999999999999998765433211 111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
.. +| ..++|........+|+++....+|.+|.. +.+|-++
T Consensus 633 kG------id---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 633 KG------ID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hh------hh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11 11 12344555567788999999999999976 5555544
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=236.03 Aligned_cols=211 Identities=36% Similarity=0.624 Sum_probs=183.2
Q ss_pred ccccCcEEEEEEEcCC-CCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCchh
Q 039736 342 LGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSH 419 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 419 (633)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999753 899999998765432 34678899999999999999999999999889999999999999999
Q ss_pred hcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcEEEeecCCCcc
Q 039736 420 HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAKVSDFGTSRS 498 (633)
Q Consensus 420 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kI~DfGla~~ 498 (633)
++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. +++++|+|||.+..
T Consensus 81 ~~~~~~---------------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~ 142 (215)
T cd00180 81 LLKENE---------------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKL 142 (215)
T ss_pred HHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEE
Confidence 886431 25899999999999999999999998 999999999999999 89999999999987
Q ss_pred CCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh
Q 039736 499 VPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI 577 (633)
Q Consensus 499 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 577 (633)
...... ......+...|++||.+... ..+.+.|+|++|+++++|
T Consensus 143 ~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------- 187 (215)
T cd00180 143 LTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------- 187 (215)
T ss_pred ccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------
Confidence 644321 12234578899999999887 788999999999999999
Q ss_pred hchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 578 LDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 578 ~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
..+.+++..|++.||++||++.++++.+
T Consensus 188 --------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=245.97 Aligned_cols=249 Identities=23% Similarity=0.398 Sum_probs=198.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc---cChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA---IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|..++.||+|+|..|..+.+. ..+.+|+|+++. .+.+++.-...|-.++.+- +||.+|.+..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368889999999999999998864 578899998775 2334444455666666655 79999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|.||+++|+|--++... ..|++.++..+..+|.-||.|||+.| |+.||||..|+|+|..|+
T Consensus 329 vieyv~ggdlmfhmqrq----------------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaegh 389 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ----------------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGH 389 (593)
T ss_pred EEEEecCcceeeehhhh----------------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCc
Confidence 99999999998888654 35889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchh-hhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE-EERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~-~~~~l~~~~~ 566 (633)
+|++|+|+++.--.. ...+..+.||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.-..+ .+.+.-++..
T Consensus 390 ikltdygmcke~l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf 468 (593)
T KOG0695|consen 390 IKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF 468 (593)
T ss_pred eeecccchhhcCCCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence 999999999864322 23345678999999999999999999999999999999999999999643221 2233334443
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt 611 (633)
....+. .+ .+|...+.+...+++.-|.+||.+|..
T Consensus 469 qvilek--------qi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 469 QVILEK--------QI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHhhh--------cc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 333222 11 234444556678889999999999853
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=246.50 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=195.5
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----CceE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVPV 406 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~~~ 406 (633)
+.+..+-||-|+||.||.... ++|+.||+|++...- -...+++.+|+++|.-++|.|++..++...-. .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344578899999999999885 489999999987532 34567899999999999999999988876532 2457
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
.+.|.|.. +|...+-. ...|+-..+.-+..||++||.|||+.+ |.||||||.|.|++.|.
T Consensus 134 V~TELmQS-DLHKIIVS----------------PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNC 193 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS----------------PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNC 193 (449)
T ss_pred HHHHHHHh-hhhheecc----------------CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCc
Confidence 88888854 67666644 346888899999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+++.-..+.....+..+-|..|.|||.+++. .|+.+.||||.||++.||+.++.-|.....-+..++..
T Consensus 194 vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt-- 271 (449)
T KOG0664|consen 194 ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII-- 271 (449)
T ss_pred eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH--
Confidence 999999999998655554445556679999999999875 58999999999999999999888776544433322222
Q ss_pred HHHHhhchhh-----------hhhchhhh---------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 566 ISLAKENKLL-----------EILDARVA---------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 566 ~~~~~~~~~~-----------~~~d~~l~---------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
..+....+. .++....+ ..-+...-.+-..+...++..||+.|.+..+.+..+
T Consensus 272 -dLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 272 -DLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred -HHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 222111111 11111100 000112234456777888999999999998887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=258.13 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=171.2
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.-|-.++.||-|+||.|.++. .+....+|.|.++..+ ..+......|-.||..-..+.||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999988 4456689999887643 334556778999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++||++-.+|... +-+.+..+..++.++..|+++.|..| +|||||||.|||||.+|++|
T Consensus 709 dYIPGGDmMSLLIrm----------------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM----------------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred eccCCccHHHHHHHh----------------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCcee
Confidence 999999999988664 34677777778889999999999999 99999999999999999999
Q ss_pred EeecCCCccCC---------CCC--------------------------------cceecccccCCCcCchhccccCCCC
Q 039736 490 VSDFGTSRSVP---------NDK--------------------------------THLTTAVQGTFGYFDPEYFQSSQYT 528 (633)
Q Consensus 490 I~DfGla~~~~---------~~~--------------------------------~~~~~~~~gt~~y~APE~l~~~~~s 528 (633)
|+||||+.-+. ++. .......+||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 99999985331 000 0001124699999999999999999
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 529 DKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 529 ~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
.-.|.||.|||||||+.|+.||-.....+
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 99999999999999999999996554443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=229.93 Aligned_cols=203 Identities=26% Similarity=0.409 Sum_probs=162.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc-cChhHHHHHHHHHHHHhc-cCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA-IDKTQIEQFINEVVILSQ-INHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~-~~~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+.......||+|++|.|-+-+. .+|...|+|+++. ...+..++.++|+.+..+ ..+|.+|.++|....++..++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4445567899999999866663 4799999999875 344556678889887555 479999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
.|+- ||..+-..-.. ....+++.-.=+||..+.+||.|||++-+ ++|||+||+||||+.+|++||
T Consensus 126 ~M~t-Sldkfy~~v~~------------~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLK------------KGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred Hhhh-hHHHHHHHHHh------------cCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEE
Confidence 9964 66655433211 14578888899999999999999999754 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc----CCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
+|||++-.+.+.-. .+...|...|||||.+.. ..|+-|+||||+|+.+.||.+++.|+...
T Consensus 191 CDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 191 CDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999976643211 122347889999998853 36889999999999999999999998643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=229.27 Aligned_cols=257 Identities=22% Similarity=0.366 Sum_probs=193.4
Q ss_pred hcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeC--CceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~--~~~~LV 408 (633)
.++|+..+++|+|-++.||.|. ..+.+.++||.++...+. ...+|++||+.+. ||||++|+++..+. ..+.|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkk---KIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKK---KIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHH---HHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999999 457889999999986554 5568999999997 99999999998764 467899
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCc
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFS 487 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~ 487 (633)
+||+++.+..... +.|+..++.....++++||.|+|+.| |.|||+||.|++||. .-.
T Consensus 114 FE~v~n~Dfk~ly-------------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhhhccccHHHHh-------------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 9999987654433 46888999999999999999999999 999999999999995 556
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
++|.|+|+|.....+.... -.+.+..|--||.+-. ..++..-|+|||||+|.+|+..+.||....+ ....++...
T Consensus 172 LrlIDWGLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIa- 247 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIA- 247 (338)
T ss_pred eeeeecchHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHH-
Confidence 9999999998875443321 2234667889998865 4578899999999999999999999864322 112222211
Q ss_pred HHHh---------------hchhhhhhchhhhccc--------CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAK---------------ENKLLEILDARVAKEA--------REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~---------------~~~~~~~~d~~l~~~~--------~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+. +.+..++++...+... ..-...+..+++...|..|..+|||++|...+
T Consensus 248 kVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 248 KVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111 1122222221111110 01123678899999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=232.64 Aligned_cols=199 Identities=36% Similarity=0.537 Sum_probs=171.6
Q ss_pred CccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
|+..+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 789999998765443 56788999999999999999999999998889999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+++|.+++..... .+++.....++.+++.++.+||+++ ++|+||+++||+++.++.++|+||
T Consensus 81 ~~~L~~~~~~~~~---------------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~ 142 (225)
T smart00221 81 GGDLFDYLRKKGG---------------KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADF 142 (225)
T ss_pred CCCHHHHHHhccc---------------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeC
Confidence 9999998865321 1889999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhcc-ccCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
|.+...............++..|++||.+ ....++.++|+|+||++++||++|+.||..
T Consensus 143 g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 143 GLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99987654321122334577889999998 667788899999999999999999999854
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=230.25 Aligned_cols=260 Identities=23% Similarity=0.326 Sum_probs=189.5
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------c
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------V 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~ 404 (633)
.+|.....+|.|.- .|-.+.. -.++.||+|++.. ......++..+|..++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46667788888887 5555542 2588999998654 22344567789999999999999999999997443 5
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+|||+|. ++|...++. .++-.....|..|+..|+.|||+.+ |+||||||+||++..
T Consensus 96 ~y~v~e~m~-~nl~~vi~~------------------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~ 153 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM------------------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNS 153 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH------------------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecc
Confidence 699999995 588887752 3666778889999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh------
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE------ 558 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~------ 558 (633)
+..+||.|||+|+....+ ...+..+.|..|.|||.+.+..+.+.+||||.||++.||++|+--|.+.+.-+.
T Consensus 154 ~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 154 DCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE 231 (369)
T ss_pred hhheeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence 999999999999875433 345566789999999999988899999999999999999999987753321100
Q ss_pred ----------hcHHHHHHHHHhh-chh-----hhh-hchhhh--cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 559 ----------RNLVAYFISLAKE-NKL-----LEI-LDARVA--KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 559 ----------~~l~~~~~~~~~~-~~~-----~~~-~d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+.......... ++. .+. -|.... .+.+.-......+|+.+||..||++|.++++++++
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000000000000 000 000 000000 01111234567889999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=254.84 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=202.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|.....+|+|.+|.|||++. +.++..|||.++-.......-...|+-+++.-+|+||+.++|.+..++..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46888899999999999999994 47899999998876666667777899999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+.+|+|.+.-+.. .+|++.++..+.++..+||.|||+.+ -+|||||-.|||+++.|.+|++
T Consensus 94 cgggslQdiy~~T----------------gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT----------------GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred cCCCcccceeeec----------------ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeec
Confidence 9999999987753 46999999999999999999999999 6899999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcc---ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|||.+..+... ........||+.|||||+. ..+.|..++|||+.|+...|+---++|....... +. .+ +
T Consensus 155 Dfgvsaqitat-i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~---l~--L 226 (829)
T KOG0576|consen 155 DFGVSAQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RA---LF--L 226 (829)
T ss_pred ccCchhhhhhh-hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HH---HH--H
Confidence 99998766322 1123456799999999986 4577899999999999999998888774311110 00 00 0
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
+... ..++.- ..-.....+.+.++++.|+-++|++||++..++.
T Consensus 227 mTkS----~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 MTKS----GFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhcc----CCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000 011110 0112334577889999999999999999987664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=245.13 Aligned_cols=196 Identities=23% Similarity=0.370 Sum_probs=165.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--------hhHHHHHHHHHHHHhccC---CCCceEEEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--------KTQIEQFINEVVILSQIN---HRHIVKLLGCCLE 401 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~ 401 (633)
.+|...+.+|+|+||.|+.+..+ +...|+||.+.+.. ....-..-.||.||..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999975 45689999765421 111123446999999997 9999999999999
Q ss_pred CCceEEEEeecc-CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 402 TEVPVLVYEYIS-NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 402 ~~~~~LV~E~~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
++..||+||-.. +-+|.+++..+ +.+++.+..-|+.||+.|+++||+++ |||||||-+|+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----------------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenv 701 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----------------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENV 701 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----------------CccchHHHHHHHHHHHhccccccccC---ceecccccccE
Confidence 999999999764 45788888653 46999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCc-ccchhhHHHHHHHHHhCCCCCC
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD-KSDVYSFGVVLLELLTGKKPIC 551 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~-ksDV~SfGvvL~elltG~~p~~ 551 (633)
.++.+|-+||.|||.+.....+.. ..++||.+|.|||.+.+..|-- .-|||++|++||.++....|++
T Consensus 702 ivd~~g~~klidfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEecCCeEEEeeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999987644332 3467999999999999887754 5899999999999999998874
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=227.96 Aligned_cols=131 Identities=25% Similarity=0.399 Sum_probs=110.5
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-----C---CCceEEEEEEeeCC-
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-----H---RHIVKLLGCCLETE- 403 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-----H---~nIv~l~g~~~~~~- 403 (633)
.+|...++||.|-|++||++.. .+.+.||+|+.+.. ..-.+..+.||++|++++ | ..||+|++.|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788999999999999999984 35789999998863 233556789999999984 3 47999999998543
Q ss_pred ---ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 404 ---VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 404 ---~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
..+||+|+. |-+|..+|.... .+.++...+.+|+.||+.||.|||... +|||-||||+||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~--------------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN--------------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC--------------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 679999999 668888887654 356999999999999999999999875 399999999999
Q ss_pred ee
Q 039736 481 LL 482 (633)
Q Consensus 481 Ll 482 (633)
|+
T Consensus 220 Ll 221 (590)
T KOG1290|consen 220 LL 221 (590)
T ss_pred ee
Confidence 99
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=269.71 Aligned_cols=196 Identities=20% Similarity=0.220 Sum_probs=138.4
Q ss_pred ccCC-CCceEEEEEE-------eeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH
Q 039736 386 QINH-RHIVKLLGCC-------LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457 (633)
Q Consensus 386 ~l~H-~nIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~ 457 (633)
.++| +||.++++.+ .+.+..++++||+ +++|.++|... ...+++.+++.++.||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~ 91 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------------DRSVDAFECFHVFRQIVE 91 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------------cccccHHHHHHHHHHHHH
Confidence 3455 5888888877 2334567889987 56999999643 235999999999999999
Q ss_pred HHHHhHhcCCCCeeccCCCCCCeeecC-------------------CCcEEEeecCCCccCCCCCc--------------
Q 039736 458 AVAYMHSAASIPIFHRDIKSSNILLDD-------------------KFSAKVSDFGTSRSVPNDKT-------------- 504 (633)
Q Consensus 458 gL~yLH~~~~~~ivHrDIk~~NILl~~-------------------~~~~kI~DfGla~~~~~~~~-------------- 504 (633)
||.|||+++ |+||||||+||||+. ++.+||+|||+++.......
T Consensus 92 al~~lH~~g---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 168 (793)
T PLN00181 92 IVNAAHSQG---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPF 168 (793)
T ss_pred HHHHHHhCC---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCC
Confidence 999999999 999999999999965 44556666666653211000
Q ss_pred -ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhh
Q 039736 505 -HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVA 583 (633)
Q Consensus 505 -~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 583 (633)
.......||+.|||||++.+..++.++|||||||+||||++|..|+.... ..+.... ...+.+..
T Consensus 169 ~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~-----~~~~~~~~- 234 (793)
T PLN00181 169 PMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLR-----HRVLPPQI- 234 (793)
T ss_pred cccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHH-----HhhcChhh-
Confidence 00011357888999999999999999999999999999999988753110 0000000 00111111
Q ss_pred cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 584 KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 584 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.........++.+||+.||.+||+|.|++++
T Consensus 235 ----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 ----LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred ----hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1112345688899999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=211.86 Aligned_cols=170 Identities=24% Similarity=0.224 Sum_probs=126.8
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ...++|.+++.|+.|++.||.|||+++ ||+|||++.++.+|+ ||
T Consensus 1 GsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG 54 (176)
T smart00750 1 VSLADILEVR---------------GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DG 54 (176)
T ss_pred CcHHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--cc
Confidence 6788888643 236999999999999999999999876 999999999999999 99
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++...... ..|++.|+|||++.+..++.++||||||+++|||++|+.|+....... ..........
T Consensus 55 ~~~~~~~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~~~~~~~~-- 121 (176)
T smart00750 55 SVAFKTPEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AILEILLNGM-- 121 (176)
T ss_pred ceEeecccc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHHHHHHHHh--
Confidence 988654322 257899999999999999999999999999999999999985322111 1111111000
Q ss_pred hhhhchhhhcccCHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 575 LEILDARVAKEAREEDIE--AVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~--~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.. .++. ....+..... .+.+++.+||+.||.+||++.|+++++..+..+
T Consensus 122 ~~-~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 122 PA-DDPR-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred cc-CCcc-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 00 0000 0001122222 689999999999999999999999999877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=225.84 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=194.4
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC----CCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCce
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVP 405 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~ 405 (633)
...+.|...++||+|.|++||++.+. .++.||+|.+...+. ..+..+|+++|..+. +.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34567888999999999999999954 367899998776432 446789999999995 99999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD- 484 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 484 (633)
.+|+||++...-.++.. .++...+..+...+..||.++|+.| ||||||||+|+|.+.
T Consensus 111 ~ivlp~~~H~~f~~l~~-------------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~ 168 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR-------------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRR 168 (418)
T ss_pred EEEecccCccCHHHHHh-------------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccc
Confidence 99999999877776663 4778889999999999999999999 999999999999984
Q ss_pred CCcEEEeecCCCccCC---------C----------C---------------C---------cceecccccCCCcCchhc
Q 039736 485 KFSAKVSDFGTSRSVP---------N----------D---------------K---------THLTTAVQGTFGYFDPEY 521 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~---------~----------~---------------~---------~~~~~~~~gt~~y~APE~ 521 (633)
.++-.|.|||+|.... . + . ........||+||.|||+
T Consensus 169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv 248 (418)
T KOG1167|consen 169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV 248 (418)
T ss_pred cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence 5678999999997210 0 0 0 000012459999999999
Q ss_pred ccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh--hcHHHHHHH------HHhhch--hhh--------------
Q 039736 522 FQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE--RNLVAYFIS------LAKENK--LLE-------------- 576 (633)
Q Consensus 522 l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~--~~l~~~~~~------~~~~~~--~~~-------------- 576 (633)
+.. +.-++++||||-||+++-+++++.||....++-+ ..+...+.. ....++ +.+
T Consensus 249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f 328 (418)
T KOG1167|consen 249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF 328 (418)
T ss_pred HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence 864 5678999999999999999999999965443211 111111100 000111 100
Q ss_pred -hhc-hhhhc--------c-cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 577 -ILD-ARVAK--------E-AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 577 -~~d-~~l~~--------~-~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
-++ ..+.. . .....+..+++|+.+|++.||.+|.|++|.+++
T Consensus 329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 00000 0 011223478999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=230.64 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=199.8
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccC------CCCceEEEEEEeeCC
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN------HRHIVKLLGCCLETE 403 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~------H~nIv~l~g~~~~~~ 403 (633)
....+|......|+|-|++|.+|... -|..||||++...... .+.=+.|++||++|+ --|.++|+-.|...+
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34567888889999999999999954 4779999998764322 234467999999996 348899999999999
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
.++||+|-+. .+|.+.|...+. ...|....+..++.|+.-||..|...+ |+|.||||.|||++
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~-------------nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGR-------------NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN 570 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCc-------------ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence 9999999874 589999987654 245888999999999999999999999 99999999999998
Q ss_pred C-CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 D-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+ ...+||||||.|........ +...-+..|.|||++.+-.|+...|+||.||.||||.||+.-|.+..... ++
T Consensus 571 E~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~---ML 644 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ---ML 644 (752)
T ss_pred cCcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH---HH
Confidence 6 56799999999987644322 22234567999999999999999999999999999999999886554322 12
Q ss_pred HHHHH--------HHhhch-hhhhh--------------------------ch------hhhcc--cC---HHHHHHHHH
Q 039736 563 AYFIS--------LAKENK-LLEIL--------------------------DA------RVAKE--AR---EEDIEAVAE 596 (633)
Q Consensus 563 ~~~~~--------~~~~~~-~~~~~--------------------------d~------~l~~~--~~---~~~~~~l~~ 596 (633)
.++.. ++..+. ..+.+ .| .+... ++ +.....|.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 22111 111000 00011 11 11110 12 344578899
Q ss_pred HHHhccccCCCCCCCHHHHHHH
Q 039736 597 LAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 597 L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|+..|+..||++|.|..+.+++
T Consensus 725 LLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=207.79 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=192.2
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
...+|.+...|..|+|++. |..+++|++.. ......++|.+|.-.|+.+.||||+.++|.|.....+.++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 3456788888999999995 55666777654 23334457889999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe--ec
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS--DF 493 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~--Df 493 (633)
+|...|+.... ...+-.+..+++.++|+|++|||+... -|.---|.+..+++|++.+++|+ |-
T Consensus 273 slynvlhe~t~--------------vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 273 SLYNVLHEQTS--------------VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred HHHHHHhcCcc--------------EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccc
Confidence 99999987543 357778999999999999999999873 24555799999999999998885 21
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCC---cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT---DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s---~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
-++... ....-.+.||+||.+...+.+ ..+|+|||+++||||.|...||....+.+..
T Consensus 338 kfsfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg----------- 398 (448)
T KOG0195|consen 338 KFSFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG----------- 398 (448)
T ss_pred eeeeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----------
Confidence 111110 111125789999999876543 4799999999999999999998654332211
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.++--..++-.+|+..+..+.+|+.-|+..||.+||.++.|+-.|+++.
T Consensus 399 ----mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 ----MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ----hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 0111123445567778889999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=216.91 Aligned_cols=165 Identities=19% Similarity=0.187 Sum_probs=128.9
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC--CCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceE-EEEEEee
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVK-LLGCCLE 401 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~--~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~-l~g~~~~ 401 (633)
....++|...+.||+|+||.||+|... +++.||||+.... .....+.|.+|+++|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 344578999999999999999999864 5778899986432 2234567899999999999999985 443
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC-CCCCe
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI-KSSNI 480 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI-k~~NI 480 (633)
.+..+|||||+++++|... .. .. ...++.++++||.|||+++ |+|||| ||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~-------------------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NI 143 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP-------------------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNW 143 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc-------------------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceE
Confidence 2467999999999999621 10 00 1357789999999999999 999999 99999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcc-------eecccccCCCcCchhcccc
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTH-------LTTAVQGTFGYFDPEYFQS 524 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~-------~~~~~~gt~~y~APE~l~~ 524 (633)
|++.++++||+|||+++........ ..+...+++.|+|||.+..
T Consensus 144 Lv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 144 LMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999999999876433211 1134568889999999854
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=202.11 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=180.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEE-eeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCC-LETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~-~~~~~~~LV~ 409 (633)
.+.|.+.+.+|+|.||.+-.+..+ ..+.+++|-+... ....++|.+|..---.| .|.||+.-+++. ...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357888999999999999999975 4678999977653 23456899998765555 589999877654 4556677899
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec--CCCc
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD--DKFS 487 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~ 487 (633)
||++.|+|.+-+... .+.+....+++.|++.|+.|||+.+ +||||||.+||||- +..+
T Consensus 102 E~aP~gdL~snv~~~-----------------GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~r 161 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA-----------------GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYR 161 (378)
T ss_pred ccCccchhhhhcCcc-----------------cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccE
Confidence 999999998877542 4677778899999999999999999 99999999999993 3448
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccC-----CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+|++|||+.+..+..- ....-+-.|.+||..... ...+.+|||.||++++.++||+.|+...... ....+
T Consensus 162 vKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~ 236 (378)
T KOG1345|consen 162 VKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYW 236 (378)
T ss_pred EEeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHH
Confidence 9999999998653221 112235569999976432 3567899999999999999999998632211 11222
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.|.. +... ..+++...+ ....+.+..+.++-+..++++|=...++.++-
T Consensus 237 ~~~~--w~~r-----k~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 237 EWEQ--WLKR-----KNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHH--Hhcc-----cCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 2211 1111 111111111 12345677888889999999995555555443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=203.11 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=194.3
Q ss_pred CCccCCcccccCcEEEEEEEcCCC--CEEEEEEccccChhHHHHHHHHHHHHhccCC----CCceEEEEEE-eeCCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDG--SIVAVKRSRAIDKTQIEQFINEVVILSQINH----RHIVKLLGCC-LETEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g--~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H----~nIv~l~g~~-~~~~~~~L 407 (633)
+|...++||+|+||.||.+...+. ..+|+|............+..|..++..+.+ +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4788887655333222256788888888873 6888999888 46667899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC--
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-- 485 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-- 485 (633)
||+.. |.+|.++..... ...++..+.++|+.|++.+|.+||+.| ++||||||.|+++...
T Consensus 99 VM~l~-G~sL~dl~~~~~--------------~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~ 160 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--------------PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSR 160 (322)
T ss_pred EEecc-CccHHHHHHhCC--------------CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCC
Confidence 99987 679988765432 246999999999999999999999999 9999999999999865
Q ss_pred ---CcEEEeecCCCc--cCCCCCc----ce---ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 486 ---FSAKVSDFGTSR--SVPNDKT----HL---TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 486 ---~~~kI~DfGla~--~~~~~~~----~~---~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
..+.|.|||+++ ....... .. .....||..|.+++...+...+.+.|+||++.++.|+..|..|+...
T Consensus 161 ~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 161 SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 469999999999 4321111 11 12356999999999999999999999999999999999999998543
Q ss_pred chhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ...+..... ...... .....+..+.++...+-..+..++|....+...|+....+.
T Consensus 241 ~~~~~---~~~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 241 EMTDL---KSKFEKDPR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred cccch---HHHHHHHhh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 32111 001111110 000100 11223345666666666689999999999999998877664
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-20 Score=194.93 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=195.1
Q ss_pred CccCCcccccCcEEEEEEEcCCCCEEEEEEccccChh---HHHHHHHHHHHHhccCCC-CceEEEEEEeeCCceEEEEee
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT---QIEQFINEVVILSQINHR-HIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~---~~~~~~~Ei~il~~l~H~-nIv~l~g~~~~~~~~~LV~E~ 411 (633)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+...+..++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556788999999999999985 78999987653322 467899999999999988 799999999777778999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI 490 (633)
+.+++|.+++...... ..++......+..|++.++.|+|+.+ ++|||+||+||+++..+ .+++
T Consensus 80 ~~~~~l~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l 143 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-------------GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKL 143 (384)
T ss_pred CCCCcHHHHHHhcccc-------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEE
Confidence 9999999665432110 25888999999999999999999999 99999999999999988 7999
Q ss_pred eecCCCccCCCCCcc-----eecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchh-hhhcH
Q 039736 491 SDFGTSRSVPNDKTH-----LTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREE-EERNL 561 (633)
Q Consensus 491 ~DfGla~~~~~~~~~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~-~~~~l 561 (633)
+|||+++........ ......|+..|+|||.+.. ...+...|+||+|++++++++|..|+...... .....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 144 IDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred eccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 999999865433322 2345679999999999987 57889999999999999999999996543321 00011
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+...... .................+.+++..++..+|..|.++.+....
T Consensus 224 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111100000 000000000002223567889999999999999999887764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=199.91 Aligned_cols=218 Identities=22% Similarity=0.400 Sum_probs=163.6
Q ss_pred HhccCCCCceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH
Q 039736 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463 (633)
Q Consensus 384 l~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH 463 (633)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+... ...++|.-...+.++|++||+|||
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---------------~~~~d~~F~~s~~rdi~~Gl~ylh 65 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---------------DIKLDYFFILSFIRDISKGLAYLH 65 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---------------ccCccHHHHHHHHHHHHHHHHHHh
Confidence 46789999999999999999999999999999999999763 236999999999999999999999
Q ss_pred hcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCC-CcceecccccCCCcCchhccccC-------CCCcccchhh
Q 039736 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYS 535 (633)
Q Consensus 464 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~-------~~s~ksDV~S 535 (633)
+.. -..|+.++++|+++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||
T Consensus 66 ~s~--i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs 143 (484)
T KOG1023|consen 66 NSP--IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS 143 (484)
T ss_pred cCc--ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence 865 1399999999999999999999999998776421 11111112234579999998763 1467899999
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhh-cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 536 FGVVLLELLTGKKPICLTREEEER-NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 536 fGvvL~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
||++++|+++.+.||......... .+...+.. . ....+-|.+... .+....+..++.+||..+|.+||+++.
T Consensus 144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~---~--~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK---G--GSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred HHHHHHHHHhccCccccccccCChHHHHHHHHh---c--CCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHH
Confidence 999999999999999754322211 11111111 0 011111111111 133447899999999999999999999
Q ss_pred HHHHHHhhhhh
Q 039736 615 VSMDLEGLRRS 625 (633)
Q Consensus 615 v~~~L~~i~~s 625 (633)
|-..++.+...
T Consensus 217 i~~~~~~~~~~ 227 (484)
T KOG1023|consen 217 IRSKLLTINKG 227 (484)
T ss_pred HHhhhhhhccc
Confidence 99999887764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=178.25 Aligned_cols=139 Identities=17% Similarity=0.120 Sum_probs=107.7
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChh--H-------HHH-----------------HHHHHHHHhccCCCCc
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT--Q-------IEQ-----------------FINEVVILSQINHRHI 392 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~--~-------~~~-----------------~~~Ei~il~~l~H~nI 392 (633)
...||+|+||.||+|...+|+.||||+++..... . ..+ ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999998653211 0 112 2349999999988776
Q ss_pred eEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHh-HhcCCCCee
Q 039736 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYM-HSAASIPIF 471 (633)
Q Consensus 393 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yL-H~~~~~~iv 471 (633)
....... ....+|||||++++++...... ...+++....+++.|++.+|.|| |+.+ |+
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~----------------~~~~~~~~~~~i~~qi~~~L~~l~H~~g---ii 140 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK----------------DAPLSESKARELYLQVIQIMRILYQDCR---LV 140 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh----------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 4433222 2234899999998877644321 13588999999999999999999 6888 99
Q ss_pred ccCCCCCCeeecCCCcEEEeecCCCccC
Q 039736 472 HRDIKSSNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 472 HrDIk~~NILl~~~~~~kI~DfGla~~~ 499 (633)
||||||+|||++ ++.++|+|||+|...
T Consensus 141 HrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 141 HADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=182.92 Aligned_cols=171 Identities=15% Similarity=0.156 Sum_probs=132.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh---hHHHH------HHHHHHHHhccCCCCceEEEEEEeeC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK---TQIEQ------FINEVVILSQINHRHIVKLLGCCLET 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~---~~~~~------~~~Ei~il~~l~H~nIv~l~g~~~~~ 402 (633)
...+|...+++|.|+||.||.... ++..+|||.+..... ...+. +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 577899999875322 22223 57899999999999999999886643
Q ss_pred --------CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 403 --------EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 403 --------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+..+|+|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------------~~~----~~~~~i~~~l~~lH~~g---i~H~D 160 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------------ISE----DVKAKIKASIESLHQHG---MVSGD 160 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------------------ccH----HHHHHHHHHHHHHHHcC---CccCC
Confidence 35799999999999977631 121 23558999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHH
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELL 544 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ell 544 (633)
++|+||++++++ ++|.|||.......+... ..++....+..++|+||||+.+.-..
T Consensus 161 ikp~Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 161 PHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CChHHEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999988 999999988765322111 11334445667999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-21 Score=211.26 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=180.9
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC-hhHHHHHH---HHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID-KTQIEQFI---NEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~-~~~~~~~~---~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++...+.||++.|=.|.+++.++|. |+||++-..+ .-..+.|. .|++ ...++|||.+.+.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777889999999999999998777 8899865433 33344444 4444 555689999998887777777899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|..+ +|.|.+.. ++.|...+...|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|
T Consensus 102 yvkh-nLyDRlST----------------RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~L 161 (1431)
T KOG1240|consen 102 YVKH-NLYDRLST----------------RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYL 161 (1431)
T ss_pred HHhh-hhhhhhcc----------------chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhh
Confidence 9865 78887765 345778888899999999999999999 999999999999999889999
Q ss_pred eecCCCccC--CCCCc----ceecccccCCCcCchhccccC-----------CCCcccchhhHHHHHHHHHh-CCCCCCC
Q 039736 491 SDFGTSRSV--PNDKT----HLTTAVQGTFGYFDPEYFQSS-----------QYTDKSDVYSFGVVLLELLT-GKKPICL 552 (633)
Q Consensus 491 ~DfGla~~~--~~~~~----~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDV~SfGvvL~ellt-G~~p~~~ 552 (633)
+||.-.+.. +++.. ........-..|+|||.+-.+ ..+++.||||.||++.||++ |+++|..
T Consensus 162 tDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 162 TDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred hcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 999877543 33222 112222234579999987431 26789999999999999999 6766632
Q ss_pred CchhhhhcHHHHHHH-HH-hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 553 TREEEERNLVAYFIS-LA-KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~-~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
. .+..+-.. .. .+..+.++-| ..+.+|+..|++.||++|.++++.++.-.++
T Consensus 242 S------QL~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 242 S------QLLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred H------HHHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1 11111110 00 0011111111 2577999999999999999999999875544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=213.13 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=184.3
Q ss_pred ccCCcccccCcEEEEEEEcC-CCCEEEEEEcc----c-cChhH-HHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 337 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSR----A-IDKTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~----~-~~~~~-~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
...+.+|.|++|.|+..... ..+..+.|..+ . ..... ...+..|..+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977766632 33334444322 1 11111 223667888888899999988777666665555569
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++ +|...+... ..++-.++-.++.|+..|+.|||+.| +.|||+|++|++++.++.+|
T Consensus 401 E~~~~-Dlf~~~~~~----------------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lk 460 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----------------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILK 460 (601)
T ss_pred hcccH-HHHHHHhcc----------------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceE
Confidence 99999 998888642 25888889999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCc---ceecccccCCCcCchhccccCCCCc-ccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 490 VSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTD-KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 490 I~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~-ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
|+|||.+........ .......|...|+|||.+....|.+ ..||||.|+++..|++|+.||......+...
T Consensus 461 i~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----- 535 (601)
T KOG0590|consen 461 IIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----- 535 (601)
T ss_pred EeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----
Confidence 999999977643222 3445678999999999999999886 5999999999999999999985543322211
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..............+ .......+.....++.++|+.||.+|-|+.+|++.
T Consensus 536 ~~~~~~~~~~~~~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 536 KTNNYSDQRNIFEGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hhhccccccccccCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000000000000 11123445677899999999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=171.79 Aligned_cols=260 Identities=20% Similarity=0.271 Sum_probs=195.2
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC-CCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..|...++||+|+||.+|.|. +.+|+.||||.-..... ...+..|.++.+.++| ..|..+..+..+...-.||||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 578999999999999999999 56899999997554221 2356789999999975 5777777888888888999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC---CCcE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD---KFSA 488 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~~ 488 (633)
. |-||++...-.. ..++.++.+-+|-|++.-++|+|.++ ++||||||+|.|..- ...+
T Consensus 93 L-GPsLEdLfnfC~---------------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCS---------------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred c-CccHHHHHHHHh---------------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceE
Confidence 8 679988875442 36899999999999999999999999 999999999999964 3469
Q ss_pred EEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 489 KVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 489 kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++|||+|+...+... ...+...||.+|.+--...+..-+.+.|.-|+|.+|...--|..||.+......
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---- 229 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---- 229 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH----
Confidence 9999999987643221 222345699999988777766678899999999999999999999865433221
Q ss_pred HHHHHHHhhchhhhhhchhhhc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 563 AYFISLAKENKLLEILDARVAK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..+...+.+..+.- ..-...+.++.-.+.-|-..--++-|...-+-+.+.-+....
T Consensus 230 --------~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 230 --------KQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred --------HHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 11112222221111 111233567777788888888888888877776666655443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-19 Score=171.37 Aligned_cols=141 Identities=18% Similarity=0.156 Sum_probs=110.6
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChh--------------------------HHHHHHHHHHHHhccCCCCc
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT--------------------------QIEQFINEVVILSQINHRHI 392 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~--------------------------~~~~~~~Ei~il~~l~H~nI 392 (633)
...||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999987653210 01234578999999999987
Q ss_pred eEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCee
Q 039736 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIF 471 (633)
Q Consensus 393 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iv 471 (633)
.....+... ..+|||||++++++...... ...++..+..+++.+++.++.+||+ .+ |+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----------------~~~~~~~~~~~i~~~l~~~l~~lH~~~g---iv 140 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----------------DVPLEEEEAEELYEQVVEQMRRLYQEAG---LV 140 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----------------hccCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 554443332 24899999998865433211 1246778899999999999999999 88 99
Q ss_pred ccCCCCCCeeecCCCcEEEeecCCCccCCC
Q 039736 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501 (633)
Q Consensus 472 HrDIk~~NILl~~~~~~kI~DfGla~~~~~ 501 (633)
||||||+||+++ +++++|+|||++.....
T Consensus 141 HrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 141 HGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred cCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999999999 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=169.67 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=191.4
Q ss_pred cCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
-+|...++||+|.||..+.|+ +-+++.||||.-... .+.-++..|....+.|. .++|...+-+......-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 378899999999999999999 447999999964332 22335667888888775 68888888777766677899999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-----CC
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-----KF 486 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 486 (633)
. |-||+|+..-. ...++.++.+.||.|++.-++|+|++. +|.|||||+|.||.. ..
T Consensus 106 L-GPSLEDLFD~C---------------gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---------------GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred h-CcCHHHHHHHh---------------cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCc
Confidence 8 67898877433 347999999999999999999999999 999999999999963 34
Q ss_pred cEEEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 487 SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
.+.|.|||+|+...+... .......||.+||+--...+..-+.+.|.-|+|-+++..+-|..||.+...+...
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK- 245 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNK- 245 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchH-
Confidence 699999999988754332 2234567999999999988888899999999999999999999999754322211
Q ss_pred HHHHHHHHHhhchhhhhhchhh---hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 561 LVAYFISLAKENKLLEILDARV---AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
++...+-|..- ..+.-...+.++..-+.-.-..+-.+-|..+-+...+..+...
T Consensus 246 -----------~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 246 -----------EKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred -----------HHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 11111111100 0011122345566666666667777788887776666655443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=164.57 Aligned_cols=186 Identities=13% Similarity=0.068 Sum_probs=139.0
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh----hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEee
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK----TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~----~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.....|++|+||+||.+.- .+..++.+.+..... .....|.+|+++|++++ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999997766 678888787765332 11235789999999995 5889999886 346999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC-CCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI-KSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI-k~~NILl~~~~~~kI 490 (633)
++|.+|...+.. ....++.|++.+|.++|+++ |+|||| ||+|||++.++.++|
T Consensus 80 I~G~~L~~~~~~-----------------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~L 133 (218)
T PRK12274 80 LAGAAMYQRPPR-----------------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAV 133 (218)
T ss_pred ecCccHHhhhhh-----------------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEE
Confidence 999888543311 01346788999999999999 999999 799999999999999
Q ss_pred eecCCCccCCCCCcc---ee---------cccccCCCcCchhccccC-CCC-cccchhhHHHHHHHHHhCCCCCCCC
Q 039736 491 SDFGTSRSVPNDKTH---LT---------TAVQGTFGYFDPEYFQSS-QYT-DKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 491 ~DfGla~~~~~~~~~---~~---------~~~~gt~~y~APE~l~~~-~~s-~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
+|||++......... .. .-...++.|++|+...-- ..+ ...+.++-|.-+|.++|+..+...+
T Consensus 134 IDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 134 IDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred EECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999999865433210 00 012257788888754321 223 5678899999999999999886543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=163.84 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=106.5
Q ss_pred CccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-----CCCCceEEEEEEeeCC---c-eE
Q 039736 336 YNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-----NHRHIVKLLGCCLETE---V-PV 406 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-----~H~nIv~l~g~~~~~~---~-~~ 406 (633)
++..+.||+|+||.||. .-.++. .+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45578899999999996 322444 479987654444556789999999999 5799999999998763 3 33
Q ss_pred EEEee--ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHH-HHhHhcCCCCeeccCCCCCCeeec
Q 039736 407 LVYEY--ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV-AYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 407 LV~E~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL-~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
+|+|| ..+|+|.+++... .+++. ..++.+++.++ +|||+++ |+||||||+|||++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----------------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~ 139 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----------------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQ 139 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----------------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEe
Confidence 78999 5579999999542 24443 35677888777 9999999 99999999999997
Q ss_pred C----CCcEEEeecCCCc
Q 039736 484 D----KFSAKVSDFGTSR 497 (633)
Q Consensus 484 ~----~~~~kI~DfGla~ 497 (633)
. +++++|+||+.+.
T Consensus 140 ~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 140 RISESEVIPVVCDNIGES 157 (210)
T ss_pred ccCCCCCcEEEEECCCCc
Confidence 4 3489999955443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.8e-18 Score=172.85 Aligned_cols=237 Identities=23% Similarity=0.324 Sum_probs=151.7
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccC----------CCCceEEEEEEe
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQIN----------HRHIVKLLGCCL 400 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~----------H~nIv~l~g~~~ 400 (633)
.+...+.||.|+++.||.++.. +|+.+|||..... .....+++.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4455778999999999999965 5899999975432 2335667777775555532 223333333222
Q ss_pred eC------------C-----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH
Q 039736 401 ET------------E-----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463 (633)
Q Consensus 401 ~~------------~-----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH 463 (633)
-. . ..+++|+-+ -++|.+++..-..... ....+....++.+..|+++.+++||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~---------~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ---------THSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT---------TSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc---------ccchhHHHHHHHHHHHHHHHHHHHh
Confidence 11 1 236777777 4688777643221100 0123556677888899999999999
Q ss_pred hcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--------CCCCcccchhh
Q 039736 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--------SQYTDKSDVYS 535 (633)
Q Consensus 464 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDV~S 535 (633)
++| ++|+||+|+|++++++|.++|+||+.....+.. ... ...+..|.+||.... -.++.+.|.|+
T Consensus 163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 999 999999999999999999999999877654321 111 334578999997644 24788999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCC
Q 039736 536 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKR 609 (633)
Q Consensus 536 fGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R 609 (633)
+|+++|.|++|..|+........... .+ ..+. +.++.+..|+..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999876543321110 11 2344 677889999999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-19 Score=189.27 Aligned_cols=224 Identities=25% Similarity=0.312 Sum_probs=172.6
Q ss_pred ccccCcEEEEEEE----cCCCCEEEEEEccccCh--hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeeccC
Q 039736 342 LGQGGFGTVYKGM----LPDGSIVAVKRSRAIDK--TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 342 ig~G~~G~Vy~g~----~~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+|+|.||.|+... -+.|..+|.|.++.... ........|..++..++ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998644 23567788887654211 11114556788888887 99999999999999999999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|.|...+.... ..+..........++-+++++|+.+ ++|||+|++||+++.+|++++.|||
T Consensus 82 g~lft~l~~~~----------------~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfg 142 (612)
T KOG0603|consen 82 GDLFTRLSKEV----------------MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFG 142 (612)
T ss_pred chhhhccccCC----------------chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCch
Confidence 99988876542 3455555566778899999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchh
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 574 (633)
+++..-..... +||..|||||++. .....+|.||||++++||+||..||.. + ....++.
T Consensus 143 lske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~------~~~~Il~---- 201 (612)
T KOG0603|consen 143 LSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----D------TMKRILK---- 201 (612)
T ss_pred hhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----H------HHHHHhh----
Confidence 99876433322 7899999999998 457799999999999999999999854 1 0111111
Q ss_pred hhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 575 ~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
.....|.+.......++.+++..+|..|.-.
T Consensus 202 -------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -------AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 0123455566677788888888888888654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=188.89 Aligned_cols=201 Identities=23% Similarity=0.314 Sum_probs=157.2
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC---CCCceEEEEEEeeCC
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETE 403 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~ 403 (633)
.+.+...+.|.+.+.||+|+||+||+|...+|+.||+|.-+.... . +|.=-.+++.+|+ -+-|..+...+.-.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--W-EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--W-EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--e-eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344455567888899999999999999988899999998665221 0 1111123333443 233444444444567
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..+||+||.+.|||.+++.. .+.++|...+.++.|+++.++.||.++ ||||||||+|.||.
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~----------------~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT----------------NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLR 828 (974)
T ss_pred cceeeeeccccccHHHhhcc----------------CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEee
Confidence 78999999999999999974 346999999999999999999999999 99999999999994
Q ss_pred -------CCCcEEEeecCCCccCCC-CCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 484 -------DKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 484 -------~~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
++..++|+|||.+..+.- .........++|-++-.+|...+..++...|-|.++-+++-|+.|+.-
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 345699999999977631 112344567889999999999999999999999999999999999753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=159.02 Aligned_cols=134 Identities=22% Similarity=0.303 Sum_probs=113.3
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccCh--------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK--------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~--------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
+.||+|++|.||+|.. +|..|++|+...... ....++.+|+.++..++|+++.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 678899997553211 1234678899999999999998877777777888999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++++|.+++.. ..+ .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+
T Consensus 81 ~~G~~L~~~~~~-------------------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 81 IEGEPLKDLINS-------------------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred eCCcCHHHHHHh-------------------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEE
Confidence 999999888743 122 77899999999999999999 99999999999999 7899999
Q ss_pred ecCCCcc
Q 039736 492 DFGTSRS 498 (633)
Q Consensus 492 DfGla~~ 498 (633)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-18 Score=180.53 Aligned_cols=175 Identities=26% Similarity=0.374 Sum_probs=131.8
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
.+|+.|++++.++|.+||...+. ....+|...+.++.|++.|++| .+ .+|+|+||.||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-------------~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~ 390 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-------------GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFS 390 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-------------ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccc
Confidence 46899999999999999975543 3468899999999999999999 66 89999999999999
Q ss_pred CCCcEEEeecCCCccCCCCC-----cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 484 DKFSAKVSDFGTSRSVPNDK-----THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
.+..+||.|||+........ ....+...||..||+||.+.+.+|+.|+||||+|++|+||+. -..+++..
T Consensus 391 ~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---- 466 (516)
T KOG1033|consen 391 DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---- 466 (516)
T ss_pred cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----
Confidence 99999999999998775444 222344569999999999999999999999999999999997 22222100
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
. ....... ..+++....++|. =+.|+.+++...|.+||++.++.
T Consensus 467 -----~-t~~d~r~----g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 467 -----A-TLTDIRD----GIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred -----H-hhhhhhc----CCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHh
Confidence 0 0000111 1122222233332 35789999999999999555443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=154.29 Aligned_cols=145 Identities=23% Similarity=0.201 Sum_probs=112.4
Q ss_pred HHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh----------------------hHHHHHHHHHHHHh
Q 039736 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK----------------------TQIEQFINEVVILS 385 (633)
Q Consensus 328 el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~----------------------~~~~~~~~Ei~il~ 385 (633)
++.+....|...+.||+|+||.||++...+|+.||||+...... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445777899999999999999988899999997553210 01123667899999
Q ss_pred ccCCCC--ceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH
Q 039736 386 QINHRH--IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463 (633)
Q Consensus 386 ~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH 463 (633)
++.|++ +.+.++ ....++||||+++++|.+.... ....+++.+++.++.++|
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------------------~~~~~~~~~i~~~l~~lh 142 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------------------EDPEEVLDEILEEIVKAY 142 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------------------ccHHHHHHHHHHHHHHHH
Confidence 998874 444444 2456999999999998765421 234578899999999999
Q ss_pred hcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCC
Q 039736 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501 (633)
Q Consensus 464 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 501 (633)
+.+ ++||||||+||++++++.++|+|||++.....
T Consensus 143 ~~g---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 143 KHG---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred HCC---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 988 99999999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=162.76 Aligned_cols=196 Identities=22% Similarity=0.300 Sum_probs=137.4
Q ss_pred CCCCceEEEEEEeeC---------------------------CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhc
Q 039736 388 NHRHIVKLLGCCLET---------------------------EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440 (633)
Q Consensus 388 ~H~nIv~l~g~~~~~---------------------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 440 (633)
+|||||++.++|.++ ..+|+||.-.+. +|..++..
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----------------- 335 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----------------- 335 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----------------
Confidence 599999999988642 234777776654 77777753
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec--C--CCcEEEeecCCCccCCCCCcc-----eecccc
Q 039736 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD--D--KFSAKVSDFGTSRSVPNDKTH-----LTTAVQ 511 (633)
Q Consensus 441 ~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~--~~~~kI~DfGla~~~~~~~~~-----~~~~~~ 511 (633)
...+...+.-|..|+++|+.|||.++ +.|||+|++||||. + --.+.|+|||.+-......-. .....-
T Consensus 336 ~~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~G 412 (598)
T KOG4158|consen 336 RHRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLG 412 (598)
T ss_pred CCCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCC
Confidence 35677778889999999999999999 99999999999994 2 335889999987543221111 111223
Q ss_pred cCCCcCchhccccCC------CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcc
Q 039736 512 GTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKE 585 (633)
Q Consensus 512 gt~~y~APE~l~~~~------~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 585 (633)
|...-||||+..... -..|+|.|+.|-+-||+++...||+... +...+...+ .+..+ ..
T Consensus 413 GNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y-----qe~qL---------Pa 477 (598)
T KOG4158|consen 413 GNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY-----QESQL---------PA 477 (598)
T ss_pred CcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh-----hhhhC---------CC
Confidence 677899999986532 2369999999999999999999997522 111111111 11111 12
Q ss_pred cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 586 AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 586 ~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.+..++..+.+|+...|+.||++|++..-....|
T Consensus 478 lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 478 LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 3445566788999999999999999976554443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=158.40 Aligned_cols=142 Identities=18% Similarity=0.136 Sum_probs=110.6
Q ss_pred CCccCCcccccCcEEEEEEE--cCCCCEEEEEEccccChh------------------------HHHHHHHHHHHHhccC
Q 039736 335 NYNQSRFLGQGGFGTVYKGM--LPDGSIVAVKRSRAIDKT------------------------QIEQFINEVVILSQIN 388 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~--~~~g~~vAVK~~~~~~~~------------------------~~~~~~~Ei~il~~l~ 388 (633)
.|...+.||+|++|.||+|. ..+|+.||||+++..... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999998 568999999987643210 1123568999999997
Q ss_pred CC--CceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC
Q 039736 389 HR--HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA 466 (633)
Q Consensus 389 H~--nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~ 466 (633)
+. .+.++++. ...++||||+++++|..+.... ..+.......++.|++.+|.+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----------------VEPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc----------------CCcchHHHHHHHHHHHHHHHHHHhcC
Confidence 63 34455543 2358999999998887765321 13455567889999999999999987
Q ss_pred CCCeeccCCCCCCeeecCCCcEEEeecCCCccC
Q 039736 467 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 467 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 499 (633)
. ++||||||+||+++ +++++|+|||.+...
T Consensus 169 ~--iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 E--LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred C--EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 3 99999999999999 889999999998754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.6e-16 Score=153.09 Aligned_cols=130 Identities=22% Similarity=0.326 Sum_probs=106.7
Q ss_pred cccccCcEEEEEEEcCCCCEEEEEEccccC--------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 341 FLGQGGFGTVYKGMLPDGSIVAVKRSRAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 341 ~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.||+|+||.||+|.+ +|..|++|...... ....+++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999997 67889999854321 112356788999999999887666555566677789999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++++|.+++.... . .++.+++.+|.+||+.+ ++|||++|+||+++ ++.+++.|
T Consensus 80 ~g~~l~~~~~~~~-----------------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred CCccHHHHHhhcH-----------------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEE
Confidence 9999988764310 0 78999999999999999 99999999999999 78999999
Q ss_pred cCCCcc
Q 039736 493 FGTSRS 498 (633)
Q Consensus 493 fGla~~ 498 (633)
||++..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=177.33 Aligned_cols=138 Identities=20% Similarity=0.278 Sum_probs=112.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEE-ccc-cC------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR-SRA-ID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~-~~~-~~------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
...|...++||+|+||.||+|.+.+ ..+++|+ ... .. ....+++.+|++++++++|++++....++.+.+.
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 4455678899999999999999854 3444443 221 11 1123568899999999999999988888877778
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +
T Consensus 411 ~~lv~E~~~g~~L~~~l~------------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~ 462 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE------------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-R 462 (535)
T ss_pred CEEEEEecCCCcHHHHHH------------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-E
Confidence 899999999999988763 23568999999999999999 9999999999999 6
Q ss_pred CCcEEEeecCCCccC
Q 039736 485 KFSAKVSDFGTSRSV 499 (633)
Q Consensus 485 ~~~~kI~DfGla~~~ 499 (633)
++.++|+|||+++..
T Consensus 463 ~~~~~liDFGla~~~ 477 (535)
T PRK09605 463 DDRLYLIDFGLGKYS 477 (535)
T ss_pred CCcEEEEeCcccccC
Confidence 779999999999763
|
|
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.8e-17 Score=177.35 Aligned_cols=150 Identities=19% Similarity=0.198 Sum_probs=112.3
Q ss_pred hhcccCCCCCCHHHHHHHhCCCC----------------CcEEEEccccccCCC----------------CCcccccEEe
Q 039736 64 ITFRSEPPYDTPVSIAYLLGSEA----------------SKSVIVPVSCSCSGS----------------LYQHNAPYTT 111 (633)
Q Consensus 64 ~~~~~~~~~~~~~~i~~~~~~~~----------------~~~~~vp~~c~c~~~----------------~~~~~~~y~v 111 (633)
..|+ ...++|+..||..+|++. ++.|.||..=.-... .......|+|
T Consensus 406 ~~yt-Vk~GDTL~sIA~kygVSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtV 484 (592)
T PRK06347 406 KVYT-VVKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTV 484 (592)
T ss_pred eeEE-ecCCCCHHHHHHHhCCCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeee
Confidence 3564 456899999999999853 689999964210000 0111246999
Q ss_pred ccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceeccccCCccc-----cccceeEEEeeeccCchhhhh
Q 039736 112 KPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQT-----ENGVTYLLAYMAQAGDNMSFI 186 (633)
Q Consensus 112 ~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~c~~~~~~-----~~~~~~~~tY~v~~gDtl~~I 186 (633)
++|||||.||+ .|+ ++.++|+++|.+..+.|++||+|.||....-...... ........+|+|++|||||+|
T Consensus 485 k~GDTL~sIAk-kyg--VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL~sI 561 (592)
T PRK06347 485 AKGDSLWRIAN-NNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSLWAI 561 (592)
T ss_pred cCCCCHHHHHH-HHC--CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcHHHH
Confidence 99999999994 574 7999999999877788999999999975432111000 001123568999999999999
Q ss_pred hhhhcccchhhccccCCCCCCceeeccccccc
Q 039736 187 GNEFGVDVQSIVDANMLPNGDAIRVFTPLLIP 218 (633)
Q Consensus 187 a~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP 218 (633)
|++|||++++|++||++. .+.|++||.|.|+
T Consensus 562 A~KygvSv~~L~~~N~L~-~~~L~~GQ~L~I~ 592 (592)
T PRK06347 562 SRQYKTTVDNIKAWNKLT-SNMIHVGQKLTIK 592 (592)
T ss_pred HHHhCCCHHHHHHhcCCC-cccCCCCCEEecC
Confidence 999999999999999996 4679999999885
|
|
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-16 Score=172.36 Aligned_cols=143 Identities=17% Similarity=0.220 Sum_probs=111.3
Q ss_pred CCCCHHHHHHHhCCCC-------------------CcEEEEccccccC-------CCC------------CcccccEEec
Q 039736 71 PYDTPVSIAYLLGSEA-------------------SKSVIVPVSCSCS-------GSL------------YQHNAPYTTK 112 (633)
Q Consensus 71 ~~~~~~~i~~~~~~~~-------------------~~~~~vp~~c~c~-------~~~------------~~~~~~y~v~ 112 (633)
...++..||+++|++. .+.|+||..-.-. +.. .....+|+|+
T Consensus 270 ~~i~L~~iA~~~gvs~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~~~~~y~Vk 349 (456)
T PRK10783 270 QQIELAQAAEMAGMSLTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPLNSRSYKVR 349 (456)
T ss_pred CCcCHHHHHHHcCCCHHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcCCceEEEEC
Confidence 3568999999999843 1678888853210 000 0123479999
Q ss_pred cCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceeccccCCccccccceeEEEeeeccCchhhhhhhhhcc
Q 039736 113 PNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAYMAQAGDNMSFIGNEFGV 192 (633)
Q Consensus 113 ~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia~~f~v 192 (633)
+|||++.||+ .|+ ++.++|+++|....+.|.+||+|.||..+.+... ......++|+|++||||++||++|||
T Consensus 350 ~GDTL~sIA~-r~g--vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~----~~~~~~~~Y~Vr~GDTL~sIA~kygV 422 (456)
T PRK10783 350 SGDTLSGIAS-RLN--VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRL----ANNSDSITYRVRKGDSLSSIAKRHGV 422 (456)
T ss_pred CCCcHHHHHH-HHC--cCHHHHHHHcCCCcccCCCCCEEEecCCcccccc----cccccceeEEeCCCCCHHHHHHHhCC
Confidence 9999999994 463 6889999999777788999999999977665321 11234578999999999999999999
Q ss_pred cchhhccccCCCCCCceeecccccccccC
Q 039736 193 DVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 193 ~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
++++|++||++..+ .|++||+|.|++..
T Consensus 423 tv~~L~~~N~l~~~-~L~pGq~L~l~v~~ 450 (456)
T PRK10783 423 NIKDVMRWNSDTAK-NLQPGDKLTLFVKN 450 (456)
T ss_pred CHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence 99999999998665 89999999988854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.3e-15 Score=140.97 Aligned_cols=137 Identities=21% Similarity=0.246 Sum_probs=99.0
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChh--HHHHH----------------------HHHHHHHhccCCC--Cc
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT--QIEQF----------------------INEVVILSQINHR--HI 392 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~--~~~~~----------------------~~Ei~il~~l~H~--nI 392 (633)
.+.||+|+||.||+|...+|+.||||+.+..... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999878999999987642211 11111 3456666666443 24
Q ss_pred eEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCee
Q 039736 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIF 471 (633)
Q Consensus 393 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~iv 471 (633)
.+.+++ ...++||||++++++........ ... .....++.+++.++.++|+ ++ ++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----------------~~~-~~~~~~~~~~~~~l~~lh~~~~---iv 137 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----------------RLL-EDPEELYDQILELMRKLYREAG---LV 137 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----------------hhc-ccHHHHHHHHHHHHHHHhhccC---cC
Confidence 445443 34689999999976532211100 011 5677899999999999999 88 99
Q ss_pred ccCCCCCCeeecCCCcEEEeecCCCccCC
Q 039736 472 HRDIKSSNILLDDKFSAKVSDFGTSRSVP 500 (633)
Q Consensus 472 HrDIk~~NILl~~~~~~kI~DfGla~~~~ 500 (633)
||||||+||+++ ++.++|+|||.+....
T Consensus 138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 138 HGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred cCCCChhhEEEE-CCcEEEEECccccccc
Confidence 999999999999 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK06347 autolysin; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=165.95 Aligned_cols=154 Identities=20% Similarity=0.167 Sum_probs=114.6
Q ss_pred hhhcccCCCCCCHHHHHHHhCCCC----------------CcEEEEccccccCC--C---------------CCcccccE
Q 039736 63 FITFRSEPPYDTPVSIAYLLGSEA----------------SKSVIVPVSCSCSG--S---------------LYQHNAPY 109 (633)
Q Consensus 63 ~~~~~~~~~~~~~~~i~~~~~~~~----------------~~~~~vp~~c~c~~--~---------------~~~~~~~y 109 (633)
...|+. ..+||+..||++||++. ||.|.||..=.-.. . ......+|
T Consensus 330 ~~~Y~V-~sGDTL~~IA~rygvSv~eL~~~N~l~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~~~y 408 (592)
T PRK06347 330 AKIYTV-VKGDSLWRIANNHKVTVANLKAWNNLKSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNAKVY 408 (592)
T ss_pred ceEEEe-CCCCCHHHHHHHhCCCHHHHHHHhCCCccccccCcEEEEeccccccccccccccccccccccccccccCceeE
Confidence 344644 56999999999999954 59999997311000 0 01123479
Q ss_pred EeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceeccc------cCCcc-----ccccceeEEEeeec
Q 039736 110 TTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCAC------ATANQ-----TENGVTYLLAYMAQ 178 (633)
Q Consensus 110 ~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~c------~~~~~-----~~~~~~~~~tY~v~ 178 (633)
+|++|||++.|| ..|+ ++..+|+.+|.+..+.|.+||.|.||..-.- +.... ......-..+|+|+
T Consensus 409 tVk~GDTL~sIA-~kyg--VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~YtVk 485 (592)
T PRK06347 409 TVVKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVYTVA 485 (592)
T ss_pred EecCCCCHHHHH-HHhC--CCHHHHHHHhCCCcceeccCcEEEEecCCcccccccccccccccccccccccccceeeeec
Confidence 999999999999 5574 7999999999777778999999999964211 00000 00001124579999
Q ss_pred cCchhhhhhhhhcccchhhccccCCCCCCceeecccccccccC
Q 039736 179 AGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 179 ~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
.|||||+||++|||++++|++||++. .+.|++||.|.||...
T Consensus 486 ~GDTL~sIAkkygVSv~~L~~~N~l~-s~~L~~GQ~L~Ip~~~ 527 (592)
T PRK06347 486 KGDSLWRIANNNKVTIANLKSWNNLK-SDFIYPGQKLKVSAGS 527 (592)
T ss_pred CCCCHHHHHHHHCCCHHHHHHhcCCC-cccccCCcEEEEecCc
Confidence 99999999999999999999999996 4579999999999864
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.1e-14 Score=132.02 Aligned_cols=135 Identities=23% Similarity=0.224 Sum_probs=113.8
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC--CCceEEEEEEeeCCceEEEEeeccCC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
..+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| .++.+++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3577999999999999984 47899998765433 4578899999999976 58999999888778899999999988
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
.+..+ ++.....++.+++++|.+||......++|+|++|+||++++++.+++.|||.
T Consensus 79 ~~~~~-----------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 79 TLDEV-----------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred ecccC-----------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 77543 3445567889999999999997555699999999999999999999999999
Q ss_pred Ccc
Q 039736 496 SRS 498 (633)
Q Consensus 496 a~~ 498 (633)
++.
T Consensus 136 ~~~ 138 (155)
T cd05120 136 AGY 138 (155)
T ss_pred ccC
Confidence 875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.6e-15 Score=169.66 Aligned_cols=208 Identities=27% Similarity=0.402 Sum_probs=141.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.+|+.+++|..|++|.||..+.+ ..+..|+|+-+.. . |+ +||..+. +..+.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------l------il-----Rnilt~a------~npfvv---- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------L------IL-----RNILTFA------GNPFVV---- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccc------h------hh-----hcccccc------CCccee----
Confidence 57888999999999999999864 3456777543221 0 11 1222221 223333
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
|+-...+... ++++- +.+.+++|||+.+ |+|||+||+|.+|+.-|++|+.|
T Consensus 136 --gDc~tllk~~----------------g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTD 186 (1205)
T KOG0606|consen 136 --GDCATLLKNI----------------GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTD 186 (1205)
T ss_pred --chhhhhcccC----------------CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccc
Confidence 3333333221 12222 3378999999999 99999999999999999999999
Q ss_pred cCCCccCCCC--------------CcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh
Q 039736 493 FGTSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 558 (633)
Q Consensus 493 fGla~~~~~~--------------~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~ 558 (633)
||+++..... .......++||+.|.|||++....|...+|+|++|+++||.+-|+.||+++..++.
T Consensus 187 fgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 187 FGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred hhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 9998753211 01112346799999999999999999999999999999999999999987766552
Q ss_pred hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC
Q 039736 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611 (633)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt 611 (633)
|..+..+. ..+ .+..+....+.++++.+.|+.+|..|--
T Consensus 267 ------fg~visd~--i~w------pE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 267 ------FGQVISDD--IEW------PEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred ------Hhhhhhhh--ccc------cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 11222111 011 1113334467889999999999999953
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-14 Score=142.35 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=105.4
Q ss_pred CCccc-ccCcEEEEEEEcCCCCEEEEEEccccC-------------hhHHHHHHHHHHHHhccCCCCc--eEEEEEEeeC
Q 039736 339 SRFLG-QGGFGTVYKGMLPDGSIVAVKRSRAID-------------KTQIEQFINEVVILSQINHRHI--VKLLGCCLET 402 (633)
Q Consensus 339 ~~~ig-~G~~G~Vy~g~~~~g~~vAVK~~~~~~-------------~~~~~~~~~Ei~il~~l~H~nI--v~l~g~~~~~ 402 (633)
...|| .||.|+||+... ++..++||+..... .....++.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 889999999988 47789999774311 1223567889999999998875 6777775443
Q ss_pred Cc----eEEEEeeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 403 EV----PVLVYEYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 403 ~~----~~LV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
.. .++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----------------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp 170 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----------------PLSEE----QWQAIGQLIARFHDAG---VYHADLNA 170 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----------------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCc
Confidence 22 3599999997 6888776431 23332 3568999999999999 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccC
Q 039736 478 SNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~ 499 (633)
.|||++.++.++|+|||.+...
T Consensus 171 ~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 171 HNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred hhEEEcCCCCEEEEECCCcccC
Confidence 9999999999999999998763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.1e-15 Score=167.32 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=185.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CCCEEEEEEccccC--hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSRAID--KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV 408 (633)
..|...+.||+|.|+.|-..... ....+|+|...... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 46777888999999999877653 34466777654432 222333445777777776 99999999999999999999
Q ss_pred EeeccCCCchhhc-chhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH-hcCCCCeeccCCCCCCeeecCCC
Q 039736 409 YEYISNGTLSHHI-HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-SAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 409 ~E~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
.||.++|++.+-+ +... ...+....-..+.|+..++.|+| +.+ +.||||||+|.+++..+
T Consensus 100 ~~~s~g~~~f~~i~~~~~---------------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~ 161 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---------------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESG 161 (601)
T ss_pred cCcccccccccccccCCc---------------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCC
Confidence 9999999998888 4321 13555666778999999999999 877 99999999999999999
Q ss_pred -cEEEeecCCCccCCC--CCcceeccccc-CCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 487 -SAKVSDFGTSRSVPN--DKTHLTTAVQG-TFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 487 -~~kI~DfGla~~~~~--~~~~~~~~~~g-t~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
..+++|||+|..... +.........| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+........
T Consensus 162 ~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--- 238 (601)
T KOG0590|consen 162 SALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--- 238 (601)
T ss_pred CcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---
Confidence 999999999988765 33333344567 9999999998874 456789999999999999999999765433221
Q ss_pred HHHHHHHHhhchhhhhhchhhh--cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVA--KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
....+.+.... .............+..+++..+|..|.+.+++..
T Consensus 239 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 239 -----------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----------cceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 11111111100 0111222345567888888899999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.8e-13 Score=143.20 Aligned_cols=142 Identities=23% Similarity=0.228 Sum_probs=102.1
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHH----------------------------------------HHHH
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQI----------------------------------------EQFI 378 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~----------------------------------------~~~~ 378 (633)
.+.||.|++|.||+|++.+|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999998765321111 0245
Q ss_pred HHHHHHhcc----CCCCceEEEEEEe-eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHH
Q 039736 379 NEVVILSQI----NHRHIVKLLGCCL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453 (633)
Q Consensus 379 ~Ei~il~~l----~H~nIv~l~g~~~-~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 453 (633)
+|+..+.++ +|.+-+.+-.++. .....+|||||++|++|.++...... .. .+.+++.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---------------~~---~~~~ia~ 263 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---------------GL---DRKALAE 263 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---------------CC---CHHHHHH
Confidence 566555555 2333344333333 23457999999999999887643210 12 2345677
Q ss_pred HHHH-HHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCC
Q 039736 454 EVAG-AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501 (633)
Q Consensus 454 ~ia~-gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 501 (633)
.++. .+..+|..+ ++|+|++|.||++++++++++.|||++.....
T Consensus 264 ~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 264 NLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7766 478899988 99999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-13 Score=133.69 Aligned_cols=202 Identities=19% Similarity=0.330 Sum_probs=139.9
Q ss_pred HhccCCCCceEEEEEEeeCC-----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHH
Q 039736 384 LSQINHRHIVKLLGCCLETE-----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458 (633)
Q Consensus 384 l~~l~H~nIv~l~g~~~~~~-----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~g 458 (633)
|-++-|.|||++..++.+.. ...++.|||+.|+|..+|++.... ...+......+|+.||..|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~------------~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN------------QKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh------------hhhhhHHHHHHHHHHHHhh
Confidence 44557999999998886533 467899999999999999876543 2357777778999999999
Q ss_pred HHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCC---CCcceecccccCCCcCchhccccCCCCcccchhh
Q 039736 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN---DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYS 535 (633)
Q Consensus 459 L~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~---~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~S 535 (633)
|.|||+.. |+|+|+++.-+.|++..++-+||+----...... ..........+-++|.+||+-...+.+..+|||+
T Consensus 189 l~yLhs~~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~ 267 (458)
T KOG1266|consen 189 LSYLHSCD-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYK 267 (458)
T ss_pred hhhhhccC-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhh
Confidence 99999987 7799999999999999999888853211111100 0001111123678999999987777888999999
Q ss_pred HHHHHHHHHhCCCCCCCCchh--hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 536 FGVVLLELLTGKKPICLTREE--EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 536 fGvvL~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
||...+||.-|..-....... .+..... ....+...+ -..++..|++.+|..||+|+
T Consensus 268 fgmcAlemailEiq~tnseS~~~~ee~ia~----------~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 268 FGMCALEMAILEIQSTNSESKVEVEENIAN----------VIIGLENGL-----------QRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred hhHHHHHHHHheeccCCCcceeehhhhhhh----------heeeccCcc-----------ccCcCcccccCCCCCCcchh
Confidence 999999998876432111100 0000000 000001111 13567899999999999999
Q ss_pred HHHHHH
Q 039736 614 QVSMDL 619 (633)
Q Consensus 614 ev~~~L 619 (633)
+++.+.
T Consensus 327 ~llfHp 332 (458)
T KOG1266|consen 327 LLLFHP 332 (458)
T ss_pred hhhcCc
Confidence 988764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.1e-11 Score=114.00 Aligned_cols=131 Identities=19% Similarity=0.111 Sum_probs=97.1
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCce-EEEEEEeeCCceEEEEeeccCCCc
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV-KLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
.+.|+.|.++.||+... .+..+++|....... ....+..|+++++.+.+.+++ +++++. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35688999999999987 478899998755321 122456899999988655544 455543 3346899999999887
Q ss_pred hhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeeccCCCCCCeeecCCCcEEEeecCC
Q 039736 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA--SIPIFHRDIKSSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 418 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~~~kI~DfGl 495 (633)
.+... ....++.+++++|..||+.+ ...++|+|++|.||+++ ++.+++.|||.
T Consensus 79 ~~~~~------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 79 LTEDF------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred ccccc------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 64310 01235678999999999987 23369999999999999 66899999998
Q ss_pred Ccc
Q 039736 496 SRS 498 (633)
Q Consensus 496 a~~ 498 (633)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=7.3e-12 Score=134.49 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=175.6
Q ss_pred CCccCCcccc--cCcEEEEEEEc---CCCCEEEEEEccccCh--hHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceE
Q 039736 335 NYNQSRFLGQ--GGFGTVYKGML---PDGSIVAVKRSRAIDK--TQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 335 ~~~~~~~ig~--G~~G~Vy~g~~---~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~ 406 (633)
.|.....+|. |.+|.||.+.. .++..+|+|+-+.... ....+=.+|+.-..+++ |+|.++....+.+.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556788999 99999999986 3678899997443211 22223345676666774 999999888888889999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH----HHHHhHhcCCCCeeccCCCCCCeee
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG----AVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~----gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+-.|++. .+|..+.+... ..++....+....+... ||.++|+.. ++|-|+||.||+.
T Consensus 195 iqtE~~~-~sl~~~~~~~~---------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~ 255 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFT 255 (524)
T ss_pred eeecccc-chhHHhhhccc---------------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheec
Confidence 9999986 67777766542 24666666777777777 999999998 9999999999999
Q ss_pred cCC-CcEEEeecCCCccCCCCCcc----eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 483 DDK-FSAKVSDFGTSRSVPNDKTH----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 483 ~~~-~~~kI~DfGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
..+ ...+++|||+...+...... ......|...|++||... +.++.+.|+|++|.+..|...+.......-...
T Consensus 256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC
Confidence 999 88999999999887654311 112235778899999874 567889999999999999999876643211000
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
|. .++... +..++-..-..++..++.++++.+|-.|++.+++..
T Consensus 335 ------W~-------~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 ------WS-------QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------cc-------cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00 001101 111111122344555889999999999998776653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-10 Score=125.54 Aligned_cols=167 Identities=17% Similarity=0.231 Sum_probs=125.0
Q ss_pred CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHH
Q 039736 356 PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435 (633)
Q Consensus 356 ~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~ 435 (633)
.++.+|.|...+.......+...+-++.|+.++||||++++.....++..|||+|-+. .|..++..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------ 100 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------ 100 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------
Confidence 3678888888776555444556678899999999999999999999999999999875 45555543
Q ss_pred HhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCC
Q 039736 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515 (633)
Q Consensus 436 ~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~ 515 (633)
++-....-.+.||+.||.+||+.+. ++|++|.-..|++++.|+.||++|.++........ .......-..
T Consensus 101 -------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s 170 (690)
T KOG1243|consen 101 -------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIES 170 (690)
T ss_pred -------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhc
Confidence 2233444567899999999997653 99999999999999999999999988865432221 1111222335
Q ss_pred cCchhccccCCCCcccchhhHHHHHHHHHhCCC
Q 039736 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 516 y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
|..|+.+.... -..|.|.||++++|++.|..
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 67777654322 34699999999999999943
|
|
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=131.11 Aligned_cols=112 Identities=24% Similarity=0.292 Sum_probs=86.7
Q ss_pred cccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceecc------------------ccCCc----
Q 039736 106 NAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCA------------------CATAN---- 163 (633)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~------------------c~~~~---- 163 (633)
..+|+|++|||||.|| +.|. +++++|+++|.+.++.|.+||+|.||..-. -....
T Consensus 27 a~tytVq~GDTLw~IA-~~yg--vtv~~I~~~N~l~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIg 103 (481)
T PRK13914 27 ASTVVVEAGDTLWGIA-QSKG--TTVDAIKKANNLTTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIIT 103 (481)
T ss_pred CceEEECCCCCHHHHH-HHHC--CCHHHHHHHhCCCcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceee
Confidence 3579999999999999 4464 689999999988888999999999994320 00000
Q ss_pred ------c------ccc---------c---c--------------------------------------------------
Q 039736 164 ------Q------TEN---------G---V-------------------------------------------------- 169 (633)
Q Consensus 164 ------~------~~~---------~---~-------------------------------------------------- 169 (633)
. ..+ | |
T Consensus 104 sl~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (481)
T PRK13914 104 SIKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPA 183 (481)
T ss_pred eecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCc
Confidence 0 000 0 0
Q ss_pred -------------eeEEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccccC
Q 039736 170 -------------TYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 170 -------------~~~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
....+|+|++||+||.||++||+++++|.+||++.. ..|++||.|.||...
T Consensus 184 ~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s-~~L~pGQ~L~Ip~sa 247 (481)
T PRK13914 184 PKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSS-SSIYVGQKLAIKQTA 247 (481)
T ss_pred ccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCc-cccCCCCEEEecCCC
Confidence 011479999999999999999999999999999965 569999999999754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-10 Score=125.22 Aligned_cols=147 Identities=18% Similarity=0.189 Sum_probs=94.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChhH----------------------------------HH---
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQ----------------------------------IE--- 375 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~----------------------------------~~--- 375 (633)
..|+. +.||+|++|.||+|++++ |+.||||+.+..-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45665 789999999999999877 9999999876431100 01
Q ss_pred ---HHHHHHHHHhccC----CCCceEEEEEEee-CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHH
Q 039736 376 ---QFINEVVILSQIN----HRHIVKLLGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447 (633)
Q Consensus 376 ---~~~~Ei~il~~l~----H~nIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 447 (633)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-.... .. ...+....
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---------~~~la~~~ 268 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---------MKLLAERG 268 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---------HHHHHHHH
Confidence 2444554444442 4444444444433 34678999999999997742111000 00 00122222
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC----cEEEeecCCCccCCC
Q 039736 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF----SAKVSDFGTSRSVPN 501 (633)
Q Consensus 448 ~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~----~~kI~DfGla~~~~~ 501 (633)
...++.| ++..| ++|+|++|.||+++.++ ++++.|||++.....
T Consensus 269 v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2223333 34567 99999999999999988 999999999987754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.8e-11 Score=129.98 Aligned_cols=263 Identities=21% Similarity=0.216 Sum_probs=183.7
Q ss_pred cccCHHH-HHHHhcCCccCCcccccCcEEEEEEEcC--CCCEEEEEEccccChhH--HHHHHHHHHHHhcc-CCCCceEE
Q 039736 322 KIFTAEE-LQRATDNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSRAIDKTQ--IEQFINEVVILSQI-NHRHIVKL 395 (633)
Q Consensus 322 ~~~~~~e-l~~~~~~~~~~~~ig~G~~G~Vy~g~~~--~g~~vAVK~~~~~~~~~--~~~~~~Ei~il~~l-~H~nIv~l 395 (633)
.+|.-.+ ....+.+|..+..||.|.|+.|+....+ ++..+++|.+....... ...-+.|+.+...+ .|.++++.
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 3444444 3445568999999999999999987743 67889999876532221 12234566666666 48888888
Q ss_pred EEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
...+......|+--||++++++...+.. ...+....++++..|++.++.++|+.. ++|+|+
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~----------------~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~ 392 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVT----------------SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDV 392 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHH----------------HHhcCcchhhhhHHHHHhccccccchh---hhcccc
Confidence 7777777778899999999988766522 224777888999999999999999888 999999
Q ss_pred CCCCeeecCC-CcEEEeecCCCccCCCCCcceecccccCCCc-CchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 476 KSSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY-FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 476 k~~NILl~~~-~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y-~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
||+||++..+ +..+++|||.+..+.-. .......+..| .+++......+-.+.|+||||.-+.|.+++..--..
T Consensus 393 ~psni~i~~~~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~- 468 (524)
T KOG0601|consen 393 KPSNILISNDGFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES- 468 (524)
T ss_pred cccceeeccchhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcc-
Confidence 9999999986 88999999998643111 11111123334 366666677788899999999999999998654210
Q ss_pred chhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... | ..+....+ ...+ .....+..+.+.+...++..||.+.+...+.+....+.
T Consensus 469 ----~~~---~----------~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~ 522 (524)
T KOG0601|consen 469 ----GVQ---S----------LTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSR 522 (524)
T ss_pred ----ccc---c----------eeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhhcc
Confidence 000 0 00000000 1111 22266778888999999999999999888877665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.8e-10 Score=108.60 Aligned_cols=143 Identities=21% Similarity=0.260 Sum_probs=100.8
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccCh-hHHHHHHHHHHHHhccCC--CCceEEEEEEeeC---CceEEEEeec
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK-TQIEQFINEVVILSQINH--RHIVKLLGCCLET---EVPVLVYEYI 412 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~---~~~~LV~E~~ 412 (633)
.+.|+.|..+.||+....+|+.+++|....... .....+..|.++++.+++ .++.+++.+.... +..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999987678999998765322 134467899999999976 3457777776653 2568999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc---------------------------
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA--------------------------- 465 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~--------------------------- 465 (633)
+++++.+.+.. ..++..++..++.+++++|..||+.
T Consensus 83 ~G~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (223)
T cd05154 83 DGRVLRDRLLR-----------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQ 145 (223)
T ss_pred CCEecCCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHH
Confidence 99998876531 0133333334444444444444421
Q ss_pred --------------------------CCCCeeccCCCCCCeeecC--CCcEEEeecCCCcc
Q 039736 466 --------------------------ASIPIFHRDIKSSNILLDD--KFSAKVSDFGTSRS 498 (633)
Q Consensus 466 --------------------------~~~~ivHrDIk~~NILl~~--~~~~kI~DfGla~~ 498 (633)
....++|+|+.+.||++++ ++.+.|.||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 146 YDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-09 Score=102.84 Aligned_cols=136 Identities=16% Similarity=0.162 Sum_probs=96.9
Q ss_pred CcccccCcEEEEEEEcCC-------CCEEEEEEcccc-------------C---------hhHHHHHH----HHHHHHhc
Q 039736 340 RFLGQGGFGTVYKGMLPD-------GSIVAVKRSRAI-------------D---------KTQIEQFI----NEVVILSQ 386 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~-------g~~vAVK~~~~~-------------~---------~~~~~~~~----~Ei~il~~ 386 (633)
..||.|--+.||.|.-.+ +..+|||..+.. + ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 479999964321 0 01112222 79999998
Q ss_pred cCC--CCceEEEEEEeeCCceEEEEeeccCCCchhh-cchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHh-
Q 039736 387 INH--RHIVKLLGCCLETEVPVLVYEYISNGTLSHH-IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYM- 462 (633)
Q Consensus 387 l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yL- 462 (633)
+.. -++.+++++ ...+|||||+.++.+..- +.+ ..++..+...+..+++.+|..|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----------------~~~~~~~~~~i~~~i~~~l~~l~ 141 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----------------AKLNDEEMKNAYYQVLSMMKQLY 141 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----------------cccCHHHHHHHHHHHHHHHHHHH
Confidence 853 456666664 456999999987543211 111 1244455667789999999999
Q ss_pred HhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCC
Q 039736 463 HSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500 (633)
Q Consensus 463 H~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~ 500 (633)
|+.+ ++||||++.||++++ +.+.|+|||.+....
T Consensus 142 H~~g---lVHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 142 KECN---LVHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred HhCC---eecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 7888 999999999999974 689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.4e-09 Score=99.50 Aligned_cols=132 Identities=24% Similarity=0.317 Sum_probs=100.6
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEE-ccc------cCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKR-SRA------IDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~-~~~------~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..+++|+-+.+|.+.+- |..+++|. .++ .+. -..++-.+|+.++.+++--.|.-..=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999873 55577773 222 111 1234567899999998765555555556677788999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++-.|.+.+... +..++..+-.-+.-||..+ |+|+||.++||++.++. +.+.
T Consensus 81 I~G~~lkd~l~~~-----------------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 81 IEGELLKDALEEA-----------------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred eCChhHHHHHHhc-----------------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEE
Confidence 9999998888542 2456677777888899999 99999999999999875 9999
Q ss_pred ecCCCccC
Q 039736 492 DFGTSRSV 499 (633)
Q Consensus 492 DfGla~~~ 499 (633)
||||+...
T Consensus 134 DfGLg~~s 141 (204)
T COG3642 134 DFGLGEFS 141 (204)
T ss_pred ECCccccc
Confidence 99999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=112.49 Aligned_cols=180 Identities=21% Similarity=0.256 Sum_probs=131.2
Q ss_pred EEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEe----eCCceEEEEeeccC-CCchhhc
Q 039736 348 GTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL----ETEVPVLVYEYISN-GTLSHHI 421 (633)
Q Consensus 348 G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~l 421 (633)
.+.||+.. .||..+++||+..........-..-++.++++.|.|+|+|.+++. .+....+||+|.++ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57888884 489999999995433332223334578899999999999999887 34567999999986 5676665
Q ss_pred chhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCC
Q 039736 422 HDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501 (633)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~ 501 (633)
........+. ....-.....+++...|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|+......
T Consensus 370 F~~~~~t~~~-n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 370 FANPPFTKRT-NSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred ccCCcccccc-ccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4433221000 0001112335788999999999999999999999 88899999999999999999999988776544
Q ss_pred CCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 502 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
+.. |-+.. -.+-|.=.||.+++.|.+|..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 2367999999999999999654
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.7e-11 Score=85.49 Aligned_cols=43 Identities=26% Similarity=0.527 Sum_probs=36.0
Q ss_pred eeeccCchhhhhhhhhcccchhhcccc-CCCCCCceeeccccccc
Q 039736 175 YMAQAGDNMSFIGNEFGVDVQSIVDAN-MLPNGDAIRVFTPLLIP 218 (633)
Q Consensus 175 Y~v~~gDtl~~Ia~~f~v~~~~l~~~N-~~~~~~~i~~~~~l~iP 218 (633)
|+|++|||+++||++||++.++|++|| ++..+. |++||.|.||
T Consensus 1 y~V~~gDtl~~IA~~~~~~~~~l~~~N~~~~~~~-l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIAKRYGISVDELMELNPNIDSDN-LQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHHHHTTS-HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred CEECcCCcHHHHHhhhhhhHhHHHHhcCCCCccc-CCCCCEEEeC
Confidence 899999999999999999999999999 775555 9999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.4e-09 Score=96.65 Aligned_cols=143 Identities=22% Similarity=0.266 Sum_probs=106.2
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEE-ccc------cC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKR-SRA------ID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~-~~~------~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
...+|.+|+-+.|+++.+ .|+...||. ... .+ +-...+-.+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999999 688888884 211 11 112346778999999987656655555666777778999
Q ss_pred eeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC--
Q 039736 410 EYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-- 486 (633)
Q Consensus 410 E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-- 486 (633)
||+++ -++.+++..... ..........++..|-+.+.-||..+ |+||||..+||+|..++
T Consensus 90 E~~~g~~~vk~~i~~~~~--------------~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--------------DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EeccchhHHHHHHHHHcc--------------CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 99976 477887765432 11222223678888999999999999 99999999999996543
Q ss_pred -cEEEeecCCCcc
Q 039736 487 -SAKVSDFGTSRS 498 (633)
Q Consensus 487 -~~kI~DfGla~~ 498 (633)
.+-+.|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 458999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.6e-10 Score=124.15 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=164.9
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
...+.+...+-+.+|.++.++.+.-. .|..-++|..... ...+.+....+-.++-..+||-+++..-.+.-....+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34567777778889999999876632 2333334432221 1111222223333333345566665554455567889
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
|+++|..+++|...|+... .++..-.......+...++|||+.. +.|+|++|.|++...++
T Consensus 881 L~~~~~~~~~~~Skl~~~~----------------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~g 941 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----------------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDG 941 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----------------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccC
Confidence 9999999999998887643 2333344455667888999999987 89999999999999999
Q ss_pred cEEEeecCCCccCC-------C--------------CC------c---ceecccccCCCcCchhccccCCCCcccchhhH
Q 039736 487 SAKVSDFGTSRSVP-------N--------------DK------T---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 536 (633)
Q Consensus 487 ~~kI~DfGla~~~~-------~--------------~~------~---~~~~~~~gt~~y~APE~l~~~~~s~ksDV~Sf 536 (633)
+.+++|||...... . .. . .......||+.|.+||...+......+|.|++
T Consensus 942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~ 1021 (1205)
T KOG0606|consen 942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSS 1021 (1205)
T ss_pred CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhh
Confidence 99999998432210 0 00 0 01123568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 537 GVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 537 GvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
|++++|.++|..||........ +..+... ... ....+........+++...+..+|.+|-.+.
T Consensus 1022 g~~l~e~l~g~pp~na~tpq~~------f~ni~~~--~~~------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1022 GVCLFEVLTGIPPFNAETPQQI------FENILNR--DIP------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhcCCCCCCCcchhhh------hhccccC--CCC------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999864433221 1111110 000 1122334456677888888889999887765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.5e-08 Score=98.04 Aligned_cols=133 Identities=17% Similarity=0.122 Sum_probs=96.3
Q ss_pred EEEEEEEcCCCCEEEEEEccccChh-HHH----------HHHHHHHHHhccCCCCc--eEEEEEEee-----CCceEEEE
Q 039736 348 GTVYKGMLPDGSIVAVKRSRAIDKT-QIE----------QFINEVVILSQINHRHI--VKLLGCCLE-----TEVPVLVY 409 (633)
Q Consensus 348 G~Vy~g~~~~g~~vAVK~~~~~~~~-~~~----------~~~~Ei~il~~l~H~nI--v~l~g~~~~-----~~~~~LV~ 409 (633)
..|.+..+ +|+.+.||+....... ..+ .+.+|...+.++...+| .+++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 45677777 6889999976543311 111 37789888888753333 344555543 23468999
Q ss_pred eeccCC-CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC----
Q 039736 410 EYISNG-TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD---- 484 (633)
Q Consensus 410 E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---- 484 (633)
|++++- +|.+++..... ...+...+..++.+++..+.-||..| ++|+|++++|||++.
T Consensus 115 e~l~~~~sL~~~~~~~~~--------------~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~ 177 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT--------------NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPG 177 (268)
T ss_pred eeCCCCccHHHHHHhhcc--------------cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccC
Confidence 999986 78888743211 13455667789999999999999999 999999999999975
Q ss_pred ---CCcEEEeecCCCcc
Q 039736 485 ---KFSAKVSDFGTSRS 498 (633)
Q Consensus 485 ---~~~~kI~DfGla~~ 498 (633)
+..+.++||+.+..
T Consensus 178 ~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 178 REEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCCceEEEEECCcccc
Confidence 57899999998864
|
|
| >COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Probab=98.76 E-value=9.3e-09 Score=91.98 Aligned_cols=91 Identities=22% Similarity=0.326 Sum_probs=71.0
Q ss_pred CcchHHhhhcCCCC--CCCCCCCceeecceeccccC--Cccccccc-e-----------eEEEeeeccCchhhhhhhhhc
Q 039736 128 LTTCQALLGQNYYD--EKNLGSGVELTVPIRCACAT--ANQTENGV-T-----------YLLAYMAQAGDNMSFIGNEFG 191 (633)
Q Consensus 128 l~t~~~l~~~N~~~--~~~l~~g~~l~ip~~c~c~~--~~~~~~~~-~-----------~~~tY~v~~gDtl~~Ia~~f~ 191 (633)
.+++.+|+.+|.+. ++.+.+||+|.+|..-.-+. ........ + +..+|+|+.||+|+.||++|+
T Consensus 6 ~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~Ia~~~~ 85 (124)
T COG1388 6 GVSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKIARKYG 85 (124)
T ss_pred cccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHHHHHhC
Confidence 36999999999777 88899999999995311111 11011111 1 136899999999999999999
Q ss_pred ccchhhccccCCCCCCceeecccccccc
Q 039736 192 VDVQSIVDANMLPNGDAIRVFTPLLIPL 219 (633)
Q Consensus 192 v~~~~l~~~N~~~~~~~i~~~~~l~iP~ 219 (633)
+++..|+.+|++.++ .+++||.+-+|.
T Consensus 86 ~tv~~l~~~n~l~~~-~i~~gq~l~~~~ 112 (124)
T COG1388 86 VTVAELKQLNNLSSD-KIKVGQKLKLPV 112 (124)
T ss_pred CCHHHHHHHhccCCC-ceecCcEEEEec
Confidence 999999999999766 899999999987
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.3e-08 Score=92.20 Aligned_cols=126 Identities=30% Similarity=0.332 Sum_probs=83.1
Q ss_pred EEEEEEcCCCCEEEEEEcccc-------------------------Ch-hHHHHHHHHHHHHhccCCC--CceEEEEEEe
Q 039736 349 TVYKGMLPDGSIVAVKRSRAI-------------------------DK-TQIEQFINEVVILSQINHR--HIVKLLGCCL 400 (633)
Q Consensus 349 ~Vy~g~~~~g~~vAVK~~~~~-------------------------~~-~~~~~~~~Ei~il~~l~H~--nIv~l~g~~~ 400 (633)
.||.|...+|..+|||..+.. .. .......+|.+.|.+++.. ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999888999999954321 00 0123566799999999765 566676552
Q ss_pred eCCceEEEEeecc--CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH-hHhcCCCCeeccCCCC
Q 039736 401 ETEVPVLVYEYIS--NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY-MHSAASIPIFHRDIKS 477 (633)
Q Consensus 401 ~~~~~~LV~E~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~y-LH~~~~~~ivHrDIk~ 477 (633)
...|||||++ +..+..+. .. .++......++.+++..+.. +|..+ ++|+|+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~-----------------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~ 135 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DV-----------------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSE 135 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HC-----------------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-ST
T ss_pred ---CCEEEEEecCCCccchhhHH-hc-----------------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCCh
Confidence 4589999998 54443332 21 12234456677888886666 57888 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCC
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVP 500 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~ 500 (633)
.||+++++ .+.|.|||.+....
T Consensus 136 ~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 136 YNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TSEEEETT-CEEE--GTTEEETT
T ss_pred hhEEeecc-eEEEEecCcceecC
Confidence 99999988 99999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.8e-07 Score=96.51 Aligned_cols=266 Identities=20% Similarity=0.192 Sum_probs=160.0
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEE------eeCCc-eEEEE
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCC------LETEV-PVLVY 409 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~------~~~~~-~~LV~ 409 (633)
..+.||+|+.+.+|---- -+..|| |+...-...... ..+..|.+. .||-+-.-+.+= -+++. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch-hhchhh-eeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 467899999999995321 122333 555443322222 223444444 466443311110 01122 34666
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
..+.+..--..+.+.. ...+..+...|.-.++.+..+|.+.+.||++| .+-+|++++|+|+++++.+.
T Consensus 90 P~v~g~~pI~~~y~p~---------tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~ 157 (637)
T COG4248 90 PKVSGKEPIHMIYSPA---------TRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVV 157 (637)
T ss_pred ccCCCccchhhhcCch---------hhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEE
Confidence 6666542111111110 11233567899999999999999999999999 89999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhC-CCCCCCCchhhh-hc-H
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTG-KKPICLTREEEE-RN-L 561 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG-~~p~~~~~~~~~-~~-l 561 (633)
+.|-..-... .........+|...|.+||.-. +..-+...|-|.+||++++++.| ++||.+-..... -+ +
T Consensus 158 LVdsDsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 158 LVDSDSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred EEcccceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 9986543322 2223334467899999999754 33456789999999999999886 999865321100 00 0
Q ss_pred HHHHHHHHhhchhhhhhchh--h---hcccCH-HHHHHHHHHHHhccccC--CCCCCCHHHHHHHHHhhhhhc
Q 039736 562 VAYFISLAKENKLLEILDAR--V---AKEARE-EDIEAVAELAMGCLRLN--SKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~--l---~~~~~~-~~~~~l~~L~~~Cl~~d--P~~RPt~~ev~~~L~~i~~s~ 626 (633)
-..+.. +.....-|.+ + ....|. -....+..|..+|+... +.-|||.+-++..|..+..+.
T Consensus 236 E~~Ia~----g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 236 ETDIAH----GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhhhhc----ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 000000 0000000000 0 111222 23466788888888654 568999999999999988765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.2e-08 Score=111.54 Aligned_cols=151 Identities=22% Similarity=0.288 Sum_probs=102.5
Q ss_pred HHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCccee--------cccccCCCcCchhcccc
Q 039736 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT--------TAVQGTFGYFDPEYFQS 524 (633)
Q Consensus 453 ~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~--------~~~~gt~~y~APE~l~~ 524 (633)
.+++.||.|+|.+.+ +||++|.|++|.+++++..||++|+.+........... -...-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345699999998764 99999999999999999999999999876543211110 11234567999999999
Q ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhcccc
Q 039736 525 SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRL 604 (633)
Q Consensus 525 ~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~ 604 (633)
...+.++|+||+|+++|-+..|..+........ ..+- .....+..-...++...+.++.+=+.+.+..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~----~~~~--------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL----LSYS--------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc----chhh--------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence 888999999999999999996555532111100 0000 0000111111123344556777777888899
Q ss_pred CCCCCCCHHHHHH
Q 039736 605 NSKKRPTMKQVSM 617 (633)
Q Consensus 605 dP~~RPt~~ev~~ 617 (633)
++.-||++.++..
T Consensus 252 ~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 252 DSAVRPTLDLLLS 264 (700)
T ss_pred CcccCcchhhhhc
Confidence 9999998877654
|
|
| >PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation [] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1e-08 Score=73.63 Aligned_cols=43 Identities=35% Similarity=0.613 Sum_probs=34.6
Q ss_pred EEeccCCceeeehhcccCCCcchHHhhhcC-CCCCCCCCCCceeecc
Q 039736 109 YTTKPNDTYFLVANNTYQGLTTCQALLGQN-YYDEKNLGSGVELTVP 154 (633)
Q Consensus 109 y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N-~~~~~~l~~g~~l~ip 154 (633)
|+|++|||++.|| ..| .++.++|+++| ....+.|.+||+|.||
T Consensus 1 y~V~~gDtl~~IA-~~~--~~~~~~l~~~N~~~~~~~l~~G~~l~iP 44 (44)
T PF01476_consen 1 YTVQPGDTLWSIA-KRY--GISVDELMELNPNIDSDNLQPGQKLCIP 44 (44)
T ss_dssp EEE-TT--HHHHH-HHT--TS-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred CEECcCCcHHHHH-hhh--hhhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence 8999999999999 446 47999999999 7777779999999998
|
This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A. |
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.8e-08 Score=72.16 Aligned_cols=42 Identities=33% Similarity=0.496 Sum_probs=38.3
Q ss_pred eccCchhhhhhhhhcccchhhccccC-CCCCCceeeccccccc
Q 039736 177 AQAGDNMSFIGNEFGVDVQSIVDANM-LPNGDAIRVFTPLLIP 218 (633)
Q Consensus 177 v~~gDtl~~Ia~~f~v~~~~l~~~N~-~~~~~~i~~~~~l~iP 218 (633)
|++|||||+||++||++.++|.++|+ +.+++.+++||.|.||
T Consensus 1 v~~gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip 43 (44)
T TIGR02899 1 VQKGDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIP 43 (44)
T ss_pred CCCCCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence 68999999999999999999999997 5566789999999998
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.4e-08 Score=105.55 Aligned_cols=88 Identities=18% Similarity=0.202 Sum_probs=70.3
Q ss_pred hhcccCCCCCCHHHHHHHhCCCC----------------CcEEEEccccccCCC-CCcccccEEeccCCceeeehhcccC
Q 039736 64 ITFRSEPPYDTPVSIAYLLGSEA----------------SKSVIVPVSCSCSGS-LYQHNAPYTTKPNDTYFLVANNTYQ 126 (633)
Q Consensus 64 ~~~~~~~~~~~~~~i~~~~~~~~----------------~~~~~vp~~c~c~~~-~~~~~~~y~v~~gdt~~~ia~~~~~ 126 (633)
..|+. ..++|+.+||+++|++. ||.|.||..|.|... ......+|+|++|||+++|| +.|+
T Consensus 344 ~~y~V-k~GDTL~sIA~r~gvs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL~sIA-~kyg 421 (456)
T PRK10783 344 RSYKV-RSGDTLSGIASRLNVSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSLSSIA-KRHG 421 (456)
T ss_pred eEEEE-CCCCcHHHHHHHHCcCHHHHHHHcCCCcccCCCCCEEEecCCcccccccccccceeEEeCCCCCHHHHH-HHhC
Confidence 34644 44899999999999743 699999988876422 23345689999999999999 5574
Q ss_pred CCcchHHhhhcCCCCCCCCCCCceeecce
Q 039736 127 GLTTCQALLGQNYYDEKNLGSGVELTVPI 155 (633)
Q Consensus 127 ~l~t~~~l~~~N~~~~~~l~~g~~l~ip~ 155 (633)
+|.++|+++|....+.|.+||+|.|++
T Consensus 422 --Vtv~~L~~~N~l~~~~L~pGq~L~l~v 448 (456)
T PRK10783 422 --VNIKDVMRWNSDTAKNLQPGDKLTLFV 448 (456)
T ss_pred --CCHHHHHHhcCCCCCcCCCCCEEEEec
Confidence 799999999976555899999999986
|
|
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.4e-08 Score=84.12 Aligned_cols=50 Identities=24% Similarity=0.442 Sum_probs=42.7
Q ss_pred eEEEeeeccCchhhhhhhhhccc--------chhhccccCCCCCCceeecccccccccC
Q 039736 171 YLLAYMAQAGDNMSFIGNEFGVD--------VQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 171 ~~~tY~v~~gDtl~~Ia~~f~v~--------~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
...+|+|++|||||+||++|+++ ++.|.+.|++.++ .|+|||.|.||...
T Consensus 35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~~-~I~~Gq~L~IP~~~ 92 (103)
T PRK14125 35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPSG-HIKAGDKLVIPVLK 92 (103)
T ss_pred CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCCC-cCCCCCEEEEecCC
Confidence 35689999999999999999876 4677788999654 69999999999865
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.1e-06 Score=86.72 Aligned_cols=135 Identities=23% Similarity=0.218 Sum_probs=94.7
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--------------------C--hhHHHHHHHHHHHHhccCCC--Cc
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--------------------D--KTQIEQFINEVVILSQINHR--HI 392 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--------------------~--~~~~~~~~~Ei~il~~l~H~--nI 392 (633)
...++||-|--+.||.|...+|.++|||.-+.. + .-......+|.+.|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 346789999999999999989999999942210 0 01123456789999998654 66
Q ss_pred eEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeec
Q 039736 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFH 472 (633)
Q Consensus 393 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 472 (633)
.+.+++ +...+||||+++--|...- ++-...-.|+..|++-+.-+-..| |||
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r---------------------~~~en~~~il~~il~~~~~~~~~G---iVH 225 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR---------------------LDVENPDEILDKILEEVRKAYRRG---IVH 225 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc---------------------CcccCHHHHHHHHHHHHHHHHHcC---ccc
Confidence 666654 4568999999986664332 112223334444444444444667 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCCccC
Q 039736 473 RDIKSSNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 473 rDIk~~NILl~~~~~~kI~DfGla~~~ 499 (633)
+|+++-||+++++|.+.+.||--+...
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCchheEEEecCCCEEEEeCcccccC
Confidence 999999999999999999999665543
|
|
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.7e-08 Score=68.79 Aligned_cols=45 Identities=31% Similarity=0.580 Sum_probs=42.1
Q ss_pred EeeeccCchhhhhhhhhcccchhhccccCCCCCCceeeccccccc
Q 039736 174 AYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIP 218 (633)
Q Consensus 174 tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP 218 (633)
+|+|++|||+++||++||++..++.++|+......+.+|+.+.||
T Consensus 2 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIAQRYGISVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEecC
Confidence 699999999999999999999999999998667789999999887
|
This domain may have a general peptidoglycan binding function. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.2e-06 Score=82.71 Aligned_cols=139 Identities=21% Similarity=0.135 Sum_probs=102.4
Q ss_pred ccccCcEEEEEEEcCCCCEEEEEEccccC------hhHHHHHHHHHHHHhccCCC--CceEEEEEEeeC----CceEEEE
Q 039736 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID------KTQIEQFINEVVILSQINHR--HIVKLLGCCLET----EVPVLVY 409 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~------~~~~~~~~~Ei~il~~l~H~--nIv~l~g~~~~~----~~~~LV~ 409 (633)
-|+||-+.|++-.+ +|..+-+|+....- +-....|.+|...|+++... .+.+.+...... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46788889999877 56689999765210 22455799999999998532 344544222221 1358999
Q ss_pred eeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc-
Q 039736 410 EYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS- 487 (633)
Q Consensus 410 E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~- 487 (633)
|-+++ -+|.+++.... ..+.+...+..+..++++.+.-||+.+ +.|+|+.+.||+++.++.
T Consensus 105 e~L~g~~~L~~~l~~~~--------------~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~ 167 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--------------VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKA 167 (216)
T ss_pred EeCCCCccHHHHHhcCC--------------cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCe
Confidence 97764 47888875432 234677778899999999999999999 999999999999986666
Q ss_pred -EEEeecCCCcc
Q 039736 488 -AKVSDFGTSRS 498 (633)
Q Consensus 488 -~kI~DfGla~~ 498 (633)
+++.||.-++.
T Consensus 168 ~v~lIDlEk~r~ 179 (216)
T PRK09902 168 EAGFLDLEKSRR 179 (216)
T ss_pred eEEEEEhhccch
Confidence 99999987764
|
|
| >COG3858 Predicted glycosyl hydrolase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.3e-07 Score=94.73 Aligned_cols=98 Identities=21% Similarity=0.268 Sum_probs=80.2
Q ss_pred cEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceeccccCCccccccceeEEEeeeccCchhhhhh
Q 039736 108 PYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAYMAQAGDNMSFIG 187 (633)
Q Consensus 108 ~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia 187 (633)
.|.|++||+.+.|| ..|.. |...|...|.+..+.|.+||.+.||. + .-.|.|++||++++||
T Consensus 3 i~~~~pg~~~~~i~-~~~~~--~~~~i~~~~~~~~d~~~~~q~~~v~~-----~----------~~~y~~~~~d~~~Sia 64 (423)
T COG3858 3 IHLVGPGDSRLIIA-VYFPY--TNNRIVNGNDYTNDDLVDGQTFVVPP-----S----------GHFYDVGPGDTLTSIA 64 (423)
T ss_pred EEEccCCceeeeeh-hhccc--cccccccccccccccccCceeEEECC-----c----------ceEEEecCCcchhhhh
Confidence 47899999999999 45653 55566666644448899999999993 1 2379999999999999
Q ss_pred hhhcccchhhccccCCCCCCceeecccccccccCCC
Q 039736 188 NEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKSES 223 (633)
Q Consensus 188 ~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~~~ 223 (633)
++|||+++++...|....+..+.+|-.+.+|-....
T Consensus 65 ~~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~~~ 100 (423)
T COG3858 65 RTVGVTQDSAAIMNFVICPGYLQYGLNLYIPSARKT 100 (423)
T ss_pred hhhcCCHHHHHhhcccccccceeeeeEEeccCCCCC
Confidence 999999999999998877888989988888876533
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.1e-06 Score=82.78 Aligned_cols=106 Identities=20% Similarity=0.225 Sum_probs=82.4
Q ss_pred HHHHHHHHHHhccCCC--CceEEEEEEeeCC----ceEEEEeeccCC-CchhhcchhhhhHHHHHHHHHhhhcCCCCHHH
Q 039736 375 EQFINEVVILSQINHR--HIVKLLGCCLETE----VPVLVYEYISNG-TLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447 (633)
Q Consensus 375 ~~~~~Ei~il~~l~H~--nIv~l~g~~~~~~----~~~LV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 447 (633)
..+.+|...+..+... ...+.+++..... ..+||+|++++. +|.+++.... .++...
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----------------~~~~~~ 119 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----------------QLDPSQ 119 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----------------ccchhh
Confidence 4677888888777533 3455666665432 358999999974 7888875421 245556
Q ss_pred HHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC---cEEEeecCCCccC
Q 039736 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF---SAKVSDFGTSRSV 499 (633)
Q Consensus 448 ~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kI~DfGla~~~ 499 (633)
...++.++++.+.-||+.+ ++|+|++++|||++.+. .+.+.||+-++..
T Consensus 120 ~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 120 RRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 7789999999999999999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=2e-07 Score=94.95 Aligned_cols=48 Identities=21% Similarity=0.286 Sum_probs=45.7
Q ss_pred EeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccccC
Q 039736 174 AYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 174 tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
+|+|++|||||+||.+||++..+|.+||++.++..|++||.|.||...
T Consensus 62 ~y~Vk~GDTL~~IA~~~g~~~~~La~~N~l~~p~~I~~GQ~L~i~~~~ 109 (319)
T PRK10871 62 TYTVKKGDTLFYIAWITGNDFRDLAQRNNIQAPYSLNVGQTLQVGNAS 109 (319)
T ss_pred ceEECCCCHHHHHHHHHCcCHHHHHHhcCCCCCccccCCCEEEeCCCC
Confidence 799999999999999999999999999999999999999999998653
|
|
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.2e-07 Score=92.37 Aligned_cols=47 Identities=23% Similarity=0.353 Sum_probs=43.8
Q ss_pred eEEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeeccccccc
Q 039736 171 YLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIP 218 (633)
Q Consensus 171 ~~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP 218 (633)
...+|+|++|||||+||+|||++++.|+++|++. ++.|++||.|+||
T Consensus 292 ~~~~YiVq~GDTL~sIAkRYGVSV~~L~r~N~L~-~~~L~~GQ~L~IP 338 (338)
T TIGR02907 292 KLRMCIVQEGDTIETIAERYEISVSQLIRHNQLE-DFEVNEGQILYIP 338 (338)
T ss_pred ccEEEEECCCCCHHHHHHHHCcCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence 3568999999999999999999999999999996 7889999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >PRK14125 cell division suppressor protein YneA; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.4e-07 Score=77.33 Aligned_cols=48 Identities=21% Similarity=0.408 Sum_probs=38.8
Q ss_pred ccEEeccCCceeeehhcccCC---Ccc---hHHhhhcCCCCCCCCCCCceeecce
Q 039736 107 APYTTKPNDTYFLVANNTYQG---LTT---CQALLGQNYYDEKNLGSGVELTVPI 155 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~---l~t---~~~l~~~N~~~~~~l~~g~~l~ip~ 155 (633)
.+|+|++|||+|+|| +.|.. ++. .++|++.|..+++.|++||+|.||.
T Consensus 37 ~~~tV~~GDTLW~IA-~~y~~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~ 90 (103)
T PRK14125 37 VEITVQEGDTLWALA-DQYAGKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPV 90 (103)
T ss_pred EEEEECCCCCHHHHH-HHhCCCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEec
Confidence 469999999999999 45743 111 5778888977777899999999996
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-05 Score=79.65 Aligned_cols=153 Identities=16% Similarity=0.144 Sum_probs=86.4
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCC--ceEEEEEEeeCCceEEEEeeccCCC-
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEYISNGT- 416 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~~~gs- 416 (633)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567788876532 2234578999998886443 4667777777777889999999863
Q ss_pred chhhcchhhhhH----HHHHHH---HHhhhcCCCCHHHHHH-HHH----------HHHH-HHHHhHhc-CCCCeeccCCC
Q 039736 417 LSHHIHDHQQQQ----EQKQEL---EEEQELSSLSWENRVR-VAC----------EVAG-AVAYMHSA-ASIPIFHRDIK 476 (633)
Q Consensus 417 L~~~l~~~~~~~----~~~~~~---~~~~~~~~l~~~~~~~-ia~----------~ia~-gL~yLH~~-~~~~ivHrDIk 476 (633)
+...+....... ...... ................ +.. ++.+ ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 322222111000 000000 0000000011100000 000 0011 12222222 23457999999
Q ss_pred CCCeeecCCCcEEEeecCCCcc
Q 039736 477 SSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~ 498 (633)
|.||++++++ +.|.||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999988 99999988753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=88.62 Aligned_cols=142 Identities=20% Similarity=0.222 Sum_probs=92.7
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccChhH------------------------------H----------HHHHH
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQ------------------------------I----------EQFIN 379 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~------------------------------~----------~~~~~ 379 (633)
+-|+.++-|.||+|++++|+.||||+.+..-... . -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6788999999999999999999999654321110 0 12344
Q ss_pred HHHHHhccC----CCCceEEEEEEee-CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHH
Q 039736 380 EVVILSQIN----HRHIVKLLGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454 (633)
Q Consensus 380 Ei~il~~l~----H~nIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ 454 (633)
|+.-+.+++ ...-+++=.++.+ .....|+|||++|-.+.+...-... .++ +..++..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---------------g~d---~k~ia~~ 272 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---------------GID---RKELAEL 272 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc---------------CCC---HHHHHHH
Confidence 544444442 2222333344432 4567999999999988887532211 233 2233433
Q ss_pred HHHH-HHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCC
Q 039736 455 VAGA-VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502 (633)
Q Consensus 455 ia~g-L~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~ 502 (633)
++++ +..+=..| ++|.|..|.||+++.+++..+.|||+.......
T Consensus 273 ~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 273 LVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 3333 22333356 999999999999999999999999999877543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=75.70 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=90.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHH---------HHHHHHHhccCC---CCceEEEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQF---------INEVVILSQINH---RHIVKLLGCCL 400 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~---------~~Ei~il~~l~H---~nIv~l~g~~~ 400 (633)
..+|...+.+.......|.+-.. +|+.+++|..+.......+.| .+++..+.+++. .....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35666677777766667777666 688999997665433222222 234444444432 23333333332
Q ss_pred e-----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 401 E-----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 401 ~-----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
. ....+|+|||++|..|.++.. ++. .++..+++++.-||++| +.|+|.
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~ 161 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------------------IDE----DLAEKIVEAIKQLHKHG---FYHGDP 161 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------------------cCH----HHHHHHHHHHHHHHHcC---CccCCC
Confidence 2 123468999999988876542 221 24556778899999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCcc
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~ 498 (633)
.|.|+++++++ +++.||+..+.
T Consensus 162 hpgNFlv~~~~-i~iID~~~k~~ 183 (229)
T PF06176_consen 162 HPGNFLVSNNG-IRIIDTQGKRM 183 (229)
T ss_pred CcCcEEEECCc-EEEEECccccc
Confidence 99999999664 99999987764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.1e-05 Score=77.42 Aligned_cols=104 Identities=21% Similarity=0.320 Sum_probs=82.8
Q ss_pred HHHHHHhccCC-CCceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHH
Q 039736 379 NEVVILSQINH-RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457 (633)
Q Consensus 379 ~Ei~il~~l~H-~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~ 457 (633)
+|.-+++.+++ +++.+++|.|-. ++|.||...+++...-..-. ....-+|..|.+||.++++
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~-------------~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLS-------------QFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccc-------------cccccCHHHHHHHHHHHHH
Confidence 57888888876 699999999943 78999998876643210000 0124789999999999999
Q ss_pred HHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccC
Q 039736 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 458 gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 499 (633)
.+++|++...-.+.-.|++++|+-+++++++|+.|...+...
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999865555888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.7e-06 Score=60.92 Aligned_cols=44 Identities=27% Similarity=0.520 Sum_probs=38.6
Q ss_pred EeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccc
Q 039736 174 AYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLI 217 (633)
Q Consensus 174 tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~i 217 (633)
+|+|++|||+++||++||++..++.++|+......+.+|+.+.|
T Consensus 1 ~~~v~~gdt~~~ia~~~~~~~~~~~~~N~~~~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIARRYGISVSDLLELNNILDPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHHHHhCCCHHHHHHHcCCCCccccCCCCEEeC
Confidence 48999999999999999999999999999656677888887653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=7e-07 Score=96.74 Aligned_cols=186 Identities=17% Similarity=0.116 Sum_probs=133.0
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCC-ceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~~~~LV~E~~~ 413 (633)
-+...+-+++|++++++|.+--..+...++.+... ....-++++|.+++||| .+..++-+..++..++++++..
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33344567899999999987433333335544332 23346889999999999 7777777777778889999998
Q ss_pred CC-CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 414 NG-TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 414 ~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
.| +-..-.... .-.+...+...+.+.-+++++|||+.- -+|+| ||+..+ +..|..|
T Consensus 318 ~~rs~~~~~~~s---------------e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 318 TGRSSALEMTVS---------------EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred CCccccccCChh---------------hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccc
Confidence 77 222211110 012334445566677778999999865 48999 777776 5789999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
|+....+.... ..+...+++.|+|||....+.+..+.|+|+.|+--.+|--|-+|-
T Consensus 375 ~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 375 FAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99988765433 234567899999999999999999999999998877777777664
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.00 E-value=7e-05 Score=75.14 Aligned_cols=75 Identities=11% Similarity=0.014 Sum_probs=54.1
Q ss_pred ccccCc-EEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeeccCCCchh
Q 039736 342 LGQGGF-GTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISNGTLSH 419 (633)
Q Consensus 342 ig~G~~-G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 419 (633)
|..|.. ..||+...+ +..+.||+..... ..+..+|+++++.+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 779998764 5788999876543 234567888888874 4446678887776667899999999988875
Q ss_pred h
Q 039736 420 H 420 (633)
Q Consensus 420 ~ 420 (633)
.
T Consensus 82 ~ 82 (244)
T cd05150 82 L 82 (244)
T ss_pred h
Confidence 4
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK13914 invasion associated secreted endopeptidase; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.2e-06 Score=90.28 Aligned_cols=46 Identities=28% Similarity=0.249 Sum_probs=43.0
Q ss_pred EeeeccCchhhhhhhhhcccchhhccccCCCCCCceeeccccccccc
Q 039736 174 AYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLK 220 (633)
Q Consensus 174 tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~ 220 (633)
+|+|++|||||+||++||+++++|+++|++. ++.|++||.|.||..
T Consensus 29 tytVq~GDTLw~IA~~ygvtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~ 74 (481)
T PRK13914 29 TVVVEAGDTLWGIAQSKGTTVDAIKKANNLT-TDKIVPGQKLQVNEV 74 (481)
T ss_pred eEEECCCCCHHHHHHHHCCCHHHHHHHhCCC-cccccCCCEEEeCCC
Confidence 6999999999999999999999999999994 567999999999965
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.3e-05 Score=74.90 Aligned_cols=78 Identities=24% Similarity=0.300 Sum_probs=56.8
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC--CceEEEEEEeeC---CceEEEEeecc
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--HIVKLLGCCLET---EVPVLVYEYIS 413 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~g~~~~~---~~~~LV~E~~~ 413 (633)
.+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3568899999999999865 68999986653 3455677888888888533 356677655432 34689999999
Q ss_pred CCCchh
Q 039736 414 NGTLSH 419 (633)
Q Consensus 414 ~gsL~~ 419 (633)
+..+..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00014 Score=85.96 Aligned_cols=81 Identities=12% Similarity=0.249 Sum_probs=58.1
Q ss_pred CCcccccCcEEEEEEEcCCC---CEEEEEEccccC-hhHHHHHHHHHHHHhccC-CCCc--eEEEEEEeeC---CceEEE
Q 039736 339 SRFLGQGGFGTVYKGMLPDG---SIVAVKRSRAID-KTQIEQFINEVVILSQIN-HRHI--VKLLGCCLET---EVPVLV 408 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g---~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~-H~nI--v~l~g~~~~~---~~~~LV 408 (633)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |.++ .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56788999999998876543 367777754322 112346779999999995 6665 7888888764 467999
Q ss_pred EeeccCCCchh
Q 039736 409 YEYISNGTLSH 419 (633)
Q Consensus 409 ~E~~~~gsL~~ 419 (633)
|||+++..+.+
T Consensus 123 ME~v~G~~~~~ 133 (822)
T PLN02876 123 MEYLEGRIFVD 133 (822)
T ss_pred EEecCCcccCC
Confidence 99999866543
|
|
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=6.4e-06 Score=75.58 Aligned_cols=46 Identities=30% Similarity=0.338 Sum_probs=40.9
Q ss_pred EEeeeccCchhhhhhhhhc---ccchhhccccC--CCCCCceeeccccccc
Q 039736 173 LAYMAQAGDNMSFIGNEFG---VDVQSIVDANM--LPNGDAIRVFTPLLIP 218 (633)
Q Consensus 173 ~tY~v~~gDtl~~Ia~~f~---v~~~~l~~~N~--~~~~~~i~~~~~l~iP 218 (633)
.+|+|++|||||+||++|. .....|+++|+ +.+++.|+|||.|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 4799999999999999985 34678999998 7788899999999988
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00027 Score=69.48 Aligned_cols=152 Identities=21% Similarity=0.208 Sum_probs=96.2
Q ss_pred cCHHHHHHHhcCCccCCc---ccccCcEEEEEEEcCCCCEEEEEEccccChhH-----------------------HH-H
Q 039736 324 FTAEELQRATDNYNQSRF---LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQ-----------------------IE-Q 376 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~---ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~-----------------------~~-~ 376 (633)
.+.+.+....++...... |+.|--+.||+|.-.++..+|||+.+.....- .. -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 345556666555555554 55666778999998789999999765421110 00 1
Q ss_pred HHHHHHHHhccC--CCCceEEEEEEeeCCceEEEEeeccCCC-chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHH
Q 039736 377 FINEVVILSQIN--HRHIVKLLGCCLETEVPVLVYEYISNGT-LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453 (633)
Q Consensus 377 ~~~Ei~il~~l~--H~nIv~l~g~~~~~~~~~LV~E~~~~gs-L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 453 (633)
...|..-|.++. +=.+.+.+++. .-.|||||+.... -.-.|.+ .++...+...+..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----------------v~~e~~e~~~~~~ 173 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----------------VPLELEEAEGLYE 173 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----------------CCcCchhHHHHHH
Confidence 123555555553 33334444443 2379999996531 1111111 1233335666777
Q ss_pred HHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCC
Q 039736 454 EVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500 (633)
Q Consensus 454 ~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~ 500 (633)
++++.+.-|-. .+ +||+||+.-|||+. ++.+.|+|||-|....
T Consensus 174 ~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 174 DVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 88888877766 56 99999999999999 7799999999887653
|
|
| >PRK10871 nlpD lipoprotein NlpD; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=1.1e-05 Score=82.34 Aligned_cols=47 Identities=28% Similarity=0.274 Sum_probs=40.2
Q ss_pred cccEEeccCCceeeehhcccCCCcchHHhhhcCC-CCCCCCCCCceeecce
Q 039736 106 NAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNY-YDEKNLGSGVELTVPI 155 (633)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~-~~~~~l~~g~~l~ip~ 155 (633)
..+|+|++|||||.|| ..| .+++.+|+++|. .+++.|++||+|.||.
T Consensus 60 ~~~y~Vk~GDTL~~IA-~~~--g~~~~~La~~N~l~~p~~I~~GQ~L~i~~ 107 (319)
T PRK10871 60 GSTYTVKKGDTLFYIA-WIT--GNDFRDLAQRNNIQAPYSLNVGQTLQVGN 107 (319)
T ss_pred CCceEECCCCHHHHHH-HHH--CcCHHHHHHhcCCCCCccccCCCEEEeCC
Confidence 4579999999999999 344 479999999984 4778999999999984
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00028 Score=77.56 Aligned_cols=143 Identities=17% Similarity=0.168 Sum_probs=90.2
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhH-------------------------------------HHHHHHHH
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQ-------------------------------------IEQFINEV 381 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~-------------------------------------~~~~~~Ei 381 (633)
.+-|+.-+.|.||+|++++|+.||||+.+..-+.. .=+|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36789999999999999999999999654321110 01344455
Q ss_pred HHHhc----cCCCC---ceEEEEEEee-CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHH
Q 039736 382 VILSQ----INHRH---IVKLLGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453 (633)
Q Consensus 382 ~il~~----l~H~n---Iv~l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~ 453 (633)
+-..+ +.|-+ =|++=.++.+ .....|+|||++|..+.|.-.-. ...++-.. |+.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~---------------~~gi~~~~---i~~ 307 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID---------------KRGISPHD---ILN 307 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH---------------HcCCCHHH---HHH
Confidence 43333 34555 1222233322 34678999999999887763211 12344443 333
Q ss_pred HHHHHHH-HhHhcCCCCeeccCCCCCCeeec----CCCcEEEeecCCCccCCCC
Q 039736 454 EVAGAVA-YMHSAASIPIFHRDIKSSNILLD----DKFSAKVSDFGTSRSVPND 502 (633)
Q Consensus 454 ~ia~gL~-yLH~~~~~~ivHrDIk~~NILl~----~~~~~kI~DfGla~~~~~~ 502 (633)
.+.++.. -|=..| ++|.|=.|.||+++ .++++.+-|||+.......
T Consensus 308 ~l~~~~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 308 KLVEAYLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHHHHHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3333222 122345 99999999999999 3788999999999876543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00073 Score=69.96 Aligned_cols=80 Identities=11% Similarity=0.114 Sum_probs=58.4
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC---CCceEEEEEEee---CCceEEEEe
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH---RHIVKLLGCCLE---TEVPVLVYE 410 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H---~nIv~l~g~~~~---~~~~~LV~E 410 (633)
...+.||+|..+.||+-...++ .+.+|..+... ....|..|.+.|+.+.- -.+.++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456799999999999876555 46667644311 22477899999988853 367788888754 356899999
Q ss_pred eccCCCchh
Q 039736 411 YISNGTLSH 419 (633)
Q Consensus 411 ~~~~gsL~~ 419 (633)
+++++++.+
T Consensus 94 ~i~G~~~~~ 102 (297)
T PRK10593 94 RLRGVSVEA 102 (297)
T ss_pred ccCCEecCC
Confidence 999987743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00031 Score=70.09 Aligned_cols=75 Identities=19% Similarity=0.222 Sum_probs=47.4
Q ss_pred CcccccCcE-EEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC---CceEEEEEEeeC---CceEEEEeec
Q 039736 340 RFLGQGGFG-TVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR---HIVKLLGCCLET---EVPVLVYEYI 412 (633)
Q Consensus 340 ~~ig~G~~G-~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~---nIv~l~g~~~~~---~~~~LV~E~~ 412 (633)
+.|+.|+.. .||+. +..+++|..+... ....+.+|.++++.+... -+.+.++..... +..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777766 48874 2357778655421 234678899999887532 344455444332 2358899999
Q ss_pred cCCCchhh
Q 039736 413 SNGTLSHH 420 (633)
Q Consensus 413 ~~gsL~~~ 420 (633)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99888655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00078 Score=65.10 Aligned_cols=130 Identities=23% Similarity=0.307 Sum_probs=89.2
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccC----------------hhHHHHHHHHHHHHhccC------CCCceE
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID----------------KTQIEQFINEVVILSQIN------HRHIVK 394 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~----------------~~~~~~~~~Ei~il~~l~------H~nIv~ 394 (633)
+....||+|+.=.||.- ++.....||++.... ....++..+|+.-...+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 44678999999889863 345667888876544 223456667776665555 889999
Q ss_pred EEEEEeeCCceEEEEeeccCC------CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 039736 395 LLGCCLETEVPVLVYEYISNG------TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASI 468 (633)
Q Consensus 395 l~g~~~~~~~~~LV~E~~~~g------sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 468 (633)
++|+..++...-+|+|.+.+. +|.+++.. ..++. ...+. +-+-..||-+++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----------------~~~~~-~~~~~---L~~f~~~l~~~~-- 138 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----------------GGLTE-ELRQA---LDEFKRYLLDHH-- 138 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----------------CCccH-HHHHH---HHHHHHHHHHcC--
Confidence 999999998889999987643 35555532 23444 33333 334456777777
Q ss_pred CeeccCCCCCCeeecCCC----cEEEee
Q 039736 469 PIFHRDIKSSNILLDDKF----SAKVSD 492 (633)
Q Consensus 469 ~ivHrDIk~~NILl~~~~----~~kI~D 492 (633)
|+.+|++|+||++..+. .+.|.|
T Consensus 139 -Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 139 -IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred -CeecCCCcccEEEEecCCCceEEEEEe
Confidence 99999999999996432 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation | Back alignment and domain information |
|---|
Probab=97.64 E-value=2.8e-05 Score=55.14 Aligned_cols=44 Identities=36% Similarity=0.489 Sum_probs=37.7
Q ss_pred cEEeccCCceeeehhcccCCCcchHHhhhcCCC-CCCCCCCCceeecc
Q 039736 108 PYTTKPNDTYFLVANNTYQGLTTCQALLGQNYY-DEKNLGSGVELTVP 154 (633)
Q Consensus 108 ~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~-~~~~l~~g~~l~ip 154 (633)
.|+|++|||++.|| ..| .++..+|++.|.. ....+.+|+.|.||
T Consensus 2 ~~~v~~gdt~~~ia-~~~--~~~~~~~~~~N~~~~~~~~~~g~~l~ip 46 (46)
T cd00118 2 TYTVKKGDTLSSIA-QRY--GISVEELLKLNGLSDPDNLQVGQKLKIP 46 (46)
T ss_pred EEEECCCCCHHHHH-HHH--CcCHHHHHHHcCCCCccccCCCCEEecC
Confidence 59999999999999 446 3689999999966 56689999999987
|
This domain may have a general peptidoglycan binding function. |
| >PRK11198 LysM domain/BON superfamily protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=2.8e-05 Score=71.41 Aligned_cols=48 Identities=23% Similarity=0.339 Sum_probs=39.9
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcCC---CCCCCCCCCceeecc
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNY---YDEKNLGSGVELTVP 154 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~---~~~~~l~~g~~l~ip 154 (633)
..|+|++|||+|.||...|..-..++.|.++|. .+++.|++||+|.||
T Consensus 96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP 146 (147)
T PRK11198 96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP 146 (147)
T ss_pred eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence 469999999999999665554457889999994 356789999999998
|
|
| >TIGR02899 spore_safA spore coat assembly protein SafA | Back alignment and domain information |
|---|
Probab=97.61 E-value=2.3e-05 Score=55.73 Aligned_cols=41 Identities=20% Similarity=0.418 Sum_probs=34.3
Q ss_pred eccCCceeeehhcccCCCcchHHhhhcCC-C-CCCCCCCCceeecc
Q 039736 111 TKPNDTYFLVANNTYQGLTTCQALLGQNY-Y-DEKNLGSGVELTVP 154 (633)
Q Consensus 111 v~~gdt~~~ia~~~~~~l~t~~~l~~~N~-~-~~~~l~~g~~l~ip 154 (633)
|++|||+|.||. .|. ++.++|.++|. . ++..+.+||+|.||
T Consensus 1 v~~gdtl~~IA~-~~~--~~~~~l~~~N~~~~~~~~~~~g~~l~ip 43 (44)
T TIGR02899 1 VQKGDTLWKIAK-KYG--VDFDELIQANPQLSNPNLIYPGMKIKIP 43 (44)
T ss_pred CCCCCCHHHHHH-HHC--cCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence 689999999994 563 58999999995 3 45679999999998
|
in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins. |
| >TIGR02907 spore_VI_D stage VI sporulation protein D | Back alignment and domain information |
|---|
Probab=97.55 E-value=3.6e-05 Score=77.76 Aligned_cols=48 Identities=19% Similarity=0.297 Sum_probs=41.6
Q ss_pred cccccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecc
Q 039736 104 QHNAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVP 154 (633)
Q Consensus 104 ~~~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip 154 (633)
.....|+|++|||+|.|| .+|+ ++++.|+++|...++.|.+||.|.||
T Consensus 291 ~~~~~YiVq~GDTL~sIA-kRYG--VSV~~L~r~N~L~~~~L~~GQ~L~IP 338 (338)
T TIGR02907 291 TKLRMCIVQEGDTIETIA-ERYE--ISVSQLIRHNQLEDFEVNEGQILYIP 338 (338)
T ss_pred cccEEEEECCCCCHHHHH-HHHC--cCHHHHHHHhCCCccccCCCCEEEeC
Confidence 334579999999999999 4574 79999999997678899999999998
|
SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00047 Score=64.19 Aligned_cols=128 Identities=18% Similarity=0.170 Sum_probs=87.0
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceE-EEEEEeeCCceEEEEeeccCCC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK-LLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~-l~g~~~~~~~~~LV~E~~~~gs 416 (633)
..+.|++|.+|.||+|.+. |..+|+|.-+..+ ....+..|+++|..++-.++-. ++.+. .-++.|||++|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 4678999999999999995 6689999866533 3457789999999998766643 44432 2245599999988
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC-CCCeeecCCCcEEEeecCC
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK-SSNILLDDKFSAKVSDFGT 495 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk-~~NILl~~~~~~kI~DfGl 495 (633)
|.++-... +-.+ ...+++.---|...| |-|+.|. |...+|-++..+.|.||.-
T Consensus 99 L~~~~~~~-------------------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 99 LGKLEIGG-------------------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred hhhhhhcc-------------------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccc
Confidence 86655321 1112 233444444455556 8888886 4444444444999999998
Q ss_pred Ccc
Q 039736 496 SRS 498 (633)
Q Consensus 496 a~~ 498 (633)
|..
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00098 Score=66.34 Aligned_cols=75 Identities=19% Similarity=0.122 Sum_probs=48.4
Q ss_pred CcccccCcEEEEEEEcCC--CCEEEEEEccccChhHHHHHHHHHHHHhccCCCC-ceEEEEEEeeCCceEEEEeeccCCC
Q 039736 340 RFLGQGGFGTVYKGMLPD--GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~--g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
+.|..|-...+|+....+ ++.+++|......... -+..+|+.+++.+...+ ..++++... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457777788999988754 6788899765432211 12236888888885333 344554432 248999999977
Q ss_pred chh
Q 039736 417 LSH 419 (633)
Q Consensus 417 L~~ 419 (633)
+..
T Consensus 79 l~~ 81 (235)
T cd05157 79 LEP 81 (235)
T ss_pred CCH
Confidence 643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0017 Score=62.46 Aligned_cols=125 Identities=28% Similarity=0.423 Sum_probs=89.6
Q ss_pred cCCccCCcccccCc-EEEEEEEcCCCCEEEEEEccc---c---------Ch---------hHHHHHHHHHHHHhccC---
Q 039736 334 DNYNQSRFLGQGGF-GTVYKGMLPDGSIVAVKRSRA---I---------DK---------TQIEQFINEVVILSQIN--- 388 (633)
Q Consensus 334 ~~~~~~~~ig~G~~-G~Vy~g~~~~g~~vAVK~~~~---~---------~~---------~~~~~~~~Ei~il~~l~--- 388 (633)
.+++..+.||.|.. |.||+..+ +|..+|+|..+. . .. .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 68888999999999 99999999 688999998221 0 00 12335788888777774
Q ss_pred CCCc--eEEEEEEeeCC------------------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHH
Q 039736 389 HRHI--VKLLGCCLETE------------------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448 (633)
Q Consensus 389 H~nI--v~l~g~~~~~~------------------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 448 (633)
+.++ |+.+|+..-.. .+-+|.||++... .++.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------------~~~~--- 167 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------------PLQI--- 167 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------------ccch---
Confidence 5566 89999874321 1246777776532 1122
Q ss_pred HHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCC
Q 039736 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496 (633)
Q Consensus 449 ~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla 496 (633)
+-+.+|.+-|.-+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 168 -~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 -RDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred -hHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 23456667778899999 999999999986 3589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00059 Score=79.45 Aligned_cols=199 Identities=19% Similarity=0.215 Sum_probs=136.7
Q ss_pred HHHHHHHHHHhccCCCCceEEEEEEeeCCce----EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHH
Q 039736 375 EQFINEVVILSQINHRHIVKLLGCCLETEVP----VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450 (633)
Q Consensus 375 ~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~----~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 450 (633)
....-|++.+.++.|+|++.++++...+... .+..|++..-++...+.. ...++....+.
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----------------v~~i~~~~~r~ 290 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----------------VGSIPLETLRI 290 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----------------ccccCHHHHHH
Confidence 3334567788889999999999988765322 234455555555555533 45688888899
Q ss_pred HHHHHHHHHHHhHhcCCCCeeccCCCCC---CeeecCCCcEEEe--ecCCCccCCCCCcceecccccCCCcCchhccccC
Q 039736 451 VACEVAGAVAYMHSAASIPIFHRDIKSS---NILLDDKFSAKVS--DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS 525 (633)
Q Consensus 451 ia~~ia~gL~yLH~~~~~~ivHrDIk~~---NILl~~~~~~kI~--DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 525 (633)
+..++.+||.|+|++. ..|.-+..+ +--.+.++...++ ||+.++......... ...-+..|.++|.....
T Consensus 291 ~~~~~~~GL~~~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~ 365 (1351)
T KOG1035|consen 291 LHQKLLEGLAYLHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKEN 365 (1351)
T ss_pred HHHHHhhhHHHHHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccc
Confidence 9999999999999986 667666666 6666778888888 999888765433221 12245568888887665
Q ss_pred CCCc--ccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccc
Q 039736 526 QYTD--KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLR 603 (633)
Q Consensus 526 ~~s~--ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~ 603 (633)
.+.. ..|+|.+|..+..+..|..+-.... ....+++... ...+.....+|+.
T Consensus 366 ~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~~~~--------~~~~~d~~~~~~~ 419 (1351)
T KOG1035|consen 366 TAKKSRLTDLWCLGLLLLQLSQGEDISEKSA------------------VPVSLLDVLS--------TSELLDALPKCLD 419 (1351)
T ss_pred cchhhhhhHHHHHHHHHhhhhhcCccccccc------------------chhhhhcccc--------chhhhhhhhhhcc
Confidence 5544 4799999999999999876531100 0111111110 1145677889999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 039736 604 LNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 604 ~dP~~RPt~~ev~~~L~ 620 (633)
.++++|++..+++.+..
T Consensus 420 ~~~~~Rl~~~~ll~~~f 436 (1351)
T KOG1035|consen 420 EDSEERLSALELLTHPF 436 (1351)
T ss_pred hhhhhccchhhhhhchh
Confidence 99999999999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00095 Score=67.51 Aligned_cols=151 Identities=15% Similarity=0.071 Sum_probs=78.5
Q ss_pred ccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc-eEEEEEEeeCCceEEEEeeccCCCchhh
Q 039736 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYISNGTLSHH 420 (633)
Q Consensus 342 ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gsL~~~ 420 (633)
+..|-...+|+... +++.+++|........-.-+..+|.++++.+....+ .++++... .++|+||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998875 577888887543222110134578888888864333 34444432 3799999998776542
Q ss_pred cchhhhhHHHHHHHH---Hhh--hcCCCCHHHHH-HHH---------HHHHHHHHHhHhc-----CCCCeeccCCCCCCe
Q 039736 421 IHDHQQQQEQKQELE---EEQ--ELSSLSWENRV-RVA---------CEVAGAVAYMHSA-----ASIPIFHRDIKSSNI 480 (633)
Q Consensus 421 l~~~~~~~~~~~~~~---~~~--~~~~l~~~~~~-~ia---------~~ia~gL~yLH~~-----~~~~ivHrDIk~~NI 480 (633)
..............- ... ...+++....+ ... ..+...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 100000000000000 000 00111111111 111 1111112222211 123589999999999
Q ss_pred eecCCCcEEEeecCCCcc
Q 039736 481 LLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~ 498 (633)
++++++ +.|.||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0017 Score=69.44 Aligned_cols=76 Identities=21% Similarity=0.264 Sum_probs=55.1
Q ss_pred CCcccccCcEEEEEEEcCCC-CEEEEEEcccc----C---hhHHHHHHHHHHHHhccC---CCCceEEEEEEeeCCceEE
Q 039736 339 SRFLGQGGFGTVYKGMLPDG-SIVAVKRSRAI----D---KTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g-~~vAVK~~~~~----~---~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~L 407 (633)
.+.||.|.+..||+....+| +.|+||.-... . ....+++..|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 45789999999999998776 48999974321 1 123456777888888763 3467777777 4466799
Q ss_pred EEeeccCCC
Q 039736 408 VYEYISNGT 416 (633)
Q Consensus 408 V~E~~~~gs 416 (633)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0097 Score=62.20 Aligned_cols=171 Identities=12% Similarity=0.161 Sum_probs=85.6
Q ss_pred cCHHHHHHHhcCCcc-----CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC--CceEEE
Q 039736 324 FTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--HIVKLL 396 (633)
Q Consensus 324 ~~~~el~~~~~~~~~-----~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~ 396 (633)
.+.+++......|.. .+.|+.|....+|+....+| .+++|+....... ....|+.++..+... .+.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcce
Confidence 345555555455543 34566777778999887555 6888987532222 233445555554211 133333
Q ss_pred EE------EeeCCceEEEEeeccCCCchhhc----chhhhhHHHHHHHHHh-h----hcCCCCH-HHHHH----------
Q 039736 397 GC------CLETEVPVLVYEYISNGTLSHHI----HDHQQQQEQKQELEEE-Q----ELSSLSW-ENRVR---------- 450 (633)
Q Consensus 397 g~------~~~~~~~~LV~E~~~~gsL~~~l----~~~~~~~~~~~~~~~~-~----~~~~l~~-~~~~~---------- 450 (633)
.. ....+..++++||++|..+...- ..-...-.+....... . ....+.| ...+.
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 21 12245678999999987653210 0000000000000000 0 0001112 11111
Q ss_pred ---HHHHHHHHHHHhHhc----CCCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 451 ---VACEVAGAVAYMHSA----ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 451 ---ia~~ia~gL~yLH~~----~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
+...+...++.+.+. -...++|+|+.+.||+++++...-|.||+.+..
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 111111222333211 223599999999999999776668999998864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0059 Score=63.03 Aligned_cols=156 Identities=14% Similarity=0.156 Sum_probs=87.3
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC--CceEEEEE------EeeCCceEEEEe
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--HIVKLLGC------CLETEVPVLVYE 410 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~g~------~~~~~~~~LV~E 410 (633)
.+.|..|....+|+.... +..+++|+..... ......|++++..+.+. .+.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKVS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCCCC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777777889998764 4578889876522 23455678888777533 24444432 122345689999
Q ss_pred eccCCCchhh----cchhhhhHHHHHHHHHh-----hhcCCCCHHHHH----------HHHHHHHHHHHHhHhc----CC
Q 039736 411 YISNGTLSHH----IHDHQQQQEQKQELEEE-----QELSSLSWENRV----------RVACEVAGAVAYMHSA----AS 467 (633)
Q Consensus 411 ~~~~gsL~~~----l~~~~~~~~~~~~~~~~-----~~~~~l~~~~~~----------~ia~~ia~gL~yLH~~----~~ 467 (633)
|++|..+... ...-...-......... .......|.... .....+...+.++.+. -.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876541 00000000011111000 000112332221 0112233445555431 12
Q ss_pred CCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 468 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 468 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
..++|+|+.|.||+++++....|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3499999999999999987789999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.012 Score=61.28 Aligned_cols=171 Identities=15% Similarity=0.167 Sum_probs=89.2
Q ss_pred CHHHHHHHhcCCcc-----CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC--CceEEEE
Q 039736 325 TAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--HIVKLLG 397 (633)
Q Consensus 325 ~~~el~~~~~~~~~-----~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l~g 397 (633)
+.+++....++|.. .+.++.|....+|+...++| .+++|+...... .+....|++++..+... .+.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 34555554444533 45567777788998876545 577887654211 22344566777666422 2344443
Q ss_pred EE------eeCCceEEEEeeccCCCchhhc----chhhhhHHHHHHHHHh--hh----cCCCCHHHHH------------
Q 039736 398 CC------LETEVPVLVYEYISNGTLSHHI----HDHQQQQEQKQELEEE--QE----LSSLSWENRV------------ 449 (633)
Q Consensus 398 ~~------~~~~~~~LV~E~~~~gsL~~~l----~~~~~~~~~~~~~~~~--~~----~~~l~~~~~~------------ 449 (633)
.. ...+..++++||++|..+.... ..-...-......... .. ...-.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 1235678999999987654211 0000000000000000 00 0001111110
Q ss_pred HHHHHHHHHHHHhHh----cCCCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 450 RVACEVAGAVAYMHS----AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 450 ~ia~~ia~gL~yLH~----~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
.....+.+.++++.. .-...++|+|+.+.||++++++...|.||+.+..
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 011223344555543 2234599999999999999988778999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >smart00257 LysM Lysin motif | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00052 Score=47.80 Aligned_cols=43 Identities=35% Similarity=0.473 Sum_probs=35.2
Q ss_pred cEEeccCCceeeehhcccCCCcchHHhhhcCC-CCCCCCCCCceeec
Q 039736 108 PYTTKPNDTYFLVANNTYQGLTTCQALLGQNY-YDEKNLGSGVELTV 153 (633)
Q Consensus 108 ~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~-~~~~~l~~g~~l~i 153 (633)
.|+|++|||++.|| ..|+ ++...+...|. .....+.+|+.|.|
T Consensus 1 ~~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~i 44 (44)
T smart00257 1 TYTVKKGDTLSSIA-RRYG--ISVSDLLELNNILDPDNLQVGQKLKI 44 (44)
T ss_pred CeEeCCCCCHHHHH-HHhC--CCHHHHHHHcCCCCccccCCCCEEeC
Confidence 48999999999999 4564 47799999996 45567999998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 633 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-48 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-31 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-30 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-28 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-24 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-21 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-20 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 5e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 4eby_A | 212 | Crystal Structure Of The Ectodomain Of A Receptor L | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-126
Identities = 118/315 (37%), Positives = 171/315 (54%), Gaps = 16/315 (5%)
Query: 313 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT 372
SS ++ +L+ AT+N++ +G G FG VYKG+L DG+ VA+KR
Sbjct: 18 SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ 77
Query: 373 QIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQ 432
IE+F E+ LS H H+V L+G C E +L+Y+Y+ NG L H++
Sbjct: 78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTM--- 134
Query: 433 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492
S+SWE R+ + A + Y+H+ I HRD+KS NILLD+ F K++D
Sbjct: 135 ---------SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182
Query: 493 FGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
FG S+ D+THL+T V+GT GY DPEYF + T+KSDVYSFGVVL E+L + I
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
+ E NL + + +L +I+D +A + R E + + A+ CL L+S+ RP+
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 612 MKQVSMDLEGLRRSQ 626
M V LE R Q
Sbjct: 303 MGDVLWKLEYALRLQ 317
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 355 bits (913), Expect = e-118
Identities = 113/305 (37%), Positives = 182/305 (59%), Gaps = 17/305 (5%)
Query: 321 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIE-QFIN 379
K F+ ELQ A+DN++ LG+GGFG VYKG L DG++VAVKR + E QF
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
EV ++S HR++++L G C+ +LVY Y++NG+++ + + + Q
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ----------- 125
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499
L W R R+A A +AY+H I HRD+K++NILLD++F A V DFG ++ +
Sbjct: 126 -PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 500 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR--EEE 557
TH+TTAV+GT G+ PEY + + ++K+DV+ +GV+LLEL+TG++ L R ++
Sbjct: 185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ-VS 616
+ L+ + L KE KL ++D + ++E++E + ++A+ C + + +RP M + V
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 617 MDLEG 621
M LEG
Sbjct: 305 M-LEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-110
Identities = 103/322 (31%), Positives = 167/322 (51%), Gaps = 33/322 (10%)
Query: 316 GSSEKAKIFTAEELQRATDNYNQ------SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI 369
S + F+ EL+ T+N+++ +G+GGFG VYKG + + + VAVK+ A+
Sbjct: 7 VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAM 65
Query: 370 DKTQIEQ----FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQ 425
E+ F E+ ++++ H ++V+LLG + + LVY Y+ NG+L +
Sbjct: 66 VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD 125
Query: 426 QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485
LSW R ++A A + ++H I HRDIKS+NILLD+
Sbjct: 126 GTP-------------PLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEA 169
Query: 486 FSAKVSDFGTSRSVP-NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELL 544
F+AK+SDFG +R+ +T +T+ + GT Y PE + T KSD+YSFGVVLLE++
Sbjct: 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEII 228
Query: 545 TGKKPICLTREEEERNLVAYFISLAKENK-LLEILDARVAKEAREEDIEAVAELAMGCLR 603
TG + RE + L+ + E K + + +D ++ +A +EA+ +A CL
Sbjct: 229 TGLPAVDEHREPQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLH 285
Query: 604 LNSKKRPTMKQVSMDLEGLRRS 625
KRP +K+V L+ + S
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-75
Identities = 71/345 (20%), Positives = 123/345 (35%), Gaps = 51/345 (14%)
Query: 308 LQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSR 367
+ S E L + +G FG V+K VAVK
Sbjct: 1 MGHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP 56
Query: 368 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV----LVYEYISNGTLSHHIHD 423
DK Q Q EV L + H +I++ +G L+ + G+LS +
Sbjct: 57 IQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115
Query: 424 HQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASI-------PIFHRDIK 476
+ +SW +A +A +AY+H I HRDIK
Sbjct: 116 NV-----------------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158
Query: 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSS-----QYTDK 530
S N+LL + +A ++DFG + K+ T GT Y PE + + +
Sbjct: 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 218
Query: 531 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAR--- 587
D+Y+ G+VL EL + +E ++ + + + L ++ + V K+ R
Sbjct: 219 IDMYAMGLVLWELASRCTAADGPVDE---YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL 275
Query: 588 ------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
+ + E C +++ R + V + ++R
Sbjct: 276 RDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-68
Identities = 85/286 (29%), Positives = 134/286 (46%), Gaps = 33/286 (11%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+G G FGTV++ GS VAVK + ++ +F+ EV I+ ++ H +IV +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ +V EY+S G+L +H +++ L R+ +A +VA +
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-------------LDERRRLSMAYDVAKGM 150
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
Y+H+ + PI HR++KS N+L+D K++ KV DFG SR + +A GT + P
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAP 208
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILD 579
E + +KSDVYSFGV+L EL T ++P N ++ + K LEI
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFKCKRLEI-- 260
Query: 580 ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
VA + GC KRP+ + L L +S
Sbjct: 261 -------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 2e-66
Identities = 75/286 (26%), Positives = 134/286 (46%), Gaps = 39/286 (13%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401
+G+G FG V K VA+K+ +++ + FI E+ LS++NH +IVKL G CL
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
LV EY G+L + +H + L + + + + + VAY
Sbjct: 73 P--VCLVMEYAEGGSLYNVLHGAEP-------------LPYYTAAHAMSWCLQCSQGVAY 117
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFS-AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE 520
+HS + HRD+K N+LL + K+ DFGT+ + +TH+T G+ + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPE 173
Query: 521 YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDA 580
F+ S Y++K DV+S+G++L E++T +KP +E + ++
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGTRPPLI-- 226
Query: 581 RVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+++ + + L C + +RP+M+++ + L R
Sbjct: 227 --------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-65
Identities = 82/297 (27%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKR-------SRAIDKTQIEQFINEVVILSQINHRHIV 393
+G+GGFG V+KG + D S+VA+K + ++F EV I+S +NH +IV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
KL G P +V E++ G L H + D + W ++R+
Sbjct: 87 KLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP---------------IKWSVKLRLML 129
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-----FSAKVSDFGTSRSVPNDKTHLTT 508
++A + YM + + PI HRD++S NI L AKV+DFG S+ H +
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVS 184
Query: 509 AVQGTFGYFDPEYF--QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
+ G F + PE + YT+K+D YSF ++L +LTG+ P +E + +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DEYSYGKIKFIN 240
Query: 567 SLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
+ +E I ED + + C + KKRP + +L L
Sbjct: 241 MIREEGLRPTIP----------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-63
Identities = 80/294 (27%), Positives = 125/294 (42%), Gaps = 50/294 (17%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLG 397
+G GGFG VY+ G VAVK +R IE E + + + H +I+ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
CL+ LV E+ G L+ + + + + V A ++A
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKR-----------------IPPDILVNWAVQIAR 116
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFS--------AKVSDFGTSRSVPNDKTHLTTA 509
+ Y+H A +PI HRD+KSSNIL+ K K++DFG +R +T +A
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA 174
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
G + + PE ++S ++ SDV+S+GV+L ELLTG+ P + +A +A
Sbjct: 175 A-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVA 227
Query: 570 KENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
L I E A+L C + RP+ + L +
Sbjct: 228 MNKLALPIP----------STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-60
Identities = 55/291 (18%), Positives = 111/291 (38%), Gaps = 46/291 (15%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
L + G ++KG G+ + VK + R + F E L +H +++ +LG C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 400 LETEVP--VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
P L+ ++ G+L + +H+ + V+ A ++A
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--------------VDQSQAVKFALDMAR 122
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
+A++H+ I + S ++++D+ +A++S S + +
Sbjct: 123 GMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWV 175
Query: 518 DPEYFQSSQY---TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574
PE Q +D++SF V+L EL+T + P + + + + +A E
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALEGLR 229
Query: 575 LEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
I I V++L C+ + KRP + LE ++
Sbjct: 230 PTI----------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-60
Identities = 69/340 (20%), Positives = 121/340 (35%), Gaps = 59/340 (17%)
Query: 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVI 383
A E DN +G+G +G VYKG L D VAVK + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV---FSFANRQNFINEKNI 58
Query: 384 --LSQINHRHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
+ + H +I + + LV EY NG+L ++ H
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------------ 106
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASI------PIFHRDIKSSNILLDDKFSAKV 490
+ W + R+A V +AY+H+ I HRD+ S N+L+ + + +
Sbjct: 107 -----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
Query: 491 SDFGTSR-------SVPNDKTHLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSF 536
SDFG S P ++ + + GT Y PE + + + D+Y+
Sbjct: 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYAL 221
Query: 537 GVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAR--------- 587
G++ E+ + E +A+ + ++ ++ R
Sbjct: 222 GLIYWEIFMRCTDLFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
Query: 588 -EEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
+ ++ E C +++ R T + + L
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 1e-58
Identities = 57/306 (18%), Positives = 110/306 (35%), Gaps = 61/306 (19%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+G+G FG VY G G VA++ ++ Q++ F EV+ Q H ++V +G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ ++ TL + D + L ++A E+ +
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIV---------------LDVNKTRQIAQEIVKGM 143
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR----SVPNDKTHLTTAVQGTFG 515
Y+H + I H+D+KS N+ D+ ++DFG + G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 516 YFDPEYFQSSQ---------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
+ PE + ++ SDV++ G + EL + P +
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------------F-- 243
Query: 567 SLAKENKLLEILDARVAKEAREEDIE-----AVAELAMGCLRLNSKKRPTMKQVSMDLEG 621
K I+ + + + ++++ + C ++RPT ++ LE
Sbjct: 244 ---KTQPAEAIIWQ-MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
Query: 622 LRRSQR 627
L + R
Sbjct: 300 LPKRNR 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-58
Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 48/299 (16%)
Query: 342 LGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
LG+G FG K G ++ +K D+ F+ EV ++ + H +++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+ + + EYI GTL I Q W RV A ++A +A
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ---------------YPWSQRVSFAKDIASGMA 122
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------------- 507
Y+H S+ I HRD+ S N L+ + + V+DFG +R + ++KT
Sbjct: 123 YLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567
V G + PE Y +K DV+SFG+VL E++ + + F
Sbjct: 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTMDFGL 234
Query: 568 LAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+ + + + + C L+ +KRP+ ++ LE LR
Sbjct: 235 NVRGFLDRYC----------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 8e-57
Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 40/290 (13%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+G G FGTVYKG G VAVK A Q++ F NEV +L + H +I+ +G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
T + +V ++ +L HH+H + + + + +A + A
Sbjct: 90 --TAPQLAIVTQWCEGSSLYHHLHASETK---------------FEMKKLIDIARQTARG 132
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYF 517
+ Y+H+ I HRD+KS+NI L + + K+ DFG + +H + G+ +
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189
Query: 518 DPE---YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKL 574
PE S+ Y+ +SDVY+FG+VL EL+TG+ P N + + +
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVGRGSLS 244
Query: 575 LEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
++ + R + + L CL+ +RP+ ++ ++E L R
Sbjct: 245 PDLS------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-53
Identities = 62/314 (19%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINE--VVILSQINHRHIVKLLGCC 399
+G+G +G V+ G G VAVK T+ + E + + H +I+ +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKV---FFTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 400 LETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
++ L+ +Y NG+L ++ +L ++ +++A
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST-----------------TLDAKSMLKLAYSS 143
Query: 456 AGAVAYMHSAASI-----PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---T 507
+ ++H+ I HRD+KS NIL+ + ++D G + +D +
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
Query: 508 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
GT Y PE Q +D+YSFG++L E+ C++ E
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR----CVSGGIVEEYQ 259
Query: 562 VAYFISLAKENKLLEILDARVAKEAR---------EEDIEAVAELAMGCLRLNSKKRPTM 612
+ Y + + ++ + K+ R +E + + +L C N R T
Sbjct: 260 LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
Query: 613 KQVSMDLEGLRRSQ 626
+V L + SQ
Sbjct: 320 LRVKKTLAKMSESQ 333
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 8e-52
Identities = 59/314 (18%), Positives = 118/314 (37%), Gaps = 54/314 (17%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINE--VVILSQINHRHIVKLLGCC 399
+G+G FG V++G G VAVK + + E + + H +I+ +
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 400 LETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
+ LV +Y +G+L +++ + +++ E +++A
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----------------TVTVEGMIKLALST 148
Query: 456 AGAVAYMHS-----AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR---SVPNDKTHLT 507
A +A++H I HRD+KS NIL+ + ++D G + S +
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208
Query: 508 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
GT Y PE + + ++D+Y+ G+V E+ C E
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR----CSIGGIHEDYQ 264
Query: 562 VAYFISLAKENKLLEILDARVAKEAR---------EEDIEAVAELAMGCLRLNSKKRPTM 612
+ Y+ + + + E+ ++ R E + +A++ C N R T
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 613 KQVSMDLEGLRRSQ 626
++ L L + +
Sbjct: 325 LRIKKTLSQLSQQE 338
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 54/310 (17%), Positives = 108/310 (34%), Gaps = 54/310 (17%)
Query: 342 LGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVI--LSQINHRHIVKLLGCC 399
+G+G +G V++G G VAVK + + E + + H +I+ +
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 400 LETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
+ + L+ Y G+L ++ +L + +R+ +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT-----------------TLDTVSCLRIVLSI 114
Query: 456 AGAVAYMHSAASI-----PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---T 507
A +A++H I HRD+KS NIL+ ++D G + L
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 508 TAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
GT Y PE + D+++FG+VL E+ ++ E
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR----MVSNGIVEDYK 230
Query: 562 VAYFISLAKENKLLEILDARVAKEAR---------EEDIEAVAELAMGCLRLNSKKRPTM 612
++ + + ++ + R + + ++A+L C N R T
Sbjct: 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA 290
Query: 613 KQVSMDLEGL 622
++ L +
Sbjct: 291 LRIKKTLTKI 300
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-49
Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQINH 389
N+ + +G+G F VY+ L DG VA+K+ +D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+++K +E +V E G LS I + ++QK+ + E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVW--------- 139
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
+ ++ A+ +MHS + HRDIK +N+ + K+ D G R + T +
Sbjct: 140 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
V GT Y PE + Y KSD++S G +L E+ + P ++ NL +
Sbjct: 197 V-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYS-LCKKI 250
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
++ + ++E R +L C+ + +KRP + V
Sbjct: 251 EQCDYPPLPSDHYSEELR--------QLVNMCINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
++Y +G G +G K DG I+ K ++ + + + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 391 HIVKLLGCCLETEVPVL--VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+IV+ ++ L V EY G L+ I + +++Q L+EE L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVL-------- 114
Query: 449 VRVACEVAGAVAYMHS--AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
RV ++ A+ H + HRD+K +N+ LD K + K+ DFG +R + +D +
Sbjct: 115 -RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 173
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
T V GT Y PE Y +KSD++S G +L EL P +
Sbjct: 174 KTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAG 226
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + + R + E E+ L L RP+++++
Sbjct: 227 KIREGK--FRRIPYRYSDELN--------EIITRMLNLKDYHRPSVEEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 64/302 (21%), Positives = 118/302 (39%), Gaps = 37/302 (12%)
Query: 317 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQ 373
S + T ++ + Y + + +G+G FG DG +K + +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 374 IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQE 433
E+ EV +L+ + H +IV+ E +V +Y G L I ++
Sbjct: 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-----NAQKGVL 121
Query: 434 LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493
+E+Q L ++ A+ ++H I HRDIKS NI L + ++ DF
Sbjct: 122 FQEDQIL---------DWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDF 169
Query: 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 553
G +R + + + GT Y PE ++ Y +KSD+++ G VL EL T K
Sbjct: 170 GIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--- 225
Query: 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613
E ++ + + + + + + R L + N + RP++
Sbjct: 226 ---EAGSMKNLVLKIISGS--FPPVSLHYSYDLR--------SLVSQLFKRNPRDRPSVN 272
Query: 614 QV 615
+
Sbjct: 273 SI 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 61/303 (20%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN 388
+R ++ + +G GGFG V+K DG +KR + E+ EV L++++
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLD 62
Query: 389 HRHIVKLLGCCLETEVPV----------------LVYEYISNGTLSHHIHDHQQQQEQKQ 432
H +IV GC + + E+ GTL I ++ + +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EKRRGE 117
Query: 433 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492
+L++ +L ++ V Y+HS + +RD+K SNI L D K+ D
Sbjct: 118 KLDKVL---ALEL------FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGD 165
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 552
FG S+ ND + GT Y PE S Y + D+Y+ G++L ELL
Sbjct: 166 FGLVTSLKNDGKRTRSK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--- 220
Query: 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612
E + ++ + K+ + L L + RP
Sbjct: 221 --AFETSKF----FTDLRDGII----SDIFDKKEKT--------LLQKLLSKKPEDRPNT 262
Query: 613 KQV 615
++
Sbjct: 263 SEI 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-44
Identities = 67/305 (21%), Positives = 121/305 (39%), Gaps = 45/305 (14%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+Y + LG+GGF V L DG A+KR ++ E+ E + NH +I+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 394 KLLGCCLETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+L+ CL L+ + GTL + I ++ +++ L E+Q L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQIL--------- 137
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
+ + + +H+ HRD+K +NILL D+ + D G+ A
Sbjct: 138 WLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 510 VQ--------GTFGYFDPEYFQSSQY---TDKSDVYSFGVVLLELLTGKKPICLTREEEE 558
+ T Y PE F + +++DV+S G VL ++ G+ P +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DM 248
Query: 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618
++LA +N+L R + +L + ++ +RP + +
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRHSSALW--------QLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 619 LEGLR 623
LE L+
Sbjct: 301 LEALQ 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 69/310 (22%), Positives = 115/310 (37%), Gaps = 59/310 (19%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKT-QIEQFINEVVILSQIN 388
R ++ + LG+GGFG V++ D A+KR R ++ E+ + EV L+++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 389 HRHIVKLLGCCLE---------TEVPVLVY---EYISNGTLSHHIHDHQQQQEQKQELEE 436
H IV+ LE + V +Y + L + + +E E
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM----NGRCTIEERER 117
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
L + ++A AV ++HS + HRD+K SNI KV DFG
Sbjct: 118 SVCL---------HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLV 165
Query: 497 RSVPNDKTHLTTAVQ-----------GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545
++ D+ T GT Y PE + Y+ K D++S G++L ELL
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
Query: 546 GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLN 605
P + ER + + K + + E + L +
Sbjct: 226 ---PF---STQMERVRTLTDV---RNLKFPPLFTQKYPCE---------YVMVQDMLSPS 267
Query: 606 SKKRPTMKQV 615
+RP +
Sbjct: 268 PMERPEAINI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 70/316 (22%), Positives = 127/316 (40%), Gaps = 68/316 (21%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKT--QIEQFINEVVILSQI 387
R ++ + LGQG FG V K D A+K+ I T ++ ++EV++L+ +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK---IRHTEEKLSTILSEVMLLASL 59
Query: 388 NHRHIVKLLGCCLETEVPV-------------LVYEYISNGTLSHHIHDHQQQQEQKQEL 434
NH+++V+ LE V + EY NGTL I +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI------HSENLNQ 113
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
+ ++ W R+ ++ A++Y+HS I HRD+K NI +D+ + K+ DFG
Sbjct: 114 QRDE-----YW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFG 161
Query: 495 TSRSVPND--------------KTHLTTAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVV 539
+++V +LT+A+ GT Y E + Y +K D+YS G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 540 LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAM 599
E++ ER + + + + D K + ++
Sbjct: 221 FFEMIYPFST------GMERVNILKKL-RSVSIEFPPDFDDNKMKVEK--------KIIR 265
Query: 600 GCLRLNSKKRPTMKQV 615
+ + KRP + +
Sbjct: 266 LLIDHDPNKRPGARTL 281
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 43/281 (15%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G F TVYKG+ VA + R + K++ ++F E +L + H +IV+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 399 CLETEVP----VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
T VLV E +++GTL ++ + + + +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK----------------VMKIKVLRSWCRQ 137
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+ + ++H+ + PI HRD+K NI + S K+ D G + AV GT
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGT 193
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE ++ +Y + DVY+FG+ +LE+ T + P E +N + + K
Sbjct: 194 PEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYS-----ECQNAAQIYRRVTSGVK 247
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
D E + E+ GC+R N +R ++K
Sbjct: 248 -PASFDKVAIPEVK--------EIIEGCIRQNKDERYSIKD 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 6e-43
Identities = 61/300 (20%), Positives = 116/300 (38%), Gaps = 57/300 (19%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SRAIDKTQIEQFINEVVILSQINH--R 390
Y+ + +G GG V++ + I A+K D ++ + NE+ L+++
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
I++L + + +V E N L+ + + S+ +
Sbjct: 89 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----------------SID-PWERK 130
Query: 451 V-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--HLT 507
+ AV +H I H D+K +N L+ D K+ DFG + + D T
Sbjct: 131 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186
Query: 508 TAVQGTFGYFDPEYFQSS-----------QYTDKSDVYSFGVVLLELLTGKKPICLTREE 556
+ V GT Y PE + + + KSDV+S G +L + GK P
Sbjct: 187 SQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 238
Query: 557 EERNLVAYFISLAKE-NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
F + + +KL I+D E + + + ++ CL+ + K+R ++ ++
Sbjct: 239 --------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-42
Identities = 63/322 (19%), Positives = 120/322 (37%), Gaps = 57/322 (17%)
Query: 313 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SRAID 370
+KA E + Y+ + +G GG V++ + I A+K D
Sbjct: 35 LGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD 94
Query: 371 KTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQ 428
++ + NE+ L+++ I++L + + +V E N L+ + +
Sbjct: 95 NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--- 150
Query: 429 EQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487
S+ + + AV +H I H D+K +N L+ D
Sbjct: 151 -------------SID-PWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-M 192
Query: 488 AKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-----------QYTDKSDVY 534
K+ DFG + + D T + V G Y PE + + + KSDV+
Sbjct: 193 LKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251
Query: 535 SFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE-NKLLEILDARVAKEAREEDIEA 593
S G +L + GK P F + + +KL I+D E + +
Sbjct: 252 SLGCILYYMTYGKTP---------------FQQIINQISKLHAIIDPNHEIEFPDIPEKD 296
Query: 594 VAELAMGCLRLNSKKRPTMKQV 615
+ ++ CL+ + K+R ++ ++
Sbjct: 297 LQDVLKCCLKRDPKQRISIPEL 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 62/300 (20%), Positives = 117/300 (39%), Gaps = 57/300 (19%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SRAIDKTQIEQFINEVVILSQINH--R 390
Y+ + +G GG V++ + I A+K D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
I++L + + +V E N L+ + + S+ +
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK----------------SID-PWERK 111
Query: 451 V-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--HLT 507
+ AV +H I H D+K +N L+ D K+ DFG + + D T
Sbjct: 112 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 167
Query: 508 TAVQGTFGYFDPEYFQ-----------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556
+ V GT Y PE + S+ + KSDV+S G +L + GK P
Sbjct: 168 SQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------- 219
Query: 557 EERNLVAYFISLAKE-NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
F + + +KL I+D E + + + ++ CL+ + K+R ++ ++
Sbjct: 220 --------FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-39
Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
Y + RFLG+GGF ++ + A K +S + Q E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+H+V G E V +V E +L ++++ L E E R
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEP--------EAR 118
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
++ Y+H + HRD+K N+ L++ K+ DFG + V D
Sbjct: 119 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568
GT Y PE ++ + DV+S G ++ LL GK P E L +
Sbjct: 175 LC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY--- 224
Query: 569 AKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ I + A L L+ + RPT+ ++
Sbjct: 225 ---LR---IKKNEYSIPKHINPVAA--------SLIQKMLQTDPTARPTINEL 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 65/293 (22%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
Y + RFLG+GGF ++ + A K +S + Q E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+H+V G E V +V E +L ++++ L E E R
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEP--------EAR 144
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
++ Y+H + HRD+K N+ L++ K+ DFG + V D
Sbjct: 145 -YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568
GT Y PE ++ + DV+S G ++ LL GK P E L +
Sbjct: 201 LC-GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF------ETSCLKETY--- 250
Query: 569 AKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ I + A L L+ + RPT+ ++
Sbjct: 251 ---LR---IKKNEYSIPKHINPVAA--------SLIQKMLQTDPTARPTINEL 289
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-39
Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 52/313 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI----EQFINEVVILSQIN 388
+ S LGQG V++G G + A+K + + + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 389 HRHIVKLLGC--CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H++IVKL T VL+ E+ G+L + + L E + L
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP----SNAYGLPESEFL------ 115
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 502
V +V G + ++ I HR+IK NI+ D + K++DFG +R + +D
Sbjct: 116 ---IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 503 KTHLTTAVQGTFGYFDPEYFQSS--------QYTDKSDVYSFGVVLLELLTGKKPICLTR 554
+ GT Y P+ ++ + +Y D++S GV TG P
Sbjct: 170 -EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI------------EAVAELAMGCL 602
V Y I K + + + + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 603 RLNSKKRPTMKQV 615
+ +K Q
Sbjct: 288 EADQEKCWGFDQF 300
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 62/289 (21%), Positives = 103/289 (35%), Gaps = 44/289 (15%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQI 387
++ + LG G +G V+K DG + AVKRS + + EV ++
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 388 -NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H V+L E + L E +L H + L E Q
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC------EAWGASLPEAQVW------ 160
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ A+A++HS + H D+K +NI L + K+ DFG +
Sbjct: 161 ---GYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGA 212
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
+G Y PE Q Y +DV+S G+ +LE+ + E + L
Sbjct: 213 GEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL----- 264
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
++ L A ++ E R + + L + K R T + +
Sbjct: 265 ---RQGYLPPEFTAGLSSELR--------SVLVMMLEPDPKLRATAEAL 302
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-39
Identities = 73/299 (24%), Positives = 125/299 (41%), Gaps = 52/299 (17%)
Query: 340 RFLGQGGFGTVYKGMLPDGSI-VAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLG 397
+G+G FG V+ G L + VAVK R + +F+ E IL Q +H +IV+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 398 CCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
C + + P+ +V E + G + + L + +++ + A
Sbjct: 180 VCTQKQ-PIYIVMELVQGGDFLTFLRTEGAR---------------LRVKTLLQMVGDAA 223
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ Y+ S I HRD+ + N L+ +K K+SDFG SR + + A G
Sbjct: 224 AGMEYLESKCCI---HRDLAARNCLVTEKNVLKISDFGMSREEADG---VYAASGGL-RQ 276
Query: 517 F-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFISLA 569
PE +Y+ +SDV+SFG++L E + G P L+ ++ F+
Sbjct: 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREFVE-- 329
Query: 570 KENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
+ L E +AV L C +RP+ + +L+ +R+ R
Sbjct: 330 -KGGRLP----------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 59/242 (24%), Positives = 97/242 (40%), Gaps = 23/242 (9%)
Query: 313 SSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDK 371
S + E E D LG+G +G VY G L + +A+K D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 372 TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQK 431
+ E+ + + H++IV+ LG E + E + G+LS + + +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALL----RSKWGP 116
Query: 432 QELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAK 489
+ E+ + ++ + Y+H I HRDIK N+L++ K
Sbjct: 117 LKDNEQT----------IGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLK 163
Query: 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGK 547
+SDFGTS+ + T GT Y PE Y +D++S G ++E+ TGK
Sbjct: 164 ISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 548 KP 549
P
Sbjct: 223 PP 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 39/300 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGS------IVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG V+ + S +VAVK + + F E +L+ + H HIV
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
K G C + + ++V+EY+ +G L+ + H + + Q L + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++A + Y+ AS HRD+ + N L+ K+ DFG SR V + + G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193
Query: 514 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFI 566
PE ++T +SDV+SFGV+L E+ T GK+P L+ E I
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VI 245
Query: 567 SLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+ ++LE R + V ++ +GC + ++R +K++ L L ++
Sbjct: 246 ECITQGRVLE----------RPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-38
Identities = 79/325 (24%), Positives = 125/325 (38%), Gaps = 66/325 (20%)
Query: 326 AEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------EQFI 378
+++ Q A +++ R LG+G FG VY I+A+K + K Q+ Q
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALK---VLFKAQLEKAGVEHQLR 57
Query: 379 NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
EV I S + H +I++L G V L+ EY GT+ + + EQ+
Sbjct: 58 REVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA---- 112
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
E+A A++Y HS + HRDIK N+LL K++DFG S
Sbjct: 113 ------------TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV 157
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
P+ + GT Y PE + + +K D++S GV+ E L GK P E
Sbjct: 158 HAPSSRRT-DLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------E 208
Query: 558 ERNLVAYFISLAKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
+ + I V + AR +L L+ N +RP
Sbjct: 209 ANTYQETY------KR---ISRVEFTFPDFVTEGAR--------DLISRLLKHNPSQRPM 251
Query: 612 MKQVSMD---LEGLRRSQRCVEIDK 633
+++V + C +
Sbjct: 252 LREVLEHPWITANSSKPSNCQNKES 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-38
Identities = 73/296 (24%), Positives = 118/296 (39%), Gaps = 60/296 (20%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------EQFINEVVILSQ 386
+++ LG+G F VY+ + G VA+K IDK + ++ NEV I Q
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK---MIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 387 INHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+ H I++L E V LV E NG ++ ++ + + E
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK------NRVKPFSE--------N 112
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
E R ++ + Y+HS I HRD+ SN+LL + K++DFG + +
Sbjct: 113 EAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
T GT Y PE S + +SDV+S G + LL G+ P + +
Sbjct: 169 HYTLC-GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF------DTDTVKNTL 221
Query: 566 ISLAKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
NK ++ A ++ EA+ +L LR N R ++ V
Sbjct: 222 ------NK---VVLADYEMPSFLSIEAK--------DLIHQLLRRNPADRLSLSSV 260
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 46/294 (15%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQ 386
E + +G+G FG V++ G AVK+ + E+V +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK---VRLEVFRV--EELVACAG 106
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
++ IV L G E + E + G+L Q +++ L E
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLG-------------QLIKQMGCLP----E 149
Query: 447 NRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKT 504
+R + + Y+H+ I H D+K+ N+LL A + DFG + + D
Sbjct: 150 DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 505 HLTTA----VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560
+ + GT + PE K D++S ++L +L G P T+
Sbjct: 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP--WTQYFRGP- 263
Query: 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
+ I A E + + A + LR R + +
Sbjct: 264 -LCLKI--ASEPPPIREIPPSCAPLTA--------QAIQEGLRKEPVHRASAME 306
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 8e-38
Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 35/228 (15%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG+V + L VAVK ++ I + IE+F+ E + + +H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 394 KLLGCCLETE------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
KL+G L + +P+++ ++ +G L + + + +L +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP----------FNLPLQT 138
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
VR ++A + Y+ +S HRD+ + N +L + + V+DFG SR + + +
Sbjct: 139 LVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193
Query: 508 TAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
QG E + YT SDV++FGV + E++T G+ P
Sbjct: 194 --RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 79/309 (25%), Positives = 143/309 (46%), Gaps = 50/309 (16%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVK--RSRAIDKTQIEQFIN 379
E+ R + SR LGQG FG VY+G+ VA+K A + +IE F+N
Sbjct: 21 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 77
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
E ++ + N H+V+LLG + + +++ E ++ G L ++ + +
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL------RPAMANNPV 131
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499
L+ S +++A E+A +AY+ + HRD+ + N ++ + F+ K+ DFG +R +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 500 PNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-L 552
+ +G G PE + +T SDV+SFGVVL E+ T ++P L
Sbjct: 189 YETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPT 611
+ E+ V F+ E LL+ + ++ + + EL C + N K RP+
Sbjct: 245 SNEQ-----VLRFV---MEGGLLD----------KPDNCPDMLFELMRMCWQYNPKMRPS 286
Query: 612 MKQVSMDLE 620
++ ++
Sbjct: 287 FLEIISSIK 295
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 55/228 (24%), Positives = 101/228 (44%), Gaps = 47/228 (20%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI---VAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
+ LG G FGTVYKG+ + VA+K R K E ++E +++ +++ H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE-ILDEAYVMASVDNPHV 79
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+LLG CL + V L+ + + G L ++ +H+ + + +
Sbjct: 80 CRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN---------------IGSQYLLNWC 123
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT----- 507
++A + Y+ + HRD+ + N+L+ K++DFG ++ + ++
Sbjct: 124 VQIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 508 -----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A E YT +SDV+S+GV + EL+T G KP
Sbjct: 181 VPIKWMA---------LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 69/297 (23%), Positives = 130/297 (43%), Gaps = 31/297 (10%)
Query: 340 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
+ LG+G FG+V G +VAVK+ + + + F E+ IL + H +IVK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 395 LLGCCLET-EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
G C + L+ EY+ G+L ++ H+++ + ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------------IDHIKLLQYT 120
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
++ + Y+ + I HRD+ + NIL++++ K+ DFG ++ +P DK G
Sbjct: 121 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 513 TFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL--VAYFISL 568
F PE S+++ SDV+SFGVVL EL T + E R + +
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
L+E+L + + + + C N +RP+ + +++ ++ +R +
Sbjct: 238 VFH--LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 62/336 (18%), Positives = 128/336 (38%), Gaps = 56/336 (16%)
Query: 316 GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI 374
S F + ++ R L +GGF VY+ + G A+KR + ++ +
Sbjct: 10 ASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN 69
Query: 375 EQFINEVVILSQI-NHRHIVKLLGCCLETEVP-------VLVYEYISNGTLSHHIHDHQQ 426
I EV + ++ H +IV+ + L+ + G L + +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQL----VEFLK 125
Query: 427 QQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486
+ E + L + L ++ + AV +MH PI HRD+K N+LL ++
Sbjct: 126 KMESRGPLSCDTVL---------KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG 175
Query: 487 SAKVSDFGTSRSVPNDKTHLTTAVQ-----------GTFGYFDPEYFQSSQ---YTDKSD 532
+ K+ DFG++ ++ + + +A + T Y PE +K D
Sbjct: 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235
Query: 533 VYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIE 592
+++ G +L L + P F ++ L I++ + + +
Sbjct: 236 IWALGCILYLLCFRQHP---------------F----EDGAKLRIVNGKYSIPPHDTQYT 276
Query: 593 AVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628
L L++N ++R ++ +V L+ + ++
Sbjct: 277 VFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 63/313 (20%), Positives = 109/313 (34%), Gaps = 52/313 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI----EQFINEVVILSQIN 388
+ S LGQG V++G G + A+K + + + E +L ++N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 389 HRHIVKLLGC--CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H++IVKL T VL+ E+ G+L + + L E + L
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP----SNAYGLPESEFL------ 115
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPND 502
V +V G + ++ I HR+IK NI+ D + K++DFG +R + +D
Sbjct: 116 ---IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169
Query: 503 KTHLTTAVQGTFGYFDPEYFQSS--------QYTDKSDVYSFGVVLLELLTGKKPICLTR 554
+ GT Y P+ ++ + +Y D++S GV TG P
Sbjct: 170 -EQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI------------EAVAELAMGCL 602
V Y I K + + + + + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 603 RLNSKKRPTMKQV 615
+ +K Q
Sbjct: 288 EADQEKCWGFDQF 300
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 69/297 (23%), Positives = 117/297 (39%), Gaps = 33/297 (11%)
Query: 340 RFLGQGGFGTVYKGMLP-----DGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
R LG+G FG V G VAVK + + I E+ IL + H +I
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENI 85
Query: 393 VKLLGCCLETEV-PV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
VK G C E + L+ E++ +G+L ++ ++ + KQ+L+
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK--------------- 130
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
A ++ + Y+ S + HRD+ + N+L++ + K+ DFG ++++ DK + T
Sbjct: 131 YAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 511 QGTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567
F PE S++ SDV+SFGV L ELLT + +
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247
Query: 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
L+ L + V +L C R + + + E L +
Sbjct: 248 TVTR--LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 27/214 (12%)
Query: 342 LGQGGFGTVYKGMLPD---GSIVAVKRSR---AIDKTQIEQFINEVVILSQINHRHIVKL 395
LG GG TVY D VA+K + +++F EV SQ++H++IV +
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
+ E + LV EYI TLS +I H LS + + ++
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----------------LSVDTAINFTNQI 120
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
+ + H I HRDIK NIL+D + K+ DFG ++++ T V GT
Sbjct: 121 LDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
YF PE + + +D+YS G+VL E+L G+ P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 76/334 (22%), Positives = 142/334 (42%), Gaps = 46/334 (13%)
Query: 301 KQNGGYLLQQRLSSCGSSEKAKIFTAE------ELQRATDNYNQSRFLGQGGFGTVYKGM 354
L+ K I+ E++R + LG G +G VY+G+
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMER--TDITMKHKLGGGQYGEVYEGV 240
Query: 355 LPDGSI-VAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413
S+ VAVK + D ++E+F+ E ++ +I H ++V+LLG C ++ E+++
Sbjct: 241 WKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 299
Query: 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHR 473
G L ++ + +Q+ L + +A +++ A+ Y+ I HR
Sbjct: 300 YGNLLDYLRECNRQEVSAVVL--------------LYMATQISSAMEYLEKKNFI---HR 342
Query: 474 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDV 533
++ + N L+ + KV+DFG SR + D + + PE ++++ KSDV
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 534 YSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI- 591
++FGV+L E+ T G P + L+ +++ +E R E
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRME----------RPEGCP 445
Query: 592 EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
E V EL C + N RP+ ++ E + +
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 61/217 (28%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
LG G FG V+ G + VAVK + + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 400 LETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
T+ P+ + EY+ NG+L + + +L + +A ++A
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKL--------------LDMAAQIAEG 121
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 517
+A++ I HRD++++NIL+ D S K++DFG +R + +++ TA +G F
Sbjct: 122 MAFIEERNYI---HRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG--AKFP 173
Query: 518 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE +T KSDV+SFG++L E++T G+ P
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 334 DNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSRAIDKTQI------EQFINEVVILSQ 386
D+++ R LG+G FG VY + I+A+K + K+Q+ Q E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALK---VLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 387 INHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+ H +I+++ + L+ E+ G L + Q+ +
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-----QKHGR-----------FD- 112
Query: 446 ENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E R E+A A+ Y H + HRDIK N+L+ K K++DFG S P+ +
Sbjct: 113 EQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T GT Y PE + + +K D++ GV+ E L G P
Sbjct: 170 R-TMC--GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 77/300 (25%), Positives = 129/300 (43%), Gaps = 40/300 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGS------IVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
LG+G FG V+ + +VAVK + ++ + F E +L+ + H+HIV
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+ G C E ++V+EY+ +G L+ + H + E+ L + VA
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP-GPLGLGQLLAVAS 165
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+VA + Y+ A + HRD+ + N L+ K+ DFG SR + + + G
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV----GG 218
Query: 514 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNLVAYFI 566
PE ++T +SDV+SFGVVL E+ T GK+P L+ E I
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------AI 270
Query: 567 SLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+ + LE R V + GC + ++R ++K V L+ L ++
Sbjct: 271 DCITQGRELE----------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-37
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 46/292 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIV 393
++ LG G GT+ + D VAVKR I EV +L + + H +++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+ + + + E + TL ++ EQK E +L ++
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV-------EQKDFAHLGLEPITL-----LQ--- 125
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-----FSAKVSDFGTSRSVPNDKTHLT- 507
+ +A++HS I HRD+K NIL+ A +SDFG + + + +
Sbjct: 126 QTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 508 -TAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ V GT G+ PE T D++S G V +++ + + N
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN--- 239
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
I L + + AR EL + ++ +KRP+ K V
Sbjct: 240 --ILLGACSLDCLHPEKHEDVIAR--------ELIEKMIAMDPQKRPSAKHV 281
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ LG G FG V G VAVK + ++F E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ +V EYISNG L +++ H + L + + +V +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---------------LEPSQLLEMCYDVCEGM 117
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-- 517
A++ S I HRD+ + N L+D KVSDFG +R V +D+ + G F
Sbjct: 118 AFLESHQFI---HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVG--TKFPV 169
Query: 518 ---DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE F +Y+ KSDV++FG+++ E+ + GK P
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 69/297 (23%), Positives = 130/297 (43%), Gaps = 31/297 (10%)
Query: 340 RFLGQGGFGTVYKGMLP-----DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK 394
+ LG+G FG+V G +VAVK+ + + + F E+ IL + H +IVK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 395 LLGCCLET-EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
G C + L+ EY+ G+L ++ H+++ + ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------------IDHIKLLQYT 151
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
++ + Y+ + I HRD+ + NIL++++ K+ DFG ++ +P DK + G
Sbjct: 152 SQICKGMEYLGTKRYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208
Query: 513 TFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL--VAYFISL 568
F PE S+++ SDV+SFGVVL EL T + E R + +
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
L+E+L + + + + C N +RP+ + +++ ++ +R
Sbjct: 269 VFH--LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 30/217 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGSI-VAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
LG G +G VY+G+ S+ VAVK + D ++E+F+ E ++ +I H ++V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
C ++ E+++ G L ++ + +Q+ L + +A +++ A
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL--------------LYMATQISSA 123
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 517
+ Y+ I HRD+ + N L+ + KV+DFG SR + D TA G F
Sbjct: 124 MEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAG--AKFP 175
Query: 518 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++++ KSDV++FGV+L E+ T G P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 35/300 (11%)
Query: 340 RFLGQGGFGTVYKGML-----PDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
R LG+G FG V G +VAVK ++ A + + + E+ IL + H HI
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG-WKQEIDILRTLYHEHI 95
Query: 393 VKLLGCCLET-EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+K GCC + + LV EY+ G+L ++ H S+ +
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----------------SIGLAQLLL 138
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
A ++ +AY+H+ I HRD+ + N+LLD+ K+ DFG +++VP +
Sbjct: 139 FAQQICEGMAYLHAQHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 195
Query: 511 QGTFGYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567
G F PE + ++ SDV+SFGV L ELLT + E +A
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
L E+L+ ++ V L C + RPT + + L+ + +
Sbjct: 256 TVLR--LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 32/229 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSRAIDKTQIEQFINEVVILSQINHRH 391
LG+ FG VYKG L + VA+K + +A + E F +E ++ +++ H +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPN 73
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V LLG + + +++ Y S+G L + + ++ S+L + V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND----KTHLT 507
++A + Y+ +S + H+D+ + N+L+ DK + K+SD G R V +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 508 ------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A PE +++ SD++S+GVVL E+ + G +P
Sbjct: 191 LLPIRWMA---------PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-37
Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 30/296 (10%)
Query: 342 LGQGGFGTVYKGMLP-----DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLL 396
LG+G FG+V G++VAVK+ + Q F E+ IL ++ IVK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 397 GCCLET-EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
G + LV EY+ +G L + H+ + + + L + +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL---------------YSSQ 135
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ + Y+ S + HRD+ + NIL++ + K++DFG ++ +P DK + G
Sbjct: 136 ICKGMEYLGSRRCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 515 GYF--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571
F PE + ++ +SDV+SFGVVL EL T K + E +
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
LLE+L+ A V EL C + + RP+ + L+ L R
Sbjct: 253 --LLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 9e-37
Identities = 64/305 (20%), Positives = 114/305 (37%), Gaps = 38/305 (12%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQI 387
+ + LG GGFG V + + G VA+K+ + + E++ E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 388 NHRHIVKLLGCCLETE-------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL 440
NH ++V + +P+L EY G L +++ E L+E
Sbjct: 70 NHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF----ENCCGLKEGPIR 124
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSR 497
+ LS +++ A+ Y+H I HRD+K NI+L K+ D G ++
Sbjct: 125 TLLS---------DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC------ 551
+ T V GT Y PE + +YT D +SFG + E +TG +P
Sbjct: 173 ELDQG-ELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
Query: 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAE-LAMGCLRLNSKKRP 610
+ + + ++ + E L + ++R
Sbjct: 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290
Query: 611 TMKQV 615
T Q
Sbjct: 291 TDPQN 295
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 340 RFLGQGGFGTVYKGML------PDGSIVAVK--RSRAIDKTQIEQFINEVVILSQI-NHR 390
+ LG+G FG V + VAVK + A ++E+ IL I +H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 91
Query: 391 HIVKLLGCCLETEVPVLV-YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
++V LLG C + P++V E+ G LS ++ + + + E+ L+ E+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
+ +VA + ++ AS HRD+ + NILL +K K+ DFG +R + D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 204
Query: 510 VQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
V+ PE YT +SDV+SFGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 32/222 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVK 394
+G+G FG VY G L D AVK I D ++ QF+ E +I+ +H +++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 395 LLGCCLETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LLG CL +E L V Y+ +G L + I + K +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---------------LIGFGL 135
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+VA + Y+ AS HRD+ + N +LD+KF+ KV+DFG +R + + + + + T
Sbjct: 136 QVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY--SVHNKT 190
Query: 514 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E Q+ ++T KSDV+SFGV+L EL+T G P
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 72/301 (23%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 340 RFLGQGGFGTVYKGMLPD--------GSIVAVK--RSRAIDKTQIEQFINEVVILSQI-N 388
+ LG+G FG V VAVK + A +K + ++E+ ++ I
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H++I+ LLG C + ++ EY S G L ++ + + +++++
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
V ++A + Y+ AS HRD+ + N+L+ + K++DFG +R + N +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213
Query: 509 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 561
+ T G PE YT +SDV+SFGV++ E+ T G P + EE
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 267
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621
L KE ++ E + + C +RPT KQ+ DL+
Sbjct: 268 ---LFKLLKEGHRMDKPA-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 315
Query: 622 L 622
+
Sbjct: 316 I 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 30/216 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ LG G FG V G VA+K + ++FI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ ++ EY++NG L +++ + + + + +Q LE + +V A+
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLE---------------MCKDVCEAM 133
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-- 517
Y+ S + HRD+ + N L++D+ KVSDFG SR V +D+ T+ G F
Sbjct: 134 EYLESKQFL---HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVG--SKFPV 185
Query: 518 ---DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE S+++ KSD+++FGV++ E+ + GK P
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 68/222 (30%), Positives = 106/222 (47%), Gaps = 32/222 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVK 394
+G+G FG VY G L D AVK I D ++ QF+ E +I+ +H +++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 395 LLGCCLETEVPVL-VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LLG CL +E L V Y+ +G L + I + K +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---------------LIGFGL 199
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+VA + ++ AS HRD+ + N +LD+KF+ KV+DFG +R + + + + T
Sbjct: 200 QVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKT 254
Query: 514 FGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
E Q+ ++T KSDV+SFGV+L EL+T G P
Sbjct: 255 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 28/320 (8%), Positives = 72/320 (22%), Gaps = 57/320 (17%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVI 383
L + L G V+ + A+K ++++E+
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 384 LSQINHRHIVKLLGCCLETEVP--------------------------VLVYEYISNGTL 417
+++ + +L+ S L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL 174
Query: 418 SHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477
+ + + ++ A + S + H
Sbjct: 175 ELLFSTLDFVYVFRGDEGILA---------LHILTAQLIRLAANLQSKG---LVHGHFTP 222
Query: 478 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYS 535
N+ + + D V A Y E+ +S +T + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQ 278
Query: 536 FGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVA 595
G+ + + P L + + + + + L + +
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVK-------- 330
Query: 596 ELAMGCLRLNSKKRPTMKQV 615
L L + ++R +
Sbjct: 331 TLIGRFLNFDRRRRLLPLEA 350
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGS---IVAVK--RSRAIDKTQIEQFINEVVILSQI-NHRHIV 393
+G+G FG V K + A+K + A + F E+ +L ++ +H +I+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LLG C L EY +G L + + + S+LS + + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHLT----- 507
+VA + Y+ + HRD+ + NIL+ + + AK++DFG SR K +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206
Query: 508 -TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A E S YT SDV+S+GV+L E+++ G P
Sbjct: 207 WMA---------IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-36
Identities = 63/256 (24%), Positives = 122/256 (47%), Gaps = 32/256 (12%)
Query: 301 KQNGGYLLQQRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSI 360
K+ L Q+ C SS+ K + + + ++ + LG G FG V+ +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214
Query: 361 VAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSH 419
VAVK + +E F+ E ++ + H +VKL T+ P+ ++ E+++ G+L
Sbjct: 215 VAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLD 271
Query: 420 HIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479
+ + ++ +L + + ++A +A++ I HRD++++N
Sbjct: 272 FLKSDEGSKQPLPKL--------------IDFSAQIAEGMAFIEQRNYI---HRDLRAAN 314
Query: 480 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVY 534
IL+ K++DFG +R + +++ TA +G F PE +T KSDV+
Sbjct: 315 ILVSASLVCKIADFGLARVIEDNE---YTAREG--AKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 535 SFGVVLLELLT-GKKP 549
SFG++L+E++T G+ P
Sbjct: 370 SFGILLMEIVTYGRIP 385
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
LGQG FG V+ G + VA+K + E F+ E ++ ++ H +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+E P+ +V EY+S G+L + + + +L V +A ++A
Sbjct: 249 --SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--------------VDMAAQIASG 292
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD 518
+AY+ + HRD++++NIL+ + KV+DFG +R + +++ + +
Sbjct: 293 MAYVERMNYV---HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 519 PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++T KSDV+SFG++L EL T G+ P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 5e-36
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDG------SIVAVK--RSRAIDKTQIEQFINEVVILSQINHRH 391
+ LG+G FG V K + VAVK + A + ++E +L Q+NH H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPH 87
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDH--------QQQQEQKQELEEEQELSSL 443
++KL G C + +L+ EY G+L + + + + + +L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
+ + + A +++ + Y+ A + + HRD+ + NIL+ + K+SDFG SR V +
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 504 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
++ V+ + G E YT +SDV+SFGV+L E++T G P
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-36
Identities = 65/254 (25%), Positives = 121/254 (47%), Gaps = 27/254 (10%)
Query: 301 KQNGGYLLQQRLSSCGSSEKAKIFTAE---ELQRATDNYNQSRFLGQGGFGTVYKGMLPD 357
++ L + + C +S+ A+ E+ R ++ LGQG FG V+ G
Sbjct: 233 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPR--ESLRLEVKLGQGCFGEVWMGTWNG 290
Query: 358 GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGT 416
+ VA+K + E F+ E ++ ++ H +V+L +E P+ +V EY+S G+
Sbjct: 291 TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGS 347
Query: 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476
L + + + +L V +A ++A +AY+ + HRD++
Sbjct: 348 LLDFLKGETGKYLRLPQL--------------VDMAAQIASGMAYVERMNYV---HRDLR 390
Query: 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 536
++NIL+ + KV+DFG +R + +++ + + PE ++T KSDV+SF
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 537 GVVLLELLT-GKKP 549
G++L EL T G+ P
Sbjct: 451 GILLTELTTKGRVP 464
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-36
Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ +G G FG V+ G + VA+K R E FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
LE P+ LV E++ +G LS ++ + + L + +V
Sbjct: 73 LEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETLLG---------------MCLDVCEG 116
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF- 517
+AY+ A I HRD+ + N L+ + KVSDFG +R V +D+ T+ G F
Sbjct: 117 MAYLEEACVI---HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTG--TKFP 168
Query: 518 ----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE F S+Y+ KSDV+SFGV++ E+ + GK P
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ LG+G FG+V +G L VAVK + + +IE+F++E + +H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 394 KLLGCCLETE-----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+LLG C+E P+++ ++ G L ++ E + +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----------LYSRLETGPKHIPLQTL 149
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
++ ++A + Y+ ++ HRD+ + N +L D + V+DFG S+ + + +
Sbjct: 150 LKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY--- 203
Query: 509 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
QG E YT KSDV++FGV + E+ T G P
Sbjct: 204 -RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 72/317 (22%), Positives = 132/317 (41%), Gaps = 51/317 (16%)
Query: 340 RFLGQGGFGTVYKGMLPDG------SIVAVK--RSRAIDKTQIEQFINEVVILSQINHRH 391
R +G+G FG V++ P ++VAVK + A Q + F E ++++ ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTL--------SHHIHDHQQQQEQKQELEEEQELSSL 443
IVKLLG C + L++EY++ G L H + + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
S ++ +A +VA +AY+ + HRD+ + N L+ + K++DFG SR++ +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 504 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREE 556
+ PE ++YT +SDV+++GVVL E+ + G +P + EE
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 284
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQV 615
I ++ +L E+ + L C RP+ +
Sbjct: 285 --------VIYYVRDGNILA----------CPENCPLELYNLMRLCWSKLPADRPSFCSI 326
Query: 616 SMDLEG-LRRSQRCVEI 631
L+ R++ V +
Sbjct: 327 HRILQRMCERAEGTVGV 343
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-36
Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 45/302 (14%)
Query: 340 RFLGQGGFGTVYKGML--------PDGSIVAVK--RSRAIDKTQIEQFINEVVILSQI-N 388
+ LG+G FG V + VAVK + A +K + ++E+ ++ I
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 145
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H++I+ LLG C + ++ EY S G L ++ + + +++++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
V ++A + Y+ AS HRD+ + N+L+ + K++DFG +R + N +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259
Query: 509 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 561
+ T G PE YT +SDV+SFGV++ E+ T G P + EE
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
L KE ++ + + + + C +RPT KQ+ DL+
Sbjct: 314 ---LFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360
Query: 621 GL 622
+
Sbjct: 361 RI 362
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI---VAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
+ +G G FG VYKGML G VA+K ++ +K +++ F+ E I+ Q +H +I
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
++L G + + +++ EY+ NG L + + + S V +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---------------FSVLQLVGML 153
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
+A + Y+ + + HRD+ + NIL++ KVSDFG SR + +D T G
Sbjct: 154 RGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 513 TFGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++T SDV+SFG+V+ E++T G++P
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSRAI-DKTQIEQFINEVV 382
+ + R +G+G FG VY G D + A+K I + Q+E F+ E +
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 383 ILSQINHRHIVKLLGCCLETE-VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
++ +NH +++ L+G L E +P ++ Y+ +G L I Q+ K
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD--------- 125
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+ +VA + Y+ A HRD+ + N +LD+ F+ KV+DFG +R +
Sbjct: 126 ------LISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDI-- 174
Query: 502 DKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ Q E Q+ ++T KSDV+SFGV+L ELLT G P
Sbjct: 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 69/312 (22%), Positives = 123/312 (39%), Gaps = 55/312 (17%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-N 388
Q + + LG G GTV G VAVKR + + + E+ +L++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDD 67
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H ++++ C T+ + + E N L + E + +E N
Sbjct: 68 HPNVIRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKE---------YN 116
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-------------FSAKVSDFG 494
+ + ++A VA++H S+ I HRD+K NIL+ +SDFG
Sbjct: 117 PISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 495 TSRSVPNDK----THLTTAVQGTFGYFDPEYFQSS-------QYTDKSDVYSFGVVLLEL 543
+ + + + T+L GT G+ PE + S + T D++S G V +
Sbjct: 174 LCKKLDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 544 LTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLR 603
L+ K + E N++ SL +++ + D + EA +L +
Sbjct: 233 LSKGKHPFGDKYSRESNIIRGIFSL---DEMKCLHDRSLIAEAT--------DLISQMID 281
Query: 604 LNSKKRPTMKQV 615
+ KRPT +V
Sbjct: 282 HDPLKRPTAMKV 293
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 56/218 (25%), Positives = 106/218 (48%), Gaps = 38/218 (17%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ +G+G FG V G G+ VAVK + + + F+ E +++Q+ H ++V+LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+E + + +V EY++ G+L ++ + L ++ + +V A
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------------LKFSLDVCEA 129
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------TAVQG 512
+ Y+ + HRD+ + N+L+ + AKVSDFG ++ + TA
Sbjct: 130 MEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA--- 182
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE + +++ KSDV+SFG++L E+ + G+ P
Sbjct: 183 ------PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 30/221 (13%)
Query: 338 QSRFLGQGGFGTVYKGMLPDGSI---VAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
+ + LG G FGTV KG + VAVK ++ A D ++ + E ++ Q+++ +I
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 393 VKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
V+++G C LV E G L+ ++ ++ + +N + +
Sbjct: 81 VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH----------------VKDKNIIEL 122
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
+V+ + Y+ + + HRD+ + N+LL + AK+SDFG S+++ D+ +
Sbjct: 123 VHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 512 GTF--GYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
G + ++ PE +++ KSDV+SFGV++ E + G+KP
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 61/249 (24%), Positives = 104/249 (41%), Gaps = 52/249 (20%)
Query: 318 SEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS-----IVAVKRSRAI-DK 371
A+IF EL++ + LG G FGTV+KG+ V +K +
Sbjct: 4 KVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 56
Query: 372 TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQK 431
+ + ++ + ++H HIV+LLG C LV +Y+ G+L H+ H+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGA---- 111
Query: 432 QELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491
L + + ++A + Y+ + HR++ + N+LL +V+
Sbjct: 112 -----------LGPQLLLNWGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSPSQVQVA 157
Query: 492 DFGTSRSVPNDKTHLT----------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLL 541
DFG + +P D L A E +YT +SDV+S+GV +
Sbjct: 158 DFGVADLLPPDDKQLLYSEAKTPIKWMA---------LESIHFGKYTHQSDVWSYGVTVW 208
Query: 542 ELLT-GKKP 549
EL+T G +P
Sbjct: 209 ELMTFGAEP 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 47/243 (19%), Positives = 95/243 (39%), Gaps = 44/243 (18%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR--AIDKTQIEQFINEVVILSQI 387
R T +++ +G G FG+V+K + DG I A+KRS+ + + EV + +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 388 -NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H H+V+ E + ++ EY + G+L+ I + +E +
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYFKEAELK------ 118
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-------------------DKFS 487
+ +V + Y+HS + + H DIK SNI + +K
Sbjct: 119 ---DLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTG 546
K+ D G + + + +G + E Q + + K+D+++ + ++
Sbjct: 173 FKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
Query: 547 KKP 549
+
Sbjct: 228 EPL 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 79/311 (25%), Positives = 130/311 (41%), Gaps = 43/311 (13%)
Query: 340 RFLGQGGFGTVYKGMLPD--------GSIVAVK--RSRAIDKTQIEQFINEVVILSQI-N 388
+ LG+G FG V + VAVK +S A +K + I+E+ ++ I
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK 133
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H++I+ LLG C + ++ EY S G L ++ + + LS ++
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
V A +VA + Y+ AS HRD+ + N+L+ + K++DFG +R + + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 509 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPIC-LTREEEERNL 561
+ T G PE YT +SDV+SFGV+L E+ T G P + EE
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 301
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEG 621
L KE ++ E + + C +RPT KQ+ DL+
Sbjct: 302 ---LFKLLKEGHRMDKPS-----NCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLDR 349
Query: 622 LRRSQRCVEID 632
+ E+
Sbjct: 350 IVALTSNQEMG 360
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 72/317 (22%), Positives = 126/317 (39%), Gaps = 56/317 (17%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVK--RSRAIDKTQIEQFIN 379
E+ R N R LG G FG VY+G + VAVK ++ +++ F+
Sbjct: 26 EVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLM 82
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
E +I+S+ NH++IV+ +G L++ ++ E ++ G L + + + + Q L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DKFSAKVSDFGTS 496
L VA ++A Y+ HRDI + N LL AK+ DFG +
Sbjct: 143 LH---------VARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
Query: 497 RSVPNDKTHLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI 550
R + + +G PE F +T K+D +SFGV+L E+ + G P
Sbjct: 191 RDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246
Query: 551 -CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKK 608
+ +E V F+ ++ ++ V + C + +
Sbjct: 247 PSKSNQE-----VLEFV---TSGGRMD----------PPKNCPGPVYRIMTQCWQHQPED 288
Query: 609 RPTMKQVSMDLEGLRRS 625
RP + +E +
Sbjct: 289 RPNFAIILERIEYCTQD 305
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 38/218 (17%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
+ +G+G FG V G G+ VAVK + D T + F+ E +++Q+ H ++V+LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 400 LETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGA 458
+E + + +V EY++ G+L ++ + L ++ + +V A
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------------LKFSLDVCEA 301
Query: 459 VAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------TAVQG 512
+ Y+ + HRD+ + N+L+ + AKVSDFG ++ + TA
Sbjct: 302 MEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEA-SSTQDTGKLPVKWTA--- 354
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE + +++ KSDV+SFG++L E+ + G+ P
Sbjct: 355 ------PEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 53/218 (24%), Positives = 82/218 (37%), Gaps = 31/218 (14%)
Query: 340 RFLGQGGFGTVYKGMLPD---GSIVAVKRSR---AIDKTQIEQFINEVVILSQINHRHIV 393
R +G+GG G VY+ D IVA+K + D + E ++ H+V
Sbjct: 40 RLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+ + I+ L+ + L+ V +
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ----------------GPLAPPRAVAIVR 141
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--AVQ 511
++ A+ H+A HRD+K NIL+ A + DFG + + LT
Sbjct: 142 QIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTV 196
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE F S T ++D+Y+ VL E LTG P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 52/227 (22%), Positives = 99/227 (43%), Gaps = 45/227 (19%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI---VAVKRSRAI-DKTQIEQFINEVVILSQINHRHIV 393
+ LG G FGTVYKG+ + VA+K R ++ ++E +++ +++ H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+LLG CL L+ + + G L ++ +H+ + + +
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---------------IGSQYLLNWCV 124
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT------ 507
++A + Y+ + HRD+ + N+L+ K++DFG ++ + ++
Sbjct: 125 QIAKGMNYLEDRRLV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 508 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A E YT +SDV+S+GV + EL+T G KP
Sbjct: 182 PIKWMA---------LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 68/342 (19%), Positives = 113/342 (33%), Gaps = 78/342 (22%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKT-QIEQFINEVVILSQIN 388
R ++ + +G+GGFG V++ D A+KR R ++ E+ + EV L+++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H IV+ LET E + + + S +N
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 448 RVRVA---------------CE----------------------------VAGAVAYMHS 464
V C +A AV ++HS
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 465 AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ-----------GT 513
+ HRD+K SNI KV DFG ++ D+ T GT
Sbjct: 183 KG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
Y PE + Y+ K D++S G++L ELL + ER + I+ + K
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST------QMERVRI---ITDVRNLK 290
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + +E + L + +RP +
Sbjct: 291 FPLLFTQKYPQE---------HMMVQDMLSPSPTERPEATDI 323
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 69/305 (22%), Positives = 122/305 (40%), Gaps = 54/305 (17%)
Query: 340 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSRAIDKTQIEQFINEVVILSQINHRH 391
R LG G FG VY+G + VAVK ++ +++ F+ E +I+S+ NH++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV+ +G L++ ++ E ++ G L + + + + Q L L V
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH---------V 186
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DKFSAKVSDFGTSRSVPNDKTHLTT 508
A ++A Y+ HRDI + N LL AK+ DFG +R + +
Sbjct: 187 ARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY--- 240
Query: 509 AVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI-CLTREEEERNL 561
+G PE F +T K+D +SFGV+L E+ + G P + +E
Sbjct: 241 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----- 294
Query: 562 VAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
V F+ ++ ++ V + C + + RP + +E
Sbjct: 295 VLEFV---TSGGRMD----------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341
Query: 621 GLRRS 625
+
Sbjct: 342 YCTQD 346
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ +G G G V G L VA+K ++ ++ + + F++E I+ Q +H +I+
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L G + ++V EY+ NG+L + H Q + V +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---------------FTIMQLVGMLR 158
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
V + Y+ + HRD+ + N+L+D KVSDFG SR + +D T G
Sbjct: 159 GVGAGMRYLSDLGYV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 514 FGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++ SDV+SFGVV+ E+L G++P
Sbjct: 216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 4e-35
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 33/226 (14%)
Query: 336 YNQSRFLGQGGFGTVYKGMLPD---GSIVAVK--RSR-AIDKTQIEQFINEVVILSQINH 389
Y LG GG V+ D VAVK R+ A D + +F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 390 RHIVKLL--GC--CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
IV + G +P +V EY+ TL +H ++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------------MTP 115
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
+ + V + A+ + H I HRD+K +NI++ + KV DFG +R++ +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 506 LTT--AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+T AV GT Y PE + +SDVYS G VL E+LTG+ P
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 28/216 (12%)
Query: 342 LGQGGFGTVYKGML--PDGSI-VAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG G FG+V +G+ I VA+K + +K E+ + E I+ Q+++ +IV+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 398 CCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
C + LV E G L + +++ + N + +V+
Sbjct: 78 VC--QAEALMLVMEMAGGGPLHKFLVGKREE---------------IPVSNVAELLHQVS 120
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ Y+ + HRD+ + N+LL ++ AK+SDFG S+++ D ++ T G +
Sbjct: 121 MGMKYLEEKNFV---HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 517 F--DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE +++ +SDV+S+GV + E L+ G+KP
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 8e-35
Identities = 71/305 (23%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSRAIDKTQIEQ 376
+F + ++ Y + + LG G +G V A+K R ++ + +
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELE 435
+ EV +L ++H +I+KL E + LV E G L I + E
Sbjct: 83 LLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA--- 138
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSD 492
+ +V V Y+H I HRD+K N+LL+ K K+ D
Sbjct: 139 -------------AVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 552
FG S N K + + GT Y PE + Y +K DV+S GV+L LL G P
Sbjct: 183 FGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGG 239
Query: 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRP 610
++E L ++ + ++ E +++ A +L L+ +S++R
Sbjct: 240 QTDQE---------------ILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
Query: 611 TMKQV 615
+ +Q
Sbjct: 285 SAQQA 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ +G G FG V G L S VA+K + +K + + F+ E I+ Q +H +I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L G +++ ++V EY+ NG+L + H Q + V +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---------------FTVIQLVGMLR 154
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+A + Y+ + HRD+ + NIL++ KVSDFG R + +D T G
Sbjct: 155 GIASGMKYLSDMGYV---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 514 FGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE ++T SDV+S+G+VL E+++ G++P
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 47/227 (20%)
Query: 340 RFLGQGGFGTVYKGMLPDGSI----VAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
R LG+G FG VY+G+ + VAVK + + + F++E VI+ ++H HIV
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHIV 76
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
KL+G E P ++ E G L H++ ++ + + +
Sbjct: 77 KLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL---------------YS 119
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT----- 507
++ A+AY+ S + HRDI NIL+ K+ DFG SR + ++ +
Sbjct: 120 LQICKAMAYLESINCV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 508 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T SDV+ F V + E+L+ GK+P
Sbjct: 177 PIKWMS---------PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 47/227 (20%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI--VAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
R +G+G FG V++G+ P+ VA+K ++ D + + F+ E + + Q +H HIV
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 79
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
KL+G TE PV ++ E + G L + + L + + A
Sbjct: 80 KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYS---------------LDLASLILYA 122
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT----- 507
+++ A+AY+ S + HRDI + N+L+ K+ DFG SR + + +
Sbjct: 123 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 508 ----TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A PE ++T SDV+ FGV + E+L G KP
Sbjct: 180 PIKWMA---------PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 75/293 (25%), Positives = 116/293 (39%), Gaps = 48/293 (16%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQIN 388
+D Y R LG+G FG V G AVK + + KT E + EV +L Q++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H +I+KL E + LV E + G L I ++ E
Sbjct: 85 HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA--------------- 128
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPNDKT 504
R+ +V + YMH I HRD+K N+LL+ K + ++ DFG S K
Sbjct: 129 -ARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
+ + GT Y PE + Y +K DV+S GV+L LL+G P
Sbjct: 185 -MKDKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP--------------- 226
Query: 565 FISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + + L ++ + E + + + A +L L R + +
Sbjct: 227 FNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 63/310 (20%), Positives = 120/310 (38%), Gaps = 48/310 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK-----------------RSRAIDKTQIEQ 376
++Y R L QG F + D A+K + K++ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELE 435
F NE+ I++ I + + + G + V ++YEY+ N ++ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGT 495
Q + + V + +Y+H+ +I HRD+K SNIL+D K+SDFG
Sbjct: 149 PIQVIK--------CIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGE 198
Query: 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD--KSDVYSFGVVLLELLTGKKPICLT 553
S + + K + GT+ + PE+F + + K D++S G+ L + P
Sbjct: 199 SEYMVDKKIK-GSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--- 252
Query: 554 REEEERNLVAYFISLAKEN-KLLEILDARVAKEAREEDIEAVAELAMGC-------LRLN 605
+ +LV F ++ +N + + + ++ + L+ LR N
Sbjct: 253 --SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310
Query: 606 SKKRPTMKQV 615
+R T +
Sbjct: 311 PAERITSEDA 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 63/232 (27%), Positives = 99/232 (42%), Gaps = 35/232 (15%)
Query: 340 RFLGQGGFGTVYKGMLPD------GSIVAVK--RSRAIDKTQIEQFINEVVILSQI-NHR 390
+ LG G FG V + VAVK + A + ++E+ +LS + NH
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHI--HDHQQQQEQKQELEEEQELSSLSWENR 448
+IV LLG C +++ EY G L + + + E + +L E+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND----KT 504
+ + +VA +A++ AS HRD+ + NILL K+ DFG +R + ND
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 505 HLT------TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
A PE + YT +SDV+S+G+ L EL + G P
Sbjct: 205 GNARLPVKWMA---------PESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 31/221 (14%)
Query: 340 RFLGQGGFGTVYKGML--PDGSI--VAVK---RSRAIDKTQIEQFINEVVILSQINHRHI 392
LG G FG V +G P G VAVK ++ FI EV + ++HR++
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 393 VKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++L G L P+ +V E G+L + HQ R
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGH---------------FLLGTLSRY 126
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
A +VA + Y+ S I HRD+ + N+LL + K+ DFG R++P + H
Sbjct: 127 AVQVAEGMGYLESKRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 512 GTFGY--FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++ ++ SD + FGV L E+ T G++P
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 75/305 (24%), Positives = 122/305 (40%), Gaps = 54/305 (17%)
Query: 340 RFLGQGGFGTVYKGMLPD------GSIVAVK--RSRAIDKTQIEQFINEVVILSQI-NHR 390
+ LG G FG V + VAVK +S A + ++E+ I+S + H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV LLG C +++ EY G L + + + E S+ S + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN--STASTRDLLH 168
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND-------K 503
+ +VA +A++ AS HRD+ + N+LL + AK+ DFG +R + ND
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 504 THLT---TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPI--CLTREEE 557
L A PE YT +SDV+S+G++L E+ + G P L +
Sbjct: 226 ARLPVKWMA---------PESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK- 275
Query: 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617
F L K+ + A + + + C L RPT +Q+
Sbjct: 276 -------FYKLVKDGYQMAQPA-----FAPKN----IYSIMQACWALEPTHRPTFQQICS 319
Query: 618 DLEGL 622
L+
Sbjct: 320 FLQEQ 324
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-34
Identities = 43/217 (19%), Positives = 76/217 (35%), Gaps = 38/217 (17%)
Query: 342 LGQGGFGTVYKG--MLPDGSIVAVKRSR-AIDKTQIEQFINEVVILSQINHRHIVKLL-- 396
+ GG G +Y +G V +K + D + E L+++ H IV++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 397 ---GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
V +V EY+ +L L +
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------------------LPVAEAIAYLL 189
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
E+ A++Y+HS + + D+K NI+L ++ K+ D G + + GT
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS-FGYLYGT 240
Query: 514 FGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLTGKKP 549
G+ PE + T +D+Y+ G L L
Sbjct: 241 PGFQAPE--IVRTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-34
Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 30/232 (12%)
Query: 340 RFLGQGGFGTVYKGMLPDGS------IVAVK--RSRAIDKTQIEQFINEVVILSQI-NHR 390
+ LG G FG V S VAVK + +A + ++E+ +++Q+ +H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHE 109
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDH-------QQQQEQKQELEEEQELSSL 443
+IV LLG C + L++EY G L +++ + + E ++ LEEE++L+ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503
++E+ + A +VA + ++ HRD+ + N+L+ K+ DFG +R + +D
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 504 THLTTAVQGTFGYF-----DPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ V PE YT KSDV+S+G++L E+ + G P
Sbjct: 227 NY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 58/303 (19%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK-------------RSRAIDKTQIEQFI 378
++Y + R LG G +G V S A+K + E+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 379 NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
NE+ +L ++H +I+KL E + LV E+ G L I + + E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFDECDA----- 148
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFG 494
+ ++ + Y+H I HRDIK NILL++K + K+ DFG
Sbjct: 149 -----------ANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554
S D L + GT Y PE + Y +K DV+S GV++ LL G P
Sbjct: 195 LSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQN 251
Query: 555 EEEERNLVAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTM 612
+++ + ++ + + + ++I A EL L + KR T
Sbjct: 252 DQD---------------IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 613 KQV 615
++
Sbjct: 297 EEA 299
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 78/321 (24%), Positives = 130/321 (40%), Gaps = 65/321 (20%)
Query: 311 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAI 369
++ C K+ +E + Y LG GGFG+VY G+ + D VA+K +
Sbjct: 20 HMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH---V 76
Query: 370 DKTQIEQFIN---------EVVILSQINHR--HIVKLLGCCLETEVP-VLVYEYISN-GT 416
+K +I + EVV+L +++ +++LL E VL+ E
Sbjct: 77 EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQD 135
Query: 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476
L I ++ L+EE R +V AV + H+ + HRDIK
Sbjct: 136 LFDFI-------TERGALQEE--------LAR-SFFWQVLEAVRHCHNCG---VLHRDIK 176
Query: 477 SSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVY 534
NIL+D ++ K+ DFG+ + + T T GT Y PE+ + +Y + V+
Sbjct: 177 DENILIDLNRGELKLIDFGSGALLKD--TVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 535 SFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAV 594
S G++L +++ G P E +E + RV+ E +
Sbjct: 234 SLGILLYDMVCGDIPF----EHDEEIIRGQV-----------FFRQRVSSECQ------- 271
Query: 595 AELAMGCLRLNSKKRPTMKQV 615
L CL L RPT +++
Sbjct: 272 -HLIRWCLALRPSDRPTFEEI 291
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 44/247 (17%), Positives = 75/247 (30%), Gaps = 34/247 (13%)
Query: 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSRAIDKTQIE 375
I E Q + LG+G F VY+ + +K + + +
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 376 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
+ L +K L VLV E S GTL + I+ ++ E+
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV---- 168
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA------- 488
+ + A + + +H I H DIK N +L + F
Sbjct: 169 -------MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 489 ----KVSDFGTSR--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 542
+ D G S + T T T G+ E + + + D + +
Sbjct: 219 SAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277
Query: 543 LLTGKKP 549
+L G
Sbjct: 278 MLFGTYM 284
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 57/215 (26%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 342 LGQGGFGTVYKGML--PDGSI-VAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLG 397
LG G FG+V +G+ I VA+K + +K E+ + E I+ Q+++ +IV+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
C + +LV E G L + +++ + N + +V+
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---------------IPVSNVAELLHQVSM 447
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY- 516
+ Y+ + HR++ + N+LL ++ AK+SDFG S+++ D ++ T G +
Sbjct: 448 GMKYLEEKNFV---HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 517 -FDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE +++ +SDV+S+GV + E L+ G+KP
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 41/198 (20%), Positives = 67/198 (33%), Gaps = 30/198 (15%)
Query: 60 CQSFITFRSEPPYDTPVSIAYLLGSEAS--------------------------KSVIVP 93
C + T I L S + V+VP
Sbjct: 5 CPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVP 64
Query: 94 VSCSCS-GSLYQHNAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELT 152
C C G HN Y+ + DTY VA + Y LTT ++L +N + N+ L
Sbjct: 65 FPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLN 124
Query: 153 VPIRCACATANQTENGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVF 212
V + C+C + + + Y + D++S I GV + N P +
Sbjct: 125 VLVNCSCGDESVS-KDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYN--PGVNFNSGN 181
Query: 213 TPLLIPLKSESCSANPEK 230
+ +P + + + P K
Sbjct: 182 GIVYVPGRDPNGAFPPFK 199
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-33
Identities = 73/292 (25%), Positives = 110/292 (37%), Gaps = 47/292 (16%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINH 389
+ YN LG+G FG V K AVK + + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+I+KL E +V E + G L I ++ E
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA---------------- 123
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPNDKTH 505
R+ +V + YMH I HRD+K NILL+ K K+ DFG S +
Sbjct: 124 ARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
+ + GT Y PE + + Y +K DV+S GV+L LL+G P F
Sbjct: 180 MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP---------------F 222
Query: 566 ISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+ + L + + A + + I A +L L + R T Q
Sbjct: 223 YGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 71/341 (20%), Positives = 119/341 (34%), Gaps = 63/341 (18%)
Query: 317 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK-----RSRAID 370
S + F L Y+ +GQG +G V + +I A+K + R I+
Sbjct: 9 SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 371 KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQE 429
+E+ EV ++ +++H +I +L E E + LV E G L ++
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 430 QKQELEEEQELSSLSWENRVRVACE------------------------VAGAVAYMHSA 465
K ++ + E + A+ Y+H+
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 466 ASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSV----PNDKTHLTTAVQGTFGYFDP 519
I HRDIK N L S K+ DFG S+ + +TT GT + P
Sbjct: 188 G---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAP 243
Query: 520 EYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLE- 576
E ++ Y K D +S GV+L LL G P F + +
Sbjct: 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP---------------FPG-VNDADTISQ 287
Query: 577 ILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+L+ ++ E + +A +L L N +R +
Sbjct: 288 VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 340 RFLGQGGFGTVYKGMLPDGS----IVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIV 393
R +G+G FG V++G+ VA+K ++ D + + F+ E + + Q +H HIV
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
KL+G TE PV ++ E + G L + + L + + A
Sbjct: 455 KLIGVI--TENPVWIIMELCTLGELRSFLQVRKFS---------------LDLASLILYA 497
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
+++ A+AY+ S + HRDI + N+L+ K+ DFG SR + + + + +
Sbjct: 498 YQLSTALAYLESKRFV---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
+ PE ++T SDV+ FGV + E+L G KP
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 42/318 (13%), Positives = 82/318 (25%), Gaps = 53/318 (16%)
Query: 340 RFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
LGQ + G V + I+Q EV+ L + K
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 396 LGCCLETEVPVLVYE-----------------YISNGTLSHHIHDHQQQQEQKQELEEEQ 438
L P + + ++ + + Q + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498
SL R+++ +V +A +H + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 499 VPNDKTHLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPICLT 553
Q T D ++ G+ + + P T
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NT 318
Query: 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTM 612
+ F ++I + V L G LR + R
Sbjct: 319 DDAALGGSEWIF--------------------RSCKNIPQPVRALLEGFLRYPKEDRLLP 358
Query: 613 KQVSMDLEGLRRSQRCVE 630
Q M+ + + +
Sbjct: 359 LQA-METPEYEQLRTELS 375
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-32
Identities = 51/232 (21%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 340 RFLGQGGFGTVYKGMLPDGSI--------VAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
LGQG F ++KG+ + V +K + E F ++S+++H+H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V G C+ + +LV E++ G+L ++ ++ +LE V
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE---------------V 118
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS--------AKVSDFGTSRSVPNDK 503
A ++A A+ ++ I H ++ + NILL + K+SD G S +V
Sbjct: 119 AKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 504 THLT----TAVQGTFGYFDPEYFQ-SSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE + +D +SFG L E+ + G KP
Sbjct: 176 ILQERIPWVP---------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 46/351 (13%), Positives = 95/351 (27%), Gaps = 87/351 (24%)
Query: 310 QRLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---- 364
+S+ + EL + LGQ + G V
Sbjct: 49 SLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYF 108
Query: 365 ----RSRAIDKTQIE--------------------QFINEVVILSQINHRHIVKLLGCCL 400
S AI + + E +FI ++ + ++++
Sbjct: 109 TERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168
Query: 401 ETEVP--VLVYE--YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVA 456
+ V +Y + T + H + SL R+++ +V
Sbjct: 169 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK------------SLVHHARLQLTLQVI 216
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+A +H + H ++ +I+LD + ++ F + + G+
Sbjct: 217 RLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGF 268
Query: 517 FDPEYFQSSQ-----------YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
PE T D ++ G+V+ + PI + +
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI------TKDAALGGS 322
Query: 566 ISLAKENKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQV 615
+ ++I + V L G LR + R Q
Sbjct: 323 ------EWIFR----------SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 76/306 (24%), Positives = 122/306 (39%), Gaps = 79/306 (25%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN---------EVVI 383
Y LG+GGFGTV+ G L D VA+K I + ++ + EV +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKV---IPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 384 LSQIN----HRHIVKLLGCCLETEVP-VLVYEYISNGT-LSHHIHDHQQQQEQKQELEEE 437
L ++ H +++LL ET+ +LV E L +I +K L E
Sbjct: 88 LWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI-------TEKGPLGEG 139
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 496
+R +V A+ + HS + HRDIK NIL+D + AK+ DFG+
Sbjct: 140 --------PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG 187
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTRE 555
+ + T GT Y PE+ QY + V+S G++L +++ G P
Sbjct: 188 ALLHD--EPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----- 239
Query: 556 EEERNLVAYFISLAKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKR 609
E ++ EIL+A V+ + L CL R
Sbjct: 240 ERDQ----------------EILEAELHFPAHVSPDCC--------ALIRRCLAPKPSSR 275
Query: 610 PTMKQV 615
P+++++
Sbjct: 276 PSLEEI 281
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 83/305 (27%), Positives = 130/305 (42%), Gaps = 62/305 (20%)
Query: 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI-----EQFI 378
+ + Q NY + +G+G F V + G VA+K IDKTQ+ ++
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIK---IIDKTQLNPTSLQKLF 62
Query: 379 NEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
EV I+ +NH +IVKL +ETE + L+ EY S G + ++ H + +E+
Sbjct: 63 REVRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK------- 114
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
E R ++ AV Y H I HRD+K+ N+LLD + K++DFG S
Sbjct: 115 --------EAR-SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS- 161
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREE 556
+ L G Y PE FQ +Y + DV+S GV+L L++G P
Sbjct: 162 NEFTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF------ 214
Query: 557 EERNLVAYFISLAKENKLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRP 610
+ +NL +L + ++ + L L LN KR
Sbjct: 215 DGQNLKELR---------ERVLRGKYRIPFYMSTDCE--------NLLKRFLVLNPIKRG 257
Query: 611 TMKQV 615
T++Q+
Sbjct: 258 TLEQI 262
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID----KTQIEQFINEVVILSQIN 388
D+Y +G G V P VA+KR I+ +T +++ + E+ +SQ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR---INLEKCQTSMDELLKEIQAMSQCH 71
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H +IV + + LV + +S G++ I + E K + +E +++
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT------ 125
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
+ EV + Y+H I HRD+K+ NILL + S +++DFG S +
Sbjct: 126 --ILREVLEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 509 AVQGTF-G---YFDPEYF-QSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
V+ TF G + PE Q Y K+D++SFG+ +EL TG P
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-31
Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 66/301 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV L L + +V EY++ G+L+ + + ++E Q +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--------ETCMDEGQ----------IAA 120
Query: 452 AC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
C E A+ ++HS I HRDIKS NILL S K++DFG + +++ +T V
Sbjct: 121 VCRECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 177
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP--------------------- 549
GT + PE Y K D++S G++ +E++ G+ P
Sbjct: 178 -GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 550 ---------------ICLTREEEER----NLVAY-FISLAKENKLLEILDARVAKEAREE 589
CL + E+R L+ + F+ +AK L L A AKEA +
Sbjct: 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA-AKEATKN 295
Query: 590 D 590
+
Sbjct: 296 N 296
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 31/225 (13%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID----KTQIEQFINEVVILSQI 387
+ + + +G+G FG V+KG+ +VA+K ID + +IE E+ +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI---IDLEEAEDEIEDIQQEITVLSQC 77
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
+ ++ K G L+ ++ EY+ G+ + + L+E Q
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--------EPGPLDETQ--------- 120
Query: 448 RVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ E+ + Y+HS I HRDIK++N+LL + K++DFG + + + +
Sbjct: 121 -IATILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
T V GT + PE + S Y K+D++S G+ +EL G+ P
Sbjct: 177 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS 220
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 43/294 (14%)
Query: 333 TDNYN---QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI- 387
+Y+ + + LG+G F K + AVK I K E+ L
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCE 63
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H +IVKL ++ LV E ++ G L I + E +
Sbjct: 64 GHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKKHFSETEA-------------- 108
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDK 503
+ ++ AV++MH + HRD+K N+L D+ K+ DFG +R P D
Sbjct: 109 --SYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
L T T Y PE + Y + D++S GV+L +L+G+ P + +
Sbjct: 164 QPLKTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF---QSHDRSLTCT 219
Query: 564 YFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+ + K +I + E +++ A +L G L ++ KR M +
Sbjct: 220 SAVEIMK-----KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 66/299 (22%), Positives = 108/299 (36%), Gaps = 53/299 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ--------IEQFINEVVI 383
D Y +G+G F V + + G AVK +D + E E I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREASI 79
Query: 384 LSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSS 442
+ H HIV+LL ++ + +V+E++ L I ++
Sbjct: 80 CHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEI------------VKRADAGFV 126
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSV 499
S ++ A+ Y H I HRD+K +LL K ++ K+ FG + +
Sbjct: 127 YSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183
Query: 500 PNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559
V GT + PE + Y DV+ GV+L LL+G P
Sbjct: 184 GESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP---------- 232
Query: 560 NLVAYFISLAKENKLLE-ILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + +L E I+ + R+ I A +L L L+ +R T+ +
Sbjct: 233 -----F--YGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 75/294 (25%), Positives = 115/294 (39%), Gaps = 49/294 (16%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSRAIDKTQ----IEQFINEVVILSQI 387
D + R LG G FG V+ G +K I+K + +EQ E+ +L +
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK---TINKDRSQVPMEQIEAEIEVLKSL 77
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+H +I+K+ E + +V E G L I + + +LS E
Sbjct: 78 DHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERI------------VSAQARGKALS-E 123
Query: 447 NRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPND 502
V ++ A+AY HS + H+D+K NIL D K+ DFG + +D
Sbjct: 124 GYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
+ T A GT Y PE F+ T K D++S GVV+ LLTG P
Sbjct: 181 EH-STNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP------------- 224
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + E + + A +L L + ++RP+ QV
Sbjct: 225 --FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHR 390
+ ++ LG+G +G+VYK + G IVA+K+ + ++ +++ I E+ I+ Q +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ---VPVESDLQEIIKEISIMQQCDSP 84
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
H+VK G + +V EY G++S I + L E++ +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT------LTEDE----------IA 128
Query: 451 VAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
+ Y+H I HRDIK+ NILL+ + AK++DFG + + + T
Sbjct: 129 TILQSTLKGLEYLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV 185
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT + PE Q Y +D++S G+ +E+ GK P
Sbjct: 186 I-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 42/236 (17%)
Query: 333 TDNYNQSRFLGQG--GFGTVYKGM-LPDGSIVAVKRSRAID-----KTQIEQFINEVVIL 384
Y +G+G TV P G V V+R I+ + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR---INLEACSNEMVTFLQGELHVS 80
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
NH +IV + +V +++ G+ I H + E
Sbjct: 81 KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-----MNELA------ 129
Query: 445 WENRVRVAC---EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+A V A+ Y+H + HR +K+S+IL+ +S ++ S+ +
Sbjct: 130 ------IAYILQGVLKALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMIS 180
Query: 502 DKTHLTTAVQ------GTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKP 549
+ PE Q + Y KSD+YS G+ EL G P
Sbjct: 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL 400
+G+G G V G VAVK + + E NEVVI+ H ++V++ L
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAV 459
E ++ E++ G L+ + + L EEQ + C V A+
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS--------QVRLNEEQ----------IATVCEAVLQAL 154
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
AY+H+ I HRDIKS +ILL K+SDFG + D + V GT + P
Sbjct: 155 AYLHAQGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
E S Y + D++S G++++E++ G+ P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-30
Identities = 62/296 (20%), Positives = 105/296 (35%), Gaps = 53/296 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINH 389
T+ Y LG+G F V + + + G A ++ + ++ E I + H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+IV+L E L+++ ++ G L I + E
Sbjct: 70 PNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSE------------------- 109
Query: 449 VRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 501
A + AV + H + HR++K N+LL K K++DFG + V
Sbjct: 110 -ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
++ GT GY PE + Y D+++ GV+L LL G P
Sbjct: 166 EQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP------------ 212
Query: 562 VAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + +I + E + + A +L L +N KR T +
Sbjct: 213 ---FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 342 LGQGGFGTVYKGML-PDGSIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCC 399
LG G G V+K P G ++A K I Q I E+ +L + N +IV G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAV 459
+ E++ G+L + + EQ L +V+ V +
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGRI--------PEQILG--------KVSIAVIKGL 144
Query: 460 AYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDP 519
Y+ I HRD+K SNIL++ + K+ DFG S + + + + V GT Y P
Sbjct: 145 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSP 199
Query: 520 EYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
E Q + Y+ +SD++S G+ L+E+ G+ PI
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 65/297 (21%), Positives = 105/297 (35%), Gaps = 59/297 (19%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVKRSRAIDKTQI---EQFINEVVILSQIN 388
Y +G+G +G V A K+ I K + ++F E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSLD 64
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H +I++L E + LV E + G L + + +E
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRE------------------ 105
Query: 448 RVRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVP 500
A V AVAY H + HRD+K N L K+ DFG +
Sbjct: 106 --SDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560
K + T V GT Y P+ + Y + D +S GV++ LL G P
Sbjct: 161 PGKM-MRTKV-GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP----------- 206
Query: 561 LVAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + +L+I + ++ ++ A L L + K+R T Q
Sbjct: 207 ----FSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 34/224 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------EQFINEVVILSQI 387
+Y LG G FG V G G VAVK +++ +I + E+ L
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVK---ILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H HI+KL + T +V EY+S G L +I H + +E E
Sbjct: 69 RHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---------------E 112
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
R R+ ++ AV Y H + HRD+K N+LLD +AK++DFG S ++ +D L
Sbjct: 113 AR-RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFL 167
Query: 507 TTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
T+ G+ Y PE Y + D++S GV+L LL G P
Sbjct: 168 RTSC-GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 73/296 (24%), Positives = 108/296 (36%), Gaps = 55/296 (18%)
Query: 333 TDNYNQSRFLGQGGFGTVYKG-MLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINH 389
+ YN LG+G FG V K AVK + + EV +L +++H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+I+KL E +V E + G L I ++ E
Sbjct: 81 PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSE------------------- 120
Query: 449 VRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPN 501
A V + YMH I HRD+K NILL+ K K+ DFG S
Sbjct: 121 -HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
+ + + GT Y PE + + Y +K DV+S GV+L LL+G P
Sbjct: 177 NTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP------------ 221
Query: 562 VAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
F + + L + + A + + I A +L L + R T Q
Sbjct: 222 ---FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 69/292 (23%), Positives = 115/292 (39%), Gaps = 49/292 (16%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ-IEQFINEVVILSQINHR 390
+D + LG+G VY+ A+K + KT + E+ +L +++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRLSHP 108
Query: 391 HIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+I+KL ET + LV E ++ G L I + E+
Sbjct: 109 NIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDA----------------A 151
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDKTHL 506
++ AVAY+H I HRD+K N+L K++DFG S+ V + +
Sbjct: 152 DAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
T GT GY PE + Y + D++S G++ LL G +P F
Sbjct: 208 KTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP---------------FY 251
Query: 567 SLAKENKLLE-ILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+ + IL+ + +++ A +L + L+ KKR T Q
Sbjct: 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 44/290 (15%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
D Y+ LG G FG V++ + G + K NE+ I++Q++H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
++ L + VL+ E++S G L I E+ ++S N +R
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI------------AAEDYKMSEAEVINYMRQ 157
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTA 509
ACE + +MH + I H DIK NI+ + K ++ K+ DFG + + D+ +
Sbjct: 158 ACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVT 210
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
T + PE +D+++ GV+ LL+G P F
Sbjct: 211 T-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---------------FAGED 254
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAM----GCLRLNSKKRPTMKQV 615
L + E E+ +V+ A L+ +KR T+
Sbjct: 255 DLETLQNVKRCDW--EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 70/318 (22%), Positives = 117/318 (36%), Gaps = 54/318 (16%)
Query: 311 RLSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSR 367
++ + F + +DNY+ LG+G F V + + G A K ++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTK 65
Query: 368 AIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQ 426
+ ++ E I ++ H +IV+L + E LV++ ++ G L I +
Sbjct: 66 KLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 427 QQEQKQELEEEQELSSLSWENRVRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILL 482
E A + ++AY HS I HR++K N+LL
Sbjct: 125 YSE--------------------ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLL 161
Query: 483 DDKFSA---KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV 539
K K++DFG + V + + GT GY PE + Y+ D+++ GV+
Sbjct: 162 ASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
Query: 540 LLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEARE-EDIEAVA-EL 597
L LL G P F + +I + E + + A L
Sbjct: 220 LYILLVGYPP---------------FWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 598 AMGCLRLNSKKRPTMKQV 615
L +N KKR T Q
Sbjct: 265 IDSMLTVNPKKRITADQA 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 73/293 (24%), Positives = 111/293 (37%), Gaps = 51/293 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI---EQFINEVVILSQIN 388
+ LG G F V+ G + A+K I K+ NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC---IKKSPAFRDSSLENEIAVLKKIK 64
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H +IV L E+ LV + +S G L I E + ++
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRI----------------LERGVYTEKD 107
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSAKVSDFGTSRSVPNDKT 504
V +V AV Y+H I HRD+K N+L ++ ++DFG S+ N
Sbjct: 108 ASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
++TA GT GY PE Y+ D +S GV+ LL G P EE E L
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF---YEETESKL--- 215
Query: 565 FISLAKENKLLEILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+I + E+ +DI A + L + +R T ++
Sbjct: 216 ---------FEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 68/305 (22%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
+ + LG G FG VYK G++ A K + ++E +I E+ IL+ +H +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IVKLLG ++ E+ G + + E + L E Q ++V
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQ----------IQV 121
Query: 452 AC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
C ++ A+ ++HS I HRD+K+ N+L+ + +++DFG S + +
Sbjct: 122 VCRQMLEALNFLHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 511 QGTFGYFDPE-----YFQSSQYTDKSDVYSFGVVLLELLTGKKP---------------- 549
GT + PE + + Y K+D++S G+ L+E+ + P
Sbjct: 179 -GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237
Query: 550 --------------------ICLTREEEER----NLVAY-FISLAKENKLLEILDARVAK 584
I L + E R L+ + F+S NK L L A
Sbjct: 238 DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKA 297
Query: 585 EAREE 589
E EE
Sbjct: 298 EVMEE 302
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 25/243 (10%)
Query: 317 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRA-IDKTQI 374
SS K KI + ++ +G+G +G+V K + P G I+AVKR R+ +D+ +
Sbjct: 5 SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64
Query: 375 EQFINEV-VILSQINHRHIVKLLGCCL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQ 432
+Q + ++ V++ + +IV+ G E + + E + + + +
Sbjct: 65 KQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVI 122
Query: 433 ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492
E+ L ++ A+ ++ I HRDIK SNILLD + K+ D
Sbjct: 123 P---EEILG--------KITLATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCD 169
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKK 548
FG S + + A G Y PE S Y +SDV+S G+ L EL TG+
Sbjct: 170 FGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
Query: 549 PIC 551
P
Sbjct: 228 PYP 230
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 37/228 (16%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINH 389
+DNY+ LG+G F V + + G A K ++ + ++ E I ++ H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+IV+L + E LV++ ++ G L I ++ E
Sbjct: 65 PNIVRLHDSI-QEESFHYLVFDLVTGGELFEDI-------VAREFYSE------------ 104
Query: 449 VRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 501
A + ++AY HS I HR++K N+LL K K++DFG + V +
Sbjct: 105 -ADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT GY PE + Y+ D+++ GV+L LL G P
Sbjct: 161 SEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 66/301 (21%), Positives = 110/301 (36%), Gaps = 55/301 (18%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSRAIDKTQIEQFINEVVI 383
D Y S+ LG G G V VA++ A + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
L ++NH I+K+ + E +V E + G L + +++ +E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------- 242
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSAKVSDFGTSRSVP 500
++ AV Y+H I HRD+K N+LL ++ K++DFG S+ +
Sbjct: 243 ------LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL- 292
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
+ + + T GT Y PE S Y D +S GV+L L+G P
Sbjct: 293 GETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP-------- 343
Query: 558 ERNLVAYFISLAKENKLLE-ILDARVAKEAREED-IEAVA-ELAMGCLRLNSKKRPTMKQ 614
F + L + I + + A +L L ++ K R T ++
Sbjct: 344 -------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 615 V 615
Sbjct: 397 A 397
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 62/232 (26%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI----EQFINEVVILSQIN 388
++++ + LG+G +G V + VAVK +D + E E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------QELS 441
H ++VK G L EY S G L I E + E +L
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPDAQRFFHQLM 115
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS---RS 498
+ V Y+H I HRDIK N+LLD++ + K+SDFG + R
Sbjct: 116 A---------------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 499 VPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
++ L GT Y PE + ++ + DV+S G+VL +L G+ P
Sbjct: 158 NNRER-LLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQ 386
+ + Y + LG+G FG V++ + K + + D+ ++ E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
HR+I+ L E V+++E+IS + I EL+ E
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI------------NTSAFELN----E 101
Query: 447 NRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDK 503
+ +V A+ ++HS I H DI+ NI+ + S+ K+ +FG +R +
Sbjct: 102 REIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
Y+ PE Q + +D++S G ++ LL+G P
Sbjct: 159 N-FRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 65/273 (23%), Positives = 108/273 (39%), Gaps = 41/273 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN-----------EVV 382
Y+ LG G FG V+ + V VK I K ++ + E+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVK---FIKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 383 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGT-LSHHIHDHQQQQEQKQELEEEQEL 440
ILS++ H +I+K+L E + LV E +G L I ++ L+E
Sbjct: 82 ILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFI-------DRHPRLDEP--- 130
Query: 441 SSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVP 500
+ ++ AV Y+ I HRDIK NI++ + F+ K+ DFG++ +
Sbjct: 131 -----LAS-YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA-AYL 180
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEER 559
T GT Y PE + Y + +++S GV L L+ + P C E E
Sbjct: 181 ERGKLFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA 239
Query: 560 NL-VAYFISLAKENKLLEILDARVAKEAREEDI 591
+ Y +S + + +L + E +
Sbjct: 240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKL 272
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 62/231 (26%), Positives = 96/231 (41%), Gaps = 45/231 (19%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI----EQFINEVVILSQIN 388
++++ + LG+G +G V + VAVK +D + E E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------QELS 441
H ++VK G L EY S G L I E + E +L
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPDAQRFFHQLM 115
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVP 500
+ V Y+H I HRDIK N+LLD++ + K+SDFG +
Sbjct: 116 A---------------GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 501 NDKTH-LTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
N++ L GT Y PE + ++ + DV+S G+VL +L G+ P
Sbjct: 158 NNRERLLNKMC-GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRA-IDKTQIEQFINEV-VILSQINHRHIVKLLGC 398
LG+G +G V K +P G I+AVKR RA ++ + ++ + ++ + + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 399 CL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
E +V + E + ++Q ++ Q + E+ L ++A +
Sbjct: 75 LFREGDV-WICMELMDTSLDK----FYKQVIDKGQTIPEDI----LG-----KIAVSIVK 120
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
A+ ++HS S+ HRD+K SN+L++ K+ DFG S + +D A G Y
Sbjct: 121 ALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYM 176
Query: 518 DPE----YFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE Y+ KSD++S G+ ++EL + P
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 52/295 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQ-INHR 390
TD Y +G G + + + AVK IDK++ + E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 391 HIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+I+ L + V +V E + G L I + E++
Sbjct: 77 NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFFSEREA----------------S 119
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDKFSAKVSDFGTSRSVPNDKTH 505
V + V Y+H+ + HRD+K SNIL + S ++ DFG ++ + +
Sbjct: 120 AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
L T T + PE + Y D++S GV+L +LTG P F
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP---------------F 220
Query: 566 ISLAKEN--KLLE-ILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
+ + ++L I + + + A +L L ++ +R T V
Sbjct: 221 ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 23/220 (10%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
D+Y+ LG G FG V++ G+ A K ++ E E+ +S + H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+V L + V++YE++S G L + +E ++S +R
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKV------------ADEHNKMSEDEAVEYMRQ 263
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTA 509
C+ + +MH H D+K NI+ K S K+ DFG + + ++ +
Sbjct: 264 VCK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVT 316
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT + PE + +D++S GV+ LL+G P
Sbjct: 317 T-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 73/273 (26%), Positives = 114/273 (41%), Gaps = 31/273 (11%)
Query: 287 IREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFT---AEELQRAT-DNYNQSRFL 342
+ + + L ++L + YL + S F E Q T + + Q R L
Sbjct: 133 LEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVL 192
Query: 343 GQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
G+GGFG V + G + A K + R + +NE IL ++N R +V L
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AY 251
Query: 399 CLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVA 456
ET+ + LV ++ G L HI + E R A E+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHI-----YHMGQAGFPEA----------RAVFYAAEIC 296
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ +H I +RD+K NILLDD ++SD G + VP +T GT GY
Sbjct: 297 CGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGY 351
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE ++ +YT D ++ G +L E++ G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 65/273 (23%), Positives = 111/273 (40%), Gaps = 28/273 (10%)
Query: 287 IREKRSRMLKEKLFKQNGGYLLQQRLSSCGSSEKAKIFT---AEELQRAT-DNYNQSRFL 342
R L + L + +L Q S F E Q D + R L
Sbjct: 134 ARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVL 193
Query: 343 GQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
G+GGFG V+ + G + A K + R + + + E IL++++ R IV L
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-Y 252
Query: 399 CLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVA 456
ET+ + LV ++ G + +HI++ + QE R ++
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-------------PRAIFYTAQIV 299
Query: 457 GAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGY 516
+ ++H I +RD+K N+LLDD + ++SD G + + +T GT G+
Sbjct: 300 SGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGF 355
Query: 517 FDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
PE +Y D ++ GV L E++ + P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 333 TDNYN--QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH 389
Y ++ LG G FG V+K G +A K + E+ NE+ +++Q++H
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
++++L E++ + LV EY+ G L I D + E +
Sbjct: 146 ANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIID-------ESYNLTELDTILF----- 192
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHL 506
++ CE + +MH I H D+K NIL ++ + K+ DFG +R + L
Sbjct: 193 MKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-L 245
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT + PE + +D++S GV+ LL+G P
Sbjct: 246 KVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 60/254 (23%), Positives = 106/254 (41%), Gaps = 34/254 (13%)
Query: 312 LSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAID 370
++S + L+ + +G G +G VYKG + G + A+K +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VT 60
Query: 371 KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV------LVYEYISNGTLSHHIHD 423
+ E+ E+ +L + +HR+I G ++ P LV E+ G+++ I +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 424 HQQQQEQKQELEEEQELSSLSWENRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILL 482
+ L+EE + C E+ ++++H I HRDIK N+LL
Sbjct: 121 TKGNT-----LKEEW----------IAYICREILRGLSHLHQHKVI---HRDIKGQNVLL 162
Query: 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-----YFQSSQYTDKSDVYSFG 537
+ K+ DFG S + T + GT + PE + Y KSD++S G
Sbjct: 163 TENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 538 VVLLELLTGKKPIC 551
+ +E+ G P+C
Sbjct: 222 ITAIEMAEGAPPLC 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 64/275 (23%), Positives = 108/275 (39%), Gaps = 72/275 (26%)
Query: 340 RFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRH 391
+ LG+G FG V + VAVK + ++ ++E+ IL I +H +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 392 IVKLLGCCLETEVPVLV-YEYISNGTLSHHIHDHQQ------------------------ 426
+V LLG C + P++V E+ G LS ++ +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 427 --------------------------QQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460
+++E E+ L+ E+ + + +VA +
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD-- 518
++ AS HRD+ + NILL +K K+ DFG +R + D + V+
Sbjct: 208 FL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLK 260
Query: 519 ---PEYFQSSQYTDKSDVYSFGVVLLELLT-GKKP 549
PE YT +SDV+SFGV+L E+ + G P
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 29/226 (12%)
Query: 333 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQIN 388
+ Y S+ LG+G F V + + G A K + R + + ++E+ +L
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 389 HR-HIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
++ L E + L+ EY + G + + E+ E ++ L
Sbjct: 87 SCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLC------LPELAEMVSENDVIRL--- 136
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDK 503
++ E V Y+H I H D+K NILL + K+ DFG SR + +
Sbjct: 137 --IKQILE---GVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
L + GT Y PE T +D+++ G++ LLT P
Sbjct: 189 E-LREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 46/238 (19%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------------EQFIN 379
+NY LG+G V + + P AVK ID T E +
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKI---IDVTGGGSFSAEEVQELREATLK 72
Query: 380 EVVILSQIN-HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
EV IL +++ H +I++L ET LV++ + G L ++ + E++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET----- 126
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
++ + + +H I HRD+K NILLDD + K++DFG S
Sbjct: 127 -----------RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 498 SVPNDKTHLTTAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ + L GT Y PE Y + D++S GV++ LL G P
Sbjct: 173 QLDPGEK-LREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 67/224 (29%), Positives = 102/224 (45%), Gaps = 34/224 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------EQFINEVVILSQI 387
+Y LG G FG V G G VAVK +++ +I + E+ L
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVK---ILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H HI+KL + T + +V EY+S G L +I + + E+ E
Sbjct: 74 RHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---------------E 117
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+R R+ ++ V Y H + HRD+K N+LLD +AK++DFG S ++ +D L
Sbjct: 118 SR-RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFL 172
Query: 507 TTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
T+ G+ Y PE Y + D++S GV+L LL G P
Sbjct: 173 RTSC-GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 40/232 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ---------IEQFINEVV 382
D+Y LG G F V K G A K I K + E+ EV
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVN 60
Query: 383 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
IL +I H +I+ L E + V L+ E +S G L + +K+ L E++
Sbjct: 61 ILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFL-------AEKESLTEDEA-- 110
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSR 497
+ ++ V Y+HS I H D+K NI+L DK K+ DFG +
Sbjct: 111 -------TQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT + PE ++D++S GV+ LL+G P
Sbjct: 161 KIEAGNE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 78/308 (25%), Positives = 123/308 (39%), Gaps = 50/308 (16%)
Query: 333 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ---IEQFINEVVILSQI 387
D Y Q LG+G V + L AVK I+K + EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVFREVEMLYQC 67
Query: 388 -NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
HR++++L+ E E LV+E + G++ HIH + E +
Sbjct: 68 QGHRNVLELIEFF-EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA------------- 113
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSV--- 499
V +VA A+ ++H+ I HRD+K NIL + K+ DF +
Sbjct: 114 ---SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 500 ----PNDKTHLTTAVQGTFGYFDPE-----YFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
P L T G+ Y PE ++S Y + D++S GV+L LL+G P
Sbjct: 168 GDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226
Query: 551 CLTREEEERNLVAYFISLAKENKLLE-ILDARVAKEARE-EDI-EAVAELAMGCLRLNSK 607
+ R + A +N L E I + + ++ I A +L L ++K
Sbjct: 227 -VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285
Query: 608 KRPTMKQV 615
+R + QV
Sbjct: 286 QRLSAAQV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 67/305 (21%), Positives = 106/305 (34%), Gaps = 63/305 (20%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--------RSRAIDKTQIEQFINEVVI 383
D Y S+ LG G G V VA+K A + E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
L ++NH I+K+ + E +V E + G L + +++ +E
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKE-------------- 113
Query: 444 SWENRVRVACE----VAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTS 496
+ AV Y+H I HRD+K N+LL + K++DFG S
Sbjct: 114 ------ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLT 553
+ + + T GT Y PE S Y D +S GV+L L+G P
Sbjct: 165 KILGETSL-MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP---- 218
Query: 554 REEEERNLVAYFISLAKENKLLE-ILDARVAKEARE-EDI-EAVAELAMGCLRLNSKKRP 610
F + L + I + ++ E +L L ++ K R
Sbjct: 219 -----------FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF 267
Query: 611 TMKQV 615
T ++
Sbjct: 268 TTEEA 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 49/231 (21%), Positives = 92/231 (39%), Gaps = 40/231 (17%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN-------EVVILSQ 386
Y LG+G +G V + + AVK + K ++ + N E+ +L +
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVK---ILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 387 INHRHIVKLLG-CCLETEVPV-LVYEYISNGT--LSHHIHDHQQQQEQKQELEEEQELSS 442
+ H+++++L+ E + + +V EY G + + ++
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--------PEKRFPV------ 108
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN- 501
+ C++ + Y+HS I H+DIK N+LL + K+S G + ++
Sbjct: 109 --CQAH-GYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 502 -DKTHLTTAVQGTFGYFDPEYFQSSQYTD--KSDVYSFGVVLLELLTGKKP 549
T+ QG+ + PE K D++S GV L + TG P
Sbjct: 163 AADDTCRTS-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 68/302 (22%), Positives = 107/302 (35%), Gaps = 61/302 (20%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ---------IEQFINEVV 382
D Y+ LG G F V K G A K I K + E EV
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVS 66
Query: 383 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
IL +I H +++ L E + V L+ E ++ G L + + + E++
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEA--------- 116
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSR 497
++ V Y+HS I H D+K NI+L D+ K+ DFG +
Sbjct: 117 -------TEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
+ GT + PE ++D++S GV+ LL+G P
Sbjct: 167 KIDFGNE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-------- 216
Query: 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELA----MGCLRLNSKKRPTMK 613
F+ K+ L + E +E + LA L + KKR T++
Sbjct: 217 -------FLGDTKQETLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 267
Query: 614 QV 615
Sbjct: 268 DS 269
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 70/306 (22%), Positives = 115/306 (37%), Gaps = 73/306 (23%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQIN 388
++ R +G G FG VY + + +VA+K+ S + + I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H + ++ GC L LV EY G+ S + H++ L+E +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP------LQEVE---------- 155
Query: 449 VRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT 507
+ +AY+HS I HRD+K+ NILL + K+ DFG++ + +
Sbjct: 156 IAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--- 209
Query: 508 TAVQGTFGYFDPE---YFQSSQYTDKSDVYSFGVVLLELLTGKKP--------------- 549
GT + PE QY K DV+S G+ +EL K P
Sbjct: 210 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267
Query: 550 --------------------ICLTREEEER----NLVAY-FISLAKENKLLEILDARVAK 584
CL + ++R L+ + F+ + ++ L R
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 327
Query: 585 EAREED 590
RE D
Sbjct: 328 AVRELD 333
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 40/232 (17%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ---------IEQFINEVV 382
D Y+ LG G F V K G A K I K Q E+ EV
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVS 67
Query: 383 ILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
IL Q+ H +++ L E V L+ E +S G L + ++E E+E +
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL--------AQKESLSEEEAT 118
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSR 497
S ++ + V Y+H+ I H D+K NI+L DK K+ DFG +
Sbjct: 119 SF-----IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 498 SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ + GT + PE ++D++S GV+ LL+G P
Sbjct: 168 EIEDGVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRA-IDKTQIEQFINEV-VILSQINHRHIVKLLGC 398
+G G G V+K G ++AVK+ R +K + ++ + ++ V+L + +IV+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 399 CL-ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAG 457
+ T+V + E + GT + + ++ + + E L ++ +
Sbjct: 93 FITNTDV-FIAMELM--GTCAEKL-----KKRMQGPIPERI----LG-----KMTVAIVK 135
Query: 458 AVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYF 517
A+ Y+ + HRD+K SNILLD++ K+ DFG S + +DK +A G Y
Sbjct: 136 ALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYM 191
Query: 518 DPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPIC 551
PE Y ++DV+S G+ L+EL TG+ P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 61/241 (25%), Positives = 95/241 (39%), Gaps = 53/241 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI-----------EQFINE 380
Y+ +G+G V + + G AVK ++ T E E
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKI---MEVTAERLSPEQLEEVREATRRE 149
Query: 381 VVILSQI-NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
IL Q+ H HI+ L+ E+ + LV++ + G L ++ +K L E
Sbjct: 150 THILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYL-------TEKVALSE-- 199
Query: 439 ELSSLSWENRVRVACEV----AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
+ + AV+++H+ I HRD+K NILLDD ++SDFG
Sbjct: 200 -----------KETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245
Query: 495 TSRSVPNDKTHLTTAVQGTFGYFDPE------YFQSSQYTDKSDVYSFGVVLLELLTGKK 548
S + + L GT GY PE Y + D+++ GV+L LL G
Sbjct: 246 FSCHLEPGEK-LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303
Query: 549 P 549
P
Sbjct: 304 P 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 62/236 (26%), Positives = 91/236 (38%), Gaps = 44/236 (18%)
Query: 327 EELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI--EQFINEVVI 383
+ +D Y+ + +G G FG +VAVK I++ E E++
Sbjct: 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK---YIERGAAIDENVQREIIN 69
Query: 384 LSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE----- 437
+ H +IV+ + T + ++ EY S G L I E+
Sbjct: 70 HRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERI-------CNAGRFSEDEARFF 121
Query: 438 -QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFG 494
Q+L S V+Y HS I HRD+K N LLD + K+ DFG
Sbjct: 122 FQQLLS---------------GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
S+S + V GT Y PE +Y +DV+S GV L +L G P
Sbjct: 164 YSKSSVLHS-QPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 50/225 (22%), Positives = 89/225 (39%), Gaps = 32/225 (14%)
Query: 334 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
+++ + LG+G F TV A+K + I + ++ E ++S+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
++H VKL + E Y NG L + + + E
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY-------------IRKIGSFD----E 129
Query: 447 NRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
R E+ A+ Y+H I HRD+K NILL++ +++DFGT++ + +
Sbjct: 130 TCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 186
Query: 506 LTTA-VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE SD+++ G ++ +L+ G P
Sbjct: 187 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 58/228 (25%), Positives = 89/228 (39%), Gaps = 32/228 (14%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK------RSRAIDKTQIEQFINEVVILS 385
D Y+ LG G F V K G A K + E+ EV IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
Q+ H +I+ L VL+ E +S G L + ++E E+E +S
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--------AQKESLSEEEATSF-- 120
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----KVSDFGTSRSVPN 501
++ + V Y+H+ I H D+K NI+L DK K+ DFG + + +
Sbjct: 121 ---IKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT + PE ++D++S GV+ LL+G P
Sbjct: 172 GVE-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 67/299 (22%), Positives = 114/299 (38%), Gaps = 56/299 (18%)
Query: 333 TDNYNQSR-FLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NH 389
TD+Y S+ LG G G V + G A+K + + + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYDSPKAR--QEVDHHWQASGG 81
Query: 390 RHIVKLLGCCLETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
HIV +L ++ E + G L I QE+ + E+E + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI------QERGDQAFTEREAAEI-- 133
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---FSAKVSDFGTSRSVPND 502
+R ++ A+ ++HS I HRD+K N+L K K++DFG ++ +
Sbjct: 134 ---MR---DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
L T T Y PE +Y D++S GV++ LL G P + +
Sbjct: 185 A--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM 241
Query: 563 AYFISLAKENKLLEILD------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
I L + + V+++A+ +L L+ + +R T+ Q
Sbjct: 242 KRRIRLGQ-------YGFPNPEWSEVSEDAK--------QLIRLLLKTDPTERLTITQF 285
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQI------EQFINEVVILSQI 387
Y LG+G FG V VA+K I + + + E+ L +
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLL 66
Query: 388 NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
H HI+KL + T + +V EY G L +I + ++ E E
Sbjct: 67 RHPHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED---------------E 109
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
R R ++ A+ Y H I HRD+K N+LLDD + K++DFG S ++ D L
Sbjct: 110 GR-RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFL 164
Query: 507 TTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKP 549
T+ G+ Y PE Y + DV+S G+VL +L G+ P
Sbjct: 165 KTSC-GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQIN- 388
++++ R +G+GGFG VY D G + A+K + R K +NE ++LS ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 389 --HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
IV + T + + + ++ G L +H+ H E
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---------------- 291
Query: 446 ENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
+R A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K
Sbjct: 292 -ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 505 HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKP 549
H +V GT GY PE Q Y +D +S G +L +LL G P
Sbjct: 348 H--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 340 RFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
R +G+G FG V D + A+K + + +++ ++ E+ I+ + H +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-ACE 454
+ E +V + + G L +H+ QQ + E V++ CE
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFK------------EETVKLFICE 123
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTF 514
+ A+ Y+ + I HRD+K NILLD+ ++DF + +P + T A GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTK 178
Query: 515 GYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKP 549
Y PE F S + Y+ D +S GV ELL G++P
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 70/300 (23%), Positives = 114/300 (38%), Gaps = 57/300 (19%)
Query: 333 TDNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NH 389
D+Y S+ LG G G V + A+K + + EV + +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---LQD--CPKARREVELHWRASQC 114
Query: 390 RHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
HIV+++ E +V E + G L I Q++ + E+E S +
Sbjct: 115 PHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEI- 166
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPN 501
++ + A+ Y+HS I I HRD+K N+L K K++DFG ++ +
Sbjct: 167 ----MK---SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
+ LTT T Y PE +Y D++S GV++ LL G P
Sbjct: 217 HNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP------------ 262
Query: 562 VAYFIS---LAKENKLLE-ILDARVAKEARE-EDI-EAVAELAMGCLRLNSKKRPTMKQV 615
F S LA + I + E ++ E V L L+ +R T+ +
Sbjct: 263 ---FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 28/214 (13%), Positives = 59/214 (27%), Gaps = 57/214 (26%)
Query: 342 LGQGGFGTVYKGMLPD---GSIVAVK---RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
G ++ + D VA+ + +++ ++ + LS+I+ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEV 455
L ++V E+I G+L S +R +
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS------------------PSPVGAIRAMQSL 138
Query: 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG 515
A A H A + S + + ++ T
Sbjct: 139 AAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPDA---------------- 179
Query: 516 YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+P+ D+ G L LL + P
Sbjct: 180 --NPQ----------DDIRGIGASLYALLVNRWP 201
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 56/248 (22%), Positives = 97/248 (39%), Gaps = 55/248 (22%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQ----------------- 373
Y +G+G +G V D + A+K + + I +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 374 ------IEQFINEVVILSQINHRHIVKL---LGCCLETEVPVLVYEYISNGTLSHHIHDH 424
IEQ E+ IL +++H ++VKL L E + +V+E ++ G +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVP--- 129
Query: 425 QQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484
+ L E+Q ++ + Y+H I HRDIK SN+L+ +
Sbjct: 130 -----TLKPLSEDQA---------RFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGE 172
Query: 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YT-DKSDVYSFGVVLL 541
K++DFG S L+ V GT + PE ++ ++ DV++ GV L
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231
Query: 542 ELLTGKKP 549
+ G+ P
Sbjct: 232 CFVFGQCP 239
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 334 DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
++Y + +G+G FG V K + A+K + I ++ F E I++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
N +V+L + +V EY+ G L + + ++ E+
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--------SNYDVPEK--------- 168
Query: 447 NRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
R EV A+ +HS + HRD+K N+LLD K++DFGT + +
Sbjct: 169 -WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224
Query: 506 LTTAVQGTFGYFDPEYFQS----SQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE +S Y + D +S GV L E+L G P
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 48/235 (20%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFIN-EVVILSQINHR 390
+Y ++ +G G FG VY+ L G +VA+K+ Q ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHC 107
Query: 391 HIVKLLGCCLET-----EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------- 437
+IV+L + EV + LV +Y+ T+ + + KQ L
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMY 163
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTS 496
Q SL AY+HS I HRDIK N+LLD D K+ DFG++
Sbjct: 164 QLFRSL----------------AYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ + + + + + Y PE F ++ YT DV+S G VL ELL G +PI
Sbjct: 205 KQLVRGEP-NVSYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 55/247 (22%), Positives = 95/247 (38%), Gaps = 41/247 (16%)
Query: 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK---RSRAIDKT 372
+ + +E++ D++ + +G+G F V K G + A+K + + +
Sbjct: 47 EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRG 103
Query: 373 QIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQK 431
++ F E +L + R I +L + E + LV EY G L + K
Sbjct: 104 EVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--------SK 154
Query: 432 QELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490
+ + R E+ A+ +H + HRDIK NILLD ++
Sbjct: 155 ----FGERIP----AEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRL 203
Query: 491 SDFGTS-RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVY-------SFGVVLLE 542
+DFG+ + + AV GT Y PE Q+ + Y + GV E
Sbjct: 204 ADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262
Query: 543 LLTGKKP 549
+ G+ P
Sbjct: 263 MFYGQTP 269
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 35/227 (15%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQF--------INEV 381
Q + Y + +G+G +G VYK G IVA+KR R ++ I E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREI 70
Query: 382 VILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
+L +++H +IV L+ LV+E++ D ++ ++ + ++ ++
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFME--------KDLKKVLDENKTGLQDSQIK 122
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
++ + VA+ H I HRD+K N+L++ + K++DFG +R+
Sbjct: 123 IYLYQ--------LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
Query: 502 DKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
T V T Y P+ S +Y+ D++S G + E++TGK
Sbjct: 172 PVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 46/238 (19%)
Query: 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFIN-EVVIL 384
+ ++ Y + +G G FG V++ L + VA+K+ Q ++F N E+ I+
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL-----QDKRFKNRELQIM 86
Query: 385 SQINHRHIVKLLGCCLET-----EVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE- 437
+ H ++V L EV + LV EY+ T+ + + KQ +
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK---LKQTMPMLL 142
Query: 438 ------QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKV 490
Q L SL AY+HS I HRDIK N+LLD K+
Sbjct: 143 IKLYMYQLLRSL----------------AYIHSIG---ICHRDIKPQNLLLDPPSGVLKL 183
Query: 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
DFG+++ + + +++ + Y PE F ++ YT D++S G V+ EL+ G+
Sbjct: 184 IDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 48/227 (21%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF--------INEVVIL 384
Y + +G+G +GTV+K IVA+KR R ++ + E+ +L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
++ H++IV+L + LV+E+ D ++ + + + + S
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD--------QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
++ + + + HS + HRD+K N+L++ K+++FG +R+
Sbjct: 108 FQ--------LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156
Query: 505 HLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
+ V T Y P+ F + Y+ D++S G + EL +P+
Sbjct: 157 CYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 58/247 (23%), Positives = 104/247 (42%), Gaps = 39/247 (15%)
Query: 319 EKAKIFTAE--ELQRATDNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK---RSRAI 369
E AK FT++ +++ +++ + +G+G FG V K + A+K + +
Sbjct: 57 EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEML 113
Query: 370 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQ 428
+ + F E +L + + I L + + + LV +Y G L + +
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL----SKF 168
Query: 429 EQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487
E + E R E+ A+ +H + HRDIK NIL+D
Sbjct: 169 EDRLP------------EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGH 213
Query: 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLE 542
+++DFG+ + D T ++ GT Y PE Q+ + Y + D +S GV + E
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 543 LLTGKKP 549
+L G+ P
Sbjct: 274 MLYGETP 280
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 59/243 (24%), Positives = 107/243 (44%), Gaps = 35/243 (14%)
Query: 325 TAEELQRATDNYNQSRF-LGQGGFGTVYKGM---LPDGSIVAVKRSRA--IDKTQIEQFI 378
+ E +R D + +G+G +G VYK D A+K+ I +
Sbjct: 11 LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR--- 67
Query: 379 NEVVILSQINHRHIVKLLGCCLE-TEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELE- 435
E+ +L ++ H +++ L L + V L+++Y + L H I H+ + K+ ++
Sbjct: 68 -EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----KVS 491
+ SL ++ + + Y+H+ + HRD+K +NIL+ + K++
Sbjct: 126 PRGMVKSLLYQ--------ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174
Query: 492 DFGTSR--SVPNDK-THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
D G +R + P L V TF Y PE + YT D+++ G + ELLT
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-S 232
Query: 548 KPI 550
+PI
Sbjct: 233 EPI 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 4e-22
Identities = 58/232 (25%), Positives = 101/232 (43%), Gaps = 33/232 (14%)
Query: 326 AEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN----- 379
A +++ Y + FLG+G F TVYK IVA+K+ + +++ + IN
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
E+ +L +++H +I+ LL LV++++ D + + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--------TDLEVIIKDNSLVLTPSH 113
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-- 497
+ + + Y+H I HRD+K +N+LLD+ K++DFG ++
Sbjct: 114 IKAYML--------MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162
Query: 498 SVPNDK-THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
PN TH V T Y PE F + Y D+++ G +L ELL
Sbjct: 163 GSPNRAYTHQ--VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 60/224 (26%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
D +++ + LG G FG V ML G+ A+K + + + QIE +NE IL
Sbjct: 41 DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+N +VKL + +V EY++ G + H L S E
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH-------------LRRIGRFS----E 140
Query: 447 NRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
R A ++ Y+HS + +RD+K N+L+D + +V+DFG ++ V
Sbjct: 141 PHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T + GT PE S Y D ++ GV++ E+ G P
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 55/222 (24%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQF----INEVVILSQIN 388
+ Y + LG+G + TVYKG ++VA+K R + E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H +IV L + LV+EY+ D +Q + + + ++
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLD--------KDLKQYLDDCGNIINMHNVKLFLFQ-- 108
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHL 506
+ +AY H + HRD+K N+L++++ K++DFG +R S+P
Sbjct: 109 ------LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--Y 157
Query: 507 TTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
V T Y P+ S+ Y+ + D++ G + E+ TG+
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
+ + + LG+G FG V G A+K + + K ++ + E +L H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 390 RHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+ L +T + V EY + G L H+ +E+ E+R
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFS------------EDR 249
Query: 449 VRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHL 506
R E+ A+ Y+HS ++ +RD+K N++LD K++DFG + + + T
Sbjct: 250 ARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 305
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 306 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQINH 389
+ Y+ +G+G +G VYK G A+K+ R ++K E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-LEKED-EGIPSTTIREISILKELKH 59
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+IVKL + VLV+E++ D ++ + + E S +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD--------QDLKKLLDVCEGGLESVTAKSFLLQ--- 108
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDKTHLT 507
+ +AY H + HRD+K N+L++ + K++DFG +R +P K T
Sbjct: 109 -----LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YT 158
Query: 508 TAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
+ T Y P+ S +Y+ D++S G + E++ G
Sbjct: 159 HEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR------AIDKTQIEQFINEVVILSQ 386
+ Y + +G+G +G V+K G IVA+K+ I K + E+ +L Q
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR----EIRMLKQ 58
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+ H ++V LL LV+EY H + ++ Q E + S++W+
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCD--------HTVLHELDRYQRGVPEHLVKSITWQ 110
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
AV + H HRD+K NIL+ K+ DFG +R + +
Sbjct: 111 --------TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159
Query: 507 TTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
V T Y PE +QY DV++ G V ELL+G
Sbjct: 160 DDEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 7e-21
Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 30/225 (13%)
Query: 332 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILSQ 386
++ + Q LG G + TVYKG+ G VA+K + +D E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSE--EGTPSTAIREISLMKE 59
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+ H +IV+L LV+E++ +D ++ + + + L
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMD--------NDLKKYMDSRTVGNTPRGLE----L 107
Query: 447 NRVRVAC-EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPNDK 503
N V+ ++ +A+ H I HRD+K N+L++ + K+ DFG +R +P +
Sbjct: 108 NLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164
Query: 504 THLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
++ V T Y P+ S Y+ D++S G +L E++TGK
Sbjct: 165 --FSSEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 342 LGQGGFGTVY---KGMLPD-GSIVAVKRSRAIDKTQIEQFINEVV-------ILSQINHR 390
LG+GG+G V+ K + G I A+K + K I + + IL ++ H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMK---VLKKAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 391 HIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
IV L+ +T + L+ EY+S G L + ++E E+
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-----EREGIFM------------EDTA 123
Query: 450 RV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLT 507
E++ A+ ++H I +RD+K NI+L+ + K++DFG + S+ + T
Sbjct: 124 CFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--T 178
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE S + D +S G ++ ++LTG P
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 342 LGQGGFGTVY---KGMLPD-GSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKL 395
LGQG FG V+ K D + A+K + + + E IL ++NH IVKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 396 LGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV-AC 453
+TE + L+ +++ G L + +E E V+
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFT------------EEDVKFYLA 133
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQG 512
E+A A+ ++HS I +RD+K NILLD++ K++DFG S+ S+ ++K + G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCG 188
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T Y PE +T +D +SFGV++ E+LTG P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 43/250 (17%)
Query: 321 AKIFTAEELQ--RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF 377
AK + + E Y + +GQG FG V+K G VA+K+ ++ + E F
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEK-EGF 59
Query: 378 ----INEVVILSQINHRHIVKLLGCCLETEVPV--------LVYEYISNGTLSHHIHDHQ 425
+ E+ IL + H ++V L+ C P LV+++ HD
Sbjct: 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLA 111
Query: 426 QQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485
E+ + + + Y+H I HRD+K++N+L+
Sbjct: 112 GLLSNVLVKFTLSEIKRVMQM--------LLNGLYYIHRNK---ILHRDMKAANVLITRD 160
Query: 486 FSAKVSDFGTSRS----VPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVL 540
K++DFG +R+ + T V T Y PE Y D++ G ++
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIM 219
Query: 541 LELLTGKKPI 550
E+ T + PI
Sbjct: 220 AEMWT-RSPI 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 38/230 (16%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQF----INEVVILS 385
+ D Y + LG+G +G VYK + VA+KR R ++ + E I EV +L
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEE-EGVPGTAIREVSLLK 88
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
++ HR+I++L L++EY +D ++ ++ ++ + S +
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMR-VIKSFLY 139
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA-----KVSDFGTSR--S 498
+ + V + HS HRD+K N+LL ++ K+ DFG +R
Sbjct: 140 Q--------LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
Query: 499 VPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
+P + T + T Y PE S Y+ D++S + E+L
Sbjct: 189 IPIRQ--FTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 54/227 (23%), Positives = 93/227 (40%), Gaps = 36/227 (15%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR------AIDKTQIEQFINEVVI 383
++ + Y +G+G +G V K G IVA+K+ + K + E+ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR----EIKL 77
Query: 384 LSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
L Q+ H ++V LL C + + LV+E++ H E + Q +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVD--------HTILDDLELFPNGLDYQVVQKY 129
Query: 444 SWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR--SVPN 501
++ + + + HS I HRDIK NIL+ K+ DFG +R + P
Sbjct: 130 LFQ--------IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178
Query: 502 DKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
+ V T Y PE +Y DV++ G ++ E+ G+
Sbjct: 179 EV--YDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
++ R LG G FG V L +G A+K + + Q+E +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+ H I+++ G + + ++ +YI G L + ++ Q+
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----RKSQRFP------------N 105
Query: 447 NRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH 505
+ A EV A+ Y+HS I +RD+K NILLD K++DFG ++ VP D T+
Sbjct: 106 PVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY 161
Query: 506 LTTAVQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T G Y PE + Y D +SFG+++ E+L G P
Sbjct: 162 -------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 38/233 (16%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSR-AIDKTQIEQF----INEVVIL 384
AT Y +G G +GTVYK G VA+K R + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 385 SQIN---HRHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
++ H ++V+L+ C + LV+E++ L ++ L
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-----LPA 119
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
E + L + + ++H+ I HRD+K NIL+ + K++DFG +
Sbjct: 120 ET-IKDLMRQ--------FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA 167
Query: 497 R--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
R S T + T Y PE S Y D++S G + E+ K
Sbjct: 168 RIYSYQMALTPVVV----TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 53/240 (22%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKR--SRAIDKTQIEQFINEVVILSQ 386
++ D + R GQG FGTV G G VA+K+ + + Q + + L+
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD---LAV 75
Query: 387 INHRHIVKLLGCCLETEVP-------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEE-- 437
++H +IV+L +V EY+ + TL ++ ++ +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILI 131
Query: 438 -----QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVS 491
Q + S+ +H S+ + HRDIK N+L++ + K+
Sbjct: 132 KVFLFQLIRSI----------------GCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLC 174
Query: 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
DFG+++ + + ++ + Y PE F + YT D++S G + E++ G +PI
Sbjct: 175 DFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
++++ + LG+G FG V +L G A+K + I K ++ + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 387 INHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
H + L +T + V EY + G L H+ +E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFT------------ 103
Query: 446 ENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDK 503
E R R E+ A+ Y+HS + +RDIK N++LD K++DFG + + +
Sbjct: 104 EERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T GT Y PE + + Y D + GVV+ E++ G+ P
Sbjct: 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 40/233 (17%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSRAIDKTQIEQF----INEVVIL 384
RA Y +G+G +G V+K + G VA+KR R + + E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGE-EGMPLSTIREVAVL 65
Query: 385 SQIN---HRHIVKLLGCCLETEVP-----VLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
+ H ++V+L C + LV+E++ L+ ++ +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV------PEPGVP 118
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
+ + + ++ + + ++HS + HRD+K NIL+ K++DFG +
Sbjct: 119 TETIKDMMFQ--------LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 497 R--SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
R S T + T Y PE S Y D++S G + E+ K
Sbjct: 168 RIYSFQMALTSVVV----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 47/231 (20%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHR 390
D+Y R LG+G + V++ + + + V VK + + K +I E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 391 HIVKLLGCCL--ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEE-------QELS 441
+I+ L + P LV+E+++N Q L + + L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILK 141
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVP 500
A+ Y HS I HRD+K N+++D + ++ D+G +
Sbjct: 142 ----------------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182
Query: 501 NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPI 550
+ V + + PE Q D S D++S G +L ++ K+P
Sbjct: 183 PGQE-YNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 61/250 (24%), Positives = 105/250 (42%), Gaps = 57/250 (22%)
Query: 316 GSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSRA 368
G+ + + +++ R +G+G + V +L I A+K +
Sbjct: 1 GAMDPLGL----------QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELV 47
Query: 369 IDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQ 426
D I+ E + Q NH +V L C +TE + V EY++ G L H+
Sbjct: 48 NDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM----- 101
Query: 427 QQEQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485
Q+++K E R + E++ A+ Y+H I +RD+K N+LLD +
Sbjct: 102 QRQRKLP------------EEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSE 146
Query: 486 FSAKVSDFGTSRS--VPNDKTHLTTAVQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVV 539
K++D+G + P D T TF G Y PE + Y D ++ GV+
Sbjct: 147 GHIKLTDYGMCKEGLRPGDTTS-------TFCGTPNYIAPEILRGEDYGFSVDWWALGVL 199
Query: 540 LLELLTGKKP 549
+ E++ G+ P
Sbjct: 200 MFEMMAGRSP 209
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 53/247 (21%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFIN-EVVILSQINHR 390
+ Y+ + LG G FG V + + G A+K+ Q ++ N E+ I+ ++H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKVLDHV 60
Query: 391 HIVKLLGC---CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQEL------- 440
+I+KL+ + E N + + + + + L
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 441 -SSLSWENRVRVACEVAG-----------------AVAYMHSAASIPIFHRDIKSSNILL 482
+L +V + +G AV ++HS I HRDIK N+L+
Sbjct: 121 PDTLH---KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLV 174
Query: 483 D-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVL 540
+ + K+ DFG+++ + + + + Y PE +++YT D++S G V
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 541 LELLTGK 547
EL+ GK
Sbjct: 233 GELILGK 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 334 DNYNQSRFLGQGGFGTVY---KGMLPD-GSIVAVK--RSRAI--DKTQIEQFINEVVILS 385
+N+ + LG G +G V+ K D G + A+K + I E E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 386 QINHRH-IVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
I +V L +TE + L+ +YI+ G L H+ Q ++
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL-----SQRERFT---------- 157
Query: 444 SWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
E+ V++ E+ A+ ++H I +RDIK NILLD ++DFG S+ D
Sbjct: 158 --EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQY-TDKS-DVYSFGVVLLELLTGKKP 549
+T GT Y P+ + DK+ D +S GV++ ELLTG P
Sbjct: 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 8e-19
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 47/224 (20%)
Query: 342 LGQGGFGTVY----KGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQI-NHRHIV 393
+G+G + V K I A++ + D I+ E + Q NH +V
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 451
L C +TE + V EY++ G L H+ Q+++K E R
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHM-----QRQRKLP------------EEHARFY 158
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS--VPNDKTHLTTA 509
+ E++ A+ Y+H I +RD+K N+LLD + K++D+G + P D T
Sbjct: 159 SAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---- 211
Query: 510 VQGTF-G---YFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
TF G Y PE + Y D ++ GV++ E++ G+ P
Sbjct: 212 ---TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 72/249 (28%), Positives = 109/249 (43%), Gaps = 41/249 (16%)
Query: 316 GSSEKAKIFTAEELQRAT----DNYNQSRFLGQGGFGTVY----KGMLPDGSIVAVK--- 364
G E +K + + DN+ R LG+G FG V K G + AVK
Sbjct: 1 GPKESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLK 57
Query: 365 RSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIH 422
+ + +E + E ILS NH + +L CC +T + V E+++ G L HI
Sbjct: 58 KDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI- 115
Query: 423 DHQQQQEQKQELEEEQELSSLSWENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481
Q+ ++ + E R R A E+ A+ ++H I +RD+K N+L
Sbjct: 116 ----QKSRRFD------------EARARFYAAEIISALMFLHDKG---IIYRDLKLDNVL 156
Query: 482 LDDKFSAKVSDFGTSR-SVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 540
LD + K++DFG + + N T T GT Y PE Q Y D ++ GV+L
Sbjct: 157 LDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 541 LELLTGKKP 549
E+L G P
Sbjct: 215 YEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 37/219 (16%)
Query: 342 LGQGGFGTVYKGML----PDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ-INHRHIV 393
+G+G FG V +L + AVK + + K + + ++E +L + + H +V
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 451
L +T + V +YI+ G L +H+ Q+E+ E R R
Sbjct: 103 GLH-FSFQTADKLYFVLDYINGGELFYHL-----QRERCFL------------EPRARFY 144
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS-RSVPNDKTHLTTAV 510
A E+A A+ Y+HS I +RD+K NILLD + ++DFG ++ ++ T T+
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTF 199
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE Y D + G VL E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/239 (22%), Positives = 85/239 (35%), Gaps = 52/239 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKR--SRAIDKTQIEQFIN---------EV 381
Y RF+ G +G V G+ +G VA+KR + D + + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 382 VILSQINHRHIVKLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
+L+ +H +I+ L + E P LV E + T + Q+ +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRI-----VISP 133
Query: 437 E-------QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489
+ L L +H A + HRD+ NILL D
Sbjct: 134 QHIQYFMYHILLGL----------------HVLHEAG---VVHRDLHPGNILLADNNDIT 174
Query: 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
+ DF +R D + T V Y PE Q +T D++S G V+ E+ K
Sbjct: 175 ICDFNLAREDTAD-ANKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 60/296 (20%), Positives = 98/296 (33%), Gaps = 77/296 (26%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIV 393
S+ LG G G V + A+K + + EV + + HIV
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQD--CPKARREVELHWRASQCPHIV 74
Query: 394 KLLGCCLETEVPV-----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+++ E +V E + G L I Q++ + E+E S +
Sbjct: 75 RIVDVY-ENLYAGRKCLLIVMECLDGGELFSRI------QDRGDQAFTEREASEI----- 122
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA---KVSDFGTSRSVPNDKTH 505
++ + A+ Y+HS I HRD+K N+L K K++DFG
Sbjct: 123 MK---SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG----------- 165
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
F E Y D++S GV++ LL G P F
Sbjct: 166 -----------FAKETTGEK-YDKSCDMWSLGVIMYILLCGYPP---------------F 198
Query: 566 IS---LAKENKLLE-ILDARVAKEARE-EDIEAVA-ELAMGCLRLNSKKRPTMKQV 615
S LA + I + E ++ L L+ +R T+ +
Sbjct: 199 YSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 37/227 (16%)
Query: 334 DNYNQSRFLGQGGFGTV----YKGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ 386
++N LG+G FG V KG + AVK + I +E + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 387 I-NHRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+ +L C +T + V EY++ G L +HI QQ + +
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK----------- 119
Query: 445 WENRVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPND 502
E A E+A + ++ S I +RD+K N++LD + K++DFG + ++ +
Sbjct: 120 -EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T T GT Y PE Y D ++FGV+L E+L G+ P
Sbjct: 176 VT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 47/231 (20%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQINH 389
Y + +G G G V VA+K+ SR + E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 390 RHIVKLL-----GCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------ 437
++I+ LL LE V +V E + + + EL+ E
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQV--------IQMELDHERMSYLL 133
Query: 438 -QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
Q L + ++HSA I HRD+K SNI++ + K+ DFG +
Sbjct: 134 YQMLC----------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
R+ +T V T Y PE Y + D++S G ++ E++ G
Sbjct: 175 RTAGTS-FMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 8e-18
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVVILSQIN- 388
++N LG+G FG V + AVK + I +E + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 389 HRHIVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
+ +L C +T + V EY++ G L +HI QQ + + E
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGRFK------------EP 442
Query: 448 RVRV-ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTH 505
A E+A + ++ S I +RD+K N++LD + K++DFG + ++ + T
Sbjct: 443 HAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 498
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
T GT Y PE Y D ++FGV+L E+L G+ P
Sbjct: 499 -TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 62/349 (17%), Positives = 124/349 (35%), Gaps = 100/349 (28%)
Query: 334 DNYNQSRF-----LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI 387
+ Y +R+ LG G F TV+ + + + VA+K R E +E+ +L ++
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRV 72
Query: 388 N-----------HRHIVKLLGC-----------CLETEVPVLVYEYISNGTLSHHIHDHQ 425
N HI+KLL + EV L ++
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV------------LGENLLALI 120
Query: 426 QQQEQKQELEEEQELSSLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484
++ E + + V+ ++ ++ + YMH I I H DIK N+L++
Sbjct: 121 KKYEH-------RGIPL----IYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEI 167
Query: 485 ------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGV 538
K++D G + H T ++Q Y PE + + +D++S
Sbjct: 168 VDSPENLIQIKIADLGNACWYDE---HYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTAC 223
Query: 539 VLLELLTGK------KPICLTREEE---------------------------ERNLVAYF 565
++ EL+TG + T++++ +
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283
Query: 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
IS K L ++L + +++ + +++ L+L+ +KR
Sbjct: 284 ISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 342 LGQGGFGTV----YKGMLPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQ-INHRHIV 393
LG+G FG V +K A+K + + +E + E +LS H +
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV- 451
+ C +T+ + V EY++ G L +HI Q K + +R
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFD------------LSRATFY 123
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR-SVPNDKTHLTTAV 510
A E+ + ++HS I +RD+K NILLD K++DFG + ++ D T
Sbjct: 124 AAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTF 178
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
GT Y PE +Y D +SFGV+L E+L G+ P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQINH 389
Y + +G G G V VA+K+ SR + E+V++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 390 RHIVKLL-----GCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSL 443
++I+ LL LE V LV E + + + EL+ E
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQV--------IQMELDHE------ 164
Query: 444 SWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
R+ + ++ + ++HSA I HRD+K SNI++ + K+ DFG +R+
Sbjct: 165 ----RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
+T V T Y PE Y + D++S G ++ E++ K
Sbjct: 218 -FMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 56/258 (21%), Positives = 98/258 (37%), Gaps = 51/258 (19%)
Query: 309 QQRLSSCGSSEKAKIF-TAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRS 366
+++ ++ + ++ Y ++G+G +G V + VA+K+
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI 60
Query: 367 RAIDKTQIEQFI-NEVVILSQINHRHIVKLLGCCLETEVPV-----LVYEYISNGTLSHH 420
+ Q E+ IL + H +I+ + + +V + + T +
Sbjct: 61 SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYK 118
Query: 421 IHDHQQQQEQKQELEEE-------QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHR 473
+ + Q L + Q L L Y+HSA + HR
Sbjct: 119 L-------LKTQHLSNDHICYFLYQILRGL----------------KYIHSAN---VLHR 152
Query: 474 DIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEY-FQSSQYTD 529
D+K SN+LL+ K+ DFG +R D H LT V T Y PE S YT
Sbjct: 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTK 211
Query: 530 KSDVYSFGVVLLELLTGK 547
D++S G +L E+L+ +
Sbjct: 212 SIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 50/232 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQINH 389
Y +G G +G+V + G VA+K+ SR + E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 390 RHIVKLLGCCLETEVPV------LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------ 437
+++ LL LV ++ T I + EE
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKI--------MGLKFSEEKIQYLV 132
Query: 438 -QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
Q L L Y+HSA + HRD+K N+ +++ K+ DFG +
Sbjct: 133 YQMLKGL----------------KYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLELLTGK 547
R + T T Y PE Y D++S G ++ E+LTGK
Sbjct: 174 RHADAEMTGYVV----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 56/244 (22%), Positives = 85/244 (34%), Gaps = 62/244 (25%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFI-NEVVILSQINHR 390
+ ++ LG+G +G V P G IVA+K+ DK E+ IL H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 391 HIVKLLGCCLETEVPV-----LVYEY--------ISNGTLSHHIHDHQQ----QQEQKQE 433
+I+ + ++ E IS LS DH Q Q
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQ------ 120
Query: 434 LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493
AV +H + + HRD+K SN+L++ KV DF
Sbjct: 121 -----------------TLR----AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF 156
Query: 494 GTSRSVPNDKTHLTTAVQGTFG---------YFDPEY-FQSSQYTDKSDVYSFGVVLLEL 543
G +R + + G Y PE S++Y+ DV+S G +L EL
Sbjct: 157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 544 LTGK 547
+
Sbjct: 217 FLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQINH 389
Y + +G G +G V + G+ VA+K+ R + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 390 RHIVKLLGCCLETEVPV------LVYEYISNGTLSHHIHDHQQQQEQKQELEEE------ 437
+++ LL E LV ++ GT + + ++L E+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKL-------MKHEKLGEDRIQFLV 134
Query: 438 -QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
Q L L Y+H+A I HRD+K N+ +++ K+ DFG +
Sbjct: 135 YQMLKGL----------------RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEY-FQSSQYTDKSDVYSFGVVLLELLTGK 547
R ++ +T V T Y PE +YT D++S G ++ E++TGK
Sbjct: 176 RQADSE---MTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 62/245 (25%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQIN 388
Y + LG GG G V+ + VA+K+ + + E+ I+ +++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66
Query: 389 HRHIVKLL------GCCLETEVPV--------LVYEYISNGTLSHHIHDHQQQQEQKQEL 434
H +IVK+ G L +V +V EY+ T ++ ++ L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANV-------LEQGPL 117
Query: 435 EEE-------QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF- 486
EE Q L L Y+HSA + HRD+K +N+ ++ +
Sbjct: 118 LEEHARLFMYQLLRGL----------------KYIHSAN---VLHRDLKPANLFINTEDL 158
Query: 487 SAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPE-YFQSSQYTDKSDVYSFGVVLLE 542
K+ DFG +R + +H L+ + T Y P + YT D+++ G + E
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 543 LLTGK 547
+LTGK
Sbjct: 218 MLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 51/255 (20%), Positives = 87/255 (34%), Gaps = 66/255 (25%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQINH 389
DNY +G+G +G VY VA+K+ +R + + I E+ IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 390 RHIVKLLGCCLETEVPV-----LVYEYISNGT-LSHHIHDHQQQQEQKQELEEE------ 437
+I++L + ++ +V E + L L EE
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFK-------TPIFLTEEHIKTIL 135
Query: 438 -QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
L ++H + I HRD+K +N LL+ S KV DFG +
Sbjct: 136 YNLLL----------------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 497 RSVPNDKTHLTTAVQGTFGYFDP----------EY------------FQSSQYTDKSDVY 534
R++ ++K P + YT D++
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236
Query: 535 SFGVVLLELLTGKKP 549
S G + ELL +
Sbjct: 237 STGCIFAELLNMLQS 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 61/252 (24%), Positives = 100/252 (39%), Gaps = 53/252 (21%)
Query: 317 SSEKAKIFTAEELQRA----TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAID 370
S++ F +EL + + Y +G G +G+V G VAVK+ SR
Sbjct: 8 HSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ 67
Query: 371 KTQIEQFI-NEVVILSQINHRHIVKLLGCCLETEVPV------LVYEYISNGTLSHHIHD 423
+ E+ +L + H +++ LL LV + G ++I
Sbjct: 68 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNI-- 123
Query: 424 HQQQQEQKQELEEE-------QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476
+ Q+L ++ Q L L Y+HSA I HRD+K
Sbjct: 124 -----VKCQKLTDDHVQFLIYQILRGL----------------KYIHSAD---IIHRDLK 159
Query: 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPE-YFQSSQYTDKSDVYS 535
SN+ +++ K+ DFG +R ++ +T V T Y PE Y D++S
Sbjct: 160 PSNLAVNEDCELKILDFGLARHTADE---MTGYVA-TRWYRAPEIMLNWMHYNQTVDIWS 215
Query: 536 FGVVLLELLTGK 547
G ++ ELLTG+
Sbjct: 216 VGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 57/270 (21%), Positives = 90/270 (33%), Gaps = 77/270 (28%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-----SRAIDKTQIEQFINEVVILSQ 386
D Y +G G +G V + + +VA+K+ ID +I + E+ IL++
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNR 108
Query: 387 INHRHIVKLLGCCLETEVPV-----LVYEYISNGT-LSHHIHDHQQQQEQKQELEEE--- 437
+NH H+VK+L + +V +V E + L E
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFR-------TPVYLTELHIK 159
Query: 438 ----QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493
L V Y+HSA I HRD+K +N L++ S KV DF
Sbjct: 160 TLLYNLLV----------------GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF 200
Query: 494 GTSRSVPNDKTHLTTAVQGTFGYFDP---------------EY------------FQSSQ 526
G +R+V + + +
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 527 YTDKSDVYSFGVVLLELLTGKKPICLTREE 556
YT+ DV+S G + ELL K +
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 66/341 (19%), Positives = 105/341 (30%), Gaps = 96/341 (28%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR---- 390
Y + +G+G FG V K VA+K R + Q E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAEEIRILEHLRKQDKDN 157
Query: 391 --HIVKLLGC-------CLETEVPVL---VYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
+++ +L C+ E+ L +YE I ++ + Q L
Sbjct: 158 TMNVIHMLENFTFRNHICMTFEL--LSMNLYELI------------KKNKFQGFSL---- 199
Query: 439 ELSSLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGT 495
VR A + + +H I H D+K NILL + + KV DFG+
Sbjct: 200 --------PLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248
Query: 496 SRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK-------- 547
S + T +Q F Y PE ++Y D++S G +L ELLTG
Sbjct: 249 SCYEHQ---RVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304
Query: 548 ----------------------------------KPICLTREEEERNLVAYFISLAKENK 573
C + ++V +
Sbjct: 305 GDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
+ D + CL + R T Q
Sbjct: 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 58/246 (23%), Positives = 96/246 (39%), Gaps = 53/246 (21%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR- 390
D Y +G+G FG V K + VA+K + Q EV +L +N
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHD 111
Query: 391 -----HIVKLLGC-------CLETEVPVL---VYEYISNGTLSHHIHDHQQQQEQKQELE 435
+IV L CL E+ L +Y+ + + + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEM--LSYNLYDLL--------------RNTNFRGV- 154
Query: 436 EEQELSSLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILL--DDKFSAKVSD 492
SL N R A ++ A+ ++ + + I H D+K NILL + + K+ D
Sbjct: 155 ------SL---NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 552
FG+S + + +Q F Y PE Y D++S G +L+E+ TG +P+
Sbjct: 205 FGSSCQLGQ---RIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFS 259
Query: 553 TREEEE 558
E +
Sbjct: 260 GANEVD 265
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 70/382 (18%), Positives = 119/382 (31%), Gaps = 121/382 (31%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI---- 387
Y+ R LG G F TV+ + VA+K ++ + E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSD 94
Query: 388 ----NHRHIVKLLGCCLETEVP-----VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
N +V+LL + +V+E L HH+ + +
Sbjct: 95 PNDPNREMVVQLLDD-FKISGVNGTHICMVFE-----VLGHHLLKWIIKSNYQ------- 141
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---------------- 482
L ++ +V + Y+H+ I H DIK NILL
Sbjct: 142 ---GLPLPCVKKIIQQVLQGLDYLHTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 483 ---------------------------------DDKFSAKVSDFGTSRSVPNDKTHLTTA 509
+K K++D G + V H T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTED 253
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK---KPICLTREEEERNLVA--- 563
+Q T Y E S Y +D++S + EL TG +P + + +A
Sbjct: 254 IQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 564 -------------------YF--------ISLAKENKLLEILDARVAKEAREEDIEAVAE 596
+F I+ K L E+L + E +E+ +
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTD 370
Query: 597 LAMGCLRLNSKKRPTMKQVSMD 618
+ L L +KR T +
Sbjct: 371 FLLPMLELIPEKRATAAECLRH 392
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 66/251 (26%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFI-NEVVILSQIN- 388
Y + LG+G +G V+K + G +VAVK+ A + Q E++IL++++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 389 HRHIVKLLGCCLE---TEVPVLVYEYISNGT-LSHHIHDHQQQQEQKQELEEE------- 437
H +IV LL +V LV++Y+ T L I LE
Sbjct: 68 HENIVNLLNVLRADNDRDV-YLVFDYM--ETDLHAVIR--------ANILEPVHKQYVVY 116
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
Q + + Y+HS + HRD+K SNILL+ + KV+DFG SR
Sbjct: 117 QLIK----------------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 498 SVPNDKTHLTTAVQGTFGYFDP---------EY------------FQSSQYTDKSDVYSF 536
S N + + +Y S++YT D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 537 GVVLLELLTGK 547
G +L E+L GK
Sbjct: 218 GCILGEILCGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-12
Identities = 34/270 (12%), Positives = 78/270 (28%), Gaps = 54/270 (20%)
Query: 312 LSSCGSSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSR---- 367
+ C T+ + +G+G FG V++ + D + VA+K
Sbjct: 2 MGECSQKG---PVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGP 56
Query: 368 ----AIDKTQIEQFINEVVILSQI---------NHRHIVKLLGCCL----ETEVPVLVYE 410
+ E+ + E++I ++ + L + + ++
Sbjct: 57 DLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWD 116
Query: 411 Y--ISNGTLSHHIHDHQQQQ-------EQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461
+ + G+ + + Q E E+ S + ++ ++A
Sbjct: 117 HYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176
Query: 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFG------ 515
+ S+ HRD+ N+LL K+ +S + +
Sbjct: 177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS-TIPSCGLQVSIIDYTLSRLER 233
Query: 516 ---------YFDPEYFQSSQYTDKSDVYSF 536
D + F + D+Y
Sbjct: 234 DGIVVFCDVSMDEDLFT-GDGDYQFDIYRL 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 60/348 (17%), Positives = 107/348 (30%), Gaps = 101/348 (29%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM--LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR 390
+ Y LG+G FG V + + S VA+K R + K + E E+ +L +I +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYR-EAARLEINVLKKIKEK 76
Query: 391 ------HIVKLLGC-------CLETEVPVL---VYEYI-SNGTLSHHIHDHQQQQEQKQE 433
V + C+ E+ L +E++ N + + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFEL--LGKNTFEFLKENNFQPYPLPHVR-------- 126
Query: 434 LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA----- 488
+A ++ A+ ++H + H D+K NIL +
Sbjct: 127 ----------------HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNE 167
Query: 489 --------------KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVY 534
+V+DFG++ + + H TT V Y PE + DV+
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSA--TFDHEHH-TTIVATRH-YRPPEVILELGWAQPCDVW 223
Query: 535 SFGVVLLELLTGKKPICLTREEEE----------------------------RNLVAYFI 566
S G +L E G + T E E LV
Sbjct: 224 SIGCILFEYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDEN 282
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
S + + + +L L + +R T+ +
Sbjct: 283 SSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAE 330
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 70/354 (19%), Positives = 112/354 (31%), Gaps = 113/354 (31%)
Query: 336 YNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR---- 390
+ R +G G FG V + + AVK R I K E IL +I +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINN 95
Query: 391 -HIVKLLGC-------CLETEVPVL---VYEYI-SNGTLSHHIHDHQQQQEQKQELEEEQ 438
+IVK G CL E L +YE I N HI
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITRNNYNGFHI----------------- 136
Query: 439 ELSSLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--------- 488
++ E+ A+ Y+ + + H D+K NILLDD +
Sbjct: 137 --------EDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV 185
Query: 489 ----------------KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSD 532
K+ DFG + H + + Y PE + + SD
Sbjct: 186 TDGKKIQIYRTKSTGIKLIDFGC--ATFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSD 241
Query: 533 VYSFGVVLLELLTGKKPICLTREEEE---------------------RNLVAYFISLAKE 571
++SFG VL EL TG + T E E + + +++ K+
Sbjct: 242 MWSFGCVLAELYTG-SLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVN--KD 298
Query: 572 NKLLEILDARVAKEARE-----------EDIEAVAELAMGCLRLNSKKRPTMKQ 614
L + + + + E + L+++ RP+ +
Sbjct: 299 ELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAE 352
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 9e-11
Identities = 97/650 (14%), Positives = 186/650 (28%), Gaps = 171/650 (26%)
Query: 7 YTYLSILLMILCTFLHDLQQSTCQQT--YLGNV--DLECNKSV----SISKGY-----LC 53
Y Y IL + F+ + C+ ++ E + + ++S L
Sbjct: 16 YQYKDILSVFEDAFVDNFD---CKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLL 72
Query: 54 NGPQNLCQSFITFRSEPPYD---TPVSIAYLLGSEASKSVIVPVSCSCSGSLYQHNAPYT 110
+ + + Q F+ Y +P+ S ++ I LY N +
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI-----EQRDRLYNDNQVFA 127
Query: 111 TKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNL------GSG-------VELTVPIRC 157
Y + Y L QALL KN+ GSG V L+ ++C
Sbjct: 128 K-----YNVSRLQPYLKLR--QALLELR--PAKNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 158 ACATANQTENGVTYL-LAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLL 216
+ + + +L L + + + +D N D
Sbjct: 179 ------KMDFKIFWLNLKNCNSPETVLEMLQK-----LLYQIDPNWTSRSDH-----SSN 222
Query: 217 IPLKSESCSANPEKFFC--QCKNGFLV-D-----GILK--GLHCKPDGKKFPVKLVTLLG 266
I L+ S A + +N LV L CK L+T
Sbjct: 223 IKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK--------ILLTTRF 274
Query: 267 LGIGLGFLSLVLLGCYLYKVIREKRSRMLKEK----LFKQNGGYLLQ--QRLSS--CGSS 318
+ + L + + S L L + YL Q L ++
Sbjct: 275 KQV-----TDFLSAATTTHISLDHHSMTLTPDEVKSLLLK---YLDCRPQDLPREVLTTN 326
Query: 319 EKA-KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRS-RAIDKTQIEQ 376
+ I AE ++ ++ +K + D ++ S ++ + +
Sbjct: 327 PRRLSII-AESIRDGLATWDN------------WKHVNCDKLTTIIESSLNVLEPAEYRK 373
Query: 377 FINEVVILSQINHRHI-VKLLG---CCLETEVPVLVYEYISNGTL--------SHHIHDH 424
+ + + HI LL + ++V + +L + I
Sbjct: 374 MFDRLSVFP--PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS- 430
Query: 425 QQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIP-----IF-----H-- 472
E K +LE E L +R V + P + H
Sbjct: 431 -IYLELKVKLENEYAL------HRSIVDH-YNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482
Query: 473 ------RDIKSSNILLDDKF-SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS 525
R + LD +F K+ T+ + + ++++
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQ---------QLKFYK-- 531
Query: 526 QY-TDKSDVYSFGV-VLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
Y D Y V +L+ L + + + +L+ I+L E++
Sbjct: 532 PYICDNDPKYERLVNAILDFLPKIEENLI--CSKYTDLLR--IALMAEDE 577
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 68/346 (19%), Positives = 124/346 (35%), Gaps = 103/346 (29%)
Query: 336 YNQSRFLGQGGFGTVYKG--MLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--- 390
Y LG+G FG V + G VAVK + +D+ E +E+ +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPN 74
Query: 391 ---HIVKLLGC-------CLETEVPVL---VYEYI-SNGTLSHHIHDHQQQQEQKQELEE 436
V++L C+ E+ L Y++I NG L +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFEL--LGLSTYDFIKENGFLPFRL--------------- 117
Query: 437 EQELSSLSWENRVR-VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD----------- 484
+ +R +A ++ +V ++HS + H D+K NIL
Sbjct: 118 ----------DHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 485 --------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSF 536
KV DFG++ +D+ H +T V Y PE + ++ DV+S
Sbjct: 165 KRDERTLINPDIKVVDFGSA--TYDDEHH-STLVSTRH-YRAPEVILALGWSQPCDVWSI 220
Query: 537 GVVLLELLTGKKPICLTREEEE-------------RNLVA------YFISLAKENKLLEI 577
G +L+E G + T + +E ++++ YF +
Sbjct: 221 GCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS 279
Query: 578 LDARVAKEAR---------EEDIEAVAELAMGCLRLNSKKRPTMKQ 614
V++ + + + E + +L L + KR T+++
Sbjct: 280 AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 26/177 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH-RH 391
+ Y R +G G FG +Y G + G VA+K KT+ Q E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I + C E + V+V E L + D +K S + + +
Sbjct: 67 IPTIRWCGAEGDYNVMVMEL-----LGPSLEDLFNFCSRK-----------FSLKTVLLL 110
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSAKVSDFGTSRSVPNDKTH 505
A ++ + Y+HS HRD+K N L+ + DFG ++ + +TH
Sbjct: 111 ADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 46/234 (19%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRH 391
+ + R +G G FG +Y G + VA+K KT+ Q + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I + +E + VLV + L + D +K LS + + +
Sbjct: 65 IPNVRWFGVEGDYNVLVMDL-----LGPSLEDLFNFCSRK-----------LSLKTVLML 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK---VSDFGTSRS--VPNDKTHL 506
A ++ V ++HS + HRDIK N L+ A + DFG ++ + H+
Sbjct: 109 ADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 507 ----TTAVQGTFGYFDPEYFQSSQYTDKS-------DVYSFGVVLLELLTGKKP 549
+ GT Y +S T D+ S G VL+ L G P
Sbjct: 166 PYRENKNLTGTARY-------ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 37/179 (20%), Positives = 63/179 (35%), Gaps = 28/179 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRH 391
+Y R +G+G FG +++G L + VA+K ++ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I + E VLV + L + D +K S +
Sbjct: 68 IPNVYYFGQEGLHNVLVIDL-----LGPSLEDLLDLCGRK-----------FSVKTVAMA 111
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK-----VSDFGTSRSVPNDKTH 505
A ++ V +H + + +RDIK N L+ S V DFG + + T
Sbjct: 112 AKQMLARVQSIHEKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 33/178 (18%), Positives = 64/178 (35%), Gaps = 28/178 (15%)
Query: 335 NYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHI 392
N+ + +G G FG + G L VA+K K++ Q E Q+ + I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
++ + +V E L + D ++ S + + +A
Sbjct: 68 PQVYYFGPCGKYNAMVLEL-----LGPSLEDLFDLCDRT-----------FSLKTVLMIA 111
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS-----DFGTSRSVPNDKTH 505
++ + Y+HS I +RD+K N L+ + DF ++ + +T
Sbjct: 112 IQLISRMEYVHSKNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} Length = 167 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 5e-07
Identities = 16/54 (29%), Positives = 19/54 (35%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKSESCSANP 228
Q GD + IG F D I N + N D I L +P K S
Sbjct: 65 VTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAG 118
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 38/241 (15%), Positives = 78/241 (32%), Gaps = 52/241 (21%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLG 397
+GQGGFG +Y + V + + + E+ +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL---------KFYQRAA 91
Query: 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQK----------QELEE--EQELSSLSW 445
+ + + + G + + + +L++ E S
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSR 151
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV--SDFGTSRSVPNDK 503
+ ++++ + + Y+H + H DIK+SN+LL+ K +V D+G + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 504 THL------TTAVQGTFGYFDPEY---------FQSSQYTDKSDVYSFGVVLLELLTGKK 548
H GT E+ S + D+ G +++ LTG
Sbjct: 209 VHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSR----RGDLEILGYCMIQWLTGHL 259
Query: 549 P 549
P
Sbjct: 260 P 260
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 1e-05
Identities = 14/48 (29%), Positives = 27/48 (56%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKSE 222
+ + GD ++ + ++GV ++ I AN L D+I + L IP+ +E
Sbjct: 18 HQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTE 65
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/175 (15%), Positives = 67/175 (38%), Gaps = 17/175 (9%)
Query: 340 RFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+ +G GGFG +Y A + ++ + +E+ ++ + +K
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 399 CLETE---VPVLVYEYISNGTLSHHIHDHQQ--QQEQKQELEEEQELS-SLSWENRVRVA 452
+ + +P+ +G ++ + +L++ + + +++
Sbjct: 102 RKQLDYLGIPLFYG----SGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLG 157
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV--SDFGTSRSVPNDKTH 505
+ + Y+H + H DIK++N+LL K +V +D+G S + H
Sbjct: 158 IRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 28/192 (14%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 340 RFLGQGGFGTVYKGM---------LPDGSIVAVK--------------RSRAIDKTQIEQ 376
F + G +Y+ P ++K RA Q+ +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 377 FINEVVILSQINHRHIVKLLGC-CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
+ L I +G + + LV L + +
Sbjct: 108 WKK----LYSTPLLAIPTCMGFGVHQDKYRFLVLPS-----LGRSLQSALDVSPKH---- 154
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV--SDF 493
LS + ++VAC + A+ ++H + H ++ + NI +D + ++V + +
Sbjct: 155 ------VLSERSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGY 205
Query: 494 GTSRSVPNDKTH 505
G + H
Sbjct: 206 GFAFRYCPSGKH 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4eby_A | 212 | Chitin elicitor receptor kinase 1; pathogen-associ | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 98.93 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 2l9y_A | 167 | CVNH-LYSM lectin; carbohydrate, sugar binding prot | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 1e0g_A | 48 | Membrane-bound lytic murein transglycosylase D; ce | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.44 | |
| 2djp_A | 77 | Hypothetical protein SB145; LYSM, structural genom | 98.43 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.83 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.44 | |
| 2gu1_A | 361 | Zinc peptidase; alpha/beta, beta barrel, structura | 97.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.26 | |
| 4a1k_A | 165 | Putative L, D-transpeptidase YKUD; transferase, pe | 97.09 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.08 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.92 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.84 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.74 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.44 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.34 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.56 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 93.46 | |
| 3slu_A | 371 | M23 peptidase domain protein; outer membrane, hydr | 91.58 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.77 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.48 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=460.05 Aligned_cols=273 Identities=26% Similarity=0.455 Sum_probs=214.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...++||+|+||.||+|.++ +++.||||+++..+....++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999864 478899999988777778899999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.++++........... .......+++|.++++|+.|||.||+|||+++ |+||||||+||||+++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAG-GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC------------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccc-cccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999765432111000 01112357999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+. +
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~------~ 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA------I 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH------H
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH------H
Confidence 9999999998764332 223345679999999999999999999999999999999999 8999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ......|..++..+.+|+.+||+.||++||||.||+++|+.|.++.
T Consensus 271 ~~i~~----------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 271 DCITQ----------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHH----------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHc----------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 11111 1122345566788999999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-56 Score=456.84 Aligned_cols=270 Identities=27% Similarity=0.473 Sum_probs=220.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...+.||+|+||.||+|.+. ++..||||+++..+....++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999863 467899999988777778899999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.++|+....... ..........++|.++++|+.|||.||+|||+++ |+||||||+||||+++++
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~---~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAV---LMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHH---HC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhcCcccc---cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCc
Confidence 9999999999999976543110 0001112357999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+|+........ ......||+.|||||.+.++.++.|+|||||||+||||+| |+.||......+. +
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~------~ 240 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV------I 240 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------H
Confidence 999999999876443322 2234569999999999999999999999999999999999 8999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.... .+ .....|..++..+.+|+.+||+.||++||||.||.+.|+++.++
T Consensus 241 ~~i~-~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECIT-QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH-cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111 11 11234556678899999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-56 Score=457.51 Aligned_cols=271 Identities=24% Similarity=0.398 Sum_probs=214.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
.+++..++||+|+||.||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999963 46789999987533 334578999999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
|||||+++|+|.++|.....................++|.++++|+.|||.||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 999999999999999654321000000000111347999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
++||+|||+++...... ........||++|||||++.++.++.++|||||||+||||+| |+.||......+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~------ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 99999999998764332 223344679999999999999999999999999999999999 8999865433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.. .... ....+.+.+++..+.+|+.+||+.||++||||.||+++|+.+.
T Consensus 257 ~~-~i~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 257 VE-MIRN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH-HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH-HHHc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 11 1111 1122345667788999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=444.25 Aligned_cols=262 Identities=27% Similarity=0.464 Sum_probs=208.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.+++...++||+|+||+||+|++++ .||||+++.. +....++|.+|+++|++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3577788999999999999999853 5999998753 45567789999999999999999999999864 56899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.++|+... ..++|.++++|+.|||.||+|||+++ ||||||||+||||++++++||
T Consensus 112 y~~gGsL~~~l~~~~---------------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---------------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CCSSCBHHHHHHTSC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEE
T ss_pred cCCCCCHHHHHhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEE
Confidence 999999999997542 36999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCC-cceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 491 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 491 ~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+|||+|+...... ........||+.|||||++.+ +.++.|+|||||||+||||+||+.||........ +.
T Consensus 174 ~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~ 247 (307)
T 3omv_A 174 GDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------II 247 (307)
T ss_dssp CCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HH
T ss_pred eeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HH
Confidence 9999998764322 223345679999999999863 4689999999999999999999999964332211 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.....+ ...+.+ ...+.+++..+.+|+.+||+.||++||||.||++.|+.|+.+.
T Consensus 248 ~~~~~~----~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 248 FMVGRG----YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHTT----CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHhcC----CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 111111 011111 1234456678999999999999999999999999999887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=448.03 Aligned_cols=285 Identities=25% Similarity=0.386 Sum_probs=226.0
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEcCC------CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCC-CCceEE
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRAI-DKTQIEQFINEVVILSQINH-RHIVKL 395 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H-~nIv~l 395 (633)
++..+++...++|+..+.||+|+||.||+|.+.. ++.||||+++.. .....+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 5566677777899999999999999999998532 358999998764 34456789999999999975 899999
Q ss_pred EEEEeeC-CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 396 LGCCLET-EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 396 ~g~~~~~-~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+|+|.+. +..+|||||+++|+|.++|+....................++|.+++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 4689999999999999999765431100000001111346999999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 552 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~ 552 (633)
|||+|||+++++++||+|||+|+....+.. .......||+.|||||++.++.++.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997754433 33445679999999999999999999999999999999998 8999864
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....+. +.... ....+...|..++.++.+|+.+||+.||++|||+.||+++|+.+.+++
T Consensus 291 ~~~~~~------~~~~i---------~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEE------FCRRL---------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHH------HHHHH---------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHH------HHHHH---------HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 332211 11111 111222345556678999999999999999999999999999998765
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=434.88 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=203.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC----ceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----VPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----~~~LV~ 409 (633)
++|...++||+|+||.||+|++ +|+.||||+++..... ...+..|+..+.+++|||||+++|++.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567788999999999999998 6899999998754322 122334666667899999999999998764 469999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-----CCCCeeccCCCCCCeeecC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-----ASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-----~~~~ivHrDIk~~NILl~~ 484 (633)
||+++|+|.++++. ..++|..+++|+.|++.||+|||++ ..++|+||||||+||||++
T Consensus 81 Ey~~~gsL~~~l~~-----------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp ECCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred cCCCCCcHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 99999999999964 3689999999999999999999987 2345999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcce---ecccccCCCcCchhccccC------CCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
++++||+|||+|+......... .....||+.|||||++.+. .++.|+|||||||+||||+||+.|+.....
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 9999999999998764433221 2345799999999998754 467899999999999999999887643221
Q ss_pred hhh--------hcHHHHHHHHHhhchhhhhhchhhhcc-cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 556 EEE--------RNLVAYFISLAKENKLLEILDARVAKE-AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 556 ~~~--------~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... ............+. .++|.+... .+.+.+..+.+|+.+||+.||++||||.||++.|++|.+.+
T Consensus 224 ~~~p~~~~~~~~~~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 224 YQLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchhcccccchHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 100 00011111111111 112222111 12356678999999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=433.15 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=205.1
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||.||+|+. .+|+.||||++.. ......+.|.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 4799999999864 344567789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.++|.... ...+++.+++.|+.||+.||+|||+++ |+||||||+||||++++++||
T Consensus 104 y~~gg~L~~~i~~~~--------------~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl 166 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--------------GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQL 166 (350)
T ss_dssp CCTTCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEE
T ss_pred CCCCCcHHHHHHHcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEE
Confidence 999999999996543 235789999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||+|+..... ........||+.|||||++.+..++.++|||||||+||||++|+.||......+ .+.....
T Consensus 167 ~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~ 239 (350)
T 4b9d_A 167 GDFGIARVLNST-VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIIS 239 (350)
T ss_dssp CSTTEESCCCHH-HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH
T ss_pred cccccceeecCC-cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHc
Confidence 999999876432 122345679999999999999999999999999999999999999996543322 1111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. . ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~-~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 GS-F---------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TC-C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC-C---------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 0 12233455778999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=417.89 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=198.4
Q ss_pred ccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCceEEEE
Q 039736 337 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY 409 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~LV~ 409 (633)
...++||+|+||.||+|... ++..||||++.. ......+.|.+|+++|++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999964 688999998864 345566789999999999999999999999875 24579999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~ 488 (633)
||+++|+|.+++... ..+++..+..|+.||+.||+|||+++ ++|+||||||+||||+. ++++
T Consensus 109 Ey~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~v 171 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCE
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCE
Confidence 999999999999653 46999999999999999999999987 45999999999999984 8999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+|+..... ......||+.|||||++.+ .++.++|||||||+||||+||+.||....... ......
T Consensus 172 Kl~DFGla~~~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i 242 (290)
T 3fpq_A 172 KIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV 242 (290)
T ss_dssp EECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH
T ss_pred EEEeCcCCEeCCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHH
Confidence 99999999864332 2345679999999998864 69999999999999999999999995432211 111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .+.. + ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~-~~~~-----~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 243 T-SGVK-----P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp T-TTCC-----C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-cCCC-----C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1100 0 11122234568899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=428.07 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=209.2
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+.|+..++||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..||||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999964 79999999987654445567889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++++||+|
T Consensus 154 ~gg~L~~~l~~-----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~D 213 (346)
T 4fih_A 154 EGGALTDIVTH-----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 213 (346)
T ss_dssp TTEEHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEec
Confidence 99999998853 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||......+. +......
T Consensus 214 FGla~~~~~~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~- 285 (346)
T 4fih_A 214 FGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDN- 285 (346)
T ss_dssp CTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-
T ss_pred CcCceecCCCCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC-
Confidence 999987654322 23456799999999999999999999999999999999999999965433221 1111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+.+ ......+..+.+|+.+||+.||++|||+.|++++
T Consensus 286 -----~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 286 -----LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp -----SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 1123345678999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=424.67 Aligned_cols=256 Identities=21% Similarity=0.264 Sum_probs=209.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+.|...++||+|+||.||+|+. .+|+.||||+++... .+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4677788999999999999995 468999999987532 1247999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cEEEe
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SAKVS 491 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~kI~ 491 (633)
++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++ ++||+
T Consensus 133 ~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 133 EGGSLGQLIKQM----------------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp TTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEEC
T ss_pred CCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEe
Confidence 999999999653 46999999999999999999999999 99999999999999987 69999
Q ss_pred ecCCCccCCCCCcc----eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 492 DFGTSRSVPNDKTH----LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 492 DfGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
|||+|+........ ......||+.|||||++.+..++.++|||||||+||||++|+.||......+. . ..
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~---~~ 267 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---C---LK 267 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---H---HH
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HH
Confidence 99999876433211 12335799999999999999999999999999999999999999964332211 1 11
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
..... + -....+...+..+.+|+.+||+.||++|||+.|++++|........
T Consensus 268 i~~~~-------~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 268 IASEP-------P-PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHHSC-------C-GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HHcCC-------C-CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 11111 0 0113345566789999999999999999999999999988776543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=417.24 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=208.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+++. .+|+.||||++... +....+.+.+|+++|++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 47899999998642 2334568999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+||||++++++|
T Consensus 112 Ey~~gG~L~~~i~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred ecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEE
Confidence 999999999999653 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+|+...... .......+||+.|||||++.+..++.++||||+||+||||++|+.||......+ .+...
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i 246 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKI 246 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999999765332 233455789999999999999999999999999999999999999996543322 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
.... ..++...+.++.+|+.+||+.||++|||+.|+.
T Consensus 247 ~~~~-----------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 247 IKLE-----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHTC-----------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred HcCC-----------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1110 122334456789999999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=429.30 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=209.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+.|+..++||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 57889999999999999999964 68999999987655555567889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ |+||||||+||||+.++++||+|
T Consensus 231 ~gG~L~~~i~~-----------------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~D 290 (423)
T 4fie_A 231 EGGALTDIVTH-----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSD 290 (423)
T ss_dssp TTEEHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECC
T ss_pred CCCcHHHHHhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEec
Confidence 99999998853 35999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||......+. +......
T Consensus 291 FGla~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~- 362 (423)
T 4fie_A 291 FGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDN- 362 (423)
T ss_dssp CTTCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-
T ss_pred CccceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcC-
Confidence 99998764432 223456799999999999999999999999999999999999999965433221 1111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+.+ ......+..+.+|+.+||+.||++|||+.|++++
T Consensus 363 -----~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 363 -----LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -----CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 1123345678999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=401.89 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=192.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 47899999998642 2233567899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+ +|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++|
T Consensus 93 Ey~-~g~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vk 152 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----------------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVK 152 (275)
T ss_dssp ECC-CEEHHHHHHHS----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEE
T ss_pred eCC-CCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEE
Confidence 999 68999888642 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+|+...... ......||+.|||||++.+..+ +.++||||+||+||||++|+.||....... .+...
T Consensus 153 l~DFGla~~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i 224 (275)
T 3hyh_A 153 IADFGLSNIMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNI 224 (275)
T ss_dssp ECCSSCC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EeecCCCeecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH
Confidence 99999998764322 2334679999999999988776 579999999999999999999996543221 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... . ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 225 ~~~-~----------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 SNG-V----------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp HHT-C----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred HcC-C----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 0 11233445678899999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=411.52 Aligned_cols=247 Identities=25% Similarity=0.328 Sum_probs=197.8
Q ss_pred cCCccCCcccccCcEEEEEEEc----CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|+. ..++.||||+++... .....++.+|+++|++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999984 247899999886421 2233468899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++++++
T Consensus 104 vmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~ 164 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----------------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGH 164 (304)
T ss_dssp EECCCTTCEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSC
T ss_pred EEEcCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCC
Confidence 99999999999999653 46999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+|+...... .......||+.|||||++.+..++.++|||||||+||||++|+.||......+. +..
T Consensus 165 vKl~DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~ 237 (304)
T 3ubd_A 165 IKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET------MTM 237 (304)
T ss_dssp EEEESSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEecccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH------HHH
Confidence 9999999998653322 223346799999999999999999999999999999999999999975433221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSM 617 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~ 617 (633)
.... ....+...+..+.+|+.+||+.||++||| ++|+++
T Consensus 238 i~~~-----------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 238 ILKA-----------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHcC-----------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1111 01233445677899999999999999998 466664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=403.44 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=189.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------- 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~------- 404 (633)
++|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688999999999999999995 478999999986533 3455689999999999999999999999876542
Q ss_pred -----eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 405 -----PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 405 -----~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
.|+||||+++|+|.+++..... .....+..++.|+.||+.||+|||+++ |+||||||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~N 148 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-------------IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSN 148 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-------------GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-------------CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHH
Confidence 6899999999999999976433 234667788999999999999999999 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcc-----------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTH-----------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
|||+.++++||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||++
T Consensus 149 ILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 149 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp EEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred eEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 99999999999999999876433211 1233579999999999999999999999999999999996
Q ss_pred CCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 549 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 549 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
||.... +. ...+... ..... +. ........+.+|+.+||+.||++|||+.|++++
T Consensus 226 Pf~~~~--~~---~~~~~~~-~~~~~-----p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 226 PFSTQM--ER---VRTLTDV-RNLKF-----PP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CCSSHH--HH---HHHHHHH-HTTCC-----CH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCcc--HH---HHHHHHH-hcCCC-----CC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 653211 10 1111111 11111 00 112233456789999999999999999999873
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=396.34 Aligned_cols=290 Identities=40% Similarity=0.680 Sum_probs=248.3
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE 403 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 403 (633)
++..++..++++|+..+.||+|+||.||+|..++|+.||||++........+.+.+|++++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445666789999999999999999999998889999999988766667788999999999999999999999999999
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++||||+++|+|.+++...... ...++|..++.++.|++.||.|||+++ ++||||||+||+++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~ 173 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLP------------TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCC------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEEC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCC------------ccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEEC
Confidence 999999999999999999754320 235999999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++.+||+|||+++...... ........||+.|+|||.+.++.++.++||||||+++|||++|+.||......+.....
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 99999999999998653222 22233456899999999999999999999999999999999999999766555545555
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
.+.......+.+.+.+++.+....+.+.+..+.+++.+||+.||++|||+.|++++|+.+.+.++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp HHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred HHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 555555555666677777777777888999999999999999999999999999999999876643
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=392.76 Aligned_cols=297 Identities=37% Similarity=0.674 Sum_probs=250.3
Q ss_pred cccccCHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChh-HHHHHHHHHHHHhccCCCCceEEEEE
Q 039736 320 KAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT-QIEQFINEVVILSQINHRHIVKLLGC 398 (633)
Q Consensus 320 ~~~~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~ 398 (633)
....|+..++..+.++|+..+.||+|+||.||+|...+|+.||||++...... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 34678999999999999999999999999999999888999999998764322 22368899999999999999999999
Q ss_pred EeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 399 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
+.+.+..++||||+++|+|.+++...... ...++|..++.|+.|++.||.|||++..++|+||||||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~ 163 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPES------------QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTT------------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGG
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchh
Confidence 99999999999999999999999764321 346999999999999999999999993233999999999
Q ss_pred CeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc--hh
Q 039736 479 NILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR--EE 556 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~--~~ 556 (633)
|||++.++++||+|||+++..............||+.|+|||.+.++.++.++||||||+++|||++|+.||.... ..
T Consensus 164 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (326)
T 3uim_A 164 NILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243 (326)
T ss_dssp GEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred hEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence 9999999999999999998776555555555679999999999999999999999999999999999999985322 11
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
.......+.........+....+..+....+.+.+..+.+++.+||+.||++|||+.||+++|++.....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~ 315 (326)
T 3uim_A 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW 315 (326)
T ss_dssp SCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred cchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence 233455555555556667777777777788889999999999999999999999999999999976655443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=397.70 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=202.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee------CCc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE------TEV 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~------~~~ 404 (633)
++|+..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 47999999998653 34456788999999999999999999999764 356
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.||||||++ |+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----------------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~ 193 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----------------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNE 193 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEeCCC-CCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCC
Confidence 899999996 6899888653 46999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCC---cceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 485 KFSAKVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~---~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
++.+||+|||+|+...... ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-- 271 (398)
T 4b99_A 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-- 271 (398)
T ss_dssp TCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--
T ss_pred CCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--
Confidence 9999999999998764321 2233456899999999998775 468999999999999999999999976543322
Q ss_pred HHHHHHHHHhhch-----------hhhhhchhhh--ccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKENK-----------LLEILDARVA--KEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~~~-----------~~~~~d~~l~--~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+........ ....+. .+. ... .......+.+|+.+||+.||++|||+.|++++
T Consensus 272 -l~~I~~~~g~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 272 -LQLIMMVLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -HHHHHHHHCCCCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -HHHHHHhcCCCChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111111100 000000 000 000 11234678899999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=387.23 Aligned_cols=200 Identities=22% Similarity=0.378 Sum_probs=170.3
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC----CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCce
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 405 (633)
...++|+..++||+|+||.||+|+.+ .++.||||++.... ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999742 46789999886533 234678999999998 699999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
|+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 96 ~lvmE~~~g~~L~~~~~-------------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~ 153 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRR 153 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETT
T ss_pred EEEEeCCCcccHHHHHc-------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCC
Confidence 99999999999998873 4889999999999999999999999 9999999999999877
Q ss_pred -CcEEEeecCCCccCCCCCc---------------------------ceecccccCCCcCchhccccC-CCCcccchhhH
Q 039736 486 -FSAKVSDFGTSRSVPNDKT---------------------------HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSF 536 (633)
Q Consensus 486 -~~~kI~DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~Sf 536 (633)
+.+||+|||+|+....... .......||+.|+|||++.+. .++.++||||+
T Consensus 154 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSl 233 (361)
T 4f9c_A 154 LKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSA 233 (361)
T ss_dssp TTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHH
T ss_pred CCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhh
Confidence 7999999999976533211 112234699999999999775 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCc
Q 039736 537 GVVLLELLTGKKPICLTR 554 (633)
Q Consensus 537 GvvL~elltG~~p~~~~~ 554 (633)
||++|||++|+.||....
T Consensus 234 G~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 234 GVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHHHHTCSSSSCCS
T ss_pred HHHHHHHHHCCCCCCCCC
Confidence 999999999999996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=405.10 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=210.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||++.. .+|+.||+|++........+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999995 47899999998876666777899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC--CcEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK--FSAK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--~~~k 489 (633)
+++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 236 ~~gg~L~~~i~~~~---------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vK 297 (573)
T 3uto_A 236 MSGGELFEKVADEH---------------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 297 (573)
T ss_dssp CCCCBHHHHHTCTT---------------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEE
T ss_pred cCCCcHHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEE
Confidence 99999999986532 36899999999999999999999999 9999999999999854 8999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+...... ......||+.|||||++.+..++.++||||+||+||||++|+.||......+. +....
T Consensus 298 l~DFG~a~~~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~ 369 (573)
T 3uto_A 298 LIDFGLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVK 369 (573)
T ss_dssp ECCCSSCEECCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH
T ss_pred EeeccceeEccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHH
Confidence 99999999875432 23445799999999999999999999999999999999999999975443321 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..+........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 370 ~~~-------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 370 SCD-------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTC-------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 001111112334678899999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.34 Aligned_cols=284 Identities=35% Similarity=0.600 Sum_probs=232.1
Q ss_pred ccccCHHHHHHHhcCCccC------CcccccCcEEEEEEEcCCCCEEEEEEcccc----ChhHHHHHHHHHHHHhccCCC
Q 039736 321 AKIFTAEELQRATDNYNQS------RFLGQGGFGTVYKGMLPDGSIVAVKRSRAI----DKTQIEQFINEVVILSQINHR 390 (633)
Q Consensus 321 ~~~~~~~el~~~~~~~~~~------~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~----~~~~~~~~~~Ei~il~~l~H~ 390 (633)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4569999999999999988 8999999999999998 6889999987642 234467899999999999999
Q ss_pred CceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 039736 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPI 470 (633)
Q Consensus 391 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 470 (633)
||+++++++.+.+..++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+++ +
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i 154 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-------------TPPLSWHMRCKIAQGAANGINFLHENH---H 154 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCC---e
Confidence 999999999999999999999999999999865432 346999999999999999999999999 9
Q ss_pred eccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 471 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 471 vHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
+||||||+||++++++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|
T Consensus 155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999876433222 2334568999999998864 588999999999999999999999
Q ss_pred CCCCchhhhhcHHHHHHHHHh-hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 550 ICLTREEEERNLVAYFISLAK-ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
|........ ...+...... ...+.+.+++.+ ...+......+.+++.+||+.||.+|||+.|+++.|+++.+|
T Consensus 234 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 234 VDEHREPQL--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp BCTTBSSSB--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred cccCcchHH--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 865433221 1111111111 223444444433 345677788999999999999999999999999999998765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=371.25 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=215.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|...+.||+|+||.||++... +++.||+|++...+....+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999964 68999999988777777889999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ..++|.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 90 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 90 KGGTLRGIIKSMD---------------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp TTCBHHHHHHHCC---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECC
T ss_pred CCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEee
Confidence 9999999996532 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcce-------------ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 493 FGTSRSVPNDKTHL-------------TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 493 fGla~~~~~~~~~~-------------~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764332211 11456899999999999999999999999999999999999987543221110
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. ........+ ...+..++..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 232 ~----------~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 232 F----------GLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp S----------SBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H----------hhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 000111111 1123344567889999999999999999999999999998653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=399.94 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=200.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+++.. +|+.||||+++... .........++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999954 68999999986421 111222334567788889999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
|||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|
T Consensus 269 lVmEy~~GGdL~~~l~~~----------------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G 329 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH----------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 329 (689)
T ss_dssp EEECCCCSCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTS
T ss_pred EEEecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCC
Confidence 999999999999999653 46999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
++||+|||+|+...... ....+||+.|||||++.. ..|+.++|+||+||+||||++|+.||....... .....
T Consensus 330 ~vKL~DFGlA~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~ 403 (689)
T 3v5w_A 330 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEID 403 (689)
T ss_dssp CEEECCCTTCEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHH
T ss_pred CEEecccceeeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH
Confidence 99999999998764432 234679999999999975 478999999999999999999999996432211 11111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSM 617 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~ 617 (633)
...... ...++...+..+.+|+.+||+.||.+|++ +.||.+
T Consensus 404 ~~i~~~-----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 404 RMTLTM-----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred HhhcCC-----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111111 11234445677899999999999999998 677764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=371.47 Aligned_cols=269 Identities=30% Similarity=0.449 Sum_probs=210.1
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
+++....++|+..+.||+|+||.||+|.. +|+.||||++... .....+++.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33344457899999999999999999988 6889999997653 34556789999999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++|+||||||+|||++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~ 174 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGA-------------REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDK 174 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTH-------------HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECT
T ss_pred eEEEEecCCCCcHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeC
Confidence 9999999999999999976432 124899999999999999999999987 45999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 175 ~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------ 247 (309)
T 3p86_A 175 KYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------ 247 (309)
T ss_dssp TCCEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------
T ss_pred CCcEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------
Confidence 9999999999998653322 222345689999999999999999999999999999999999999865433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....... ......+......+.+|+.+||+.||++|||+.|+++.|+.+..+.
T Consensus 248 ~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 248 VAAVGFK---------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHhc---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1111000 0112233445577899999999999999999999999999988654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=383.38 Aligned_cols=260 Identities=26% Similarity=0.458 Sum_probs=215.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|...+.||+|+||.||+|... +++.||||.++.. .....++|.+|+++|++++||||++++|++.+++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 467888999999999999999975 7899999998754 33445678999999999999999999999999899999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||++.++.+||
T Consensus 193 ~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---------------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp CCTTCBHHHHHHHHG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred cCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEE
Confidence 999999999996532 25899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCccee-cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
+|||+++.......... ....++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+.
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---------- 324 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---------- 324 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----------
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence 99999986543221111 11235778999999999999999999999999999998 9999865433221
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+.+........+..++..+.+|+.+||+.||++|||+.|+++.|+.++..+
T Consensus 325 ------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 325 ------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1111111122334455678999999999999999999999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=371.26 Aligned_cols=268 Identities=24% Similarity=0.454 Sum_probs=213.2
Q ss_pred hcCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
.++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 36788999999999999999984 36889999999887777778999999999999999999999998654 458
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~ 150 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---------------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE 150 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEET
T ss_pred EEEEEeCCCCCHHHHHHhcc---------------cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCC
Confidence 99999999999999996542 25899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+++||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......
T Consensus 151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~------ 224 (295)
T 3ugc_A 151 NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF------ 224 (295)
T ss_dssp TEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH------
T ss_pred CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH------
Confidence 99999999999876443221 2223456778999999999999999999999999999999999975432110
Q ss_pred HHHHHHhh--------chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 564 YFISLAKE--------NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 564 ~~~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
...... ..+.+.+........+..++..+.+|+.+||+.||++|||+.|+++.|++++...
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 225 --MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp --HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000 0111112222223344566788999999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.34 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=215.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..+.||+|+||.||+|...++..||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467889999999999999999988888999999876432 3457889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|
T Consensus 86 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~D 147 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---------------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSD 147 (268)
T ss_dssp TTCBHHHHHHHHG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEcc
Confidence 9999999996542 25999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .......
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~ 221 (268)
T 3sxs_A 148 FGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVSQG 221 (268)
T ss_dssp TTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTT
T ss_pred CccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHHHcC
Confidence 99998765544433444556778999999998899999999999999999999 9999865443321 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+++..+
T Consensus 222 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~k 267 (268)
T 3sxs_A 222 ----------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267 (268)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC---
T ss_pred ----------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhccC
Confidence 0111223345678999999999999999999999999999987664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=378.36 Aligned_cols=275 Identities=24% Similarity=0.399 Sum_probs=216.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc--------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML--------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~--------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36888999999999999999984 23557999998764 344567899999999999 899999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..|+||||+++|+|.+++.....................+++.+++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999999765321100000000011236899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~-- 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--
Confidence 9999999999999986643322 12233457889999999999999999999999999999999 9999865432221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. ..+........+..+...+.+++.+||+.||++||++.|+++.|+++....
T Consensus 315 -~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 -F-------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -H-------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -H-------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 111111122334455678999999999999999999999999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=371.35 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=213.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+.||+|+||.||+|... .+..||||+++.. .....+.|.+|++++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56788899999999999999963 3456999998764 445567899999999999999999999999998899999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 129 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD---------------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp EECCTTCBHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred eeCCCCCcHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCE
Confidence 99999999999986532 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~ 264 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------I 264 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------H
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH------H
Confidence 99999999876443221 2223446778999999998999999999999999999999 9999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
... ........+..++..+.+|+.+||+.||++|||+.||++.|+.+..+..
T Consensus 265 ~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 265 SSV----------EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp HHH----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred HHH----------HcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111 1111222344556789999999999999999999999999999987764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=379.12 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=205.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|... ++..||||+++.. .....++|.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 5678999998764 345567899999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 125 ~e~~~~~sL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 186 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD---------------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVC 186 (373)
T ss_dssp EECCTTCBHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EeCCCCCcHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCE
Confidence 99999999999996542 36999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 187 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~------- 259 (373)
T 2qol_A 187 KVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV------- 259 (373)
T ss_dssp EECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-------
T ss_pred EECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999876443221 1122345778999999999999999999999999999998 9999864432221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
.+.++.......+..++..+.+|+.+||+.||++||++.||++.|+++......
T Consensus 260 ---------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 260 ---------IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp ---------HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred ---------HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 111111222233445667899999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=362.06 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=214.8
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57888999999999999999988889999999875432 23578999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 89 ~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Df 150 (269)
T 4hcu_A 89 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 150 (269)
T ss_dssp TCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHHhcC---------------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccc
Confidence 999999986532 36899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~------~~~~~~-- 222 (269)
T 4hcu_A 151 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDIST-- 222 (269)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHT--
T ss_pred cccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHhc--
Confidence 9998764433333334456788999999999999999999999999999999 9999865433221 111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
......+...+..+.+++.+||+.||++|||+.|++++|+++.++
T Consensus 223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 223 --------GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111122333456789999999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=392.21 Aligned_cols=266 Identities=23% Similarity=0.418 Sum_probs=219.6
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++++...++|...+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344455667899999999999999999999888899999987643 34678999999999999999999999986 5678
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~ 320 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG--------------SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSAS 320 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTT
T ss_pred EEEEeecCCCcHHHHHHhccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCC
Confidence 999999999999999975432 25899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
+.+||+|||+++..............++..|+|||.+..+.++.++||||||++||||++ |+.||......+.
T Consensus 321 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~------ 394 (454)
T 1qcf_A 321 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV------ 394 (454)
T ss_dssp CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH------
T ss_pred CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999998764332222233446788999999999999999999999999999999 9999865433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... +........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus 395 ~~~----------i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 395 IRA----------LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHH----------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HHH----------HHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111 1111122334456678999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=359.28 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=212.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|...+.||+|+||.||++...++..||||+++.... ..+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468888999999999999999998888999999876432 2357889999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++++||+|
T Consensus 102 ~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~D 163 (283)
T 3gen_A 102 ANGCLLNYLREMR---------------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSD 163 (283)
T ss_dssp TTCBHHHHHHCGG---------------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECS
T ss_pred CCCcHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcc
Confidence 9999999996542 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~-- 235 (283)
T 3gen_A 164 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIA-- 235 (283)
T ss_dssp TTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHH--
T ss_pred ccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HHHHh--
Confidence 99998764433222333456788999999999999999999999999999998 9999865433221 11111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.......+......+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 236 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 236 --------QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --------cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111223334567899999999999999999999999999988653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=359.36 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=211.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++.. .+++.||+|++.. ......+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 5789999999999999999995 4689999998753 23445678999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++++|
T Consensus 91 e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~k 151 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH----------------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLK 151 (294)
T ss_dssp ECCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eCCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 999999999998643 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 152 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~ 225 (294)
T 4eqm_A 152 IFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHI 225 (294)
T ss_dssp ECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHH
T ss_pred EEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh
Confidence 999999987654443334456799999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhhhhcc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-t~~ev~~~L~~i~~s~~ 627 (633)
... . +......+.+.+..+.+++.+||+.||++|| ++.++.+.|+.+..+.+
T Consensus 226 ~~~-~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 226 QDS-V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SSC-C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred hcc-C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 110 0 1111222334557899999999999999998 89999999999876553
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=360.56 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=208.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999994 57899999998765555567889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~~~~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~ 158 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLT 158 (297)
T ss_dssp CTTCBHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEEC
T ss_pred CCCCCHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEe
Confidence 999999998853 25899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 159 Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~ 231 (297)
T 3fxz_A 159 DFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATN 231 (297)
T ss_dssp CCTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHH
T ss_pred eCCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC
Confidence 9999987644332 22345699999999999999999999999999999999999999865433221 1111111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. + ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 232 GT------P--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CS------C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC------C--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 0 011123445678999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.32 Aligned_cols=268 Identities=25% Similarity=0.333 Sum_probs=209.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc----eEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV----PVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~----~~LV 408 (633)
.++|+..+.||+|+||.||+|... ++.||||++..... ....+.+|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 368899999999999999999984 89999999875433 33456679999999999999999999987543 6999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc----------CCCCeeccCCCCC
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA----------ASIPIFHRDIKSS 478 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----------~~~~ivHrDIk~~ 478 (633)
|||+++|+|.+++.. ..++|..++.++.|++.||.|||+. + |+||||||+
T Consensus 101 ~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~ 160 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSK 160 (322)
T ss_dssp EECCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGG
T ss_pred EecCCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChH
Confidence 999999999999853 2589999999999999999999998 7 999999999
Q ss_pred CeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCC
Q 039736 479 NILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
|||++.++++||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 161 Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 240 (322)
T 3soc_A 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240 (322)
T ss_dssp GEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred hEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876443222 2233568999999999986 3566789999999999999999999865
Q ss_pred CchhhhhcHHH---------HHHHHHhhchhhhhhchhhhcc-cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 553 TREEEERNLVA---------YFISLAKENKLLEILDARVAKE-AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 553 ~~~~~~~~l~~---------~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
........... ........... .+.+... ........+.+|+.+||+.||++|||+.||++.|++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcchhccchhhhhccCCchhhhhhhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 43221111000 00011111111 1111111 1234567799999999999999999999999999999
Q ss_pred hhhc
Q 039736 623 RRSQ 626 (633)
Q Consensus 623 ~~s~ 626 (633)
.+..
T Consensus 317 ~~~~ 320 (322)
T 3soc_A 317 QRLT 320 (322)
T ss_dssp HHHC
T ss_pred HHHh
Confidence 8754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.32 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=216.0
Q ss_pred cccCHHHHHHHhcC----------CccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCC
Q 039736 322 KIFTAEELQRATDN----------YNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR 390 (633)
Q Consensus 322 ~~~~~~el~~~~~~----------~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~ 390 (633)
..++.++++.+++. |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45888898888865 666789999999999999965 7999999998765555667899999999999999
Q ss_pred CceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 039736 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPI 470 (633)
Q Consensus 391 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 470 (633)
||+++++++...+..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---i 162 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----------------VRLNEEQIATVCEAVLQALAYLHAQG---V 162 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 999999999999999999999999999998753 25899999999999999999999998 9
Q ss_pred eccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 471 FHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 471 vHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
+||||||+|||++.++++||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 163 vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp ECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999987644322 223456999999999999999999999999999999999999998
Q ss_pred CCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 551 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ ...... ...+.+ ..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~------~~~~~~------~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 242 FSDSPVQA------MKRLRD------SPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTSCHHHH------HHHHHH------SSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHH------HHHHhc------CCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 65433221 111111 011111 0112334678899999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=373.45 Aligned_cols=286 Identities=26% Similarity=0.394 Sum_probs=222.6
Q ss_pred ccCHHHHHHHhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceE
Q 039736 323 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVK 394 (633)
Q Consensus 323 ~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~ 394 (633)
.+...+++...++|...+.||+|+||.||+|.+ .+++.||||+++.. .....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 356677777789999999999999999999973 34679999998763 344567899999999999 7999999
Q ss_pred EEEEEeeCCc-eEEEEeeccCCCchhhcchhhhhHHH-------------------------------------------
Q 039736 395 LLGCCLETEV-PVLVYEYISNGTLSHHIHDHQQQQEQ------------------------------------------- 430 (633)
Q Consensus 395 l~g~~~~~~~-~~LV~E~~~~gsL~~~l~~~~~~~~~------------------------------------------- 430 (633)
+++++.+.+. .++||||+++|+|.+++.........
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 89999999999999999765321000
Q ss_pred --HH-----HHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCC
Q 039736 431 --KQ-----ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDK 503 (633)
Q Consensus 431 --~~-----~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~ 503 (633)
.. ..........+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 00 0000000123899999999999999999999999 9999999999999999999999999998764333
Q ss_pred c-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchh
Q 039736 504 T-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKENKLLEILDAR 581 (633)
Q Consensus 504 ~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 581 (633)
. .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. +..... ..
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~---------~~ 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLK---------EG 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHH---------HT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHH---------cC
Confidence 2 23344568999999999999999999999999999999998 9999865432211 111111 11
Q ss_pred hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 582 VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 582 l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.....+......+.+++.+||+.||++|||+.|++++|+.+..+.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 112223344567899999999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=388.24 Aligned_cols=261 Identities=26% Similarity=0.445 Sum_probs=218.3
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCC-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
..++|...+.||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34678889999999999999999754 7899999987643 246789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 297 ~~~~g~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 297 FMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp CCTTCBHHHHHHHSC--------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred ccCCCCHHHHHHhcC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEE
Confidence 999999999996532 235899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++..............++..|+|||.+..+.++.++||||||++||||++ |+.|+......+.
T Consensus 360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~----------- 428 (495)
T 1opk_A 360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------- 428 (495)
T ss_dssp CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------
T ss_pred eecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence 9999998775443333334456789999999999999999999999999999999 9999865432221
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+.+........+..++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 429 -----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 429 -----YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred -----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 1112222223345556678999999999999999999999999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=382.08 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=210.7
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
...++|...+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 34567888999999999999999998778899999876432 34689999999999999999999999876 67899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 259 ~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp CCTTCBHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred hhcCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEE
Confidence 9999999999975322 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++..............++..|+|||.+..+.++.++||||||++||||++ |+.|+......+. ...
T Consensus 322 ~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~------~~~-- 393 (452)
T 1fmk_A 322 ADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ-- 393 (452)
T ss_dssp CCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHH--
T ss_pred CCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH------HHH--
Confidence 9999998765433333334457789999999999999999999999999999999 9999864433221 111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+........+..++..+.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus 394 --------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 394 --------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp --------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1111122334556678999999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.83 Aligned_cols=259 Identities=24% Similarity=0.421 Sum_probs=201.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||+|.... +..||+|+.+.. .....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4688899999999999999999642 457999998753 3445678999999999999999999999984 567899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 93 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 154 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---------------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 154 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEecCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCC
Confidence 999999999999986532 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||+++..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 155 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~--- 228 (281)
T 1mp8_A 155 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG--- 228 (281)
T ss_dssp EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---
T ss_pred EEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH---
Confidence 9999999998765443333334457789999999998999999999999999999997 9999865433221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.... . .....+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 229 ~i~~-~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 229 RIEN-G---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHc-C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 0 111233445678899999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=352.84 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=213.7
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|...+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888999999999999999987888999999876432 23578999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 87 ~~~L~~~~~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 87 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp TCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhCc---------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccc
Confidence 999999986532 36899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~i~~~- 221 (267)
T 3t9t_A 149 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG- 221 (267)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTT-
T ss_pred ccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH------HHHHhcC-
Confidence 9998764332222233456788999999998899999999999999999999 8999865432221 1111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.....+......+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 222 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 ---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11112333456789999999999999999999999999999865
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=378.61 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=210.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-ceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-~~~LV~E~ 411 (633)
.++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.+|++++||||+++++++.+.+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46788899999999999999998 47899999987643 4568999999999999999999999988765 68999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++.... ...+++..++.++.||+.||+|||+++ ++||||||+|||+++++.+||+
T Consensus 269 ~~~g~L~~~l~~~~--------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~ 331 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG--------------RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 331 (450)
T ss_dssp CTTCBHHHHHHHHC--------------TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEEC
T ss_pred cCCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEe
Confidence 99999999997542 134799999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++...... ....++..|+|||.+.+..++.++||||||++||||++ |+.||......+. .
T Consensus 332 DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~-------- 396 (450)
T 1k9a_A 332 DFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-------- 396 (450)
T ss_dssp CCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H--------
T ss_pred eCCCcccccccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------
Confidence 999998643221 12356889999999999999999999999999999998 9999864432221 1
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
+.+........+..++..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 397 -----~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 397 -----PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11111122234455678899999999999999999999999999998765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=369.28 Aligned_cols=277 Identities=27% Similarity=0.396 Sum_probs=218.0
Q ss_pred HhcCCccCCcccccCcEEEEEEEc--------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML--------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 401 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~--------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~ 401 (633)
..++|...+.||+|+||.||+|.. ..+..||||+++.. .....+++.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 346889999999999999999984 23357999998764 345567899999999999 89999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
++..++||||+++|+|.+++.....................+++..++.|+.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 99999999999999999999764310000000000000135999999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEER 559 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~ 559 (633)
+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~- 302 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999987643322 22334457889999999999999999999999999999999 9999864432221
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
. .... .......+......+.+|+.+||+.||++|||+.||++.|+++.....
T Consensus 303 -----~-~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 303 -----F-KLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp -----H-HHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -----H-HHHH---------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1 1111 111122334456789999999999999999999999999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=351.51 Aligned_cols=254 Identities=29% Similarity=0.481 Sum_probs=199.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh----hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK----TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~----~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||+|.. .|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999998 589999998765322 2356788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC----
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD---- 484 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---- 484 (633)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+++..+++||||||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~-----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~ 147 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----------------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN 147 (271)
T ss_dssp EECCTTEEHHHHHTS-----------------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS
T ss_pred EEcCCCCCHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc
Confidence 999999999988853 36899999999999999999999998666999999999999986
Q ss_pred ----CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 485 ----KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 485 ----~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
++.+||+|||+++....... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 148 ~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-- 222 (271)
T 3dtc_A 148 GDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-- 222 (271)
T ss_dssp SCCSSCCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH--
T ss_pred ccccCcceEEccCCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence 77899999999986543222 234689999999999999999999999999999999999999865433221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
.... .........+...+..+.+++.+||+.||++|||+.|++++|++|
T Consensus 223 ----~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 223 ----AYGV---------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHH---------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHhh---------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0111 111111223344567899999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.99 Aligned_cols=276 Identities=26% Similarity=0.438 Sum_probs=217.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
..++|...+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357888999999999999999985 24578999998753 34556789999999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHH--------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQE--------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
.++||||+++|+|.+++........ .............+++.++++++.|++.||.|||+++ ++|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432100 0000000011235899999999999999999999999 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCc
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTR 554 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~ 554 (633)
|+||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876443322 2223457788999999998889999999999999999999 999986543
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.... . .. +........+...+..+.+++.+||+.||++||++.|+++.|+++....
T Consensus 258 ~~~~---~----~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 PERL---F----NL---------LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp GGGH---H----HH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHH---H----HH---------hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 3221 1 11 1111112233445678999999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=364.39 Aligned_cols=257 Identities=23% Similarity=0.462 Sum_probs=204.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|... +++ .||+|.++.. .....++|.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 57888999999999999999953 444 3688887543 234457899999999999999999999999865 4789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.+++
T Consensus 94 v~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~ 155 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EEECCTTCBHHHHHHHST---------------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCC
Confidence 999999999999996542 36999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------- 228 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------- 228 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH-------
Confidence 999999999876433322 2233456889999999999999999999999999999999 9999865433221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.+.+........+..+...+.+++.+||+.||++||++.|++++|+.+...
T Consensus 229 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 ---------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111111112223444567899999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.31 Aligned_cols=248 Identities=29% Similarity=0.392 Sum_probs=207.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++... +....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999995 57999999998653 4456678899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++++|
T Consensus 94 e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~k 154 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----------------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIK 154 (328)
T ss_dssp CCCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ECCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEE
Confidence 999999999998653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++...... ......||+.|+|||.+.+..++ .++||||||+++|||++|+.||......+. ....
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i 226 (328)
T 3fe3_A 155 IADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL------RERV 226 (328)
T ss_dssp ECSTTCCGGGSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred EeeccCceecCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 99999998764332 22445799999999999888765 799999999999999999999965433221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. + ....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 227 ~~-~----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 227 LR-G----------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HH-C----------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred Hh-C----------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1 011233345678899999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=353.56 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=214.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..++|+..+.||+|+||.||+|...++..||||.++.... ..+.+.+|++++++++||||+++++++. ++..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 3468889999999999999999988888999999875432 3567899999999999999999999986 4568999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+
T Consensus 89 ~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~ 151 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG--------------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIA 151 (279)
T ss_dssp CTTCBHHHHTTSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred CCCCCHHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEEC
Confidence 999999999975422 25999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+......+. ......
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~ 225 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLER 225 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------HHHHHT
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH------HHHHhc
Confidence 999998765443333344557889999999998889999999999999999999 8999865433221 111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
......+...+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 226 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----------ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1111223345578999999999999999999999999999988664
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=372.42 Aligned_cols=268 Identities=25% Similarity=0.397 Sum_probs=214.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999943 4568999998653 345566899999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++....... .....+++.+++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRP---------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 217 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCS---------SSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEEEeCCCCCHHHHHHhhcccc---------CccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecC
Confidence 99999999999999997643210 01246999999999999999999999999 9999999999999955
Q ss_pred C---cEEEeecCCCccCCCC-CcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 486 F---SAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 486 ~---~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+ .+||+|||+++..... .........||+.|+|||.+.++.++.++||||||+++|||++ |+.||......+.
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-- 295 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 295 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 4 5999999999754211 1122233457899999999999999999999999999999998 9999865433221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
...... ......+..++..+.+|+.+||+.||++|||+.||++.|+.+......
T Consensus 296 ----~~~i~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~ 349 (367)
T 3l9p_A 296 ----LEFVTS----------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 349 (367)
T ss_dssp ----HHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----HHHHHc----------CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence 111111 111222344556789999999999999999999999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=348.36 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=208.9
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~LV~ 409 (633)
++|...+.||+|+||.||+|.. +|+.||||+++.. .....+.|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788899999999999999998 5889999998753 345567899999999999999999999999876 6789999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ ++++||||||+||+++.++.++
T Consensus 89 e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--------------NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp ECCTTCBHHHHHHSCS--------------SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEE
T ss_pred cccCCCcHHHHHhhcc--------------cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCccee
Confidence 9999999999997532 135899999999999999999999976 4599999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCc---ccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTD---KSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|.|||++...... ...||+.|+|||.+.+...+. ++||||||+++|||++|+.||........ ..
T Consensus 154 l~~~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~ 221 (271)
T 3kmu_A 154 ISMADVKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GM 221 (271)
T ss_dssp EEGGGSCCTTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HH
T ss_pred EEeccceeeeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HH
Confidence 9999887653322 235789999999998765544 79999999999999999999865433221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
.... .......+...+..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 222 ~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 KVAL---------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHH---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111 111122334456779999999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=363.38 Aligned_cols=278 Identities=24% Similarity=0.396 Sum_probs=215.8
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 402 (633)
....++|...+.||+|+||.||+|... +++.||||.++.. .....+.|.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334578999999999999999999964 3478999998764 344567899999999999999999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHH--------HHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQ--------ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~--------~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+..++||||+++|+|.+++........... ..........+++.+++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976432110000 0000011257999999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 552 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~ 552 (633)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999976533221 12233457889999999999999999999999999999999 9999865
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....+. .. ....+.. ...+...+..+.+|+.+||+.||++||++.|+++.|+++....
T Consensus 280 ~~~~~~------~~-~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 280 MAHEEV------IY-YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp SCHHHH------HH-HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CChHHH------HH-HHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 433221 11 1111111 1223445578999999999999999999999999999998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=375.75 Aligned_cols=261 Identities=21% Similarity=0.309 Sum_probs=212.4
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh---hHHHHHHHHHHHHhccCCCCceEEEEEEe
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCL 400 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~ 400 (633)
...+++..+++|+..++||+|+||.||+|... +++.||||+++.... ...+.+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667789999999999999999999965 578999999865221 12234889999999999999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
+++..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NI 206 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---------------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNI 206 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHe
Confidence 9999999999999999999996532 36999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
||+.++++||+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||.....
T Consensus 207 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp EECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred eEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999877555444445567999999999987 56789999999999999999999999975443
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccC---HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAR---EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~---~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
.+. +..... .......+ ......+.+|+.+||..+|++ ||++.|++++
T Consensus 287 ~~~------~~~i~~---------~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 287 VET------YGKIMN---------HKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHH------HHHHHT---------HHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hHH------HHhhhh---------ccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 221 111111 10001111 224567889999999988888 9999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=350.99 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=209.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|...+.||+|+||.||+|...+ +..||||.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4688899999999999999998532 236999998764 34556789999999999999999999999764 56799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 90 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 151 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---------------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPEC 151 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTE
T ss_pred EEecCCCCCHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCc
Confidence 999999999999986532 36899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 152 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~-- 226 (281)
T 3cc6_A 152 VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGV-- 226 (281)
T ss_dssp EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHH--
T ss_pred EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHH--
Confidence 9999999998765443333334557889999999998999999999999999999998 9999865433221 110
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
... ......+...+..+.+++.+||+.||++|||+.|+++.|+.+....+-
T Consensus 227 --~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 277 (281)
T 3cc6_A 227 --LEK---------GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277 (281)
T ss_dssp --HHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred --Hhc---------CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence 110 011122333456789999999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=354.09 Aligned_cols=260 Identities=21% Similarity=0.360 Sum_probs=201.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhc--cCCCCceEEEEEEeeC----CceE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLET----EVPV 406 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~g~~~~~----~~~~ 406 (633)
.++|...+.||+|+||.||+|.. +|+.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998653 33456667777666 7999999999997653 3579
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCCeeccCCCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--------SAASIPIFHRDIKSS 478 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ivHrDIk~~ 478 (633)
+||||+++|+|.+++.. ..+++..+++++.|++.||+||| +.+ |+||||||+
T Consensus 83 lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~ 142 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----------------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSK 142 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGG
T ss_pred EehhhccCCCHHHHHhh-----------------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChH
Confidence 99999999999999953 36899999999999999999999 767 999999999
Q ss_pred CeeecCCCcEEEeecCCCccCCCCCcce---ecccccCCCcCchhccccC------CCCcccchhhHHHHHHHHHhC---
Q 039736 479 NILLDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTG--- 546 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~s~ksDV~SfGvvL~elltG--- 546 (633)
|||++.++++||+|||+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~ 222 (301)
T 3q4u_A 143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222 (301)
T ss_dssp GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence 9999999999999999997654333221 2234689999999999876 455799999999999999999
Q ss_pred -------CCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhh-cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 547 -------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVA-KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 547 -------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.||........ .. ............ .+.+. ...+...+..+.+|+.+||+.||++|||+.||++.
T Consensus 223 ~~~~~~~~~pf~~~~~~~~-~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 223 NGIVEDYKPPFYDVVPNDP-SF-EDMRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTBCCCCCCTTTTTSCSSC-CH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccccccccccccccCCCCc-ch-hhhhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 777743322111 11 111111111100 11111 11233567889999999999999999999999999
Q ss_pred HHhh
Q 039736 619 LEGL 622 (633)
Q Consensus 619 L~~i 622 (633)
|++|
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 9986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=355.18 Aligned_cols=277 Identities=26% Similarity=0.400 Sum_probs=217.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEccccC-hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAID-KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 403 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 403 (633)
..++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346889999999999999999984 356799999987543 34567899999999999 9999999999999999
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHH--HHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQK--QELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
..++||||+++|+|.+++.......... ...........+++..++.++.|++.||.|||+++ ++||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 9999999999999999997653210000 00000011235999999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEER 559 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~ 559 (633)
++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 999999999999999877544332 2233457889999999999999999999999999999999 9999864432211
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.... +........+...+..+.+++.+||+.||.+|||+.|+++.|+++..+.
T Consensus 257 -----~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 -----FYKM---------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp -----HHHH---------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----HHHH---------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1111 1111112223344578899999999999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=385.90 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=216.0
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+...++|...++||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++|+||+++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 344577888999999999999999998778899999876432 34689999999999999999999999876 6789999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++..... ..+++.+++.|+.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 341 e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~k 403 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCK 403 (535)
T ss_dssp CCCTTEEHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred ehhcCCcHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEE
Confidence 99999999999975322 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++..............++..|+|||.+..+.++.++||||||++||||++ |+.||......+. ...
T Consensus 404 l~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~------~~~- 476 (535)
T 2h8h_A 404 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV------LDQ- 476 (535)
T ss_dssp ECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH------HHH-
T ss_pred EcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHH-
Confidence 99999998764332222223446788999999999999999999999999999999 8999864433221 111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..+.
T Consensus 477 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 477 ---------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1111122334456678999999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=357.06 Aligned_cols=266 Identities=26% Similarity=0.450 Sum_probs=199.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcCCCC----EEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~~g~----~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
..++|+..+.||+|+||.||+|...... .||||+++.. .....+++.+|++++++++||||+++++++...+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3468999999999999999999965332 7999998753 345567899999999999999999999999876654
Q ss_pred ------EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 406 ------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 406 ------~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
++||||+++|+|.+++....... ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~N 167 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGE----------NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARN 167 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC-------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccc----------cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcce
Confidence 99999999999999996543210 1236999999999999999999999999 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999987643322 12223456789999999999999999999999999999999 899986543322
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. . ...... .....+...+..+.+|+.+||+.||++|||+.|+++.|+++....
T Consensus 248 ~---~---~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 248 I---Y---NYLIGG----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp H---H---HHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H---H---HHHhcC----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 1 111111 111223445578999999999999999999999999999998654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=352.16 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=219.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
..++|...+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578899999999999999999965 47899999987543 346789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 90 ~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp CCTTEEHHHHHHHCC--------------TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhcc--------------cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEE
Confidence 999999999996532 236999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------- 221 (288)
T 3kfa_A 153 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------- 221 (288)
T ss_dssp CCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------
T ss_pred ccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------
Confidence 9999998876555444455567889999999999999999999999999999999 9999865432221
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+.+........+...+..+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 222 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 222 -----YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111222334455678999999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=360.58 Aligned_cols=274 Identities=27% Similarity=0.408 Sum_probs=216.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~ 406 (633)
++|+..+.||+|+||.||++.+ .+++.||||++........+.+.+|++++++++|+||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999983 3688999999988777777889999999999999999999999874 45689
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++.... ..+++..++.|+.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~ 164 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---------------ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEA 164 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred EEEeecCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCC
Confidence 9999999999999996542 25999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++||+|||+++........ ......||..|+|||.+.+..++.++||||||+++|||++|+.|+.......... ...
T Consensus 165 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~ 243 (327)
T 3lxl_A 165 HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGC 243 (327)
T ss_dssp EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC-
T ss_pred CEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccc
Confidence 9999999999876543322 2233457888999999999889999999999999999999999975432211000 000
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.........+.+.+........+...+..+.+|+.+||+.||++|||+.|++++|+.+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 244 ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp ---CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 00000001122222233333445566788999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=361.78 Aligned_cols=279 Identities=25% Similarity=0.438 Sum_probs=213.2
Q ss_pred HHhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
...++|...+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999995 24568999998753 233456889999999999 899999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHH-------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQE-------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
+..++||||+++|+|.+++........ .............+++..++.++.||+.||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999976532100 0000011111245899999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCC
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLT 553 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~ 553 (633)
||+|||++.++.+||+|||++........ .......||+.|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987643322 22334567889999999999999999999999999999998 99998654
Q ss_pred chhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
..... +.... ........+...+..+.+|+.+||+.||.+|||+.|++++|+.+.....
T Consensus 279 ~~~~~------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDAN------FYKLI---------QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSHH------HHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHHH------HHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 32211 11111 1111222334456789999999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.95 Aligned_cols=266 Identities=18% Similarity=0.196 Sum_probs=213.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35789999999999999999994 578999999876532 233577899999999 79999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc---
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS--- 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--- 487 (633)
|+ +|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 87 ~~-~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~ 147 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---------------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 147 (298)
T ss_dssp CC-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTT
T ss_pred ec-CCCHHHHHHHhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCC
Confidence 99 999999996532 36999999999999999999999999 999999999999987776
Q ss_pred --EEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 488 --AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 488 --~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 227 (298)
T 1csn_A 148 NMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227 (298)
T ss_dssp TCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH
T ss_pred CeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH
Confidence 999999999876433221 223456999999999999999999999999999999999999999764322211
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
.....+......... .......+..+.+++.+||+.||++||++.+|++.|+++......
T Consensus 228 ~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 228 QKYERIGEKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHhhccCccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111111111100000 011123456889999999999999999999999999999887644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.53 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=209.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--Cce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 405 (633)
++|+..+.||+|+||.||++.+ .+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688899999999999999983 368899999987532 33457889999999999999999999999876 568
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.+
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~ 162 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---------------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESE 162 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred EEEEEeCCCCcHHHHHHhcc---------------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCC
Confidence 99999999999999996532 36999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+++||+|||++......... ......||..|+|||.+.+..++.++||||||+++|||++|+.|+.....
T Consensus 163 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------- 234 (302)
T 4e5w_A 163 HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA-------- 234 (302)
T ss_dssp TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--------
T ss_pred CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--------
Confidence 99999999999876544332 22345678889999999999999999999999999999999988532110
Q ss_pred HHHHHHh-------hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 564 YFISLAK-------ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 564 ~~~~~~~-------~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.+..... ...+...+........+...+..+.+|+.+||+.||.+|||+.|+++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0111100 01111112222223344556678999999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=349.99 Aligned_cols=270 Identities=23% Similarity=0.343 Sum_probs=213.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC--ceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57889999999999999999965 58999999987533 234567889999999999999999999998765 679999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee----cCC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDK 485 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~ 485 (633)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.+
T Consensus 89 e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-------------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSC
T ss_pred eCCCCCCHHHHHHHhcc-------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCC
Confidence 99999999999976433 234999999999999999999999999 9999999999999 888
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccc--------cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ--------SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
+.+||+|||+++....... .....||+.|+|||.+. +..++.++||||||+++|||++|+.||.......
T Consensus 153 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 153 SVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp EEEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred ceEEEccCCCceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 8999999999987654332 23356899999999986 5778999999999999999999999986433222
Q ss_pred hhcHHHHHHHHHhhc---hhhh---hh--------chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 558 ERNLVAYFISLAKEN---KLLE---IL--------DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~---~~~~---~~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
.. ...+....... .... .. +.......+......+.+++.+||+.||++|||+.|++++.+...
T Consensus 231 ~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 231 RN--KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp GC--HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hh--HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11 11111111110 0000 00 001112345677888999999999999999999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.52 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=212.2
Q ss_pred cCCccCC-cccccCcEEEEEEEcC---CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~-~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+ .||+|+||.||+|... ++..||||+++.. .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4565665 8999999999999853 5778999998764 345677899999999999999999999999 55678999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 88 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp EECCTTEEHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEE
T ss_pred EEeCCCCCHHHHHHhCC---------------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCE
Confidence 99999999999986432 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~ 223 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M 223 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------H
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH------H
Confidence 999999998765433322 123346889999999998889999999999999999998 9999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ......+...+..+.+++.+||+.||++||++.|++++|+.+..+.
T Consensus 224 -~~i~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 224 -AFIEQ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp -HHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHhc---------CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11111 1112234455678999999999999999999999999999998775
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=357.59 Aligned_cols=278 Identities=25% Similarity=0.432 Sum_probs=221.2
Q ss_pred cccCHHHHHHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceE
Q 039736 322 KIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVK 394 (633)
Q Consensus 322 ~~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~ 394 (633)
..+..++++...++|...+.||+|+||.||+|... +++.||||.+... .......+.+|++++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34555566667789999999999999999999853 3678999998753 3345567999999999999999999
Q ss_pred EEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 395 LLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 395 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+++++.+.+..++||||+++|+|.+++........ .......+++..+++++.|++.||.|||+++ |+|||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 163 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA------NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRD 163 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHH------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhc------cCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 99999998999999999999999999976433110 1111346799999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 552 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~ 552 (633)
|||+||+++.++++||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus 164 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 164 LAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred CccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 9999999999999999999999865332221 1223456889999999999999999999999999999999 8888864
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
...... ..... ... ....+...+..+.+++.+||+.||.+|||+.|++++|+++..
T Consensus 244 ~~~~~~------~~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 244 LSNEQV------LRFVM-EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp SCHHHH------HHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCHHHH------HHHHH-cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 432221 11111 111 112233455778999999999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=353.31 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=203.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|...+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46899999999999999999998889999999986532 2335678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++ +|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 100 ~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl 160 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---------------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160 (311)
T ss_dssp CCSE-EHHHHHHTCT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CCCC-CHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEE
Confidence 9984 7877775432 35999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+....
T Consensus 161 ~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~ 236 (311)
T 3niz_A 161 ADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSIL 236 (311)
T ss_dssp CCCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHH
T ss_pred ccCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHH
Confidence 99999987643222 2233468999999999876 5689999999999999999999999965443322 11122211
Q ss_pred hhch---hhhh------h-------chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENK---LLEI------L-------DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~---~~~~------~-------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .... . +.............++.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 0000 0 0000001112234678899999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=359.61 Aligned_cols=268 Identities=25% Similarity=0.461 Sum_probs=215.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-----CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC--ce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-----PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-----~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~ 405 (633)
.++|...+.||+|+||.||++.+ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35788899999999999999983 368899999998776677788999999999999999999999987654 68
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.+
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 181 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---------------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENE 181 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---------------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEET
T ss_pred EEEEECCCCCCHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCC
Confidence 99999999999999996532 35899999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+++||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 182 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~------- 254 (326)
T 2w1i_A 182 NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE------- 254 (326)
T ss_dssp TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------
T ss_pred CcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------
Confidence 999999999998765443221 22345677899999999888999999999999999999999986432111
Q ss_pred HHHHHHhh--------chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 564 YFISLAKE--------NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 564 ~~~~~~~~--------~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+...... ..+.+.+........+..++..+.+|+.+||+.||++|||+.|+++.|++++...
T Consensus 255 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 255 -FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp -HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 0010000 0111222222222334556678999999999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=355.54 Aligned_cols=271 Identities=27% Similarity=0.405 Sum_probs=214.7
Q ss_pred CccCCcccccCcEEEEEEEcC-----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--CceEE
Q 039736 336 YNQSRFLGQGGFGTVYKGMLP-----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET--EVPVL 407 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~~-----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~L 407 (633)
|...+.||+|+||.||++.+. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988642 5789999998764 344567899999999999999999999999874 46799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 113 v~e~~~~~~L~~~l~~-----------------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~ 172 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----------------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRL 172 (318)
T ss_dssp EECCCTTCBHHHHGGG-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEecccCCcHHHHHhh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCC
Confidence 9999999999999854 25899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ....+.
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~ 251 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIA 251 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSC
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhccc
Confidence 999999999877543322 22334578889999999998999999999999999999999999754321110 000000
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
........+.+.++.......+...+..+.+|+.+||+.||++|||+.|+++.|+.+.+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 00011112223333333334455667889999999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.30 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=207.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||++... +|+.||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367899999999999999999964 6899999998653 233456788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++
T Consensus 84 ~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EeCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCE
Confidence 9999999999888642 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....
T Consensus 145 kL~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i 217 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI 217 (337)
T ss_dssp EECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EEeeccchhhcccCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHH
Confidence 9999999986432221 2334579999999999999999999999999999999999999986543222 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.... ...+...+..+.+|+.+||+.||++|| ++.|++++
T Consensus 218 ~~~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 218 LMEE-----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHCC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HcCC-----------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1110 112334457789999999999999999 89999765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.99 Aligned_cols=260 Identities=28% Similarity=0.465 Sum_probs=206.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...+.||+|+||.||+|.... +..||||+++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466778999999999999998642 235999998754 34456689999999999999999999999999899999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 124 v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---------------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 185 (333)
T ss_dssp EEECCTTEEHHHHHHHT---------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred EEeCCCCCcHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCc
Confidence 99999999999998653 236999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------ 259 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------ 259 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH------
Confidence 999999999876433221 1222346788999999999999999999999999999999 9999864433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
..... . ......+...+..+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 260 ~~~~~-~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 260 MKAIN-D---------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp HHHHH-T---------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHH-C---------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 11111 1 11112234456788999999999999999999999999999887654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=354.50 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=199.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------ 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~------ 404 (633)
.++|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999975 78999999987533 3356789999999999999999999999876432
Q ss_pred ---------------------------------------------------eEEEEeeccCCCchhhcchhhhhHHHHHH
Q 039736 405 ---------------------------------------------------PVLVYEYISNGTLSHHIHDHQQQQEQKQE 433 (633)
Q Consensus 405 ---------------------------------------------------~~LV~E~~~~gsL~~~l~~~~~~~~~~~~ 433 (633)
.++||||+++|+|.+++.....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------- 157 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS------- 157 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-------
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-------
Confidence 7999999999999999976543
Q ss_pred HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCc---------
Q 039736 434 LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT--------- 504 (633)
Q Consensus 434 ~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~--------- 504 (633)
....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 158 ------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 228 (332)
T 3qd2_B 158 ------LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228 (332)
T ss_dssp ------GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC-----------
T ss_pred ------ccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccc
Confidence 234678889999999999999999999 99999999999999999999999999987654321
Q ss_pred --ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhh
Q 039736 505 --HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARV 582 (633)
Q Consensus 505 --~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 582 (633)
.......||+.|+|||.+.+..++.++||||||+++|||++|..|+. +. ...... ......
T Consensus 229 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~---~~~~~~-~~~~~~-------- 291 (332)
T 3qd2_B 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ER---VRIITD-VRNLKF-------- 291 (332)
T ss_dssp ---CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HH---HHHHHH-HHTTCC--------
T ss_pred ccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HH---HHHHHH-hhccCC--------
Confidence 11233469999999999999999999999999999999999977631 10 000000 001000
Q ss_pred hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 583 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..........+.+|+.+||+.||++|||+.|++++
T Consensus 292 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 292 -PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp -CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred -CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 01112334567899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=357.51 Aligned_cols=275 Identities=25% Similarity=0.398 Sum_probs=214.8
Q ss_pred hcCCccCCcccccCcEEEEEEEc--------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML--------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~--------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||+|.. .++..||||+++.. .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 47899999999999999999985 24678999998754 345567899999999999 899999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..++||||+++|+|.+++.....................+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 9999999999999999999764321000000000000235899999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL-- 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH--
Confidence 99999999999999876543322 2233457889999999998889999999999999999999 9999865432221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... ... ......+......+.+++.+||+.||.+|||+.|+++.|+++....
T Consensus 269 ----~~~-~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 269 ----FKL-LKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ----HHH-HHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHH-Hhc---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 111 111 1112233445577899999999999999999999999999998654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.33 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=202.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999964 789999999865332 234568899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 86 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl 146 (323)
T 3tki_A 86 YCSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146 (323)
T ss_dssp CCTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred cCCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEE
Confidence 99999999999653 35999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCC-cceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 491 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 491 ~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
+|||+++...... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ . +...
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~~~~ 221 (323)
T 3tki_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDW 221 (323)
T ss_dssp CCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----HHHH
T ss_pred EEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHH
Confidence 9999998653222 222234579999999999987765 7799999999999999999999965433211 0 0011
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ............+.+|+.+||+.||++|||+.|++++
T Consensus 222 ~~~~---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 222 KEKK---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HTTC---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hccc---------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1100 0001112334677899999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.14 Aligned_cols=264 Identities=17% Similarity=0.214 Sum_probs=210.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|.. .+|+.||||.+..... .+.+.+|+++++++ +|+||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5789999999999999999994 5789999998765322 23678999999999 999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc----
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS---- 487 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~---- 487 (633)
+ +|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.
T Consensus 87 ~-~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---------------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp C-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTT
T ss_pred C-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCc
Confidence 9 999999986531 36999999999999999999999999 999999999999999887
Q ss_pred -EEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 488 -AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 488 -~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~- 226 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK- 226 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH-
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH-
Confidence 999999999875432211 123467999999999999999999999999999999999999999754322211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
..+...... ... ... .......+ .+.+++..||+.||.+||++.+|.+.|+.+....+.
T Consensus 227 --~~~~~i~~~-~~~--~~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 227 --ERYQKIGDT-KRA--TPI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp --HHHHHHHHH-HHH--SCH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred --HHHHHHHhh-hcc--CCH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 111111100 000 000 00011123 899999999999999999999999999998876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.01 Aligned_cols=257 Identities=26% Similarity=0.471 Sum_probs=205.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCE----EEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSI----VAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~----vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|...+.||+|+||.||+|... +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888999999999999999953 4443 8888765422 233446778999999999999999999986 566899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+++
T Consensus 92 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---------------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---------------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSC
T ss_pred EEEeCCCCCHHHHHHHcc---------------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCe
Confidence 999999999999986542 25899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.||......+..
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------ 227 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------ 227 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH------
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH------
Confidence 999999999877543322 2334567889999999999999999999999999999999 99998654332210
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.. +........+..+...+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 228 -~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 228 -DL---------LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -HH---------HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -HH---------HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 111111122333445688999999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=352.45 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=201.6
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..+.||+|+||.||+|.. .++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788899999999999999998 4789999998753 34568999999999999999999999886 45899999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc-EEEee
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS-AKVSD 492 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-~kI~D 492 (633)
+|+|.+++..... ...+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|
T Consensus 83 ~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~D 149 (307)
T 2eva_A 83 GGSLYNVLHGAEP-------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICD 149 (307)
T ss_dssp TCBHHHHHHCSSS-------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECC
T ss_pred CCCHHHHHhccCC-------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcc
Confidence 9999999975432 335889999999999999999999933223999999999999998886 79999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 150 fg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~- 220 (307)
T 2eva_A 150 FGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHNG- 220 (307)
T ss_dssp CCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHTT-
T ss_pred cccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhcC-
Confidence 9999765322 1234589999999999999999999999999999999999999864322111 111111110
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.....+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 221 ---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 221 ---------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ---------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ---------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 011122334567899999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.67 Aligned_cols=270 Identities=16% Similarity=0.225 Sum_probs=209.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC------CCEEEEEEccccChhH-----------HHHHHHHHHHHhccCCCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD------GSIVAVKRSRAIDKTQ-----------IEQFINEVVILSQINHRHIVKL 395 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~------g~~vAVK~~~~~~~~~-----------~~~~~~Ei~il~~l~H~nIv~l 395 (633)
.++|...+.||+|+||.||+|...+ ++.||||++....... ...+..|+..+++++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999999754 4789999976543211 1234456667788899999999
Q ss_pred EEEEeeC----CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCee
Q 039736 396 LGCCLET----EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIF 471 (633)
Q Consensus 396 ~g~~~~~----~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~iv 471 (633)
++++... ...++||||+ +|+|.+++... ...+++..++.|+.||+.||+|||+++ |+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---------------~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---------------AKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 9999865 3479999999 99999998653 246999999999999999999999998 99
Q ss_pred ccCCCCCCeeec--CCCcEEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHH
Q 039736 472 HRDIKSSNILLD--DKFSAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLEL 543 (633)
Q Consensus 472 HrDIk~~NILl~--~~~~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~el 543 (633)
||||||+|||++ .++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 8999999999999776432211 11234599999999999999999999999999999999
Q ss_pred HhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 544 LTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 544 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
++|+.||........ ....... .....+.+++++.+. ....+..+.+++..||+.||++||++.+|++.|+.+.
T Consensus 255 ~~g~~Pf~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 255 LTGHLPWEDNLKDPK--YVRDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp HHSCCTTGGGTTCHH--HHHHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HhCCCCccccccCHH--HHHHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 999999864322111 1111111 111233444444332 1233567899999999999999999999999999998
Q ss_pred hhcc
Q 039736 624 RSQR 627 (633)
Q Consensus 624 ~s~~ 627 (633)
....
T Consensus 329 ~~~~ 332 (364)
T 3op5_A 329 KAIG 332 (364)
T ss_dssp HHTT
T ss_pred HHcC
Confidence 7654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=346.68 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=204.0
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChh---H----HHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKT---Q----IEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~---~----~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
++|+..+.||+|+||.||+|.. .+++.||||++...... . .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6788999999999999999996 47899999987643221 1 167899999999999999999999986543
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++ ++++||||||+|||++.+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~ 160 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK---------------AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSL 160 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT---------------TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCC
T ss_pred eEEEEecCCCCHHHHHhcc---------------cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEecc
Confidence 7999999999998888653 236999999999999999999999987 459999999999999887
Q ss_pred Cc-----EEEeecCCCccCCCCCcceecccccCCCcCchhcc--ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh
Q 039736 486 FS-----AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF--QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 558 (633)
Q Consensus 486 ~~-----~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~ 558 (633)
+. +||+|||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||........
T Consensus 161 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 161 DENAPVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp CTTCSCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCCceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 76 99999999985433 22345689999999998 445678999999999999999999999864332221
Q ss_pred hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
....... ........+...+..+.+++.+||+.||++|||+.|+++.|++|
T Consensus 237 ----~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 ----KFINMIR---------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----HHHHHHH---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----HHHHHHh---------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111111 11112223445567899999999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=349.65 Aligned_cols=253 Identities=22% Similarity=0.407 Sum_probs=205.6
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-C-------CEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-G-------SIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g-------~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
++|...+.||+|+||.||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999998542 3 47999998876666778899999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 149 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK---------------NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIRE 149 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecC
Confidence 99999999999999996542 24899999999999999999999999 9999999999999988
Q ss_pred Cc--------EEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 486 FS--------AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 486 ~~--------~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+. +||+|||++...... ....|+..|+|||.+.+ ..++.++||||||+++|||++|..|+......
T Consensus 150 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 150 EDRKTGNPPFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp CBGGGTBCCEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CcccccccceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 87 999999999765322 23457899999999987 77899999999999999999966554322211
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.. .. ..... ....+......+.+|+.+||+.||++|||+.|+++.|+++..+.
T Consensus 225 ~~-----~~-~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 225 QR-----KL-QFYED-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HH-----HH-HHHHT-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HH-----HH-HHhhc-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 10 00 00000 01112223456889999999999999999999999999997654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.51 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=197.4
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh--------------------------hHHHHHHHHHHHHh
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK--------------------------TQIEQFINEVVILS 385 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~--------------------------~~~~~~~~Ei~il~ 385 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999985 4688999998764321 12356889999999
Q ss_pred ccCCCCceEEEEEEee--CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH
Q 039736 386 QINHRHIVKLLGCCLE--TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH 463 (633)
Q Consensus 386 ~l~H~nIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH 463 (633)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..++.++.|++.||+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH 154 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----------------KPLSEDQARFYFQDLIKGIEYLH 154 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----------------SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999986 4578999999999999987642 36999999999999999999999
Q ss_pred hcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC---CCcccchhhHHHHH
Q 039736 464 SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVL 540 (633)
Q Consensus 464 ~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDV~SfGvvL 540 (633)
+++ |+||||||+|||++.++++||+|||+++....... ......||+.|+|||.+.+.. .+.++||||||+++
T Consensus 155 ~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l 230 (298)
T 2zv2_A 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230 (298)
T ss_dssp HTT---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred HCC---eeccCCCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence 999 99999999999999999999999999987644322 233456899999999997765 37789999999999
Q ss_pred HHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 541 LELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 541 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|||++|+.||....... ....... .. .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~l~~g~~pf~~~~~~~------~~~~~~~-~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 231 YCFVFGQCPFMDERIMC------LHSKIKS-QA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHSSCSSCCSSHHH------HHHHHHH-CC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHHCCCCCCCccHHH------HHHHHhc-cc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 99999999986433211 1111111 10 0011112345678999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=352.67 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=207.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||++... +++.||+|.++... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468899999999999999999964 68899999887543 3456788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--CCcEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD--KFSAK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 489 (633)
+++|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+|
T Consensus 83 ~~g~~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~k 144 (321)
T 1tki_A 83 ISGLDIFERINTS---------------AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp CCCCBHHHHHTSS---------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEE
T ss_pred CCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEE
Confidence 9999999998653 236999999999999999999999999 999999999999997 78999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +....
T Consensus 145 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~ 216 (321)
T 1tki_A 145 IIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIM 216 (321)
T ss_dssp ECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred EEECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHH
Confidence 99999998765432 22345689999999999988899999999999999999999999965443221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
... .. .+.... ...+..+.+|+.+||+.||.+|||+.|++++-
T Consensus 217 ~~~-~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 217 NAE-YT--FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HTC-CC--CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cCC-CC--CChhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 110 00 011111 12346788999999999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.58 Aligned_cols=260 Identities=28% Similarity=0.522 Sum_probs=198.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|... ..||||+++.. .....+.|.+|++++++++|+||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999874 35999987643 445567899999999999999999999965 4567899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 100 ~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl 161 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---------------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKI 161 (289)
T ss_dssp CCCEEEHHHHHTTC------------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEE
T ss_pred ecCCCcHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEE
Confidence 999999999986542 36999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCC-CcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 491 SDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 491 ~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+|||+++..... .........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~ 235 (289)
T 3og7_A 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------II 235 (289)
T ss_dssp CCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HH
T ss_pred ccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HH
Confidence 999999865422 122223456899999999986 56788899999999999999999999865432221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
........ .+.+ ......++..+.+|+.+||+.||.+|||+.|+++.|+++.+
T Consensus 236 ~~~~~~~~----~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 236 EMVGRGSL----SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHHHTSC----CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHhccccc----Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11111111 0100 11223455789999999999999999999999999999865
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=368.62 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=210.2
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
..+++...++|+..+.||+|+||.||++... +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455556789999999999999999999964 58899999986521 1123357899999999999999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NIL 200 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNML 200 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHee
Confidence 9999999999999999998853 25899999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCC----CCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ----YTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++.++++||+|||+++..............||+.|+|||++.+.. ++.++||||||++||||++|+.||......+
T Consensus 201 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 201 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp ECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999877555444444667999999999997655 7889999999999999999999997543322
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccC--HHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAR--EEDIEAVAELAMGCLRLNSKK--RPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~L~~~Cl~~dP~~--RPt~~ev~~~ 618 (633)
. +.... .......++ ...+..+.+|+.+||+.+|.+ ||++.||+++
T Consensus 281 ~------~~~i~---------~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 281 T------YSKIM---------NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H------HHHHH---------THHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred H------HHHHH---------hccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1 11111 111011111 234567899999999999988 9999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=354.55 Aligned_cols=285 Identities=26% Similarity=0.401 Sum_probs=220.6
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEE
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKL 395 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l 395 (633)
+...++....++|...+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566666678999999999999999999983 35689999998763 334566899999999999 79999999
Q ss_pred EEEEeeCC-ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 396 LGCCLETE-VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 396 ~g~~~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
++++...+ ..++||||+++|+|.+++.....................+++..++.++.|++.||.|||+++ ++|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998765 489999999999999999764321000000000000123899999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCC
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICL 552 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~ 552 (633)
|||+||+++.++++||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987644332 22334567899999999999999999999999999999998 9999864
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
...... +....... .....+......+.+++.+||+.||.+|||+.|++++|+.+..+.
T Consensus 254 ~~~~~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEE------FCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHH------HHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHH------HHHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 332211 11111111 111223334567899999999999999999999999999998765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=345.45 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=209.4
Q ss_pred CCccCCcccccCcEEEEEEEcC-CC---CEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce-EEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP-VLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g---~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~-~LV 408 (633)
.|...++||+|+||.||+|... ++ ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999853 22 37999998753 345567899999999999999999999999876654 999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
+||+.+|+|.+++... ...+++..++.++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 102 ~e~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~ 163 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---------------QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTV 163 (298)
T ss_dssp ECCCTTCBHHHHHHCT---------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EecccCCCHHHHHhcc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence 9999999999999653 236899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCc---ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~-- 239 (298)
T 3pls_A 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTH-- 239 (298)
T ss_dssp EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHH--
T ss_pred EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHH--
Confidence 9999999986643221 122334578899999999999999999999999999999996666533222111 111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccccc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCVE 630 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~~~ 630 (633)
.+........+...+..+.+++.+||+.||.+|||+.|+++.|+++.......+
T Consensus 240 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 240 -----------FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp -----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred -----------HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 111111112233445678999999999999999999999999999988764433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=382.66 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=206.3
Q ss_pred CCccCC-cccccCcEEEEEEEcC---CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~-~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++...+ .||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999863 45679999987643 3456789999999999999999999999975 5689999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||+++++.+|
T Consensus 415 E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp ECCTTCBHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEE
T ss_pred EeCCCCcHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEE
Confidence 9999999999996542 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||+++.......... ....+++.|+|||++.++.++.++||||||++||||++ |+.||......+. .
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------~- 549 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M- 549 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH------H-
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------H-
Confidence 999999987644332221 22345689999999999999999999999999999998 9999865433221 1
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+.+........+..++..+.+|+.+||+.||++||++.+|++.|+.+..+.
T Consensus 550 ---------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 550 ---------AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---------HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111111122344556788999999999999999999999999999987654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=350.68 Aligned_cols=274 Identities=22% Similarity=0.345 Sum_probs=206.7
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc--CCCCceEEEEEEeeC-
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI--NHRHIVKLLGCCLET- 402 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l--~H~nIv~l~g~~~~~- 402 (633)
...-....++|...+.||+|+||.||+|... |+.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3334445678999999999999999999984 8999999986532 23455666666655 899999999999887
Q ss_pred ---CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeeccC
Q 039736 403 ---EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA-----SIPIFHRD 474 (633)
Q Consensus 403 ---~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrD 474 (633)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++. .++|+|||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 167 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-----------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecc
Confidence 678999999999999999853 25899999999999999999999981 11299999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcce---ecccccCCCcCchhccccCCCCcc------cchhhHHHHHHHHHh
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL---TTAVQGTFGYFDPEYFQSSQYTDK------SDVYSFGVVLLELLT 545 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~k------sDV~SfGvvL~ellt 545 (633)
|||+|||++.++++||+|||+++......... .....||+.|+|||.+.+...+.+ +||||||+++|||++
T Consensus 168 ikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred cchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh
Confidence 99999999999999999999997664332221 123468999999999988766665 999999999999999
Q ss_pred C----------CCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcc-cCHHHHHHHHHHHHhccccCCCCCCCHHH
Q 039736 546 G----------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKE-AREEDIEAVAELAMGCLRLNSKKRPTMKQ 614 (633)
Q Consensus 546 G----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e 614 (633)
| +.|+........ .............. .+..... .+..++..+.+|+.+||+.||++|||+.|
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 321 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDP--SYEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSC--CHHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccCcccccccccccHhhhcCCCC--chhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence 9 555533211110 01111111111111 1111111 12366788999999999999999999999
Q ss_pred HHHHHHhhhhhc
Q 039736 615 VSMDLEGLRRSQ 626 (633)
Q Consensus 615 v~~~L~~i~~s~ 626 (633)
|+++|+++.+++
T Consensus 322 ll~~L~~l~~~~ 333 (337)
T 3mdy_A 322 VKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHhhc
Confidence 999999999876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.51 Aligned_cols=254 Identities=26% Similarity=0.460 Sum_probs=203.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-CceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||++.. +|+.||||.++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46889999999999999999998 58899999987643 456789999999999999999999997655 478999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 97 ~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp CTTEEHHHHHHHHHH--------------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEEC
T ss_pred CCCCCHHHHHHhccc--------------ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEe
Confidence 999999999965421 24889999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. .
T Consensus 160 Dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~-------- 224 (278)
T 1byg_A 160 DFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-------- 224 (278)
T ss_dssp CCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H--------
T ss_pred eccccccccccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------
Confidence 999998653321 22357889999999999999999999999999999998 9999864432221 1
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+.+........+...+..+.+++.+||+.||++|||+.|+++.|+.++...
T Consensus 225 -----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 225 -----PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp -----HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -----HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 001111112233445678999999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.65 Aligned_cols=251 Identities=26% Similarity=0.332 Sum_probs=205.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChh------HHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKT------QIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||++... +|+.||+|.++..... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999964 6899999988653221 346788999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~ 151 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCT
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCC
Confidence 9999999999999998642 36999999999999999999999999 9999999999999887
Q ss_pred C----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+ .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~~~vkl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--- 226 (361)
T 2yab_A 152 NIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 226 (361)
T ss_dssp TSSSCCEEECCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---
T ss_pred CCCccCEEEEecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---
Confidence 7 79999999998764432 22345699999999999998999999999999999999999999965433221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
+...... .. -+++... ...+..+.+|+.+||..||.+|||+.|+++
T Consensus 227 ---~~~i~~~-~~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 227 ---LANITAV-SY--DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---HHHHHTT-CC--CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhc-CC--CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110 00 0111111 123467889999999999999999999985
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=350.57 Aligned_cols=245 Identities=23% Similarity=0.274 Sum_probs=194.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..++||+|+||+||+|... +|+.||||++... .......+..|+..+.++ +|+||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999975 7899999987542 233444566676666655 8999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+ +|+|.+++... ...++|..++.|+.|++.||+|||+.+ |+||||||+|||++.++++|
T Consensus 137 e~~-~~~L~~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---------------GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp ECC-CCBHHHHHHHH---------------CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEE
T ss_pred ecc-CCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEE
Confidence 999 67998888653 236999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... ......||++|+|||++.+ .++.++||||||+++|||++|..|+..... ....
T Consensus 198 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~ 264 (311)
T 3p1a_A 198 LGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQL 264 (311)
T ss_dssp ECCCTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHH
T ss_pred EccceeeeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHH
Confidence 99999998764332 2234568999999999875 789999999999999999999777542111 0011
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ...+.+ +......+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~----~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 RQG----YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TTT----CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcc----CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111 111111 12334678999999999999999999999863
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.90 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=205.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 357889999999999999999964 689999998765322 1356789999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~ 150 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCS
T ss_pred EEEEEcCCCCCHHHHHHhc----------------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecC
Confidence 9999999999999998642 36999999999999999999999999 9999999999999988
Q ss_pred C----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+ .+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 151 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--- 225 (326)
T 2y0a_A 151 NVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 225 (326)
T ss_dssp SSSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---
T ss_pred CCCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---
Confidence 7 899999999987643322 2335689999999999999999999999999999999999999865433221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ . ..... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 226 ---~~~~~~~~-~--~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 ---LANVSAVN-Y--EFEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---HHHHHHTC-C--CCCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHhcC-C--CcCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111000 0 00011 111234678899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.87 Aligned_cols=264 Identities=22% Similarity=0.313 Sum_probs=211.1
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEE
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCC 399 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~ 399 (633)
+..++++...++|+..+.||+|+||.||++... +|+.||||+++... ....+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667789999999999999999999964 78999999986522 22334588999999999999999999999
Q ss_pred eeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 400 LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 400 ~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---------------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N 192 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---------------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDN 192 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHH
Confidence 99999999999999999999996532 36999999999999999999999999 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc-------cCCCCcccchhhHHHHHHHHHhCCCCCCC
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-------SSQYTDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-------~~~~s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
||++.++++||+|||+++..............||+.|+|||++. .+.++.++|||||||++|||++|+.||..
T Consensus 193 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp EEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999999999999999877554443344567999999999987 45689999999999999999999999975
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKR---PTMKQVSMD 618 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R---Pt~~ev~~~ 618 (633)
....+. +........ ...-+ ..+...+..+.+|+.+||. +|.+| |++.|++++
T Consensus 273 ~~~~~~------~~~i~~~~~--~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 273 DSTAET------YGKIVHYKE--HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp SSHHHH------HHHHHTHHH--HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCHHHH------HHHHHhccc--CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 443221 111111000 00000 1123345778999999999 99998 689998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.25 Aligned_cols=278 Identities=25% Similarity=0.407 Sum_probs=216.9
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEcCC-C-----CEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEe
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGMLPD-G-----SIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCL 400 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~~~-g-----~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~ 400 (633)
++...++|...+.||+|+||.||+|.... + ..||+|.++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 33445789999999999999999999532 2 47999998764 334567899999999999 8999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
+.+..++||||+++|+|.+++............ .......+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--FAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhccccccccc--ccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 999999999999999999999764321000000 0001236899999999999999999999998 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhh
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEE 558 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~ 558 (633)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999999999986643322 22233457889999999999999999999999999999999 8889854332211
Q ss_pred hcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 559 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+... +........+...+..+.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus 276 ------~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 276 ------FYKL---------VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp ------HHHH---------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------HHHH---------HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111 1111112223334567899999999999999999999999999988765
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=355.04 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=201.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCC--CCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||++...+++.||||++.. ......+.+.+|+.++++++| +||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 357889999999999999999988899999998764 344556789999999999986 9999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|| +.+|+|.+++... ..+++.++..++.|++.||.|||+++ |+||||||+|||++ ++.+
T Consensus 88 ~e-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~ 146 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGML 146 (343)
T ss_dssp EC-CCSEEHHHHHHHS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEE
T ss_pred Ee-CCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcE
Confidence 99 5688999998653 46999999999999999999999999 99999999999997 5789
Q ss_pred EEeecCCCccCCCCCcc-eecccccCCCcCchhcccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 489 KVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 226 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 226 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH
Confidence 99999999876443322 2334579999999999865 67889999999999999999999998542221
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
. . .+...+++......+......+.+|+.+||+.||.+|||+.|++++-
T Consensus 227 ~-----~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 227 I-----S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp H-----H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred H-----H---------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1 1 11222333333334444456789999999999999999999998763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=357.65 Aligned_cols=248 Identities=24% Similarity=0.327 Sum_probs=199.1
Q ss_pred ccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccCC
Q 039736 337 NQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNG 415 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~g 415 (633)
...+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3356899999999999985 468999999998766667778999999999999999999999999999999999999999
Q ss_pred CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee--cCCCcEEEeec
Q 039736 416 TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL--DDKFSAKVSDF 493 (633)
Q Consensus 416 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl--~~~~~~kI~Df 493 (633)
+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++++||+||
T Consensus 172 ~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DF 233 (373)
T 2x4f_A 172 ELFDRIIDES---------------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDF 233 (373)
T ss_dssp EEHHHHHHTG---------------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCC
T ss_pred cHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeC
Confidence 9999886532 25899999999999999999999999 9999999999999 67789999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +.......
T Consensus 234 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~- 304 (373)
T 2x4f_A 234 GLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACR- 304 (373)
T ss_dssp SSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTC-
T ss_pred CCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcc-
Confidence 99987643322 2234689999999999999999999999999999999999999965443221 11111110
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
. . ............+.+|+.+||+.||.+|||+.|+++
T Consensus 305 ~-~-----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 305 W-D-----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp C-C-----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-C-----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0 000111233467899999999999999999999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.53 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=198.9
Q ss_pred CCccCCcccccCcEEEEEEEcC--CC--CEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCceEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVLV 408 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~--~g--~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~LV 408 (633)
.|...+.||+|+||.||+|... ++ ..||||.++.. .....++|.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999853 22 36899988653 34567789999999999999999999999765 4578999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+
T Consensus 170 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 231 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---------------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTV 231 (373)
T ss_dssp EECCTTCBHHHHHHCT---------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EECCCCCCHHHHHhhc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCE
Confidence 9999999999999653 236899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcc---eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 489 KVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+ ....
T Consensus 232 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~ 308 (373)
T 3c1x_A 232 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY 308 (373)
T ss_dssp EECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH
T ss_pred EEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH
Confidence 99999999866432211 1223457789999999999999999999999999999999 566664332211 1111
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
... + .....+..++..+.+++.+||+.||++|||+.|+++.|+.+..+...
T Consensus 309 ---~~~-~---------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 309 ---LLQ-G---------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ---HHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---HHc-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 111 1 01112334557799999999999999999999999999999876643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=346.52 Aligned_cols=262 Identities=23% Similarity=0.334 Sum_probs=201.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||.||+|...+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999987899999999865332 2346788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 142 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---------------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA 142 (288)
T ss_dssp CSE-EHHHHHHTST---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cCC-CHHHHHHhcc---------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 985 8888876432 36899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .........
T Consensus 143 Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~ 218 (288)
T 1ob3_A 143 DFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILG 218 (288)
T ss_dssp CTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred ECccccccCcccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHC
Confidence 9999976543221 1233468999999999876 4589999999999999999999999875443221 111111111
Q ss_pred hchhh--------hhhchhhh-------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLL--------EILDARVA-------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~--------~~~d~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ...++... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10000 00111110 11112345678899999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=346.08 Aligned_cols=265 Identities=24% Similarity=0.387 Sum_probs=203.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||+|.. .+|+.||||+++. .+....+++.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35789999999999999999995 4789999998864 3345567899999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 111 ~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~ 175 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK------------QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVV 175 (310)
T ss_dssp EECCCSCBHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred EecCCCCCHHHHHHHhcc------------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCE
Confidence 999999999999865322 1346899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 176 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~ 250 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI 250 (310)
T ss_dssp EECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHH
T ss_pred EEEeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHh
Confidence 9999999987643221 223346899999999999999999999999999999999999998543211 11111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... ........+..+.+|+.+||+.||++|||+.||++.|+++.+..
T Consensus 251 -~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 251 -EQCDY--------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp -HTTCS--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -hcccC--------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 11100 01111234567899999999999999999999999999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=355.09 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=204.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-----hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
.++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35789999999999999999985 468999999875421 113567899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~ 167 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRAD------------AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKE 167 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSS
T ss_pred EEEeCCCCCCHHHHHHHhcc------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCC
Confidence 99999999999988865432 1235899999999999999999999999 99999999999998765
Q ss_pred c---EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 487 S---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
. +||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 168 ~~~~vkl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------- 239 (351)
T 3c0i_A 168 NSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER------- 239 (351)
T ss_dssp TTCCEEECCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------
T ss_pred CCCcEEEecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------
Confidence 5 99999999987654322 223456999999999999999999999999999999999999998653211
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+...... .. ...+... ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~i~~~-~~--~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 240 LFEGIIKG-KY--KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHT-CC--CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcC-CC--CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111111 00 0111111 1234678899999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=357.33 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=208.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||+|... +|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 468999999999999999999964 6889999998876666667899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--CCcEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD--KFSAK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 489 (633)
+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 130 ~~gg~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vk 191 (387)
T 1kob_A 130 LSGGELFDRIAAED---------------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVK 191 (387)
T ss_dssp CCCCBHHHHTTCTT---------------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEE
T ss_pred CCCCcHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceE
Confidence 99999999986532 36899999999999999999999999 999999999999974 57899
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 192 L~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~ 263 (387)
T 1kob_A 192 IIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVK 263 (387)
T ss_dssp ECCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH
T ss_pred EEecccceecCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999987654322 2334689999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... . ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 264 ~~~-~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 264 RCD-W------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HCC-C------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hCC-C------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 100 0 00111122345678999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.58 Aligned_cols=258 Identities=23% Similarity=0.456 Sum_probs=203.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..+.||+|+||.||+|... +++ .||+|.+... .....+.+.+|+.++++++||||+++++++... ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceE
Confidence 57889999999999999999953 444 3577776542 334567899999999999999999999999865 4789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|+||+++|+|.+++.... ..+++..++.|+.|++.||.|||+++ |+||||||+|||++.++.
T Consensus 94 v~~~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---------------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEecCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCC
Confidence 999999999999986542 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------- 228 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------- 228 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------
Confidence 999999999876433222 2223456788999999999999999999999999999999 9999865433321
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+.+........+......+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 229 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 229 ---------SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---------HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1111111122233445667899999999999999999999999999987543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=350.93 Aligned_cols=273 Identities=27% Similarity=0.436 Sum_probs=211.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCE--EEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSI--VAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~--vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+.||+|+||.||+|... +|.. ||||+++.. .....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67889999999999999999964 4554 499988753 334456789999999999 899999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.....................+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 9999999999999765421111111111122357999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~------~~- 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE- 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HH-
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH------HH-
Confidence 99999999754221 11123346889999999998889999999999999999998 9999865432221 11
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
. +........+...+..+.+|+.+||+.||.+|||+.|+++.|+++..+..
T Consensus 253 ~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 K---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H---------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H---------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1 11111122334455789999999999999999999999999999987663
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=346.26 Aligned_cols=258 Identities=25% Similarity=0.402 Sum_probs=208.7
Q ss_pred hcCCccCC-cccccCcEEEEEEEc---CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 333 TDNYNQSR-FLGQGGFGTVYKGML---PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 333 ~~~~~~~~-~ig~G~~G~Vy~g~~---~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
.++|...+ .||+|+||.||+|.+ .+++.||||+++... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45777777 999999999999964 246789999987532 23466899999999999999999999999 567789
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 94 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 154 (291)
T ss_dssp EEEECCTTEEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred EEEEeCCCCCHHHHHHhC----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCC
Confidence 999999999999998653 35899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCccee--cccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
.+||+|||++........... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----- 229 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----- 229 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-----
Confidence 999999999987654433222 22346788999999998889999999999999999999 9999865433221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
...... ......+...+..+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 230 --~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 230 --TAMLEK---------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111111 1112233455678999999999999999999999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.23 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=201.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||++... +|+.||||+++.. .....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999964 6899999998753 233456788999999988 79999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 102 v~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ 162 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----------------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGH 162 (353)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCC
Confidence 99999999999998653 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. +..
T Consensus 163 ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~ 235 (353)
T 3txo_A 163 CKLADFGMCKEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEA 235 (353)
T ss_dssp EEECCCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEEccccceeecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 9999999998643222 223445799999999999998999999999999999999999999975443221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM------KQVSM 617 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~------~ev~~ 617 (633)
..... ..++......+.+|+.+||+.||++||++ .|+++
T Consensus 236 i~~~~-----------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 ILNDE-----------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHcCC-----------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11110 12233345678899999999999999998 66664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=354.38 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=206.8
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
...++|...+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999964 6899999998643 34556789999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF- 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 486 (633)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++
T Consensus 106 v~e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~ 166 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR----------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166 (362)
T ss_dssp EECCCCSCBHHHHHTTC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSST
T ss_pred EEecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCC
Confidence 99999999999988643 36899999999999999999999999 99999999999998654
Q ss_pred --cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 487 --SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 487 --~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 167 ~~~~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~ 238 (362)
T 2bdw_A 167 GAAVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------L 238 (362)
T ss_dssp TCCEEECCCTTCBCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred CCCEEEeecCcceEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------H
Confidence 599999999987653322 234569999999999999899999999999999999999999986543221 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... +... . ........+..+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~i~~-~~~~-~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 239 YAQIKA-GAYD-Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHHHHH-TCCC-C-----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHh-CCCC-C-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111 1000 0 000112234678899999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=354.61 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=201.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+.|...+.||+|+||.||+|.. .+|+.||||++... .....+++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999995 57899999998643 2334568999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++ |+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 134 e~~~-g~l~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 194 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 194 (348)
T ss_dssp ECCS-EEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEE
T ss_pred ecCC-CCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEE
Confidence 9997 6888877543 246999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||+++..... ....||+.|+|||.+. .+.++.++||||||+++|||++|+.||........ ..
T Consensus 195 L~DfG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~ 263 (348)
T 1u5q_A 195 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY 263 (348)
T ss_dssp ECCCTTCBSSSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH
T ss_pred EeeccCceecCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HH
Confidence 9999999875432 2346899999999984 56789999999999999999999999864432211 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
...... .+ ...+...+..+.+|+.+||+.||++|||+.|++++.
T Consensus 264 ~~~~~~------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 264 HIAQNE------SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHHHSC------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HHHhcC------CC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 111111 00 111223446788999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=349.00 Aligned_cols=266 Identities=22% Similarity=0.330 Sum_probs=209.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~L 407 (633)
.++|...+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999995 5789999999877667777889999999999999999999999873 336799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ ++||||||+|||++.++.
T Consensus 108 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD------------KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred EEEeCCCCcHHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCC
Confidence 9999999999999975322 1347999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc--------eecccccCCCcCchhccccCC---CCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 488 AKVSDFGTSRSVPNDKTH--------LTTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~--------~~~~~~gt~~y~APE~l~~~~---~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+||+|||++......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||......
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 999999998765321110 011234799999999987543 688999999999999999999997421111
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
. .. .............+...+..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 253 ~-~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 253 G-DS-------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp T-SC-------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred c-ch-------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0 00 000011111111223445789999999999999999999999999999886553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.58 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=206.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee-CCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-TEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~L 407 (633)
.+|...+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999998532 236899988753 44556789999999999999999999998754 457899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||++++++.
T Consensus 105 v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~ 166 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---------------THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFT 166 (298)
T ss_dssp EEECCTTCBHHHHHHCT---------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCC
T ss_pred EEeCCCCCCHHHHHHhc---------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCC
Confidence 99999999999999653 236899999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc---ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCchhhhhcHHH
Q 039736 488 AKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVA 563 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~-p~~~~~~~~~~~l~~ 563 (633)
+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+......+ ...
T Consensus 167 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~ 243 (298)
T 3f66_A 167 VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV 243 (298)
T ss_dssp EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH
T ss_pred EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH
Confidence 99999999987643322 11233457889999999999999999999999999999999554 443222111 111
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
..... .....+...+..+.+++.+||+.||++|||+.|+++.|+++......
T Consensus 244 ---~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 244 ---YLLQG----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---HHhcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 01110 01112233456789999999999999999999999999999886643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=348.84 Aligned_cols=268 Identities=23% Similarity=0.370 Sum_probs=192.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999964 68999999886533 2234578899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|++ |+|.+++...... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~-~~L~~~l~~~~~~----------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl 149 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG----------NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKL 149 (317)
T ss_dssp CCC-CBHHHHHHHHHSS----------SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred ecC-CCHHHHHHhcccc----------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEE
Confidence 998 6999988654210 01235899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+....
T Consensus 150 ~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~ 225 (317)
T 2pmi_A 150 GDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIM 225 (317)
T ss_dssp CCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHH
T ss_pred CcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh
Confidence 99999987643222 1233468999999999976 4689999999999999999999999976544332 11111111
Q ss_pred hhc--hhhhh------hc------------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KEN--KLLEI------LD------------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~--~~~~~------~d------------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..... .. ..+....+......+.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 100 00000 00 000111112334678999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=348.64 Aligned_cols=267 Identities=24% Similarity=0.431 Sum_probs=203.7
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC----CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC-
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE- 403 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~- 403 (633)
...++|...+.||+|+||.||+|... .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34568888999999999999999853 3458999998753 3455678999999999999999999999998654
Q ss_pred ----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 404 ----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 404 ----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
..++||||+++|+|.+++...... .....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 177 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLE----------TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARN 177 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBT----------TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGG
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhh----------cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 349999999999999998543211 01346999999999999999999999998 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEE 557 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~ 557 (633)
|+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.......
T Consensus 178 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 178 CMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp EEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 99999999999999999876433221 2233457889999999999999999999999999999999 888876543322
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. . ...... .....+...+..+.+++.+||+.||.+|||+.|++++|+++..+.
T Consensus 258 ~---~---~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 258 M---Y---DYLLHG----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp H---H---HHHHTT----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred H---H---HHHHcC----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1 1 111111 111223345578999999999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=341.59 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=206.1
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee---------
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--------- 401 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--------- 401 (633)
..++|+..+.||+|+||.||+|... +|+.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3467899999999999999999975 78999999987643 256689999999999999999998864
Q ss_pred -------CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 402 -------TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 402 -------~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ ++|||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 147 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--------------GEKLDKVLALELFEQITKGVDYIHSKK---LINRD 147 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG--------------GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 345799999999999999996542 246999999999999999999999999 99999
Q ss_pred CCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 475 IKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 475 Ik~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
|||+||++++++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus 148 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-- 223 (284)
T 2a19_B 148 LKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-- 223 (284)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--
T ss_pred CCHHHEEEcCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--
Confidence 999999999999999999999987654322 2334689999999999999999999999999999999999988521
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcccc
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRCV 629 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~~ 629 (633)
.. .... ..... ..+...+..+.+++.+||+.||++|||+.|++++|+.++.+.+..
T Consensus 224 ---~~---~~~~-~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 224 ---TS---KFFT-DLRDG------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp ---HH---HHHH-HHHTT------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred ---HH---HHHH-Hhhcc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 00 0111 11111 112223456889999999999999999999999999998876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.95 Aligned_cols=254 Identities=22% Similarity=0.328 Sum_probs=205.6
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
..++|+..+.||+|+||.||++.. .+|+.+|+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999985 47899999987653 334566789999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec---CC
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DK 485 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~ 485 (633)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+
T Consensus 89 ~E~~~gg~L~~~i~~~----------------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~ 149 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR----------------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKG 149 (444)
T ss_dssp ECCCBCCBHHHHHHHC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTT
T ss_pred EEeCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCC
Confidence 9999999999988642 46999999999999999999999999 99999999999998 56
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......+. .
T Consensus 150 ~~vkL~DFG~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~ 222 (444)
T 3soa_A 150 AAVKLADFGLAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------Y 222 (444)
T ss_dssp CCEEECCCSSCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------H
T ss_pred CcEEEccCceeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------H
Confidence 8899999999987654332 22345699999999999998999999999999999999999999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... +.. + .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~i~~-~~~-~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 223 QQIKA-GAY-D-----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHH-TCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHh-CCC-C-----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111 100 0 0001112345678999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=348.26 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=205.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||++... +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367889999999999999999964 68999999986532 23456788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++
T Consensus 85 ~e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS----------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp ECCCCSCBHHHHHHHT----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCE
T ss_pred EeCCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCE
Confidence 9999999999998642 35899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+...
T Consensus 146 kL~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i 215 (318)
T 1fot_A 146 KITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKI 215 (318)
T ss_dssp EECCCSSCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH
T ss_pred EEeecCcceecCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99999999875432 234569999999999999999999999999999999999999986543221 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
... . ...+......+.+++.+||+.||++|| ++.|++++
T Consensus 216 ~~~---------~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 216 LNA---------E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHC---------C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhC---------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111 0 112334456789999999999999999 88888753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.51 Aligned_cols=273 Identities=22% Similarity=0.343 Sum_probs=212.8
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhc--cCCCCceEEEEEEee
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQ--INHRHIVKLLGCCLE 401 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~g~~~~ 401 (633)
.....-....++|...+.||+|+||.||+|.. +|+.||||++... ..+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 44444556667999999999999999999998 5899999998653 34567789998887 789999999999987
Q ss_pred CC----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH--------hcCCCC
Q 039736 402 TE----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--------SAASIP 469 (633)
Q Consensus 402 ~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH--------~~~~~~ 469 (633)
.+ ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--- 167 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--- 167 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc-----------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---
Confidence 76 78999999999999999853 25899999999999999999999 666
Q ss_pred eeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcc---eecccccCCCcCchhccccC------CCCcccchhhHHHHH
Q 039736 470 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVL 540 (633)
Q Consensus 470 ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDV~SfGvvL 540 (633)
|+||||||+|||++.++++||+|||+++........ ......||+.|+|||.+.+. .++.++||||||+++
T Consensus 168 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 247 (342)
T 1b6c_B 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF 247 (342)
T ss_dssp EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence 999999999999999999999999999876443322 12345689999999999765 334789999999999
Q ss_pred HHHHhC----------CCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcc-cCHHHHHHHHHHHHhccccCCCCC
Q 039736 541 LELLTG----------KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKE-AREEDIEAVAELAMGCLRLNSKKR 609 (633)
Q Consensus 541 ~elltG----------~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~L~~~Cl~~dP~~R 609 (633)
|||++| +.||....... ..... +........ ..+.+... ...+....+.+|+.+||+.||++|
T Consensus 248 ~el~tg~~~~~~~~~~~~p~~~~~~~~-~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (342)
T 1b6c_B 248 WEIARRCSIGGIHEDYQLPYYDLVPSD-PSVEE-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321 (342)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSS-CCHHH-HHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGS
T ss_pred HHHHhccCcCCcccccccCccccCcCc-ccHHH-HHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhC
Confidence 999999 66764332111 01111 111111111 11111111 123567789999999999999999
Q ss_pred CCHHHHHHHHHhhhhhc
Q 039736 610 PTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 610 Pt~~ev~~~L~~i~~s~ 626 (633)
||+.||+++|+++....
T Consensus 322 ps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 322 LTALRIKKTLSQLSQQE 338 (342)
T ss_dssp CCHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHHHHHh
Confidence 99999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=343.32 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=201.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||.||+|... +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999964 6899999988643 33345688899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl 142 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---------------NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp CCSE-EHHHHHHHT---------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred cCCC-CHHHHHHhC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence 9985 555555332 246999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+....... .....+....
T Consensus 143 ~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~ 219 (292)
T 3o0g_A 143 ANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLL 219 (292)
T ss_dssp CCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHH
T ss_pred eecccceecCCccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHh
Confidence 99999987643222 223356899999999997765 7999999999999999999988864332221 1111111111
Q ss_pred hhchhhhh---h---ch---------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEI---L---DA---------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~---~---d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......+ . +. .............+.+|+.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11100000 0 00 00001112345678899999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.05 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=210.0
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEE-eeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~-~~~~~~~LV~E 410 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .+.+.+|+.+++.++|++++..++.+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999995 5789999998765332 23678999999999998877666665 45667899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCCc
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFS 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~ 487 (633)
|+ +|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||+|||+ +.++.
T Consensus 86 ~~-~~~L~~~~~~~~---------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~ 146 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---------------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNL 146 (296)
T ss_dssp CC-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTC
T ss_pred ec-CCCHHHHHHhhc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCe
Confidence 99 999999986432 36999999999999999999999999 9999999999999 48899
Q ss_pred EEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 488 AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 999999999876443221 12345689999999999999999999999999999999999999975433222222
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
........... ..+. .....+..+.+++.+||+.||++|||+.||++.|+.+..+...
T Consensus 227 ~~~~~~~~~~~-----~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 227 YERISEKKMST-----PIEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHS-----CHHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hhhhcccccCC-----chHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 21111110000 0001 1122346789999999999999999999999999999887754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.46 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=198.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce---
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP--- 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~--- 405 (633)
.++|+..+.||+|+||.||++.. .+++.||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36899999999999999999995 57899999998753 334456889999999999999999999998866543
Q ss_pred -EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 406 -VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 406 -~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~ 151 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 151 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred cEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcC
Confidence 9999999999999998642 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 152 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---- 227 (311)
T 3ork_A 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---- 227 (311)
T ss_dssp TSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----
T ss_pred CCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----
Confidence 99999999999987643322 222345689999999999999999999999999999999999999965443221
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH-HHHHHHhhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ-VSMDLEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e-v~~~L~~i~ 623 (633)
.......... .+ .......+..+.+++.+||+.||++||+..+ +...|.++.
T Consensus 228 --~~~~~~~~~~----~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 228 --AYQHVREDPI----PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --HHHHHHCCCC----CH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --HHHHhcCCCC----Cc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111111100 00 0111234567899999999999999997555 555565544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=344.47 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=202.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999964 6889999998653 233457889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 113 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~ 173 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----------------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFA 173 (309)
T ss_dssp EECCCCEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred EEecCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCE
Confidence 9999999999998642 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++...............|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~ 246 (309)
T 2h34_A 174 YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAH 246 (309)
T ss_dssp EECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHH
T ss_pred EEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHH
Confidence 999999998765443333344568999999999999999999999999999999999999986433211 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhhhhc
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-t~~ev~~~L~~i~~s~ 626 (633)
.... . .. ....+...+..+.+++.+||+.||++|| ++.++++.|+.+....
T Consensus 247 ~~~~-~---~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 247 INQA-I---PR---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHSC-C---CC---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred hccC-C---CC---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1110 0 00 1122334456789999999999999999 9999999999887665
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.54 Aligned_cols=267 Identities=20% Similarity=0.255 Sum_probs=207.1
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEE-eeCCceEEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCC-LETEVPVLVY 409 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~-~~~~~~~LV~ 409 (633)
..++|...+.||+|+||.||+|.. .+++.||||++..... .+.+.+|++++++++|++++..++.+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999994 5789999998654322 23577899999999988877776666 5566789999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKF 486 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~ 486 (633)
||+ +|+|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++
T Consensus 85 e~~-~~~L~~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~ 145 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC---------------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGN 145 (296)
T ss_dssp ECC-CCBHHHHHHHT---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTT
T ss_pred Ecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCC
Confidence 999 99999998643 236999999999999999999999999 9999999999999 7899
Q ss_pred cEEEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 487 SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 225 (296)
T 4hgt_A 146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 225 (296)
T ss_dssp CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence 999999999987643322 12234568999999999999999999999999999999999999997544332222
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
............. .+ ......+..+.+++.+||+.||++|||+.|+++.|+.+..+...
T Consensus 226 ~~~~~~~~~~~~~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 226 KYERISEKKMSTP-----IE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHHSC-----HH----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhhhhhcccccch-----hh----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 2111111110000 00 01122346789999999999999999999999999999987753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.73 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=200.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccc--cChhHHHHHHHHHHHHhccC--CCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRA--IDKTQIEQFINEVVILSQIN--HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~--H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||++...+++.||||++.. ......+.+.+|+.+|++++ |+||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46899999999999999999987899999998764 34456678999999999996 599999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
| +.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+|
T Consensus 136 E-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~k 194 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLK 194 (390)
T ss_dssp E-CCSEEHHHHHHHC----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEE
T ss_pred e-cCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEE
Confidence 9 5688999998653 36899999999999999999999999 99999999999996 57999
Q ss_pred EeecCCCccCCCCCcc-eecccccCCCcCchhcccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 490 VSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 490 I~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.......
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 274 (390)
T 2zmd_A 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274 (390)
T ss_dssp ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence 9999999876433222 2334569999999999865 468899999999999999999999985432111
Q ss_pred hhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .+..++++......+......+.+|+.+||+.||++|||+.|++++
T Consensus 275 -----~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 275 -----S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----H---------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1 1122233332223333345678999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.00 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=200.3
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999964 58999999875532 3345678899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 83 ~~~~~~l~~~~~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl 143 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----------------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKL 143 (311)
T ss_dssp CCSEEHHHHHHHTS----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred eCCCchHHHHHhhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEE
Confidence 99999998877542 36999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH----
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF---- 565 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~---- 565 (633)
+|||++........ ......||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........
T Consensus 144 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 144 CDFGFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp CCCTTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eeCCCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 99999987643322 2234468999999999876 66899999999999999999999999765543321111100
Q ss_pred ----HHHHhhchhhhh---hchhhh---cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ----ISLAKENKLLEI---LDARVA---KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ----~~~~~~~~~~~~---~d~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
............ .++... .......+..+.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 000000 00002345678999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=348.00 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=196.2
Q ss_pred hcCCccCCcccccCcEEEEEEEc----CCCCEEEEEEccccC----hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.++|+..+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 478999999987532 2344567899999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~ 156 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----------------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNH 156 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECT
T ss_pred EEEEEeCCCCCcHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECC
Confidence 99999999999999988642 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++++||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------ 229 (327)
T 3a62_A 157 QGHVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------ 229 (327)
T ss_dssp TSCEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------
T ss_pred CCcEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------
Confidence 9999999999998643222 122345689999999999999999999999999999999999999965433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
....... ....+......+.+|+.+||+.||++|| ++.|++++
T Consensus 230 ~~~i~~~-----------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 230 IDKILKC-----------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHT-----------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHhC-----------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111110 0122334457789999999999999999 77788764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=380.31 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=202.8
Q ss_pred CcccccCcEEEEEEEcC---CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLP---DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
+.||+|+||.||+|.+. .++.||||+++.. +....++|.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999652 4678999998753 2344678999999999999999999999996 4568999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 454 g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFG 514 (635)
T 4fl3_A 454 GPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 514 (635)
T ss_dssp EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTT
T ss_pred CCHHHHHhhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcC
Confidence 9999999542 36999999999999999999999999 9999999999999999999999999
Q ss_pred CCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 495 TSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 495 la~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
+++........ ......+|+.|+|||.+.+..++.++||||||++||||++ |+.||......+.
T Consensus 515 la~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~------------- 581 (635)
T 4fl3_A 515 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------------- 581 (635)
T ss_dssp HHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------------
T ss_pred CccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------------
Confidence 99876443322 2233456789999999999999999999999999999998 9999865443321
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.+.+........+..++..+.+|+.+||+.||++||++.+|++.|+.+..+
T Consensus 582 ---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 582 ---TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111111122234455668899999999999999999999999999988654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=356.53 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=199.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||+++.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 368999999999999999999964 5789999998753 223344678899999887 89999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 131 V~E~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp EEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSC
T ss_pred EEEcCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCC
Confidence 99999999999888643 36999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh--hcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE--RNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~--~~l~~~~ 565 (633)
+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 192 ikL~DFGla~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~ 270 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270 (396)
T ss_dssp EEECCCTTCBCCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHH
T ss_pred EEEeecceeeecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHH
Confidence 9999999998642222 223446799999999999999999999999999999999999999964322111 1111111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
....... ....+......+.+|+.+||+.||++||++
T Consensus 271 ~~~i~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHhcc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111111 112344456778999999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=355.00 Aligned_cols=269 Identities=20% Similarity=0.266 Sum_probs=204.4
Q ss_pred hcCCccCCccccc--CcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQG--GFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G--~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+| +||.||++... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999965 6899999998653 34556788899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~ 166 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--------------MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGK 166 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCC
T ss_pred EEEccCCCCHHHHHhhhc--------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence 999999999999986542 246999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc------ceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 488 AKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
+||+|||.+........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 246 (389)
T 3gni_B 167 VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246 (389)
T ss_dssp EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH
T ss_pred EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999865422111 11123468899999999987 57899999999999999999999999654322110
Q ss_pred --cHHHHHHHHHh------------------hchhhhhhch---------hhhcccCHHHHHHHHHHHHhccccCCCCCC
Q 039736 560 --NLVAYFISLAK------------------ENKLLEILDA---------RVAKEAREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 560 --~l~~~~~~~~~------------------~~~~~~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
........... .....+.+.. ......+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 326 (389)
T 3gni_B 247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326 (389)
T ss_dssp HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTSC
T ss_pred HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCC
Confidence 00000000000 0000000000 000112233456799999999999999999
Q ss_pred CHHHHHHH
Q 039736 611 TMKQVSMD 618 (633)
Q Consensus 611 t~~ev~~~ 618 (633)
|+.|++++
T Consensus 327 ta~ell~h 334 (389)
T 3gni_B 327 SASTLLNH 334 (389)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.24 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=205.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68899999999999999999964 68999999986532 234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 121 e~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~k 181 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp ECCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred cCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEE
Confidence 999999999998643 36899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+....
T Consensus 182 L~DFg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~ 251 (350)
T 1rdq_E 182 VTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV 251 (350)
T ss_dssp ECCCTTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred EcccccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHH
Confidence 9999999876432 234568999999999999999999999999999999999999986543222 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
. +. ...+......+.+|+.+||+.||.+||+ +.||+++
T Consensus 252 ~-~~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 252 S-GK----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp H-CC----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred c-CC----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 10 1223344577899999999999999998 8888753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=352.48 Aligned_cols=265 Identities=19% Similarity=0.249 Sum_probs=200.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC----CCCEEEEEEccccChh-----------HHHHHHHHHHHHhccCCCCceEEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAIDKT-----------QIEQFINEVVILSQINHRHIVKLLGC 398 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~~~~-----------~~~~~~~Ei~il~~l~H~nIv~l~g~ 398 (633)
++|...+.||+|+||.||+|... ++..||||+....... ..+.+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57889999999999999999975 5678999987653221 11246778899999999999999999
Q ss_pred Eee----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 399 CLE----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 399 ~~~----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
+.. ....++||||+ +++|.+++... ..+++..++.|+.||+.||+|||+++ |+|||
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 176 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----------------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGD 176 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----------------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 987 66789999999 99999999753 25999999999999999999999998 99999
Q ss_pred CCCCCeeecCCC--cEEEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhC
Q 039736 475 IKSSNILLDDKF--SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546 (633)
Q Consensus 475 Ik~~NILl~~~~--~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG 546 (633)
|||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 256 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCG 256 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999887 999999999987632211 111345689999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 547 KKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 547 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
+.||........ .. ...... ....+...+.... ....+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 257 ~~pf~~~~~~~~-~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 257 KLPWEQNLKDPV-AV-QTAKTN-----LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp SCTTGGGTTCHH-HH-HHHHHH-----HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred CCCccccccccH-HH-HHHHHh-----hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 999853211111 00 000000 1111111111100 113456899999999999999999999999999987653
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.77 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=194.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEee--------C
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLE--------T 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~--------~ 402 (633)
..+|...+.||+|+||.||++.. .+|+.||||++........+.+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 45889999999999999999995 478999999987766777788999999999996 9999999999952 3
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
...++||||++ |+|.+++..... ...+++..++.++.||+.||.|||+++ ++|+||||||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-------------RGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLL 171 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-------------TCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEE
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEE
Confidence 34799999996 799998865332 346999999999999999999999986 459999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcce-----------ecccccCCCcCchhcc---ccCCCCcccchhhHHHHHHHHHhCCC
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHL-----------TTAVQGTFGYFDPEYF---QSSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~-----------~~~~~gt~~y~APE~l---~~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
+.++++||+|||+++......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998764332211 1134589999999998 56678999999999999999999999
Q ss_pred CCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 549 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 549 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
||....... .+........+......+.+|+.+||+.||++|||+.|+++.|+.+....
T Consensus 252 p~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 252 PFEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp CC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 985321110 01111111111222345789999999999999999999999999998765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.83 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=204.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67899999999999999999954 6889999987642 2234567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|
T Consensus 95 e~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----------------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp CCCTTEEHHHHHHTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEE
Confidence 999999999998652 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||+++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||............ .
T Consensus 156 L~DFG~a~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~ 230 (384)
T 4fr4_A 156 ITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---H 230 (384)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---H
T ss_pred EeccceeeeccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---H
Confidence 99999998764332 2344679999999999864 45889999999999999999999999654332211111 1
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-MKQVSM 617 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-~~ev~~ 617 (633)
.... ....++...+..+.+|+.+||+.||.+||+ +.++..
T Consensus 231 ~~~~-----------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 231 TFET-----------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHH-----------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHhh-----------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1110 012234445678899999999999999999 666654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.83 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=201.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+++.. +|+.||+|+++.. .....+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57889999999999999999964 6889999998653 344566788999999988 899999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++++
T Consensus 89 ~e~~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~ 149 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----------------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHI 149 (345)
T ss_dssp ECCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCE
Confidence 9999999999988642 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh--cHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER--NLVAYFI 566 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~--~l~~~~~ 566 (633)
||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .......
T Consensus 150 kL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 228 (345)
T 3a8x_A 150 KLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228 (345)
T ss_dssp EECCGGGCBCSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH
T ss_pred EEEeccccccccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH
Confidence 999999998643222 2234457999999999999999999999999999999999999999643211100 0001111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
...... ....+...+..+.+|+.+||+.||.+||++
T Consensus 229 ~~i~~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 229 QVILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHC----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHcC----------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111111 112334455778999999999999999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.83 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=190.9
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
..++|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4568999999999999999999975 57899999987632 34568899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC---CCc
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD---KFS 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~---~~~ 487 (633)
|+++|+|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.
T Consensus 129 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~ 189 (349)
T 2w4o_A 129 LVTGGELFDRIVEK----------------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAP 189 (349)
T ss_dssp CCCSCBHHHHHTTC----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCC
T ss_pred eCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCC
Confidence 99999999988653 35899999999999999999999999 999999999999975 889
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .+..
T Consensus 190 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~ 262 (349)
T 2w4o_A 190 LKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRR 262 (349)
T ss_dssp EEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHH
T ss_pred EEEccCccccccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHH
Confidence 9999999998764322 22345689999999999999999999999999999999999999864332211 1111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... . .............+.+|+.+||+.||++|||+.|++++
T Consensus 263 i~~~~-~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 263 ILNCE-Y------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHTTC-C------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCC-C------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 0 00011112345678999999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=352.52 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=204.4
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
....++|...+.||+|+||.||+|... +|+.||||+++... ....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344578999999999999999999964 68899999987532 23456778899999887 89999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC----------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDK 153 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEeCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECC
Confidence 99999999999999998642 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
++++||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 154 ~g~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------ 226 (345)
T 1xjd_A 154 DGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------ 226 (345)
T ss_dssp TSCEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------
T ss_pred CCCEEEeEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH------
Confidence 9999999999998643222 123446799999999999999999999999999999999999999965433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK-QVS 616 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~-ev~ 616 (633)
+....... ...+......+.+|+.+||+.||++||++. |+.
T Consensus 227 ~~~i~~~~-----------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 227 FHSIRMDN-----------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHCC-----------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHhCC-----------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11111110 112333456789999999999999999997 654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=349.74 Aligned_cols=274 Identities=22% Similarity=0.278 Sum_probs=203.5
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-----ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-----DKTQIEQFINEVVILSQINHRHIVKLLGCCLET 402 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 402 (633)
+....++|...+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 455677899999999999999999996 46889999987642 334567899999999999999999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHH-----------------HHHHH-------HhhhcCCCCHHHHHHHHHHHHHH
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQ-----------------KQELE-------EEQELSSLSWENRVRVACEVAGA 458 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~-----------------~~~~~-------~~~~~~~l~~~~~~~ia~~ia~g 458 (633)
+..++||||+++|+|.+++......... ..... .......+++..++.|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998632110000 00000 00001124577888999999999
Q ss_pred HHHhHhcCCCCeeccCCCCCCeeecCCC--cEEEeecCCCccCCC---CCcceecccccCCCcCchhcccc--CCCCccc
Q 039736 459 VAYMHSAASIPIFHRDIKSSNILLDDKF--SAKVSDFGTSRSVPN---DKTHLTTAVQGTFGYFDPEYFQS--SQYTDKS 531 (633)
Q Consensus 459 L~yLH~~~~~~ivHrDIk~~NILl~~~~--~~kI~DfGla~~~~~---~~~~~~~~~~gt~~y~APE~l~~--~~~s~ks 531 (633)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.... ..........||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998776 899999999986532 11122334568999999999875 6788999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC
Q 039736 532 DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611 (633)
Q Consensus 532 DV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt 611 (633)
||||||+++|||++|+.||......+. .......... . ...........+.+|+.+||+.||.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~--~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLC--F-----ENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC--T-----TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccc--c-----CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999865443321 1111111100 0 00111123467899999999999999999
Q ss_pred HHHHHHH
Q 039736 612 MKQVSMD 618 (633)
Q Consensus 612 ~~ev~~~ 618 (633)
+.|++++
T Consensus 325 ~~~~l~h 331 (345)
T 3hko_A 325 AMRALQH 331 (345)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=353.72 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=209.2
Q ss_pred ccCHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-----CCCceEEE
Q 039736 323 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-----HRHIVKLL 396 (633)
Q Consensus 323 ~~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-----H~nIv~l~ 396 (633)
.|+..+.....++|...++||+|+||.||+|.. .+++.||||+++.. ....+.+..|++++++++ ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 344455555668999999999999999999996 47889999998753 344556788999999986 99999999
Q ss_pred EEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 397 GCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 397 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
+++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++ |+|||||
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlk 164 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN--------------YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLK 164 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCC
Confidence 9999999999999999 999999986543 235999999999999999999999999 9999999
Q ss_pred CCCeeecC-------------------------CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCccc
Q 039736 477 SSNILLDD-------------------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKS 531 (633)
Q Consensus 477 ~~NILl~~-------------------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ks 531 (633)
|+|||++. ++.+||+|||+++...... ....||+.|+|||.+.+..++.++
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~ 240 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSS 240 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCcc
Confidence 99999975 8899999999998653322 235689999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhh---chh--------hhhhchh-hhcc--------------
Q 039736 532 DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE---NKL--------LEILDAR-VAKE-------------- 585 (633)
Q Consensus 532 DV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~--------~~~~d~~-l~~~-------------- 585 (633)
||||||+++|||++|+.||......+... .+...... ... ...++.. +...
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 317 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLA---MMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHH
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHH---HHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhh
Confidence 99999999999999999997654432211 11111100 000 0000000 0000
Q ss_pred ------cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 586 ------AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 586 ------~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+......+.+|+.+||+.||++|||+.|++++
T Consensus 318 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 001112668899999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=349.59 Aligned_cols=268 Identities=25% Similarity=0.412 Sum_probs=210.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||+|.. .++..||||++... ......++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999984 24678999998653 345566899999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD- 484 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 484 (633)
++||||+++|+|.+++....... .....+++..++.++.|++.||.|||+++ ++||||||+|||++.
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~---------~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~ 176 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRP---------SQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCS---------SSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCS
T ss_pred EEEEecCCCCcHHHHHHhhcccc---------cccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecC
Confidence 99999999999999997643210 00135999999999999999999999999 999999999999994
Q ss_pred --CCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 485 --KFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 485 --~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+..+||+|||+++....... .......|++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 254 (327)
T 2yfx_A 177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 254 (327)
T ss_dssp STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH--
Confidence 45699999999975432221 22233457889999999999999999999999999999998 8899864432211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhccc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQRC 628 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~~ 628 (633)
...... . .....+...+..+.+++.+||+.||.+||++.|++++|+.+......
T Consensus 255 ----~~~~~~-~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 308 (327)
T 2yfx_A 255 ----LEFVTS-G---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308 (327)
T ss_dssp ----HHHHHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred ----HHHHhc-C---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence 111111 1 11122334456789999999999999999999999999998876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.67 Aligned_cols=251 Identities=22% Similarity=0.324 Sum_probs=204.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999964 5779999998765555677899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCCcE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSA 488 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 488 (633)
+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+
T Consensus 88 ~~~~~L~~~~~~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 148 (277)
T 3f3z_A 88 CTGGELFERVVHK----------------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPL 148 (277)
T ss_dssp CCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred cCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcE
Confidence 9999999988643 35899999999999999999999999 9999999999999 888999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++........ .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. ....
T Consensus 149 ~l~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~ 219 (277)
T 3f3z_A 149 KLIDFGLAARFKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLKI 219 (277)
T ss_dssp EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred EEEecccceeccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence 9999999987643322 233468999999999865 489999999999999999999999865443221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. .... ..... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 220 ~~-~~~~--~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 220 RE-GTFT--FPEKD----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HH-CCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred Hh-CCCC--CCchh----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1000 00000 01234678999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.72 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=196.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 46899999998752 334456788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCc
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.
T Consensus 227 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~ 287 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----------------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGH 287 (446)
T ss_dssp ECCCSSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSC
T ss_pred EeeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCC
Confidence 9999999999888542 369999999999999999999998 78 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++....... ......||+.|+|||++.+..++.++||||||++||||++|+.||........ ...
T Consensus 288 ~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~ 360 (446)
T 4ejn_A 288 IKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FEL 360 (446)
T ss_dssp EEECCCCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH
T ss_pred EEEccCCCceeccCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHH
Confidence 99999999986433222 23346799999999999999999999999999999999999999965433221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
..... ...+......+.+|+.+||+.||.+|| ++.|++++
T Consensus 361 i~~~~-----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 361 ILMEE-----------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHCC-----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHhCC-----------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11110 112334456789999999999999999 99999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.98 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=197.8
Q ss_pred cCCccC-CcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~-~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
+.|... +.||+|+||.||++.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 7899999999999995 47899999998765555567889999999985 79999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc---
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS--- 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--- 487 (633)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 92 ~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~ 152 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----------------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSP 152 (316)
T ss_dssp CCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCS
T ss_pred cCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCc
Confidence 99999999998653 35899999999999999999999998 999999999999998776
Q ss_pred EEEeecCCCccCCCCCc------ceecccccCCCcCchhcccc-----CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 488 AKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQS-----SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~-----~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+||+|||++........ .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 232 (316)
T 2ac3_A 153 VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGS 232 (316)
T ss_dssp EEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred eEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccc
Confidence 99999999986532211 11123458999999999875 56889999999999999999999999654321
Q ss_pred hhhcH--------HHHHHHHHhhchhhhhhchhhhcccCH----HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 557 EERNL--------VAYFISLAKENKLLEILDARVAKEARE----EDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 557 ~~~~l--------~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.... ............ ...+. .....+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 233 DCGWDRGEACPACQNMLFESIQEGK----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSCC----CCHHHHHHHHHHHHHCC----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccchhHHHHHHHHHhccC----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 10000 000001111110 01111 234678999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.92 Aligned_cols=260 Identities=26% Similarity=0.442 Sum_probs=200.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CCC--EEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DGS--IVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g~--~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57889999999999999999853 333 6999988653 2345678999999999999999999999998654 89
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---------------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 158 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---------------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred eeEecccCCCHHHHHHhcc---------------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCC
Confidence 9999999999999986542 25899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+.
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----- 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----- 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-----
Confidence 9999999999876543322 1223457888999999998889999999999999999999 9999865433221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
........ .....+...+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 234 -~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 234 -LHKIDKEG---------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -HHHHHTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -HHHHHccC---------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 11111110 1112233455789999999999999999999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=350.49 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=202.3
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5789999999999999999995 578999999876421 112347889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+ +|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+|
T Consensus 89 E~~-~g~l~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----------------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp CCC-CEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEE
T ss_pred ECC-CCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEE
Confidence 999 78998888543 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++........ .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 149 l~DFG~s~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------- 216 (336)
T ss_dssp ECCSSCTBTTTTSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------
T ss_pred EEEeccceeccCCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------
Confidence 999999987644322 234569999999999988776 6899999999999999999999864322110
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+... ....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 217 ------~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 217 ------FKKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ------BCCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ------HHHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000000 012233445678999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.36 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=194.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999965 789999999875332 235678999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc--EE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS--AK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~--~k 489 (633)
+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +|
T Consensus 98 ~~~~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~k 158 (361)
T 3uc3_A 98 ASGGELYERICNA----------------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLK 158 (361)
T ss_dssp CCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEE
T ss_pred CCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEE
Confidence 9999999988542 36999999999999999999999999 999999999999987765 99
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcc-cchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDK-SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~k-sDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++...... ......||+.|+|||.+.+..++.+ +||||||+++|||++|+.||....... .........
T Consensus 159 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~ 234 (361)
T 3uc3_A 159 ICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRI 234 (361)
T ss_dssp ECCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHH
T ss_pred EeecCccccccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHH
Confidence 99999998542221 2233469999999999988887666 899999999999999999986432211 111111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ...............+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 L---------SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp H---------TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred h---------cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1 1111111111234678899999999999999999999876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=353.82 Aligned_cols=264 Identities=27% Similarity=0.401 Sum_probs=194.9
Q ss_pred HHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCC--c
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETE--V 404 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~--~ 404 (633)
...++|...+.||+|+||.||+|.. .+|+.||||++.. ......+++.+|+.++++++ ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 4789999998754 33455678889999999997 999999999997554 6
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~ 144 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNA 144 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred EEEEecccC-cCHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcC
Confidence 899999998 588887753 25899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCC--------------------CcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHH
Q 039736 485 KFSAKVSDFGTSRSVPND--------------------KTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLEL 543 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~--------------------~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~el 543 (633)
++.+||+|||+++..... .........||+.|+|||.+.+ ..++.++|||||||++|||
T Consensus 145 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 145 ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp TCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred CCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 999999999999865321 1112233579999999999876 6789999999999999999
Q ss_pred HhCCCCCCCCchhhhhcHHHHHHHHHhhchhh-----------hhhc---------------------hh-hhcccCHHH
Q 039736 544 LTGKKPICLTREEEERNLVAYFISLAKENKLL-----------EILD---------------------AR-VAKEAREED 590 (633)
Q Consensus 544 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----------~~~d---------------------~~-l~~~~~~~~ 590 (633)
++|+.||......+.. ..+.......... ..++ .. .........
T Consensus 225 l~g~~pf~~~~~~~~~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQL---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 9999999765433221 1111111100000 0000 00 000001133
Q ss_pred HHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 591 IEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 591 ~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+.+|+.+||+.||++|||+.|++++
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 4678999999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.68 Aligned_cols=268 Identities=25% Similarity=0.379 Sum_probs=199.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHH--HhccCCCCceEEEEEEee-----CCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVI--LSQINHRHIVKLLGCCLE-----TEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~i--l~~l~H~nIv~l~g~~~~-----~~~~ 405 (633)
.++|...+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++|+||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36889999999999999999988 68999999987533 2344455554 455899999999986643 2246
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc---------CCCCeeccCCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA---------ASIPIFHRDIK 476 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~---------~~~~ivHrDIk 476 (633)
++||||+++|+|.+++.. ...+|..+++++.||+.||.|||+. + |+|||||
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dik 147 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLN 147 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCS
T ss_pred EEEEecCCCCcHHHHHhh-----------------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccc
Confidence 899999999999999854 2468999999999999999999998 6 9999999
Q ss_pred CCCeeecCCCcEEEeecCCCccCCCCCc-------ceecccccCCCcCchhcccc-------CCCCcccchhhHHHHHHH
Q 039736 477 SSNILLDDKFSAKVSDFGTSRSVPNDKT-------HLTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLE 542 (633)
Q Consensus 477 ~~NILl~~~~~~kI~DfGla~~~~~~~~-------~~~~~~~gt~~y~APE~l~~-------~~~s~ksDV~SfGvvL~e 542 (633)
|+|||++.++.+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||||+++||
T Consensus 148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e 227 (336)
T 3g2f_A 148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227 (336)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence 9999999999999999999987643221 11223468999999999976 456679999999999999
Q ss_pred HHhCCCCCCCCchhhhh-c----------HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC
Q 039736 543 LLTGKKPICLTREEEER-N----------LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611 (633)
Q Consensus 543 lltG~~p~~~~~~~~~~-~----------l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt 611 (633)
|++|+.|+......... . .................+.... ......+..+.+|+.+||+.||++|||
T Consensus 228 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (336)
T 3g2f_A 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLT 305 (336)
T ss_dssp HHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcc
Confidence 99998776433221100 0 0000011111110000000000 012345678999999999999999999
Q ss_pred HHHHHHHHHhhhhhc
Q 039736 612 MKQVSMDLEGLRRSQ 626 (633)
Q Consensus 612 ~~ev~~~L~~i~~s~ 626 (633)
+.|+++.|+++....
T Consensus 306 ~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 306 AQXAEERMAELMMIW 320 (336)
T ss_dssp HHHHHHHHHHHHHCC
T ss_pred hHHHHHHHHHHHHHH
Confidence 999999999998655
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=349.75 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=205.2
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~ 406 (633)
..++|+..+.||+|+||.||++... +|+.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999975 4789999998753 223456788999999988 7999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 98 lv~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV----------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTS
T ss_pred EEEeCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCC
Confidence 999999999999998642 36999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
++||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+.
T Consensus 159 ~vkL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~ 231 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQ 231 (353)
T ss_dssp CEEECCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred cEEEEeCCcccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHH
Confidence 99999999998643222 22344579999999999999999999999999999999999999996543322 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
..... . ..++...+..+.+|+.+||+.||.+||+ +.|++++
T Consensus 232 ~i~~~---------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 232 SIMEH---------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHC---------C--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHhC---------C--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 0 1223345577899999999999999995 5676653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=336.21 Aligned_cols=248 Identities=29% Similarity=0.440 Sum_probs=202.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 468999999999999999999854 57799999876422 12245788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 88 ~e~~~~~~l~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp ECCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCE
T ss_pred EecCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCE
Confidence 9999999999988542 36999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 149 ~l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~ 219 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRI 219 (279)
T ss_dssp EECSCCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEEeccccccCCccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHH
Confidence 999999986553322 2335689999999999999999999999999999999999999865433221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
.. .....+......+.+|+.+||+.||++|||+.|++++-
T Consensus 220 ~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 220 SR-----------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HH-----------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred Hh-----------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 10 11122333456788999999999999999999999763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.52 Aligned_cols=273 Identities=23% Similarity=0.343 Sum_probs=214.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC--ceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETE--VPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57889999999999999999965 58999999987533 234567889999999999999999999998765 679999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee----cCC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----DDK 485 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~~~ 485 (633)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.+
T Consensus 89 e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 152 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-------------AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQ 152 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSC
T ss_pred ecCCCCCHHHHHHhhhc-------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCc
Confidence 99999999999976433 234999999999999999999999999 9999999999999 888
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--------CCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--------SQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
+.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 153 ~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 153 SVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp EEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred eeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 899999999998764432 2234568999999999865 567889999999999999999999986433221
Q ss_pred hhcHHHHHHHHHhhch---h---hhhh--------chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 558 ERNLVAYFISLAKENK---L---LEIL--------DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~---~---~~~~--------d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
. . ...+........ . .... +.......+......+.+++.+||+.||++||++.|+++.++.+.
T Consensus 231 ~-~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 231 R-N-KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp T-C-HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred c-h-HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 1 1 111112221110 0 0000 000112334677888999999999999999999999999999987
Q ss_pred hhc
Q 039736 624 RSQ 626 (633)
Q Consensus 624 ~s~ 626 (633)
...
T Consensus 309 ~~~ 311 (396)
T 4eut_A 309 HRM 311 (396)
T ss_dssp TCE
T ss_pred hce
Confidence 643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.07 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=179.8
Q ss_pred CCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 339 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
.+.||+|+||.||++... +|+.||||++... ....+.+|+.++++++ ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999998653 3456778999999997 9999999999999999999999999999
Q ss_pred chhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC---cEEEeec
Q 039736 417 LSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF---SAKVSDF 493 (633)
Q Consensus 417 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~---~~kI~Df 493 (633)
|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+||
T Consensus 93 L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 93 LFERIKKK----------------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp HHHHHHHC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCC
T ss_pred HHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecc
Confidence 99998652 46999999999999999999999999 99999999999998765 8999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh-hcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE-RNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~ 572 (633)
|+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... ...+
T Consensus 154 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~ 231 (325)
T 3kn6_A 154 GFARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKG 231 (325)
T ss_dssp TTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTT
T ss_pred ccceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcC
Confidence 99986543322 22345689999999999999999999999999999999999999865432211 111111111 1111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ..........+..+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 232 DF------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CC------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CC------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 00 00001112345778999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.15 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=199.9
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-----hhHHHHHHHHHHHHhccC---CCCceEEEEEEeeC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-----KTQIEQFINEVVILSQIN---HRHIVKLLGCCLET 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-----~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~ 402 (633)
..++|+..+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 478999999876422 111235567777777664 99999999999875
Q ss_pred C-----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 403 E-----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 403 ~-----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
. ..++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp 148 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--------------PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKP 148 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 5 4799999997 599999865432 34999999999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
+|||++.++++||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 149 ~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 149 ENILVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp TTEEECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred HHEEEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999998764322 2244568999999999999999999999999999999999999997654332
Q ss_pred hhcHHHHHHHHHhhchhhhh------hchhh-------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKENKLLEI------LDARV-------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~~~~~~~------~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ...+...........+ ....+ ......+....+.+|+.+||+.||++|||+.|++++
T Consensus 227 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 227 Q---LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp H---HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 2 1111111110000000 00000 001112345678999999999999999999999874
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=335.07 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=205.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|+..+.||+|+||.||+|... +|+.||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999954 689999998764 34455678899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc--
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS-- 487 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~-- 487 (633)
||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 85 e~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~ 145 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----------------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGA 145 (284)
T ss_dssp CCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTC
T ss_pred ecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCC
Confidence 999999998888543 36999999999999999999999999 999999999999987655
Q ss_pred -EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 488 -AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 -~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..
T Consensus 146 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~ 217 (284)
T 3kk8_A 146 AVKLADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YA 217 (284)
T ss_dssp CEEECCCTTCEECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred cEEEeeceeeEEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH------HH
Confidence 99999999977643322 2335689999999999999999999999999999999999999865433221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ... . ............+.+|+.+||+.||++|||+.|++++
T Consensus 218 ~~~~-~~~-~-----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 218 QIKA-GAY-D-----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHH-TCC-C-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHh-ccc-c-----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111 000 0 0001112334678899999999999999999999885
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.94 Aligned_cols=248 Identities=20% Similarity=0.351 Sum_probs=201.8
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~L 407 (633)
..++|+..+.||+|+||.||+|... +++.||||+++.. ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3468999999999999999999965 7899999998753 334456788999999999 99999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC---
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD--- 484 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--- 484 (633)
||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~ 153 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI------------MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSI 153 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----
T ss_pred EEEecCCCcHHHHHHhhccc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCC
Confidence 99999999999999754321 256999999999999999999999999 999999999999984
Q ss_pred ----------------CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCC
Q 039736 485 ----------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGK 547 (633)
Q Consensus 485 ----------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~ 547 (633)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 228 (289)
T 1x8b_A 154 PNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred CcccccccccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence 4489999999998764332 23489999999999765 5678999999999999999998
Q ss_pred CCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 548 KPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 548 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.++..... ... ..... ....+...+..+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~---------~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 229 PLPRNGDQ---------WHE-IRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCSSSHH---------HHH-HHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCcchhH---------HHH-HHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 87532211 000 11111 112233445778999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=334.86 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=204.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999964 6899999998643 23445688999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 86 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 146 (276)
T 2yex_A 86 YCSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKI 146 (276)
T ss_dssp CCTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred ecCCCcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEE
Confidence 99999999999653 35899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCc-ceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 491 ~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
+|||++........ .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ . +...
T Consensus 147 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~ 221 (276)
T 2yex_A 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDW 221 (276)
T ss_dssp CCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-H----HHHH
T ss_pred eeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHh
Confidence 99999986532221 12234568999999999987665 7799999999999999999999865433211 0 0011
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ...........+.+|+.+||+.||++|||+.|++++
T Consensus 222 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 222 KEKKT---------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp HTTCT---------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hhccc---------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 11000 000112334678899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=338.31 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=208.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~L 407 (633)
.++|+..+.||+|+||.||++... +|+.||+|++... .....+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468899999999999999999964 6899999998643 34556789999999999999999999998864 457899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeeccCCCCCCeeecCC
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA--SIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~ 485 (633)
||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ..+++||||||+||+++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK------------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS
T ss_pred EEeCCCCCCHHHHHHhhcc------------cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC
Confidence 9999999999999975432 1345999999999999999999999987 2349999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+.+||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. .
T Consensus 153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~ 225 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------A 225 (279)
T ss_dssp SCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred CCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH------H
Confidence 9999999999987643321 12334689999999999998999999999999999999999999865432211 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
.....+. ....+...+..+.+++.+||+.||++||++.|+++++..-..
T Consensus 226 -~~i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 226 -GKIREGK---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -HHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -HHHhhcc---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1111111 112233455789999999999999999999999987765443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.71 Aligned_cols=267 Identities=16% Similarity=0.236 Sum_probs=208.2
Q ss_pred cCCccCCcccccCcEEEEEEEcCC---------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceE----------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD---------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVK---------- 394 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~---------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~---------- 394 (633)
++|...+.||+|+||.||+|.... ++.||||.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 589999999999999999999753 789999998753 36779999999999999987
Q ss_pred -----EEEEEee-CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 039736 395 -----LLGCCLE-TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASI 468 (633)
Q Consensus 395 -----l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 468 (633)
+++++.. ++..++||||+ +|+|.+++.... ...+++..++.++.||+.||.|||+++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 179 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--------------KHVLSERSVLQVACRLLDALEFLHENE-- 179 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--------------GGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--------------cCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 6777776 66789999999 999999997542 146999999999999999999999998
Q ss_pred CeeccCCCCCCeeecCCC--cEEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHH
Q 039736 469 PIFHRDIKSSNILLDDKF--SAKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVL 540 (633)
Q Consensus 469 ~ivHrDIk~~NILl~~~~--~~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL 540 (633)
|+||||||+|||++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++|
T Consensus 180 -ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 258 (352)
T 2jii_A 180 -YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258 (352)
T ss_dssp -CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 99999999999999998 9999999999876432211 11334689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 541 LELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 541 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
|||++|+.||........ ........... ....+.+... .....+..+.+|+.+||+.||++|||+.|+++.|+
T Consensus 259 ~el~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTE-DIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HHHHHSCCTTGGGTTCHH-HHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHH-HHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 999999999864321111 11111111110 0011111000 00123467899999999999999999999999999
Q ss_pred hhhhhcccc
Q 039736 621 GLRRSQRCV 629 (633)
Q Consensus 621 ~i~~s~~~~ 629 (633)
++..+.+..
T Consensus 333 ~~~~~~~~~ 341 (352)
T 2jii_A 333 ALLQDLRVS 341 (352)
T ss_dssp HHHHHTTCC
T ss_pred HHHHhcCCC
Confidence 999877544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.35 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=200.6
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
+|.....||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445566999999999999995 4688999999887666667789999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-CCcEEEee
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-KFSAKVSD 492 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-~~~~kI~D 492 (633)
+|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||+++. ++.+||+|
T Consensus 103 ~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 103 GGSLSALLRSKWG-------------PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EEEHHHHHHHTTC-------------CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECC
T ss_pred CCCHHHHHHhhcc-------------CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEee
Confidence 9999999865422 235778999999999999999999998 999999999999997 89999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
||++....... .......|++.|+|||.+.++. ++.++||||||+++|||++|+.||........ .......
T Consensus 167 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~- 240 (295)
T 2clq_A 167 FGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGM- 240 (295)
T ss_dssp TTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHH-
T ss_pred cccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhcc-
Confidence 99998764322 1223456899999999997654 78999999999999999999999853222111 0000000
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......+......+.+++.+||+.||++||++.|++++
T Consensus 241 ---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 241 ---------FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---------HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---------ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001122334455788999999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=342.82 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=205.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|...+.||+|+||.||++... +|+.||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457889999999999999999964 689999998765322 1356789999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~ 151 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----------------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----------------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCT
T ss_pred EEEEEcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecC
Confidence 9999999999999998642 35899999999999999999999999 9999999999999988
Q ss_pred C----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+ ++||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 152 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--- 226 (321)
T 2a2a_A 152 NIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 226 (321)
T ss_dssp TSSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---
T ss_pred CCCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH---
Confidence 8 899999999987644322 2334689999999999999999999999999999999999999865433221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ ...++... ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 227 ---~~~i~~~~---~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 227 ---LANITSVS---YDFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---HHHHHTTC---CCCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHhcc---cccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111100 00111111 1234678899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=374.71 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=210.2
Q ss_pred HHHhcCCccCCcccccCcEEEEEEEcC----CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~~~----~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
+...++|...+.||+|+||.||+|... .+..||||+++.. .....+.|.+|+.++++++||||++++|++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 334567888999999999999999863 2457999998753 3445578999999999999999999999985 466
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~ 526 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK---------------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSS 526 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT---------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEE
T ss_pred eEEEEEcCCCCcHHHHHHhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeC
Confidence 899999999999999986432 36899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++..............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 527 ~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~----- 601 (656)
T 2j0j_A 527 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----- 601 (656)
T ss_dssp TTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred CCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-----
Confidence 9999999999998775444333334557889999999998999999999999999999997 9999865433221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
...... ......+..++..+.+|+.+||+.||++|||+.|+++.|+.+....
T Consensus 602 -~~~i~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 602 -IGRIEN----------GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -HHHHHH----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHHc----------CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 111111 1111234455678999999999999999999999999999997654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=336.92 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=184.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh---hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK---TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||+|.. .+|+.||||.+..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36788999999999999999995 4789999999864321 2246789999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 90 ~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~ 151 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---------------VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNI 151 (278)
T ss_dssp EECCTTEEHHHHHHTC---------------SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCE
T ss_pred EecCCCCcHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCE
Confidence 9999999999998653 246999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 152 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (278)
T 3cok_A 152 KIADFGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------- 220 (278)
T ss_dssp EECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred EEEeecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence 9999999987643221 12234689999999999998899999999999999999999999864332111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+....... ...+......+.+++.+||+.||++|||+.|++++
T Consensus 221 -----~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 221 -----LNKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----HHHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 00000000 11233345678899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.58 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=197.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhH-HHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~-~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999964 78999999887533221 22456799999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 82 ~~-~~l~~~~~~~~---------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~ 142 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---------------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLA 142 (324)
T ss_dssp CS-EEHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEEC
T ss_pred cc-cCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEc
Confidence 97 58888886532 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 143 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 218 (324)
T 3mtl_A 143 DFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILG 218 (324)
T ss_dssp SSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred cCcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 9999986543222 2233468999999999876 5689999999999999999999999976544332 111222111
Q ss_pred h---chhhhhhchhh-------------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 E---NKLLEILDARV-------------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~---~~~~~~~d~~l-------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ........... ...........+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 1 11111110000 000112334678899999999999999999999873
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=338.14 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=207.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999985 468999999986532 3456789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++++||
T Consensus 101 ~~~~~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 160 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----------------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKL 160 (303)
T ss_dssp CCTTEEHHHHHTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEE
T ss_pred eCCCCcHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEE
Confidence 9999999998853 36899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+........ ......
T Consensus 161 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~ 233 (303)
T 3a7i_A 161 ADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFLIPK 233 (303)
T ss_dssp CCCTTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH
T ss_pred eecccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHHhhc
Confidence 99999987643321 22345689999999999999999999999999999999999999864432211 111110
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
. .....+...+..+.+|+.+||+.||++|||+.|++++.-
T Consensus 234 -~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 234 -N---------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp -S---------CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred -C---------CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 0 011122334567899999999999999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=349.61 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=205.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57889999999999999999964 6899999998754 344567899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcEEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 113 ~~~~~L~~~l~~~----------------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl 173 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKL 173 (360)
T ss_dssp CTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEE
T ss_pred CCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEE
Confidence 9999999998643 3589999999999999999999995 8 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH-----
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF----- 565 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~----- 565 (633)
+|||++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+........
T Consensus 174 ~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 174 CDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp CCCCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred EECCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 999999754211 123356899999999999999999999999999999999999999765433211110000
Q ss_pred ------------------HHHHhhchhhhhhchhhhcc----cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ------------------ISLAKENKLLEILDARVAKE----AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ------------------~~~~~~~~~~~~~d~~l~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..........+.++...... .+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000001111111111111 112245679999999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=335.22 Aligned_cols=256 Identities=26% Similarity=0.354 Sum_probs=204.1
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh------hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK------TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|...+.||+|+||.||++... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57889999999999999999965 689999998765321 13568899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----------------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKN 145 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEeecCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCC
Confidence 999999999999998542 36999999999999999999999999 99999999999999877
Q ss_pred ----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 487 ----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 487 ----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---- 219 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET---- 219 (283)
T ss_dssp SSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----
T ss_pred CCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH----
Confidence 899999999987643322 2334689999999999999999999999999999999999999865433221
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
........ ....+.. ....+..+.+++.+||+.||++|||+.|++++ ++.+.
T Consensus 220 --~~~~~~~~---~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 220 --LTNISAVN---YDFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --HHHHHTTC---CCCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --HHHhHhcc---cCCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 11111000 0001111 11234678899999999999999999999984 44443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=335.85 Aligned_cols=253 Identities=28% Similarity=0.348 Sum_probs=199.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 57889999999999999999954 68899999876532 33457889999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCCcE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSA 488 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 488 (633)
+++|+|.+++...... ...+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+
T Consensus 102 ~~~~~L~~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~ 166 (285)
T 3is5_A 102 CEGGELLERIVSAQAR------------GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPI 166 (285)
T ss_dssp CSCCBHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCE
T ss_pred CCCCcHHHHHHhhhhc------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCE
Confidence 9999999998654321 357999999999999999999999999 9999999999999 556889
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+.. ...
T Consensus 167 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~ 237 (285)
T 3is5_A 167 KIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKA 237 (285)
T ss_dssp EECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH
T ss_pred EEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhh
Confidence 999999998764332 223456899999999986 56899999999999999999999998654432211 000
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... .+.... ........+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~-------~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 238 TYK-------EPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHC-------CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccC-------Cccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000000 001134678899999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=357.38 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=196.4
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
.++|+..+.||+|+||.||+|.. .+|+.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999985 46899999998653 4455678899999999999999999999997553
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..|+||||++++ |.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~------------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~ 198 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 198 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEEeCCCCC-HHHHHh------------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEe
Confidence 469999999864 555442 25899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
.++++||+|||+++..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||......+. ..
T Consensus 199 ~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~ 273 (464)
T 3ttj_A 199 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WN 273 (464)
T ss_dssp TTSCEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH
T ss_pred CCCCEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 9999999999999876432 223445789999999999999999999999999999999999999976543321 11
Q ss_pred HHHHHHhhc----------hhhhhhc---------------hhhhc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 039736 564 YFISLAKEN----------KLLEILD---------------ARVAK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615 (633)
Q Consensus 564 ~~~~~~~~~----------~~~~~~d---------------~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev 615 (633)
.+....... .....++ ..+.. .........+.+|+.+||+.||++|||+.|+
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 353 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 111111100 0000000 00000 0011225678999999999999999999999
Q ss_pred HHH
Q 039736 616 SMD 618 (633)
Q Consensus 616 ~~~ 618 (633)
+++
T Consensus 354 L~H 356 (464)
T 3ttj_A 354 LQH 356 (464)
T ss_dssp HTS
T ss_pred hcC
Confidence 875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=347.43 Aligned_cols=259 Identities=18% Similarity=0.229 Sum_probs=207.2
Q ss_pred HHHhcCCccCCcccccCcEEEEEEE------cCCCCEEEEEEccccChhHHHHHHHHHHHHhccC---CCCceEEEEEEe
Q 039736 330 QRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCL 400 (633)
Q Consensus 330 ~~~~~~~~~~~~ig~G~~G~Vy~g~------~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~ 400 (633)
+...++|...+.||+|+||.||+|. ..+++.||||+++.... .++..|++++++++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445789999999999999999994 44688999999876543 35667777777775 999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
..+..++||||+++|+|.+++...... ....++|..++.|+.||+.||+|||+++ |+||||||+||
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NI 203 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNT-----------PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNF 203 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTS-----------TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGE
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcc-----------cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHE
Confidence 999999999999999999999754321 1346999999999999999999999999 99999999999
Q ss_pred eecC-----------CCcEEEeecCCCccCCC-CCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC
Q 039736 481 LLDD-----------KFSAKVSDFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK 548 (633)
Q Consensus 481 Ll~~-----------~~~~kI~DfGla~~~~~-~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~ 548 (633)
|++. ++.+||+|||+++.... ..........||++|+|||++.+..++.++||||||+++|||++|+.
T Consensus 204 ll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 283 (365)
T 3e7e_A 204 ILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283 (365)
T ss_dssp EECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9998 89999999999976431 22233445679999999999999999999999999999999999999
Q ss_pred CCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHHHhhhhhc
Q 039736 549 PICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKR-PTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 549 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~R-Pt~~ev~~~L~~i~~s~ 626 (633)
||........ .. ...+.. . .....+.+++..|++.+|.+| |++.++.+.|+.+....
T Consensus 284 pf~~~~~~~~--------------~~----~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 284 MKVKNEGGEC--------------KP----EGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CCEEEETTEE--------------EE----CSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccCCCCce--------------ee----chhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 9853222110 00 000111 1 124567789999999999998 67999999998887654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.39 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=198.8
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~L 407 (633)
.|...+.||+|+||.||+|.. .++..||+|.+.. ......+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 466778899999999999995 4678999998764 345567789999999999999999999999875 345799
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-CCC
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKF 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~ 486 (633)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++++||||||+|||++ .++
T Consensus 107 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~ 169 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTS
T ss_pred EEEecCCCCHHHHHHHc----------------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCC
Confidence 99999999999998642 36899999999999999999999986 4599999999999998 789
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
.+||+|||++....... .....|++.|+|||.+. +.++.++||||||+++|||++|+.||........ ...
T Consensus 170 ~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~ 240 (290)
T 1t4h_A 170 SVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYR 240 (290)
T ss_dssp CEEECCTTGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHH
T ss_pred CEEEeeCCCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHH
Confidence 99999999997654332 23356899999999886 4589999999999999999999999864332211 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ... ....+......+.+++.+||+.||.+|||+.|++++
T Consensus 241 ~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 RVTS-GVK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHTT-TCC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhc-cCC--------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111 100 011122223578999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.47 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=204.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc----CCCCEEEEEEccccC----hhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAID----KTQIEQFINEVVILSQI-NHRHIVKLLGCCLETE 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 403 (633)
.++|...+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|+++++++ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999996 368999999876421 12334677899999999 6999999999999999
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~ 193 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLD 193 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEC
Confidence 999999999999999998642 36999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
.++++||+|||+++..............||+.|+|||.+.+ ..++.++||||||++||||++|+.||........ .
T Consensus 194 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~ 271 (355)
T 1vzo_A 194 SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--Q 271 (355)
T ss_dssp TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--H
T ss_pred CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--H
Confidence 99999999999998764433333445679999999999985 3478899999999999999999999864332211 1
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMDL 619 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~L 619 (633)
.......... ....+......+.+|+.+||+.||++|| ++.|++++.
T Consensus 272 ~~~~~~~~~~-----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 272 AEISRRILKS-----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHHHC-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHHhcc-----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111111110 1123344557789999999999999999 999998764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.66 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=203.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||++... +|+.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 467889999999999999999964 7899999998865544556788999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCCcE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFSA 488 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~~ 488 (633)
+++|+|.+++... ..+++..++.++.|++.||.|||+.+ ++||||||+||++ ++++.+
T Consensus 88 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~ 148 (304)
T 2jam_A 88 VSGGELFDRILER----------------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKI 148 (304)
T ss_dssp CCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCE
T ss_pred CCCccHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCE
Confidence 9999999988542 36899999999999999999999999 9999999999999 788999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ....
T Consensus 149 kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i 219 (304)
T 2jam_A 149 MITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEKI 219 (304)
T ss_dssp EBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH
T ss_pred EEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH
Confidence 99999999765332 12334589999999999999999999999999999999999999865432211 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .... ..........+..+.+++.+||+.||++|||+.|++++
T Consensus 220 ~-~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 220 K-EGYY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp H-HCCC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred H-cCCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1100 00011123345678999999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.79 Aligned_cols=247 Identities=28% Similarity=0.388 Sum_probs=205.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999964 78999999986532 123567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|
T Consensus 96 E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 96 EYVSGGELFDYICKN----------------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp ECCSSEEHHHHTTSS----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEE
T ss_pred eCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeE
Confidence 999999999999653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .+...
T Consensus 157 L~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i 228 (476)
T 2y94_A 157 IADFGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKI 228 (476)
T ss_dssp ECCCSSCEECCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHH
T ss_pred EEeccchhhccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHH
Confidence 99999998764432 2234569999999999988765 689999999999999999999986433221 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. + . ...+......+.+|+.+||+.||++|||+.|++++
T Consensus 229 ~~-~--------~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 229 CD-G--------I--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HT-T--------C--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hc-C--------C--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11 1 0 11223344678899999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=334.11 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=206.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367888999999999999999965 5789999987643 344567889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++++
T Consensus 94 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 154 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV 154 (294)
T ss_dssp EECCTTCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred EecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCE
Confidence 9999999999887542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 155 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~ 227 (294)
T 2rku_A 155 KIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI 227 (294)
T ss_dssp EECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEEeccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 9999999987643222 22335689999999999998899999999999999999999999865433221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ....+......+.+++.+||+.||++|||+.|++++
T Consensus 228 ~~~-----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 KKN-----------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HTT-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhc-----------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 110 011223344678899999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=349.29 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=193.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHH-HhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVI-LSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~i-l~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||+++.. +++.||||+++... ....+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 367999999999999999999964 57899999986532 2334566777776 577899999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 117 v~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ 177 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----------------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGH 177 (373)
T ss_dssp EEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSC
T ss_pred EEeCCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCC
Confidence 99999999999988643 35889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+..
T Consensus 178 ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~ 250 (373)
T 2r5t_A 178 IVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDN 250 (373)
T ss_dssp EEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHH
T ss_pred EEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHH
Confidence 9999999998642221 22344679999999999999999999999999999999999999996543322 1111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
.... . ...+......+.+|+.+||+.||.+||++.+.+
T Consensus 251 i~~~---------~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 251 ILNK---------P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp HHHS---------C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred HHhc---------c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 1111 0 112333456789999999999999999986433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.88 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=202.4
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLET 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 402 (633)
..++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999984 478899999876532 11334677899999999999999999999999
Q ss_pred CceEEEEeeccCC-CchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 403 EVPVLVYEYISNG-TLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 403 ~~~~LV~E~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
+..++||||+.+| +|.+++... ..+++..++.|+.|++.||.|||+++ |+||||||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIl 162 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH----------------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIV 162 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CEEEEEEEeCCCCccHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEE
Confidence 9999999999877 999888643 36999999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
++.++.+||+|||+++....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......
T Consensus 163 l~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---- 236 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---- 236 (335)
T ss_dssp ECTTSCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred EcCCCcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence 99999999999999987654332 233568999999999988776 78999999999999999999998532110
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 237 -----------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 -----------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01122245678999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=345.07 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=200.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|+..+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367889999999999999999964 5899999987543 3334567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+|
T Consensus 104 e~~~~~~l~~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~k 164 (331)
T 4aaa_A 104 EFVDHTILDDLELF----------------PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVK 164 (331)
T ss_dssp ECCSEEHHHHHHHS----------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred ecCCcchHHHHHhh----------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEE
Confidence 99999999887543 236999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH----
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY---- 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~---- 564 (633)
|+|||+++....... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||......+.......
T Consensus 165 l~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 165 LCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp ECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 999999987643222 22334689999999999775 789999999999999999999999976544322110000
Q ss_pred ----HHHHHh-hchhhhhhchhhhcc-----cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 ----FISLAK-ENKLLEILDARVAKE-----AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ----~~~~~~-~~~~~~~~d~~l~~~-----~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... .........+..... .....+..+.+|+.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 000000000111101 112345789999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=364.63 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=207.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999964 78999999986521 22345788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++++
T Consensus 263 mEy~~gg~L~~~l~~~~--------------~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG--------------QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp ECCCCSCBHHHHHHSSS--------------SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCE
T ss_pred EEcCCCCcHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCe
Confidence 99999999999986532 135999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 326 KL~DFGla~~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i 401 (576)
T 2acx_A 326 RISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLV 401 (576)
T ss_dssp EECCCTTCEECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHH
T ss_pred EEEecccceecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHh
Confidence 9999999987654332 2335799999999999998999999999999999999999999965432111 01111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.. ....++...+..+.+|+.+||+.||.+|| ++.||+++
T Consensus 402 ~~-----------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 402 KE-----------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HH-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hc-----------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 10 11223344557889999999999999999 78888764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.03 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=206.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999964 5789999987643 345567889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 120 ~e~~~~~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 180 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----------------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEV 180 (335)
T ss_dssp ECCCTTCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EecCCCCCHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCE
Confidence 9999999999887542 36999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. ....
T Consensus 181 kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~ 253 (335)
T 2owb_A 181 KIGDFGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI 253 (335)
T ss_dssp EECCCTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH
T ss_pred EEeeccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHH
Confidence 9999999987643222 22345689999999999998899999999999999999999999865433221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... ...+......+.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 KKNE-----------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHTC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hcCC-----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100 11223344678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.61 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=188.8
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-h-hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-K-TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|+..+.||+|+||.||++.. .+|+.||||+++... . ...+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46889999999999999999995 478999999987532 2 23334455556688899999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
||++ |+|.+++..... ....+++..++.++.|++.||.|||++ + ++||||||+||+++.++++
T Consensus 86 e~~~-~~l~~~l~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID------------KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp ECCS-EEHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCE
T ss_pred ehhc-cchHHHHHHHHh------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCE
Confidence 9997 588888765322 135799999999999999999999998 8 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
||+|||+++....... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ .
T Consensus 150 kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~ 222 (290)
T 3fme_A 150 KMCDFGISGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----Q 222 (290)
T ss_dssp EBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----H
T ss_pred EEeecCCccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----H
Confidence 9999999987643322 2234589999999996 566789999999999999999999999864322111 1
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
....... ..........+..+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 223 LKQVVEE---------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHHS---------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHhcc---------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111111 1111112234567899999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.62 Aligned_cols=270 Identities=23% Similarity=0.302 Sum_probs=202.7
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc-----------ChhHHHHHHHHHHHHhccCCCCce
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI-----------DKTQIEQFINEVVILSQINHRHIV 393 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~-----------~~~~~~~~~~Ei~il~~l~H~nIv 393 (633)
...++....++|...+.||+|+||.||+|...+|+.||||++... +....+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 356788888999999999999999999999888999999987542 122347899999999999999999
Q ss_pred EEEEEEeeCC-----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCC
Q 039736 394 KLLGCCLETE-----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASI 468 (633)
Q Consensus 394 ~l~g~~~~~~-----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~ 468 (633)
++++++...+ ..++||||++ |+|.+++... ...+++..++.++.||+.||.|||+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 154 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---------------RIVISPQHIQYFMYHILLGLHVLHEAG-- 154 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---------------ccCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 9999986432 4799999998 6888887643 236999999999999999999999999
Q ss_pred CeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCC
Q 039736 469 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGK 547 (633)
Q Consensus 469 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~ 547 (633)
|+||||||+|||++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus 155 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 231 (362)
T 3pg1_A 155 -VVHRDLHPGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231 (362)
T ss_dssp -CCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred -CEecCCChHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence 9999999999999999999999999998643322 2233568999999999877 67899999999999999999999
Q ss_pred CCCCCCchhhhhcHHHHHHHHHhhch-----------hhhhhchhh-------hcccCHHHHHHHHHHHHhccccCCCCC
Q 039736 548 KPICLTREEEERNLVAYFISLAKENK-----------LLEILDARV-------AKEAREEDIEAVAELAMGCLRLNSKKR 609 (633)
Q Consensus 548 ~p~~~~~~~~~~~l~~~~~~~~~~~~-----------~~~~~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~R 609 (633)
.||......+. ...+........ ..+.+.... ...........+.+|+.+||+.||++|
T Consensus 232 ~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 232 ALFRGSTFYNQ---LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp CSCCCSSHHHH---HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCHHHH---HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence 99976543321 111111111111 011110000 001112335678999999999999999
Q ss_pred CCHHHHHHH
Q 039736 610 PTMKQVSMD 618 (633)
Q Consensus 610 Pt~~ev~~~ 618 (633)
||+.|++++
T Consensus 309 pt~~ell~h 317 (362)
T 3pg1_A 309 ISTEQALRH 317 (362)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHHcC
Confidence 999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.97 Aligned_cols=246 Identities=17% Similarity=0.163 Sum_probs=192.6
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc---cChhHHHHHHHHH---HHHhccCCCCceEEE-------EE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA---IDKTQIEQFINEV---VILSQINHRHIVKLL-------GC 398 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~---~~~~~~~~~~~Ei---~il~~l~H~nIv~l~-------g~ 398 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999996 4689999999863 3344567899999 555566899999998 66
Q ss_pred EeeCC-----------------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q 039736 399 CLETE-----------------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAY 461 (633)
Q Consensus 399 ~~~~~-----------------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~y 461 (633)
+.+.+ ..|+||||+ +|+|.+++........ ....++|..++.|+.||+.||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~---------~~~~l~~~~~~~i~~qi~~aL~~ 221 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS---------THKSLVHHARLQLTLQVIRLLAS 221 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT---------TTHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc---------ccccccHHHHHHHHHHHHHHHHH
Confidence 65543 278999999 6899999976432100 01235678999999999999999
Q ss_pred hHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-----------CCCcc
Q 039736 462 MHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-----------QYTDK 530 (633)
Q Consensus 462 LH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~k 530 (633)
||+++ |+||||||+|||++.++++||+|||+++.... ......| +.|+|||.+.+. .++.+
T Consensus 222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 99999 99999999999999999999999999986432 2234557 999999999887 89999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC
Q 039736 531 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 531 sDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
+||||||++||||++|+.||....... ....+.. .....+..+.+|+.+||+.||++||
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~---------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALG---------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------C---------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred hhHHHHHHHHHHHHHCCCCCccccccc---------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCC
Confidence 999999999999999999985322111 0111111 1123346788999999999999999
Q ss_pred CHHHHHH
Q 039736 611 TMKQVSM 617 (633)
Q Consensus 611 t~~ev~~ 617 (633)
|+.|+++
T Consensus 353 t~~e~l~ 359 (377)
T 3byv_A 353 LPLQAME 359 (377)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=332.05 Aligned_cols=246 Identities=25% Similarity=0.384 Sum_probs=204.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67889999999999999999964 57899999876432 122457889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 94 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k 154 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----------------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELK 154 (284)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEE
T ss_pred EeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEE
Confidence 999999999988643 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .....
T Consensus 155 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~ 225 (284)
T 2vgo_A 155 IADFGWSVHAPSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIV 225 (284)
T ss_dssp ECCCTTCEECSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred EecccccccCcccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHh
Confidence 99999997654322 2335689999999999999999999999999999999999999865433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. . ....+......+.+++.+||+.||.+||++.|++++
T Consensus 226 ~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 226 N---------V--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp T---------T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c---------c--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1 0 012233445678999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.76 Aligned_cols=252 Identities=22% Similarity=0.318 Sum_probs=191.7
Q ss_pred cCCccC-CcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhc-cCCCCceEEEEEEee----CCceE
Q 039736 334 DNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQ-INHRHIVKLLGCCLE----TEVPV 406 (633)
Q Consensus 334 ~~~~~~-~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~----~~~~~ 406 (633)
++|... +.||+|+||.||++... +|+.||||+++.. ..+.+|++++.+ .+||||+++++++.. .+..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999964 6899999998642 356688888744 589999999999875 45689
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-- 484 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 484 (633)
+||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+++ |+||||||+|||++.
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~ 198 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--------------QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 198 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----------------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSS
T ss_pred EEEEeCCCCcHHHHHHHhCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCC
Confidence 99999999999999975321 36999999999999999999999999 999999999999998
Q ss_pred -CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh-cHH
Q 039736 485 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER-NLV 562 (633)
Q Consensus 485 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~-~l~ 562 (633)
++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...
T Consensus 199 ~~~~~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 276 (400)
T 1nxk_A 199 PNAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_dssp TTCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH
T ss_pred CCccEEEEecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH
Confidence 7899999999998654322 223456899999999999999999999999999999999999999654322110 011
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
..+ ..+.. .............+.+|+.+||+.||++|||+.|++++-
T Consensus 277 ~~i----~~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 277 TRI----RMGQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp HHH----HHTCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HHH----HcCcc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 110 00000 000001123456789999999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.49 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=206.4
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--------hhHHHHHHHHHHHHhcc-CCCCceEE
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--------KTQIEQFINEVVILSQI-NHRHIVKL 395 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l-~H~nIv~l 395 (633)
........++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999975 79999999876432 11245688999999999 79999999
Q ss_pred EEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dl 226 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK----------------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDL 226 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 99999999999999999999999998642 36999999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc------CCCCcccchhhHHHHHHHHHhCCCC
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
||+|||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|
T Consensus 227 kp~NIl~~~~~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p 304 (365)
T 2y7j_A 227 KPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304 (365)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred CHHHEEECCCCCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence 99999999999999999999987643322 234568999999999863 3578899999999999999999999
Q ss_pred CCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 550 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
|........ ...... .... ...+. . ...+..+.+++.+||+.||++|||+.|++++
T Consensus 305 f~~~~~~~~------~~~i~~-~~~~-~~~~~-~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 305 FWHRRQILM------LRMIME-GQYQ-FSSPE-W----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp SCCSSHHHH------HHHHHH-TCCC-CCHHH-H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCHHHH------HHHHHh-CCCC-CCCcc-c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 865432211 111111 1000 00000 0 1224568899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=344.54 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=194.6
Q ss_pred HHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
...++|...+.||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 4789999999865432 234578899999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee-----
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----- 482 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----- 482 (633)
||||++ |+|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN----------------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp EEECCS-EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC---
T ss_pred EEecCC-CCHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCC
Confidence 999998 5998888543 35999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
++++.+||+|||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~ 247 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--L 247 (329)
T ss_dssp --CCEEEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H
T ss_pred CccceEEECcCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--H
Confidence 4566699999999986543222 22334679999999999874 489999999999999999999999865443321 1
Q ss_pred HHHHHHHHhhc---hhh------h-------hhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKEN---KLL------E-------ILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~---~~~------~-------~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+ ...... ... . .....+....+......+.+|+.+||+.||++|||+.|++++
T Consensus 248 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 248 FKIF-EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHH-HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHH-HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 1111 111000 000 0 000000001111234678899999999999999999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.52 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=186.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~ 404 (633)
.++|...+.||+|+||.||+|... +|+.||||++.. .+....+++.+|+++|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999854 689999998865 3445567899999999999999999999999543 46
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~ 191 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----------------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQ 191 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECT
T ss_pred EEEEEecc-ccchhhhcccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECC
Confidence 89999998 47888887542 36999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCc--------------------------ceecccccCCCcCchhcc-ccCCCCcccchhhHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKT--------------------------HLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFG 537 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~--------------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDV~SfG 537 (633)
++.+||+|||+++....... .......||+.|+|||++ ....++.++||||||
T Consensus 192 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG 271 (458)
T 3rp9_A 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271 (458)
T ss_dssp TCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred CCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHH
Confidence 99999999999987642211 112345689999999976 556799999999999
Q ss_pred HHHHHHHh-----------CCCCCCCCchh-----------------hhhcHHHHHHHHHhhch---hhhhhch---hh-
Q 039736 538 VVLLELLT-----------GKKPICLTREE-----------------EERNLVAYFISLAKENK---LLEILDA---RV- 582 (633)
Q Consensus 538 vvL~ellt-----------G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~~---~~~~~d~---~l- 582 (633)
|+||||++ |+++|.+.... ...+....+........ +..+... ..
T Consensus 272 ~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 351 (458)
T 3rp9_A 272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYI 351 (458)
T ss_dssp HHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHH
T ss_pred HHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHH
Confidence 99999999 45554332100 00111111111111100 0000000 00
Q ss_pred ----------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 583 ----------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 583 ----------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...........+.+|+.+||+.||++|||+.|++++
T Consensus 352 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 352 RIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000112235678899999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.73 Aligned_cols=258 Identities=20% Similarity=0.322 Sum_probs=196.6
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999996 4789999999854 23445668899999999999999999999998653
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 162 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN 162 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEc
Confidence 459999999 7899888753 35899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++.+||+|||+++..... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l 235 (367)
T 1cm8_A 163 EDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---L 235 (367)
T ss_dssp TTCCEEECCCTTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H
T ss_pred CCCCEEEEeeecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 9999999999999875432 233568999999999877 6799999999999999999999999976543221 1
Q ss_pred HHHHHHHhhc-----------hhhhhhch------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKEN-----------KLLEILDA------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~-----------~~~~~~d~------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+....... .....+.. .-...........+.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1111111000 00000000 00011122345678999999999999999999999884
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=336.29 Aligned_cols=256 Identities=21% Similarity=0.365 Sum_probs=200.0
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEee--CCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLE--TEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~--~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|.. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6788999999999999999984 578999999987543 357889999999997 9999999999987 56789999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~ 488 (633)
||+++++|.+++. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+
T Consensus 113 e~~~~~~l~~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp ECCCCCCHHHHGG-------------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred eccCchhHHHHHH-------------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEE
Confidence 9999999988873 3788999999999999999999999 99999999999999776 89
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++....... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+.. ...
T Consensus 171 kl~Dfg~a~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~-~~~ 246 (330)
T 3nsz_A 171 RLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVR-IAK 246 (330)
T ss_dssp EECCCTTCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHH-HHH
T ss_pred EEEeCCCceEcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHH-HHH
Confidence 9999999987643322 233468899999999877 6789999999999999999999999854332211 1111 111
Q ss_pred HHhhchhhhhhch-------h----------------hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDA-------R----------------VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~-------~----------------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........+.++. . .....+......+.+|+.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111111111110 0 0011112245789999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.18 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=208.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCC-CCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|...++||+|+||.||+|.. .+++.||||++..... .+++.+|+++++.++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36899999999999999999995 5789999998765322 2357789999999987 556666666777788899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCCCc
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDKFS 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~~~ 487 (633)
|+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.
T Consensus 84 ~~-g~sL~~ll~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~ 144 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQ 144 (483)
T ss_dssp CC-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTC
T ss_pred CC-CCCHHHHHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCe
Confidence 99 999999986432 36999999999999999999999999 9999999999999 68899
Q ss_pred EEEeecCCCccCCCCCcc------eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 488 AKVSDFGTSRSVPNDKTH------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+||+|||+++........ ......||..|+|||.+.+..++.++||||||++||||++|+.||...........
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 999999999876433221 12245799999999999999999999999999999999999999975433221111
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
...+... .....++ .+ ...++.++.+|+..||+.||++||++.+|++.|+.+.....
T Consensus 225 ~~~i~~~----~~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 225 YEKISEK----KVATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp HHHHHHH----HHHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHhhc----cccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 1111111 1111010 11 11234678999999999999999999999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.06 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=198.4
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChh-----HHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKT-----QIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~-----~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
...++|...+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 5899999998653221 12467899999999999999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||+++ +|.+++... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN---------------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDE 147 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC---------------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEEcCCC-CHHHHHHhc---------------CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcC
Confidence 9999999986 888887653 236899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|..|+......+. +..
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~ 224 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR 224 (346)
T ss_dssp TCCEEECCCGGGSTTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH
T ss_pred CCCEEEEecccceeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH
Confidence 99999999999987643322 22345689999999998764 588999999999999999999999865443221 111
Q ss_pred HHHHHHhhchhhhhhc---------hhhhc-----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILD---------ARVAK-----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d---------~~l~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+...........+.+ ..... .........+.+|+.+||+.||++|||+.|++++
T Consensus 225 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 225 -IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp -HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -HHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 111111100000000 00000 0112334789999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.80 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=199.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC--------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLET-------- 402 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-------- 402 (633)
++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999996 478999999875432 22345778999999999999999999999873
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..++||||+++ +|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~ 157 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV---------------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLI 157 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred ceEEEEEeccCC-CHHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEE
Confidence 457999999985 777766543 236999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCC---cceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh
Q 039736 483 DDKFSAKVSDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE 558 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~ 558 (633)
+.++.+||+|||+++...... ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 158 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 237 (351)
T 3mi9_A 158 TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 237 (351)
T ss_dssp CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 999999999999998764222 122234568999999999876 4579999999999999999999999976544332
Q ss_pred hcHHHHHHHHHhh---chhhhhhchhhh--------cccC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 559 RNLVAYFISLAKE---NKLLEILDARVA--------KEAR-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 559 ~~l~~~~~~~~~~---~~~~~~~d~~l~--------~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ..+...... ......-+.... .... ......+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 238 L---ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp H---HHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H---HHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 111111110 000000000000 0000 0013568899999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=345.52 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=200.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
..++|+..+.||+|+||.||++... +|+.||||+++.... .+.+|++++.++ +||||+++++++.+.+..|+||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567999999999999999999964 688999999875432 234688888888 7999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC----
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---- 485 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---- 485 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+.++
T Consensus 96 E~~~gg~L~~~i~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~ 156 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ----------------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNP 156 (342)
T ss_dssp CCCCSCBHHHHHHTC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSG
T ss_pred eCCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCc
Confidence 999999999988653 35899999999999999999999999 9999999999998543
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+.+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+
T Consensus 157 ~~~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~ 232 (342)
T 2qr7_A 157 ESIRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EIL 232 (342)
T ss_dssp GGEEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHH
T ss_pred CeEEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHH
Confidence 3599999999987643322 223456899999999998888899999999999999999999999653221111 111
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .+.. .+........+..+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~i~-~~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 233 ARIG-SGKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHH-HCCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHc-cCCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111 1110 01111223345678999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=351.41 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=192.4
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--------hhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999854 68899999876421 112235789999999999999999999975
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIl 271 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN----------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred cCceEEEEEcCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEE
Confidence 45689999999999999988653 36999999999999999999999999 999999999999
Q ss_pred ecCC---CcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 482 LDDK---FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 482 l~~~---~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
++.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred EecCCCcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9754 45999999999876432 22334569999999999853 6688899999999999999999999864322
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. .+... ....... ..+... ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 350 ~~--~~~~~----i~~~~~~--~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 350 QV--SLKDQ----ITSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SC--CHHHH----HHTTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hH--HHHHH----HhcCCCC--CCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11 11111 1111000 001111 1234678999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=341.22 Aligned_cols=261 Identities=23% Similarity=0.416 Sum_probs=200.3
Q ss_pred cCHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee
Q 039736 324 FTAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE 401 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~ 401 (633)
++..++....++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33444555678899999999999999999996 478999999986533 2345788999999999 79999999999987
Q ss_pred ------CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 402 ------TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 402 ------~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
.+..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++ ++||||
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 155 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--------------GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDI 155 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG--------------GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 457899999999999999986542 236899999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
||+|||++.++.+||+|||++........ ......|++.|+|||.+. +..++.++||||||+++|||++|+.||
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 234 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999987543211 123346899999999987 567889999999999999999999998
Q ss_pred CCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 551 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ ........ . + ...+...+..+.+++.+||+.||.+||++.|++++
T Consensus 235 ~~~~~~~~------~~~~~~~~-~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 235 CDMHPMRA------LFLIPRNP-A-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp TTSCHHHH------HHHHHHSC-C-----C---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCcHHHH------HHHhhcCc-c-----c---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 64332211 11111100 0 0 11122334678999999999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=329.16 Aligned_cols=247 Identities=29% Similarity=0.394 Sum_probs=196.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999965 78999999986532 223567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+|
T Consensus 91 e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 91 EYVSGGELFDYICKH----------------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp ECCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEE
T ss_pred eccCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEE
Confidence 999999999998643 35899999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||++........ .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~ 223 (276)
T 2h6d_A 152 IADFGLSNMMSDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKI 223 (276)
T ss_dssp ECCCCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred EeecccccccCCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHh
Confidence 999999987644321 233468999999999987765 689999999999999999999986533221 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ... ...+......+.+++.+||+.||++|||+.|++++
T Consensus 224 ~-~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 224 R-GGV----------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp H-HCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h-cCc----------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1 100 11223345678899999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.02 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred HHHHhcCCccC-CcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCC
Q 039736 329 LQRATDNYNQS-RFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQIN-HRHIVKLLGCCLETE 403 (633)
Q Consensus 329 l~~~~~~~~~~-~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~ 403 (633)
.+...+.|... +.||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++ ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445667776 88999999999999964 68999999876532 233568889999999995 699999999999999
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~ 165 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPEL--------------AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLS 165 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEES
T ss_pred eEEEEEEecCCCcHHHHHHHhc--------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEe
Confidence 9999999999999999986532 246999999999999999999999999 99999999999999
Q ss_pred C---CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 484 D---KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 484 ~---~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
. ++.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-- 241 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-- 241 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--
T ss_pred cCCCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--
Confidence 8 78999999999987643321 2335689999999999999999999999999999999999999865443221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
....... ...............+.+|+.+||+.||++|||+.|++++
T Consensus 242 ----~~~i~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 242 ----YLNISQV-------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----HHHHHHT-------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----HHHHHhc-------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111100 0011111123345678899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=334.68 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=200.6
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
..++|+..+.||+|+||.||+|... +|+.||||.+.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4568999999999999999999964 58999999987532 34578899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++++||
T Consensus 105 ~~~~~~L~~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 166 (314)
T 3com_A 105 YCGAGSVSDIIRLR---------------NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKL 166 (314)
T ss_dssp CCTTEEHHHHHHHH---------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred cCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEE
Confidence 99999999998532 246999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ......
T Consensus 167 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~ 239 (314)
T 3com_A 167 ADFGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIPT 239 (314)
T ss_dssp CCCTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH
T ss_pred eecccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhc
Confidence 99999976543221 22334689999999999999999999999999999999999999864332211 111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. .+. ...+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 240 ~~------~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 240 NP------PPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SC------CCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CC------Ccc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 000 01122334678999999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.59 Aligned_cols=253 Identities=25% Similarity=0.458 Sum_probs=194.7
Q ss_pred HhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee---------
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--------- 401 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--------- 401 (633)
..++|+..+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346789999999999999999995 47899999998653 3456789999999999999999999999865
Q ss_pred ----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 402 ----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 402 ----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ ++||||||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp 144 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN---------------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKP 144 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC---------------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc---------------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCH
Confidence 345799999999999999996532 24788899999999999999999999 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCC-------------cceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHH
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDK-------------THLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLEL 543 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~el 543 (633)
+|||++.++.+||+|||+++...... ........|++.|+|||.+.+. .++.++||||||+++|||
T Consensus 145 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 224 (303)
T 1zy4_A 145 MNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224 (303)
T ss_dssp GGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHH
T ss_pred HhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHH
Confidence 99999999999999999998764321 1112335689999999999764 789999999999999999
Q ss_pred HhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 544 LTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 544 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
++ |+... .... ....... . ....+....+......+.+++.+||+.||.+|||+.|++++
T Consensus 225 ~~---p~~~~--~~~~---~~~~~~~-~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 225 IY---PFSTG--MERV---NILKKLR-S------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HS---CCSSH--HHHH---HHHHHHH-S------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hh---ccCCc--hhHH---HHHHhcc-c------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 98 43211 1111 1111111 0 01111223344455678999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.37 Aligned_cols=270 Identities=23% Similarity=0.358 Sum_probs=189.1
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
...++|...+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999953 68899999886532 33456788999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++....... ......+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~ 160 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKG--------EHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSV 160 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTT--------TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ehhccCCchHHHHHHHhhcc--------ccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCE
Confidence 99999999999986532210 001246999999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCc----ceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 489 KVSDFGTSRSVPNDKT----HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 489 kI~DfGla~~~~~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
||+|||++........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 161 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----- 235 (303)
T 2vwi_A 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV----- 235 (303)
T ss_dssp EECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----
T ss_pred EEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-----
Confidence 9999999876543211 11233568999999999876 5689999999999999999999999865433221
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........ ....................+.+|+.+||+.||.+|||+.|++++
T Consensus 236 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 -LMLTLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHHHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHHhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01111110 000000000011112334678999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.55 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=196.0
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEe------------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCL------------ 400 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~------------ 400 (633)
++|...+.||+|+||.||+|... +|+.||||++...+....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57889999999999999999965 48999999988777777788999999999999999999999874
Q ss_pred --eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 401 --ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 401 --~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
+.+..++||||++ |+|.+++.. ..+++..++.++.|++.||+|||+++ ++||||||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 149 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----------------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----------------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 3356799999998 699988853 35899999999999999999999999 999999999
Q ss_pred Ceeec-CCCcEEEeecCCCccCCCCCc--ceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 479 NILLD-DKFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 479 NILl~-~~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
|||++ +++.+||+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99997 577999999999987643211 11233457899999998865 678999999999999999999999997654
Q ss_pred hhhhhcHHHHHHHHHh---hc---hhhh----hhchhhh------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAK---EN---KLLE----ILDARVA------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~---~~---~~~~----~~d~~l~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+.. ........ .. .+.. .+..... .......+..+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 230 ELEQM---QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHH---HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHH---HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 32211 11100000 00 0000 0000000 01112345789999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=346.44 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=199.0
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC----
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE---- 403 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~---- 403 (633)
++...++|...+.||+|+||.||+|.. .+|+.||||++..... ...+|+++++.++||||+++++++...+
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345567899999999999999999985 5789999998865322 2337999999999999999999985432
Q ss_pred ----------------------------------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHH
Q 039736 404 ----------------------------------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449 (633)
Q Consensus 404 ----------------------------------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 449 (633)
..++||||++ |+|.+.+..... ....+++..+.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------------~~~~l~~~~~~ 144 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR------------SGRSIPMNLIS 144 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHH------------TTCCCCHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh------------cCCCCCHHHHH
Confidence 3789999998 588888765322 13579999999
Q ss_pred HHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CC
Q 039736 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QY 527 (633)
Q Consensus 450 ~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~ 527 (633)
.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....... .....||..|+|||.+.+. .+
T Consensus 145 ~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~ 219 (383)
T 3eb0_A 145 IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEY 219 (383)
T ss_dssp HHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSC
T ss_pred HHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCC
Confidence 99999999999999999 99999999999998 689999999999987643322 2334689999999998764 48
Q ss_pred CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhh--hc-------------hhhhcccCHHHHH
Q 039736 528 TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEI--LD-------------ARVAKEAREEDIE 592 (633)
Q Consensus 528 s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~d-------------~~l~~~~~~~~~~ 592 (633)
+.++||||||+++|||++|+.||......+. ...+...........+ ++ .......+...+.
T Consensus 220 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (383)
T 3eb0_A 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296 (383)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred CcchhhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH
Confidence 9999999999999999999999976543321 1111111111111000 00 1111122334556
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 593 AVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 593 ~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+.+|+.+||+.||++|||+.|++++
T Consensus 297 ~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 297 LAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcC
Confidence 78999999999999999999999853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=357.46 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=203.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||++... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888999999999999999964 68999999986532 223567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++++|
T Consensus 265 E~~~gg~L~~~l~~~~~~------------~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED------------NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT------------SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred EeccCCCHHHHHHHhhcc------------cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEE
Confidence 999999999998654210 236999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ..........
T Consensus 330 L~DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~ 406 (543)
T 3c4z_A 330 ISDLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVL 406 (543)
T ss_dssp ECCCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHH
T ss_pred EeecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHh
Confidence 999999987644322 2234579999999999999999999999999999999999999996542211 1111111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~ 612 (633)
.. ...++...+..+.+|+.+||+.||++||++
T Consensus 407 ~~-----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 EQ-----------AVTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HC-----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred hc-----------ccCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 11 112334456788999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=350.06 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=166.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~ 404 (633)
.++|...+.||+|+||.||+|... +|+.||||+++. ......+++.+|+++|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999954 688999999865 3344567899999999999999999999999866 56
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~ 164 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----------------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQ 164 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECT
T ss_pred EEEEEecCC-cCHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECC
Confidence 899999986 5999888542 35999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCc---------------------ceecccccCCCcCchhcc-ccCCCCcccchhhHHHHHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKT---------------------HLTTAVQGTFGYFDPEYF-QSSQYTDKSDVYSFGVVLLE 542 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~---------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDV~SfGvvL~e 542 (633)
++.+||+|||+++....... .......||+.|+|||.+ ....++.++|||||||++||
T Consensus 165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e 244 (432)
T 3n9x_A 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244 (432)
T ss_dssp TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence 99999999999987643221 112446789999999986 55679999999999999999
Q ss_pred HHhCCCCC
Q 039736 543 LLTGKKPI 550 (633)
Q Consensus 543 lltG~~p~ 550 (633)
|++|..|+
T Consensus 245 ll~g~~p~ 252 (432)
T 3n9x_A 245 LLNMLQSH 252 (432)
T ss_dssp HHTTCTTT
T ss_pred HHhccccc
Confidence 99865554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=334.32 Aligned_cols=264 Identities=21% Similarity=0.317 Sum_probs=206.2
Q ss_pred cCCccCCcccccCcEEEEEEEc--CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCC------ceEEEEEEeeCCce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH------IVKLLGCCLETEVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~--~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n------Iv~l~g~~~~~~~~ 405 (633)
++|+..+.||+|+||.||++.. .+|+.||||+++.. ....+.+.+|++++++++|+| ++++++++.+.+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5899999999999999999985 36889999998753 344567889999999987654 99999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD- 484 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 484 (633)
++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG--------------FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQS 154 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCC
T ss_pred EEEEcCC-CCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecc
Confidence 9999999 889999886532 236899999999999999999999999 999999999999987
Q ss_pred ------------------CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhC
Q 039736 485 ------------------KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTG 546 (633)
Q Consensus 485 ------------------~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG 546 (633)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 6789999999998653322 234689999999999999999999999999999999999
Q ss_pred CCCCCCCchhhhhcHHHHHHHHHhh--------chhhhh---------------------hchh-hhcccCHHHHHHHHH
Q 039736 547 KKPICLTREEEERNLVAYFISLAKE--------NKLLEI---------------------LDAR-VAKEAREEDIEAVAE 596 (633)
Q Consensus 547 ~~p~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~---------------------~d~~-l~~~~~~~~~~~l~~ 596 (633)
+.||......+.... +...... ...... ..+. -....+......+.+
T Consensus 231 ~~pf~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (339)
T 1z57_A 231 FTVFPTHDSKEHLAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307 (339)
T ss_dssp SCSCCCSCHHHHHHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCCCChHHHHHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence 999976544332111 1111100 000000 0000 001112345678999
Q ss_pred HHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 597 LAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 597 L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
|+.+||+.||.+|||+.|++++ ++.++
T Consensus 308 li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 308 LIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred HHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 9999999999999999999865 44443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.97 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=200.4
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccc--cChhHHHHHHHHHHHHhccC--CCCceEEEEEEeeCCceE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRA--IDKTQIEQFINEVVILSQIN--HRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~--H~nIv~l~g~~~~~~~~~ 406 (633)
...++|+..+.||+|+||.||++...+++.||||++.. ......+.+.+|++++++++ |+||+++++++.+++..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 34567999999999999999999988899999998764 34456678999999999997 599999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||| +.+|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+|||+++ +
T Consensus 105 lv~e-~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK----------------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-G 163 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-T
T ss_pred EEEe-cCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-C
Confidence 9999 6688999998643 36899999999999999999999999 999999999999975 7
Q ss_pred cEEEeecCCCccCCCCCcc-eecccccCCCcCchhcccc-----------CCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 487 SAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQS-----------SQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
.+||+|||+++........ ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 9999999999876433221 2234468999999999875 468889999999999999999999985432
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L 619 (633)
... .. +...+++......+......+.+++.+||+.||++||++.|++++-
T Consensus 244 ~~~-----~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 244 NQI-----SK---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp SHH-----HH---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHH-----HH---------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 211 01 1122222222233333456789999999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=336.76 Aligned_cols=253 Identities=24% Similarity=0.357 Sum_probs=199.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 468899999999999999999975 5889999998776666678899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 98 ~~~~~l~~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 98 CPGGAVDAIMLEL---------------DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp CTTEEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CCCCcHHHHHHhh---------------ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEE
Confidence 9999999988643 236999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhcc-----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF-----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l-----~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|||++...... ........|+..|+|||.+ ....++.++||||||+++|||++|+.|+....... ...
T Consensus 160 Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~ 232 (302)
T 2j7t_A 160 DFGVSAKNLKT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLL 232 (302)
T ss_dssp CCHHHHHHHHH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH
T ss_pred ECCCCcccccc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHH
Confidence 99987542111 0111234589999999998 46678999999999999999999999986543221 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
....... .. ...+...+..+.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 233 KIAKSDP-PT-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHSCC-CC-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHhccCC-cc-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1111110 00 01123345678999999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=343.93 Aligned_cols=263 Identities=24% Similarity=0.296 Sum_probs=202.6
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC--------CCCceEEEEEEe---
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN--------HRHIVKLLGCCL--- 400 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~--------H~nIv~l~g~~~--- 400 (633)
.++|...++||+|+||.||+|.. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 36899999999999999999984 46889999998753 344567889999999985 788999999987
Q ss_pred -eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCC
Q 039736 401 -ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSS 478 (633)
Q Consensus 401 -~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~ 478 (633)
+....++||||+ +|+|.+++.... ...+++..++.|+.||+.||.|||++ + |+||||||+
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~ 176 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--------------YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPE 176 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--------------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGG
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 445789999999 566666664432 24699999999999999999999998 8 999999999
Q ss_pred CeeecCCC-------------------------------------------------cEEEeecCCCccCCCCCcceecc
Q 039736 479 NILLDDKF-------------------------------------------------SAKVSDFGTSRSVPNDKTHLTTA 509 (633)
Q Consensus 479 NILl~~~~-------------------------------------------------~~kI~DfGla~~~~~~~~~~~~~ 509 (633)
|||++.++ .+||+|||+++..... ...
T Consensus 177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~ 252 (397)
T 1wak_A 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTE 252 (397)
T ss_dssp GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCS
T ss_pred HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----Ccc
Confidence 99999775 7999999999876432 233
Q ss_pred cccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhh---hcHHHHHHHHHhhch---------hhhh
Q 039736 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE---RNLVAYFISLAKENK---------LLEI 577 (633)
Q Consensus 510 ~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~---~~l~~~~~~~~~~~~---------~~~~ 577 (633)
..||+.|+|||.+.+..++.++||||||++||||++|+.||......+. ............... ..++
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 4689999999999999999999999999999999999999965443221 111111111111100 0000
Q ss_pred hch-----------------h--hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 578 LDA-----------------R--VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 578 ~d~-----------------~--l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.. . -....+......+.+|+.+||+.||++|||+.|++++
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0 0112356677889999999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=349.09 Aligned_cols=253 Identities=12% Similarity=0.056 Sum_probs=183.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHH---HHHhccCCCCceEEE-------EE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEV---VILSQINHRHIVKLL-------GC 398 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei---~il~~l~H~nIv~l~-------g~ 398 (633)
..+|...+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+ .+|++ +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 346888999999999999999954 78999999987643 23455677885 45555 799988865 44
Q ss_pred EeeCC-----------------ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHH------HHHHHHH
Q 039736 399 CLETE-----------------VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR------VRVACEV 455 (633)
Q Consensus 399 ~~~~~-----------------~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~------~~ia~~i 455 (633)
+...+ ..++||||++ |+|.+++..... .+.+..+ +.++.||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------------~~~~~~~~~~~vk~~i~~qi 203 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------------VYVFRGDEGILALHILTAQL 203 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------------SCCCCHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------------ccchhhhhhhhhHHHHHHHH
Confidence 44332 2799999999 899999976422 4566667 8889999
Q ss_pred HHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc--CCCCcccch
Q 039736 456 AGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS--SQYTDKSDV 533 (633)
Q Consensus 456 a~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDV 533 (633)
+.||+|||+++ |+||||||+|||++.++++||+|||+++..... .....+|+.|+|||.+.+ ..++.++||
T Consensus 204 ~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 204 IRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccH
Confidence 99999999999 999999999999999999999999999865321 113456799999999987 679999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH
Q 039736 534 YSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613 (633)
Q Consensus 534 ~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ 613 (633)
||||++||||++|+.||.......... ......................+..+.+|+.+||+.||++|||+.
T Consensus 277 wSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred HHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999999999999999986543221100 000000000011111111124467889999999999999999999
Q ss_pred HHHH
Q 039736 614 QVSM 617 (633)
Q Consensus 614 ev~~ 617 (633)
|+++
T Consensus 349 e~l~ 352 (371)
T 3q60_A 349 EAME 352 (371)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=329.49 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=203.6
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---------hhHHHHHHHHHHHHhccC-CCCceEEEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---------KTQIEQFINEVVILSQIN-HRHIVKLLGCCL 400 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---------~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~ 400 (633)
..++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999964 68899999986432 123457889999999995 999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
+.+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Ni 155 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENI 155 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceE
Confidence 999999999999999999998642 36999999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc------cCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ------SSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
+++.++.+||+|||++........ .....|++.|+|||.+. ...++.++||||||+++|||++|+.|+....
T Consensus 156 l~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 156 LLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp EECTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEcCCCcEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 999999999999999987643322 23356899999999985 4568899999999999999999999986543
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.... ........ .. .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~------~~~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 QMLM------LRMIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHH------HHHHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHH------HHHHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 2211 11111110 00 000111234567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=344.67 Aligned_cols=257 Identities=23% Similarity=0.348 Sum_probs=185.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC------C
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------E 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------~ 403 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36899999999999999999984 4789999999865 2344567889999999999999999999998754 4
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~ 166 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 166 (367)
T ss_dssp CCEEEEECC-CEECC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred eEEEEeccc-CCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEEC
Confidence 579999999 6899988853 35999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++.+||+|||+++..... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .
T Consensus 167 ~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l 239 (367)
T 2fst_X 167 EDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---L 239 (367)
T ss_dssp TTCCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H
T ss_pred CCCCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 9999999999999875432 233568999999999877 6789999999999999999999999976543321 1
Q ss_pred HHHHHHHhhc-----------hhhhhhchhhh--c-----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKEN-----------KLLEILDARVA--K-----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~-----------~~~~~~d~~l~--~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+....... .....+.. +. . .........+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQS-LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHT-SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhc-cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1111111100 00000000 00 0 0011234678999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=341.74 Aligned_cols=260 Identities=21% Similarity=0.375 Sum_probs=201.2
Q ss_pred HHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 331 RATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 331 ~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
...++|...+.||+|+||.||+|...+ .||+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999999743 49999876432 23345677899999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ ++.+
T Consensus 108 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK---------------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp CBCCCSEEHHHHTTSSC---------------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CC
T ss_pred eecccCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCE
Confidence 99999999999996532 36899999999999999999999999 99999999999998 6799
Q ss_pred EEeecCCCccCCCCC----cceecccccCCCcCchhcccc---------CCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 489 KVSDFGTSRSVPNDK----THLTTAVQGTFGYFDPEYFQS---------SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 489 kI~DfGla~~~~~~~----~~~~~~~~gt~~y~APE~l~~---------~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
||+|||+++...... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987653211 112223458999999999864 4578899999999999999999999865443
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
... ..... .. ..+.. .+...+..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 249 ~~~------~~~~~-~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 249 EAI------IWQMG-TG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHH------HHHHH-TT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHH------HHHhc-cC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 221 11111 11 01111 11123456889999999999999999999999999998765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=348.22 Aligned_cols=260 Identities=24% Similarity=0.288 Sum_probs=202.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhcc------CCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQI------NHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l------~H~nIv~l~g~~~~~~~~ 405 (633)
..+|+..+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 357899999999999999999854 5889999998753 33445677888888877 577999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+. |+|.+++.... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++.+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~ 236 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--------------FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQ 236 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESST
T ss_pred EEEEeccC-CCHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccC
Confidence 99999996 68988886543 235999999999999999999999999 9999999999999998
Q ss_pred Cc--EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 486 FS--AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 486 ~~--~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
+. +||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......+.. .
T Consensus 237 ~~~~vkL~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l---~ 309 (429)
T 3kvw_A 237 GRSGIKVIDFGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL---A 309 (429)
T ss_dssp TSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H
T ss_pred CCcceEEeecccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH---H
Confidence 87 999999999765332 22346899999999999999999999999999999999999998765443321 1
Q ss_pred HHHHHHhh---------chhhhhhchhh------------------------------------hcccCHHHHHHHHHHH
Q 039736 564 YFISLAKE---------NKLLEILDARV------------------------------------AKEAREEDIEAVAELA 598 (633)
Q Consensus 564 ~~~~~~~~---------~~~~~~~d~~l------------------------------------~~~~~~~~~~~l~~L~ 598 (633)
.+...... .....+++..- ....+......+.+|+
T Consensus 310 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli 389 (429)
T 3kvw_A 310 CMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389 (429)
T ss_dssp HHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHH
T ss_pred HHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHH
Confidence 11111110 00111111000 0000111246789999
Q ss_pred HhccccCCCCCCCHHHHHHH
Q 039736 599 MGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 599 ~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+||+.||++|||+.|++++
T Consensus 390 ~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 390 KQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHTCSSTTTSCCHHHHHTS
T ss_pred HHHCCCChhhCCCHHHHhCC
Confidence 99999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.39 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=199.2
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC----hhHHHHHHHHHHHHhccCCCCceEEEEEEe--eCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID----KTQIEQFINEVVILSQINHRHIVKLLGCCL--ETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~--~~~~~ 405 (633)
.++|...+.||+|+||.||++... +++.||+|+++... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999986532 234568999999999999999999999985 34578
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++| |.+++.... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--------------~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~ 145 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--------------EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--------------TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEehhccCC-HHHHHHhCc--------------ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCC
Confidence 9999999876 666664432 246999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCC-CcceecccccCCCcCchhccccCC--CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 486 FSAKVSDFGTSRSVPND-KTHLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.+||+|||++...... .........|+..|+|||.+.+.. .+.++||||||+++|||++|+.||......+
T Consensus 146 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----- 220 (305)
T 2wtk_C 146 GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----- 220 (305)
T ss_dssp CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred CcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----
Confidence 99999999999876432 222233456899999999987644 3779999999999999999999986543221
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...... ... ...+......+.+++.+||+.||++|||+.|++++
T Consensus 221 -~~~~i~-~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 -LFENIG-KGS----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -HHHHHH-HCC----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHHHHh-cCC----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 110 11233445678899999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.31 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=193.1
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
.++|...+.||+|+||.||+|.. .+|+.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 36899999999999999999985 3688999999865 23455678899999999999999999999998654
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~ 161 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 161 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred ceEEEEEcCCC-CHHHHHh------------------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEc
Confidence 67999999974 6776663 25899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH-
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV- 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~- 562 (633)
.++.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.....
T Consensus 162 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 162 SDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp TTSCEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEEEEeeccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999998654321 223456899999999999999999999999999999999999999765432210000
Q ss_pred ---------------HHHHHHHhh-c-----hhhhhhchhhhc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 ---------------AYFISLAKE-N-----KLLEILDARVAK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ---------------~~~~~~~~~-~-----~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... . ...+.+...... ..+......+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 240 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp C-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 0 000000000000 0112336788999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=341.32 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=204.1
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChh-----------------HHHHHHHHHHHHhccCCCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKT-----------------QIEQFINEVVILSQINHRHIVKL 395 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~-----------------~~~~~~~Ei~il~~l~H~nIv~l 395 (633)
.++|...+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 8999999987643211 11688999999999999999999
Q ss_pred EEEEeeCCceEEEEeeccCCCchhh------cchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCC
Q 039736 396 LGCCLETEVPVLVYEYISNGTLSHH------IHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASI 468 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~ 468 (633)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ ++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 172 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--------------TCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--------------CCCCCHHHHHHHHHHHHHHHHHHHHTSC--
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--------------ccCCCHHHHHHHHHHHHHHHHHHhccCC--
Confidence 9999999999999999999999999 54321 2479999999999999999999999 88
Q ss_pred CeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCc-ccchhhHHHHHHHHHhC
Q 039736 469 PIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTD-KSDVYSFGVVLLELLTG 546 (633)
Q Consensus 469 ~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDV~SfGvvL~elltG 546 (633)
++||||||+||+++.++++||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|
T Consensus 173 -i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 -ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred -EeecCCChHhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875433 23445689999999999877 6666 99999999999999999
Q ss_pred CCCCCCCchhhhhcHHHHHHHHHhhchhhh------hh---chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 547 KKPICLTREEEERNLVAYFISLAKENKLLE------IL---DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 547 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------~~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
+.||........ ..... ....... .. .+.............+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~pf~~~~~~~~-----~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 249 VVPFSLKISLVE-----LFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSSCCSSCSHH-----HHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCcHHH-----HHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999865433110 11111 1110000 00 000000111344578899999999999999999999987
Q ss_pred H
Q 039736 618 D 618 (633)
Q Consensus 618 ~ 618 (633)
+
T Consensus 323 h 323 (348)
T 2pml_X 323 H 323 (348)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=341.28 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=201.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~~ 405 (633)
.++|...+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999854 6889999998753 344457899999999999999999999999754 357
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||++ |+|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~ 164 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTT 164 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTT
T ss_pred EEEEcccC-cCHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCC
Confidence 99999997 588887743 36999999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcce--ecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+.+||+|||+++......... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. .
T Consensus 165 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~ 241 (364)
T 3qyz_A 165 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---L 241 (364)
T ss_dssp CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---H
T ss_pred CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---H
Confidence 999999999998764322211 233578999999998755 4589999999999999999999999965543322 1
Q ss_pred HHHHHHHhhch---hhhhhch---h----h--h-----cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKENK---LLEILDA---R----V--A-----KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~---~~~~~d~---~----l--~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+........ +..+.+. . + . ..........+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 242 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111100 0000000 0 0 0 00112234678999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=367.65 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=206.3
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~ 406 (633)
..++|+..+.||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +|+||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999964 6789999998742 223456788999999988 7999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
|||||+++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++
T Consensus 419 lV~E~~~gg~L~~~l~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g 479 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----------------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 479 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSS
T ss_pred EEEeCcCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCC
Confidence 999999999999998653 36999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
++||+|||+++...... .......||+.|+|||++.+..++.++||||||++||||++|+.||......+ .+.
T Consensus 480 ~ikL~DFGla~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~------~~~ 552 (674)
T 3pfq_A 480 HIKIADFGMCKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQ 552 (674)
T ss_dssp CEEECCCTTCEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH
T ss_pred cEEEeecceeeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH------HHH
Confidence 99999999998643222 22345679999999999999999999999999999999999999997543322 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM-----KQVSM 617 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~-----~ev~~ 617 (633)
.... .. ..++......+.+|+.+||+.||++||++ .||.+
T Consensus 553 ~i~~---------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 553 SIME---------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHS---------SC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHh---------CC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111 11 12344556788999999999999999997 66654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=352.91 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=202.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999964 7899999997542 2234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec---CCC
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DKF 486 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~ 486 (633)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 101 e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp CCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTC
T ss_pred EcCCCCcHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCC
Confidence 999999999888543 36999999999999999999999999 99999999999995 566
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
.+||+|||+++...... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~ 232 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LK 232 (486)
T ss_dssp CEEECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred CEEEEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 79999999998764332 2234568999999999875 589999999999999999999999965443221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .... .........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~i~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 233 RVET-GKYA------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHH-TCCC------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHh-CCCC------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 1000 0001112334678899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=353.49 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=198.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|...+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457899999999999999999964 68899999886532 233567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC---C
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK---F 486 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~---~ 486 (633)
||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +
T Consensus 116 e~~~~g~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----------------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred ecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCC
Confidence 999999999888542 36999999999999999999999999 9999999999999764 5
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
.+||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||......+. ..
T Consensus 177 ~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~ 247 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LR 247 (494)
T ss_dssp CEEECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred cEEEEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence 59999999998764332 223456999999999986 5689999999999999999999999975443221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .... .+. ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 248 ~i~~-~~~~--~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 248 KVEK-GKYT--FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHH-TCCC--CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHh-CCCC--CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 1000 000 0012234678899999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=338.29 Aligned_cols=271 Identities=21% Similarity=0.280 Sum_probs=193.4
Q ss_pred HHHHHHHhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc
Q 039736 326 AEELQRATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV 404 (633)
Q Consensus 326 ~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 404 (633)
.++.....++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3556677889999999999999999999964 68999999875432 223456788888999999999999999976443
Q ss_pred -------eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH--hcCCCCeeccCC
Q 039736 405 -------PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH--SAASIPIFHRDI 475 (633)
Q Consensus 405 -------~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH--~~~~~~ivHrDI 475 (633)
.++||||+++ +|.+.+..... ....+++..+..++.|++.||.||| +++ |+||||
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dl 157 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR------------RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDI 157 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT------------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCC
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh------------cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcC
Confidence 7899999986 55544432211 1347899999999999999999999 777 999999
Q ss_pred CCCCeeecC-CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 476 KSSNILLDD-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 476 k~~NILl~~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
||+|||++. ++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 158 kp~NIll~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 235 (360)
T 3e3p_A 158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235 (360)
T ss_dssp CGGGEEEETTTTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEeCCCCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence 999999997 89999999999987654332 2334689999999998665 4899999999999999999999999765
Q ss_pred chhhhhcHHHHHHHHHhhc--hhhhhhch----------------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 039736 554 REEEERNLVAYFISLAKEN--KLLEILDA----------------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~--~~~~~~d~----------------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev 615 (633)
...... ..+....... .....+++ ......+......+.+|+.+||+.||.+|||+.|+
T Consensus 236 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 236 NSAGQL---HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp SHHHHH---HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ChHHHH---HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 433221 1111111000 00001110 00111122356789999999999999999999999
Q ss_pred HHH
Q 039736 616 SMD 618 (633)
Q Consensus 616 ~~~ 618 (633)
+++
T Consensus 313 l~h 315 (360)
T 3e3p_A 313 LCH 315 (360)
T ss_dssp TTS
T ss_pred hcC
Confidence 875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.56 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=201.2
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-------------hHHHHHHHHHHHHhccCCCCceEEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-------------TQIEQFINEVVILSQINHRHIVKLLG 397 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-------------~~~~~~~~Ei~il~~l~H~nIv~l~g 397 (633)
..++|...++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999964 678999998765321 23567889999999999999999999
Q ss_pred EEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 398 CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 398 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
++.+.+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp 174 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----------------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcH
Confidence 999999999999999999999988542 36999999999999999999999999 99999999
Q ss_pred CCeeecCCC---cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 478 SNILLDDKF---SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 478 ~NILl~~~~---~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
+|||++.++ .+||+|||+++...... ......||+.|+|||.+. +.++.++||||||+++|||++|+.||....
T Consensus 175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 175 ENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp GGEEESSTTCCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEEecCCCCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999775 69999999998764432 223456999999999987 568999999999999999999999997544
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..+. ...... +... .+.... ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 252 ~~~~------~~~i~~-~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 252 DQDI------IKKVEK-GKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHH------HHHHHH-CCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHH------HHHHHc-CCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 3321 111111 1100 000000 1234678999999999999999999999865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=355.18 Aligned_cols=251 Identities=29% Similarity=0.396 Sum_probs=204.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999964 7899999987542 233467889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee---cCC
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL---DDK 485 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl---~~~ 485 (633)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +.+
T Consensus 105 ~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 165 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----------------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKD 165 (484)
T ss_dssp ECCCCSCBHHHHHHTC----------------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTT
T ss_pred EecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCC
Confidence 9999999999988653 46999999999999999999999999 9999999999999 567
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+.+||+|||+++....... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+. .
T Consensus 166 ~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~ 236 (484)
T 3nyv_A 166 ANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------L 236 (484)
T ss_dssp CCEEECCTTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred CcEEEEeeeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH------H
Confidence 8999999999987644322 233568999999999865 689999999999999999999999975443221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... .... .........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~i~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 237 KKVEK-GKYT------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHHHH-CCCC------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHc-CCCC------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11111 1100 0001112345678999999999999999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.53 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=196.2
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC--------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLET 402 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 402 (633)
..++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999964 67899999876421 12234588999999999999999999998755
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+ .++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~ 147 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN----------------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLL 147 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEE
Confidence 4 89999999999999988653 36899999999999999999999999 9999999999999
Q ss_pred cCCCc---EEEeecCCCccCCCCCcceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 483 DDKFS---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 483 ~~~~~---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+.++. +||+|||+++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......
T Consensus 148 ~~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 148 SSQEEDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp SSSSSSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred ecCCCCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 87664 9999999998764322 223456899999999974 567889999999999999999999998643321
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
. .+...+ ...... ..+... ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~--~~~~~~----~~~~~~--~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 V--SLKDQI----TSGKYN--FIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp S--CHHHHH----HHTCCC--CCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H--HHHHHH----HhCccc--cCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1 111111 111000 001111 123467899999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.99 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=197.6
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce----
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP---- 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~---- 405 (633)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 368889999999999999999854 6899999998753 344467889999999999999999999999876654
Q ss_pred --EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 406 --VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 406 --~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
++||||++ |+|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~ 178 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVN 178 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEcccc-ccHHHHhh------------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEEC
Confidence 99999997 68877763 35899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..
T Consensus 179 ~~~~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--- 251 (371)
T 4exu_A 179 EDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL--- 251 (371)
T ss_dssp TTCCEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---
T ss_pred CCCCEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH---
Confidence 9999999999999865332 233568999999999887 67899999999999999999999999765432211
Q ss_pred HHHHHHHhhc--hhhhhhc--------hhhh-------cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKEN--KLLEILD--------ARVA-------KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~--~~~~~~d--------~~l~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......... .....++ ..+. ..........+.+|+.+||+.||++|||+.|++++
T Consensus 252 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 252 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1111111000 0000000 0000 00112335788999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=334.40 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=201.5
Q ss_pred HhcCCccCCcccccCcEEEEEEEc--CCCCEEEEEEccccC--hhHHHHHHHHHHHHhcc---CCCCceEEEEEEe----
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGML--PDGSIVAVKRSRAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCL---- 400 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~--~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~---- 400 (633)
+.++|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999996 468899999876432 11223566777777766 8999999999987
Q ss_pred -eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCC
Q 039736 401 -ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSN 479 (633)
Q Consensus 401 -~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~N 479 (633)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--------------~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~N 150 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--------------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 150 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHH
Confidence 4456899999998 699998865321 35899999999999999999999999 9999999999
Q ss_pred eeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhh
Q 039736 480 ILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559 (633)
Q Consensus 480 ILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~ 559 (633)
|+++.++.+||+|||+++...... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 151 ili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 227 (326)
T 1blx_A 151 ILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ- 227 (326)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred eEEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-
Confidence 999999999999999998754322 22345689999999999999999999999999999999999999875543321
Q ss_pred cHHHHHHHHHhhchhhhhh----------c---hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 560 NLVAYFISLAKENKLLEIL----------D---ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~----------d---~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
...+...........+. . ..............+.+|+.+||+.||++|||+.|++++
T Consensus 228 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 228 --LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp --HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111111100000000 0 000011223345778999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=344.12 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=195.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc------eEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------PVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~------~~L 407 (633)
.+|...+.||+|+||.||+|...++..||+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 47889999999999999999987777799998754322 22369999999999999999999975443 789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-CCC
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKF 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~ 486 (633)
||||++++.+........ ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++
T Consensus 116 v~e~~~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~ 179 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAK-------------LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSG 179 (394)
T ss_dssp EEECCSEEHHHHHHHHHH-------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTT
T ss_pred EeeccCccHHHHHHHHHh-------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCC
Confidence 999998754433322111 1347999999999999999999999999 99999999999999 799
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +.. +
T Consensus 180 ~~kL~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~-i 254 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVE-I 254 (394)
T ss_dssp EEEECCCTTCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-H
T ss_pred cEEEeeCCCcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-H
Confidence 999999999987643322 2334689999999998764 589999999999999999999999976543321 111 1
Q ss_pred HHHHhhchh--hhhhchhh-------------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKL--LEILDARV-------------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~--~~~~d~~l-------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ...+++.. ....+......+.+|+.+||+.||++|||+.|++++
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 111111000 00111111 111222345689999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.33 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=200.7
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~~ 405 (633)
.++|...+.||+|+||.||+|... +|+.||||++.... .....++.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999964 68899999987533 34456788999999999999999999998754 568
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||++ |+|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~ 148 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSN 148 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEeccC-ccHHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCC
Confidence 99999997 688887743 36899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCCccCCCCCcc---------eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 486 FSAKVSDFGTSRSVPNDKTH---------LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~---------~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
+.+||+|||+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 149 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999876432211 1123468999999998764 6789999999999999999999999976543
Q ss_pred hhhhcHHHHHHHHHhhc------------hhhhhhchh------hhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 556 EEERNLVAYFISLAKEN------------KLLEILDAR------VAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~------------~~~~~~d~~------l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
.... ..+....... ...+.+... ............+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 229 RHQL---LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHH---HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHH---HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 3211 1111111100 000000000 000011234567899999999999999999999987
Q ss_pred H
Q 039736 618 D 618 (633)
Q Consensus 618 ~ 618 (633)
+
T Consensus 306 h 306 (353)
T 2b9h_A 306 H 306 (353)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=334.23 Aligned_cols=256 Identities=22% Similarity=0.340 Sum_probs=197.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc------
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV------ 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~------ 404 (633)
++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5788899999999999999995 46899999998652 34446688999999999999999999999987654
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.++||||++ |+|.+++. ..+++..++.++.||+.||.|||+++ ++||||||+||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~------------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~ 161 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECT
T ss_pred EEEEecccc-CCHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECC
Confidence 499999997 68888773 25899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ..
T Consensus 162 ~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~ 234 (353)
T 3coi_A 162 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LT 234 (353)
T ss_dssp TCCEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HH
T ss_pred CCcEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 999999999999865332 223468999999999877 6789999999999999999999999976543221 11
Q ss_pred HHHHHHhhc--hh---------hhhhc---hhhh---cccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKEN--KL---------LEILD---ARVA---KEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~--~~---------~~~~d---~~l~---~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... .. ...+. .... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111000 00 00000 0000 01122446789999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=346.63 Aligned_cols=272 Identities=21% Similarity=0.319 Sum_probs=185.0
Q ss_pred cCCcc-CCcccccCcEEEEEEEcC---CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceEE
Q 039736 334 DNYNQ-SRFLGQGGFGTVYKGMLP---DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVL 407 (633)
Q Consensus 334 ~~~~~-~~~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~L 407 (633)
+.|.. .++||+|+||.||+|... +++.||||++..... .+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 458999999999999964 578999999875432 2467899999999999999999999965 567899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee----c
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL----D 483 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl----~ 483 (633)
||||++ |+|.+++........ ......+++..++.|+.||+.||.|||+++ |+||||||+|||+ +
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~-------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKA-------NKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGP 166 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC--------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSST
T ss_pred EEeCCC-CCHHHHHHHhccccc-------cccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCC
Confidence 999997 588888764432110 011235999999999999999999999999 9999999999999 7
Q ss_pred CCCcEEEeecCCCccCCCCCc--ceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhh---
Q 039736 484 DKFSAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEE--- 557 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~--- 557 (633)
.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++|||||||+||||++|+.||.......
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 246 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246 (405)
T ss_dssp TTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred CCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccc
Confidence 789999999999987643222 222345789999999999874 58999999999999999999999996544321
Q ss_pred ---hhcHHHHHHHHHhhch---hhhh------------hchhhhcc---------cCHHHHHHHHHHHHhccccCCCCCC
Q 039736 558 ---ERNLVAYFISLAKENK---LLEI------------LDARVAKE---------AREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 558 ---~~~l~~~~~~~~~~~~---~~~~------------~d~~l~~~---------~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
.......+........ ...+ +....... ........+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ 326 (405)
T 3rgf_A 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 326 (405)
T ss_dssp CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSC
T ss_pred ccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCC
Confidence 0011111111111000 0000 00000000 0001145678999999999999999
Q ss_pred CHHHHHHH
Q 039736 611 TMKQVSMD 618 (633)
Q Consensus 611 t~~ev~~~ 618 (633)
|+.|++++
T Consensus 327 ta~e~L~h 334 (405)
T 3rgf_A 327 TSEQAMQD 334 (405)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=345.76 Aligned_cols=260 Identities=25% Similarity=0.336 Sum_probs=194.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------ceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------VPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~~~ 406 (633)
.+|...+.||+|+||.||+|... +|+.||||++..... .+.+|+++|++++|+||+++++++...+ ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999974 689999998865322 2347999999999999999999986421 257
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC-
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK- 485 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~- 485 (633)
+||||+++ +|.+.+..... ....+++..+..++.||++||.|||+++ |+||||||+|||++.+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~ 193 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSR------------AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDT 193 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHH------------TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTT
T ss_pred eehhcccc-cHHHHHHHHhh------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCC
Confidence 99999985 66665543211 1357999999999999999999999999 9999999999999965
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
+.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+. +...
T Consensus 194 ~~~kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i 269 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEI 269 (420)
T ss_dssp TEEEECCCTTCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred CeEEeccchhhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence 6789999999987643322 2335689999999998764 789999999999999999999999976543221 1111
Q ss_pred HHHHHhhchhhh--hhchhh-------------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 FISLAKENKLLE--ILDARV-------------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~--~~d~~l-------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+ .......... .+++.. ...++......+.+|+.+||+.||++|||+.|++++
T Consensus 270 ~-~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 270 I-KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp H-HHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H-HHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 1 1111110000 011110 011222345788999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.48 Aligned_cols=252 Identities=28% Similarity=0.392 Sum_probs=202.3
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
..++|...+.||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3468999999999999999999964 6899999997643 233467889999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC---
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK--- 485 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~--- 485 (633)
+||+++++|.+++... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.+
T Consensus 100 ~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 100 GELYTGGELFDEIIKR----------------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKD 160 (287)
T ss_dssp ECCCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTT
T ss_pred EEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCc
Confidence 9999999999888542 35899999999999999999999999 9999999999999764
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+.+||+|||++........ .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+. .
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~ 231 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------L 231 (287)
T ss_dssp CCEEECSTTGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------H
T ss_pred ccEEEeccCcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 4799999999987643322 123358899999999865 489999999999999999999999865433221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .+... .+ .......+..+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~-~~~~~--~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 232 KRVE-TGKYA--FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHHH-HCCCC--CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHH-cCCCC--CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111 11100 00 00012234678999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.83 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=181.5
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc-ChhHHHHHHHHHH-HHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI-DKTQIEQFINEVV-ILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~-~~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|...+.||+|+||.||+|... +|+.||||+++.. ......++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368889999999999999999964 6899999998754 3344456666666 778889999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
||+++ +|.+++..... .....+++..+..++.|++.||.|||+. + ++||||||+|||++.++.+
T Consensus 101 e~~~~-~l~~~~~~~~~-----------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~ 165 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYS-----------VLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNI 165 (327)
T ss_dssp CCCSE-EHHHHHHHHHH-----------TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEE
T ss_pred eecCC-ChHHHHHHHHh-----------hhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCE
Confidence 99985 88777753211 1134799999999999999999999998 8 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhcc----ccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----QSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~ 564 (633)
||+|||+++....... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 166 kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------ 237 (327)
T 3aln_A 166 KLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------ 237 (327)
T ss_dssp EECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred EEccCCCceecccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------
Confidence 9999999987643321 2233689999999998 456789999999999999999999999864321100
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... .......+.+...........+.+|+.+||+.||++|||+.|++++
T Consensus 238 ---~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 238 ---QLT--QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -----C--CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHH--HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000 0000000111111122345689999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=332.91 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=200.5
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-----------CCCceEEEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-----------HRHIVKLLGCCLE 401 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-----------H~nIv~l~g~~~~ 401 (633)
++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5799999999999999999995 47899999998753 334567889999999886 8999999999986
Q ss_pred CC----ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCC
Q 039736 402 TE----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIK 476 (633)
Q Consensus 402 ~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk 476 (633)
.+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ + |+|||||
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dik 159 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE--------------HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIK 159 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT--------------TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCS
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh--------------ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCC
Confidence 54 679999999 899999986532 23599999999999999999999998 8 9999999
Q ss_pred CCCeeec------CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 477 SSNILLD------DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 477 ~~NILl~------~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
|+|||++ .++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 160 p~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp GGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 9999994 4558999999999876432 22346899999999999999999999999999999999999999
Q ss_pred CCCchhhhh---cHHHHHHHHHhh--------ch----------------------hhhhhchhhhcccCHHHHHHHHHH
Q 039736 551 CLTREEEER---NLVAYFISLAKE--------NK----------------------LLEILDARVAKEAREEDIEAVAEL 597 (633)
Q Consensus 551 ~~~~~~~~~---~l~~~~~~~~~~--------~~----------------------~~~~~d~~l~~~~~~~~~~~l~~L 597 (633)
......... .....+...... .. +.+.+.. ....+......+.+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 313 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDF 313 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHH
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHH
Confidence 754322111 111111111110 00 0000000 123456778899999
Q ss_pred HHhccccCCCCCCCHHHHHHH
Q 039736 598 AMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 598 ~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+.+||+.||++|||+.|++++
T Consensus 314 i~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 314 LSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHhccCccccCCHHHHhhC
Confidence 999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.43 Aligned_cols=260 Identities=19% Similarity=0.275 Sum_probs=200.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CC-CEEEEEEccccChhHHHHHHHHHHHHhccCCCC------ceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DG-SIVAVKRSRAIDKTQIEQFINEVVILSQINHRH------IVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g-~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n------Iv~l~g~~~~~~~ 404 (633)
.++|...+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++++++|++ ++.+.+++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 368999999999999999999953 34 68999998753 334567889999999997766 9999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee--
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL-- 482 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl-- 482 (633)
.++||||+ +|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~ 158 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--------------FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVN 158 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--------------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESC
T ss_pred EEEEEecc-CCChHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEec
Confidence 99999999 667777765432 246999999999999999999999998 9999999999999
Q ss_pred -----------------cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh
Q 039736 483 -----------------DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545 (633)
Q Consensus 483 -----------------~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt 545 (633)
+.++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 678899999999998653322 23568999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhcHHHHHHHHHhh--------chhhhh-----------------hchhh-----hcccCHHHHHHHH
Q 039736 546 GKKPICLTREEEERNLVAYFISLAKE--------NKLLEI-----------------LDARV-----AKEAREEDIEAVA 595 (633)
Q Consensus 546 G~~p~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~-----------------~d~~l-----~~~~~~~~~~~l~ 595 (633)
|+.||......+... .+...... ...... ..... ...........+.
T Consensus 235 g~~pf~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 311 (355)
T 2eu9_A 235 GFTLFQTHENREHLV---MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLF 311 (355)
T ss_dssp SSCSCCCSSHHHHHH---HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred CCCCCCCCCHHHHHH---HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHH
Confidence 999997654433211 11111100 000000 00000 0011223456889
Q ss_pred HHHHhccccCCCCCCCHHHHHHH
Q 039736 596 ELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 596 ~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+|+.+||+.||++|||+.|++++
T Consensus 312 ~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 312 DLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhcCChhhCcCHHHHhcC
Confidence 99999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.45 Aligned_cols=203 Identities=27% Similarity=0.369 Sum_probs=171.2
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccC-CC-----CceEEEEEEeeCCc
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HR-----HIVKLLGCCLETEV 404 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~-----nIv~l~g~~~~~~~ 404 (633)
..++|...+.||+|+||.||+|... +++.||||+++.. ....+.+..|+.+++.++ |+ +|+++.+++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999854 6889999998753 334567778898888875 44 49999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD- 483 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~- 483 (633)
.++||||++ |+|.+++.... ...+++..+..++.|++.||.|||++. .+|+||||||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~ 194 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN--------------FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCN 194 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT--------------TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESS
T ss_pred eEEEEecCC-CCHHHHHhhcC--------------cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEec
Confidence 999999996 59999986542 246999999999999999999999532 2399999999999994
Q ss_pred -CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCch
Q 039736 484 -DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTRE 555 (633)
Q Consensus 484 -~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~ 555 (633)
.++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 195 ~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 195 PKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 5788999999999876432 2235689999999999999999999999999999999999999976543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.10 Aligned_cols=245 Identities=27% Similarity=0.400 Sum_probs=191.9
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh------hHHHHHHHHHHHHhcc----CCCCceEEEE
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK------TQIEQFINEVVILSQI----NHRHIVKLLG 397 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l----~H~nIv~l~g 397 (633)
.+...++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 4688999999865322 1233466799999998 8999999999
Q ss_pred EEeeCCceEEEEee-ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCC
Q 039736 398 CCLETEVPVLVYEY-ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIK 476 (633)
Q Consensus 398 ~~~~~~~~~LV~E~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk 476 (633)
++.+.+..++|+|+ +.+++|.+++... ..+++..++.++.|++.||.|||+++ ++|||||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 166 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK----------------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIK 166 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCS
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCC
Confidence 99998999999999 7899999998652 35999999999999999999999999 9999999
Q ss_pred CCCeeec-CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCC-cccchhhHHHHHHHHHhCCCCCCCCc
Q 039736 477 SSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYT-DKSDVYSFGVVLLELLTGKKPICLTR 554 (633)
Q Consensus 477 ~~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s-~ksDV~SfGvvL~elltG~~p~~~~~ 554 (633)
|+||+++ +++.+||+|||+++...... .....|+..|+|||.+.+..+. .++||||||+++|||++|+.||....
T Consensus 167 p~Nil~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 167 DENILIDLRRGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp GGGEEEETTTTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred hhhEEEeCCCCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 9999999 89999999999998764432 2334589999999999877664 58999999999999999999985311
Q ss_pred hhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 555 EEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 555 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. ... . ....+......+.+++.+||+.||++|||+.|++++
T Consensus 244 ~------------~~~---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 E------------ILE---------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H------------HHH---------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred H------------Hhh---------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 0 011223345678899999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=341.26 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=186.9
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEeecc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456789999999997665557999999988653 234678999999886 89999999999999999999999995
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC--------
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK-------- 485 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~-------- 485 (633)
|+|.+++........ .....++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 93 -gsL~~~l~~~~~~~~---------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 93 -LNLQDLVESKNVSDE---------NLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp -EEHHHHHHTC---------------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCT
T ss_pred -CCHHHHHhccCCCch---------hhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccc
Confidence 699999976432110 0112345567899999999999999999 9999999999999754
Q ss_pred -----CcEEEeecCCCccCCCCCcc---eecccccCCCcCchhcccc-------CCCCcccchhhHHHHHHHHHh-CCCC
Q 039736 486 -----FSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQS-------SQYTDKSDVYSFGVVLLELLT-GKKP 549 (633)
Q Consensus 486 -----~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-------~~~s~ksDV~SfGvvL~ellt-G~~p 549 (633)
+++||+|||+++........ ......||++|+|||.+.+ ..++.++|||||||++|||++ |+.|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 58999999999876543322 1234569999999999975 678999999999999999999 9999
Q ss_pred CCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 550 ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 550 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
|........ ...... . . .+......+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 240 f~~~~~~~~--------~i~~~~-~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 240 FGDKYSRES--------NIIRGI-F-S--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TCSTTTHHH--------HHHHTC-C-C--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhHH--------HHhcCC-C-C--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 854322110 011100 0 0 000111123456788999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=332.04 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=199.4
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh------hHHHHHHHHHHHHhccC--CCCceEE
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK------TQIEQFINEVVILSQIN--HRHIVKL 395 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l~--H~nIv~l 395 (633)
...+.....++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++++++ |+||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 3344455567899999999999999999984 4788999998765321 12245678999999996 5999999
Q ss_pred EEEEeeCCceEEEEeeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccC
Q 039736 396 LGCCLETEVPVLVYEYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRD 474 (633)
Q Consensus 396 ~g~~~~~~~~~LV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrD 474 (633)
++++.+.+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||.|||+.+ |+|||
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 174 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER----------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRD 174 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCC
Confidence 9999999999999999986 8999988642 36899999999999999999999999 99999
Q ss_pred CCCCCeeec-CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCC
Q 039736 475 IKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICL 552 (633)
Q Consensus 475 Ik~~NILl~-~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~ 552 (633)
|||+|||++ +++.+||+|||+++...... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus 175 lkp~NIll~~~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 175 IKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCHHHEEEeCCCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 999999999 78999999999998764322 223468999999999987765 6789999999999999999999853
Q ss_pred CchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 553 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ..... ...+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 252 ~~~------------~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 252 DEE------------IIRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHH------------HHHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhh------------hhccc-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 210 00000 01122334678899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=328.07 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=173.6
Q ss_pred hcCCccCC-cccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCceE
Q 039736 333 TDNYNQSR-FLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPV 406 (633)
Q Consensus 333 ~~~~~~~~-~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~ 406 (633)
.++|...+ .||+|+||.||+|... +|+.||||++..... .. .+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-AR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788854 6999999999999965 689999999865321 11 222344667799999999999876 34579
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-- 484 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 484 (633)
+||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 103 lv~e~~~gg~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~ 165 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--------------DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKE 165 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---------------CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSS
T ss_pred EEEeccCCCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecC
Confidence 9999999999999997542 236999999999999999999999999 999999999999986
Q ss_pred -CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus 166 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~ 239 (336)
T 3fhr_A 166 KDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---P 239 (336)
T ss_dssp TTCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred CCceEEEeccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---h
Confidence 4559999999998654322 23346899999999998888999999999999999999999998543322110 0
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ............+..+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 240 GMKRRIRLG------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHhhhcc------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000000 0000111112345678999999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=321.31 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=179.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhH-HHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQ-IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~-~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.++|...+.||+|+||.||+|... +|+.||||++.... ... .+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999964 68999999987542 222 334445556788889999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
||+ ++.+..+.... ...+++..++.++.|++.||.|||+. + ++||||||+||+++.++++
T Consensus 104 e~~-~~~~~~l~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---------------QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp CCC-SEEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCE
T ss_pred ecc-CCcHHHHHHHh---------------ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCE
Confidence 999 44444333221 24699999999999999999999995 8 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
||+|||++........ .....|++.|+|||.+. ...++.++||||||+++|||++|+.||....... .
T Consensus 165 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~ 237 (318)
T 2dyl_A 165 KLCDFGISGRLVDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----E 237 (318)
T ss_dssp EECCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H
T ss_pred EEEECCCchhccCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----H
Confidence 9999999976543221 22346899999999984 5568899999999999999999999986432211 1
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... .+.+ ......+..+.+++.+||+.||.+||++.|++++
T Consensus 238 ~~~~~~~~~------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 238 VLTKVLQEE------PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHHSC------CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhccC------CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111110 0000 0112234678999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.57 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=186.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
..+|...+.||+|+||+||.....+|+.||||++..... +.+.+|+++|+++ +||||+++++++.+.+..|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 356888999999999995544444789999999865332 2355899999999 799999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-----CC
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-----KF 486 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 486 (633)
++ |+|.+++.... ..+.+..++.++.||+.||.|||+++ |+||||||+|||++. ..
T Consensus 100 ~~-g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---------------FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp CS-EEHHHHHHSSS---------------CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBC
T ss_pred CC-CCHHHHHHhcC---------------CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCce
Confidence 96 69999986542 24566677899999999999999999 999999999999953 34
Q ss_pred cEEEeecCCCccCCCCCc--ceecccccCCCcCchhccc---cCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 487 SAKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQ---SSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~---~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
.+||+|||+++....... .......||++|+|||.+. ...++.++|||||||++|||++ |+.||........
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-- 238 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-- 238 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--
Confidence 688999999987643322 2233456999999999997 4567889999999999999999 8888753322110
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
......... +.. .........+.+|+.+||+.||++|||+.|+++
T Consensus 239 -----~~~~~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 -----NILLGACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----HHHTTCCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----HHHhccCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 001110000 000 111234456789999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=350.23 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=194.5
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc-----e
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV-----P 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-----~ 405 (633)
++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999964 5899999988643 34556688999999999999999999999987665 6
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
||||||+++++|.+++.. .++|.+++.|+.||+.||.|||+++ |+||||||+|||++.+
T Consensus 160 ~lv~E~~~g~~L~~~~~~------------------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~ 218 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------------------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE 218 (681)
T ss_dssp EEEEECCCCEECC----C------------------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS
T ss_pred EEEEEeCCCCcHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC
Confidence 999999999999887632 5999999999999999999999999 9999999999999986
Q ss_pred CcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 486 FSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 486 ~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+++..... ....||++|+|||++.++. +.++||||||++||||++|..|+.......
T Consensus 219 -~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------- 283 (681)
T 2pzi_A 219 -QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------- 283 (681)
T ss_dssp -CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS--------
T ss_pred -cEEEEecccchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc--------
Confidence 9999999999876433 3356899999999987654 889999999999999999988864311100
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHHHhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-MKQVSMDLEGLR 623 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-~~ev~~~L~~i~ 623 (633)
+. . ..........+.+|+.+||+.||++||+ +.++...|..+.
T Consensus 284 --------~~---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 --------LP---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp --------CC---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------cc---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0 0001122356889999999999999995 677777777664
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.67 Aligned_cols=269 Identities=23% Similarity=0.367 Sum_probs=206.1
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee------CCce
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE------TEVP 405 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~------~~~~ 405 (633)
++|...+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999996 46899999988753 45556789999999999999999999999765 5678
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
++||||+++|+|.+++..... ...+++..++.|+.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~-------------~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFEN-------------CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPG 157 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSC-------------TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhccc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecC
Confidence 999999999999999975432 236999999999999999999999999 9999999999999976
Q ss_pred Cc---EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 486 FS---AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 486 ~~---~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
+. +||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 158 g~~~~vKL~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~---- 231 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ---- 231 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH----
T ss_pred CCceeEEEcccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh----
Confidence 65 99999999987644322 2345689999999999999999999999999999999999999865322110
Q ss_pred HHHHHH----Hhhchhhhhhch--------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHH-----HHHHHHhhhhh
Q 039736 563 AYFISL----AKENKLLEILDA--------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ-----VSMDLEGLRRS 625 (633)
Q Consensus 563 ~~~~~~----~~~~~~~~~~d~--------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~e-----v~~~L~~i~~s 625 (633)
|.... .......+.... ..........+..+.+++..||+.||++|||+.| +++.++.+...
T Consensus 232 -~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 232 -WHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp -SSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred -hhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00000 000000000000 0012234556788999999999999999999988 66677666643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.01 Aligned_cols=233 Identities=13% Similarity=0.094 Sum_probs=184.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|...+.||+|+||.||+|... +|+.||||++... +....+.|.+|+.++++++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999964 4899999998753 2344578999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++++|.+++.. .....++.+|+.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 111 e~~~g~~L~~~l~~------------------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 111 EWIRGGSLQEVADT------------------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp ECCCEEEHHHHHTT------------------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEE
T ss_pred EecCCCCHHHHHhc------------------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEE
Confidence 99999999999843 1345578899999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+++| |++| ++.++||||||+++|||++|+.||...........
T Consensus 170 l~~~~---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------- 213 (286)
T 3uqc_A 170 LAYPA---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------- 213 (286)
T ss_dssp ECSCC---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------
T ss_pred EEecc---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------
Confidence 98443 3433 58899999999999999999999865432210000
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
....... ............+..+.+|+.+||+.||++| |+.|+++.|+++....
T Consensus 214 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 214 AERDTAG--QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CCBCTTS--CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred HHHHhcc--CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 0000000 0000011123345678999999999999999 9999999999988654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=325.33 Aligned_cols=248 Identities=17% Similarity=0.181 Sum_probs=181.7
Q ss_pred HhcCCccCCcccccCcEEEEEEE-cCCCCEEEEEEccccCh---hHHHHHHHHHHHHhccCC-CCc---------e----
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDK---TQIEQFINEVVILSQINH-RHI---------V---- 393 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~~~---~~~~~~~~Ei~il~~l~H-~nI---------v---- 393 (633)
.+.+|...+.||+|+||.||+|. ..+|+.||||+++.... ...+.|.+|+.+++.++| +|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34567788999999999999999 45799999998874222 235678999999999987 221 1
Q ss_pred --------EEEEEEee-----CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHH
Q 039736 394 --------KLLGCCLE-----TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVA 460 (633)
Q Consensus 394 --------~l~g~~~~-----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~ 460 (633)
.+...... ....+++|+++ +|+|.+++....... .....++|..++.|+.|++.||+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~ 225 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS---------STHKSLVHHARLQLTLQVIRLLA 225 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT---------TTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc---------ccCCCCCHHHHHHHHHHHHHHHH
Confidence 11111111 12346666655 689998885322100 01235788999999999999999
Q ss_pred HhHhcCCCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcc----------ccCCCCcc
Q 039736 461 YMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYF----------QSSQYTDK 530 (633)
Q Consensus 461 yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~k 530 (633)
|||+++ |+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.+
T Consensus 226 ~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp HHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred HHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 999999 999999999999999999999999999865322 334567 999999999 55568889
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC
Q 039736 531 SDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610 (633)
Q Consensus 531 sDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 610 (633)
+|||||||++|||++|+.||......+. ....+. . ....+..+.+|+.+||+.||++||
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~---------------~~~~~~----~--~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGG---------------SEWIFR----S--CKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSC---------------SGGGGS----S--CCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhh---------------HHHHHh----h--cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999999999864332211 111111 0 112346789999999999999999
Q ss_pred CHHHHHHH
Q 039736 611 TMKQVSMD 618 (633)
Q Consensus 611 t~~ev~~~ 618 (633)
++.|++++
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 98887553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.91 Aligned_cols=227 Identities=23% Similarity=0.328 Sum_probs=178.2
Q ss_pred cCCccC-CcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHH-hccCCCCceEEEEEEee----CCceE
Q 039736 334 DNYNQS-RFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVIL-SQINHRHIVKLLGCCLE----TEVPV 406 (633)
Q Consensus 334 ~~~~~~-~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il-~~l~H~nIv~l~g~~~~----~~~~~ 406 (633)
++|... +.||+|+||.||++.. .+++.||||+++.. ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567666 7799999999999995 47899999998642 3566888887 55689999999999876 56789
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-- 484 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-- 484 (633)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 154 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG--------------DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKR 154 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT--------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSS
T ss_pred EEEeecCCCcHHHHHHhcc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCC
Confidence 9999999999999997542 236999999999999999999999999 999999999999998
Q ss_pred -CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 -KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 -~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+||+|||++.... +..++.++||||||+++|||++|+.||........
T Consensus 155 ~~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----- 206 (299)
T 3m2w_A 155 PNAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----- 206 (299)
T ss_dssp TTCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------
T ss_pred CCCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----
Confidence 7899999999987542 23457899999999999999999999854322110
Q ss_pred HHHHHHhhchhhhhhchhhhcccC----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENKLLEILDARVAKEAR----EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.......+.... ...+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 207 ------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 207 ------SPGMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -------CCSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------hHHHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000000000 0111 2235678999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.02 Aligned_cols=241 Identities=17% Similarity=0.221 Sum_probs=185.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--------hhHHHHHHHHHHHHhccC---------CCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--------KTQIEQFINEVVILSQIN---------HRHIVKL 395 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~---------H~nIv~l 395 (633)
.++|...+.||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.++++++ |+||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35788899999999999999998 78999999987532 223467889999988885 8888888
Q ss_pred EEEEe------------------------------eCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCH
Q 039736 396 LGCCL------------------------------ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445 (633)
Q Consensus 396 ~g~~~------------------------------~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~ 445 (633)
.+++. +.+..++||||+++|++.+.+.. ..+++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------------~~~~~ 160 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------------KLSSL 160 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------------TCCCH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------------cCCCH
Confidence 88753 15678999999999987777643 25899
Q ss_pred HHHHHHHHHHHHHHHHhH-hcCCCCeeccCCCCCCeeecCCC--------------------cEEEeecCCCccCCCCCc
Q 039736 446 ENRVRVACEVAGAVAYMH-SAASIPIFHRDIKSSNILLDDKF--------------------SAKVSDFGTSRSVPNDKT 504 (633)
Q Consensus 446 ~~~~~ia~~ia~gL~yLH-~~~~~~ivHrDIk~~NILl~~~~--------------------~~kI~DfGla~~~~~~~~ 504 (633)
..+..|+.||+.||+||| +++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 161 ~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-- 235 (336)
T 2vuw_A 161 ATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-- 235 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--
T ss_pred HHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--
Confidence 999999999999999999 899 99999999999999887 9999999999876432
Q ss_pred ceecccccCCCcCchhccccCCCCcccchhhHHHH-HHHHHhCCCCCCCCchhhhhcHHHHH-HHHHhhchhhhhhchhh
Q 039736 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVV-LLELLTGKKPICLTREEEERNLVAYF-ISLAKENKLLEILDARV 582 (633)
Q Consensus 505 ~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvv-L~elltG~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~d~~l 582 (633)
...||+.|+|||.+.+.. +.++||||+|++ .+++++|..|+.. . ...... ........ .....
T Consensus 236 ----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----~-~~~~~~~~~~~~~~~----~~~~~ 300 (336)
T 2vuw_A 236 ----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----V-LWLHYLTDKMLKQMT----FKTKC 300 (336)
T ss_dssp ----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----H-HHHHHHHHHHHHTCC----CSSCC
T ss_pred ----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----h-hhhhHHHHhhhhhhc----cCccc
Confidence 346899999999998665 889999998777 7788999998621 0 000001 01110000 00011
Q ss_pred hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 039736 583 AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616 (633)
Q Consensus 583 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~ 616 (633)
........+..+.+|+.+||+.| |+.|++
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11223456788999999999976 899887
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=256.60 Aligned_cols=162 Identities=24% Similarity=0.374 Sum_probs=141.2
Q ss_pred cccc-chhhcccCCCCCCHHHHHHHhCCCC--------------------------CcEEEEccccccCCC-CCcccccE
Q 039736 58 NLCQ-SFITFRSEPPYDTPVSIAYLLGSEA--------------------------SKSVIVPVSCSCSGS-LYQHNAPY 109 (633)
Q Consensus 58 ~~C~-~~~~~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~vp~~c~c~~~-~~~~~~~y 109 (633)
++|+ +|+.|+.++ +||+..||++||++. +|.|+||++|+|.++ ++++..+|
T Consensus 3 ~~C~~a~~~Y~V~~-GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~Y 81 (212)
T 4eby_A 3 TSCPLALASYYLEN-GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSY 81 (212)
T ss_dssp CCCSCEEEEEECCT-TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEEE
T ss_pred CCCccceEEEEeCC-CCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceEE
Confidence 4799 999997655 999999999999874 399999999999854 55677899
Q ss_pred EeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecceeccccCCccccccceeEEEeeeccCchhhhhhhh
Q 039736 110 TTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAYMAQAGDNMSFIGNE 189 (633)
Q Consensus 110 ~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia~~ 189 (633)
+|++|||||.||++.|++++++++|+++|...++.|++||+|.||..|+|++.. ...+....++|+|++|||||+||++
T Consensus 82 ~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~~-~~~~~~~~~~Y~V~~GDTL~~IA~~ 160 (212)
T 4eby_A 82 SVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDES-VSKDFGLFVTYPLRPEDSLSSIARS 160 (212)
T ss_dssp ECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCTT-TCSSCCCEEEEECCTTCCHHHHHHH
T ss_pred EecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCcc-cccCCCCeEEEEECCCCcHHHHHHH
Confidence 999999999999768999999999999999888899999999999999998753 4445567889999999999999999
Q ss_pred hcccchhhccccCCCCCCceeecccccccccCCC
Q 039736 190 FGVDVQSIVDANMLPNGDAIRVFTPLLIPLKSES 223 (633)
Q Consensus 190 f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~~~ 223 (633)
||+++++|++||++.+ ..+.+|+ |+||.+...
T Consensus 161 fgvsv~~L~~~N~~~~-~~~~~g~-l~IP~~~~~ 192 (212)
T 4eby_A 161 SGVSADILQRYNPGVN-FNSGNGI-VYVPGRDPN 192 (212)
T ss_dssp HTSCHHHHHHHSTTCC-TTSCSSE-EEEECCCTT
T ss_pred HCcCHHHHHHhcCCCc-cCCCCCE-EEecCCCCC
Confidence 9999999999999864 4566666 999998644
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-29 Score=278.13 Aligned_cols=184 Identities=18% Similarity=0.140 Sum_probs=128.5
Q ss_pred ccccCcEEEEEEE-cCCCCEEEEEEcccc----------ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEEE
Q 039736 342 LGQGGFGTVYKGM-LPDGSIVAVKRSRAI----------DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 342 ig~G~~G~Vy~g~-~~~g~~vAVK~~~~~----------~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.+.|++|.+..++ .--|+.+|+|.+... .....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4555555554433 124788999987542 123456799999999999 6999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||++||+|.++|... .+++.. +|+.||+.||+|||+++ ||||||||+||||++++++|
T Consensus 322 Eyv~G~~L~d~i~~~----------------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----------------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp ECCCSEEHHHHHHTT----------------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEE
T ss_pred ecCCCCcHHHHHHhC----------------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEE
Confidence 999999999999653 345543 58899999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
|+|||+|+....... ......||++|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus 380 L~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999987654332 2344679999999999875 567789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.2e-26 Score=253.87 Aligned_cols=184 Identities=16% Similarity=0.213 Sum_probs=145.2
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
...++||+|+||.||+|.. .++.+++|+..... ....+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999976 57889999753311 11245689999999999999999666666677888999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++.. ++.++.|+++||+|||+++ |+||||||+|||+++ ++
T Consensus 418 mE~~~ggsL~~~l~~------------------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~ 468 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DL 468 (540)
T ss_dssp EECCCSEEHHHHSTT------------------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SE
T ss_pred EECCCCCCHHHHHHH------------------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eE
Confidence 999999999999853 3579999999999999999 999999999999999 99
Q ss_pred EEeecCCCccCCCCCcce------ecccccCCCcCchhcccc--CCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 489 KVSDFGTSRSVPNDKTHL------TTAVQGTFGYFDPEYFQS--SQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
||+|||+++......... .....||+.|||||++.. ..|+.+.|+|+..+-.++.+.++.++
T Consensus 469 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 469 YIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp EECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 999999999875432211 235679999999999987 56788899999999999888877654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4e-23 Score=210.96 Aligned_cols=151 Identities=19% Similarity=0.140 Sum_probs=120.6
Q ss_pred HHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccCh------------------hHHHHHHHHHHHHhccCC
Q 039736 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDK------------------TQIEQFINEVVILSQINH 389 (633)
Q Consensus 328 el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~------------------~~~~~~~~Ei~il~~l~H 389 (633)
.+......|...+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 34444556667799999999999999997799999999864221 135578999999999994
Q ss_pred CCceEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCC
Q 039736 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIP 469 (633)
Q Consensus 390 ~nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ 469 (633)
+++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+++
T Consensus 164 ---~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------------------~~~~~i~~qi~~~l~~lH~~g--- 213 (282)
T 1zar_A 164 ---LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------------------ENPDEVLDMILEEVAKFYHRG--- 213 (282)
T ss_dssp ---SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------------------SCHHHHHHHHHHHHHHHHHTT---
T ss_pred ---CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------------------hhHHHHHHHHHHHHHHHHHCC---
Confidence 55555443 356799999999999988 421 123469999999999999999
Q ss_pred eeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccc
Q 039736 470 IFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ 523 (633)
Q Consensus 470 ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~ 523 (633)
|+||||||+|||++ ++++||+|||+++. +..++|||++.
T Consensus 214 iiHrDlkp~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 214 IVHGDLSQYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EECSCCSTTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred CEeCCCCHHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999999 99999999999974 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=7.1e-19 Score=177.09 Aligned_cols=140 Identities=18% Similarity=0.151 Sum_probs=105.7
Q ss_pred CccCCcccccCcEEEEEEEc-CCCCE--EEEEEccccCh------------------------hHHHHHHHHHHHHhccC
Q 039736 336 YNQSRFLGQGGFGTVYKGML-PDGSI--VAVKRSRAIDK------------------------TQIEQFINEVVILSQIN 388 (633)
Q Consensus 336 ~~~~~~ig~G~~G~Vy~g~~-~~g~~--vAVK~~~~~~~------------------------~~~~~~~~Ei~il~~l~ 388 (633)
|...+.||+|+||.||+|.. .+|+. ||||+++.... .....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678999999999999997 67888 99998653211 11236788999999998
Q ss_pred CCCc--eEEEEEEeeCCceEEEEeeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhH-h
Q 039736 389 HRHI--VKLLGCCLETEVPVLVYEYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMH-S 464 (633)
Q Consensus 389 H~nI--v~l~g~~~~~~~~~LV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH-~ 464 (633)
|+++ ..+++. +..+|||||+.+ |.+...+..... ..++..+..++.|++.||.||| +
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~---------------~~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR---------------ELKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG---------------GGGGSCHHHHHHHHHHHHHHHHHT
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh---------------ccChHHHHHHHHHHHHHHHHHHHH
Confidence 8754 444443 357999999952 533322221110 1235567889999999999999 8
Q ss_pred cCCCCeeccCCCCCCeeecCCCcEEEeecCCCccC
Q 039736 465 AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499 (633)
Q Consensus 465 ~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~ 499 (633)
.+ |+||||||+|||+++ .++|+|||+|...
T Consensus 190 ~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 88 999999999999998 9999999999764
|
| >4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-19 Score=171.76 Aligned_cols=109 Identities=16% Similarity=0.304 Sum_probs=93.1
Q ss_pred ccccEEeccCCceeeehhcccCCCcch--------HHhhhcC-CC-CCCCCCCCceeecceeccccCCccccccceeEEE
Q 039736 105 HNAPYTTKPNDTYFLVANNTYQGLTTC--------QALLGQN-YY-DEKNLGSGVELTVPIRCACATANQTENGVTYLLA 174 (633)
Q Consensus 105 ~~~~y~v~~gdt~~~ia~~~~~~l~t~--------~~l~~~N-~~-~~~~l~~g~~l~ip~~c~c~~~~~~~~~~~~~~t 174 (633)
+-.+|+|++|||||.||+ .|+ ++. ++|+++| .+ +++.|.+||+|.||..|.|.... ......+
T Consensus 8 a~~~Y~V~~GDTL~~IA~-~~~--vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~----~~~~~~~ 80 (212)
T 4eby_A 8 ALASYYLENGTTLSVINQ-NLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD----FLGHNFS 80 (212)
T ss_dssp EEEEEECCTTCCHHHHHH-HTC--CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT----EEEEEEE
T ss_pred ceEEEEeCCCCCHHHHHH-HHC--CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc----cccCceE
Confidence 456799999999999994 575 465 9999999 66 47789999999999999997432 1234578
Q ss_pred eeeccCchhhhhh-hhhc--ccchhhccccCCCCCCceeecccccccccC
Q 039736 175 YMAQAGDNMSFIG-NEFG--VDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 175 Y~v~~gDtl~~Ia-~~f~--v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
|+|++|||||+|| ++|+ +++++|++||++ +++.|++||.|.||..+
T Consensus 81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~-~~~~l~~Gq~L~IP~~~ 129 (212)
T 4eby_A 81 YSVRQEDTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNC 129 (212)
T ss_dssp EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCS-CTTCCCTTCEEEEEEEC
T ss_pred EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCC-CcccCCCCCEEEEcCCC
Confidence 9999999999999 8999 999999999995 66789999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=3.7e-16 Score=164.29 Aligned_cols=137 Identities=12% Similarity=0.142 Sum_probs=100.3
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--------------hhHHHH--------HHHHHHHHhccCCCCc
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--------------KTQIEQ--------FINEVVILSQINHRHI 392 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--------------~~~~~~--------~~~Ei~il~~l~H~nI 392 (633)
-|+..+.||+|+||.||+|...+|+.||||+++... ...... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 488899999999999999998899999999764310 000111 2345666666654433
Q ss_pred --eEEEEEEeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCe
Q 039736 393 --VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPI 470 (633)
Q Consensus 393 --v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~i 470 (633)
...++. ...+|||||+++++|.++... .....++.|++.+|.|||+++ |
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------------------~~~~~l~~qll~~l~~lH~~g---I 226 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------------------PDPASLYADLIALILRLAKHG---L 226 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------------------SCHHHHHHHHHHHHHHHHHTT---E
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhccc----------------------HHHHHHHHHHHHHHHHHHHCC---C
Confidence 222222 234799999999888665421 233568899999999999999 9
Q ss_pred eccCCCCCCeeecCCC----------cEEEeecCCCccCC
Q 039736 471 FHRDIKSSNILLDDKF----------SAKVSDFGTSRSVP 500 (633)
Q Consensus 471 vHrDIk~~NILl~~~~----------~~kI~DfGla~~~~ 500 (633)
|||||||.|||+++++ .+.|+||+-+....
T Consensus 227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999999998876 48999999886543
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.7e-13 Score=125.56 Aligned_cols=96 Identities=14% Similarity=0.024 Sum_probs=74.1
Q ss_pred cccccEEeccCCceeeehhcccCCCcchHHhhhcC-CCCCCCCCCCceeecceeccccCCccccccceeEEEeeeccCch
Q 039736 104 QHNAPYTTKPNDTYFLVANNTYQGLTTCQALLGQN-YYDEKNLGSGVELTVPIRCACATANQTENGVTYLLAYMAQAGDN 182 (633)
Q Consensus 104 ~~~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N-~~~~~~l~~g~~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDt 182 (633)
.+..+|+||+|||||.||. .| .+++.+|+++| +.+++.|+|||+|.||..-.-+... ..........|+|+.||+
T Consensus 60 ~~~~~y~V~~GDTL~~IA~-~~--~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~~Gdt 135 (167)
T 2l9y_A 60 GGTATVTVQQGDTLRDIGR-RF--DCDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVDGGKV 135 (167)
T ss_dssp CSCEEEEECTTCCHHHHHH-HT--TCCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEETTTTE
T ss_pred CCCceEEECCCCcHHHHHH-Hc--CCCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccc-cccccccceEEEeCCcCC
Confidence 3457899999999999995 57 47999999999 5566899999999999643211100 000112346799999999
Q ss_pred hhhhhhhhcccchhhccccCC
Q 039736 183 MSFIGNEFGVDVQSIVDANML 203 (633)
Q Consensus 183 l~~Ia~~f~v~~~~l~~~N~~ 203 (633)
|++||++||.++.+.+.+|..
T Consensus 136 L~aIA~r~G~~v~s~i~Ln~~ 156 (167)
T 2l9y_A 136 LEAELRYSGGWNRSRIYLDEH 156 (167)
T ss_dssp EEEEEEETTEEEEEEECGGGT
T ss_pred hHHHHHHcCCceEEEEEcccc
Confidence 999999999999999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=7.3e-12 Score=125.61 Aligned_cols=147 Identities=17% Similarity=0.129 Sum_probs=113.0
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEE
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~L 407 (633)
+......|.....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 344556788888888888899999986 47899999876522122335778999999884 6778899999988889999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC---------------------
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA--------------------- 466 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--------------------- 466 (633)
||||++|.+|.+.+.. ..+...++.+++++|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp EEECCSSEEHHHHCCT---------------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred EEEecCCeehhhccCC---------------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 9999999998765311 1223467788888888898711
Q ss_pred -----------------------------------CCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 467 -----------------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 467 -----------------------------------~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+.++|+|+++.||+++++..+.|.||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1448999999999999887667799998775
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.3e-12 Score=101.64 Aligned_cols=62 Identities=29% Similarity=0.415 Sum_probs=55.7
Q ss_pred CCceeecceeccccCCccccccceeEEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccccC
Q 039736 147 SGVELTVPIRCACATANQTENGVTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 147 ~g~~l~ip~~c~c~~~~~~~~~~~~~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
.||.|.+|.. ....+|+|++|||||+||++||+++++|+++|++.+++.|++||.|.||...
T Consensus 3 ~Gq~l~ip~~-------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~ 64 (77)
T 2djp_A 3 SGSSGCSPVR-------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILT 64 (77)
T ss_dssp CCCCCCCCCC-------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred CCcEeeccCC-------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence 6899999841 2467899999999999999999999999999999878899999999999864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=5.4e-11 Score=118.59 Aligned_cols=137 Identities=15% Similarity=0.141 Sum_probs=95.3
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCC--ceEEEEEEeeCCceEEEEeec
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH--IVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~~~~~~~~~LV~E~~ 412 (633)
++....+.+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44433333456669999998777888999986653 2235678999999886544 556888888777889999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC--------------------------
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA-------------------------- 466 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-------------------------- 466 (633)
+|.+|. +-.. + ...++.++++.|..||+..
T Consensus 98 ~G~~l~-~~~~--------------------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 98 PGQDLL-SSHL--------------------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp SSEETT-TSCC--------------------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred CCcccC-cCcC--------------------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 999885 2110 0 1133444444444444422
Q ss_pred -----------------------------CCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 467 -----------------------------SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 467 -----------------------------~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
.+.++|+|++|.||+++++..+.|.||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 22399999999999998876678999998753
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=99.01 E-value=8.2e-11 Score=85.31 Aligned_cols=46 Identities=22% Similarity=0.400 Sum_probs=42.9
Q ss_pred EEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeeccccccccc
Q 039736 173 LAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLK 220 (633)
Q Consensus 173 ~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~ 220 (633)
.+|+|++|||||+||++||++.++|.++|+ ++..|++||.+.||+.
T Consensus 3 ~~y~V~~GDtl~~Ia~~~~~~~~~l~~~N~--~~~~l~~G~~l~ip~~ 48 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNS--DTANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCS--CGGGCCTTEEEECCCC
T ss_pred EEEEEcCCCcHHHHHHHHCcCHHHHHHhCC--CCCcCCcCCEEEEecC
Confidence 379999999999999999999999999999 7788999999999963
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.3e-09 Score=114.45 Aligned_cols=141 Identities=17% Similarity=0.254 Sum_probs=106.6
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEcc--ccC-hhHHHHHHHHHHHHhccC--CCCceEEEEEEeeC---CceEEEEe
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSR--AID-KTQIEQFINEVVILSQIN--HRHIVKLLGCCLET---EVPVLVYE 410 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~--~~~-~~~~~~~~~Ei~il~~l~--H~nIv~l~g~~~~~---~~~~LV~E 410 (633)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+.++++++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 567899999999999875 5678888765 322 122346778999999987 45678899988766 45899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC------------------------
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA------------------------ 466 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~------------------------ 466 (633)
|++|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~------------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (359)
T 3dxp_A 122 FVSGRVLWDQS------------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT 183 (359)
T ss_dssp CCCCBCCCCTT------------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred ecCCeecCCCc------------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence 99998885422 124677888889999999999999731
Q ss_pred -------------------------------CCCeeccCCCCCCeeecCCCc--EEEeecCCCcc
Q 039736 467 -------------------------------SIPIFHRDIKSSNILLDDKFS--AKVSDFGTSRS 498 (633)
Q Consensus 467 -------------------------------~~~ivHrDIk~~NILl~~~~~--~kI~DfGla~~ 498 (633)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 69999998864
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=98.93 E-value=8e-11 Score=123.42 Aligned_cols=111 Identities=14% Similarity=0.120 Sum_probs=82.6
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcCCCC-----CCCCCCCceeecceecccc--------CCc------cccc
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYD-----EKNLGSGVELTVPIRCACA--------TAN------QTEN 167 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~-----~~~l~~g~~l~ip~~c~c~--------~~~------~~~~ 167 (633)
.+|+|++||||+.||+ .|+ ++.++|.++|... .+.|++||+|.||..-.-. +.. ....
T Consensus 8 ~~~~Vk~GDTL~~Ia~-r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~ 84 (361)
T 2gu1_A 8 IHYMVKVGDTLSGIFA-QLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND 84 (361)
T ss_dssp EEEECCTTCCHHHHHH-HTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred eEEEECCCCcHHHHHH-HcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence 5799999999999994 463 7999999988543 4679999999999631100 000 0001
Q ss_pred c-----------ceeEEEeeeccCchhhhhhhhhcccchhhccccCCCCC-----Cceeeccccccccc
Q 039736 168 G-----------VTYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNG-----DAIRVFTPLLIPLK 220 (633)
Q Consensus 168 ~-----------~~~~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~-----~~i~~~~~l~iP~~ 220 (633)
| .....+|.|+.|||||+||++||++.+.|++||++... ..|++|+.+.|+..
T Consensus 85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~ 153 (361)
T 2gu1_A 85 GSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK 153 (361)
T ss_dssp SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred CcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence 1 11245799999999999999999999999999987543 45999999999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1e-09 Score=112.51 Aligned_cols=185 Identities=19% Similarity=0.227 Sum_probs=116.9
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCC--ceEEEEEEeeCC---ceEEEEeec
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRH--IVKLLGCCLETE---VPVLVYEYI 412 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~n--Iv~l~g~~~~~~---~~~LV~E~~ 412 (633)
.+.++.|....||+.. ..+++|.... ......+.+|.++|+.+. +.. +.++++.....+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999852 4588887553 234567889999998883 332 445555544333 458999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc---------------------------
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSA--------------------------- 465 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~--------------------------- 465 (633)
+|.+|.+... ..++..++..++.++++.|..||+.
T Consensus 99 ~G~~l~~~~~------------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (304)
T 3sg8_A 99 KGVPLTPLLL------------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKL 160 (304)
T ss_dssp CCEECCHHHH------------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHH
T ss_pred CCeECCcccc------------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHH
Confidence 9988865321 1345555555666666666666641
Q ss_pred ----------------------------CCCCeeccCCCCCCeeecC--CCcEEEeecCCCccCCCCCcceecc------
Q 039736 466 ----------------------------ASIPIFHRDIKSSNILLDD--KFSAKVSDFGTSRSVPNDKTHLTTA------ 509 (633)
Q Consensus 466 ----------------------------~~~~ivHrDIk~~NILl~~--~~~~kI~DfGla~~~~~~~~~~~~~------ 509 (633)
..+.++|+|+++.||++++ +..+.|.||+.+...... ......
T Consensus 161 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~ 239 (304)
T 3sg8_A 161 LSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEE 239 (304)
T ss_dssp HTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTS
T ss_pred hcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccc
Confidence 1245899999999999998 566899999988643211 000000
Q ss_pred --------cccCCCcCc-hhccccCCCCcccchhhHHHHHHHHHhCCCCC
Q 039736 510 --------VQGTFGYFD-PEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550 (633)
Q Consensus 510 --------~~gt~~y~A-PE~l~~~~~s~ksDV~SfGvvL~elltG~~p~ 550 (633)
.....+... |+..... ....+.|++|.++|++.+|..++
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 000111222 2222111 12358899999999999998764
|
| >2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15} | Back alignment and structure |
|---|
Probab=98.83 E-value=7e-10 Score=102.54 Aligned_cols=50 Identities=30% Similarity=0.376 Sum_probs=47.2
Q ss_pred EEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccccC
Q 039736 172 LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLKS 221 (633)
Q Consensus 172 ~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~~ 221 (633)
..+|+|++|||||+||++||++..+|++||++.+++.|+|||.|.||...
T Consensus 62 ~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~ 111 (167)
T 2l9y_A 62 TATVTVQQGDTLRDIGRRFDCDFHEIARRNNIQNEDLIYPGQVLQVPTKG 111 (167)
T ss_dssp CEEEEECTTCCHHHHHHHTTCCHHHHHHHHTCCGGGCCCTTEEEEESCCC
T ss_pred CceEEECCCCcHHHHHHHcCCCHHHHHHHcCCCCcccccCCCEEEEcCCC
Confidence 35899999999999999999999999999999999999999999999864
|
| >1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-08 Score=73.48 Aligned_cols=45 Identities=22% Similarity=0.304 Sum_probs=40.0
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecce
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPI 155 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~ 155 (633)
.+|+|++|||+|.|| ..|+ +++++|+++|. .++.|.+||+|.||+
T Consensus 3 ~~y~V~~GDtl~~Ia-~~~~--~~~~~l~~~N~-~~~~l~~G~~l~ip~ 47 (48)
T 1e0g_A 3 ITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNS-DTANLQPGDKLTLFV 47 (48)
T ss_dssp CEEEECTTCCHHHHH-HHHT--CCHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred EEEEEcCCCcHHHHH-HHHC--cCHHHHHHhCC-CCCcCCcCCEEEEec
Confidence 579999999999999 4563 68999999999 777899999999995
|
| >2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.43 E-value=2.5e-08 Score=79.94 Aligned_cols=60 Identities=22% Similarity=0.174 Sum_probs=48.0
Q ss_pred CCcEEEEccccccCCCCCcccccEEeccCCceeeehhcccCCCcchHHhhhcCCCC-CCCCCCCceeeccee
Q 039736 86 ASKSVIVPVSCSCSGSLYQHNAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYD-EKNLGSGVELTVPIR 156 (633)
Q Consensus 86 ~~~~~~vp~~c~c~~~~~~~~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~-~~~l~~g~~l~ip~~ 156 (633)
.+|.+.||..- .-.+|+|++|||||.|| ..|. ++.++|+++|... ++.|.+||+|.||..
T Consensus 3 ~Gq~l~ip~~~--------~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~ 63 (77)
T 2djp_A 3 SGSSGCSPVRE--------RRLEHQLEPGDTLAGLA-LKYG--VTMEQIKRANRLYTNDSIFLKKTLYIPIL 63 (77)
T ss_dssp CCCCCCCCCCE--------EEEEECCCTTCCHHHHH-HHHT--CCHHHHHHHHTCCCSSCGGGSSCEEEEEE
T ss_pred CCcEeeccCCC--------CcEEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEEECCC
Confidence 45777777531 23579999999999999 4574 6999999999654 678999999999974
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.8e-06 Score=88.32 Aligned_cols=75 Identities=12% Similarity=0.108 Sum_probs=55.6
Q ss_pred CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC---CceEEEEEEe-eCCceEEEEeeccC
Q 039736 339 SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR---HIVKLLGCCL-ETEVPVLVYEYISN 414 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~---nIv~l~g~~~-~~~~~~LV~E~~~~ 414 (633)
.+.++.|....||+. |..+++|+... ......+.+|.++|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456788888899987 46688887432 33456788999999999752 3566777764 44567999999999
Q ss_pred CCchh
Q 039736 415 GTLSH 419 (633)
Q Consensus 415 gsL~~ 419 (633)
.+|.+
T Consensus 98 ~~l~~ 102 (306)
T 3tdw_A 98 QILGE 102 (306)
T ss_dssp EECHH
T ss_pred eECch
Confidence 88876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.5e-06 Score=85.31 Aligned_cols=78 Identities=14% Similarity=0.107 Sum_probs=57.3
Q ss_pred cccccCcE-EEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEEeeccCCCc
Q 039736 341 FLGQGGFG-TVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVYEYISNGTL 417 (633)
Q Consensus 341 ~ig~G~~G-~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~E~~~~gsL 417 (633)
.+..|..| .||+-... ++..+.+|+-... ...++.+|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455554 68987754 4567899976542 3446778999988874 33467888999888999999999999887
Q ss_pred hhhc
Q 039736 418 SHHI 421 (633)
Q Consensus 418 ~~~l 421 (633)
.+..
T Consensus 108 ~~~~ 111 (272)
T 4gkh_A 108 FQVL 111 (272)
T ss_dssp HHHH
T ss_pred cccc
Confidence 6654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=3.6e-06 Score=87.85 Aligned_cols=82 Identities=5% Similarity=-0.017 Sum_probs=56.9
Q ss_pred CCcc-cccCcEEEEEEEcC-------CCCEEEEEEccccC---hhHHHHHHHHHHHHhccC-C--CCceEEEEEEeeC--
Q 039736 339 SRFL-GQGGFGTVYKGMLP-------DGSIVAVKRSRAID---KTQIEQFINEVVILSQIN-H--RHIVKLLGCCLET-- 402 (633)
Q Consensus 339 ~~~i-g~G~~G~Vy~g~~~-------~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~-H--~nIv~l~g~~~~~-- 402 (633)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988763 26678899765422 001134667888888874 3 3567788887655
Q ss_pred -CceEEEEeeccCCCchhh
Q 039736 403 -EVPVLVYEYISNGTLSHH 420 (633)
Q Consensus 403 -~~~~LV~E~~~~gsL~~~ 420 (633)
+..++||||++|.++.+.
T Consensus 105 ~g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp TSSCEEEEECCCCBCCCBT
T ss_pred cCCceEEEEecCCCChhhc
Confidence 357899999999888753
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=3.2e-06 Score=77.94 Aligned_cols=47 Identities=21% Similarity=0.438 Sum_probs=41.8
Q ss_pred EEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccc
Q 039736 172 LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPL 219 (633)
Q Consensus 172 ~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~ 219 (633)
+++|+|++||||+.||++|+++...|+++|...++. +.+|+.+.||.
T Consensus 2 ~~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~-l~~g~~i~ip~ 48 (165)
T 4a1k_A 2 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAG-LTAGQSIVIPG 48 (165)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGC-CCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCc-cCCCccccCcc
Confidence 579999999999999999999999999999764443 78899999984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00015 Score=74.54 Aligned_cols=153 Identities=14% Similarity=0.130 Sum_probs=79.7
Q ss_pred CcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-----CCCceEEE-E--EEeeCCceEEEEee
Q 039736 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-----HRHIVKLL-G--CCLETEVPVLVYEY 411 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-----H~nIv~l~-g--~~~~~~~~~LV~E~ 411 (633)
+.|+.|..+.||+....+| .+++|+.... . .++..|..+++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566667889999887544 5899987752 2 22334555555442 34443310 1 11235667999999
Q ss_pred ccCCCchhh----cchhhhhHHHHHHHHHhh--h------cCCCCHHHHH------------------------------
Q 039736 412 ISNGTLSHH----IHDHQQQQEQKQELEEEQ--E------LSSLSWENRV------------------------------ 449 (633)
Q Consensus 412 ~~~gsL~~~----l~~~~~~~~~~~~~~~~~--~------~~~l~~~~~~------------------------------ 449 (633)
++|.++... +..-...-.........- . ...-.|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 998776410 000000000000000000 0 0011232211
Q ss_pred -HHHHHHHHHHHHhHh----------cCCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 450 -RVACEVAGAVAYMHS----------AASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 450 -~ia~~ia~gL~yLH~----------~~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
.+...+..++.+|++ ...+.++|+|+++.||+++.++.+.|.||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446667763 123559999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=8e-05 Score=78.87 Aligned_cols=76 Identities=18% Similarity=0.213 Sum_probs=50.2
Q ss_pred CCcccccCcEEEEEEEcC-CCCEEEEEEccccCh-------hHHHHHHHHHHHHhccCC--C-CceEEEEEEeeCCceEE
Q 039736 339 SRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDK-------TQIEQFINEVVILSQINH--R-HIVKLLGCCLETEVPVL 407 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~-------~~~~~~~~Ei~il~~l~H--~-nIv~l~g~~~~~~~~~L 407 (633)
.+.||.|..+.||++... +++.++||....... ...+++..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467899999999999754 468899997543211 123456778888887742 3 34456654 4556789
Q ss_pred EEeeccCCC
Q 039736 408 VYEYISNGT 416 (633)
Q Consensus 408 V~E~~~~gs 416 (633)
|||++++..
T Consensus 113 vmE~l~g~~ 121 (397)
T 2olc_A 113 VMEDLSHLK 121 (397)
T ss_dssp EECCCTTSE
T ss_pred EEEeCCCcc
Confidence 999998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00026 Score=71.40 Aligned_cols=80 Identities=16% Similarity=0.146 Sum_probs=57.5
Q ss_pred CCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC---CCceEEEEEEeeCCceEEEEee
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH---RHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H---~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.....+.+|.|..+.||+..+.||+.|.+|+...........|..|+..|+.+.- --+.+.+++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3455678999999999999998999999998654333333457789988887742 134455554 235899999
Q ss_pred ccCCCch
Q 039736 412 ISNGTLS 418 (633)
Q Consensus 412 ~~~gsL~ 418 (633)
++++...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9887654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0012 Score=67.32 Aligned_cols=77 Identities=14% Similarity=0.069 Sum_probs=61.2
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC---CCCceEEEEEEeeCCceEEEEeeccC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN---HRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
..+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.++++++...+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356789999999999887 5678889976542 2456788999888884 35688889888877889999999999
Q ss_pred CCch
Q 039736 415 GTLS 418 (633)
Q Consensus 415 gsL~ 418 (633)
..+.
T Consensus 116 ~~~~ 119 (312)
T 3jr1_A 116 SKNK 119 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 8764
|
| >2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae} | Back alignment and structure |
|---|
Probab=97.44 E-value=1.7e-05 Score=82.91 Aligned_cols=49 Identities=22% Similarity=0.213 Sum_probs=44.1
Q ss_pred EEEeeeccCchhhhhhhhhcccchhhccccCCCC----CCceeeccccccccc
Q 039736 172 LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPN----GDAIRVFTPLLIPLK 220 (633)
Q Consensus 172 ~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~----~~~i~~~~~l~iP~~ 220 (633)
..+|+|++||||++||++||++.++|.++|++.. .+.|++||+|.||..
T Consensus 7 ~~~~~Vk~GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~ 59 (361)
T 2gu1_A 7 RIHYMVKVGDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMD 59 (361)
T ss_dssp CEEEECCTTCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEEC
T ss_pred ceEEEECCCCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEEC
Confidence 3579999999999999999999999999998743 478999999999975
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00079 Score=71.78 Aligned_cols=78 Identities=12% Similarity=0.118 Sum_probs=47.6
Q ss_pred CCCeeccCCCCCCeeecCCCcEEEeecCCCccCCCCCcceeccc-ccCCCcCchhccccC---CCCcccchhhHHHHHHH
Q 039736 467 SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV-QGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLE 542 (633)
Q Consensus 467 ~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~-~gt~~y~APE~l~~~---~~s~ksDV~SfGvvL~e 542 (633)
.+.++|||+++.|||+++++ ++|.||+.+..-.... ...... .-...|++|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34599999999999999876 9999999887532110 000000 011346666655311 11223555678888888
Q ss_pred HHhC
Q 039736 543 LLTG 546 (633)
Q Consensus 543 lltG 546 (633)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=9.7e-05 Score=67.97 Aligned_cols=46 Identities=26% Similarity=0.350 Sum_probs=38.5
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecce
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPI 155 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~ 155 (633)
.+|+||+||||..|| +.|+ +.+++|+++|+.....|++|++|.||.
T Consensus 3 ~~y~V~~GdtL~~IA-~~f~--~g~~~l~~aNp~vd~~l~~g~~i~ip~ 48 (165)
T 4a1k_A 3 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIPG 48 (165)
T ss_dssp EEEECCTTCCHHHHH-HHTT--CCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred EEEEECCCCCHHHHH-HHhC--CCHHHHHHhCccCCCccCCCccccCcc
Confidence 579999999999999 4575 699999999964433589999999983
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0014 Score=66.76 Aligned_cols=171 Identities=11% Similarity=0.087 Sum_probs=88.8
Q ss_pred cCHHHHHHHhcCCcc-----CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCC--ceEEE
Q 039736 324 FTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH--IVKLL 396 (633)
Q Consensus 324 ~~~~el~~~~~~~~~-----~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~ 396 (633)
++.+++.....+|.. .+.|+.|....+|+....+| .+++|...... ..+++..|+.+++.+...+ +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 556777777666654 23466788889999887555 57889876521 1124456777777664212 22332
Q ss_pred EE------EeeCCceEEEEeeccCCCchhhc----chhhhhHHHHHHHHHhhhcC------CCCHHHHHH----------
Q 039736 397 GC------CLETEVPVLVYEYISNGTLSHHI----HDHQQQQEQKQELEEEQELS------SLSWENRVR---------- 450 (633)
Q Consensus 397 g~------~~~~~~~~LV~E~~~~gsL~~~l----~~~~~~~~~~~~~~~~~~~~------~l~~~~~~~---------- 450 (633)
.. ....+..+++++|++|..+...- ..-...-.........-... ...|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 11 11235678999999987654310 00000000000000000000 001221110
Q ss_pred --HHHHHHHHHHHhHhc----CCCCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 451 --VACEVAGAVAYMHSA----ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 451 --ia~~ia~gL~yLH~~----~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
+...+.+.++.+++. ....++|+|+.+.||+++++..+.|.||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 23459999999999999987666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0048 Score=63.02 Aligned_cols=94 Identities=13% Similarity=0.031 Sum_probs=57.0
Q ss_pred ccCHHHHHHHhcCCcc-----CCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCC--CceEE
Q 039736 323 IFTAEELQRATDNYNQ-----SRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR--HIVKL 395 (633)
Q Consensus 323 ~~~~~el~~~~~~~~~-----~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~--nIv~l 395 (633)
..+.+++......|.. ...++ |....||+....+|+.+++|....... ..+.+..|..+++.+... .+.++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecce
Confidence 3555666665555532 23466 777899998776777899998763211 223555677777776422 23334
Q ss_pred EEE-----EeeCCceEEEEeeccCCCch
Q 039736 396 LGC-----CLETEVPVLVYEYISNGTLS 418 (633)
Q Consensus 396 ~g~-----~~~~~~~~LV~E~~~~gsL~ 418 (633)
+.. ....+..++++||++|.++.
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~ 115 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFE 115 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCC
Confidence 332 11245568899999986654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0047 Score=63.33 Aligned_cols=154 Identities=14% Similarity=0.111 Sum_probs=75.0
Q ss_pred CcccccCcEE-EEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC--CCceEEEEEEeeCCceEEEEeeccCCC
Q 039736 340 RFLGQGGFGT-VYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 340 ~~ig~G~~G~-Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
+.|+.|.... +|+....+|..+++|....... +++..|+.+++.+.. -.+.+++.+..+. -+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565555444 6677654467787876543221 123356666666632 2345666664333 378999998777
Q ss_pred chhhcchhhhh-HHHH---HH-HHH--hh---hcCCCCHHHH---------------H-----HHHHHHHHHHHHhH---
Q 039736 417 LSHHIHDHQQQ-QEQK---QE-LEE--EQ---ELSSLSWENR---------------V-----RVACEVAGAVAYMH--- 463 (633)
Q Consensus 417 L~~~l~~~~~~-~~~~---~~-~~~--~~---~~~~l~~~~~---------------~-----~ia~~ia~gL~yLH--- 463 (633)
+.+++...... .... .. +.. .. ....++.... + .....+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 77665432110 0000 00 000 00 0001111000 0 00011122222221
Q ss_pred hcCCCCeeccCCCCCCeeecCC----CcEEEeecCCCcc
Q 039736 464 SAASIPIFHRDIKSSNILLDDK----FSAKVSDFGTSRS 498 (633)
Q Consensus 464 ~~~~~~ivHrDIk~~NILl~~~----~~~kI~DfGla~~ 498 (633)
....+.++|||+.+.||+++.+ ..+.|.||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999875 6899999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0024 Score=64.58 Aligned_cols=73 Identities=16% Similarity=0.107 Sum_probs=45.1
Q ss_pred cCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc-eEEEEEEeeCCceEEEEeec-cCC
Q 039736 338 QSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYI-SNG 415 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~g~~~~~~~~~LV~E~~-~~g 415 (633)
..+.|+.|....+|+. +.+++|+....... .-+..+|..+++.+...++ .+++++. .+.-++++||+ ++.
T Consensus 22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp SCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred ceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 3677888999999998 45888876542211 1122467777777642222 4566543 44457999999 665
Q ss_pred Cch
Q 039736 416 TLS 418 (633)
Q Consensus 416 sL~ 418 (633)
+|.
T Consensus 94 ~l~ 96 (301)
T 3dxq_A 94 TMS 96 (301)
T ss_dssp ECC
T ss_pred cCC
Confidence 554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0054 Score=64.29 Aligned_cols=155 Identities=17% Similarity=0.208 Sum_probs=83.6
Q ss_pred CCcccccCcEEEEEEEcC--------CCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEE
Q 039736 339 SRFLGQGGFGTVYKGMLP--------DGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~--------~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.+.|..|-...+|+.... +++.+.+|+.... ........+|..+++.+. +.-..++++.+.+ -+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 345666777788998864 2478999986332 122445668999888874 3223567776643 2999
Q ss_pred eeccCCCchhh-cchhhhhHHHHHHHH--Hhh---hcCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 039736 410 EYISNGTLSHH-IHDHQQQQEQKQELE--EEQ---ELSSLS--WENRVRVACEVAG-------------------AVAYM 462 (633)
Q Consensus 410 E~~~~gsL~~~-l~~~~~~~~~~~~~~--~~~---~~~~l~--~~~~~~ia~~ia~-------------------gL~yL 462 (633)
||++|.+|..- +........-...+. ... ...... |.++.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998776532 111000000000000 000 001122 3444444433321 23333
Q ss_pred H----hc-CCCCeeccCCCCCCeeecCC----CcEEEeecCCCcc
Q 039736 463 H----SA-ASIPIFHRDIKSSNILLDDK----FSAKVSDFGTSRS 498 (633)
Q Consensus 463 H----~~-~~~~ivHrDIk~~NILl~~~----~~~kI~DfGla~~ 498 (633)
. .. ....++|+|+.+.||+++++ +.+.|.||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22 23459999999999999876 7899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0072 Score=64.51 Aligned_cols=75 Identities=21% Similarity=0.246 Sum_probs=50.8
Q ss_pred CCcccccCcEEEEEEEcCC--------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc-eEEEEEEeeCCceEEEE
Q 039736 339 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVY 409 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~g~~~~~~~~~LV~ 409 (633)
.+.|+.|....+|+....+ ++.+.+|+...... .+.+.+|..+++.+...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998643 47899998743211 1355679988888853333 567776532 3899
Q ss_pred eeccCCCchh
Q 039736 410 EYISNGTLSH 419 (633)
Q Consensus 410 E~~~~gsL~~ 419 (633)
||+++.+|..
T Consensus 152 e~l~G~~l~~ 161 (429)
T 1nw1_A 152 EYIPSRPLSC 161 (429)
T ss_dssp CCCCEEECCT
T ss_pred EEeCCcccCh
Confidence 9998766643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.51 E-value=0.023 Score=61.07 Aligned_cols=75 Identities=13% Similarity=0.034 Sum_probs=48.0
Q ss_pred CCcccccCcEEEEEEEcCC-CCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc-eEEEEEEeeCCceEEEEeeccCCC
Q 039736 339 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI-VKLLGCCLETEVPVLVYEYISNGT 416 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~g~~~~~~~~~LV~E~~~~gs 416 (633)
.+.|+.|-...+|+....+ +..+++|+......... +-.+|..+++.+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4567788888999998754 47888987643221111 11478888888864444 56777762 2 35999999866
Q ss_pred ch
Q 039736 417 LS 418 (633)
Q Consensus 417 L~ 418 (633)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.0058 Score=63.70 Aligned_cols=74 Identities=12% Similarity=0.103 Sum_probs=44.2
Q ss_pred CCcccccCcEEEEEEEcCC---------CCEEEEEEccccChhHHHHHHHHHHHHhccCCCC-ceEEEEEEeeCCceEEE
Q 039736 339 SRFLGQGGFGTVYKGMLPD---------GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH-IVKLLGCCLETEVPVLV 408 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~---------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~~~~LV 408 (633)
.+.|+.|....+|+....+ +..+++|+....... ..+...|..+++.+...+ ..++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3456777778899988643 268888876542221 112346888888775333 34666554 2 3789
Q ss_pred EeeccCCCc
Q 039736 409 YEYISNGTL 417 (633)
Q Consensus 409 ~E~~~~gsL 417 (633)
|||++|.++
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999998665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.34 E-value=0.015 Score=55.25 Aligned_cols=103 Identities=13% Similarity=0.052 Sum_probs=66.9
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
-||.+.|... ..+|++.++|.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+...+ +
T Consensus 33 vSL~eIL~~~---------------~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~ 94 (229)
T 2yle_A 33 LSLEEILRLY---------------NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-A 94 (229)
T ss_dssp EEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C
T ss_pred ccHHHHHHHc---------------CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-c
Confidence 3688887654 35899999999999999998776221111 1233456899999999988864 1
Q ss_pred CCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC
Q 039736 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549 (633)
Q Consensus 495 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p 549 (633)
.+. .....+.+||... ...+.+.-|||+|++||.-+--..|
T Consensus 95 ~s~-------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 95 ADD-------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccc-------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 111 0122466888763 3457899999999999998875544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.021 Score=58.85 Aligned_cols=31 Identities=23% Similarity=0.366 Sum_probs=27.5
Q ss_pred CCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 468 IPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 468 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
+.++|+|+.+.||++++++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.56 E-value=0.15 Score=53.99 Aligned_cols=75 Identities=7% Similarity=-0.010 Sum_probs=47.6
Q ss_pred CCcccccCcEEEEEEEcCC--------CCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEE
Q 039736 339 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.+.+..|-...+|+....+ ++.+++|+......... +-.+|..+++.+. +.-..++++.+. -++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3556677778899988643 57899998654322111 2246888887774 222345665432 37899
Q ss_pred eeccCCCch
Q 039736 410 EYISNGTLS 418 (633)
Q Consensus 410 E~~~~gsL~ 418 (633)
||++|.+|.
T Consensus 150 efI~G~~l~ 158 (424)
T 3mes_A 150 EFIDGEPLT 158 (424)
T ss_dssp ECCCSEECC
T ss_pred EEeCCccCC
Confidence 999987764
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=93.46 E-value=0.026 Score=58.58 Aligned_cols=110 Identities=12% Similarity=0.054 Sum_probs=66.3
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcC-----CCCCCCCCCCceeecceeccccCCcc-----ccccc-------
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQN-----YYDEKNLGSGVELTVPIRCACATANQ-----TENGV------- 169 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N-----~~~~~~l~~g~~l~ip~~c~c~~~~~-----~~~~~------- 169 (633)
..|+|++||||..|-. .+ |+ +.+++.+.+ ..+...|++||+|.+.+.-. ..-.. ...+.
T Consensus 15 ~~~~V~~GDTL~~IL~-r~-Gl-s~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~-~~l~~l~~~~~~~~~~~~v~i~ 90 (371)
T 3slu_A 15 VQEAVQPGDSLADVLA-RS-GM-ARDEIARITEKYGGEADLRHLRADQSVHVLVGGD-GGAREVQFFTDEDGERNLVALE 90 (371)
T ss_dssp EEEECCTTCCHHHHHH-HT-TC-CHHHHHHHHTTC------CCBCSSSEEEEEECTT-SCEEEEEEEECCTTEEEEEEEE
T ss_pred EEEEECCCCcHHHHHH-Hc-CC-CHHHHHHHHHhccccCchhhCCCCCEEEEEECCC-CCeEEEEEEecCCCceeEEEEE
Confidence 3599999999999984 34 43 555555432 23456799999999976311 00000 00000
Q ss_pred ----ee------------EEEeeeccCchhhhhhhhhcccchhhccccCCCCCC----ceeeccccccccc
Q 039736 170 ----TY------------LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGD----AIRVFTPLLIPLK 220 (633)
Q Consensus 170 ----~~------------~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~----~i~~~~~l~iP~~ 220 (633)
.+ ...+...-.++|+..|.+.|++...++.++.+-..+ .|++|+.+-|...
T Consensus 91 ~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~ 161 (371)
T 3slu_A 91 KKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD 161 (371)
T ss_dssp EETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred ecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence 00 001223348999999999999988777776543222 3888888777764
|
| >3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis} | Back alignment and structure |
|---|
Probab=91.58 E-value=0.075 Score=55.08 Aligned_cols=51 Identities=14% Similarity=0.143 Sum_probs=42.6
Q ss_pred eeEEEeeeccCchhhhhhhhhcccchhhccccCCC----CCCceeeccccccccc
Q 039736 170 TYLLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLP----NGDAIRVFTPLLIPLK 220 (633)
Q Consensus 170 ~~~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~----~~~~i~~~~~l~iP~~ 220 (633)
.+-.+|+|++||||.+|-+++|++..++.+++... +...|++||++.+.+.
T Consensus 12 ~~W~~~~V~~GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~ 66 (371)
T 3slu_A 12 AYWVQEAVQPGDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVG 66 (371)
T ss_dssp CEEEEEECCTTCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEEC
T ss_pred CceEEEEECCCCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEEC
Confidence 45678999999999999999999999988876543 4577999999998775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.77 E-value=1.1 Score=46.98 Aligned_cols=29 Identities=34% Similarity=0.442 Sum_probs=24.9
Q ss_pred eeccCCCCCCeee------cCCCcEEEeecCCCcc
Q 039736 470 IFHRDIKSSNILL------DDKFSAKVSDFGTSRS 498 (633)
Q Consensus 470 ivHrDIk~~NILl------~~~~~~kI~DfGla~~ 498 (633)
++|+|+.+.|||+ +++..+++.||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999988864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.48 E-value=0.18 Score=54.15 Aligned_cols=61 Identities=7% Similarity=0.052 Sum_probs=18.4
Q ss_pred cCCcccccCcEEEEEEEcCC-CCEEEE------EEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 338 QSRFLGQGGFGTVYKGMLPD-GSIVAV------KRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~~-g~~vAV------K~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
..+.|| ||.||+|.+.. ..+||| |..+.. ..+....|.+|..+++..+|+|+++..++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 99999999853 357888 766542 23345578899999999999999999888754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 633 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-76 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-68 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-67 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-63 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-63 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-48 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-43 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-22 | |
| d1e0ga_ | 48 | d.7.1.1 (A:) Membrane-bound lytic murein transclyc | 1e-04 | |
| d1y7ma2 | 48 | d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (616), Expect = 8e-76
Identities = 77/302 (25%), Positives = 126/302 (41%), Gaps = 36/302 (11%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI 387
E+ + +G G FGTVYKG V + A Q++ F NEV +L +
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
H +I+ +G +V ++ +L HH+H + +
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE---------------TKFEMIK 105
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN-DKTHL 506
+ +A + A + Y+H+ I HRD+KS+NI L + + K+ DFG + +H
Sbjct: 106 LIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 507 TTAVQGTFGYFDPEYFQSSQ---YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ G+ + PE + Y+ +SDVY+FG+VL EL+TG+ P N
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRD 216
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
I + L L + R +A+ L CL+ +RP Q+ +E L
Sbjct: 217 QIIFMVGRGYLSPDLS-----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271
Query: 624 RS 625
RS
Sbjct: 272 RS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 4e-69
Identities = 71/292 (24%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ +G G FG V+ G + VA+K R E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L G CLE LV+E++ +G LS ++ + + E + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---------------AAETLLGMCL 108
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+V +AY+ A + HRD+ + N L+ + KVSDFG +R V +D+ +T +
Sbjct: 109 DVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE F S+Y+ KSDV+SFGV++ E+ + K R E
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------------- 210
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
++E + V ++ C + + RP ++ L + S
Sbjct: 211 VVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 3e-68
Identities = 70/316 (22%), Positives = 122/316 (38%), Gaps = 50/316 (15%)
Query: 329 LQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQ 386
++ D++ + LG G G V+K P G ++A K I Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
N +IV G + E++ G+L + + + +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----------------IPEQ 104
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+V+ V + Y+ I HRD+K SNIL++ + K+ DFG S + +
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 160
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE--------- 557
+ GT Y PE Q + Y+ +SD++S G+ L+E+ G+ PI +E
Sbjct: 161 -NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 558 --------------ERNLVAYFISLAKENKLLEILDARVAKEAREEDI----EAVAELAM 599
R L +Y + + E+LD V + + +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 600 GCLRLNSKKRPTMKQV 615
CL N +R +KQ+
Sbjct: 280 KCLIKNPAERADLKQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-68
Identities = 62/287 (21%), Positives = 121/287 (42%), Gaps = 34/287 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ LG G FG V+ G + VAVK + + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L + + ++ EY+ NG+L + + L+ + +A
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIK--------------LTINKLLDMAA 116
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++A +A++ HRD++++NIL+ D S K++DFG +R + +++ +
Sbjct: 117 QIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE +T KSDV+SFG++L E++T + E
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------------- 218
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
+++ L+ + E + +L C + + RPT + LE
Sbjct: 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 2e-67
Identities = 72/308 (23%), Positives = 136/308 (44%), Gaps = 37/308 (12%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQ 386
E++R + LG G +G VY+G+ VAVK + D ++E+F+ E ++ +
Sbjct: 13 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
I H ++V+LLG C ++ E+++ G L ++ + +Q+ +S
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------------VSAV 115
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ +A +++ A+ Y+ HRD+ + N L+ + KV+DFG SR + D
Sbjct: 116 VLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
+ + PE ++++ KSDV++FGV+L E+ T
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PY 217
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
+++ E+L+ E E E V EL C + N RP+ ++ E + +
Sbjct: 218 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
Query: 627 RCV-EIDK 633
E++K
Sbjct: 278 SISDEVEK 285
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (549), Expect = 9e-66
Identities = 67/312 (21%), Positives = 125/312 (40%), Gaps = 34/312 (10%)
Query: 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKR-SRAIDKTQIEQFIN 379
L+ +N R +G+G FG V++ P ++VAVK F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 380 EVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
E ++++ ++ +IVKLLG C + L++EY++ G L+ + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 440 LSS--------LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491
+ LS ++ +A +VA +AY+ HRD+ + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIA 182
Query: 492 DFGTSRSVPN-DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPI 550
DFG SR++ + D + PE ++YT +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ- 241
Query: 551 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP 610
+ +A E + + D + E + L C RP
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRP 287
Query: 611 TMKQVSMDLEGL 622
+ + L+ +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-65
Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
++ LGQG FG V+ G + VA+K + E F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L E + +V EY+S G+L + + + V +A
Sbjct: 76 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLR--------------LPQLVDMAA 120
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
++A +AY+ HRD++++NIL+ + KV+DFG +R + +++ +
Sbjct: 121 QIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE ++T KSDV+SFG++L EL T + E
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------------- 222
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+L+ ++ E E++ +L C R ++RPT + + LE S
Sbjct: 223 VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 6e-65
Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
++Y +G G +G K DG I+ K ++ + + + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 391 HIVKLLGCCLETE--VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+IV+ ++ +V EY G L+ I ++++ L E
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ------------YLDEEFV 111
Query: 449 VRVACEVAGAVAYMH--SAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+RV ++ A+ H S + HRD+K +N+ LD K + K+ DFG +R + +D +
Sbjct: 112 LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA 171
Query: 507 TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
GT Y PE Y +KSD++S G +L EL P ++E +
Sbjct: 172 KA-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI---- 226
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+E K I R + E E+ L L RP+++++
Sbjct: 227 ---REGKFRRI-PYRYSDELN--------EIITRMLNLKDYHRPSVEEI 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 8e-65
Identities = 64/294 (21%), Positives = 132/294 (44%), Gaps = 40/294 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ +G+G FG V G G+ VAVK + + + F+ E +++Q+ H ++V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 394 KLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+LLG +E + + +V EY++ G+L ++ + S L + ++ +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--------------SVLGGDCLLKFS 109
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQG 512
+V A+ Y+ HRD+ + N+L+ + AKVSDFG ++ + + +
Sbjct: 110 LDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKL 162
Query: 513 TFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572
+ PE + +++ KSDV+SFG++L E+ + + ++ + ++
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKG 216
Query: 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626
++ D AV E+ C L++ RP+ Q+ LE ++ +
Sbjct: 217 YKMDAPDGCP---------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 2e-64
Identities = 65/320 (20%), Positives = 129/320 (40%), Gaps = 51/320 (15%)
Query: 324 FTAEELQRATDNYNQS---------RFLGQGGFGTVYKGMLP----DGSIVAVKR-SRAI 369
FT E+ A + + + +G G FG V G L VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 370 DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQE 429
+ Q F++E I+ Q +H +++ L G ++ +++ E++ NG+L + + Q
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 430 QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489
+ V + +A + Y+ HRD+ + NIL++ K
Sbjct: 126 --------------TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCK 168
Query: 490 VSDFGTSRSVPNDKTHLTT----AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT 545
VSDFG SR + +D + T + + PE Q ++T SDV+S+G+V+ E+++
Sbjct: 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
Query: 546 GKKPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLN 605
+ ++ ++ ++ + A+ +L + C + +
Sbjct: 229 YGERPYWDMTNQD---------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKD 273
Query: 606 SKKRPTMKQVSMDLEGLRRS 625
RP Q+ L+ + R+
Sbjct: 274 RNHRPKFGQIVNTLDKMIRN 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 6e-64
Identities = 63/287 (21%), Positives = 120/287 (41%), Gaps = 34/287 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIV 393
+ + LG G FG V G VA+K + ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+L G C + ++ EY++NG L +++ + + + + + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---------------FQTQQLLEMCK 107
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+V A+ Y+ S HRD+ + N L++D+ KVSDFG SR V +D+ + +
Sbjct: 108 DVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE S+++ KSD+++FGV++ E+ + K E
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------------- 209
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
E + + E V + C + +RPT K + ++
Sbjct: 210 TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 8e-64
Identities = 68/298 (22%), Positives = 134/298 (44%), Gaps = 33/298 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGS------IVAVKR-SRAIDKTQIEQFINEVVILSQ 386
+N + LG G FG V S VAVK D ++ E ++E+ +++Q
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 387 I-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQ-------QEQKQELEEEQ 438
+ +H +IV LLG C + L++EY G L +++ +++ E ++ LEEE+
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498
+L+ L++E+ + A +VA + ++ HRD+ + N+L+ K+ DFG +R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 499 VPNDKTHLT-TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
+ +D ++ + + PE YT KSDV+S+G++L E+ +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + + +++ + E + + C +S+KRP+ +
Sbjct: 267 -------YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-63
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 41/300 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGS-----IVAVKR-SRAIDKTQIEQFINEVVILSQI 387
+ + +G G FG VYKGML S VA+K + Q F+ E I+ Q
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
+H +I++L G + + +++ EY+ NG L + + + S
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---------------FSVLQ 111
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND--KTH 505
V + +A + Y+ + HRD+ + NIL++ KVSDFG SR + +D T+
Sbjct: 112 LVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
T+ + + PE ++T SDV+SFG+V+ E++T + E
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------- 221
Query: 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625
+++ ++ + A+ +L M C + +RP + L+ L R+
Sbjct: 222 --------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-63
Identities = 72/306 (23%), Positives = 126/306 (41%), Gaps = 30/306 (9%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SRAIDKTQIEQFINE 380
E R + + + LG G FG V + VAVK + T+ E ++E
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 381 VVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE--E 437
+ +LS + NH +IV LLG C +++ EY G L + + + + E
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
+ +L E+ + + +VA +A++ S HRD+ + NILL K+ DFG +R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 498 SVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556
+ ND + + + + PE + YT +SDV+S+G+ L EL +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616
+ K +++ + E + ++ C + KRPT KQ+
Sbjct: 254 DS--------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
Query: 617 MDLEGL 622
+E
Sbjct: 300 QLIEKQ 305
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 1e-62
Identities = 69/286 (24%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
+++ R LG+G FG VY I+A+K +++ Q EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+I++L G + L+ EY GT+ + + +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----------------FDEQRTA 109
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
E+A A++Y HS + HRDIK N+LL K++DFG S P+ +
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---T 163
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
+ GT Y PE + + +K D++S GV+ E L GK P +E +
Sbjct: 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----SR 218
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
E + + E +L L+ N +RP +++V
Sbjct: 219 VEFTFPDFVT------------EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-62
Identities = 69/299 (23%), Positives = 117/299 (39%), Gaps = 25/299 (8%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGS---IVAVKR-SRAIDKTQIEQFINEVVILSQI-N 388
++ +G+G FG V K + A+KR K F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H +I+ LLG C L EY +G L + + + S+LS +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
+ A +VA + Y+ HRD+ + NIL+ + + AK++DFG SR T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568
+ + E S YT SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627
+L E L E + V +L C R +RP+ Q+ + L + ++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-61
Identities = 76/318 (23%), Positives = 145/318 (45%), Gaps = 42/318 (13%)
Query: 317 SSEKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGMLPDGS----IVAVKR-SRAIDK 371
+ E + + ++ + + +G+G FG VY G L D AVK +R D
Sbjct: 10 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 372 TQIEQFINEVVILSQINHRHIVKLLGCCLETE-VPVLVYEYISNGTLSHHIHDHQQQQEQ 430
++ QF+ E +I+ +H +++ LLG CL +E P++V Y+ +G L + I +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--- 126
Query: 431 KQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490
+ ++ + +VA + ++ S HRD+ + N +LD+KF+ KV
Sbjct: 127 ------------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 171
Query: 491 SDFGTSRSVPNDK---THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK 547
+DFG +R + + + H T + + E Q+ ++T KSDV+SFGV+L EL+T
Sbjct: 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231
Query: 548 KPICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSK 607
P + N + L + +LL+ E + + E+ + C ++
Sbjct: 232 APP-----YPDVNTFDITVYLLQGRRLLQP----------EYCPDPLYEVMLKCWHPKAE 276
Query: 608 KRPTMKQVSMDLEGLRRS 625
RP+ ++ + + +
Sbjct: 277 MRPSFSELVSRISAIFST 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 39/289 (13%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
D + LG G FG VYK + + A K + ++E ++ E+ IL+ +H +
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IVKLL ++ E+ + G + + + ++ L+ V
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER---------------PLTESQIQVV 115
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
+ A+ Y+H I HRD+K+ NIL K++DFG S + +
Sbjct: 116 CKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI- 171
Query: 512 GTFGYFDPEYFQSSQ-----YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566
GT + PE Y K+DV+S G+ L+E+ + P E N + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLL 225
Query: 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+AK +R + + + CL N R T Q+
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFK--------DFLKKCLEKNVDARWTTSQL 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 55/312 (17%), Positives = 116/312 (37%), Gaps = 46/312 (14%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFI--NEVVILSQINHRHIVKLLG 397
+G+G FG V++G G VAVK + + E+ + H +I+ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 398 CCLETEVPV----LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
+ LV +Y +G+L +++ + +++ E +++A
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----------------TVTVEGMIKLAL 107
Query: 454 EVAGAVAYMHSAA-----SIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL-- 506
A +A++H I HRD+KS NIL+ + ++D G + + +
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 507 -TTAVQGTFGYFDPEYFQSS------QYTDKSDVYSFGVVLLELLTGKKPICLTREEE-- 557
GT Y PE S + ++D+Y+ G+V E+ + + +
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 558 --ERNLVAYFISLAKENKLLEILDARVAKEARE-EDIEAVAELAMGCLRLNSKKRPTMKQ 614
+ + ++ + L + + E + +A++ C N R T +
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
Query: 615 VSMDLEGLRRSQ 626
+ L L + +
Sbjct: 288 IKKTLSQLSQQE 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-61
Identities = 67/301 (22%), Positives = 130/301 (43%), Gaps = 41/301 (13%)
Query: 327 EELQRATDNYNQSRF-LGQGGFGTVYKGML---PDGSIVAVKR-SRAIDKTQIEQFINEV 381
++L DN + LG G FG+V +G+ VA+K + +K E+ + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 382 VILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
I+ Q+++ +IV+L+G C + E +LV E G L + +++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE-------------- 105
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+ N + +V+ + Y+ HRD+ + N+LL ++ AK+SDFG S+++
Sbjct: 106 -IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161
Query: 502 DKTHLT--TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559
D ++ T +A + ++ PE +++ +SDV+S+GV + E L+ + + E
Sbjct: 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE- 220
Query: 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
++ ++ K +E E + L C + RP V +
Sbjct: 221 -----VMAFIEQGKRMEC---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 620 E 620
Sbjct: 267 R 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 5e-61
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRH 391
Y + +GQG GTVY M + G VA+++ + + E INE++++ + + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IV L L + +V EY++ G+L+ + + V
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----------------DEGQIAAV 121
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
E A+ ++HS + HRDIKS NILL S K++DFG + +++ +T V
Sbjct: 122 CRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKE 571
GT + PE Y K D++S G++ +E++ G+ P +++
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPL 222
Query: 572 NKLLEILDARVAKEAREEDI-EAVAELAMGCLRLNSKKRPTMKQV 615
L I + E + + CL ++ +KR + K++
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 5e-61
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 43/282 (15%)
Query: 342 LGQGGFGTVYKGMLPD-GSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHIVKLLGC 398
+G+G F TVYKG+ + VA + R + K++ ++F E +L + H +IV+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 399 CLET----EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACE 454
T + VLV E +++GTL ++ + + + +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----------------MKIKVLRSWCRQ 120
Query: 455 VAGAVAYMHSAASIPIFHRDIKSSNILLDDK-FSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+ + ++H+ + PI HRD+K NI + S K+ D G + + AV GT
Sbjct: 121 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGT 176
Query: 514 FGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573
+ PE ++ +Y + DVY+FG+ +LE+ T + P Y
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQI 221
Query: 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + I V E+ GC+R N +R ++K +
Sbjct: 222 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-60
Identities = 64/290 (22%), Positives = 125/290 (43%), Gaps = 42/290 (14%)
Query: 338 QSRFLGQGGFGTVYKGMLPD---GSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRHI 392
+ + LG G FGTV KG VAVK ++ A D ++ + E ++ Q+++ +I
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V+++G C E E +LV E G L+ ++ ++ + +N + +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----------------VKDKNIIELV 113
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT--AV 510
+V+ + Y+ + HRD+ + N+LL + AK+SDFG S+++ D+ +
Sbjct: 114 HQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
+ ++ PE +++ KSDV+SFGV++ E + + + E
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------------ 218
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
+ +L+ + +L C + + RP V + L
Sbjct: 219 ---VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-60
Identities = 66/305 (21%), Positives = 120/305 (39%), Gaps = 41/305 (13%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKR-SRAIDKTQIEQFINEVV 382
E+QR + R +G+G FG V++G+ VA+K + E+F+ E +
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 383 ILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSS 442
+ Q +H HIVKL+G E V ++ E + G L + + S
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY---------------S 104
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
L + + A +++ A+AY+ S HRDI + N+L+ K+ DFG SR + +
Sbjct: 105 LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
+ + + + PE ++T SDV+ FGV + E+L + + V
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V 218
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622
I + + + L C + +RP ++ L +
Sbjct: 219 IGRIENGERLPMPPNCP------------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
Query: 623 RRSQR 627
++
Sbjct: 267 LEEEK 271
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (513), Expect = 2e-60
Identities = 66/304 (21%), Positives = 114/304 (37%), Gaps = 49/304 (16%)
Query: 319 EKAKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQI 374
+ A++F ++ ++ R +G G FG VY + + +VA+K+ S +
Sbjct: 3 DVAELFFKDDP---EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 375 EQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQEL 434
+ I EV L ++ H + ++ GC L LV EY +
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--------- 110
Query: 435 EEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494
L V +AY+HS + HRD+K+ NILL + K+ DFG
Sbjct: 111 -------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160
Query: 495 TSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS---QYTDKSDVYSFGVVLLELLTGKKPIC 551
++ + + GT + PE + QY K DV+S G+ +EL K P+
Sbjct: 161 SASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
Query: 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
+A +N+ + ++ R CL+ + RPT
Sbjct: 216 NMNAMSALYHIA-------QNESPALQSGHWSEYFR--------NFVDSCLQKIPQDRPT 260
Query: 612 MKQV 615
+ +
Sbjct: 261 SEVL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 69/286 (24%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQINHRH 391
++++ + LG+G +G V + VAVK E E+ I +NH +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
+VK G E + L EY S G L I + + R
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------------GMPEPDAQRF 108
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKTHLTTAV 510
++ V Y+H I HRDIK N+LLD++ + K+SDFG + N++ L +
Sbjct: 109 FHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165
Query: 511 QGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
GT Y PE + ++ + DV+S G+VL +L G+ P + + S
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ------EYSDW 219
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
KE K ++ L L N R T+ +
Sbjct: 220 KEKKTYLNPWKKIDSAPL--------ALLHKILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-58
Identities = 60/301 (19%), Positives = 129/301 (42%), Gaps = 42/301 (13%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGS----IVAVKR-SRAIDKTQIEQFINEVVIL 384
+ T+ + + + LG G FGTVYKG+ +P+G VA+K A ++ ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 385 SQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+ +++ H+ +LLG CL + V L+ + + G L ++ +H+
Sbjct: 66 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNI---------------G 109
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDK 503
+ + ++A + Y+ + HRD+ + N+L+ K++DFG ++ + +K
Sbjct: 110 SQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ + + E YT +SDV+S+GV + EL+T
Sbjct: 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------- 212
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
+++ IL+ V + + C +++ RP +++ ++ +
Sbjct: 213 -PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271
Query: 624 R 624
R
Sbjct: 272 R 272
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-58
Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 29/308 (9%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGM------LPDGSIVAVKR-SRAIDKTQIEQFINE 380
E R D + LG+G FG V + VAVK ++ ++E
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 381 VVILSQINHRH-IVKLLGCCLETEVPV-LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQ 438
+ IL I H +V LLG C + P+ ++ E+ G LS ++ + + + E+
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 439 ELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498
L+ E+ + + +VA + ++ S HRD+ + NILL +K K+ DFG +R
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 499 VPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557
+ D ++ + + PE YT +SDV+SFGV+L E+ +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----P 238
Query: 558 ERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617
+ F KE + D + + + C +RPT ++
Sbjct: 239 GVKIDEEFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
Query: 618 DLEGLRRS 625
L L ++
Sbjct: 290 HLGNLLQA 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 7e-58
Identities = 74/310 (23%), Positives = 138/310 (44%), Gaps = 32/310 (10%)
Query: 321 AKIFTAEELQRATDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKR-SRAIDKTQ 373
A ++ +E + A + SR LGQG FG VY+G+ + VA+K + A +
Sbjct: 7 ADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66
Query: 374 IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQE 433
+F+NE ++ + N H+V+LLG + + +++ E ++ G L ++ +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL------RPA 120
Query: 434 LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493
+ L+ S +++A E+A +AY+++ HRD+ + N ++ + F+ K+ DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 494 GTSRSVP-NDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICL 552
G +R + D + PE + +T SDV+SFGVVL E+ T +
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 553 TREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTM 612
E+ + E LL+ D + + EL C + N K RP+
Sbjct: 238 GLSNEQ------VLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSF 282
Query: 613 KQVSMDLEGL 622
++ ++
Sbjct: 283 LEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-57
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 31/306 (10%)
Query: 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLP--------DGSIVAVKR-SRAIDKTQIEQFI 378
EL R D + LG+G FG V + VAVK + + I
Sbjct: 9 ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 379 NEVVILSQI-NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEE 437
+E+ ++ I H++I+ LLG C + ++ EY S G L ++ + +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 126
Query: 438 QELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497
LS ++ V A +VA + Y+ S HRD+ + N+L+ + K++DFG +R
Sbjct: 127 NPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183
Query: 498 SVPNDKTHLTTAV-QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556
+ + + T + + PE YT +SDV+SFGV+L E+ T
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVS 616
EE L ++L + + + C +RPT KQ+
Sbjct: 244 EE---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 617 MDLEGL 622
DL+ +
Sbjct: 289 EDLDRI 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 194 bits (494), Expect = 4e-57
Identities = 59/285 (20%), Positives = 111/285 (38%), Gaps = 36/285 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
D+Y+ LG G FG V++ G+ A K ++ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
V L + V++YE++S G L + D + +S + V
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---------------MSEDEAVEYM 130
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS--AKVSDFGTSRSVPNDKTHLTTAV 510
+V + +MH H D+K NI+ K S K+ DFG + + ++ T
Sbjct: 131 RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-- 185
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
GT + PE + +D++S GV+ LL+G P ++E V +
Sbjct: 186 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSC 240
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + + + ++++ + + L + R T+ Q
Sbjct: 241 DWNMDDSAFSGISEDGK--------DFIRKLLLADPNTRMTIHQA 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 67/302 (22%), Positives = 114/302 (37%), Gaps = 45/302 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLP----DGSIVAVKR---SRAIDKTQIEQFINEVVILSQ 386
+ LG G FG V +G VAVK ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
++HR++++L G L + +V E G+L + HQ
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ---------------GHFLLG 111
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTH- 505
R A +VA + Y+ S HRD+ + N+LL + K+ DFG R++P + H
Sbjct: 112 TLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 168
Query: 506 -LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
+ + F + PE ++ ++ SD + FGV L E+ T +
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------P 214
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624
+I L L +I E+ + + + + C + RPT + + L
Sbjct: 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL---RDFLLE 271
Query: 625 SQ 626
+Q
Sbjct: 272 AQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-56
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 41/299 (13%)
Query: 330 QRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILS 385
++ +++ + LG+G F TV L A+K + I + ++ E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 386 QINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSW 445
+++H VKL + E Y NG L +I S
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------------SFDE 107
Query: 446 ENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV-PNDKT 504
E+ A+ Y+H I HRD+K NILL++ +++DFGT++ + P K
Sbjct: 108 TCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY 564
+ GT Y PE SD+++ G ++ +L+ G P
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--------------- 209
Query: 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623
F + + +I+ + E+ +L L L++ KR +++
Sbjct: 210 FRAGNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 182 bits (463), Expect = 1e-53
Identities = 70/303 (23%), Positives = 117/303 (38%), Gaps = 43/303 (14%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---SRAIDKTQIEQFINEVVILSQIN 388
+D Y LG GG V+ L VAVK A D + +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 389 HRHIVKLLGCCLETE----VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
H IV + +P +V EY+ TL +H ++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----------------MT 109
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
+ + V + A+ + H I HRD+K +NI++ + KV DFG +R++ +
Sbjct: 110 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
Query: 505 HL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
+ T AV GT Y PE + +SDVYS G VL E+LTG+ P + +
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVS 221
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEG 621
+ + ++ ++ + + + L N + R T ++ DL
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLD--------AVVLKALAKNPENRYQTAAEMRADLVR 273
Query: 622 LRR 624
+
Sbjct: 274 VHN 276
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 8e-53
Identities = 58/285 (20%), Positives = 106/285 (37%), Gaps = 37/285 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
+ Y + LG+G FG V++ + K + + T E+ IL+ HR+I
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNI 63
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+ L E V+++E+IS + I+ + L+ V
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFE---------------LNEREIVSYV 108
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTAV 510
+V A+ ++HS I H DI+ NI+ + S+ K+ +FG +R +
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-- 163
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
Y+ PE Q + +D++S G ++ LL+G P ++ + +
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI-----MNA 218
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
E E ++ EA + L K R T +
Sbjct: 219 EYTFDEEAFKEISIEAM--------DFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 182 bits (464), Expect = 8e-53
Identities = 60/285 (21%), Positives = 107/285 (37%), Gaps = 36/285 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
D Y+ LG G FG V++ + G + K NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 393 VKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVA 452
+ L + VL+ E++S G L I + +S +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK---------------MSEAEVINYM 133
Query: 453 CEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA--KVSDFGTSRSVPNDKTHLTTAV 510
+ + +MH I H DIK NI+ + K ++ K+ DFG + + D+ T
Sbjct: 134 RQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-- 188
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
T + PE +D+++ GV+ LL+G P + E V
Sbjct: 189 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRC 243
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ + E + V+ EA+ + L+ +KR T+
Sbjct: 244 DWEFDEDAFSSVSPEAK--------DFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (453), Expect = 8e-52
Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 33/285 (11%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQINHR 390
D Y+ LG G F V +VA+K ++ + + NE+ +L +I H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV L L+ + +S G L I + + + R
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----------------YTERDASR 111
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
+ +V AV Y+H + + LD+ +SDFG S+ D + +
Sbjct: 112 LIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTA 169
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570
GT GY PE Y+ D +S GV+ LL G P + + + L
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKA 224
Query: 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
E + ++ A+ + + + +KR T +Q
Sbjct: 225 EYEFDSPYWDDISDSAK--------DFIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (446), Expect = 4e-51
Identities = 64/299 (21%), Positives = 113/299 (37%), Gaps = 51/299 (17%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR---------SRAIDKTQIEQFINEVVI 383
+NY LG+G V + + P AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 384 LSQIN-HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSS 442
L +++ H +I++L LV++ + G L ++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------------- 106
Query: 443 LSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPND 502
LS + ++ + + +H I HRD+K NILLDD + K++DFG S + D
Sbjct: 107 LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL--D 161
Query: 503 KTHLTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLTREE 556
V GT Y PE + S Y + D++S GV++ LL G P
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----W 216
Query: 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ ++ + ++ + + + +L L + +KR T ++
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK--------DLVSRFLVVQPQKRYTAEEA 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 61/304 (20%), Positives = 113/304 (37%), Gaps = 32/304 (10%)
Query: 329 LQRATDNYNQSRFLGQGGFGTVYKG--MLPDGSIVAVK--RSRAIDKTQIEQFINEVVIL 384
L RA Y +G+G +G V+K + G VA+K R + ++ I EV +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 385 SQI---NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELS 441
+ H ++V+L C + + + + + + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---------- 111
Query: 442 SLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPN 501
+ E + ++ + ++HS + HRD+K NIL+ K++DFG +R
Sbjct: 112 GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561
T+V T Y PE S Y D++S G + E+ K + + ++
Sbjct: 169 QMAL--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 226
Query: 562 VAYFISLAKE----------NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
+ I L E + A+ ++ + E +L + CL N KR +
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
Query: 612 MKQV 615
Sbjct: 287 AYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 172 bits (436), Expect = 1e-49
Identities = 59/296 (19%), Positives = 109/296 (36%), Gaps = 33/296 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHRH 391
+ Y+ +G+G +G VYK G A+K R D+ I E+ IL ++ H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
IVKL + VLV+E++ L
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------------LESVTAKSF 105
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQ 511
++ +AY H + HRD+K N+L++ + K++DFG +R+ T +
Sbjct: 106 LLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV 162
Query: 512 GTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV--------- 562
+ S +Y+ D++S G + E++ G E ++ +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 563 ---AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
L K + + + + + E+ +L L+L+ +R T KQ
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (441), Expect = 2e-49
Identities = 66/293 (22%), Positives = 118/293 (40%), Gaps = 44/293 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVK---RSRAIDKTQIEQFINEVV---ILSQ 386
++++ R +G+GGFG VY D G + A+K + R K +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 387 INHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
+ IV + + + + ++ G L +H+ H E
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE----------------A 107
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHL 506
+ A E+ + +MH+ + +RD+K +NILLD+ ++SD G + K H
Sbjct: 108 DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA 164
Query: 507 TTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565
+ GT GY PE Q Y +D +S G +L +LL G P + +++ +
Sbjct: 165 S---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618
+++A E L + E R L G L+ + +R
Sbjct: 222 LTMAVE------LPDSFSPELR--------SLLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (433), Expect = 7e-49
Identities = 68/289 (23%), Positives = 114/289 (39%), Gaps = 44/289 (15%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
++ R LG G FG V+ +G A+K + + Q+E +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
I+++ G + + ++ +YI G L + Q+
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----------------PNPVAK 107
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
A EV A+ Y+HS I +RD+K NILLD K++DFG ++ VP+ L
Sbjct: 108 FYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-- 162
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
GT Y PE + Y D +SFG+++ E+L G P + + Y L
Sbjct: 163 --GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-----YDSNTMKTYEKILN 215
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618
E + + E V +L + + +R Q +
Sbjct: 216 AELRFPPFFN------------EDVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 7e-48
Identities = 62/286 (21%), Positives = 106/286 (37%), Gaps = 42/286 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILS-QIN 388
+++ + LG+G FG V+ A+K + + +E + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 389 HRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
H + + E V EY++ G L +HI +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----------------FDLSRA 105
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTT 508
A E+ + ++HS I +RD+K NILLD K++DFG + T
Sbjct: 106 TFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162
Query: 509 AVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568
GT Y PE +Y D +SFGV+L E+L G+ P ++ + + I +
Sbjct: 163 FC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEELFHSIRM 217
Query: 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
+ KEA+ +L + +KR ++
Sbjct: 218 DNPF-----YPRWLEKEAK--------DLLVKLFVREPEKRLGVRG 250
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 56/297 (18%), Positives = 104/297 (35%), Gaps = 33/297 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
+N+ + +G+G +G VYK G +VA+K R + I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IVKLL LV+E++ +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---------------GIPLPLIKS 106
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ +A+ HS + HRD+K N+L++ + + K++DFG +R+ T V
Sbjct: 107 YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV 163
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ICLTREEEE 558
+ Y+ D++S G + E++T + I T +
Sbjct: 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 223
Query: 559 RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
+ S+ + + E L L + KR + K
Sbjct: 224 EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 7e-47
Identities = 61/302 (20%), Positives = 115/302 (38%), Gaps = 35/302 (11%)
Query: 333 TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR-SRAIDKTQIEQFINEVVILSQINHR 390
Y ++G+G +G V + VA+K+ S +T ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+I+ + + + Y+ + ++ + Q LS ++
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-------------HLSNDHICY 113
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLT--T 508
++ + Y+HSA + HRD+K SN+LL+ K+ DFG +R D H T
Sbjct: 114 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 509 AVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567
T Y PE +S+ KS D++S G +L E+L+ + ++ N + +
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 568 LAKENKLLEILDARVAKEAREEDI--------------EAVAELAMGCLRLNSKKRPTMK 613
+ L I++ + +L L N KR ++
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290
Query: 614 QV 615
Q
Sbjct: 291 QA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 67/304 (22%), Positives = 111/304 (36%), Gaps = 48/304 (15%)
Query: 323 IFTAEELQRATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SRAIDKTQIE 375
+F E + D Y+ LG G F V K G A K + E
Sbjct: 2 VFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 376 QFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELE 435
EV IL +I H +++ L +L+ E ++ G L + + +
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---------- 108
Query: 436 EEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD----KFSAKVS 491
SL+ E ++ V Y+HS I H D+K NI+L D K K+
Sbjct: 109 ------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159
Query: 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPIC 551
DFG + + D + + GT + PE ++D++S GV+ LL+G P
Sbjct: 160 DFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217
Query: 552 LTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT 611
++E V A + + + + A+ + L + KKR T
Sbjct: 218 GDTKQETLANV-----SAVNYEFEDEYFSNTSALAK--------DFIRRLLVKDPKKRMT 264
Query: 612 MKQV 615
++
Sbjct: 265 IQDS 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-46
Identities = 49/298 (16%), Positives = 102/298 (34%), Gaps = 35/298 (11%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
Y + +G+G +GTV+K IVA+K R D+ + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 391 HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVR 450
+IV+L + LV+E+ + + E
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----------------PEIVKS 105
Query: 451 VACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAV 510
++ + + HS + HRD+K N+L++ K+++FG +R+ + V
Sbjct: 106 FLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV 162
Query: 511 QGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEE------------ 558
+ F + Y+ D++S G + EL +P+ + ++
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 559 -RNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
L + +L L+ N +R + ++
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-46
Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 41/302 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGMLPD-GSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI 392
+Y ++ +G G FG VY+ L D G +VA+K+ + + + E+ I+ +++H +I
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK---VLQDK-RFKNRELQIMRKLDHCNI 75
Query: 393 VKLLGCCLETEVP------VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
V+L + LV +Y+ H + +Q +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-------------TLPVI 122
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTH 505
++ ++AY+HS I HRDIK N+LLD D K+ DFG+++ + + +
Sbjct: 123 YVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 506 LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ICLT 553
++ + + F ++ YT DV+S G VL ELL G+ I
Sbjct: 180 VSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK 613
R + E K +I K R L L R T
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 614 QV 615
+
Sbjct: 299 EA 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-45
Identities = 58/294 (19%), Positives = 110/294 (37%), Gaps = 38/294 (12%)
Query: 340 RFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQ-----IEQFINEVVILSQINHRHIV 393
FLG+G F TVYK IVA+K+ + +++ + E+ +L +++H +I+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 394 KLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVAC 453
LL LV++++ + L+ +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----------------LTPSHIKAYML 107
Query: 454 EVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGT 513
+ Y+H I HRD+K +N+LLD+ K++DFG ++S + T V T
Sbjct: 108 MTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VT 163
Query: 514 FGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572
Y PE ++ Y D+++ G +L ELL + + ++ + + E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 573 KLLEILDARVAKEAREEDI-----------EAVAELAMGCLRLNSKKRPTMKQV 615
+ ++ + + + +L G N R T Q
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 5e-45
Identities = 59/307 (19%), Positives = 99/307 (32%), Gaps = 41/307 (13%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH 389
R + Y R +G G FG +Y G + G VA+K KT+ Q E I +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQG 61
Query: 390 RHIVKLLG-CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENR 448
+ + C E + V+V E + ++ S +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----------------FSLKTV 105
Query: 449 VRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL---LDDKFSAKVSDFGTSRSVPNDKTH 505
+ +A ++ + Y+HS HRD+K N L + DFG ++ + +TH
Sbjct: 106 LLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 506 ------LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEER 559
+ GT Y + + + D+ S G VL+ G P + +R
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDL 619
K + +E+L E C L +P +
Sbjct: 223 QKYERISE-KKMSTPIEVLCKGYPSEFA--------TYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 620 EGLRRSQ 626
L Q
Sbjct: 274 RNLFHRQ 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 9e-45
Identities = 59/292 (20%), Positives = 104/292 (35%), Gaps = 43/292 (14%)
Query: 334 DNYN-QSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHR 390
D+Y S+ LG G G V + A+K + + EV + +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCP 65
Query: 391 HIVKLLGCC----LETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWE 446
HIV+++ + ++V E + G L I D Q + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--------------AFTER 111
Query: 447 NRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF---SAKVSDFGTSRSVPNDK 503
+ + A+ Y+HS I HRD+K N+L K K++DFG ++ +
Sbjct: 112 EASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563
+ T T Y PE +Y D++S GV++ LL G P +
Sbjct: 169 SLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226
Query: 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
I + + + V++E + L L+ +R T+ +
Sbjct: 227 TRI-RMGQYEFPNPEWSEVSEEVK--------MLIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 7e-44
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 55/293 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKR------SRAIDKTQIEQFINEVVILSQ 386
Y LG GGFG+VY G+ + D VA+K S + + EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 387 INHRH--IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
++ +++LL + VL+ E + +L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---------------ALQ 108
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDK 503
E +V AV + H+ + HRDIK NIL+D ++ K+ DFG+ + +
Sbjct: 109 EELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 165
Query: 504 THLTTAVQGTFGYFDPEYFQSSQYTDKS-DVYSFGVVLLELLTGKKPICLTREEEERNLV 562
T GT Y PE+ + +Y +S V+S G++L +++ G P
Sbjct: 166 ---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------- 209
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQV 615
F + + RV+ E + L CL L RPT +++
Sbjct: 210 --FEHDEEIIRGQVFFRQRVSSECQ--------HLIRWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 63/285 (22%), Positives = 110/285 (38%), Gaps = 41/285 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
++++ + LG+G FG V G A+K + I K ++ + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+ L + V EY + G L H+ + + E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----------------FTEERAR 108
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
E+ A+ Y+HS + +RDIK N++LD K++DFG + +D + T
Sbjct: 109 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569
GT Y PE + + Y D + GVV+ E++ G+ P + + + + L
Sbjct: 166 C-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILM 219
Query: 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQ 614
+E + L EA+ L G L+ + K+R
Sbjct: 220 EEIRFPRTLS----PEAK--------SLLAGLLKKDPKQRLGGGP 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 8e-42
Identities = 59/315 (18%), Positives = 112/315 (35%), Gaps = 49/315 (15%)
Query: 331 RATDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQI 387
Y + +GQG FG V+K G VA+K + + E+ IL +
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 388 NHRHIVKLLGCCLETEVPV--------LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQE 439
H ++V L+ C P LV+++ + + +
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------------- 113
Query: 440 LSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV 499
+ RV + + Y+H I HRD+K++N+L+ K++DFG +R+
Sbjct: 114 ---FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167
Query: 500 PNDKT---HLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTRE 555
K + T T Y PE + Y D++ G ++ E+ T + E
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227
Query: 556 EEERNLVAYFI--------------SLAKENKLLEILDARVAKEAREEDIEAVA-ELAMG 600
+ + L++ L ++ +L++ +V + + A +L
Sbjct: 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 287
Query: 601 CLRLNSKKRPTMKQV 615
L L+ +R
Sbjct: 288 LLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 56/314 (17%), Positives = 111/314 (35%), Gaps = 41/314 (13%)
Query: 324 FTAEELQRAT----DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQ 376
F +E+ + Y + +G G +G V + G+ VA+K + ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
E+ +L + H +++ LL E ++ + E+
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK------ 117
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
L + + ++ + Y+H+A I HRD+K N+ +++ K+ DFG +
Sbjct: 118 ------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------- 549
R + +T V + +YT D++S G ++ E++TGK
Sbjct: 169 RQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 225
Query: 550 --------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGC 601
+ T E + + L E+ A AV L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV-NLLEKM 284
Query: 602 LRLNSKKRPTMKQV 615
L L++++R T +
Sbjct: 285 LVLDAEQRVTAGEA 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (371), Expect = 2e-40
Identities = 50/310 (16%), Positives = 91/310 (29%), Gaps = 43/310 (13%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHR-H 391
+Y R +G+G FG +++G L + VA+K ++ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 392 IVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRV 451
I + E VLV + + ++ S +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK----------------FSVKTVAMA 106
Query: 452 ACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS-----AKVSDFGTSRSVPNDKT-- 504
A ++ V +H + +RDIK N L+ S V DFG + + T
Sbjct: 107 AKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163
Query: 505 ----HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560
+ GT Y + + + D+ + G V + L G P +
Sbjct: 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-- 221
Query: 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620
K ++ E + +E E + L P +
Sbjct: 222 -------KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 621 GLRRSQRCVE 630
+ E
Sbjct: 275 KVLERLNTTE 284
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 2e-40
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK---RSRAIDKTQIEQFINEVVILSQINH 389
D +++ + LG G FG V G+ A+K + + + QIE +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
+VKL + +V EY++ G + H+ + S +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----------------FSEPHAR 144
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKTHLTTA 509
A ++ Y+HS + +RD+K N+L+D + +V+DFG ++ V
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 197
Query: 510 VQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP 549
+ GT PE S Y D ++ GV++ E+ G P
Sbjct: 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 144 bits (363), Expect = 6e-39
Identities = 53/309 (17%), Positives = 115/309 (37%), Gaps = 54/309 (17%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRH 391
D+Y R LG+G + V++ + + + V VK + + ++ E+ IL + +
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 392 IVKLLGCCLE--TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
I+ L + + P LV+E+++N +L+ +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------------------TLTDYDIR 132
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSAKVSDFGTSRSVPNDKTHLTT 508
E+ A+ Y HS I HRD+K N+++D + ++ D+G + + +
Sbjct: 133 FYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 187
Query: 509 AVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI- 566
+ + PE Q Y D++S G +L ++ K+P + ++ + +
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247
Query: 567 ------------SLAKENKLLEILDARVAK--------EAREEDIEAVAELAMGCLRLNS 606
++ + + +IL K E + + LR +
Sbjct: 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDH 307
Query: 607 KKRPTMKQV 615
+ R T ++
Sbjct: 308 QSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 43/296 (14%)
Query: 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVK---RSRAIDKTQ-IEQFINEVVILS 385
+N+ + LG G +G V+ G + A+K ++ + K + E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 386 QINHR-HIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
I +V L L+ +YI+ G L H+ ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------------FT 127
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E+ A+ ++H I +RDIK NILLD ++DFG S+ D+T
Sbjct: 128 EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
Query: 505 HLTTAVQGTFGYFDPEYFQSSQ--YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562
GT Y P+ + + D +S GV++ ELLTG P + E+ + +
Sbjct: 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244
Query: 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618
+ K ++ A+ +L L + KKR D
Sbjct: 245 -----SRRILKSEPPYPQEMSALAK--------DLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 61/314 (19%), Positives = 113/314 (35%), Gaps = 41/314 (13%)
Query: 324 FTAEELQRA----TDNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQ 376
F +EL + + Y +G G +G+V G VAVK ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 377 FINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEE 436
E+ +L + H +++ LL + L ++ + ++
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------ 117
Query: 437 EQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTS 496
L+ ++ + ++ + Y+HSA I HRD+K SN+ +++ K+ DFG +
Sbjct: 118 ------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168
Query: 497 RSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------- 549
R + +T V + Y D++S G ++ ELLTG+
Sbjct: 169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 550 --------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGC 601
+ T E ++ + L ++ A + AV +L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV-DLLEKM 284
Query: 602 LRLNSKKRPTMKQV 615
L L+S KR T Q
Sbjct: 285 LVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-35
Identities = 56/317 (17%), Positives = 109/317 (34%), Gaps = 60/317 (18%)
Query: 334 DNYNQSRFLGQGGFGTVYKGM-LPDGSIVAVK--RSRAIDKTQIEQFINEVVILSQINHR 390
Y + +G G G V VA+K ++T ++ E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 391 HIVKLLGCCL------ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLS 444
+I+ LL E + LV E + +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------------------D 117
Query: 445 WENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSVPNDKT 504
E + ++ + ++HS I HRD+K SNI++ + K+ DFG +R+ +
Sbjct: 118 HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTS 172
Query: 505 HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA- 563
+ T T Y PE Y + D++S G ++ E++ K ++ N V
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
Query: 564 -------------------------YFISLAKENKLLEILDARVAKEAREEDIEAVAELA 598
+ L + L ++ + + +A +L
Sbjct: 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR-DLL 291
Query: 599 MGCLRLNSKKRPTMKQV 615
L ++ KR ++
Sbjct: 292 SKMLVIDPAKRISVDDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (331), Expect = 2e-34
Identities = 59/327 (18%), Positives = 118/327 (36%), Gaps = 54/327 (16%)
Query: 334 DNYNQSRF-----LGQGGFGTVYKGM-LPDGSIVAVKRSRAIDKTQIEQFINEVVILSQI 387
+ Y +R+ LG G F TV+ + + + VA+K R DK E +E+ +L ++
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRV 66
Query: 388 NHRHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWEN 447
N K + +L + H + + E L ++ E +
Sbjct: 67 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIY 126
Query: 448 RVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD------DKFSAKVSDFGTSRSVPN 501
+++ ++ + YMH I H DIK N+L++ + K++D G +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 502 DKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP------------ 549
T+ T Y PE + + +D++S ++ EL+TG
Sbjct: 185 HYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 550 ---------------------ICLTREEEERNLVAYFISLAKENKLLEILDARVAKEARE 588
TR + IS K L ++L + + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY--KFSK 298
Query: 589 EDIEAVAELAMGCLRLNSKKRPTMKQV 615
++ + +++ L+L+ +KR +
Sbjct: 299 DEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.5 bits (229), Expect = 3e-22
Identities = 38/215 (17%), Positives = 65/215 (30%), Gaps = 41/215 (19%)
Query: 340 RFLGQGGFGTVYKGMLPDGSIVAVKRSRA----------IDKTQIEQFINEVVILSQINH 389
+ +G+G V+ VK + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 390 RHIVKLLGCCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRV 449
R + KL G + VY + N L I + + + EN
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVR--------------VENPD 106
Query: 450 RVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRSV--PNDKTHLT 507
V + VA + I H D+ N+L+ + + DF S V + L
Sbjct: 107 EVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE 162
Query: 508 TAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLE 542
V+ YF S Y + D+ S +L+
Sbjct: 163 RDVRNIITYF------SRTYRTEKDINSAIDRILQ 191
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Score = 37.7 bits (88), Expect = 1e-04
Identities = 10/46 (21%), Positives = 22/46 (47%), Gaps = 2/46 (4%)
Query: 175 YMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLK 220
Y + GD++S I GV+++ ++ N ++ L + +K
Sbjct: 5 YRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA--NLQPGDKLTLFVK 48
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Score = 36.3 bits (84), Expect = 4e-04
Identities = 10/47 (21%), Positives = 22/47 (46%), Gaps = 1/47 (2%)
Query: 172 LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIP 218
+L Y + GD ++ I +F + +++ AN + ++IP
Sbjct: 1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQ-AGLTAGQSIVIP 46
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 633 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 99.36 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 99.32 | |
| d1y7ma2 | 48 | Hypothetical protein YkuD, N-terminal domain {Baci | 98.96 | |
| d1e0ga_ | 48 | Membrane-bound lytic murein transclycosylase D, Ml | 98.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.25 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.79 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.78 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=431.48 Aligned_cols=258 Identities=27% Similarity=0.435 Sum_probs=204.5
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4688899999999999999999888899999987533 334689999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..++|..+++|+.|||.||+|||+++ |+||||||+|||+++++++||+||
T Consensus 84 ~g~L~~~l~~~~---------------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---------------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp TCBHHHHHHTTT---------------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSC
T ss_pred CCcHHHHhhccc---------------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEeccc
Confidence 999999986542 36899999999999999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhch
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKENK 573 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 573 (633)
|+++..............||+.|+|||.+.++.++.|+|||||||++|||+|+..|+....... ......
T Consensus 146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i----- 215 (263)
T d1sm2a_ 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI----- 215 (263)
T ss_dssp C------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHH-----
T ss_pred chheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHH-----
Confidence 9998775544444445678999999999999999999999999999999999655543222111 111111
Q ss_pred hhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 574 LLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 574 ~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
........+..++.++.+|+.+||+.||++||||+||+++|++|.+|
T Consensus 216 -----~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 216 -----STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11112223444567899999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=430.94 Aligned_cols=259 Identities=24% Similarity=0.458 Sum_probs=203.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-CC---CEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DG---SIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g---~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+|+..++||+|+||.||+|... +| ..||||++.. ......++|.+|+++|++++|||||+++|++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4555689999999999999964 23 2689998765 34556678999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++.... ..++|.++++|+.|||+||.|||+++ |+||||||+||||+.++++|
T Consensus 107 Ey~~~g~L~~~~~~~~---------------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND---------------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp ECCTTEEHHHHHHTTT---------------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred EecCCCcceeeecccc---------------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEE
Confidence 9999999999886542 36999999999999999999999998 99999999999999999999
Q ss_pred EeecCCCccCCCCCcce----ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHH
Q 039736 490 VSDFGTSRSVPNDKTHL----TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAY 564 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~----~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~ 564 (633)
|+|||+++......... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||......+.
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~------ 242 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV------ 242 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH------
Confidence 99999998765432221 122457899999999999999999999999999999998 8999864433221
Q ss_pred HHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 565 FISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 565 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
... +........+.+++..+.+|+.+||+.||++||||.||++.|+++.++..
T Consensus 243 ~~~----------i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 243 INA----------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp HHH----------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHH----------HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 111 11112223445567889999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-53 Score=427.42 Aligned_cols=259 Identities=24% Similarity=0.403 Sum_probs=214.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46788899999999999999999888899999987543 335679999999999999999999998854 5679999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++..... ..++|..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|
T Consensus 90 ~~g~L~~~~~~~~~--------------~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~D 152 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG--------------IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD 152 (272)
T ss_dssp TTCBHHHHTTSHHH--------------HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCCcHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecc
Confidence 99999998865432 36999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+|+..............||+.|+|||.+.++.++.++|||||||+||||+||+.|+....... ......
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~~~~~i---- 223 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNL---- 223 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH----
T ss_pred ccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----HHHHHH----
Confidence 99999876554444555678999999999999999999999999999999999766654322211 111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
........+...+..+.+|+.+||+.||++||||+||++.|+.+-.+
T Consensus 224 ------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 224 ------ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 11112223445567899999999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=421.03 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=208.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..+.||+|+||.||+|+++ ..||||+++.. +....+.|.+|+++|++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999974 35999998643 45567889999999999999999999998754 56899999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ..++|..+++|+.|||+||+|||+++ |+||||||+||||+.++++||
T Consensus 84 y~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl 145 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---------------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKI 145 (276)
T ss_dssp CCCEEEHHHHHHTSC---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEE
T ss_pred cCCCCCHHHHHhhcc---------------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEE
Confidence 999999999996542 36999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCC-cceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 491 SDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 491 ~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
+|||+|+...... ........||+.|||||.+.+ +.++.++|||||||+||||+||+.||........ +.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~ 219 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------II 219 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HH
Confidence 9999998764332 223345679999999999864 4588999999999999999999999864332221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.....+. ..+.+ ...+..++..+.+|+.+||+.||++|||+.||+++|+.|.++
T Consensus 220 ~~~~~~~----~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 220 FMVGRGY----LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHHTS----CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHhcCC----CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1111110 11111 123445567899999999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-52 Score=428.99 Aligned_cols=262 Identities=25% Similarity=0.426 Sum_probs=220.6
Q ss_pred HhcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 332 ATDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 332 ~~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
..++|+..+.||+|+||.||+|.+. +|+.||||+++... ...++|.+|+++|++++|||||+++|++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3468888999999999999999965 58899999987543 345689999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+++|+|.+++.... ...++|..++.|+.||+.||+|||+++ |+||||||+||||++++++||
T Consensus 94 ~~~~g~l~~~l~~~~--------------~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl 156 (287)
T d1opja_ 94 FMTYGNLLDYLRECN--------------RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 156 (287)
T ss_dssp CCTTCBHHHHHHHSC--------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cccCcchHHHhhhcc--------------ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEE
Confidence 999999999986532 246999999999999999999999998 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||+|+..............|++.|+|||.+.++.++.|+|||||||++|||++|+.|+........
T Consensus 157 ~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------------ 224 (287)
T d1opja_ 157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------------ 224 (287)
T ss_dssp CCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------------
T ss_pred ccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH------------
Confidence 99999998766555555556789999999999999999999999999999999998777643222111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+.+.+........+...+..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 225 ---~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 225 ---VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp ---HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred ---HHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11122222233445556678999999999999999999999999999886543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=413.04 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=216.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeecc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYIS 413 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~ 413 (633)
++|+..++||+|+||.||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57889999999999999999998888999999876433 34689999999999999999999999999999999999999
Q ss_pred CCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeec
Q 039736 414 NGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDF 493 (633)
Q Consensus 414 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~Df 493 (633)
+|+|.+++.... ..+++..+++|+.|+++||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 83 ~g~l~~~~~~~~---------------~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 83 NGCLLNYLREMR---------------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp TEEHHHHHHSGG---------------GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCC
T ss_pred CCcHHHhhhccc---------------cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcc
Confidence 999999976543 36899999999999999999999998 999999999999999999999999
Q ss_pred CCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 494 GTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 494 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
|+++..............||+.|+|||.+.+..++.|+||||||+++|||+| |+.||......+. ... ...
T Consensus 145 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~~-i~~- 216 (258)
T d1k2pa_ 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEH-IAQ- 216 (258)
T ss_dssp SSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHH-HHT-
T ss_pred hhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HHH-HHh-
Confidence 9998765544444445678999999999999999999999999999999998 7989865443321 111 111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
......+...+..+.+|+.+||+.||++|||+.||+++|..|
T Consensus 217 --------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 217 --------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred --------CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 112233445567899999999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=417.12 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=207.3
Q ss_pred cCCccCCcccccCcEEEEEEEcCCC-----CEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDG-----SIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g-----~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
+.|+..++||+|+||.||+|.+++. ..||||+++.. ......+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999997532 37999998653 44456689999999999999999999999999999999
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ...++|.++++++.||+.||+|||+++ |+||||||+||||+.++.
T Consensus 87 v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---------------DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLV 148 (283)
T ss_dssp EEECCTTEEHHHHHHHT---------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCC
T ss_pred EEEecccCcchhhhhcc---------------cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCe
Confidence 99999999998887543 247999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCc--ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKT--HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++....... .......||+.|||||++.++.++.++|||||||+||||++|+.|+........ .
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-----~- 222 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----V- 222 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----H-
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-----H-
Confidence 99999999987644322 222345689999999999999999999999999999999997666543222111 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+.+....+...+.+++..+.+|+.+||+.||++||||.||++.|+++.++.
T Consensus 223 ---------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 223 ---------MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp ---------HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---------HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1112222233445566788999999999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=414.04 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=210.8
Q ss_pred cCCccCC-cccccCcEEEEEEEcC---CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSR-FLGQGGFGTVYKGMLP---DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~-~ig~G~~G~Vy~g~~~---~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+ +||+|+||.||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999853 3457999998753 45567789999999999999999999999864 568999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++...+ ..+++.++++|+.||+.||+|||+++ |+||||||+||||+.++.+
T Consensus 87 mE~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---------------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp EECCTTEEHHHHHTTCT---------------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEE
T ss_pred EEeCCCCcHHHHhhccc---------------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCce
Confidence 99999999999986542 36999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
||+|||+++......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+. .
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~------~ 222 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M 222 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------H
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH------H
Confidence 999999998775443322 233468999999999999999999999999999999998 8999865432221 1
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
..... ....+.+..++..+.+|+.+||+.||++||||.+|++.|+.+..+
T Consensus 223 -~~i~~---------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 -AFIEQ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -HHHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHc---------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111 112234455667899999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=409.48 Aligned_cols=248 Identities=26% Similarity=0.428 Sum_probs=202.3
Q ss_pred CcccccCcEEEEEEEcCC---CCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeeccC
Q 039736 340 RFLGQGGFGTVYKGMLPD---GSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYISN 414 (633)
Q Consensus 340 ~~ig~G~~G~Vy~g~~~~---g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~~~ 414 (633)
++||+|+||.||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 468999998642 33446689999999999999999999999854 567999999999
Q ss_pred CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEeecC
Q 039736 415 GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSDFG 494 (633)
Q Consensus 415 gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~DfG 494 (633)
|+|.+++... ..++|.++++|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 92 g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFG 152 (277)
T d1xbba_ 92 GPLNKYLQQN----------------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG 152 (277)
T ss_dssp EEHHHHHHHC----------------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcHHHHHhhc----------------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchh
Confidence 9999998653 46999999999999999999999998 9999999999999999999999999
Q ss_pred CCccCCCCCcce--ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 495 TSRSVPNDKTHL--TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 495 la~~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
+++......... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......+. ....
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-------~~~i-- 223 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAML-- 223 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHH--
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-------HHHH--
Confidence 998765443332 233568999999999999999999999999999999998 8999865433221 1111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLR 623 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~ 623 (633)
........+..++..+.+|+.+||+.||++|||+.||++.|+..-
T Consensus 224 -------~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 224 -------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 111122344556678999999999999999999999999888764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=412.45 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=208.8
Q ss_pred hcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
.++|+..+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 367999999999999999999998888999999875432 3467999999999999999999999985 45689999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++..... ..++|.+++.|+.||+.||+|||+++ |+||||||+|||||.++++||+|
T Consensus 94 ~~g~l~~~~~~~~~--------------~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~D 156 (285)
T d1fmka3 94 SKGSLLDFLKGETG--------------KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 156 (285)
T ss_dssp TTCBHHHHHSHHHH--------------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCchhhhhhhccc--------------ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcc
Confidence 99999998876432 46999999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+++..............||+.|+|||++..+.++.++||||||++||||++|+.|+........ ....
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-----~~~~----- 226 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ----- 226 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHH-----
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHH-----
Confidence 999987754444444456789999999999999999999999999999999997777543322111 1111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
+......+.+..++.++.+|+.+||+.||++||+|++|+++|+....+.
T Consensus 227 -----i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 227 -----VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----HHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111223345556678999999999999999999999999999877554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=408.94 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=203.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+++.+|+++|++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5789999999999999999996 468999999986533 23345789999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+
T Consensus 85 ~~gg~L~~~l~~~----------------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~ 145 (271)
T d1nvra_ 85 CSGGELFDRIEPD----------------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKIS 145 (271)
T ss_dssp CTTEEGGGGSBTT----------------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEEC
T ss_pred cCCCcHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEc
Confidence 9999999999653 35999999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCC-cceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 492 DFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 492 DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|||+|+...... ........||+.|||||.+.+..+ +.++|||||||+||||++|+.||......... +....
T Consensus 146 DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~ 220 (271)
T d1nvra_ 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWK 220 (271)
T ss_dssp CCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHH
T ss_pred cchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HHHHh
Confidence 999998764332 223345679999999999988776 57899999999999999999999654322110 01111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 221 ~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 221 EKK---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTC---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCC---------CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 110 0011112334677899999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=408.79 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=197.8
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee--CCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE--TEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~LV 408 (633)
++|+..+.||+|+||.||+|+. .+|+.||||++... +....+.+.+|+++|++++||||+++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999985 47899999987653 44556789999999999999999999999875 3468999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC--CCCeeccCCCCCCeeecCCC
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA--SIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~--~~~ivHrDIk~~NILl~~~~ 486 (633)
|||+++|+|.+++...... ...+++..++.++.||+.||+|||+.+ ..+|+||||||+||||+.++
T Consensus 84 mEy~~~g~L~~~i~~~~~~------------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE------------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH------------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EecCCCCcHHHHHHhcccc------------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 9999999999998654321 357999999999999999999999875 23499999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
.+||+|||+++...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||......+ ...
T Consensus 152 ~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~ 224 (269)
T d2java1 152 NVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAG 224 (269)
T ss_dssp CEEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHH
T ss_pred cEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHH
Confidence 99999999998764432 22345679999999999999999999999999999999999999996543322 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
... .+.. ...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~i~-~~~~---------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 KIR-EGKF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHH-HTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-cCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 1111 1233445578999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-50 Score=408.28 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=208.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999995 479999999987655555678999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|
T Consensus 100 ~gg~L~~~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~D 159 (293)
T d1yhwa1 100 AGGSLTDVVTE-----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTD 159 (293)
T ss_dssp TTCBHHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred CCCcHHHHhhc-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeecc
Confidence 99999887643 36999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHhhc
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAKEN 572 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 572 (633)
||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ........
T Consensus 160 FG~a~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~ 232 (293)
T d1yhwa1 160 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG 232 (293)
T ss_dssp CTTCEECCSTTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC
T ss_pred chhheeeccccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC
Confidence 999987644332 23445799999999999999999999999999999999999999964432221 11111111
Q ss_pred hhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 573 KLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 573 ~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 233 T--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp S--------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred C--------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0011223445778999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=401.11 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=207.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57889999999999999999964 68999999876422 233567889999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++++|
T Consensus 86 Ey~~~g~L~~~l~~~----------------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----------------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp ECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEE
T ss_pred eecCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEe
Confidence 999999999998643 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+...... .....||+.|||||.+.+..++.++|||||||+||||++|+.||......+. +....
T Consensus 147 l~DFG~a~~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 217 (263)
T d2j4za1 147 IADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRIS 217 (263)
T ss_dssp ECCCCSCSCCCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred ecccceeeecCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHHHH
Confidence 99999998765432 2345799999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 218 ~~-----------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 218 RV-----------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TT-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cC-----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11 112233455778999999999999999999999863
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=416.67 Aligned_cols=270 Identities=26% Similarity=0.468 Sum_probs=209.9
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC-C-----CEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD-G-----SIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~-g-----~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
.++|+..+.||+|+||.||+|+... + ..||||++... .......|.+|+.+|+++ +|||||+++|++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4688899999999999999998642 2 36999987653 334456789999999998 89999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHH-------HHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQE-------QKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKS 477 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~-------~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~ 477 (633)
.++||||+++|+|.++++..+.... .............++|..++.|+.||+.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976542110 0001111122346999999999999999999999998 99999999
Q ss_pred CCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCch
Q 039736 478 SNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTRE 555 (633)
Q Consensus 478 ~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~ 555 (633)
+|||++.++++||+|||+|+........ ......||+.|||||.+.++.++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443332 3344668999999999999999999999999999999998 8999864332
Q ss_pred hhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 039736 556 EEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLE 620 (633)
Q Consensus 556 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~ 620 (633)
... +.. ++......+.+...+..+.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~~~------~~~---------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN------FYK---------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH------HHH---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH------HHH---------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 111 11122223345556678999999999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6e-50 Score=411.88 Aligned_cols=278 Identities=24% Similarity=0.380 Sum_probs=216.3
Q ss_pred HHHHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEe
Q 039736 328 ELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCL 400 (633)
Q Consensus 328 el~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~ 400 (633)
+++...++|+..+.||+|+||.||+|+.. +++.||||+++.. .....++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999853 3578999998753 3344668999999999999999999999999
Q ss_pred eCCceEEEEeeccCCCchhhcchhhhhHHHHHH--------HHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeec
Q 039736 401 ETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQE--------LEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFH 472 (633)
Q Consensus 401 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~--------~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivH 472 (633)
+.+..+++|||+++|+|.+++............ .........++|..++.|+.|++.||+|||+++ ++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 999999999999999999999754321110000 001112346999999999999999999999999 999
Q ss_pred cCCCCCCeeecCCCcEEEeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC-CC
Q 039736 473 RDIKSSNILLDDKFSAKVSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PI 550 (633)
Q Consensus 473 rDIk~~NILl~~~~~~kI~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~-p~ 550 (633)
|||||+|||||.++++||+|||+++...... ........|++.|+|||.+.+..++.|+|||||||+||||++|.. |+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998654332 223334568899999999999999999999999999999999964 55
Q ss_pred CCCchhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 551 CLTREEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 551 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
......+. ... ..++. ....+...+..+.+|+.+||+.||++||||.||+++|++|.+
T Consensus 244 ~~~~~~e~------~~~-v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 244 YGMAHEEV------IYY-VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTSCHHHH------HHH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCHHHH------HHH-HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 44333221 111 11111 122344556789999999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=400.44 Aligned_cols=252 Identities=27% Similarity=0.469 Sum_probs=203.1
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-CceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||+|.+ .|+.||||+++.. ...+.|.+|++++++++||||++++|++.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5678889999999999999999 5889999999753 3456899999999999999999999999754 5689999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~d 146 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--------------SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD 146 (262)
T ss_dssp TTEEHHHHHHHHHH--------------HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECC
T ss_pred CCCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecc
Confidence 99999999975432 25899999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHHHHHhh
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFISLAKE 571 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 571 (633)
||+++...... ....++..|+|||++.++.++.++||||||+++|||+| |+.|+......+ ...
T Consensus 147 fg~s~~~~~~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~-------- 211 (262)
T d1byga_ 147 FGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP-------- 211 (262)
T ss_dssp CCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHH--------
T ss_pred cccceecCCCC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHH--------
Confidence 99998653322 23457899999999999999999999999999999998 677765433222 111
Q ss_pred chhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 572 NKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 572 ~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
.+......+.+...+..+.+|+.+||+.||++||||.|++++|++|+..
T Consensus 212 -----~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 212 -----RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -----HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1111222344555567899999999999999999999999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=406.81 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=207.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
+.|+..+.||+|+||.||+|.. .+|+.||||+++.......+.|.+|+++|++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999996 468999999988766667778999999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.+++... ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++++||+|
T Consensus 92 ~~g~L~~~~~~~---------------~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~D 153 (288)
T d2jfla1 92 AGGAVDAVMLEL---------------ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLAD 153 (288)
T ss_dssp TTEEHHHHHHHH---------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred CCCcHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEe
Confidence 999999987643 236999999999999999999999999 99999999999999999999999
Q ss_pred cCCCccCCCCCcceecccccCCCcCchhccc-----cCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 493 FGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQ-----SSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 493 fGla~~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|+...... .......||+.|+|||++. +..++.++|||||||+||||++|+.||......+. +..
T Consensus 154 FG~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~ 226 (288)
T d2jfla1 154 FGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLK 226 (288)
T ss_dssp CTTCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHH
T ss_pred chhhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHH
Confidence 99997643211 1223457999999999984 45688999999999999999999999865433221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... . + ....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 227 i~~~~-~-----~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 227 IAKSE-P-----P--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSC-C-----C--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHcCC-C-----C--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111 0 0 011223445788999999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=401.91 Aligned_cols=259 Identities=24% Similarity=0.414 Sum_probs=202.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC----CCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD----GSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~----g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
.++|+..+.||+|+||.||+|.... +..||||.++.. .....+.|.+|++++++++||||++++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678899999999999999998642 347999988653 3445678999999999999999999999985 567899
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
||||+++|+|.+++... ...+++..++.++.||++||.|||+++ ++||||||+||++++++.
T Consensus 85 v~E~~~~g~l~~~~~~~---------------~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~ 146 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR---------------KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDC 146 (273)
T ss_dssp EEECCTTEEHHHHHHHT---------------TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTE
T ss_pred EEEeccCCcHHhhhhcc---------------CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCc
Confidence 99999999999887543 236999999999999999999999999 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~~ 566 (633)
+||+|||+++..............||+.|+|||.+.++.++.++|||||||++|||++ |..|+......+. ..
T Consensus 147 ~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~--- 220 (273)
T d1mp8a_ 147 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG--- 220 (273)
T ss_dssp EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---
T ss_pred EEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HH---
Confidence 9999999998775544444455678999999999999999999999999999999998 8888865433221 11
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... .....+...+..+.+|+.+||+.||++|||+.||++.|+.+.+..
T Consensus 221 ~i~~~----------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 221 RIENG----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcC----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11111 112234456678999999999999999999999999999987654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=396.80 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=197.6
Q ss_pred ccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee----CCceEEEE
Q 039736 337 NQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE----TEVPVLVY 409 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~LV~ 409 (633)
+..++||+|+||+||+|... +++.||+|++... .....+.|.+|+++|++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45668999999999999964 6889999987643 45566789999999999999999999999875 23579999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec-CCCcE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD-DKFSA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~-~~~~~ 488 (633)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+
T Consensus 92 E~~~~g~L~~~l~~~----------------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~ 154 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----------------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSV 154 (270)
T ss_dssp ECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCE
T ss_pred eCCCCCcHHHHHhcc----------------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCE
Confidence 999999999998653 36999999999999999999999987 4599999999999996 58899
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++..... ......||+.|||||.+.+ .++.++|||||||+||||++|+.||....... ......
T Consensus 155 Kl~DFGla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i 225 (270)
T d1t4ha_ 155 KIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRV 225 (270)
T ss_dssp EECCTTGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHH
T ss_pred EEeecCcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHH
Confidence 99999999865332 2234679999999999865 69999999999999999999999986432221 111111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. +.. . ...+.....++.+|+.+||+.||++|||+.|++++
T Consensus 226 ~~-~~~----~----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TS-GVK----P----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TT-TCC----C----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Hc-CCC----C----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11 100 0 11122234568899999999999999999999763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=406.95 Aligned_cols=284 Identities=25% Similarity=0.376 Sum_probs=209.7
Q ss_pred CHHHHHHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEccc-cChhHHHHHHHHHHHHhcc-CCCCceEEE
Q 039736 325 TAEELQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRA-IDKTQIEQFINEVVILSQI-NHRHIVKLL 396 (633)
Q Consensus 325 ~~~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l-~H~nIv~l~ 396 (633)
+..+++...++|+..++||+|+||.||+|... +++.||||+++. ......+.+.+|..++.++ +|+||++++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34444445578999999999999999999853 346899999875 3344566788898888887 689999999
Q ss_pred EEEeeCC-ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCC
Q 039736 397 GCCLETE-VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDI 475 (633)
Q Consensus 397 g~~~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDI 475 (633)
+++.+.+ ..++||||+++|+|.++++....................++|.+++.++.||+.||+|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 9987654 589999999999999999765431111000111111346999999999999999999999999 999999
Q ss_pred CCCCeeecCCCcEEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCC-CCCCCC
Q 039736 476 KSSNILLDDKFSAKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK-KPICLT 553 (633)
Q Consensus 476 k~~NILl~~~~~~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~-~p~~~~ 553 (633)
||+||||++++++||+|||+|+........ ......||+.|+|||.+.++.++.++|||||||++|||++|. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876443322 334467999999999999999999999999999999999975 455432
Q ss_pred chhhhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 554 REEEERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 554 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
...+. +..... .......+...+..+.+|+.+||+.||++|||+.||+++|++|.+++
T Consensus 241 ~~~~~------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 241 KIDEE------FCRRLK---------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp CCSHH------HHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHH------HHHHHh---------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 22111 111111 11122334455678999999999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=406.55 Aligned_cols=257 Identities=23% Similarity=0.456 Sum_probs=206.7
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCC----EEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGS----IVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~----~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~L 407 (633)
++|+..++||+|+||+||+|.+. +|+ .||||+++.. +....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 36899999999999999999964 444 5899988653 34456789999999999999999999999976 45788
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCc
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFS 487 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~ 487 (633)
++||+.+|+|.+++... ...++|..+++|+.|||.||+|||+++ |+||||||+||||+.+++
T Consensus 88 v~e~~~~~~l~~~~~~~---------------~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~ 149 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---------------KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 149 (317)
T ss_dssp EEECCTTCBHHHHHHHT---------------SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTE
T ss_pred EEEeccCCccccccccc---------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCC
Confidence 99999999999887654 347999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCCccCCCCCcc-eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTH-LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~~~ 565 (633)
+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||+||||+| |+.|+......+.
T Consensus 150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~------- 222 (317)
T d1xkka_ 150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------- 222 (317)
T ss_dssp EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-------
T ss_pred eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-------
Confidence 999999999876543332 2334568999999999999999999999999999999999 7888754432221
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
...+........+..++..+.+|+.+||+.||++|||+.||+++|+++...
T Consensus 223 ---------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 223 ---------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---------HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111111222334455667899999999999999999999999999988643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-49 Score=404.54 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=201.7
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
+.|+..+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999995 47889999998653 2344567999999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+||||+.++++|
T Consensus 95 E~~~~g~l~~~~~~----------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----------------KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp ECCSEEHHHHHHHH----------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEE
T ss_pred EecCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEE
Confidence 99999998765533 246999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhcccc---CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS---SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFI 566 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~ 566 (633)
|+|||+|+..... ....||+.|||||++.+ +.++.++|||||||++|||++|+.||......+ .+.
T Consensus 156 l~DFG~a~~~~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~ 224 (309)
T d1u5ra_ 156 LGDFGSASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY 224 (309)
T ss_dssp ECCCTTCBSSSSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH
T ss_pred EeecccccccCCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHH
Confidence 9999999875332 23569999999999854 568999999999999999999999986433221 111
Q ss_pred HHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 567 SLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 567 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...... .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 225 ~i~~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 225 HIAQNE---------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHSC---------CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhCC---------CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 001112234567899999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=404.09 Aligned_cols=273 Identities=26% Similarity=0.421 Sum_probs=214.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCC-CC--EEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPD-GS--IVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~-g~--~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|+..+.||+|+||.||+|.+++ |. .||||+++.. .....++|.+|+++|+++ +||||++++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999753 43 5888887643 344566899999999998 799999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.++++....................++|.++++++.|||.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999765432222222222333567999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCC-CCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKK-PICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~-p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+++....... .....||..|+|||.+.++.++.++||||||+++|||++|.. |+......+ ...
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------~~~- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE- 237 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH-
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------HHH-
Confidence 9999999986532221 223458999999999999999999999999999999999765 554322211 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
.+......+.+...+..+.+|+.+||+.||++||||.||+++|+++.+..+
T Consensus 238 ---------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 238 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 111112233445566789999999999999999999999999999987653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=408.37 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=206.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.++|+..++||+|+||+||+|.. .+|+.||+|+++.. .....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999995 47899999998653 33445688999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCCeeecCCCcEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ++ |+||||||+||||++++++|
T Consensus 85 y~~gg~L~~~l~~~----------------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vk 145 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----------------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIK 145 (322)
T ss_dssp CCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEE
T ss_pred cCCCCcHHHHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEE
Confidence 99999999998653 369999999999999999999997 47 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHH-HHH-
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAY-FIS- 567 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~-~~~- 567 (633)
|+|||+|+..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....... ...
T Consensus 146 l~DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~ 222 (322)
T d1s9ja_ 146 LCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222 (322)
T ss_dssp ECCCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------
T ss_pred EeeCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCC
Confidence 9999999865321 22345799999999999999999999999999999999999999975443221100000 000
Q ss_pred ---------------------HHhhchhhhhhchhhhcc---cC-HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 ---------------------LAKENKLLEILDARVAKE---AR-EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ---------------------~~~~~~~~~~~d~~l~~~---~~-~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........+..+...... .+ ...+.++.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 223 AAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -----------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000111111100000 00 1234678899999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=400.20 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=205.2
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999996 47899999998642 2234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 88 Ey~~gg~L~~~~~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vk 148 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----------------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQ 148 (288)
T ss_dssp CCCTTEEHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEE
T ss_pred EccCCCCHHHhhhcc----------------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEE
Confidence 999999999988643 46999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCC-cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDK-THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 490 I~DfGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
|+|||+|+...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||......+ .+...
T Consensus 149 l~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i 222 (288)
T d1uu3a_ 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKI 222 (288)
T ss_dssp ECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred ecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHH
Confidence 99999998765332 223344679999999999999999999999999999999999999996543222 11111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ....+...+..+.+|+.+||+.||++|||++|+...
T Consensus 223 ~~~-----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 223 IKL-----------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HTT-----------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HcC-----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111 012333455678999999999999999999997543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=395.28 Aligned_cols=255 Identities=26% Similarity=0.446 Sum_probs=199.6
Q ss_pred cCCccCCcccccCcEEEEEEEcC--CC--CEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP--DG--SIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~--~g--~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|+++|++++||||++++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 22 37899988653 33446789999999999999999999999965 5678
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++.... ..++|..+++++.|||+||.|||+++ |+||||||+||||+.++
T Consensus 87 lv~e~~~~~~l~~~~~~~~---------------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---------------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRD 148 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---------------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETT
T ss_pred eeeeeecCcchhhhhhccc---------------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhcccccc
Confidence 9999999999998876542 36999999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcc--eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~l~~ 563 (633)
.+||+|||+++........ ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------ 222 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ 222 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------
Confidence 9999999999987544332 2233557889999999999999999999999999999998 899986443322
Q ss_pred HHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhh
Q 039736 564 YFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGL 622 (633)
Q Consensus 564 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i 622 (633)
....+... ....+.+...+..+.+|+.+||+.||++||||.||.+.|.+.
T Consensus 223 ~~~~i~~~---------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 223 ILHKIDKE---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhC---------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122211 111223344557899999999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=399.02 Aligned_cols=255 Identities=27% Similarity=0.483 Sum_probs=207.3
Q ss_pred CCcccccCcEEEEEEEcCCC----CEEEEEEccc-cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-CceEEEEeec
Q 039736 339 SRFLGQGGFGTVYKGMLPDG----SIVAVKRSRA-IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET-EVPVLVYEYI 412 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~g----~~vAVK~~~~-~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-~~~~LV~E~~ 412 (633)
.++||+|+||+||+|.+.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 2699999874 4566678999999999999999999999998764 5789999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEee
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVSD 492 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~D 492 (633)
++|+|.++++.. ...+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|
T Consensus 112 ~~g~l~~~~~~~---------------~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~D 173 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---------------THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD 173 (311)
T ss_dssp TTCBHHHHHHCT---------------TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred ecCchhhhhccc---------------cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEec
Confidence 999999998654 236889999999999999999999998 99999999999999999999999
Q ss_pred cCCCccCCCCCcc---eecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 493 FGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 493 fGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
||+++........ ......||..|+|||.+..+.++.++||||||+++|||++|+.|+....... +. .....
T Consensus 174 FG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~---~~~i~ 248 (311)
T d1r0pa_ 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DI---TVYLL 248 (311)
T ss_dssp SGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C---HHHHH
T ss_pred ccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HH---HHHHH
Confidence 9999876443222 2233568999999999999999999999999999999999888875322111 11 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
. + .....+..++..+.+|+.+||+.||++||+|.||+++|+++..+.
T Consensus 249 ~-g---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 249 Q-G---------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp T-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred c-C---------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1 1 111233445578999999999999999999999999999998775
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.4e-48 Score=403.97 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=210.8
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|+..+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999995 47899999999877677778899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec--CCCcEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD--DKFSAK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~k 489 (633)
+++|+|.+++... ...+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+|
T Consensus 105 ~~gg~L~~~l~~~---------------~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vk 166 (350)
T d1koaa2 105 MSGGELFEKVADE---------------HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELK 166 (350)
T ss_dssp CCSCBHHHHHTCT---------------TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEE
T ss_pred CCCCCHHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEE
Confidence 9999999998643 236999999999999999999999999 99999999999996 468899
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++....... .....||+.|||||++.+..++.++|||||||++|||++|+.||......+. +....
T Consensus 167 L~DFG~a~~~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 238 (350)
T d1koaa2 167 LIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVK 238 (350)
T ss_dssp ECCCTTCEECCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred Eeecchheecccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999999987654332 3345799999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... ...........+..+.+|+.+||+.||++|||+.|++++
T Consensus 239 ~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 SCD-------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HTC-------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred hCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 000111112334678899999999999999999999885
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=398.05 Aligned_cols=273 Identities=26% Similarity=0.403 Sum_probs=210.4
Q ss_pred hcCCccCCcccccCcEEEEEEEcCC--------CCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeC
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLPD--------GSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLET 402 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~~--------g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 402 (633)
.++|...+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +|||||+++|+|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3678889999999999999998522 247999998763 345567899999999888 899999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..++||||+++|+|.+++.....................+++.++++++.||+.||+|||+++ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 9999999999999999999765432111111111122457999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHh-CCCCCCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLT-GKKPICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~ellt-G~~p~~~~~~~~~~~ 560 (633)
+.++.+||+|||+++....... .......|++.|+|||.+.++.++.|+||||||+++|||++ |..|+.......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999987744332 22344568999999999999999999999999999999998 677765333221
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
... .+........+...+..+.+|+.+||+.||++|||+.||++.|++|.+
T Consensus 246 ----~~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ----LFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 111122223344556789999999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=400.54 Aligned_cols=273 Identities=25% Similarity=0.408 Sum_probs=219.3
Q ss_pred HHHHhcCCccCCcccccCcEEEEEEEcC------CCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEee
Q 039736 329 LQRATDNYNQSRFLGQGGFGTVYKGMLP------DGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLE 401 (633)
Q Consensus 329 l~~~~~~~~~~~~ig~G~~G~Vy~g~~~------~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~ 401 (633)
++...++|...+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3344578899999999999999999863 3578999998753 44555679999999999999999999999999
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
++..++||||+++|+|.+++....... ........++|..+++++.|+|+||.|||+++ |+||||||+|||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL 165 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAM------ANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 165 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHH------HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred CCceeEEEeecCCCCHHHHHHhccccc------ccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence 999999999999999999997654321 11122456899999999999999999999998 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCcce-ecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCC-CCCCCCchhhhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKTHL-TTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGK-KPICLTREEEER 559 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~-~p~~~~~~~~~~ 559 (633)
+++++++||+|||+++......... .....||+.|+|||.+.++.++.++||||||++||||+||. .|+......+
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-- 243 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-- 243 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998764433322 23346899999999999999999999999999999999985 5554332221
Q ss_pred cHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 560 NLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 560 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
.+..... + ...+.+..++..+.+|+.+||+.||++||||.||+++|++..+..
T Consensus 244 ----~~~~i~~-~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 244 ----VLRFVME-G---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp ----HHHHHHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred ----HHHHHHh-C---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111 1 112234455678999999999999999999999999999876543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-48 Score=398.17 Aligned_cols=252 Identities=25% Similarity=0.350 Sum_probs=192.3
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC-hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID-KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
.+.|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999964 68999999986533 2234568899999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec---CCCc
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DKFS 487 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~ 487 (633)
|+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ +++.
T Consensus 88 ~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~ 148 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----------------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSK 148 (307)
T ss_dssp CCCSCBHHHHHHTC----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCC
T ss_pred ccCCCcHHHhhhcc----------------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCce
Confidence 99999999998642 46999999999999999999999999 99999999999994 5789
Q ss_pred EEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 488 AKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 488 ~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
+||+|||+++...... ......||+.|||||.+.+..++.++|||||||+||||++|+.||......+. ...
T Consensus 149 vkl~DFG~a~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~ 220 (307)
T d1a06a_ 149 IMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQ 220 (307)
T ss_dssp EEECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH
T ss_pred EEEeccceeEEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH------HHH
Confidence 9999999998764332 22345799999999999999999999999999999999999999965433221 111
Q ss_pred HHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 568 LAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 568 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
..... ...........+..+.+|+.+||+.||++|||+.|++++
T Consensus 221 i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAE-------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhccC-------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111 001111223445678999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-47 Score=400.57 Aligned_cols=252 Identities=22% Similarity=0.313 Sum_probs=210.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEeec
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEYI 412 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~~ 412 (633)
++|+..+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++||||+++++++.+++..|+||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999995 479999999988766666678899999999999999999999999999999999999
Q ss_pred cCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec--CCCcEEE
Q 039736 413 SNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD--DKFSAKV 490 (633)
Q Consensus 413 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~--~~~~~kI 490 (633)
++|+|.+++.... ..+++.+++.|+.||+.||.|||+++ |+||||||+||||+ .++++||
T Consensus 109 ~gg~L~~~~~~~~---------------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL 170 (352)
T d1koba_ 109 SGGELFDRIAAED---------------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKI 170 (352)
T ss_dssp CCCBHHHHTTCTT---------------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEE
T ss_pred CCChHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEE
Confidence 9999998876532 36999999999999999999999999 99999999999998 6789999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
+|||+|+....... .....||+.|+|||++.+..++.++||||+||+||||++|+.||......+. +.....
T Consensus 171 ~DFGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~ 242 (352)
T d1koba_ 171 IDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKR 242 (352)
T ss_dssp CCCTTCEECCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH
T ss_pred eecccceecCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh
Confidence 99999988754332 3345689999999999999999999999999999999999999965433221 111111
Q ss_pred hchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
. +...........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 243 ~-------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 C-------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp C-------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred C-------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0111112223445678999999999999999999999874
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=395.52 Aligned_cols=275 Identities=25% Similarity=0.377 Sum_probs=217.3
Q ss_pred hcCCccCCcccccCcEEEEEEEc------CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhcc-CCCCceEEEEEEeeCCc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML------PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQI-NHRHIVKLLGCCLETEV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~------~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~ 404 (633)
.++|+..++||+|+||.||+|++ .+++.||||+++.. .......|.+|+.+++++ +|||||+++|++.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 46888899999999999999985 24568999998753 345566899999999999 69999999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHH--HHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQ--ELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
.++||||+++|+|.++++.......... ..........+++..+++++.||++||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 9999999999999999976543111000 0001112347999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCc-ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCC-CCCCchhhhhc
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKT-HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKP-ICLTREEEERN 560 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p-~~~~~~~~~~~ 560 (633)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+|++.| +......+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 9999999999999998754433 333456799999999999999999999999999999999995544 433222111
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhh
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRS 625 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s 625 (633)
+.++++.......+...+..+.+|+.+||+.||++||||.||+++|+++..+
T Consensus 257 -------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1122222233334445567899999999999999999999999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=390.63 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=206.1
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC------hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCce
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID------KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVP 405 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 405 (633)
.++|+..+.||+|+||.||+|.. .+|+.||||+++... ....+.|.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999996 478999999875421 12356899999999999999999999999999999
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCC
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDK 485 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~ 485 (633)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----------------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----------------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 149 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCS
T ss_pred EEEEEcCCCccccchhccc----------------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecC
Confidence 9999999999999998653 36999999999999999999999999 9999999999999877
Q ss_pred C----cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 486 F----SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 486 ~----~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
+ .+||+|||+++....... .....||+.|+|||.+.+..++.++|||||||+||||++|+.||......+.
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--- 224 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--- 224 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---
T ss_pred CCcccceEecchhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---
Confidence 6 599999999987643322 2345689999999999999999999999999999999999999975443221
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
+....... .......+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 225 ---~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 ---LANVSAVN-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ---HHHHHTTC-------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---HHHHHhcC-------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111110 000011112234678899999999999999999999863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=391.99 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=201.9
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHH--HHHHHhccCCCCceEEEEEEeeCC----ceEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFIN--EVVILSQINHRHIVKLLGCCLETE----VPVL 407 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~--Ei~il~~l~H~nIv~l~g~~~~~~----~~~L 407 (633)
++|...+.||+|+||.||+|++ +|+.||||+++... .+++.. |+..+.+++||||++++|++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4567788999999999999998 68999999986532 234444 445556789999999999998754 4789
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcC-----CCCeeccCCCCCCeee
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAA-----SIPIFHRDIKSSNILL 482 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~-----~~~ivHrDIk~~NILl 482 (633)
||||+++|+|.+++++ ..++|.++++++.|+|.||+|||+.. ..+|+||||||+||||
T Consensus 79 v~Ey~~~g~L~~~l~~-----------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl 141 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred EEecccCCCHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence 9999999999999964 25899999999999999999999741 2349999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcc---eecccccCCCcCchhccccCC------CCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTH---LTTAVQGTFGYFDPEYFQSSQ------YTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~~------~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
+.++++||+|||+++........ ......||+.|+|||++.+.. ++.|+|||||||+||||+||..|+...
T Consensus 142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 99999999999999876433322 223467999999999987643 577999999999999999998886432
Q ss_pred chhhh--------hcHHHHHHHHHhhchhhhhhchhhhccc-CHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhh
Q 039736 554 REEEE--------RNLVAYFISLAKENKLLEILDARVAKEA-REEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRR 624 (633)
Q Consensus 554 ~~~~~--------~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~ 624 (633)
..... .............+. ++|.+.... +.+....+.+|+.+||+.||++|||+.||++.|++|..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccchhhcccccchHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 21110 001111111111111 122221111 23456779999999999999999999999999999986
Q ss_pred hc
Q 039736 625 SQ 626 (633)
Q Consensus 625 s~ 626 (633)
..
T Consensus 298 ~~ 299 (303)
T d1vjya_ 298 QE 299 (303)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.3e-47 Score=384.61 Aligned_cols=259 Identities=28% Similarity=0.393 Sum_probs=204.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCc----
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEV---- 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~---- 404 (633)
.++|+..+.||+|+||.||+|.. .+|+.||||+++.. +....+.|.+|++++++++||||+++++++..++.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999995 47899999998642 34456689999999999999999999999986543
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----------------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----------------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISA 146 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred EEEEEECCCCCEehhhhccc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCc
Confidence 78999999999999887543 46999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCC--cceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDK--THLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
++..+|+|||.+....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~----- 221 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----- 221 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----
Confidence 9999999999987653322 223345679999999999999999999999999999999999999996543322
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHHHhhh
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-TMKQVSMDLEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-t~~ev~~~L~~i~ 623 (633)
.+......... .........+..+.+++.+||+.||++|| |++|+.+.|.++.
T Consensus 222 -~~~~~~~~~~~-------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 222 -VAYQHVREDPI-------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHHCCCC-------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCC-------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11112211111 01112233457789999999999999999 8999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=389.57 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=208.7
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
.++|+..+.||+|+||.||+++. .+|+.||||+++.. .....+.+.+|+++|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999995 47999999998642 233467789999999999999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++++
T Consensus 84 ~ey~~gg~L~~~~~~~----------------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~v 144 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE----------------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp EECCTTCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred eeccCCCchhhhhhcc----------------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCE
Confidence 9999999999988653 36899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+|+....... ......||+.|+|||++.+..++.++||||+||+||||++|+.||......+. +...
T Consensus 145 kl~DFG~a~~~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~------~~~i 217 (337)
T d1o6la_ 145 KITDFGLCKEGISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELI 217 (337)
T ss_dssp EECCCTTCBCSCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred EEeecccccccccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH------HHHH
Confidence 9999999987643322 23446799999999999999999999999999999999999999976543221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
.. . ....+...+.++.+|+.+||+.||++||+ +.|++++
T Consensus 218 ~~-~----------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 218 LM-E----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HH-C----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred hc-C----------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11 1 01233445567889999999999999995 7888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-46 Score=387.66 Aligned_cols=245 Identities=26% Similarity=0.383 Sum_probs=206.3
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5789999999999999999995 46899999998642 2234668899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+++|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++++|
T Consensus 84 E~~~gg~l~~~~~~~----------------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----------------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp CCCCSCBHHHHHHHT----------------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEE
T ss_pred eecCCcccccccccc----------------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEE
Confidence 999999998888653 46889999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+...... ....||+.|||||.+.+..++.++|||||||+||||++|+.||......+. .....
T Consensus 145 L~DFG~a~~~~~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~ 214 (316)
T d1fota_ 145 ITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKIL 214 (316)
T ss_dssp ECCCSSCEECSSCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred EecCccceEecccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHH
Confidence 99999998764332 346799999999999999999999999999999999999999965433221 11111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
.. ....+...+..+.+++.+||+.||.+|| |++|++++
T Consensus 215 ~~-----------~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 215 NA-----------ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HC-----------CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred cC-----------CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11 0122334456788999999999999996 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-46 Score=376.88 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=204.8
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccC---------hhHHHHHHHHHHHHhccC-CCCceEEEEEEeeC
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAID---------KTQIEQFINEVVILSQIN-HRHIVKLLGCCLET 402 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~---------~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~ 402 (633)
++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6889999999999999999995 478999999876422 122346889999999997 99999999999999
Q ss_pred CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeee
Q 039736 403 EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILL 482 (633)
Q Consensus 403 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl 482 (633)
+..||||||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----------------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill 143 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----------------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILL 143 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred cceEEEEEcCCCchHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEE
Confidence 9999999999999999999642 46999999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhcccc------CCCCcccchhhHHHHHHHHHhCCCCCCCCchh
Q 039736 483 DDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS------SQYTDKSDVYSFGVVLLELLTGKKPICLTREE 556 (633)
Q Consensus 483 ~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~ 556 (633)
+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||......
T Consensus 144 ~~~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 144 DDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp CTTCCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCCCeEEccchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 9999999999999987654322 234579999999999853 34688999999999999999999999754432
Q ss_pred hhhcHHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 557 EERNLVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 557 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.. ........ . ..........+.++.+|+.+||+.||++|||+.||+++
T Consensus 222 ~~------~~~i~~~~-~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 222 LM------LRMIMSGN-Y------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HH------HHHHHHTC-C------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HH------HHHHHhCC-C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 21 11111111 0 00111122345678999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-45 Score=385.77 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=205.8
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc---ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI---DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~ 409 (633)
++|+..+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999996 47999999987642 2234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAK 489 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~k 489 (633)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++++|
T Consensus 121 e~~~~g~l~~~l~~~----------------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ik 181 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----------------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181 (350)
T ss_dssp ECCTTCBHHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ccccccchhhhHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEE
Confidence 999999999988653 36999999999999999999999999 99999999999999999999
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+|+...... ....||+.|||||++.+..++.++|||||||+||||++|+.||....... ......
T Consensus 182 L~DFG~a~~~~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~ 251 (350)
T d1rdqe_ 182 VTDFGFAKRVKGRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV 251 (350)
T ss_dssp ECCCTTCEECSSCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred eeeceeeeeccccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHh
Confidence 99999998764322 34579999999999999999999999999999999999999996543221 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSM 617 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~ 617 (633)
... ...+...+..+.+|+.+||+.||.+|+ |+.|+++
T Consensus 252 ~~~-----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 252 SGK-----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HCC-----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCC-----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 110 112334456789999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=381.51 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=206.0
Q ss_pred hcCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.++|...+.||+|+||.||+|... +|+.||||.++.... +...+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999964 688999999876443 345688999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC--CCcEE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD--KFSAK 489 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~--~~~~k 489 (633)
+++|+|.+++.... ..+++.++..|+.||+.||+|||+++ |+||||||+|||++. ..++|
T Consensus 83 ~~gg~L~~~i~~~~---------------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ik 144 (321)
T d1tkia_ 83 ISGLDIFERINTSA---------------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIK 144 (321)
T ss_dssp CCCCBHHHHHTSSS---------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEE
T ss_pred CCCCcHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEE
Confidence 99999999996532 26999999999999999999999999 999999999999985 45899
Q ss_pred EeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 490 VSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 490 I~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
|+|||+++...... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+ .+....
T Consensus 145 l~DFG~~~~~~~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~ 216 (321)
T d1tkia_ 145 IIEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIM 216 (321)
T ss_dssp ECCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH
T ss_pred EcccchhhccccCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 99999998764432 2334568999999999999999999999999999999999999996544322 111111
Q ss_pred hhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
... . .++... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 217 ~~~-~--~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 217 NAE-Y--TFDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTC-C--CCCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCC-C--CCChhh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 110 0 001111 11234568899999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-45 Score=387.72 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=199.4
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccC---hhHHHHH---HHHHHHHhccCCCCceEEEEEEeeCCceE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAID---KTQIEQF---INEVVILSQINHRHIVKLLGCCLETEVPV 406 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~---~~~~~~~---~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 406 (633)
++|+..+.||+|+||.||+|+.. +|+.||||++.... ......+ .+|+.+++.++||||+++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999954 68999999875321 1112233 34577888889999999999999999999
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++
T Consensus 84 ivmE~~~gg~L~~~l~~~----------------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g 144 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----------------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHG 144 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSS
T ss_pred EEEEecCCCcHHHHHHhc----------------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCC
Confidence 999999999999998653 35899999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+|+...... .....||+.|+|||++..+ .++.++|||||||+||||++|+.||........ ....
T Consensus 145 ~iKl~DFGla~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~ 218 (364)
T d1omwa3 145 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEID 218 (364)
T ss_dssp CEEECCCTTCEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHH
T ss_pred cEEEeeeceeeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 99999999998764432 2345699999999999754 589999999999999999999999965432221 1110
Q ss_pred HHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 039736 566 ISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPT-----MKQVSMD 618 (633)
Q Consensus 566 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt-----~~ev~~~ 618 (633)
. .. .. .....+...+..+.+|+.+||+.||++||| +.|++++
T Consensus 219 ~-~~--------~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 219 R-MT--------LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp H-HS--------SS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred H-hc--------cc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0 00 00 011223345567899999999999999999 6888753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-46 Score=383.09 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=203.8
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEcccc---ChhHHHHHHHHHHHHh-ccCCCCceEEEEEEeeCCceEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAI---DKTQIEQFINEVVILS-QINHRHIVKLLGCCLETEVPVLV 408 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~---~~~~~~~~~~Ei~il~-~l~H~nIv~l~g~~~~~~~~~LV 408 (633)
++|...+.||+|+||+||+|+.. +|+.||||+++.. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999964 6899999998642 2234556777877765 68999999999999999999999
Q ss_pred EeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcE
Q 039736 409 YEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSA 488 (633)
Q Consensus 409 ~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~ 488 (633)
|||+++|+|.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++++
T Consensus 82 mEy~~~g~L~~~i~~~----------------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~ 142 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----------------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHI 142 (320)
T ss_dssp EECCTTCBHHHHHHHH----------------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCE
T ss_pred EeecCCCcHHHHhhcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCce
Confidence 9999999999999653 35899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISL 568 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~ 568 (633)
||+|||+++....... ......||+.|+|||.+.++.++.++|||||||++|||++|+.||........ ....
T Consensus 143 kl~DFG~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i 215 (320)
T d1xjda_ 143 KIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSI 215 (320)
T ss_dssp EECCCTTCBCCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH
T ss_pred eccccchhhhcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 9999999987643322 23345799999999999999999999999999999999999999975443221 1111
Q ss_pred HhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 039736 569 AKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMK-QVSM 617 (633)
Q Consensus 569 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~-ev~~ 617 (633)
.. . ....+...+..+.+|+.+||+.||++||++. |+++
T Consensus 216 ~~-~----------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 216 RM-D----------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HH-C----------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred Hc-C----------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 1 0122334456789999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=378.85 Aligned_cols=258 Identities=22% Similarity=0.264 Sum_probs=196.4
Q ss_pred cCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhH-----HHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 338 QSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQ-----IEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 338 ~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~-----~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
.+++||+|+||+||+|... +|+.||||+++...... .+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999964 68999999986532221 24688999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
++++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~----------------~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 82 METDLEVIIKDN----------------SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp CSEEHHHHHTTC----------------CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred hcchHHhhhhhc----------------ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccc
Confidence 999887766543 246899999999999999999999999 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||+++........ .....||+.|+|||.+..+ .++.++|||||||++|||++|+.||......+. ...+.....
T Consensus 143 DFG~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~ 218 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLG 218 (299)
T ss_dssp CCGGGSTTTSCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHC
T ss_pred cCccccccCCCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcC
Confidence 99999876543322 2335689999999998754 579999999999999999999999865543321 111111111
Q ss_pred hchhhhhhchh---------hhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEILDAR---------VAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~d~~---------l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......+.+.. ..... .......+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 11000000000 00000 11234678999999999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=382.38 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=197.6
Q ss_pred hcCCccCC-cccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhcc-CCCCceEEEEEEee----CCce
Q 039736 333 TDNYNQSR-FLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQI-NHRHIVKLLGCCLE----TEVP 405 (633)
Q Consensus 333 ~~~~~~~~-~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~----~~~~ 405 (633)
.++|.... .||+|+||.||+|.. .+|+.||||+++.. +.+.+|++++.++ +||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36788765 599999999999995 57899999998652 3566899987655 89999999999875 3568
Q ss_pred EEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-
Q 039736 406 VLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD- 484 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~- 484 (633)
|+||||+++|+|.+++.... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~--------------~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~ 147 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG--------------DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSK 147 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS--------------CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCS
T ss_pred EEEEECCCCCcHHHHHHhcC--------------CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccc
Confidence 99999999999999996532 236999999999999999999999999 999999999999985
Q ss_pred --CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 --KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 --~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||........ .
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~ 222 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---S 222 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------
T ss_pred cccccccccccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---H
Confidence 56799999999987654332 2345799999999999999999999999999999999999999964322111 0
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
........... ..+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 223 PGMKTRIRMGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCCSCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhcCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000000000 000011112345778999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=373.07 Aligned_cols=268 Identities=23% Similarity=0.339 Sum_probs=201.9
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh--hHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK--TQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..++||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999995 5789999999865322 235678999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
|+.++.+ +++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~-~~~~~~~--------------~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl 143 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA--------------LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKL 143 (298)
T ss_dssp CCSEEHH-HHHHHTT--------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ecCCchh-hhhhhhc--------------ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCccee
Confidence 9976544 3332211 246999999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||+|+....... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+. +........
T Consensus 144 ~DFG~a~~~~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~ 220 (298)
T d1gz8a_ 144 ADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLG 220 (298)
T ss_dssp CSTTHHHHHCCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred ccCCcceeccCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcC
Confidence 99999987643322 233456999999999877655 57899999999999999999999975543221 111111110
Q ss_pred hh-ch-hhhhh-chhhhcc-----------cCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 039736 570 KE-NK-LLEIL-DARVAKE-----------AREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGL 622 (633)
Q Consensus 570 ~~-~~-~~~~~-d~~l~~~-----------~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i 622 (633)
.. +. ..... .+..... ........+.+|+.+||+.||++|||+.|++++ |+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00 00 00000 0000000 011234678999999999999999999999986 5444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.2e-45 Score=370.69 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=202.0
Q ss_pred cCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccC--hhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID--KTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|+..++||+|+||+||+|..++|+.||||+++... ....+++.+|+.+|++++||||+++++++.+++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5889999999999999999998889999999986532 23356899999999999999999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEEe
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKVS 491 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI~ 491 (633)
+.++.+..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 82 ~~~~~~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~ 142 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----------------EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIA 142 (286)
T ss_dssp CSEEHHHHHHTS----------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred ehhhhHHHHHhh----------------cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEec
Confidence 988777666543 246999999999999999999999998 9999999999999999999999
Q ss_pred ecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHHh
Q 039736 492 DFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLAK 570 (633)
Q Consensus 492 DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 570 (633)
|||++........ ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+. +.. ......
T Consensus 143 DfG~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~ 218 (286)
T d1ob3a_ 143 DFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILG 218 (286)
T ss_dssp CTTHHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHC
T ss_pred ccccceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhC
Confidence 9999987643322 22334589999999998754 568999999999999999999999965443221 111 111111
Q ss_pred hchhhhhh--------chhh-------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 571 ENKLLEIL--------DARV-------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 571 ~~~~~~~~--------d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......+. +... ...........+.+|+.+||+.||++|||++|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11000000 0000 011122334678899999999999999999999853
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=369.57 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=197.3
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccCh------hHHHHHHHHHHHHhccC--CCCceEEEEEEeeCCc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDK------TQIEQFINEVVILSQIN--HRHIVKLLGCCLETEV 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~------~~~~~~~~Ei~il~~l~--H~nIv~l~g~~~~~~~ 404 (633)
++|+..+.||+|+||.||+|+. .+|+.||||+++.... ....++.+|+.+|++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999995 4789999998764211 11234678999999996 8999999999999999
Q ss_pred eEEEEeeccC-CCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 405 PVLVYEYISN-GTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 405 ~~LV~E~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
.++||||+.+ +++.+++... ..+++.++..++.||+.||+|||+++ |+||||||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----------------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----------------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 144 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----------------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEE
T ss_pred EEEEEEeccCcchHHHHHhcc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEe
Confidence 9999999986 5666666432 46999999999999999999999999 99999999999998
Q ss_pred C-CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCC-CcccchhhHHHHHHHHHhCCCCCCCCchhhhhcH
Q 039736 484 D-KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQY-TDKSDVYSFGVVLLELLTGKKPICLTREEEERNL 561 (633)
Q Consensus 484 ~-~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l 561 (633)
. ++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.....
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------ 215 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------ 215 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------
T ss_pred cCCCeEEECccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------
Confidence 5 579999999999865432 2234579999999999987765 5678999999999999999999853210
Q ss_pred HHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 562 VAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 562 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
..... ...+...+.++.+|+.+||+.||++|||++|++++ |+.+.
T Consensus 216 ------i~~~~-----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 216 ------IIRGQ-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ------HHHCC-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------Hhhcc-----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 00000 11222344678999999999999999999999874 54443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=369.91 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=199.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CC-CCEEEEEEccccC--hhHHHHHHHHHHHHhcc---CCCCceEEEEEEee----
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PD-GSIVAVKRSRAID--KTQIEQFINEVVILSQI---NHRHIVKLLGCCLE---- 401 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~-g~~vAVK~~~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~---- 401 (633)
.++|+..+.||+|+||+||+|.. .+ ++.||||+++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999995 33 6679999876422 22233466777777665 79999999999863
Q ss_pred -CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCe
Q 039736 402 -TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNI 480 (633)
Q Consensus 402 -~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NI 480 (633)
....+++|||+++|++....... ...+++..+..++.|++.||+|||+++ |+||||||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NI 147 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---------------EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 147 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---------------TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cCceEEEEEEeccCCchhhhhhcc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEE
Confidence 23579999999988775444322 246899999999999999999999999 99999999999
Q ss_pred eecCCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 481 LLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 481 Ll~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
|+++++.+||+|||+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......+.
T Consensus 148 Li~~~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-- 223 (305)
T d1blxa_ 148 LVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-- 223 (305)
T ss_dssp EECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--
T ss_pred EEcCCCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--
Confidence 9999999999999999865332 223446799999999999999999999999999999999999999976543321
Q ss_pred HHHHHHHHHhhchhhhh----------h---chhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhh
Q 039736 561 LVAYFISLAKENKLLEI----------L---DARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGL 622 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~----------~---d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i 622 (633)
...+...........+ . ...............+.+|+.+||+.||++|||+.|++++ |+.+
T Consensus 224 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 224 -LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp -HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred -HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 1111111111000000 0 0000011122345678899999999999999999999875 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=362.78 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=196.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEee--------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLE-------- 401 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-------- 401 (633)
.++|+..+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36899999999999999999995 47999999987542 23345678899999999999999999999865
Q ss_pred CCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCee
Q 039736 402 TEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNIL 481 (633)
Q Consensus 402 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NIL 481 (633)
++..++||||++++.+..+... ...++...+..++.|++.||.|||+++ |+||||||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----------------~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NIL 149 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----------------LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVL 149 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred CceEEEEEeccCCCccchhhhc----------------ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchhee
Confidence 3457999999998877655433 246888999999999999999999999 999999999999
Q ss_pred ecCCCcEEEeecCCCccCCCCCc---ceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhh
Q 039736 482 LDDKFSAKVSDFGTSRSVPNDKT---HLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEE 557 (633)
Q Consensus 482 l~~~~~~kI~DfGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~ 557 (633)
++.++.+||+|||+++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+
T Consensus 150 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~ 229 (318)
T d3blha1 150 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229 (318)
T ss_dssp ECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH
Confidence 99999999999999976643222 122235689999999998764 68999999999999999999999997554333
Q ss_pred hhcHHHHHHHHHhh---chhhh--------hhchhhhcccC-------HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 558 ERNLVAYFISLAKE---NKLLE--------ILDARVAKEAR-------EEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 558 ~~~l~~~~~~~~~~---~~~~~--------~~d~~l~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... +...... ..... .+......... ......+.+|+.+||+.||++|||++|++++
T Consensus 230 ~~~~---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 230 QLAL---ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHHH---HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHH---HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 2111 1111110 00000 00000000000 1113466789999999999999999999864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=356.58 Aligned_cols=263 Identities=21% Similarity=0.257 Sum_probs=198.6
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEE-EEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKL-LGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l-~g~~~~~~~~~LV~E~ 411 (633)
++|+..+.||+|+||.||+|+. .+|+.||||.+..... .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4799999999999999999995 4689999998765322 2357789999999987765554 5555667788999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec---CCCcE
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD---DKFSA 488 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~---~~~~~ 488 (633)
+. |+|.+.+... ...+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+
T Consensus 85 ~~-~~l~~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~v 145 (299)
T d1ckia_ 85 LG-PSLEDLFNFC---------------SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 145 (299)
T ss_dssp CC-CBHHHHHHHT---------------TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCE
T ss_pred cC-Cchhhhhhhc---------------cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCcee
Confidence 94 5666555432 246999999999999999999999999 99999999999876 45679
Q ss_pred EEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 489 KVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 489 kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............
T Consensus 146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~ 225 (299)
T d1ckia_ 146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225 (299)
T ss_dssp EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence 9999999987643322 1223457999999999999999999999999999999999999999654433221111
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhc
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQ 626 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~ 626 (633)
..... .... ...+ ......+.++.+++..||+.||++||++.++.+.|+.+..+.
T Consensus 226 ~~~~~----~~~~-~~~~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 226 ERISE----KKMS-TPIE----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHH----HHHH-SCHH----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHhhc----ccCC-CChh----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 10000 0000 0001 112234467899999999999999999999999998876543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-43 Score=365.68 Aligned_cols=263 Identities=22% Similarity=0.325 Sum_probs=197.8
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc-ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC----ceE
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI-DKTQIEQFINEVVILSQINHRHIVKLLGCCLETE----VPV 406 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----~~~ 406 (633)
+++|+..++||+|+||+||+|.. .+|+.||||+++.. .....+++++|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 35799999999999999999985 47999999998753 3445678999999999999999999999997643 235
Q ss_pred EEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC
Q 039736 407 LVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF 486 (633)
Q Consensus 407 LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~ 486 (633)
++++++.+|+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 87 ~l~~~~~~g~L~~~l~~-----------------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~ 146 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTC 146 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTC
T ss_pred EEEEeecCCchhhhhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCC
Confidence 55667779999999853 36999999999999999999999999 99999999999999999
Q ss_pred cEEEeecCCCccCCCCCcc--eecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTH--LTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
.+||+|||+++........ ......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~-- 224 (345)
T d1pmea_ 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH-- 224 (345)
T ss_dssp CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--
T ss_pred CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHH--
Confidence 9999999999876432221 2234568999999999855 4578899999999999999999999976544322111
Q ss_pred HHHHHHhhch-----------hhhhhch-hhhccc-----CHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKENK-----------LLEILDA-RVAKEA-----REEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~~-----------~~~~~d~-~l~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ....... ...... .......+.+|+.+||+.||++|||+.|++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 225 -ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp -HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110000 0000000 000000 11223568899999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=367.29 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=196.5
Q ss_pred CCccCCcccccCcEEEEEEEcC-CCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------ceEE
Q 039736 335 NYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------VPVL 407 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~~~L 407 (633)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|+||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999964 689999999875432 2347999999999999999999986432 3689
Q ss_pred EEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-
Q 039736 408 VYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF- 486 (633)
Q Consensus 408 V~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~- 486 (633)
||||+++|.+..+.+.... ...+++.++..|+.||+.||+|||+++ |+||||||+|||++.++
T Consensus 97 v~Ey~~~~~~~~l~~~~~~-------------~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~ 160 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA-------------KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTA 160 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT-------------TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTC
T ss_pred EEeccCCccHHHHHhhhhc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCC
Confidence 9999987654443322111 347999999999999999999999999 99999999999999775
Q ss_pred cEEEeecCCCccCCCCCcceecccccCCCcCchhcccc-CCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHH
Q 039736 487 SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQS-SQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYF 565 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~ 565 (633)
.+||+|||+++....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +...+
T Consensus 161 ~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~ 236 (350)
T d1q5ka_ 161 VLKLCDFGSAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII 236 (350)
T ss_dssp CEEECCCTTCEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHH
T ss_pred ceeEecccchhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHH
Confidence 899999999987644332 233568999999998765 5689999999999999999999999965543321 11111
Q ss_pred HHHHhhc---hhhhhhc------------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 566 ISLAKEN---KLLEILD------------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 566 ~~~~~~~---~~~~~~d------------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
...... .+.+... ..............+.+|+.+||+.||++|||+.|++++ ++++.
T Consensus 237 -~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 237 -KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -HHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred -HHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 111100 0000000 000111122345678999999999999999999999974 55554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-42 Score=352.22 Aligned_cols=264 Identities=18% Similarity=0.194 Sum_probs=207.4
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccCC-CCceEEEEEEeeCCceEEEEee
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEVPVLVYEY 411 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~g~~~~~~~~~LV~E~ 411 (633)
++|...+.||+|+||.||+|+. .+|+.||||.+..... .+.+.+|+++++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5789999999999999999995 4689999998755322 2356788999999975 8999999999999999999999
Q ss_pred ccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC-----CC
Q 039736 412 ISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD-----KF 486 (633)
Q Consensus 412 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~-----~~ 486 (633)
+ +|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++. ++
T Consensus 83 ~-~~~l~~~~~~~~---------------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~ 143 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---------------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNAN 143 (293)
T ss_dssp C-CCBHHHHHHHTT---------------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTT
T ss_pred c-CCCHHHHHHhhc---------------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCC
Confidence 8 689988876532 36999999999999999999999999 999999999999974 57
Q ss_pred cEEEeecCCCccCCCCCc------ceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhc
Q 039736 487 SAKVSDFGTSRSVPNDKT------HLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERN 560 (633)
Q Consensus 487 ~~kI~DfGla~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~ 560 (633)
.+||+|||+|+....... .......||+.|||||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 144 ~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~ 223 (293)
T d1csna_ 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223 (293)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred ceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH
Confidence 899999999987643211 12234579999999999999999999999999999999999999996543322211
Q ss_pred HHHHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHHHHhhhhhcc
Q 039736 561 LVAYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMDLEGLRRSQR 627 (633)
Q Consensus 561 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~L~~i~~s~~ 627 (633)
....+......... .+.....+.++.+++..|++.+|++||+++.+.+.|+++....+
T Consensus 224 ~~~~i~~~~~~~~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 224 KYERIGEKKQSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHhccCCCCh---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 11111111000000 11112234678999999999999999999999999998876554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=364.46 Aligned_cols=263 Identities=21% Similarity=0.323 Sum_probs=196.5
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCC------
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLETE------ 403 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 403 (633)
.++|+..++||+|+||+||+|.. .+|+.||||+++. .+....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999995 4699999999874 34455678999999999999999999999998654
Q ss_pred ceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeec
Q 039736 404 VPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLD 483 (633)
Q Consensus 404 ~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~ 483 (633)
..++||||+ +++|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~ 155 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVN 155 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEC
T ss_pred eEEEEEecc-cccHHHHHHh-----------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcc
Confidence 469999999 4566555432 36999999999999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 484 DKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 484 ~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
.++.+|++|||+++...... ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..........
T Consensus 156 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~-- 229 (346)
T d1cm8a_ 156 EDCELKILDFGLARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK-- 229 (346)
T ss_dssp TTCCEEECCCTTCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred cccccccccccceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH--
Confidence 99999999999998764332 345689999999998764 56899999999999999999999997654332111
Q ss_pred HHHHHHHhhc--hhhh--------hhchhh-------hcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--HHhhh
Q 039736 563 AYFISLAKEN--KLLE--------ILDARV-------AKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD--LEGLR 623 (633)
Q Consensus 563 ~~~~~~~~~~--~~~~--------~~d~~l-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~--L~~i~ 623 (633)
.. ....... ...+ .....+ ...........+.+|+.+||+.||++|||+.|++++ |+.+.
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 230 EI-MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HH-HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HH-HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 11 1100000 0000 000000 001112234677899999999999999999999986 66554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=360.25 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=203.4
Q ss_pred cCCccCCcccccCcEEEEEEEc----CCCCEEEEEEcccc----ChhHHHHHHHHHHHHhccCC-CCceEEEEEEeeCCc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML----PDGSIVAVKRSRAI----DKTQIEQFINEVVILSQINH-RHIVKLLGCCLETEV 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~----~~g~~vAVK~~~~~----~~~~~~~~~~Ei~il~~l~H-~nIv~l~g~~~~~~~ 404 (633)
++|+..+.||+|+||+||+|.. .+|+.||||+++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999984 25789999987542 12234567899999999977 899999999999999
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.+++|||+.+|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----------------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----------------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDS 164 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeeecccccHHHHHHHhc----------------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecC
Confidence 99999999999999998654 35788899999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC--CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS--QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLV 562 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~ 562 (633)
++.+||+|||+++..............|++.|+|||.+.+. .++.++|||||||+||||++|+.||........ ..
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~ 242 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QA 242 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HH
T ss_pred CCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence 99999999999987654444444556799999999998754 467899999999999999999999865432221 11
Q ss_pred HHHHHHHhhchhhhhhchhhhcccCHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 039736 563 AYFISLAKENKLLEILDARVAKEAREEDIEAVAELAMGCLRLNSKKRP-----TMKQVSMD 618 (633)
Q Consensus 563 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RP-----t~~ev~~~ 618 (633)
........ .....+...+..+.+|+.+||+.||++|| |++|++++
T Consensus 243 ~i~~~~~~-----------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 243 EISRRILK-----------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHH-----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHhccc-----------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11111000 01123445667899999999999999999 47888763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=350.24 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=204.3
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeCCceEEEEe
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLETEVPVLVYE 410 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~LV~E 410 (633)
++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+++.+|+.+|++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 47899999997643 33456789999999999999999999999999999999999
Q ss_pred eccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCCcEEE
Q 039736 411 YISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKFSAKV 490 (633)
Q Consensus 411 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~~~kI 490 (633)
++.+++|..++... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl 142 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----------------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142 (292)
T ss_dssp CCSEEHHHHHHHTT----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEE
T ss_pred eccccccccccccc----------------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceee
Confidence 99999888776543 46899999999999999999999999 999999999999999999999
Q ss_pred eecCCCccCCCCCcceecccccCCCcCchhccccCC-CCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHHHH
Q 039736 491 SDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQ-YTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFISLA 569 (633)
Q Consensus 491 ~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~~~ 569 (633)
+|||.++....... ......++..|+|||.+.... ++.++|||||||++|||++|+.|+....+... ....+....
T Consensus 143 ~DFG~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~ 219 (292)
T d1unla_ 143 ANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLL 219 (292)
T ss_dssp CCCTTCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHH
T ss_pred eecchhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhc
Confidence 99999987654332 222345778899999987655 68999999999999999999999754332221 111111111
Q ss_pred hhch------hhhhhch---------hhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 570 KENK------LLEILDA---------RVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 570 ~~~~------~~~~~d~---------~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.... .....+. .-...........+.+|+.+||+.||.+|||++|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1100 0000000 00001112334678899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-41 Score=352.08 Aligned_cols=255 Identities=20% Similarity=0.337 Sum_probs=196.3
Q ss_pred cCCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeC--CceEEEE
Q 039736 334 DNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLET--EVPVLVY 409 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~--~~~~LV~ 409 (633)
++|+..++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999995 478999999987643 457789999999995 99999999999754 4689999
Q ss_pred eeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecCCC-cE
Q 039736 410 EYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDDKF-SA 488 (633)
Q Consensus 410 E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~~~-~~ 488 (633)
||+++|+|..+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+
T Consensus 112 e~~~~~~L~~~~-------------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~v 169 (328)
T d3bqca1 112 EHVNNTDFKQLY-------------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKL 169 (328)
T ss_dssp ECCCSCBGGGTT-------------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred eecCCCcHHHHh-------------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCee
Confidence 999999997664 25899999999999999999999999 99999999999998654 69
Q ss_pred EEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHHHHHH
Q 039736 489 KVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVAYFIS 567 (633)
Q Consensus 489 kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~~~~~ 567 (633)
||+|||+|+....... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||......... ...+..
T Consensus 170 kl~DFG~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~ 245 (328)
T d3bqca1 170 RLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAK 245 (328)
T ss_dssp EECCGGGCEECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHH
T ss_pred eecccccceeccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHH
Confidence 9999999987644322 2345689999999998765 4789999999999999999999998654332211 001111
Q ss_pred HHhhch---------------hhhhhc--------hhhhcccCHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 039736 568 LAKENK---------------LLEILD--------ARVAKEAREEDIEAVAELAMGCLRLNSKKRPTMKQVSM 617 (633)
Q Consensus 568 ~~~~~~---------------~~~~~d--------~~l~~~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~ 617 (633)
...... ...... .............++.+|+.+||+.||++|||++|+++
T Consensus 246 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110000 000000 00000011223467889999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-41 Score=352.52 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=190.9
Q ss_pred cCCccCCcccccCcEEEEEEEcC-CCCEEEEEEccc--cChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC------Cc
Q 039736 334 DNYNQSRFLGQGGFGTVYKGMLP-DGSIVAVKRSRA--IDKTQIEQFINEVVILSQINHRHIVKLLGCCLET------EV 404 (633)
Q Consensus 334 ~~~~~~~~ig~G~~G~Vy~g~~~-~g~~vAVK~~~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------~~ 404 (633)
++|+..++||+|+||+||+|... +|+.||||+++. .+....+++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999954 699999999864 3445566899999999999999999999999643 46
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.|+||||+.++.+.. +. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.
T Consensus 97 ~~iv~Ey~~~~l~~~-~~------------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~ 154 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ------------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 154 (355)
T ss_dssp EEEEEECCSEEHHHH-HT------------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECT
T ss_pred eEEEEeccchHHHHh-hh------------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccc
Confidence 799999997665543 32 35899999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH-
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA- 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~- 563 (633)
++.+|++|||+++...... ......+|+.|+|||.+.+..+++++||||+||+++||++|+.||.............
T Consensus 155 ~~~~kl~df~~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~ 232 (355)
T d2b1pa1 155 DCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_dssp TCCEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccceeeechhhhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999988764322 2234568999999999999999999999999999999999999986543322110000
Q ss_pred ---------------HHHHHHhhc------hhhhhhchhhhc---ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 ---------------YFISLAKEN------KLLEILDARVAK---EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ---------------~~~~~~~~~------~~~~~~d~~l~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
......... ............ .........+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 000001000000 1123346778999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=352.75 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=195.9
Q ss_pred hcCCccCCcccccCcEEEEEEEc-CCCCEEEEEEcccc--ChhHHHHHHHHHHHHhccCCCCceEEEEEEeeC-----Cc
Q 039736 333 TDNYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAI--DKTQIEQFINEVVILSQINHRHIVKLLGCCLET-----EV 404 (633)
Q Consensus 333 ~~~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-----~~ 404 (633)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. +....+++.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999994 57999999998653 344566889999999999999999999998643 34
Q ss_pred eEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCCCeeecC
Q 039736 405 PVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSSNILLDD 484 (633)
Q Consensus 405 ~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~NILl~~ 484 (633)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----------------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~ 156 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----------------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 156 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eEEEEEeecCCchhhhccc-----------------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccc
Confidence 5777888899999998853 35999999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCCccCCCCCcceecccccCCCcCchhccccC-CCCcccchhhHHHHHHHHHhCCCCCCCCchhhhhcHHH
Q 039736 485 KFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSS-QYTDKSDVYSFGVVLLELLTGKKPICLTREEEERNLVA 563 (633)
Q Consensus 485 ~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDV~SfGvvL~elltG~~p~~~~~~~~~~~l~~ 563 (633)
++.+|++|||++..... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 157 ~~~~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~--- 229 (348)
T d2gfsa1 157 DCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--- 229 (348)
T ss_dssp TCCEEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred cccccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---
Confidence 99999999999976532 22345688999999987665 46889999999999999999999997654332211
Q ss_pred HHHHHHhhc--h---------hhhhhchhhh-c-----ccCHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 039736 564 YFISLAKEN--K---------LLEILDARVA-K-----EAREEDIEAVAELAMGCLRLNSKKRPTMKQVSMD 618 (633)
Q Consensus 564 ~~~~~~~~~--~---------~~~~~d~~l~-~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPt~~ev~~~ 618 (633)
.+....... . .......... . .........+.+|+.+||+.||++|||+.|++++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 111111000 0 0000000000 0 0011234668899999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-36 Score=316.03 Aligned_cols=263 Identities=21% Similarity=0.252 Sum_probs=191.0
Q ss_pred CCccCCcccccCcEEEEEEEc-CCCCEEEEEEccccChhHHHHHHHHHHHHhccC-----------CCCceEEEEEEeeC
Q 039736 335 NYNQSRFLGQGGFGTVYKGML-PDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-----------HRHIVKLLGCCLET 402 (633)
Q Consensus 335 ~~~~~~~ig~G~~G~Vy~g~~-~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-----------H~nIv~l~g~~~~~ 402 (633)
+|+..++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 588999999999999999995 47999999998753 233457788999988875 57899999988653
Q ss_pred --CceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHh-cCCCCeeccCCCCCC
Q 039736 403 --EVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHS-AASIPIFHRDIKSSN 479 (633)
Q Consensus 403 --~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~-~~~~~ivHrDIk~~N 479 (633)
...++++++...+.......... ....+++..+..++.||+.||+|||+ ++ |+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~N 156 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY-------------EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 156 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT-------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred cccceeeeeeecccccccccccccc-------------cccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhH
Confidence 45667777776655433332221 14578999999999999999999998 77 9999999999
Q ss_pred eeecCCC------cEEEeecCCCccCCCCCcceecccccCCCcCchhccccCCCCcccchhhHHHHHHHHHhCCCCCCCC
Q 039736 480 ILLDDKF------SAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFDPEYFQSSQYTDKSDVYSFGVVLLELLTGKKPICLT 553 (633)
Q Consensus 480 ILl~~~~------~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDV~SfGvvL~elltG~~p~~~~ 553 (633)
|||+.++ .+|++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||...
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 9998765 4999999999765322 23456899999999999999999999999999999999999998654
Q ss_pred chhhhhcHHHHH---HHHHhh--------c-hhhhhhc-----------------h--hhhcccCHHHHHHHHHHHHhcc
Q 039736 554 REEEERNLVAYF---ISLAKE--------N-KLLEILD-----------------A--RVAKEAREEDIEAVAELAMGCL 602 (633)
Q Consensus 554 ~~~~~~~l~~~~---~~~~~~--------~-~~~~~~d-----------------~--~l~~~~~~~~~~~l~~L~~~Cl 602 (633)
............ ...... . ......+ . .............+.+|+.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 233 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred ccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHC
Confidence 322111111111 111100 0 0000000 0 0011234567788999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 039736 603 RLNSKKRPTMKQVSMD 618 (633)
Q Consensus 603 ~~dP~~RPt~~ev~~~ 618 (633)
+.||.+|||++|++++
T Consensus 313 ~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNH 328 (362)
T ss_dssp CSSTTTCBCHHHHHTC
T ss_pred CCChhHCcCHHHHhcC
Confidence 9999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=1.2e-22 Score=193.01 Aligned_cols=163 Identities=20% Similarity=0.216 Sum_probs=121.1
Q ss_pred ccCCcccccCcEEEEEEEcCCCCEEEEEEccccC------------------hhHHHHHHHHHHHHhccCCCCceEEEEE
Q 039736 337 NQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAID------------------KTQIEQFINEVVILSQINHRHIVKLLGC 398 (633)
Q Consensus 337 ~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~------------------~~~~~~~~~Ei~il~~l~H~nIv~l~g~ 398 (633)
...++||+|+||.||+|...+|+.||||+++... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 3467899999999999998889999999764310 0112345568889999999999998866
Q ss_pred EeeCCceEEEEeeccCCCchhhcchhhhhHHHHHHHHHhhhcCCCCHHHHHHHHHHHHHHHHHhHhcCCCCeeccCCCCC
Q 039736 399 CLETEVPVLVYEYISNGTLSHHIHDHQQQQEQKQELEEEQELSSLSWENRVRVACEVAGAVAYMHSAASIPIFHRDIKSS 478 (633)
Q Consensus 399 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~~~~~ivHrDIk~~ 478 (633)
. ..+++|||++++.+.+ +++....+++.|++++|.|||+++ |+||||||+
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~ 132 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQY 132 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred c----CCEEEEEeeccccccc-----------------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChh
Confidence 3 2489999998765432 444556789999999999999999 999999999
Q ss_pred CeeecCCCcEEEeecCCCccCCCCCcceecccccCCCcCc------hhccccCCCCcccchhhHHHHH
Q 039736 479 NILLDDKFSAKVSDFGTSRSVPNDKTHLTTAVQGTFGYFD------PEYFQSSQYTDKSDVYSFGVVL 540 (633)
Q Consensus 479 NILl~~~~~~kI~DfGla~~~~~~~~~~~~~~~gt~~y~A------PE~l~~~~~s~ksDV~SfGvvL 540 (633)
|||++++ .++|+|||+|......... .|.. .|.+ ...++.++|+||..--+
T Consensus 133 NILv~~~-~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 133 NVLVSEE-GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp SEEEETT-EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred heeeeCC-CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999976 5899999999776432211 0111 1222 35678899999975443
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=99.36 E-value=8.7e-14 Score=98.51 Aligned_cols=47 Identities=21% Similarity=0.441 Sum_probs=43.6
Q ss_pred EEEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeecccccccc
Q 039736 172 LLAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPL 219 (633)
Q Consensus 172 ~~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~ 219 (633)
.++|+|++|||||+||++||+++++|++||++.++ .|++||.|.||.
T Consensus 1 ~i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~-~l~~Gq~L~IPg 47 (48)
T d1y7ma2 1 MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQA-GLTAGQSIVIPG 47 (48)
T ss_dssp CEEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCS-SCCTTCEEEETT
T ss_pred CEEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCC-CCCCCCEEEeCC
Confidence 36899999999999999999999999999999765 699999999995
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=99.32 E-value=1.6e-13 Score=96.66 Aligned_cols=46 Identities=22% Similarity=0.364 Sum_probs=42.7
Q ss_pred EEeeeccCchhhhhhhhhcccchhhccccCCCCCCceeeccccccccc
Q 039736 173 LAYMAQAGDNMSFIGNEFGVDVQSIVDANMLPNGDAIRVFTPLLIPLK 220 (633)
Q Consensus 173 ~tY~v~~gDtl~~Ia~~f~v~~~~l~~~N~~~~~~~i~~~~~l~iP~~ 220 (633)
++|+|++|||||+||++||+++++|++||++. +.|+|||.|.||++
T Consensus 3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~--~~l~~Gq~L~i~vk 48 (48)
T d1e0ga_ 3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT--ANLQPGDKLTLFVK 48 (48)
T ss_dssp CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence 58999999999999999999999999999984 46999999999974
|
| >d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Hypothetical protein YkuD, N-terminal domain species: Bacillus subtilis [TaxId: 1423]
Probab=98.96 E-value=4.6e-11 Score=84.19 Aligned_cols=45 Identities=27% Similarity=0.391 Sum_probs=40.2
Q ss_pred ccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecc
Q 039736 107 APYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVP 154 (633)
Q Consensus 107 ~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip 154 (633)
.+|+|++|||+|+|| +.|+ ++.++|+++|....+.|++||+|.||
T Consensus 2 i~y~V~~GDTL~~IA-~~y~--v~~~~i~~~N~~~~~~l~~Gq~L~IP 46 (48)
T d1y7ma2 2 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIP 46 (48)
T ss_dssp EEEECCTTCCHHHHH-HHTT--SCCCCCCCTSCTTCSSCCTTCEEEET
T ss_pred EEEEECCCCCHHHHH-HHhC--CCHHHHHHHcCCCCCCCCCCCEEEeC
Confidence 479999999999999 4574 79999999997777789999999999
|
| >d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: LysM domain superfamily: LysM domain family: LysM domain domain: Membrane-bound lytic murein transclycosylase D, MltD species: Escherichia coli [TaxId: 562]
Probab=98.94 E-value=8e-11 Score=82.59 Aligned_cols=46 Identities=20% Similarity=0.251 Sum_probs=40.1
Q ss_pred cccEEeccCCceeeehhcccCCCcchHHhhhcCCCCCCCCCCCceeecce
Q 039736 106 NAPYTTKPNDTYFLVANNTYQGLTTCQALLGQNYYDEKNLGSGVELTVPI 155 (633)
Q Consensus 106 ~~~y~v~~gdt~~~ia~~~~~~l~t~~~l~~~N~~~~~~l~~g~~l~ip~ 155 (633)
..+|+|++|||+|.|| ..|+ +++++|+++|... +.|+|||+|.||+
T Consensus 2 ~v~y~V~~GDTl~~IA-~~y~--vs~~~i~~~N~l~-~~l~~Gq~L~i~v 47 (48)
T d1e0ga_ 2 SITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNSDT-ANLQPGDKLTLFV 47 (48)
T ss_dssp CCEEEECTTCCHHHHH-HHHT--CCHHHHHHHCSCG-GGCCTTEEEECCC
T ss_pred cEEEEECCCCCHHHHH-HHHC--CCHHHHHHHcCCc-ccCcCCCEEEEEe
Confidence 3579999999999999 4575 7999999999765 4699999999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.7e-07 Score=91.02 Aligned_cols=94 Identities=14% Similarity=0.036 Sum_probs=66.3
Q ss_pred HHHHHHhcCCccCCcccccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCce
Q 039736 327 EELQRATDNYNQSRFLGQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVP 405 (633)
Q Consensus 327 ~el~~~~~~~~~~~~ig~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~ 405 (633)
.|+.+....|+..+..+.++...||+... +++.+.+|+...........+.+|...++.+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667777666555455578999876 56678889876544333445667888877764 43456788888888889
Q ss_pred EEEEeeccCCCchhhc
Q 039736 406 VLVYEYISNGTLSHHI 421 (633)
Q Consensus 406 ~LV~E~~~~gsL~~~l 421 (633)
++||+++++.++.+..
T Consensus 86 ~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEY 101 (263)
T ss_dssp EEEEECCSSEEHHHHT
T ss_pred EEEEEecccccccccc
Confidence 9999999998875543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=2.8e-05 Score=74.39 Aligned_cols=153 Identities=14% Similarity=0.101 Sum_probs=86.9
Q ss_pred ccccCc-EEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCC--CCceEEEEEEeeCCceEEEEeeccCCCch
Q 039736 342 LGQGGF-GTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINH--RHIVKLLGCCLETEVPVLVYEYISNGTLS 418 (633)
Q Consensus 342 ig~G~~-G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~~~~LV~E~~~~gsL~ 418 (633)
+..|.. +.||+...+++..+.+|........ .+..|...++.+.. -.+.+++++..+.+..++|||++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 6799999877888899986654332 35567777776642 33567888888888899999999987775
Q ss_pred hhcchhhhhHHHHHHHHHh-----hhcCCCC--HHHHHHHHH--------------------HHHHHHHHhHhc----CC
Q 039736 419 HHIHDHQQQQEQKQELEEE-----QELSSLS--WENRVRVAC--------------------EVAGAVAYMHSA----AS 467 (633)
Q Consensus 419 ~~l~~~~~~~~~~~~~~~~-----~~~~~l~--~~~~~~ia~--------------------~ia~gL~yLH~~----~~ 467 (633)
+........-......... .....+. +.....-.. .....+..+... ..
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred cccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCC
Confidence 5321111000000000000 0000000 110000000 011223333322 22
Q ss_pred CCeeccCCCCCCeeecCCCcEEEeecCCCc
Q 039736 468 IPIFHRDIKSSNILLDDKFSAKVSDFGTSR 497 (633)
Q Consensus 468 ~~ivHrDIk~~NILl~~~~~~kI~DfGla~ 497 (633)
+.++|+|+.|.||+++++..+-|.||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 348999999999999988777899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.25 E-value=0.00046 Score=70.45 Aligned_cols=77 Identities=18% Similarity=0.242 Sum_probs=49.0
Q ss_pred CCcccccCcEEEEEEEcCC-CCEEEEEEccc----c---ChhHHHHHHHHHHHHhccC-C--CCceEEEEEEeeCCceEE
Q 039736 339 SRFLGQGGFGTVYKGMLPD-GSIVAVKRSRA----I---DKTQIEQFINEVVILSQIN-H--RHIVKLLGCCLETEVPVL 407 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~-g~~vAVK~~~~----~---~~~~~~~~~~Ei~il~~l~-H--~nIv~l~g~~~~~~~~~L 407 (633)
.+.||.|....||+....+ ++.++||.-.. . .....++...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999998654 67899996332 1 1112234456777777663 2 345566654 4566789
Q ss_pred EEeeccCCCc
Q 039736 408 VYEYISNGTL 417 (633)
Q Consensus 408 V~E~~~~gsL 417 (633)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.07 E-value=0.0086 Score=58.85 Aligned_cols=148 Identities=13% Similarity=0.097 Sum_probs=78.0
Q ss_pred EEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc--eEEEE-----EEeeCCceEEEEeeccCCCchhh
Q 039736 348 GTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI--VKLLG-----CCLETEVPVLVYEYISNGTLSHH 420 (633)
Q Consensus 348 G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI--v~l~g-----~~~~~~~~~LV~E~~~~gsL~~~ 420 (633)
-.||+....+|+.+++|..+.... ..+++..|...+..|...++ +..+. ....++..+.++++++|..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 479999998999999998765322 23456678888777642222 11111 11234567889999987554321
Q ss_pred c----chhhhhHHHHHHH----------------------HHhhhcCCCCHHHHHHHHHHHHHHHHHhHhc----CCCCe
Q 039736 421 I----HDHQQQQEQKQEL----------------------EEEQELSSLSWENRVRVACEVAGAVAYMHSA----ASIPI 470 (633)
Q Consensus 421 l----~~~~~~~~~~~~~----------------------~~~~~~~~l~~~~~~~ia~~ia~gL~yLH~~----~~~~i 470 (633)
- ..-...-.+.... ........++...+-.+...+.+.++.+... ....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0000000000000 0000011122222222222233333444332 23358
Q ss_pred eccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 471 FHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 471 vHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999854 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.79 E-value=0.013 Score=59.29 Aligned_cols=74 Identities=20% Similarity=0.202 Sum_probs=48.5
Q ss_pred CCcccccCcEEEEEEEcCC--------CCEEEEEEccccChhHHHHHHHHHHHHhccC-CCCceEEEEEEeeCCceEEEE
Q 039736 339 SRFLGQGGFGTVYKGMLPD--------GSIVAVKRSRAIDKTQIEQFINEVVILSQIN-HRHIVKLLGCCLETEVPVLVY 409 (633)
Q Consensus 339 ~~~ig~G~~G~Vy~g~~~~--------g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~LV~ 409 (633)
.+.|+.|-.-.+|+....+ .+.|.+++... .... -+..+|..+++.+. +.=..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3567777778899988643 34577766542 2222 23457888888875 4333478887743 7899
Q ss_pred eeccCCCch
Q 039736 410 EYISNGTLS 418 (633)
Q Consensus 410 E~~~~gsL~ 418 (633)
||+++.+|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.78 E-value=0.02 Score=55.63 Aligned_cols=172 Identities=10% Similarity=0.064 Sum_probs=86.7
Q ss_pred cCHHHHHHHhcCCccCCcc-----cccCcEEEEEEEcCCCCEEEEEEccccChhHHHHHHHHHHHHhccCCCCc-----e
Q 039736 324 FTAEELQRATDNYNQSRFL-----GQGGFGTVYKGMLPDGSIVAVKRSRAIDKTQIEQFINEVVILSQINHRHI-----V 393 (633)
Q Consensus 324 ~~~~el~~~~~~~~~~~~i-----g~G~~G~Vy~g~~~~g~~vAVK~~~~~~~~~~~~~~~Ei~il~~l~H~nI-----v 393 (633)
.+.+|++....+|...+.. ..|---+.|+...++|+ +++|+...... .++...|++++..+...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 5678888888888775443 35555778998886554 88998754211 1233356666666532221 1
Q ss_pred EEE-E--EEeeCCceEEEEeeccCCCchhhcchhhhhHHH-------------------------HHHHHHhhhcCCCCH
Q 039736 394 KLL-G--CCLETEVPVLVYEYISNGTLSHHIHDHQQQQEQ-------------------------KQELEEEQELSSLSW 445 (633)
Q Consensus 394 ~l~-g--~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~-------------------------~~~~~~~~~~~~l~~ 445 (633)
... | +....+....++.+..+................ ...............
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 011234456677777665443221111100000 000000000111112
Q ss_pred HHHHHHHHHHHHHHHHhHhc-CCCCeeccCCCCCCeeecCCCcEEEeecCCCcc
Q 039736 446 ENRVRVACEVAGAVAYMHSA-ASIPIFHRDIKSSNILLDDKFSAKVSDFGTSRS 498 (633)
Q Consensus 446 ~~~~~ia~~ia~gL~yLH~~-~~~~ivHrDIk~~NILl~~~~~~kI~DfGla~~ 498 (633)
......+..+...+.-.+.. -...+||+|+.+.||+++++...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 22223333333333333321 123499999999999999998789999998853
|